DDI-DrugBank.d698.s0
DDI-DrugBank.d698.s0.e0_DDI-DrugBank.d698.s0.e1 false b2_3\NN\1740|for|vitamin|riboflavin (l_appos) riboflavin_5\NN\15090742|(|):
DDI-DrugBank.d698.s0.e0_DDI-DrugBank.d698.s0.e2 false b2_3\NN\1740|for|vitamin|riboflavin (r_nmod) interactions_0\NNS\37396|b2 (r_nsubj) impairs_9\VBZ\258857|interactions|alcohol|-|absorption (l_dep) alcohol_7\NN\7881800|
DDI-DrugBank.d698.s0.e0_DDI-DrugBank.d698.s0.e3 false b2_3\NN\1740|for|vitamin|riboflavin (r_nmod) interactions_0\NNS\37396|b2 (r_nsubj) impairs_9\VBZ\258857|interactions|alcohol|-|absorption (l_dobj) absorption_12\NN\13558490|the|intestinal|riboflavin (l_nmod) riboflavin_14\NN\15090742|of
DDI-DrugBank.d698.s0.e1_DDI-DrugBank.d698.s0.e2 false riboflavin_5\NN\15090742|(|): (r_appos) b2_3\NN\1740|for|vitamin|riboflavin (r_nmod) interactions_0\NNS\37396|b2 (r_nsubj) impairs_9\VBZ\258857|interactions|alcohol|-|absorption (l_dep) alcohol_7\NN\7881800|
DDI-DrugBank.d698.s0.e1_DDI-DrugBank.d698.s0.e3 false riboflavin_5\NN\15090742|(|): (r_appos) b2_3\NN\1740|for|vitamin|riboflavin (r_nmod) interactions_0\NNS\37396|b2 (r_nsubj) impairs_9\VBZ\258857|interactions|alcohol|-|absorption (l_dobj) absorption_12\NN\13558490|the|intestinal|riboflavin (l_nmod) riboflavin_14\NN\15090742|of
DDI-DrugBank.d698.s0.e2_DDI-DrugBank.d698.s0.e3 true alcohol_7\NN\7881800| (r_dep) impairs_9\VBZ\258857|interactions|alcohol|-|absorption (l_dobj) absorption_12\NN\13558490|the|intestinal|riboflavin (l_nmod) riboflavin_14\NN\15090742|of
DDI-DrugBank.d595.s7
DDI-DrugBank.d585.s3
DDI-DrugBank.d585.s3.e1_DDI-DrugBank.d585.s3.e0 false digoxin_17\NN\15060131|of (r_nmod) forms_15\NNS\6286395|such|dissolving|dosage|digoxin (r_nmod) drugs_8\NNS\14778436|of|various|,|forms (r_nmod) absorption_5\NN\13558490|gastrointestinal|drugs (r_dobj) affect_3\VB\126264|agents|may|absorption|; (l_nsubj) agents_1\NNS\7347|anticholinergic
DDI-DrugBank.d577.s4
DDI-DrugBank.d577.s4.e0_DDI-DrugBank.d577.s4.e1 true sulfamethoxazole_5\NN\4352070| (r_nsubj) produced_6\VBD\1617192|dose|,|sulfamethoxazole|increase|half-life|but|produce|. (l_nmod) half-life_14\NN\15113229|in|the|phenytoin (l_nmod) phenytoin_16\NN\3550533|of
DDI-DrugBank.d615.s0
DDI-DrugBank.d615.s0.e0_DDI-DrugBank.d615.s0.e2 true triprolidine_0\NN\1740| (r_nsubj) enhance_2\VB\227165|triprolidine|may|effects|. (l_dobj) effects_5\NNS\13245626|the|sedative|depressants (l_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates
DDI-DrugBank.d615.s0.e0_DDI-DrugBank.d615.s0.e1 true triprolidine_0\NN\1740| (r_nsubj) enhance_2\VB\227165|triprolidine|may|effects|. (l_dobj) effects_5\NNS\13245626|the|sedative|depressants (l_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol
DDI-DrugBank.d615.s0.e0_DDI-DrugBank.d615.s0.e3 true triprolidine_0\NN\1740| (r_nsubj) enhance_2\VB\227165|triprolidine|may|effects|. (l_dobj) effects_5\NNS\13245626|the|sedative|depressants (l_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics
DDI-DrugBank.d615.s0.e0_DDI-DrugBank.d615.s0.e4 true triprolidine_0\NN\1740| (r_nsubj) enhance_2\VB\227165|triprolidine|may|effects|. (l_dobj) effects_5\NNS\13245626|the|sedative|depressants (l_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics
DDI-DrugBank.d615.s0.e0_DDI-DrugBank.d615.s0.e5 true triprolidine_0\NN\1740| (r_nsubj) enhance_2\VB\227165|triprolidine|may|effects|. (l_dobj) effects_5\NNS\13245626|the|sedative|depressants (l_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives
DDI-DrugBank.d615.s0.e0_DDI-DrugBank.d615.s0.e6 true triprolidine_0\NN\1740| (r_nsubj) enhance_2\VB\227165|triprolidine|may|effects|. (l_dobj) effects_5\NNS\13245626|the|sedative|depressants (l_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers
DDI-DrugBank.d615.s0.e0_DDI-DrugBank.d615.s0.e7 true triprolidine_0\NN\1740| (r_nsubj) enhance_2\VB\227165|triprolidine|may|effects|. (l_dobj) effects_5\NNS\13245626|the|sedative|depressants (l_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers (l_conj) tranquillisers_24\NNS\4017429|
DDI-DrugBank.d615.s0.e2_DDI-DrugBank.d615.s0.e1 false alcohol_12\NN\7881800|including|,|barbiturates (r_nmod) depressants_10\NNS\3248958|of|central|nervous|system|alcohol
DDI-DrugBank.d615.s0.e2_DDI-DrugBank.d615.s0.e3 false alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics
DDI-DrugBank.d615.s0.e2_DDI-DrugBank.d615.s0.e4 false alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics
DDI-DrugBank.d615.s0.e2_DDI-DrugBank.d615.s0.e5 false alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives
DDI-DrugBank.d615.s0.e2_DDI-DrugBank.d615.s0.e6 false alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers
DDI-DrugBank.d615.s0.e2_DDI-DrugBank.d615.s0.e7 false alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers (l_conj) tranquillisers_24\NNS\4017429|
DDI-DrugBank.d615.s0.e1_DDI-DrugBank.d615.s0.e3 false depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics
DDI-DrugBank.d615.s0.e1_DDI-DrugBank.d615.s0.e4 false depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics
DDI-DrugBank.d615.s0.e1_DDI-DrugBank.d615.s0.e5 false depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives
DDI-DrugBank.d615.s0.e1_DDI-DrugBank.d615.s0.e6 false depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers
DDI-DrugBank.d615.s0.e1_DDI-DrugBank.d615.s0.e7 false depressants_10\NNS\3248958|of|central|nervous|system|alcohol (l_nmod) alcohol_12\NN\7881800|including|,|barbiturates (l_conj) barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers (l_conj) tranquillisers_24\NNS\4017429|
DDI-DrugBank.d615.s0.e3_DDI-DrugBank.d615.s0.e4 false barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics
DDI-DrugBank.d615.s0.e3_DDI-DrugBank.d615.s0.e5 false barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives
DDI-DrugBank.d615.s0.e3_DDI-DrugBank.d615.s0.e6 false barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers
DDI-DrugBank.d615.s0.e3_DDI-DrugBank.d615.s0.e7 false barbiturates_14\NNS\4166841|,|hypnotics (l_conj) hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers (l_conj) tranquillisers_24\NNS\4017429|
DDI-DrugBank.d615.s0.e4_DDI-DrugBank.d615.s0.e5 false hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives
DDI-DrugBank.d615.s0.e4_DDI-DrugBank.d615.s0.e6 false hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers
DDI-DrugBank.d615.s0.e4_DDI-DrugBank.d615.s0.e7 false hypnotics_16\NNS\3247620|,|analgesics (l_conj) analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers (l_conj) tranquillisers_24\NNS\4017429|
DDI-DrugBank.d615.s0.e5_DDI-DrugBank.d615.s0.e6 false analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers
DDI-DrugBank.d615.s0.e5_DDI-DrugBank.d615.s0.e7 false analgesics_19\NNS\3740161|narcotic|,|sedatives (l_conj) sedatives_21\NNS\3248958|,|and|tranquillisers (l_conj) tranquillisers_24\NNS\4017429|
DDI-DrugBank.d615.s0.e6_DDI-DrugBank.d615.s0.e7 false sedatives_21\NNS\3248958|,|and|tranquillisers (l_conj) tranquillisers_24\NNS\4017429|
DDI-DrugBank.d588.s0
DDI-DrugBank.d588.s0.e1_DDI-DrugBank.d588.s0.e3 true furosemide_2\NN\3214670|and|diuretics|given (l_acl) given_8\VBN\2327200|metolazone (l_nmod) metolazone_11\NN\1740|with
DDI-DrugBank.d588.s0.e1_DDI-DrugBank.d588.s0.e0 false furosemide_2\NN\3214670|and|diuretics|given (r_nsubj) cause_13\VB\1617192|diuretics|:|furosemide|can|losses|. (l_nsubj) diuretics_0\NNS\3247620|
DDI-DrugBank.d588.s0.e1_DDI-DrugBank.d588.s0.e2 false furosemide_2\NN\3214670|and|diuretics|given (l_conj) diuretics_7\NNS\3247620|probably|other|loop
DDI-DrugBank.d588.s0.e3_DDI-DrugBank.d588.s0.e0 false metolazone_11\NN\1740|with (r_nmod) given_8\VBN\2327200|metolazone (r_acl) furosemide_2\NN\3214670|and|diuretics|given (r_nsubj) cause_13\VB\1617192|diuretics|:|furosemide|can|losses|. (l_nsubj) diuretics_0\NNS\3247620|
DDI-DrugBank.d588.s0.e3_DDI-DrugBank.d588.s0.e2 false metolazone_11\NN\1740|with (r_nmod) given_8\VBN\2327200|metolazone (r_acl) furosemide_2\NN\3214670|and|diuretics|given (l_conj) diuretics_7\NNS\3247620|probably|other|loop
DDI-DrugBank.d588.s0.e0_DDI-DrugBank.d588.s0.e2 false diuretics_0\NNS\3247620| (r_nsubj) cause_13\VB\1617192|diuretics|:|furosemide|can|losses|. (l_nsubj) furosemide_2\NN\3214670|and|diuretics|given (l_conj) diuretics_7\NNS\3247620|probably|other|loop
DDI-DrugBank.d756.s1
DDI-DrugBank.d756.s1.e0_DDI-DrugBank.d756.s1.e1 false tramadol_2\NN\1740|with|ultram (l_appos) ultram_4\NNP\1740|(|)
DDI-DrugBank.d784.s2
DDI-DrugBank.d641.s3
DDI-DrugBank.d641.s3.e0_DDI-DrugBank.d641.s3.e2 false ibuprofen_1\NN\3828465|qid (r_nsubjpass) administered_9\VBN\2436349|although|ibuprofen|can|be|alimta (r_advcl) used_28\VBN\1156834|administered|patients|,|caution|should|be|administering|. (l_advcl) administering_30\VBG\2436349|when|ibuprofen|alimta|patients (l_dobj) ibuprofen_31\NN\3828465|
DDI-DrugBank.d641.s3.e0_DDI-DrugBank.d641.s3.e1 false ibuprofen_1\NN\3828465|qid (r_nsubjpass) administered_9\VBN\2436349|although|ibuprofen|can|be|alimta (l_nmod) alimta_11\NN\1740|with
DDI-DrugBank.d641.s3.e0_DDI-DrugBank.d641.s3.e3 false ibuprofen_1\NN\3828465|qid (r_nsubjpass) administered_9\VBN\2436349|although|ibuprofen|can|be|alimta (r_advcl) used_28\VBN\1156834|administered|patients|,|caution|should|be|administering|. (l_advcl) administering_30\VBG\2436349|when|ibuprofen|alimta|patients (l_nmod) alimta_34\NN\1740|concurrently|with
DDI-DrugBank.d641.s3.e2_DDI-DrugBank.d641.s3.e1 false ibuprofen_31\NN\3828465| (r_dobj) administering_30\VBG\2436349|when|ibuprofen|alimta|patients (r_advcl) used_28\VBN\1156834|administered|patients|,|caution|should|be|administering|. (l_advcl) administered_9\VBN\2436349|although|ibuprofen|can|be|alimta (l_nmod) alimta_11\NN\1740|with
DDI-DrugBank.d641.s3.e2_DDI-DrugBank.d641.s3.e3 true ibuprofen_31\NN\3828465| (r_dobj) administering_30\VBG\2436349|when|ibuprofen|alimta|patients (l_nmod) alimta_34\NN\1740|concurrently|with
DDI-DrugBank.d641.s3.e1_DDI-DrugBank.d641.s3.e3 false alimta_11\NN\1740|with (r_nmod) administered_9\VBN\2436349|although|ibuprofen|can|be|alimta (r_advcl) used_28\VBN\1156834|administered|patients|,|caution|should|be|administering|. (l_advcl) administering_30\VBG\2436349|when|ibuprofen|alimta|patients (l_nmod) alimta_34\NN\1740|concurrently|with
DDI-DrugBank.d597.s9
DDI-DrugBank.d686.s1
DDI-DrugBank.d686.s1.e0_DDI-DrugBank.d686.s1.e1 true thiabendazole_6\NN\2720201|of|and|derivatives (l_conj) derivatives_9\NNS\5802185|xanthine
DDI-DrugBank.d726.s2
DDI-DrugBank.d726.s2.e1_DDI-DrugBank.d726.s2.e0 false ketoconazole_33\NN\1740|such (r_nmod) inhibitor_30\NN\20090|with|a|strong|cyp3a4|ketoconazole (r_nmod) therapy_25\NN\657604|inhibitor (r_dobj) initiates_22\VBZ\1617192|if|patient|or|discontinues|therapy (r_advcl) monitored_18\VBN\2169352|concentrations|should|be|closely|initiates|. (r_conj) required_7\VBN\754942|adjustment|may|be|,|and|monitored (l_nsubjpass) adjustment_1\NN\7357388|dose|capsules (l_nmod) capsules_4\NNS\3094503|of|zemplar (l_compound) zemplar_3\JJ\1740|
DDI-DrugBank.d779.s6
DDI-DrugBank.d604.s2
DDI-DrugBank.d604.s2.e1_DDI-DrugBank.d604.s2.e2 false norethindrone_12\NN\14747338|of|and|estradiol (l_conj) estradiol_15\NN\14749794|ethinyl
DDI-DrugBank.d604.s2.e1_DDI-DrugBank.d604.s2.e3 false norethindrone_12\NN\14747338|of|and|estradiol (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (l_nmod) administration_17\NN\1133281|following|dose (l_nmod) dose_21\NN\3740161|of|a|single|containing (l_acl) containing_22\VBG\2632940|mg (l_dobj) mg_24\NN\13717155|1.0|acetate|and|g (l_nmod) acetate_27\NN\15010703|of|norethindrone
DDI-DrugBank.d604.s2.e1_DDI-DrugBank.d604.s2.e4 false norethindrone_12\NN\14747338|of|and|estradiol (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (l_nmod) administration_17\NN\1133281|following|dose (l_nmod) dose_21\NN\3740161|of|a|single|containing (l_acl) containing_22\VBG\2632940|mg (l_dobj) mg_24\NN\13717155|1.0|acetate|and|g (l_conj) g_30\NN\13717155|75|estradiol (l_nmod) estradiol_33\NN\14749794|of|ethinyl
DDI-DrugBank.d604.s2.e1_DDI-DrugBank.d604.s2.e0 false norethindrone_12\NN\14747338|of|and|estradiol (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (r_nsubjpass) studied_35\VBN\630380|women|,|profiles|were|. (r_dep) contraceptives_1\NNS\3183080|oral|:|studied
DDI-DrugBank.d604.s2.e2_DDI-DrugBank.d604.s2.e3 false estradiol_15\NN\14749794|ethinyl (r_conj) norethindrone_12\NN\14747338|of|and|estradiol (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (l_nmod) administration_17\NN\1133281|following|dose (l_nmod) dose_21\NN\3740161|of|a|single|containing (l_acl) containing_22\VBG\2632940|mg (l_dobj) mg_24\NN\13717155|1.0|acetate|and|g (l_nmod) acetate_27\NN\15010703|of|norethindrone
DDI-DrugBank.d604.s2.e2_DDI-DrugBank.d604.s2.e4 false estradiol_15\NN\14749794|ethinyl (r_conj) norethindrone_12\NN\14747338|of|and|estradiol (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (l_nmod) administration_17\NN\1133281|following|dose (l_nmod) dose_21\NN\3740161|of|a|single|containing (l_acl) containing_22\VBG\2632940|mg (l_dobj) mg_24\NN\13717155|1.0|acetate|and|g (l_conj) g_30\NN\13717155|75|estradiol (l_nmod) estradiol_33\NN\14749794|of|ethinyl
DDI-DrugBank.d604.s2.e2_DDI-DrugBank.d604.s2.e0 false estradiol_15\NN\14749794|ethinyl (r_conj) norethindrone_12\NN\14747338|of|and|estradiol (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (r_nsubjpass) studied_35\VBN\630380|women|,|profiles|were|. (r_dep) contraceptives_1\NNS\3183080|oral|:|studied
DDI-DrugBank.d604.s2.e3_DDI-DrugBank.d604.s2.e4 false acetate_27\NN\15010703|of|norethindrone (r_nmod) mg_24\NN\13717155|1.0|acetate|and|g (l_conj) g_30\NN\13717155|75|estradiol (l_nmod) estradiol_33\NN\14749794|of|ethinyl
DDI-DrugBank.d604.s2.e3_DDI-DrugBank.d604.s2.e0 false acetate_27\NN\15010703|of|norethindrone (r_nmod) mg_24\NN\13717155|1.0|acetate|and|g (r_dobj) containing_22\VBG\2632940|mg (r_acl) dose_21\NN\3740161|of|a|single|containing (r_nmod) administration_17\NN\1133281|following|dose (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (r_nsubjpass) studied_35\VBN\630380|women|,|profiles|were|. (r_dep) contraceptives_1\NNS\3183080|oral|:|studied
DDI-DrugBank.d604.s2.e4_DDI-DrugBank.d604.s2.e0 false estradiol_33\NN\14749794|of|ethinyl (r_nmod) g_30\NN\13717155|75|estradiol (r_conj) mg_24\NN\13717155|1.0|acetate|and|g (r_dobj) containing_22\VBG\2632940|mg (r_acl) dose_21\NN\3740161|of|a|single|containing (r_nmod) administration_17\NN\1133281|following|dose (r_nmod) profiles_10\NNS\6999802|the|pharmacokinetic|norethindrone|administration (r_nsubjpass) studied_35\VBN\630380|women|,|profiles|were|. (r_dep) contraceptives_1\NNS\3183080|oral|:|studied
DDI-DrugBank.d689.s3
DDI-DrugBank.d689.s3.e0_DDI-DrugBank.d689.s3.e1 true agents_5\NNS\7347|of|adrenergic (r_nmod) response_2\NN\11410625|the|pressor|agents (r_nsubjpass) potentiated_9\VBN\229605|response|may|also|be|antidepressants|. (l_nmod) antidepressants_12\NNS\3740161|by|tricyclic
DDI-DrugBank.d577.s2
DDI-DrugBank.d720.s2
DDI-DrugBank.d720.s2.e1_DDI-DrugBank.d720.s2.e0 false sumatriptan_3\NN\1740| (r_compound) clearance_4\NN\5089947|sumatriptan (r_dobj) reduce_2\VBP\441445|inhibitors|clearance|,|increasing|. (l_nsubj) inhibitors_1\NNS\20090|mao-a
DDI-DrugBank.d576.s6
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e2 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) thiopental_15\NN\2792049|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e3 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) thyroxine_17\NN\5413241|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e4 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) triiodothyronine_19\NN\5413241|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e5 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) phenytoin_21\NN\3550533|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e6 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) sulfinpyrazone_23\NN\1740|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e7 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) naproxen_25\NN\3828465|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e8 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) warfarin_27\NN\2718259|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e9 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e1_DDI-DrugBank.d576.s6.e0 false penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e3 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) thyroxine_17\NN\5413241|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e4 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) triiodothyronine_19\NN\5413241|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e5 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) phenytoin_21\NN\3550533|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e6 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) sulfinpyrazone_23\NN\1740|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e7 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) naproxen_25\NN\3828465|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e8 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) warfarin_27\NN\2718259|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e9 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e2_DDI-DrugBank.d576.s6.e0 false thiopental_15\NN\2792049| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e3_DDI-DrugBank.d576.s6.e4 false thyroxine_17\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) triiodothyronine_19\NN\5413241|
DDI-DrugBank.d576.s6.e3_DDI-DrugBank.d576.s6.e5 false thyroxine_17\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) phenytoin_21\NN\3550533|
DDI-DrugBank.d576.s6.e3_DDI-DrugBank.d576.s6.e6 false thyroxine_17\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) sulfinpyrazone_23\NN\1740|
DDI-DrugBank.d576.s6.e3_DDI-DrugBank.d576.s6.e7 false thyroxine_17\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) naproxen_25\NN\3828465|
DDI-DrugBank.d576.s6.e3_DDI-DrugBank.d576.s6.e8 false thyroxine_17\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) warfarin_27\NN\2718259|
DDI-DrugBank.d576.s6.e3_DDI-DrugBank.d576.s6.e9 false thyroxine_17\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e3_DDI-DrugBank.d576.s6.e0 false thyroxine_17\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e4_DDI-DrugBank.d576.s6.e5 false triiodothyronine_19\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) phenytoin_21\NN\3550533|
DDI-DrugBank.d576.s6.e4_DDI-DrugBank.d576.s6.e6 false triiodothyronine_19\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) sulfinpyrazone_23\NN\1740|
DDI-DrugBank.d576.s6.e4_DDI-DrugBank.d576.s6.e7 false triiodothyronine_19\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) naproxen_25\NN\3828465|
DDI-DrugBank.d576.s6.e4_DDI-DrugBank.d576.s6.e8 false triiodothyronine_19\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) warfarin_27\NN\2718259|
DDI-DrugBank.d576.s6.e4_DDI-DrugBank.d576.s6.e9 false triiodothyronine_19\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e4_DDI-DrugBank.d576.s6.e0 false triiodothyronine_19\NN\5413241| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e5_DDI-DrugBank.d576.s6.e6 false phenytoin_21\NN\3550533| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) sulfinpyrazone_23\NN\1740|
DDI-DrugBank.d576.s6.e5_DDI-DrugBank.d576.s6.e7 false phenytoin_21\NN\3550533| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) naproxen_25\NN\3828465|
DDI-DrugBank.d576.s6.e5_DDI-DrugBank.d576.s6.e8 false phenytoin_21\NN\3550533| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) warfarin_27\NN\2718259|
DDI-DrugBank.d576.s6.e5_DDI-DrugBank.d576.s6.e9 false phenytoin_21\NN\3550533| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e5_DDI-DrugBank.d576.s6.e0 false phenytoin_21\NN\3550533| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e6_DDI-DrugBank.d576.s6.e7 false sulfinpyrazone_23\NN\1740| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) naproxen_25\NN\3828465|
DDI-DrugBank.d576.s6.e6_DDI-DrugBank.d576.s6.e8 false sulfinpyrazone_23\NN\1740| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) warfarin_27\NN\2718259|
DDI-DrugBank.d576.s6.e6_DDI-DrugBank.d576.s6.e9 false sulfinpyrazone_23\NN\1740| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e6_DDI-DrugBank.d576.s6.e0 false sulfinpyrazone_23\NN\1740| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e7_DDI-DrugBank.d576.s6.e8 false naproxen_25\NN\3828465| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) warfarin_27\NN\2718259|
DDI-DrugBank.d576.s6.e7_DDI-DrugBank.d576.s6.e9 false naproxen_25\NN\3828465| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e7_DDI-DrugBank.d576.s6.e0 false naproxen_25\NN\3828465| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e8_DDI-DrugBank.d576.s6.e9 false warfarin_27\NN\2718259| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (l_conj) methotrexate_29\NN\2722166|
DDI-DrugBank.d576.s6.e8_DDI-DrugBank.d576.s6.e0 false warfarin_27\NN\2718259| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d576.s6.e9_DDI-DrugBank.d576.s6.e0 false methotrexate_29\NN\2722166| (r_conj) penicillin_13\NN\2716866|notably|,|thiopental|,|thyroxine|,|triiodothyronine|,|phenytoin|,|sulfinpyrazone|,|naproxen|,|warfarin|,|methotrexate|,|and|corticosteroids (r_appos) number_4\NN\5107765|with|a|drugs|sites|,|penicillin (r_nmod) competes_1\VBZ\1740|salicylate|number|. (l_nsubj) salicylate_0\NN\3828465|
DDI-DrugBank.d623.s5
DDI-DrugBank.d776.s7
DDI-DrugBank.d776.s7.e1_DDI-DrugBank.d776.s7.e2 true fluconazole_38\NN\1740| (r_dobj) receiving_37\VBG\2210855|fluconazole|warfarin (l_nmod) warfarin_41\NN\2718259|concurrently|with
DDI-DrugBank.d776.s7.e1_DDI-DrugBank.d776.s7.e0 false fluconazole_38\NN\1740| (r_dobj) receiving_37\VBG\2210855|fluconazole|warfarin (r_acl) patients_36\NNS\9898892|in|receiving (r_nmod) time_34\NN\7308889|in|prothrombin|patients (r_nmod) increases_31\NNS\13576355|with|time (r_nmod) association_29\NN\8008335|in|increases (r_nmod) reported_27\VBN\831651|experience|,|antifungals|,|events|have|been|association|. (l_nmod) antifungals_8\NNS\14778436|as|with|other|azole
DDI-DrugBank.d776.s7.e2_DDI-DrugBank.d776.s7.e0 false warfarin_41\NN\2718259|concurrently|with (r_nmod) receiving_37\VBG\2210855|fluconazole|warfarin (r_acl) patients_36\NNS\9898892|in|receiving (r_nmod) time_34\NN\7308889|in|prothrombin|patients (r_nmod) increases_31\NNS\13576355|with|time (r_nmod) association_29\NN\8008335|in|increases (r_nmod) reported_27\VBN\831651|experience|,|antifungals|,|events|have|been|association|. (l_nmod) antifungals_8\NNS\14778436|as|with|other|azole
DDI-DrugBank.d591.s6
DDI-DrugBank.d591.s6.e0_DDI-DrugBank.d591.s6.e1 false ketoconazole_10\NN\1740| (r_appos) inhibitor_6\NN\20090|of|a|selective|cyp3a4|,|ketoconazole|mg (l_dep) mg_13\NN\13717155|(|100|bid|days|infusion|) (l_nmod) infusion_20\NN\14589223|with|ropivacaine|administered (l_compound) ropivacaine_19\NN\1740|
DDI-DrugBank.d591.s6.e0_DDI-DrugBank.d591.s6.e2 false ketoconazole_10\NN\1740| (r_appos) inhibitor_6\NN\20090|of|a|selective|cyp3a4|,|ketoconazole|mg (l_dep) mg_13\NN\13717155|(|100|bid|days|infusion|) (l_nmod) infusion_20\NN\14589223|with|ropivacaine|administered (l_acl) administered_21\VBN\2436349|hour (l_nmod) hour_23\NN\15154774|1|ketoconazole (l_nmod) ketoconazole_25\NN\1740|after
DDI-DrugBank.d591.s6.e0_DDI-DrugBank.d591.s6.e3 true ketoconazole_10\NN\1740| (r_appos) inhibitor_6\NN\20090|of|a|selective|cyp3a4|,|ketoconazole|mg (r_nmod) coadministration_0\NN\1740|inhibitor (r_nsubj) caused_27\VBD\1617192|coadministration|reduction|. (l_dobj) reduction_31\NN\351485|a|%|clearance (l_nmod) clearance_35\NN\5089947|in|in-vivo|plasma|ropivacaine (l_nmod) ropivacaine_37\NN\1740|of
DDI-DrugBank.d591.s6.e1_DDI-DrugBank.d591.s6.e2 false ropivacaine_19\NN\1740| (r_compound) infusion_20\NN\14589223|with|ropivacaine|administered (l_acl) administered_21\VBN\2436349|hour (l_nmod) hour_23\NN\15154774|1|ketoconazole (l_nmod) ketoconazole_25\NN\1740|after
DDI-DrugBank.d591.s6.e1_DDI-DrugBank.d591.s6.e3 false ropivacaine_19\NN\1740| (r_compound) infusion_20\NN\14589223|with|ropivacaine|administered (r_nmod) mg_13\NN\13717155|(|100|bid|days|infusion|) (r_dep) inhibitor_6\NN\20090|of|a|selective|cyp3a4|,|ketoconazole|mg (r_nmod) coadministration_0\NN\1740|inhibitor (r_nsubj) caused_27\VBD\1617192|coadministration|reduction|. (l_dobj) reduction_31\NN\351485|a|%|clearance (l_nmod) clearance_35\NN\5089947|in|in-vivo|plasma|ropivacaine (l_nmod) ropivacaine_37\NN\1740|of
DDI-DrugBank.d591.s6.e2_DDI-DrugBank.d591.s6.e3 false ketoconazole_25\NN\1740|after (r_nmod) hour_23\NN\15154774|1|ketoconazole (r_nmod) administered_21\VBN\2436349|hour (r_acl) infusion_20\NN\14589223|with|ropivacaine|administered (r_nmod) mg_13\NN\13717155|(|100|bid|days|infusion|) (r_dep) inhibitor_6\NN\20090|of|a|selective|cyp3a4|,|ketoconazole|mg (r_nmod) coadministration_0\NN\1740|inhibitor (r_nsubj) caused_27\VBD\1617192|coadministration|reduction|. (l_dobj) reduction_31\NN\351485|a|%|clearance (l_nmod) clearance_35\NN\5089947|in|in-vivo|plasma|ropivacaine (l_nmod) ropivacaine_37\NN\1740|of
DDI-DrugBank.d656.s2
DDI-DrugBank.d656.s2.e0_DDI-DrugBank.d656.s2.e4 false piroxicam_3\NN\3828465|of (r_nmod) levels_1\NNS\4916342|plasma|piroxicam (r_nsubj) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_conj) has_32\VBZ\2108377|administration|effect|levels|. (l_nmod) levels_38\NNS\4916342|on|piroxicam|plasma (l_compound) piroxicam_36\NN\3828465|
DDI-DrugBank.d656.s2.e0_DDI-DrugBank.d656.s2.e1 false piroxicam_3\NN\3828465|of (r_nmod) levels_1\NNS\4916342|plasma|piroxicam (r_nsubj) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_advcl) administered_17\VBN\2436349|when|feldene|is|conjunction|, (l_nsubjpass) feldene_15\NN\3828465|
DDI-DrugBank.d656.s2.e0_DDI-DrugBank.d656.s2.e2 false piroxicam_3\NN\3828465|of (r_nmod) levels_1\NNS\4916342|plasma|piroxicam (r_nsubj) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_advcl) administered_17\VBN\2436349|when|feldene|is|conjunction|, (l_nmod) conjunction_19\NN\5048123|in|aspirin (l_nmod) aspirin_21\NN\2707683|with|mg/day
DDI-DrugBank.d656.s2.e0_DDI-DrugBank.d656.s2.e3 false piroxicam_3\NN\3828465|of (r_nmod) levels_1\NNS\4916342|plasma|piroxicam (r_nsubj) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_conj) has_32\VBZ\2108377|administration|effect|levels|. (l_nsubj) administration_29\NN\1133281|concomitant|antacids (l_nmod) antacids_31\NNS\14778436|of
DDI-DrugBank.d656.s2.e4_DDI-DrugBank.d656.s2.e1 false piroxicam_36\NN\3828465| (r_compound) levels_38\NNS\4916342|on|piroxicam|plasma (r_nmod) has_32\VBZ\2108377|administration|effect|levels|. (r_conj) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_advcl) administered_17\VBN\2436349|when|feldene|is|conjunction|, (l_nsubjpass) feldene_15\NN\3828465|
DDI-DrugBank.d656.s2.e4_DDI-DrugBank.d656.s2.e2 false piroxicam_36\NN\3828465| (r_compound) levels_38\NNS\4916342|on|piroxicam|plasma (r_nmod) has_32\VBZ\2108377|administration|effect|levels|. (r_conj) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_advcl) administered_17\VBN\2436349|when|feldene|is|conjunction|, (l_nmod) conjunction_19\NN\5048123|in|aspirin (l_nmod) aspirin_21\NN\2707683|with|mg/day
DDI-DrugBank.d656.s2.e4_DDI-DrugBank.d656.s2.e3 false piroxicam_36\NN\3828465| (r_compound) levels_38\NNS\4916342|on|piroxicam|plasma (r_nmod) has_32\VBZ\2108377|administration|effect|levels|. (l_nsubj) administration_29\NN\1133281|concomitant|antacids (l_nmod) antacids_31\NNS\14778436|of
DDI-DrugBank.d656.s2.e1_DDI-DrugBank.d656.s2.e2 true feldene_15\NN\3828465| (r_nsubjpass) administered_17\VBN\2436349|when|feldene|is|conjunction|, (l_nmod) conjunction_19\NN\5048123|in|aspirin (l_nmod) aspirin_21\NN\2707683|with|mg/day
DDI-DrugBank.d656.s2.e1_DDI-DrugBank.d656.s2.e3 false feldene_15\NN\3828465| (r_nsubjpass) administered_17\VBN\2436349|when|feldene|is|conjunction|, (r_advcl) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_conj) has_32\VBZ\2108377|administration|effect|levels|. (l_nsubj) administration_29\NN\1133281|concomitant|antacids (l_nmod) antacids_31\NNS\14778436|of
DDI-DrugBank.d656.s2.e2_DDI-DrugBank.d656.s2.e3 false aspirin_21\NN\2707683|with|mg/day (r_nmod) conjunction_19\NN\5048123|in|aspirin (r_nmod) administered_17\VBN\2436349|when|feldene|is|conjunction|, (r_advcl) depressed_5\VBN\1819147|levels|are|%|administered|but|has (l_conj) has_32\VBZ\2108377|administration|effect|levels|. (l_nsubj) administration_29\NN\1133281|concomitant|antacids (l_nmod) antacids_31\NNS\14778436|of
DDI-DrugBank.d656.s2.e7_DDI-DrugBank.d656.s2.e6 false lithium_15\NN\14625458| (r_compound) levels_16\NNS\4916342|state|plasma|lithium (r_dobj) increase_11\VB\169651|to|levels (r_xcomp) reported_9\VBN\831651|agents|have|been|increase|. (l_nsubjpass) agents_2\NNS\7347|nonsteroidal|anti-inflammatory|,|feldene|, (l_nmod) feldene_5\NNP\3828465|including
DDI-DrugBank.d656.s2.e7_DDI-DrugBank.d656.s2.e5 false lithium_15\NN\14625458| (r_compound) levels_16\NNS\4916342|state|plasma|lithium (r_dobj) increase_11\VB\169651|to|levels (r_xcomp) reported_9\VBN\831651|agents|have|been|increase|. (l_nsubjpass) agents_2\NNS\7347|nonsteroidal|anti-inflammatory|,|feldene|,
DDI-DrugBank.d656.s2.e6_DDI-DrugBank.d656.s2.e5 false feldene_5\NNP\3828465|including (r_nmod) agents_2\NNS\7347|nonsteroidal|anti-inflammatory|,|feldene|,
DDI-DrugBank.d675.s2
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e2 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (l_appos) troleandomycin_18\NN\1740|
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e3 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (l_appos) clarithromycin_20\NN\1740|
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e6 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|)
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e7 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) indinavir_34\NN\4013993|
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e8 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) nelfinavir_36\NN\4013993|
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e9 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) delavirdine_38\NN\3828155|
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e0 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e4 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e4 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e1_DDI-DrugBank.d675.s2.e5 false erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e3 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (l_appos) clarithromycin_20\NN\1740|
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e6 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|)
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e7 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) indinavir_34\NN\4013993|
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e8 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) nelfinavir_36\NN\4013993|
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e9 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) delavirdine_38\NN\3828155|
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e0 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e4 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e4 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e2_DDI-DrugBank.d675.s2.e5 false troleandomycin_18\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e6 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|)
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e7 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) indinavir_34\NN\4013993|
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e8 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) nelfinavir_36\NN\4013993|
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e9 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_dep) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) delavirdine_38\NN\3828155|
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e0 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e4 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e4 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e3_DDI-DrugBank.d675.s2.e5 false clarithromycin_20\NN\1740| (r_appos) erythromycin_16\NN\2716866|(|e.g.|,|,|troleandomycin|,|clarithromycin|) (r_dep) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e6_DDI-DrugBank.d675.s2.e7 false ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) indinavir_34\NN\4013993|
DDI-DrugBank.d675.s2.e6_DDI-DrugBank.d675.s2.e8 false ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) nelfinavir_36\NN\4013993|
DDI-DrugBank.d675.s2.e6_DDI-DrugBank.d675.s2.e9 false ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) delavirdine_38\NN\3828155|
DDI-DrugBank.d675.s2.e6_DDI-DrugBank.d675.s2.e0 false ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (r_conj) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors
DDI-DrugBank.d675.s2.e6_DDI-DrugBank.d675.s2.e4 false ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e6_DDI-DrugBank.d675.s2.e4 false ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e6_DDI-DrugBank.d675.s2.e5 false ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e7_DDI-DrugBank.d675.s2.e8 false indinavir_34\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) nelfinavir_36\NN\4013993|
DDI-DrugBank.d675.s2.e7_DDI-DrugBank.d675.s2.e9 false indinavir_34\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) delavirdine_38\NN\3828155|
DDI-DrugBank.d675.s2.e7_DDI-DrugBank.d675.s2.e0 false indinavir_34\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (r_conj) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors
DDI-DrugBank.d675.s2.e7_DDI-DrugBank.d675.s2.e4 false indinavir_34\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e7_DDI-DrugBank.d675.s2.e4 false indinavir_34\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e7_DDI-DrugBank.d675.s2.e5 false indinavir_34\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e8_DDI-DrugBank.d675.s2.e9 false nelfinavir_36\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (l_appos) delavirdine_38\NN\3828155|
DDI-DrugBank.d675.s2.e8_DDI-DrugBank.d675.s2.e0 false nelfinavir_36\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (r_conj) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors
DDI-DrugBank.d675.s2.e8_DDI-DrugBank.d675.s2.e4 false nelfinavir_36\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e8_DDI-DrugBank.d675.s2.e4 false nelfinavir_36\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e8_DDI-DrugBank.d675.s2.e5 false nelfinavir_36\NN\4013993| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e9_DDI-DrugBank.d675.s2.e0 false delavirdine_38\NN\3828155| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (r_conj) antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors
DDI-DrugBank.d675.s2.e9_DDI-DrugBank.d675.s2.e4 false delavirdine_38\NN\3828155| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e9_DDI-DrugBank.d675.s2.e4 false delavirdine_38\NN\3828155| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e9_DDI-DrugBank.d675.s2.e5 false delavirdine_38\NN\3828155| (r_appos) ritonavir_32\NN\4013993|(|e.g.|,|,|indinavir|,|nelfinavir|,|delavirdine|) (r_dep) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e0_DDI-DrugBank.d675.s2.e4 false antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals (l_compound) protease_24\NN\14732946|hiv|or|transcriptase
DDI-DrugBank.d675.s2.e0_DDI-DrugBank.d675.s2.e4 false antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e0_DDI-DrugBank.d675.s2.e5 false antibiotics_12\NNS\2716205|macrolide|erythromycin|,|inhibitors (l_conj) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e4_DDI-DrugBank.d675.s2.e4 false protease_24\NN\14732946|hiv|or|transcriptase (r_compound) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e4_DDI-DrugBank.d675.s2.e5 false protease_24\NN\14732946|hiv|or|transcriptase (r_compound) inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d675.s2.e4_DDI-DrugBank.d675.s2.e5 false inhibitors_28\NNS\20090|protease|ritonavir|or|antifungals
DDI-DrugBank.d756.s0
DDI-DrugBank.d756.s0.e1_DDI-DrugBank.d756.s0.e0 false levomepromazine_13\NN\1740| (r_nsubj) amplifies_14\VBZ\157844|because|levomepromazine|actions (r_advcl) reduced_7\VBN\441445|dosages|should|be|half|,|amplifies|. (l_nsubjpass) dosages_0\NNS\13576355|opioids (l_nmod) opioids_4\NNS\1740|of|administered
DDI-DrugBank.d756.s0.e1_DDI-DrugBank.d756.s0.e2 true levomepromazine_13\NN\1740| (r_nsubj) amplifies_14\VBZ\157844|because|levomepromazine|actions (l_dobj) actions_17\NNS\30358|the|therapeutic|and|side-effects|opioids (l_nmod) opioids_21\NNS\1740|of
DDI-DrugBank.d756.s0.e0_DDI-DrugBank.d756.s0.e2 false opioids_4\NNS\1740|of|administered (r_nmod) dosages_0\NNS\13576355|opioids (r_nsubjpass) reduced_7\VBN\441445|dosages|should|be|half|,|amplifies|. (l_advcl) amplifies_14\VBZ\157844|because|levomepromazine|actions (l_dobj) actions_17\NNS\30358|the|therapeutic|and|side-effects|opioids (l_nmod) opioids_21\NNS\1740|of
DDI-DrugBank.d743.s1
DDI-DrugBank.d641.s7
DDI-DrugBank.d634.s6
DDI-DrugBank.d710.s8
DDI-DrugBank.d781.s9
DDI-DrugBank.d776.s8
DDI-DrugBank.d776.s8.e0_DDI-DrugBank.d776.s8.e1 true diflucan_8\NN\1740|and|coumarin-type (r_compound) anticoagulants_11\NNS\3740161|diflucan
DDI-DrugBank.d652.s2
DDI-DrugBank.d652.s2.e0_DDI-DrugBank.d652.s2.e1 true metoclopramide_3\NN\1740| (r_nsubj) releases_4\VBZ\1435380|that|metoclopramide|catecholamines|patients (r_ccomp) finding_1\NN\43195|the|releases (r_nsubj) suggests_11\VBZ\1010118|finding|used|. (l_ccomp) used_16\VBN\1156834|that|it|should|be|cautiously|,|all|,|patients (l_nmod) patients_24\NNS\9898892|in|receiving (l_acl) receiving_25\VBG\2210855|inhibitors (l_dobj) inhibitors_28\NNS\20090|monoamine|oxi-dase
DDI-DrugBank.d572.s31
DDI-DrugBank.d710.s6
DDI-DrugBank.d710.s6.e1_DDI-DrugBank.d710.s6.e0 false hcl_3\NN\1740|rimantadine|,|mg|, (r_nsubjpass) given_9\VBN\2327200|hcl|was|daily|days|volunteers|. (r_appos) aspirin_0\NN\2707683|:|given
DDI-DrugBank.d588.s14
DDI-DrugBank.d653.s6
DDI-DrugBank.d653.s6.e0_DDI-DrugBank.d653.s6.e1 true aspirin_0\NN\2707683| (r_nsubjpass) used_3\VBN\1156834|aspirin|should|be|cautiously|conjunction|patients|. (l_nmod) conjunction_6\NN\5048123|in|corticosteroids (l_nmod) corticosteroids_8\NNS\14745635|with
DDI-DrugBank.d775.s13
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e2 false phenytoin_30\NN\3550533|such|or|carbamazepine (l_conj) carbamazepine_32\NN\1740|
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e4 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_dep) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (l_compound) cisplatin_40\NN\1740|
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e5 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_dep) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e6 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_dep) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (l_appos) neostigmine_44\NN\2718084|-|-
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e7 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_compound) polymyxin_46\NN\2716866|
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e8 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_conj) bacitracin_49\NN\2716866|
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e0 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) corticosteroids_10\NNS\14745635|-|medicines
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e3 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e1_DDI-DrugBank.d775.s13.e9 false phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e4 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_dep) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (l_compound) cisplatin_40\NN\1740|
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e5 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_dep) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e6 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_dep) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (l_appos) neostigmine_44\NN\2718084|-|-
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e7 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_compound) polymyxin_46\NN\2716866|
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e8 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_conj) bacitracin_49\NN\2716866|
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e0 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) corticosteroids_10\NNS\14745635|-|medicines
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e3 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e2_DDI-DrugBank.d775.s13.e9 false carbamazepine_32\NN\1740| (r_conj) phenytoin_30\NN\3550533|such|or|carbamazepine (r_nmod) seizures_27\NNS\14081375|phenytoin (r_dobj) control_26\VB\2422663|to|seizures (r_acl) medicines_24\NNS\6045562|-|control (r_conj) medicines_20\NNS\6045562|-|pain|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e4_DDI-DrugBank.d775.s13.e5 false cisplatin_40\NN\1740| (r_compound) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine
DDI-DrugBank.d775.s13.e4_DDI-DrugBank.d775.s13.e6 false cisplatin_40\NN\1740| (r_compound) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (l_appos) neostigmine_44\NN\2718084|-|-
DDI-DrugBank.d775.s13.e4_DDI-DrugBank.d775.s13.e7 false cisplatin_40\NN\1740| (r_compound) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_compound) polymyxin_46\NN\2716866|
DDI-DrugBank.d775.s13.e4_DDI-DrugBank.d775.s13.e8 false cisplatin_40\NN\1740| (r_compound) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_conj) bacitracin_49\NN\2716866|
DDI-DrugBank.d775.s13.e4_DDI-DrugBank.d775.s13.e0 false cisplatin_40\NN\1740| (r_compound) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) corticosteroids_10\NNS\14745635|-|medicines
DDI-DrugBank.d775.s13.e4_DDI-DrugBank.d775.s13.e3 false cisplatin_40\NN\1740| (r_compound) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e4_DDI-DrugBank.d775.s13.e9 false cisplatin_40\NN\1740| (r_compound) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e5_DDI-DrugBank.d775.s13.e6 false edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (l_appos) neostigmine_44\NN\2718084|-|-
DDI-DrugBank.d775.s13.e5_DDI-DrugBank.d775.s13.e7 false edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_compound) polymyxin_46\NN\2716866|
DDI-DrugBank.d775.s13.e5_DDI-DrugBank.d775.s13.e8 false edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_conj) bacitracin_49\NN\2716866|
DDI-DrugBank.d775.s13.e5_DDI-DrugBank.d775.s13.e0 false edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) corticosteroids_10\NNS\14745635|-|medicines
DDI-DrugBank.d775.s13.e5_DDI-DrugBank.d775.s13.e3 false edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e5_DDI-DrugBank.d775.s13.e9 false edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e6_DDI-DrugBank.d775.s13.e7 false neostigmine_44\NN\2718084|-|- (r_appos) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_compound) polymyxin_46\NN\2716866|
DDI-DrugBank.d775.s13.e6_DDI-DrugBank.d775.s13.e8 false neostigmine_44\NN\2718084|-|- (r_appos) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) b_47\NN\1355326|polymyxin|or|bacitracin (l_conj) bacitracin_49\NN\2716866|
DDI-DrugBank.d775.s13.e6_DDI-DrugBank.d775.s13.e0 false neostigmine_44\NN\2718084|-|- (r_appos) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) corticosteroids_10\NNS\14745635|-|medicines
DDI-DrugBank.d775.s13.e6_DDI-DrugBank.d775.s13.e3 false neostigmine_44\NN\2718084|-|- (r_appos) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e6_DDI-DrugBank.d775.s13.e9 false neostigmine_44\NN\2718084|-|- (r_appos) edrophonium_42\NN\1740|-|cisplatin|-|neostigmine (r_dep) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e7_DDI-DrugBank.d775.s13.e8 false polymyxin_46\NN\2716866| (r_compound) b_47\NN\1355326|polymyxin|or|bacitracin (l_conj) bacitracin_49\NN\2716866|
DDI-DrugBank.d775.s13.e7_DDI-DrugBank.d775.s13.e0 false polymyxin_46\NN\2716866| (r_compound) b_47\NN\1355326|polymyxin|or|bacitracin (r_conj) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) corticosteroids_10\NNS\14745635|-|medicines
DDI-DrugBank.d775.s13.e7_DDI-DrugBank.d775.s13.e3 false polymyxin_46\NN\2716866| (r_compound) b_47\NN\1355326|polymyxin|or|bacitracin (r_conj) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e7_DDI-DrugBank.d775.s13.e9 false polymyxin_46\NN\2716866| (r_compound) b_47\NN\1355326|polymyxin|or|bacitracin (r_conj) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e8_DDI-DrugBank.d775.s13.e0 false bacitracin_49\NN\2716866| (r_conj) b_47\NN\1355326|polymyxin|or|bacitracin (r_conj) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) corticosteroids_10\NNS\14745635|-|medicines
DDI-DrugBank.d775.s13.e8_DDI-DrugBank.d775.s13.e3 false bacitracin_49\NN\2716866| (r_conj) b_47\NN\1355326|polymyxin|or|bacitracin (r_conj) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e8_DDI-DrugBank.d775.s13.e9 false bacitracin_49\NN\2716866| (r_conj) b_47\NN\1355326|polymyxin|or|bacitracin (r_conj) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e0_DDI-DrugBank.d775.s13.e3 false corticosteroids_10\NNS\14745635|-|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics
DDI-DrugBank.d775.s13.e0_DDI-DrugBank.d775.s13.e9 false corticosteroids_10\NNS\14745635|-|medicines (r_appos) pills_8\NNS\4424218|interactions|are|:|-|birth|control|-|corticosteroids|medicines|-|antibiotics (l_appos) antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d775.s13.e3_DDI-DrugBank.d775.s13.e9 false antibiotics_35\NNS\2716205|certain|given|edrophonium|b|-|anesthetics (l_conj) anesthetics_52\NNS\3247620|local|anesthetics|-|succinylcholine
DDI-DrugBank.d670.s9
DDI-DrugBank.d670.s9.e1_DDI-DrugBank.d670.s9.e0 false paliperidone_7\NN\1740|invega (l_compound) invega_6\NN\1740|
DDI-DrugBank.d762.s0
DDI-DrugBank.d762.s0.e0_DDI-DrugBank.d762.s0.e1 true probenecid_0\NN\3740161| (r_nsubj) competes_1\VBZ\1740|probenecid|meropenem|secretion|and|inhibits|. (l_nmod) meropenem_3\NN\1740|with
DDI-DrugBank.d762.s0.e0_DDI-DrugBank.d762.s0.e2 false probenecid_0\NN\3740161| (r_nsubj) competes_1\VBZ\1740|probenecid|meropenem|secretion|and|inhibits|. (l_conj) inhibits_10\VBZ\2510337|thus|excretion (l_dobj) excretion_13\NN\13466586|the|renal|meropenem (l_nmod) meropenem_15\NN\1740|of
DDI-DrugBank.d762.s0.e1_DDI-DrugBank.d762.s0.e2 false meropenem_3\NN\1740|with (r_nmod) competes_1\VBZ\1740|probenecid|meropenem|secretion|and|inhibits|. (l_conj) inhibits_10\VBZ\2510337|thus|excretion (l_dobj) excretion_13\NN\13466586|the|renal|meropenem (l_nmod) meropenem_15\NN\1740|of
DDI-DrugBank.d627.s3
DDI-DrugBank.d627.s3.e0_DDI-DrugBank.d627.s3.e1 false atropine_21\NN\14712692|(|e.g.|,|,|ipratropium|) (l_appos) ipratropium_24\NN\1740|inhaled
DDI-DrugBank.d578.s3
DDI-DrugBank.d578.s3.e0_DDI-DrugBank.d578.s3.e1 true methylprednisolone_8\NN\1740|of|and|cyclosporin (l_conj) cyclosporin_10\NN\1740|
DDI-DrugBank.d622.s1
DDI-DrugBank.d622.s1.e0_DDI-DrugBank.d622.s1.e1 false atropine_9\NN\14712692|of (r_nmod) dose_7\NN\3740161|the|total|atropine (r_nsubj) large_12\JJ\1740|if|dose|has|been|and|delayed (l_conj) delayed_20\VBN\439958|administration|has|been (l_nsubjpass) administration_15\NN\1133281|the|pralidoxime (l_nmod) pralidoxime_17\NN\1740|of
DDI-DrugBank.d716.s6
DDI-DrugBank.d596.s7
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e1 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e2 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihypertensives_29\NNS\3740161|n=72
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e3 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) blockers_36\NNS\10101634|calcium|channel|n=75
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e4 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antidiabetics_41\NNS\3740161|n=21
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e5 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e6 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) estrogens_53\NNS\14745635|n=70
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e7 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) analgesics_59\NNS\3740161|salicylate|n=177
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e8 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e0_DDI-DrugBank.d596.s7.e9 false rivastigmine_14\NN\1740|of (r_nmod) pharmacokinetics_12\NNS\6054892|the|rivastigmine (r_nsubjpass) influenced_17\VBN\137313|that|pharmacokinetics|were|not|medications (l_nmod) medications_21\NNS\3247620|by|prescribed|antacids (l_nmod) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e2 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihypertensives_29\NNS\3740161|n=72
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e3 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) blockers_36\NNS\10101634|calcium|channel|n=75
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e4 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antidiabetics_41\NNS\3740161|n=21
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e5 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e6 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) estrogens_53\NNS\14745635|n=70
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e7 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) analgesics_59\NNS\3740161|salicylate|n=177
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e8 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e1_DDI-DrugBank.d596.s7.e9 false antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e2_DDI-DrugBank.d596.s7.e3 false antihypertensives_29\NNS\3740161|n=72 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) blockers_36\NNS\10101634|calcium|channel|n=75
DDI-DrugBank.d596.s7.e2_DDI-DrugBank.d596.s7.e4 false antihypertensives_29\NNS\3740161|n=72 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antidiabetics_41\NNS\3740161|n=21
DDI-DrugBank.d596.s7.e2_DDI-DrugBank.d596.s7.e5 false antihypertensives_29\NNS\3740161|n=72 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79
DDI-DrugBank.d596.s7.e2_DDI-DrugBank.d596.s7.e6 false antihypertensives_29\NNS\3740161|n=72 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) estrogens_53\NNS\14745635|n=70
DDI-DrugBank.d596.s7.e2_DDI-DrugBank.d596.s7.e7 false antihypertensives_29\NNS\3740161|n=72 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) analgesics_59\NNS\3740161|salicylate|n=177
DDI-DrugBank.d596.s7.e2_DDI-DrugBank.d596.s7.e8 false antihypertensives_29\NNS\3740161|n=72 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e2_DDI-DrugBank.d596.s7.e9 false antihypertensives_29\NNS\3740161|n=72 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e3_DDI-DrugBank.d596.s7.e4 false blockers_36\NNS\10101634|calcium|channel|n=75 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antidiabetics_41\NNS\3740161|n=21
DDI-DrugBank.d596.s7.e3_DDI-DrugBank.d596.s7.e5 false blockers_36\NNS\10101634|calcium|channel|n=75 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79
DDI-DrugBank.d596.s7.e3_DDI-DrugBank.d596.s7.e6 false blockers_36\NNS\10101634|calcium|channel|n=75 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) estrogens_53\NNS\14745635|n=70
DDI-DrugBank.d596.s7.e3_DDI-DrugBank.d596.s7.e7 false blockers_36\NNS\10101634|calcium|channel|n=75 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) analgesics_59\NNS\3740161|salicylate|n=177
DDI-DrugBank.d596.s7.e3_DDI-DrugBank.d596.s7.e8 false blockers_36\NNS\10101634|calcium|channel|n=75 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e3_DDI-DrugBank.d596.s7.e9 false blockers_36\NNS\10101634|calcium|channel|n=75 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e4_DDI-DrugBank.d596.s7.e5 false antidiabetics_41\NNS\3740161|n=21 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79
DDI-DrugBank.d596.s7.e4_DDI-DrugBank.d596.s7.e6 false antidiabetics_41\NNS\3740161|n=21 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) estrogens_53\NNS\14745635|n=70
DDI-DrugBank.d596.s7.e4_DDI-DrugBank.d596.s7.e7 false antidiabetics_41\NNS\3740161|n=21 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) analgesics_59\NNS\3740161|salicylate|n=177
DDI-DrugBank.d596.s7.e4_DDI-DrugBank.d596.s7.e8 false antidiabetics_41\NNS\3740161|n=21 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e4_DDI-DrugBank.d596.s7.e9 false antidiabetics_41\NNS\3740161|n=21 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e5_DDI-DrugBank.d596.s7.e6 false drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) estrogens_53\NNS\14745635|n=70
DDI-DrugBank.d596.s7.e5_DDI-DrugBank.d596.s7.e7 false drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) analgesics_59\NNS\3740161|salicylate|n=177
DDI-DrugBank.d596.s7.e5_DDI-DrugBank.d596.s7.e8 false drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e5_DDI-DrugBank.d596.s7.e9 false drugs_48\NNS\14778436|nonsteroidal|anti-inflammatory|n=79 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e6_DDI-DrugBank.d596.s7.e7 false estrogens_53\NNS\14745635|n=70 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) analgesics_59\NNS\3740161|salicylate|n=177
DDI-DrugBank.d596.s7.e6_DDI-DrugBank.d596.s7.e8 false estrogens_53\NNS\14745635|n=70 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e6_DDI-DrugBank.d596.s7.e9 false estrogens_53\NNS\14745635|n=70 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e7_DDI-DrugBank.d596.s7.e8 false analgesics_59\NNS\3740161|salicylate|n=177 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antianginals_64\NNS\1740|n=35
DDI-DrugBank.d596.s7.e7_DDI-DrugBank.d596.s7.e9 false analgesics_59\NNS\3740161|salicylate|n=177 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d596.s7.e8_DDI-DrugBank.d596.s7.e9 false antianginals_64\NNS\1740|n=35 (r_conj) antacids_24\NNS\14778436|such|n=77|,|antihypertensives|,|blockers|,|antidiabetics|,|drugs|,|estrogens|,|analgesics|,|antianginals|,|and|antihistamines (l_conj) antihistamines_70\NNS\3740161|n=15
DDI-DrugBank.d775.s4
DDI-DrugBank.d775.s4.e0_DDI-DrugBank.d775.s4.e1 false mivacron_9\NNP\1740|of (r_nmod) use_7\NN\407535|on|the|mivacron|agents (l_nmod) agents_15\NNS\7347|with|other|nondepolarizing|neuromuscular|blocking
DDI-DrugBank.d653.s1
DDI-DrugBank.d653.s1.e0_DDI-DrugBank.d653.s1.e1 false phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (l_conj) phenytoin_9\NN\3550533|
DDI-DrugBank.d653.s1.e0_DDI-DrugBank.d653.s1.e2 false phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (l_conj) rifampin_11\NN\2716205|
DDI-DrugBank.d653.s1.e0_DDI-DrugBank.d653.s1.e3 true phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_13\VB\169651|drugs|may|clearance|and|require|. (l_dobj) clearance_15\NN\5089947|the|corticosteroids (l_nmod) corticosteroids_17\NNS\14745635|of
DDI-DrugBank.d653.s1.e0_DDI-DrugBank.d653.s1.e4 true phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_13\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_20\VB\754942|may|increases|achieve (l_dobj) increases_21\NNS\13576355|dose (l_nmod) dose_24\NN\3740161|in|corticosteroid (l_compound) corticosteroid_23\NN\14745635|
DDI-DrugBank.d653.s1.e1_DDI-DrugBank.d653.s1.e2 false phenytoin_9\NN\3550533| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (l_conj) rifampin_11\NN\2716205|
DDI-DrugBank.d653.s1.e1_DDI-DrugBank.d653.s1.e3 true phenytoin_9\NN\3550533| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_13\VB\169651|drugs|may|clearance|and|require|. (l_dobj) clearance_15\NN\5089947|the|corticosteroids (l_nmod) corticosteroids_17\NNS\14745635|of
DDI-DrugBank.d653.s1.e1_DDI-DrugBank.d653.s1.e4 true phenytoin_9\NN\3550533| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_13\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_20\VB\754942|may|increases|achieve (l_dobj) increases_21\NNS\13576355|dose (l_nmod) dose_24\NN\3740161|in|corticosteroid (l_compound) corticosteroid_23\NN\14745635|
DDI-DrugBank.d653.s1.e2_DDI-DrugBank.d653.s1.e3 true rifampin_11\NN\2716205| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_13\VB\169651|drugs|may|clearance|and|require|. (l_dobj) clearance_15\NN\5089947|the|corticosteroids (l_nmod) corticosteroids_17\NNS\14745635|of
DDI-DrugBank.d653.s1.e2_DDI-DrugBank.d653.s1.e4 true rifampin_11\NN\2716205| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_13\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_20\VB\754942|may|increases|achieve (l_dobj) increases_21\NNS\13576355|dose (l_nmod) dose_24\NN\3740161|in|corticosteroid (l_compound) corticosteroid_23\NN\14745635|
DDI-DrugBank.d653.s1.e3_DDI-DrugBank.d653.s1.e4 false corticosteroids_17\NNS\14745635|of (r_nmod) clearance_15\NN\5089947|the|corticosteroids (r_dobj) increase_13\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_20\VB\754942|may|increases|achieve (l_dobj) increases_21\NNS\13576355|dose (l_nmod) dose_24\NN\3740161|in|corticosteroid (l_compound) corticosteroid_23\NN\14745635|
DDI-DrugBank.d744.s2
DDI-DrugBank.d776.s10
DDI-DrugBank.d776.s10.e0_DDI-DrugBank.d776.s10.e2 false phenytoin_0\NN\3550533| (r_dep) increases_3\VBZ\169651|phenytoin|:|diflucan|concentrations|. (l_dobj) concentrations_6\NNS\4916342|the|plasma|phenytoin (l_nmod) phenytoin_8\NN\3550533|of
DDI-DrugBank.d776.s10.e0_DDI-DrugBank.d776.s10.e1 false phenytoin_0\NN\3550533| (r_dep) increases_3\VBZ\169651|phenytoin|:|diflucan|concentrations|. (l_nsubj) diflucan_2\NN\1740|
DDI-DrugBank.d776.s10.e2_DDI-DrugBank.d776.s10.e1 false phenytoin_8\NN\3550533|of (r_nmod) concentrations_6\NNS\4916342|the|plasma|phenytoin (r_dobj) increases_3\VBZ\169651|phenytoin|:|diflucan|concentrations|. (l_nsubj) diflucan_2\NN\1740|
DDI-DrugBank.d738.s2
DDI-DrugBank.d776.s5
DDI-DrugBank.d776.s5.e0_DDI-DrugBank.d776.s5.e1 true diflucan_1\NN\1740| (r_nsubjpass) used_3\VBN\1156834|when|diflucan|is|concomitantly|these (l_nmod) these_6\DT\1740|with|or|agents (l_conj) agents_12\NNS\7347|other|sulfonylurea|oral|hypoglycemic
DDI-DrugBank.d776.s5.e0_DDI-DrugBank.d776.s5.e2 false diflucan_1\NN\1740| (r_nsubjpass) used_3\VBN\1156834|when|diflucan|is|concomitantly|these (r_advcl) monitored_20\VBN\2169352|used|,|concentrations|should|be|carefully|and|adjusted (l_conj) adjusted_29\VBN\126264|dose|should|be|as|. (l_nsubjpass) dose_23\NN\3740161|the|sulfonylurea (l_nmod) sulfonylurea_26\NN\2719105|of|the
DDI-DrugBank.d776.s5.e1_DDI-DrugBank.d776.s5.e2 false agents_12\NNS\7347|other|sulfonylurea|oral|hypoglycemic (r_conj) these_6\DT\1740|with|or|agents (r_nmod) used_3\VBN\1156834|when|diflucan|is|concomitantly|these (r_advcl) monitored_20\VBN\2169352|used|,|concentrations|should|be|carefully|and|adjusted (l_conj) adjusted_29\VBN\126264|dose|should|be|as|. (l_nsubjpass) dose_23\NN\3740161|the|sulfonylurea (l_nmod) sulfonylurea_26\NN\2719105|of|the
DDI-DrugBank.d595.s5
DDI-DrugBank.d599.s5
DDI-DrugBank.d639.s4
DDI-DrugBank.d777.s2
DDI-DrugBank.d766.s4
DDI-DrugBank.d628.s0
DDI-DrugBank.d628.s0.e2_DDI-DrugBank.d628.s0.e3 false morphine_25\NN\2707683|eg|,|,|meperidine|) (l_conj) meperidine_27\NN\3808564|,|and|fentanyl
DDI-DrugBank.d628.s0.e2_DDI-DrugBank.d628.s0.e4 false morphine_25\NN\2707683|eg|,|,|meperidine|) (l_conj) meperidine_27\NN\3808564|,|and|fentanyl (l_conj) fentanyl_30\NN\2707683|,|etc
DDI-DrugBank.d628.s0.e2_DDI-DrugBank.d628.s0.e0 false morphine_25\NN\2707683|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|with|(|morphine (r_nmod) reduced_10\VBN\441445|requirements|may|be|patients|,|narcotics (l_nsubjpass) requirements_3\NNS\1129920|the|induction|dose|emulsion (l_nmod) emulsion_7\NN\14588219|of|diprivan|injectable (l_compound) diprivan_5\NN\1740|
DDI-DrugBank.d628.s0.e2_DDI-DrugBank.d628.s0.e1 false morphine_25\NN\2707683|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|with|(|morphine
DDI-DrugBank.d628.s0.e3_DDI-DrugBank.d628.s0.e4 false meperidine_27\NN\3808564|,|and|fentanyl (l_conj) fentanyl_30\NN\2707683|,|etc
DDI-DrugBank.d628.s0.e3_DDI-DrugBank.d628.s0.e0 false meperidine_27\NN\3808564|,|and|fentanyl (r_conj) morphine_25\NN\2707683|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|with|(|morphine (r_nmod) reduced_10\VBN\441445|requirements|may|be|patients|,|narcotics (l_nsubjpass) requirements_3\NNS\1129920|the|induction|dose|emulsion (l_nmod) emulsion_7\NN\14588219|of|diprivan|injectable (l_compound) diprivan_5\NN\1740|
DDI-DrugBank.d628.s0.e3_DDI-DrugBank.d628.s0.e1 false meperidine_27\NN\3808564|,|and|fentanyl (r_conj) morphine_25\NN\2707683|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|with|(|morphine
DDI-DrugBank.d628.s0.e4_DDI-DrugBank.d628.s0.e0 false fentanyl_30\NN\2707683|,|etc (r_conj) meperidine_27\NN\3808564|,|and|fentanyl (r_conj) morphine_25\NN\2707683|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|with|(|morphine (r_nmod) reduced_10\VBN\441445|requirements|may|be|patients|,|narcotics (l_nsubjpass) requirements_3\NNS\1129920|the|induction|dose|emulsion (l_nmod) emulsion_7\NN\14588219|of|diprivan|injectable (l_compound) diprivan_5\NN\1740|
DDI-DrugBank.d628.s0.e4_DDI-DrugBank.d628.s0.e1 false fentanyl_30\NN\2707683|,|etc (r_conj) meperidine_27\NN\3808564|,|and|fentanyl (r_conj) morphine_25\NN\2707683|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|with|(|morphine
DDI-DrugBank.d628.s0.e0_DDI-DrugBank.d628.s0.e1 true diprivan_5\NN\1740| (r_compound) emulsion_7\NN\14588219|of|diprivan|injectable (r_nmod) requirements_3\NNS\1129920|the|induction|dose|emulsion (r_nsubjpass) reduced_10\VBN\441445|requirements|may|be|patients|,|narcotics (l_nmod) narcotics_21\NNS\3247620|with|(|morphine
DDI-DrugBank.d776.s17
DDI-DrugBank.d776.s17.e1_DDI-DrugBank.d776.s17.e0 false rifampin_20\NN\2716205|with (r_nmod) administered_18\VBN\2436349|when|it|is|rifampin (r_advcl) increasing_10\VBG\169651|to|dose|administered (l_dobj) dose_12\NN\3740161|the|diflucan (l_nmod) diflucan_14\NN\1740|of
DDI-DrugBank.d739.s8
DDI-DrugBank.d739.s8.e0_DDI-DrugBank.d739.s8.e1 false phenobarbital_17\NN\2792049|such|or|rifampin (l_conj) rifampin_19\NN\2716205|
DDI-DrugBank.d739.s8.e0_DDI-DrugBank.d739.s8.e2 true phenobarbital_17\NN\2792049|such|or|rifampin (r_nmod) inducers_13\NNS\14778436|potent|enzyme|,|phenobarbital|, (r_nsubjpass) co-administered_22\VBN\1740|when|inducers|are|montelukast (l_nmod) montelukast_24\NN\1740|with
DDI-DrugBank.d739.s8.e1_DDI-DrugBank.d739.s8.e2 true rifampin_19\NN\2716205| (r_conj) phenobarbital_17\NN\2792049|such|or|rifampin (r_nmod) inducers_13\NNS\14778436|potent|enzyme|,|phenobarbital|, (r_nsubjpass) co-administered_22\VBN\1740|when|inducers|are|montelukast (l_nmod) montelukast_24\NN\1740|with
DDI-DrugBank.d649.s0
DDI-DrugBank.d649.s0.e0_DDI-DrugBank.d649.s0.e2 true sulfamethizole_0\NN\1740| (r_nsubj) increase_2\VB\169651|sulfamethizole|may|effects|. (l_dobj) effects_4\NNS\13245626|the|barbiturates (l_nmod) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) tolbutamide_8\NN\14914301|
DDI-DrugBank.d649.s0.e0_DDI-DrugBank.d649.s0.e1 true sulfamethizole_0\NN\1740| (r_nsubj) increase_2\VB\169651|sulfamethizole|may|effects|. (l_dobj) effects_4\NNS\13245626|the|barbiturates (l_nmod) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics
DDI-DrugBank.d649.s0.e0_DDI-DrugBank.d649.s0.e3 true sulfamethizole_0\NN\1740| (r_nsubj) increase_2\VB\169651|sulfamethizole|may|effects|. (l_dobj) effects_4\NNS\13245626|the|barbiturates (l_nmod) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) uricosurics_11\NNS\1740|
DDI-DrugBank.d649.s0.e2_DDI-DrugBank.d649.s0.e1 false tolbutamide_8\NN\14914301| (r_conj) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics
DDI-DrugBank.d649.s0.e2_DDI-DrugBank.d649.s0.e3 false tolbutamide_8\NN\14914301| (r_conj) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) uricosurics_11\NNS\1740|
DDI-DrugBank.d649.s0.e1_DDI-DrugBank.d649.s0.e3 false barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) uricosurics_11\NNS\1740|
DDI-DrugBank.d750.s0
DDI-DrugBank.d750.s0.e0_DDI-DrugBank.d750.s0.e1 true alcohol_3\NN\7881800|of (r_nmod) use_1\NN\407535|concomitant|alcohol|hydrochloride (l_nmod) hydrochloride_6\NNP\14817592|with|phentermine
DDI-DrugBank.d623.s4
DDI-DrugBank.d635.s0
DDI-DrugBank.d635.s0.e1_DDI-DrugBank.d635.s0.e0 false autohaler_13\NN\1740|with|maxair (r_nmod) used_9\VBN\1156834|bronchodilators|should|not|be|concomitantly|autohaler|have|. (l_nsubjpass) bronchodilators_5\NNS\3740161|other|short-acting|adrenergic|aerosol
DDI-DrugBank.d728.s2
DDI-DrugBank.d728.s2.e0_DDI-DrugBank.d728.s2.e1 true 5-fu_2\NN\1740| (r_compound) concentrations_4\NNS\4916342|of|5-fu|plasma (r_nmod) increases_0\NNS\13576355|concentrations|% (r_nsubjpass) observed_11\VBN\2163746|increases|have|been|doses|. (l_nmod) doses_13\NNS\3740161|with|eloxatin (l_nmod) eloxatin_17\NN\1740|of|mg/m2|dosed
DDI-DrugBank.d652.s1
DDI-DrugBank.d652.s1.e0_DDI-DrugBank.d652.s1.e1 true metoclopramide_6\NN\1740| (r_nsubjpass) given_8\VBN\2327200|when|metoclopramide|is|alcohol (l_nmod) alcohol_10\NN\7881800|with|,|sedatives
DDI-DrugBank.d652.s1.e0_DDI-DrugBank.d652.s1.e2 true metoclopramide_6\NN\1740| (r_nsubjpass) given_8\VBN\2327200|when|metoclopramide|is|alcohol (l_nmod) alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics
DDI-DrugBank.d652.s1.e0_DDI-DrugBank.d652.s1.e3 true metoclopramide_6\NN\1740| (r_nsubjpass) given_8\VBN\2327200|when|metoclopramide|is|alcohol (l_nmod) alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics
DDI-DrugBank.d652.s1.e0_DDI-DrugBank.d652.s1.e4 true metoclopramide_6\NN\1740| (r_nsubjpass) given_8\VBN\2327200|when|metoclopramide|is|alcohol (l_nmod) alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers
DDI-DrugBank.d652.s1.e0_DDI-DrugBank.d652.s1.e5 true metoclopramide_6\NN\1740| (r_nsubjpass) given_8\VBN\2327200|when|metoclopramide|is|alcohol (l_nmod) alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers (l_conj) tranquilizers_19\NNS\4017429|
DDI-DrugBank.d652.s1.e1_DDI-DrugBank.d652.s1.e2 false alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics
DDI-DrugBank.d652.s1.e1_DDI-DrugBank.d652.s1.e3 false alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics
DDI-DrugBank.d652.s1.e1_DDI-DrugBank.d652.s1.e4 false alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers
DDI-DrugBank.d652.s1.e1_DDI-DrugBank.d652.s1.e5 false alcohol_10\NN\7881800|with|,|sedatives (l_conj) sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers (l_conj) tranquilizers_19\NNS\4017429|
DDI-DrugBank.d652.s1.e2_DDI-DrugBank.d652.s1.e3 false sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics
DDI-DrugBank.d652.s1.e2_DDI-DrugBank.d652.s1.e4 false sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers
DDI-DrugBank.d652.s1.e2_DDI-DrugBank.d652.s1.e5 false sedatives_12\NNS\3248958|,|hypnotics (l_conj) hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers (l_conj) tranquilizers_19\NNS\4017429|
DDI-DrugBank.d652.s1.e3_DDI-DrugBank.d652.s1.e4 false hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers
DDI-DrugBank.d652.s1.e3_DDI-DrugBank.d652.s1.e5 false hypnotics_14\NNS\3247620|,|narcotics (l_conj) narcotics_16\NNS\3247620|,|or|tranquilizers (l_conj) tranquilizers_19\NNS\4017429|
DDI-DrugBank.d652.s1.e4_DDI-DrugBank.d652.s1.e5 false narcotics_16\NNS\3247620|,|or|tranquilizers (l_conj) tranquilizers_19\NNS\4017429|
DDI-DrugBank.d753.s0
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e0 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (r_conj) opioids_20\NNS\1740|other|,|antidepressants (r_conj) phenothiazines_17\NNS\14771088|,|opioids (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (r_nmod) depressants_6\NNS\3248958|of|other|cns|sedatives
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e1 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (r_conj) opioids_20\NNS\1740|other|,|antidepressants (r_conj) phenothiazines_17\NNS\14771088|,|opioids (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e2 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (r_conj) opioids_20\NNS\1740|other|,|antidepressants (r_conj) phenothiazines_17\NNS\14771088|,|opioids (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) hypnotics_10\NNS\3247620|
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e3 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (r_conj) opioids_20\NNS\1740|other|,|antidepressants (r_conj) phenothiazines_17\NNS\14771088|,|opioids (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) tranquilizers_12\NNS\4017429|
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e4 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (r_conj) opioids_20\NNS\1740|other|,|antidepressants (r_conj) phenothiazines_17\NNS\14771088|,|opioids (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) anesthetics_15\NNS\3247620|general
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e5 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (r_conj) opioids_20\NNS\1740|other|,|antidepressants (r_conj) phenothiazines_17\NNS\14771088|,|opioids
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e6 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (r_conj) opioids_20\NNS\1740|other|,|antidepressants
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e7 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol (r_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e9_DDI-DrugBank.d753.s0.e8 false alcohol_33\NN\7881800| (r_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e1 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e2 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) hypnotics_10\NNS\3247620|
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e3 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) tranquilizers_12\NNS\4017429|
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e4 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) anesthetics_15\NNS\3247620|general
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e5 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e6 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e7 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e0_DDI-DrugBank.d753.s0.e8 false depressants_6\NNS\3248958|of|other|cns|sedatives (l_nmod) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e1_DDI-DrugBank.d753.s0.e2 false sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) hypnotics_10\NNS\3247620|
DDI-DrugBank.d753.s0.e1_DDI-DrugBank.d753.s0.e3 false sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) tranquilizers_12\NNS\4017429|
DDI-DrugBank.d753.s0.e1_DDI-DrugBank.d753.s0.e4 false sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) anesthetics_15\NNS\3247620|general
DDI-DrugBank.d753.s0.e1_DDI-DrugBank.d753.s0.e5 false sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids
DDI-DrugBank.d753.s0.e1_DDI-DrugBank.d753.s0.e6 false sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants
DDI-DrugBank.d753.s0.e1_DDI-DrugBank.d753.s0.e7 false sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e1_DDI-DrugBank.d753.s0.e8 false sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e2_DDI-DrugBank.d753.s0.e3 false hypnotics_10\NNS\3247620| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) tranquilizers_12\NNS\4017429|
DDI-DrugBank.d753.s0.e2_DDI-DrugBank.d753.s0.e4 false hypnotics_10\NNS\3247620| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) anesthetics_15\NNS\3247620|general
DDI-DrugBank.d753.s0.e2_DDI-DrugBank.d753.s0.e5 false hypnotics_10\NNS\3247620| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids
DDI-DrugBank.d753.s0.e2_DDI-DrugBank.d753.s0.e6 false hypnotics_10\NNS\3247620| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants
DDI-DrugBank.d753.s0.e2_DDI-DrugBank.d753.s0.e7 false hypnotics_10\NNS\3247620| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e2_DDI-DrugBank.d753.s0.e8 false hypnotics_10\NNS\3247620| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e3_DDI-DrugBank.d753.s0.e4 false tranquilizers_12\NNS\4017429| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) anesthetics_15\NNS\3247620|general
DDI-DrugBank.d753.s0.e3_DDI-DrugBank.d753.s0.e5 false tranquilizers_12\NNS\4017429| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids
DDI-DrugBank.d753.s0.e3_DDI-DrugBank.d753.s0.e6 false tranquilizers_12\NNS\4017429| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants
DDI-DrugBank.d753.s0.e3_DDI-DrugBank.d753.s0.e7 false tranquilizers_12\NNS\4017429| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e3_DDI-DrugBank.d753.s0.e8 false tranquilizers_12\NNS\4017429| (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e4_DDI-DrugBank.d753.s0.e5 false anesthetics_15\NNS\3247620|general (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids
DDI-DrugBank.d753.s0.e4_DDI-DrugBank.d753.s0.e6 false anesthetics_15\NNS\3247620|general (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants
DDI-DrugBank.d753.s0.e4_DDI-DrugBank.d753.s0.e7 false anesthetics_15\NNS\3247620|general (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e4_DDI-DrugBank.d753.s0.e8 false anesthetics_15\NNS\3247620|general (r_conj) sedatives_8\NNS\3248958|including|,|hypnotics|,|tranquilizers|,|anesthetics|,|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e5_DDI-DrugBank.d753.s0.e6 false phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants
DDI-DrugBank.d753.s0.e5_DDI-DrugBank.d753.s0.e7 false phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e5_DDI-DrugBank.d753.s0.e8 false phenothiazines_17\NNS\14771088|,|opioids (l_conj) opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e6_DDI-DrugBank.d753.s0.e7 false opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors
DDI-DrugBank.d753.s0.e6_DDI-DrugBank.d753.s0.e8 false opioids_20\NNS\1740|other|,|antidepressants (l_conj) antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d753.s0.e7_DDI-DrugBank.d753.s0.e8 false antidepressants_23\NNS\3740161|tricyclic|,|inhibitors (l_conj) inhibitors_30\NNS\20090|oxidase|,|and|alcohol
DDI-DrugBank.d779.s12
DDI-DrugBank.d652.s4
DDI-DrugBank.d687.s1
DDI-DrugBank.d591.s3
DDI-DrugBank.d591.s3.e0_DDI-DrugBank.d591.s3.e1 true fluvoxamine_9\NN\1740|such|, (r_nmod) inhibitors_2\NNS\20090|strong|p4501a2|,|fluvoxamine|given|, (l_acl) given_11\VBN\2327200|concomitantly|administration (l_nmod) administration_14\NN\1133281|during|ropivacaine (l_nmod) ropivacaine_16\NN\1740|of
DDI-DrugBank.d591.s3.e0_DDI-DrugBank.d591.s3.e2 false fluvoxamine_9\NN\1740|such|, (r_nmod) inhibitors_2\NNS\20090|strong|p4501a2|,|fluvoxamine|given|, (r_nsubj) interact_19\VB\2367363|thus|inhibitors|can|ropivacaine|leading|. (l_nmod) ropivacaine_21\NN\1740|with
DDI-DrugBank.d591.s3.e0_DDI-DrugBank.d591.s3.e3 false fluvoxamine_9\NN\1740|such|, (r_nmod) inhibitors_2\NNS\20090|strong|p4501a2|,|fluvoxamine|given|, (r_nsubj) interact_19\VB\2367363|thus|inhibitors|can|ropivacaine|leading|. (l_xcomp) leading_22\VBG\1752884|levels (l_nmod) levels_27\NNS\4916342|to|increased|ropivacaine|plasma (l_compound) ropivacaine_25\NN\1740|
DDI-DrugBank.d591.s3.e1_DDI-DrugBank.d591.s3.e2 false ropivacaine_16\NN\1740|of (r_nmod) administration_14\NN\1133281|during|ropivacaine (r_nmod) given_11\VBN\2327200|concomitantly|administration (r_acl) inhibitors_2\NNS\20090|strong|p4501a2|,|fluvoxamine|given|, (r_nsubj) interact_19\VB\2367363|thus|inhibitors|can|ropivacaine|leading|. (l_nmod) ropivacaine_21\NN\1740|with
DDI-DrugBank.d591.s3.e1_DDI-DrugBank.d591.s3.e3 false ropivacaine_16\NN\1740|of (r_nmod) administration_14\NN\1133281|during|ropivacaine (r_nmod) given_11\VBN\2327200|concomitantly|administration (r_acl) inhibitors_2\NNS\20090|strong|p4501a2|,|fluvoxamine|given|, (r_nsubj) interact_19\VB\2367363|thus|inhibitors|can|ropivacaine|leading|. (l_xcomp) leading_22\VBG\1752884|levels (l_nmod) levels_27\NNS\4916342|to|increased|ropivacaine|plasma (l_compound) ropivacaine_25\NN\1740|
DDI-DrugBank.d591.s3.e2_DDI-DrugBank.d591.s3.e3 false ropivacaine_21\NN\1740|with (r_nmod) interact_19\VB\2367363|thus|inhibitors|can|ropivacaine|leading|. (l_xcomp) leading_22\VBG\1752884|levels (l_nmod) levels_27\NNS\4916342|to|increased|ropivacaine|plasma (l_compound) ropivacaine_25\NN\1740|
DDI-DrugBank.d680.s1
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e1 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e2 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) cisapride_26\NN\1740|
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e3 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) antipyrine_28\NN\1740|
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e4 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) caffeine_30\NN\14712692|
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e5 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) carbamazepine_32\NN\1740|
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e6 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diazepam_34\NN\2830852|
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e7 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (l_appos) desmethyldiazepam_41\NN\1740|
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e8 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e0_DDI-DrugBank.d680.s1.e9 false pantoprazole_7\NN\1740|of (r_nmod) interactions_5\NNS\37396|possible|pantoprazole|drugs (r_dobj) evaluating_3\VBG\670261|interactions (r_acl) studies_2\NNS\635850|based|on|evaluating (r_nmod) needed_16\VBN\2604760|studies|,|adjustment|is|use|. (l_nmod) use_19\NN\407535|with|concomitant|following (l_nmod) following_22\JJ\1740|of|the|:|theophylline (l_dep) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e2 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) cisapride_26\NN\1740|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e3 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) antipyrine_28\NN\1740|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e4 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) caffeine_30\NN\14712692|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e5 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) carbamazepine_32\NN\1740|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e6 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diazepam_34\NN\2830852|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e7 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (l_appos) desmethyldiazepam_41\NN\1740|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e8 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e1_DDI-DrugBank.d680.s1.e9 false theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e2_DDI-DrugBank.d680.s1.e3 false cisapride_26\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) antipyrine_28\NN\1740|
DDI-DrugBank.d680.s1.e2_DDI-DrugBank.d680.s1.e4 false cisapride_26\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) caffeine_30\NN\14712692|
DDI-DrugBank.d680.s1.e2_DDI-DrugBank.d680.s1.e5 false cisapride_26\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) carbamazepine_32\NN\1740|
DDI-DrugBank.d680.s1.e2_DDI-DrugBank.d680.s1.e6 false cisapride_26\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diazepam_34\NN\2830852|
DDI-DrugBank.d680.s1.e2_DDI-DrugBank.d680.s1.e7 false cisapride_26\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (l_appos) desmethyldiazepam_41\NN\1740|
DDI-DrugBank.d680.s1.e2_DDI-DrugBank.d680.s1.e8 false cisapride_26\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e2_DDI-DrugBank.d680.s1.e9 false cisapride_26\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e3_DDI-DrugBank.d680.s1.e4 false antipyrine_28\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) caffeine_30\NN\14712692|
DDI-DrugBank.d680.s1.e3_DDI-DrugBank.d680.s1.e5 false antipyrine_28\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) carbamazepine_32\NN\1740|
DDI-DrugBank.d680.s1.e3_DDI-DrugBank.d680.s1.e6 false antipyrine_28\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diazepam_34\NN\2830852|
DDI-DrugBank.d680.s1.e3_DDI-DrugBank.d680.s1.e7 false antipyrine_28\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (l_appos) desmethyldiazepam_41\NN\1740|
DDI-DrugBank.d680.s1.e3_DDI-DrugBank.d680.s1.e8 false antipyrine_28\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e3_DDI-DrugBank.d680.s1.e9 false antipyrine_28\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e4_DDI-DrugBank.d680.s1.e5 false caffeine_30\NN\14712692| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) carbamazepine_32\NN\1740|
DDI-DrugBank.d680.s1.e4_DDI-DrugBank.d680.s1.e6 false caffeine_30\NN\14712692| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diazepam_34\NN\2830852|
DDI-DrugBank.d680.s1.e4_DDI-DrugBank.d680.s1.e7 false caffeine_30\NN\14712692| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (l_appos) desmethyldiazepam_41\NN\1740|
DDI-DrugBank.d680.s1.e4_DDI-DrugBank.d680.s1.e8 false caffeine_30\NN\14712692| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e4_DDI-DrugBank.d680.s1.e9 false caffeine_30\NN\14712692| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e5_DDI-DrugBank.d680.s1.e6 false carbamazepine_32\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diazepam_34\NN\2830852|
DDI-DrugBank.d680.s1.e5_DDI-DrugBank.d680.s1.e7 false carbamazepine_32\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (l_appos) desmethyldiazepam_41\NN\1740|
DDI-DrugBank.d680.s1.e5_DDI-DrugBank.d680.s1.e8 false carbamazepine_32\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e5_DDI-DrugBank.d680.s1.e9 false carbamazepine_32\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e6_DDI-DrugBank.d680.s1.e7 false diazepam_34\NN\2830852| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (l_appos) desmethyldiazepam_41\NN\1740|
DDI-DrugBank.d680.s1.e6_DDI-DrugBank.d680.s1.e8 false diazepam_34\NN\2830852| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e6_DDI-DrugBank.d680.s1.e9 false diazepam_34\NN\2830852| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e7_DDI-DrugBank.d680.s1.e8 false desmethyldiazepam_41\NN\1740| (r_appos) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) diclofenac_44\NN\1740|
DDI-DrugBank.d680.s1.e7_DDI-DrugBank.d680.s1.e9 false desmethyldiazepam_41\NN\1740| (r_appos) metabolite_39\NN\20090|its|active|,|desmethyldiazepam|) (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d680.s1.e8_DDI-DrugBank.d680.s1.e9 false diclofenac_44\NN\1740| (r_conj) theophylline_24\NN\2905612|,|cisapride|,|antipyrine|,|caffeine|,|carbamazepine|,|diazepam|(|and|metabolite|,|diclofenac|,|naproxen|,|piroxicam|,|digoxin|,|ethanol|,|glyburide|,|contraceptive|,|metoprolol|,|nifedipine|,|phenytoin|,|warfarin|,|midazolam|,|clarithromycin|,|metronidazole|,|or|amoxicillin (l_conj) naproxen_46\NN\3828465|
DDI-DrugBank.d737.s8
DDI-DrugBank.d616.s2
DDI-DrugBank.d735.s3
DDI-DrugBank.d735.s3.e0_DDI-DrugBank.d735.s3.e2 false sirolimus_0\NN\1740| (r_compound) auc_1\NN\1740|sirolimus (r_nsubjpass) increased_3\VBN\169651|auc|was|%|effect|. (l_nmod) effect_9\NN\34213|with|no|cmax|presence|sirolimus (l_nmod) sirolimus_20\NN\1740|compared|with|alone
DDI-DrugBank.d735.s3.e0_DDI-DrugBank.d735.s3.e1 true sirolimus_0\NN\1740| (r_compound) auc_1\NN\1740|sirolimus (r_nsubjpass) increased_3\VBN\169651|auc|was|%|effect|. (l_nmod) effect_9\NN\34213|with|no|cmax|presence|sirolimus (l_nmod) presence_14\NN\13954253|in|the|mycamine (l_nmod) mycamine_17\NN\1740|of|steady-state
DDI-DrugBank.d735.s3.e2_DDI-DrugBank.d735.s3.e1 false sirolimus_20\NN\1740|compared|with|alone (r_nmod) effect_9\NN\34213|with|no|cmax|presence|sirolimus (l_nmod) presence_14\NN\13954253|in|the|mycamine (l_nmod) mycamine_17\NN\1740|of|steady-state
DDI-DrugBank.d776.s31
DDI-DrugBank.d776.s31.e0_DDI-DrugBank.d776.s31.e1 false rifabutin_0\NN\1740| (r_dep) been_4\VBN\836236|rifabutin|:|there|have|reports|. (l_attr) reports_5\NNS\6470073|uveitis (l_nmod) uveitis_7\NN\14336539|of|patients (l_nmod) patients_9\NNS\9898892|in|coadministered (l_acl:relcl) coadministered_16\VBN\1740|whom|fluconazole|were (l_nsubjpass) fluconazole_12\NN\1740|and|rifabutin
DDI-DrugBank.d776.s31.e0_DDI-DrugBank.d776.s31.e2 false rifabutin_0\NN\1740| (r_dep) been_4\VBN\836236|rifabutin|:|there|have|reports|. (l_attr) reports_5\NNS\6470073|uveitis (l_nmod) uveitis_7\NN\14336539|of|patients (l_nmod) patients_9\NNS\9898892|in|coadministered (l_acl:relcl) coadministered_16\VBN\1740|whom|fluconazole|were (l_nsubjpass) fluconazole_12\NN\1740|and|rifabutin (l_conj) rifabutin_14\NN\1740|
DDI-DrugBank.d776.s31.e1_DDI-DrugBank.d776.s31.e2 true fluconazole_12\NN\1740|and|rifabutin (l_conj) rifabutin_14\NN\1740|
DDI-DrugBank.d761.s3
DDI-DrugBank.d761.s3.e1_DDI-DrugBank.d761.s3.e2 true beta-carotene_16\NN\14720962| (r_compound) supplement_17\NN\6365467|beta-carotene (r_compound) absorption_18\NN\13558490|in|supplement (r_nmod) reduction_14\NN\351485|a|%|absorption (r_dobj) showed_10\VBD\2137132|study|reduction|administered|. (l_advcl) administered_21\VBN\2436349|when|concomitantly|xenical (l_nmod) xenical_23\NN\1740|with
DDI-DrugBank.d761.s3.e1_DDI-DrugBank.d761.s3.e0 false beta-carotene_16\NN\14720962| (r_compound) supplement_17\NN\6365467|beta-carotene (r_compound) absorption_18\NN\13558490|in|supplement (r_nmod) reduction_14\NN\351485|a|%|absorption (r_dobj) showed_10\VBD\2137132|study|reduction|administered|. (r_dep) supplements_2\NNS\6365467|fat-soluble|vitamin|and|analogues|:|showed
DDI-DrugBank.d761.s3.e2_DDI-DrugBank.d761.s3.e0 false xenical_23\NN\1740|with (r_nmod) administered_21\VBN\2436349|when|concomitantly|xenical (r_advcl) showed_10\VBD\2137132|study|reduction|administered|. (r_dep) supplements_2\NNS\6365467|fat-soluble|vitamin|and|analogues|:|showed
DDI-DrugBank.d653.s5
DDI-DrugBank.d653.s5.e0_DDI-DrugBank.d653.s5.e1 false salicylate_5\NN\3828465| (r_compound) levels_7\NNS\4916342|to|decreased|salicylate|serum (r_nmod) lead_2\VB\1752884|this|could|levels|or|increase|. (l_conj) increase_9\VB\169651|risk|withdrawn (l_dobj) risk_11\NN\14541044|the|toxicity (l_nmod) toxicity_14\NN\13576101|of|salicylate (l_compound) salicylate_13\NN\3828465|
DDI-DrugBank.d653.s5.e0_DDI-DrugBank.d653.s5.e2 false salicylate_5\NN\3828465| (r_compound) levels_7\NNS\4916342|to|decreased|salicylate|serum (r_nmod) lead_2\VB\1752884|this|could|levels|or|increase|. (l_conj) increase_9\VB\169651|risk|withdrawn (l_advcl) withdrawn_18\VBN\1835496|when|corticosteroid|is (l_nsubjpass) corticosteroid_16\NN\14745635|
DDI-DrugBank.d653.s5.e1_DDI-DrugBank.d653.s5.e2 true salicylate_13\NN\3828465| (r_compound) toxicity_14\NN\13576101|of|salicylate (r_nmod) risk_11\NN\14541044|the|toxicity (r_dobj) increase_9\VB\169651|risk|withdrawn (l_advcl) withdrawn_18\VBN\1835496|when|corticosteroid|is (l_nsubjpass) corticosteroid_16\NN\14745635|
DDI-DrugBank.d633.s15
DDI-DrugBank.d633.s15.e1_DDI-DrugBank.d633.s15.e2 false digoxin_5\NN\15060131| (r_compound) levels_6\NNS\4916342|serum|digoxin (r_dobj) alter_3\VB\126264|mexitil|does|not|levels|but|used (l_conj) used_12\VBN\1156834|hydroxide|when|treat|, (l_nsubjpass) hydroxide_9\NN\14818238|magnesium-aluminum|,
DDI-DrugBank.d633.s15.e1_DDI-DrugBank.d633.s15.e4 false digoxin_5\NN\15060131| (r_compound) levels_6\NNS\4916342|serum|digoxin (r_dobj) alter_3\VB\126264|mexitil|does|not|levels|but|used (r_nsubjpass) reported_23\VBN\831651|alter|has|been|lower|. (l_xcomp) lower_25\VB\1850315|to|levels (l_dobj) levels_28\NNS\4916342|serum|digoxin (l_compound) digoxin_27\NN\15060131|
DDI-DrugBank.d633.s15.e1_DDI-DrugBank.d633.s15.e0 false digoxin_5\NN\15060131| (r_compound) levels_6\NNS\4916342|serum|digoxin (r_dobj) alter_3\VB\126264|mexitil|does|not|levels|but|used (l_nsubj) mexitil_0\NN\2715941|
DDI-DrugBank.d633.s15.e1_DDI-DrugBank.d633.s15.e3 false digoxin_5\NN\15060131| (r_compound) levels_6\NNS\4916342|serum|digoxin (r_dobj) alter_3\VB\126264|mexitil|does|not|levels|but|used (l_conj) used_12\VBN\1156834|hydroxide|when|treat|, (l_xcomp) treat_14\VB\2376958|to|symptoms (l_dobj) symptoms_16\NNS\5823932|gastrointestinal|due (l_amod) due_17\JJ\1740|mexitil (l_nmod) mexitil_19\NN\2715941|to
DDI-DrugBank.d633.s15.e2_DDI-DrugBank.d633.s15.e4 true hydroxide_9\NN\14818238|magnesium-aluminum|, (r_nsubjpass) used_12\VBN\1156834|hydroxide|when|treat|, (r_conj) alter_3\VB\126264|mexitil|does|not|levels|but|used (r_nsubjpass) reported_23\VBN\831651|alter|has|been|lower|. (l_xcomp) lower_25\VB\1850315|to|levels (l_dobj) levels_28\NNS\4916342|serum|digoxin (l_compound) digoxin_27\NN\15060131|
DDI-DrugBank.d633.s15.e2_DDI-DrugBank.d633.s15.e0 false hydroxide_9\NN\14818238|magnesium-aluminum|, (r_nsubjpass) used_12\VBN\1156834|hydroxide|when|treat|, (r_conj) alter_3\VB\126264|mexitil|does|not|levels|but|used (l_nsubj) mexitil_0\NN\2715941|
DDI-DrugBank.d633.s15.e2_DDI-DrugBank.d633.s15.e3 false hydroxide_9\NN\14818238|magnesium-aluminum|, (r_nsubjpass) used_12\VBN\1156834|hydroxide|when|treat|, (l_xcomp) treat_14\VB\2376958|to|symptoms (l_dobj) symptoms_16\NNS\5823932|gastrointestinal|due (l_amod) due_17\JJ\1740|mexitil (l_nmod) mexitil_19\NN\2715941|to
DDI-DrugBank.d633.s15.e4_DDI-DrugBank.d633.s15.e0 false digoxin_27\NN\15060131| (r_compound) levels_28\NNS\4916342|serum|digoxin (r_dobj) lower_25\VB\1850315|to|levels (r_xcomp) reported_23\VBN\831651|alter|has|been|lower|. (l_nsubjpass) alter_3\VB\126264|mexitil|does|not|levels|but|used (l_nsubj) mexitil_0\NN\2715941|
DDI-DrugBank.d633.s15.e4_DDI-DrugBank.d633.s15.e3 false digoxin_27\NN\15060131| (r_compound) levels_28\NNS\4916342|serum|digoxin (r_dobj) lower_25\VB\1850315|to|levels (r_xcomp) reported_23\VBN\831651|alter|has|been|lower|. (l_nsubjpass) alter_3\VB\126264|mexitil|does|not|levels|but|used (l_conj) used_12\VBN\1156834|hydroxide|when|treat|, (l_xcomp) treat_14\VB\2376958|to|symptoms (l_dobj) symptoms_16\NNS\5823932|gastrointestinal|due (l_amod) due_17\JJ\1740|mexitil (l_nmod) mexitil_19\NN\2715941|to
DDI-DrugBank.d633.s15.e0_DDI-DrugBank.d633.s15.e3 false mexitil_0\NN\2715941| (r_nsubj) alter_3\VB\126264|mexitil|does|not|levels|but|used (l_conj) used_12\VBN\1156834|hydroxide|when|treat|, (l_xcomp) treat_14\VB\2376958|to|symptoms (l_dobj) symptoms_16\NNS\5823932|gastrointestinal|due (l_amod) due_17\JJ\1740|mexitil (l_nmod) mexitil_19\NN\2715941|to
DDI-DrugBank.d572.s1
DDI-DrugBank.d572.s1.e0_DDI-DrugBank.d572.s1.e1 true ezetimibe_7\NN\1740| (r_dobj) adding_6\VBG\156601|to|ezetimibe|cholestyramine (l_nmod) cholestyramine_9\NN\1740|to
DDI-DrugBank.d676.s3
DDI-DrugBank.d776.s21
DDI-DrugBank.d581.s0
DDI-DrugBank.d777.s5
DDI-DrugBank.d777.s5.e1_DDI-DrugBank.d777.s5.e0 false streptokinase_5\NN\14732946|to (r_nmod) addition_1\NN\3081021|the|aspirin|streptokinase (l_nmod) aspirin_3\NN\2707683|of
DDI-DrugBank.d694.s0
DDI-DrugBank.d694.s0.e0_DDI-DrugBank.d694.s0.e1 false digoxin_0\NN\15060131| (r_dep) was_3\VBD\836236|digoxin|:|there|increase|. (l_nsubj) increase_6\NN\13576355|a|slight|area|co-administration (l_nmod) area_9\NN\8630985|in|the|curve|auc|and|concentration (l_conj) concentration_23\NN\4916342|mean|peak|drug|cmax|digoxin (l_nmod) digoxin_31\NN\15060131|of
DDI-DrugBank.d694.s0.e0_DDI-DrugBank.d694.s0.e2 false digoxin_0\NN\15060131| (r_dep) was_3\VBD\836236|digoxin|:|there|increase|. (l_nsubj) increase_6\NN\13576355|a|slight|area|co-administration (l_nmod) co-administration_34\NN\1740|with|the|sitagliptin|days (l_nmod) sitagliptin_38\NN\1740|of|mg
DDI-DrugBank.d694.s0.e1_DDI-DrugBank.d694.s0.e2 true digoxin_31\NN\15060131|of (r_nmod) concentration_23\NN\4916342|mean|peak|drug|cmax|digoxin (r_conj) area_9\NN\8630985|in|the|curve|auc|and|concentration (r_nmod) increase_6\NN\13576355|a|slight|area|co-administration (l_nmod) co-administration_34\NN\1740|with|the|sitagliptin|days (l_nmod) sitagliptin_38\NN\1740|of|mg
DDI-DrugBank.d700.s2
DDI-DrugBank.d700.s2.e0_DDI-DrugBank.d700.s2.e1 false cyclosporine_0\NN\1740| (r_nmod:npmod) unaffected_18\JJ\1740|cyclosporine|:|studied|,|cyclosporine|,|pharmacokinetics|were|dosing|. (l_nmod:npmod) cyclosporine_10\NN\1740|
DDI-DrugBank.d700.s2.e0_DDI-DrugBank.d700.s2.e2 false cyclosporine_0\NN\1740| (r_nmod:npmod) unaffected_18\JJ\1740|cyclosporine|:|studied|,|cyclosporine|,|pharmacokinetics|were|dosing|. (l_nmod) dosing_22\NN\1740|by|steady|state|myfortic (l_nmod) myfortic_24\JJ\1740|of
DDI-DrugBank.d700.s2.e1_DDI-DrugBank.d700.s2.e2 false cyclosporine_10\NN\1740| (r_nmod:npmod) unaffected_18\JJ\1740|cyclosporine|:|studied|,|cyclosporine|,|pharmacokinetics|were|dosing|. (l_nmod) dosing_22\NN\1740|by|steady|state|myfortic (l_nmod) myfortic_24\JJ\1740|of
DDI-DrugBank.d771.s4
DDI-DrugBank.d627.s0
DDI-DrugBank.d627.s0.e0_DDI-DrugBank.d627.s0.e1 true pilocarpine_0\NN\14712692| (r_nsubjpass) administered_3\VBN\2436349|pilocarpine|should|be|caution|patients|possibility|. (l_nmod) patients_7\NNS\9898892|to|taking (l_acl) taking_8\VBG\2367363|antagonists (l_dobj) antagonists_11\NNS\7846|beta|adrenergic
DDI-DrugBank.d648.s3
DDI-DrugBank.d648.s3.e1_DDI-DrugBank.d648.s3.e0 false warfarin_6\NN\2718259|concurrently|with (r_nmod) given_3\VBN\2327200|if|evista|is|warfarin (l_nsubjpass) evista_1\NNP\1740|
DDI-DrugBank.d604.s0
DDI-DrugBank.d604.s0.e0_DDI-DrugBank.d604.s0.e2 false thalidomide_0\NN\4166841| (r_nsubjpass) reported_3\VBN\831651|thalidomide|has|been|enhance|. (l_xcomp) enhance_5\VB\227165|to|activity (l_dobj) activity_8\NN\30358|the|sedative|barbiturates (l_nmod) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine (l_conj) alcohol_12\NN\7881800|
DDI-DrugBank.d604.s0.e0_DDI-DrugBank.d604.s0.e3 false thalidomide_0\NN\4166841| (r_nsubjpass) reported_3\VBN\831651|thalidomide|has|been|enhance|. (l_xcomp) enhance_5\VB\227165|to|activity (l_dobj) activity_8\NN\30358|the|sedative|barbiturates (l_nmod) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine (l_conj) chlorpromazine_14\NN\3713736|
DDI-DrugBank.d604.s0.e0_DDI-DrugBank.d604.s0.e4 false thalidomide_0\NN\4166841| (r_nsubjpass) reported_3\VBN\831651|thalidomide|has|been|enhance|. (l_xcomp) enhance_5\VB\227165|to|activity (l_dobj) activity_8\NN\30358|the|sedative|barbiturates (l_nmod) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine (l_conj) reserpine_17\NN\2721160|
DDI-DrugBank.d604.s0.e0_DDI-DrugBank.d604.s0.e1 true thalidomide_0\NN\4166841| (r_nsubjpass) reported_3\VBN\831651|thalidomide|has|been|enhance|. (l_xcomp) enhance_5\VB\227165|to|activity (l_dobj) activity_8\NN\30358|the|sedative|barbiturates (l_nmod) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine
DDI-DrugBank.d604.s0.e2_DDI-DrugBank.d604.s0.e3 false alcohol_12\NN\7881800| (r_conj) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine (l_conj) chlorpromazine_14\NN\3713736|
DDI-DrugBank.d604.s0.e2_DDI-DrugBank.d604.s0.e4 false alcohol_12\NN\7881800| (r_conj) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine (l_conj) reserpine_17\NN\2721160|
DDI-DrugBank.d604.s0.e2_DDI-DrugBank.d604.s0.e1 false alcohol_12\NN\7881800| (r_conj) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine
DDI-DrugBank.d604.s0.e3_DDI-DrugBank.d604.s0.e4 false chlorpromazine_14\NN\3713736| (r_conj) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine (l_conj) reserpine_17\NN\2721160|
DDI-DrugBank.d604.s0.e3_DDI-DrugBank.d604.s0.e1 false chlorpromazine_14\NN\3713736| (r_conj) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine
DDI-DrugBank.d604.s0.e4_DDI-DrugBank.d604.s0.e1 false reserpine_17\NN\2721160| (r_conj) barbiturates_10\NNS\4166841|of|,|alcohol|,|chlorpromazine|,|and|reserpine
DDI-DrugBank.d675.s5
DDI-DrugBank.d680.s3
DDI-DrugBank.d680.s3.e0_DDI-DrugBank.d680.s3.e1 false pantoprazole_5\NN\1740|with (r_nmod) coadministered_3\VBN\1740|when|pantoprazole (r_advcl) necessary_20\JJ\1740|therefore|,|coadministered|,|adjustment|may|not|be|. (l_nsubj) adjustment_7\NN\7357388|dosage (l_nmod) dosage_10\NN\13576355|of|the|pantoprazole|or|drugs (l_nmod) pantoprazole_12\NN\1740|of
DDI-DrugBank.d638.s1
DDI-DrugBank.d659.s4
DDI-DrugBank.d659.s4.e0_DDI-DrugBank.d659.s4.e1 false trental_0\NNP\3247620| (r_nsubjpass) used_3\VBN\1156834|trental|has|been|concurrently|drugs|,|problems|. (l_nmod) drugs_7\NNS\14778436|with|antihypertensive|,|blockers
DDI-DrugBank.d659.s4.e0_DDI-DrugBank.d659.s4.e2 false trental_0\NNP\3247620| (r_nsubjpass) used_3\VBN\1156834|trental|has|been|concurrently|drugs|,|problems|. (l_nmod) drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis
DDI-DrugBank.d659.s4.e0_DDI-DrugBank.d659.s4.e3 false trental_0\NNP\3247620| (r_nsubjpass) used_3\VBN\1156834|trental|has|been|concurrently|drugs|,|problems|. (l_nmod) drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics
DDI-DrugBank.d659.s4.e0_DDI-DrugBank.d659.s4.e4 false trental_0\NNP\3247620| (r_nsubjpass) used_3\VBN\1156834|trental|has|been|concurrently|drugs|,|problems|. (l_nmod) drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents
DDI-DrugBank.d659.s4.e0_DDI-DrugBank.d659.s4.e5 false trental_0\NNP\3247620| (r_nsubjpass) used_3\VBN\1156834|trental|has|been|concurrently|drugs|,|problems|. (l_nmod) drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics
DDI-DrugBank.d659.s4.e0_DDI-DrugBank.d659.s4.e6 false trental_0\NNP\3247620| (r_nsubjpass) used_3\VBN\1156834|trental|has|been|concurrently|drugs|,|problems|. (l_nmod) drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics (l_conj) antiarrhythmics_20\NNS\3740161|
DDI-DrugBank.d659.s4.e1_DDI-DrugBank.d659.s4.e2 false drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis
DDI-DrugBank.d659.s4.e1_DDI-DrugBank.d659.s4.e3 false drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics
DDI-DrugBank.d659.s4.e1_DDI-DrugBank.d659.s4.e4 false drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents
DDI-DrugBank.d659.s4.e1_DDI-DrugBank.d659.s4.e5 false drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics
DDI-DrugBank.d659.s4.e1_DDI-DrugBank.d659.s4.e6 false drugs_7\NNS\14778436|with|antihypertensive|,|blockers (l_conj) blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics (l_conj) antiarrhythmics_20\NNS\3740161|
DDI-DrugBank.d659.s4.e2_DDI-DrugBank.d659.s4.e3 false blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics
DDI-DrugBank.d659.s4.e2_DDI-DrugBank.d659.s4.e4 false blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents
DDI-DrugBank.d659.s4.e2_DDI-DrugBank.d659.s4.e5 false blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics
DDI-DrugBank.d659.s4.e2_DDI-DrugBank.d659.s4.e6 false blockers_10\NNS\10101634|beta|,|digitalis (l_conj) digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics (l_conj) antiarrhythmics_20\NNS\3740161|
DDI-DrugBank.d659.s4.e3_DDI-DrugBank.d659.s4.e4 false digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents
DDI-DrugBank.d659.s4.e3_DDI-DrugBank.d659.s4.e5 false digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics
DDI-DrugBank.d659.s4.e3_DDI-DrugBank.d659.s4.e6 false digitalis_12\NNS\15059939|,|diuretics (l_conj) diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics (l_conj) antiarrhythmics_20\NNS\3740161|
DDI-DrugBank.d659.s4.e4_DDI-DrugBank.d659.s4.e5 false diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics
DDI-DrugBank.d659.s4.e4_DDI-DrugBank.d659.s4.e6 false diuretics_14\NNS\3247620|,|agents (l_conj) agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics (l_conj) antiarrhythmics_20\NNS\3740161|
DDI-DrugBank.d659.s4.e5_DDI-DrugBank.d659.s4.e6 false agents_17\NNS\7347|antidiabetic|,|and|antiarrhythmics (l_conj) antiarrhythmics_20\NNS\3740161|
DDI-DrugBank.d671.s1
DDI-DrugBank.d711.s2
DDI-DrugBank.d711.s2.e2_DDI-DrugBank.d711.s2.e3 false aluminum_8\NN\14625458|,|calcium|,|and|preparations (l_conj) calcium_10\NN\14625458|or|magnesium
DDI-DrugBank.d711.s2.e2_DDI-DrugBank.d711.s2.e4 false aluminum_8\NN\14625458|,|calcium|,|and|preparations (l_conj) calcium_10\NN\14625458|or|magnesium (l_conj) magnesium_12\NN\14625458|
DDI-DrugBank.d711.s2.e2_DDI-DrugBank.d711.s2.e5 false aluminum_8\NN\14625458|,|calcium|,|and|preparations (l_conj) preparations_16\NNS\407535|iron-containing (l_amod) iron-containing_15\NN\1740|
DDI-DrugBank.d711.s2.e2_DDI-DrugBank.d711.s2.e0 false aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing (r_nmod) impaired_4\VBN\258857|absorption|is|antacids|. (l_nsubj) absorption_0\NN\13558490|tetracyclines (l_nmod) tetracyclines_2\NNS\2716205|of
DDI-DrugBank.d711.s2.e2_DDI-DrugBank.d711.s2.e1 false aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing
DDI-DrugBank.d711.s2.e3_DDI-DrugBank.d711.s2.e4 false calcium_10\NN\14625458|or|magnesium (l_conj) magnesium_12\NN\14625458|
DDI-DrugBank.d711.s2.e3_DDI-DrugBank.d711.s2.e5 false calcium_10\NN\14625458|or|magnesium (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (l_conj) preparations_16\NNS\407535|iron-containing (l_amod) iron-containing_15\NN\1740|
DDI-DrugBank.d711.s2.e3_DDI-DrugBank.d711.s2.e0 false calcium_10\NN\14625458|or|magnesium (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing (r_nmod) impaired_4\VBN\258857|absorption|is|antacids|. (l_nsubj) absorption_0\NN\13558490|tetracyclines (l_nmod) tetracyclines_2\NNS\2716205|of
DDI-DrugBank.d711.s2.e3_DDI-DrugBank.d711.s2.e1 false calcium_10\NN\14625458|or|magnesium (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing
DDI-DrugBank.d711.s2.e4_DDI-DrugBank.d711.s2.e5 false magnesium_12\NN\14625458| (r_conj) calcium_10\NN\14625458|or|magnesium (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (l_conj) preparations_16\NNS\407535|iron-containing (l_amod) iron-containing_15\NN\1740|
DDI-DrugBank.d711.s2.e4_DDI-DrugBank.d711.s2.e0 false magnesium_12\NN\14625458| (r_conj) calcium_10\NN\14625458|or|magnesium (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing (r_nmod) impaired_4\VBN\258857|absorption|is|antacids|. (l_nsubj) absorption_0\NN\13558490|tetracyclines (l_nmod) tetracyclines_2\NNS\2716205|of
DDI-DrugBank.d711.s2.e4_DDI-DrugBank.d711.s2.e1 false magnesium_12\NN\14625458| (r_conj) calcium_10\NN\14625458|or|magnesium (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing
DDI-DrugBank.d711.s2.e5_DDI-DrugBank.d711.s2.e0 false iron-containing_15\NN\1740| (r_amod) preparations_16\NNS\407535|iron-containing (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing (r_nmod) impaired_4\VBN\258857|absorption|is|antacids|. (l_nsubj) absorption_0\NN\13558490|tetracyclines (l_nmod) tetracyclines_2\NNS\2716205|of
DDI-DrugBank.d711.s2.e5_DDI-DrugBank.d711.s2.e1 false iron-containing_15\NN\1740| (r_amod) preparations_16\NNS\407535|iron-containing (r_conj) aluminum_8\NN\14625458|,|calcium|,|and|preparations (r_dobj) containing_7\VBG\2632940|aluminum (r_acl) antacids_6\NNS\14778436|by|containing
DDI-DrugBank.d711.s2.e0_DDI-DrugBank.d711.s2.e1 false tetracyclines_2\NNS\2716205|of (r_nmod) absorption_0\NN\13558490|tetracyclines (r_nsubj) impaired_4\VBN\258857|absorption|is|antacids|. (l_nmod) antacids_6\NNS\14778436|by|containing
DDI-DrugBank.d575.s2
DDI-DrugBank.d575.s2.e1_DDI-DrugBank.d575.s2.e0 false teniposide_10\NN\1740| (r_compound) injection_11\NN\320852|(|teniposide|) (r_appos) vumon_8\NN\1740|injection
DDI-DrugBank.d647.s3
DDI-DrugBank.d647.s3.e0_DDI-DrugBank.d647.s3.e1 true streptozocin_4\NN\1740|of|and|phenytoin (l_conj) phenytoin_6\NN\3550533|
DDI-DrugBank.d647.s3.e0_DDI-DrugBank.d647.s3.e2 false streptozocin_4\NN\1740|of|and|phenytoin (r_nmod) use_2\NN\407535|the|concurrent|streptozocin (r_nsubjpass) reported_9\VBN\831651|use|has|been|case|result|. (l_xcomp) result_14\VB\2633881|to|cytotoxicity (l_nmod) cytotoxicity_18\NN\13583478|in|reduced|streptozocin (l_compound) streptozocin_17\NN\1740|
DDI-DrugBank.d647.s3.e1_DDI-DrugBank.d647.s3.e2 false phenytoin_6\NN\3550533| (r_conj) streptozocin_4\NN\1740|of|and|phenytoin (r_nmod) use_2\NN\407535|the|concurrent|streptozocin (r_nsubjpass) reported_9\VBN\831651|use|has|been|case|result|. (l_xcomp) result_14\VB\2633881|to|cytotoxicity (l_nmod) cytotoxicity_18\NN\13583478|in|reduced|streptozocin (l_compound) streptozocin_17\NN\1740|
DDI-DrugBank.d737.s5
DDI-DrugBank.d737.s5.e0_DDI-DrugBank.d737.s5.e1 false probenecid_0\NN\3740161|:|influence (l_dep) influence_22\VB\137313|probenecid|did|not|noticeably|pharmacokinetics|n=|. (l_nsubj) probenecid_2\NN\3740161|,|inhibitor|,
DDI-DrugBank.d737.s5.e0_DDI-DrugBank.d737.s5.e2 false probenecid_0\NN\3740161|:|influence (l_dep) influence_22\VB\137313|probenecid|did|not|noticeably|pharmacokinetics|n=|. (l_dobj) pharmacokinetics_24\NNS\6054892|pramipexole (l_compound) pramipexole_23\NN\1740|
DDI-DrugBank.d737.s5.e1_DDI-DrugBank.d737.s5.e2 false probenecid_2\NN\3740161|,|inhibitor|, (r_nsubj) influence_22\VB\137313|probenecid|did|not|noticeably|pharmacokinetics|n=|. (l_dobj) pharmacokinetics_24\NNS\6054892|pramipexole (l_compound) pramipexole_23\NN\1740|
DDI-DrugBank.d716.s3
DDI-DrugBank.d752.s12
DDI-DrugBank.d752.s12.e0_DDI-DrugBank.d752.s12.e1 false atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) scopolamine_12\NN\14712692|,|glycopyrrolate
DDI-DrugBank.d752.s12.e0_DDI-DrugBank.d752.s12.e2 false atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam
DDI-DrugBank.d752.s12.e0_DDI-DrugBank.d752.s12.e3 false atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine
DDI-DrugBank.d752.s12.e0_DDI-DrugBank.d752.s12.e4 false atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants
DDI-DrugBank.d752.s12.e0_DDI-DrugBank.d752.s12.e5 false atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants (l_conj) relaxants_23\NNS\3247620|other|muscle
DDI-DrugBank.d752.s12.e0_DDI-DrugBank.d752.s12.e6 false atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) anesthetics_27\NNS\3247620|local
DDI-DrugBank.d752.s12.e1_DDI-DrugBank.d752.s12.e2 false scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam
DDI-DrugBank.d752.s12.e1_DDI-DrugBank.d752.s12.e3 false scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine
DDI-DrugBank.d752.s12.e1_DDI-DrugBank.d752.s12.e4 false scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants
DDI-DrugBank.d752.s12.e1_DDI-DrugBank.d752.s12.e5 false scopolamine_12\NN\14712692|,|glycopyrrolate (l_conj) glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants (l_conj) relaxants_23\NNS\3247620|other|muscle
DDI-DrugBank.d752.s12.e1_DDI-DrugBank.d752.s12.e6 false scopolamine_12\NN\14712692|,|glycopyrrolate (r_conj) atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) anesthetics_27\NNS\3247620|local
DDI-DrugBank.d752.s12.e2_DDI-DrugBank.d752.s12.e3 false glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine
DDI-DrugBank.d752.s12.e2_DDI-DrugBank.d752.s12.e4 false glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants
DDI-DrugBank.d752.s12.e2_DDI-DrugBank.d752.s12.e5 false glycopyrrolate_14\NN\1740|,|diazepam (l_conj) diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants (l_conj) relaxants_23\NNS\3247620|other|muscle
DDI-DrugBank.d752.s12.e2_DDI-DrugBank.d752.s12.e6 false glycopyrrolate_14\NN\1740|,|diazepam (r_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (r_conj) atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) anesthetics_27\NNS\3247620|local
DDI-DrugBank.d752.s12.e3_DDI-DrugBank.d752.s12.e4 false diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants
DDI-DrugBank.d752.s12.e3_DDI-DrugBank.d752.s12.e5 false diazepam_16\NN\2830852|,|hydroxyzine (l_conj) hydroxyzine_18\NN\3771443|,|and|relaxants (l_conj) relaxants_23\NNS\3247620|other|muscle
DDI-DrugBank.d752.s12.e3_DDI-DrugBank.d752.s12.e6 false diazepam_16\NN\2830852|,|hydroxyzine (r_conj) glycopyrrolate_14\NN\1740|,|diazepam (r_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (r_conj) atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) anesthetics_27\NNS\3247620|local
DDI-DrugBank.d752.s12.e4_DDI-DrugBank.d752.s12.e5 false hydroxyzine_18\NN\3771443|,|and|relaxants (l_conj) relaxants_23\NNS\3247620|other|muscle
DDI-DrugBank.d752.s12.e4_DDI-DrugBank.d752.s12.e6 false hydroxyzine_18\NN\3771443|,|and|relaxants (r_conj) diazepam_16\NN\2830852|,|hydroxyzine (r_conj) glycopyrrolate_14\NN\1740|,|diazepam (r_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (r_conj) atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) anesthetics_27\NNS\3247620|local
DDI-DrugBank.d752.s12.e5_DDI-DrugBank.d752.s12.e6 false relaxants_23\NNS\3247620|other|muscle (r_conj) hydroxyzine_18\NN\3771443|,|and|relaxants (r_conj) diazepam_16\NN\2830852|,|hydroxyzine (r_conj) glycopyrrolate_14\NN\1740|,|diazepam (r_conj) scopolamine_12\NN\14712692|,|glycopyrrolate (r_conj) atropine_10\NN\14712692|such|,|scopolamine|)|or|anesthetics (l_conj) anesthetics_27\NNS\3247620|local
DDI-DrugBank.d676.s1
DDI-DrugBank.d665.s5
DDI-DrugBank.d606.s0
DDI-DrugBank.d606.s0.e2_DDI-DrugBank.d606.s0.e0 false pseudoephedrine_10\NN\14712692|of (r_nmod) effects_8\NNS\13245626|the|pseudoephedrine (r_dobj) increase_6\VBP\169651|inhibitors|effects|. (l_nsubj) inhibitors_1\NNS\20090|mao|and|blockers
DDI-DrugBank.d606.s0.e2_DDI-DrugBank.d606.s0.e1 false pseudoephedrine_10\NN\14712692|of (r_nmod) effects_8\NNS\13245626|the|pseudoephedrine (r_dobj) increase_6\VBP\169651|inhibitors|effects|. (l_nsubj) inhibitors_1\NNS\20090|mao|and|blockers (l_conj) blockers_5\NNS\10101634|beta|adrenergic
DDI-DrugBank.d606.s0.e0_DDI-DrugBank.d606.s0.e1 false inhibitors_1\NNS\20090|mao|and|blockers (l_conj) blockers_5\NNS\10101634|beta|adrenergic
DDI-DrugBank.d647.s0
DDI-DrugBank.d639.s0
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e2 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) itraconazole_15\NN\2720201|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e3 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) clarithromycin_17\NN\1740|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e4 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) atazanavir_19\NN\1740|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e5 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) indinavir_21\NN\4013993|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e6 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nefazodone_23\NN\2718811|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e7 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nelfinavir_25\NN\4013993|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e8 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) ritonavir_27\NN\4013993|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e9 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e1_DDI-DrugBank.d639.s0.e0 false ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e3 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) clarithromycin_17\NN\1740|
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e4 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) atazanavir_19\NN\1740|
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e5 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) indinavir_21\NN\4013993|
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e6 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nefazodone_23\NN\2718811|
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e7 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nelfinavir_25\NN\4013993|
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e8 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) ritonavir_27\NN\4013993|
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e9 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e2_DDI-DrugBank.d639.s0.e0 false itraconazole_15\NN\2720201| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e3_DDI-DrugBank.d639.s0.e4 false clarithromycin_17\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) atazanavir_19\NN\1740|
DDI-DrugBank.d639.s0.e3_DDI-DrugBank.d639.s0.e5 false clarithromycin_17\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) indinavir_21\NN\4013993|
DDI-DrugBank.d639.s0.e3_DDI-DrugBank.d639.s0.e6 false clarithromycin_17\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nefazodone_23\NN\2718811|
DDI-DrugBank.d639.s0.e3_DDI-DrugBank.d639.s0.e7 false clarithromycin_17\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nelfinavir_25\NN\4013993|
DDI-DrugBank.d639.s0.e3_DDI-DrugBank.d639.s0.e8 false clarithromycin_17\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) ritonavir_27\NN\4013993|
DDI-DrugBank.d639.s0.e3_DDI-DrugBank.d639.s0.e9 false clarithromycin_17\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e3_DDI-DrugBank.d639.s0.e0 false clarithromycin_17\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e4_DDI-DrugBank.d639.s0.e5 false atazanavir_19\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) indinavir_21\NN\4013993|
DDI-DrugBank.d639.s0.e4_DDI-DrugBank.d639.s0.e6 false atazanavir_19\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nefazodone_23\NN\2718811|
DDI-DrugBank.d639.s0.e4_DDI-DrugBank.d639.s0.e7 false atazanavir_19\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nelfinavir_25\NN\4013993|
DDI-DrugBank.d639.s0.e4_DDI-DrugBank.d639.s0.e8 false atazanavir_19\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) ritonavir_27\NN\4013993|
DDI-DrugBank.d639.s0.e4_DDI-DrugBank.d639.s0.e9 false atazanavir_19\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e4_DDI-DrugBank.d639.s0.e0 false atazanavir_19\NN\1740| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e5_DDI-DrugBank.d639.s0.e6 false indinavir_21\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nefazodone_23\NN\2718811|
DDI-DrugBank.d639.s0.e5_DDI-DrugBank.d639.s0.e7 false indinavir_21\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nelfinavir_25\NN\4013993|
DDI-DrugBank.d639.s0.e5_DDI-DrugBank.d639.s0.e8 false indinavir_21\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) ritonavir_27\NN\4013993|
DDI-DrugBank.d639.s0.e5_DDI-DrugBank.d639.s0.e9 false indinavir_21\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e5_DDI-DrugBank.d639.s0.e0 false indinavir_21\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e6_DDI-DrugBank.d639.s0.e7 false nefazodone_23\NN\2718811| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) nelfinavir_25\NN\4013993|
DDI-DrugBank.d639.s0.e6_DDI-DrugBank.d639.s0.e8 false nefazodone_23\NN\2718811| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) ritonavir_27\NN\4013993|
DDI-DrugBank.d639.s0.e6_DDI-DrugBank.d639.s0.e9 false nefazodone_23\NN\2718811| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e6_DDI-DrugBank.d639.s0.e0 false nefazodone_23\NN\2718811| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e7_DDI-DrugBank.d639.s0.e8 false nelfinavir_25\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) ritonavir_27\NN\4013993|
DDI-DrugBank.d639.s0.e7_DDI-DrugBank.d639.s0.e9 false nelfinavir_25\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e7_DDI-DrugBank.d639.s0.e0 false nelfinavir_25\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e8_DDI-DrugBank.d639.s0.e9 false ritonavir_27\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (l_appos) saquinavir_29\NN\4013993|
DDI-DrugBank.d639.s0.e8_DDI-DrugBank.d639.s0.e0 false ritonavir_27\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s0.e9_DDI-DrugBank.d639.s0.e0 false saquinavir_29\NN\4013993| (r_appos) ketoconazole_13\NN\1740|(|e.g.|,|,|itraconazole|,|clarithromycin|,|atazanavir|,|indinavir|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|,|voriconizole|) (r_dep) inhibitors_5\NNS\20090|with|strong|family|ketoconazole (r_nmod) co-administration_0\NN\1740|sutent|inhibitors (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d615.s1
DDI-DrugBank.d615.s1.e1_DDI-DrugBank.d615.s1.e3 true atropine_8\NN\14712692|such|and|antidepressants (r_nmod) drugs_4\NNS\14778436|of|anticholinergic|,|atropine (r_nmod) effects_1\NNS\13245626|the|drugs (r_nsubjpass) enhanced_14\VBN\227165|effects|may|be|administration|. (l_nmod) administration_18\NN\1133281|by|the|concomitant|triprolidine (l_nmod) triprolidine_20\NN\1740|of
DDI-DrugBank.d615.s1.e1_DDI-DrugBank.d615.s1.e0 false atropine_8\NN\14712692|such|and|antidepressants (r_nmod) drugs_4\NNS\14778436|of|anticholinergic|,|atropine
DDI-DrugBank.d615.s1.e1_DDI-DrugBank.d615.s1.e2 false atropine_8\NN\14712692|such|and|antidepressants (l_conj) antidepressants_11\NNS\3740161|tricyclic
DDI-DrugBank.d615.s1.e3_DDI-DrugBank.d615.s1.e0 false triprolidine_20\NN\1740|of (r_nmod) administration_18\NN\1133281|by|the|concomitant|triprolidine (r_nmod) enhanced_14\VBN\227165|effects|may|be|administration|. (l_nsubjpass) effects_1\NNS\13245626|the|drugs (l_nmod) drugs_4\NNS\14778436|of|anticholinergic|,|atropine
DDI-DrugBank.d615.s1.e3_DDI-DrugBank.d615.s1.e2 false triprolidine_20\NN\1740|of (r_nmod) administration_18\NN\1133281|by|the|concomitant|triprolidine (r_nmod) enhanced_14\VBN\227165|effects|may|be|administration|. (l_nsubjpass) effects_1\NNS\13245626|the|drugs (l_nmod) drugs_4\NNS\14778436|of|anticholinergic|,|atropine (l_nmod) atropine_8\NN\14712692|such|and|antidepressants (l_conj) antidepressants_11\NNS\3740161|tricyclic
DDI-DrugBank.d615.s1.e0_DDI-DrugBank.d615.s1.e2 false drugs_4\NNS\14778436|of|anticholinergic|,|atropine (l_nmod) atropine_8\NN\14712692|such|and|antidepressants (l_conj) antidepressants_11\NNS\3740161|tricyclic
DDI-DrugBank.d761.s12
DDI-DrugBank.d761.s12.e0_DDI-DrugBank.d761.s12.e1 false xenical_15\JJ\1740| (r_amod) administration_16\NN\1133281|with|xenical (r_nmod) unaltered_13\JJ\1740|although|osteocalcin|was|administration (r_advcl) tended_21\VBD\2604760|unaltered|,|levels|decline|. (l_xcomp) decline_23\VB\146138|to|subjects (l_nmod) subjects_25\NNS\6598915|in|taking (l_acl) taking_26\VBG\2367363|xenical (l_dobj) xenical_27\NN\1740|
DDI-DrugBank.d671.s2
DDI-DrugBank.d671.s2.e0_DDI-DrugBank.d671.s2.e1 true cylert_9\NNP\1740| (r_dobj) receiving_8\VBG\2210855|cylert|medications. (l_nmod) medications._13\NNS\1740|with|antiepileptic
DDI-DrugBank.d675.s1
DDI-DrugBank.d597.s25
DDI-DrugBank.d597.s25.e0_DDI-DrugBank.d597.s25.e1 false methotrexate_3\NN\2722166| (r_nsubj) displace_6\VB\1850315|vitro|,|methotrexate|did|not|meloxicam|sites|. (l_dobj) meloxicam_7\NNP\1740|
DDI-DrugBank.d634.s0
DDI-DrugBank.d634.s0.e2_DDI-DrugBank.d634.s0.e0 false methimazole_17\NN\1740|to (r_nmod) attributed_15\VBN\670261|methimazole (r_acl) activity_14\NN\30358|by|anti-vitamin-k|attributed (r_nmod) potentiated_11\VBN\229605|anticoagulants|activity|may|be|activity|. (l_nsubjpass) anticoagulants_0\NNS\3740161|oral
DDI-DrugBank.d634.s0.e2_DDI-DrugBank.d634.s0.e1 false methimazole_17\NN\1740|to (r_nmod) attributed_15\VBN\670261|methimazole (r_acl) activity_14\NN\30358|by|anti-vitamin-k|attributed (r_nmod) potentiated_11\VBN\229605|anticoagulants|activity|may|be|activity|. (l_nsubjpass) activity_5\NN\30358|the|anticoagulants (l_nmod) anticoagulants_8\NNS\3740161|of|oral
DDI-DrugBank.d634.s0.e0_DDI-DrugBank.d634.s0.e1 false anticoagulants_0\NNS\3740161|oral (r_nsubjpass) potentiated_11\VBN\229605|anticoagulants|activity|may|be|activity|. (l_nsubjpass) activity_5\NN\30358|the|anticoagulants (l_nmod) anticoagulants_8\NNS\3740161|of|oral
DDI-DrugBank.d669.s1
DDI-DrugBank.d669.s1.e0_DDI-DrugBank.d669.s1.e2 false amphotericin_17\NN\2716866| (r_compound) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) bacitracin_22\NN\2716866|
DDI-DrugBank.d669.s1.e0_DDI-DrugBank.d669.s1.e3 false amphotericin_17\NN\2716866| (r_compound) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) b_25\NN\1355326|polymyxin (l_compound) polymyxin_24\NN\2716866|
DDI-DrugBank.d669.s1.e0_DDI-DrugBank.d669.s1.e4 false amphotericin_17\NN\2716866| (r_compound) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) colistin_27\NN\1740|
DDI-DrugBank.d669.s1.e0_DDI-DrugBank.d669.s1.e5 false amphotericin_17\NN\2716866| (r_compound) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) viomycin_29\NN\2716866|
DDI-DrugBank.d669.s1.e0_DDI-DrugBank.d669.s1.e6 false amphotericin_17\NN\2716866| (r_compound) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) cisplatin_32\NN\1740|
DDI-DrugBank.d669.s1.e0_DDI-DrugBank.d669.s1.e1 false amphotericin_17\NN\2716866| (r_compound) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) aminoglycosides_20\NNS\1740|
DDI-DrugBank.d669.s1.e2_DDI-DrugBank.d669.s1.e3 false bacitracin_22\NN\2716866| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) b_25\NN\1355326|polymyxin (l_compound) polymyxin_24\NN\2716866|
DDI-DrugBank.d669.s1.e2_DDI-DrugBank.d669.s1.e4 false bacitracin_22\NN\2716866| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) colistin_27\NN\1740|
DDI-DrugBank.d669.s1.e2_DDI-DrugBank.d669.s1.e5 false bacitracin_22\NN\2716866| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) viomycin_29\NN\2716866|
DDI-DrugBank.d669.s1.e2_DDI-DrugBank.d669.s1.e6 false bacitracin_22\NN\2716866| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) cisplatin_32\NN\1740|
DDI-DrugBank.d669.s1.e2_DDI-DrugBank.d669.s1.e1 false bacitracin_22\NN\2716866| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) aminoglycosides_20\NNS\1740|
DDI-DrugBank.d669.s1.e3_DDI-DrugBank.d669.s1.e4 false polymyxin_24\NN\2716866| (r_compound) b_25\NN\1355326|polymyxin (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) colistin_27\NN\1740|
DDI-DrugBank.d669.s1.e3_DDI-DrugBank.d669.s1.e5 false polymyxin_24\NN\2716866| (r_compound) b_25\NN\1355326|polymyxin (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) viomycin_29\NN\2716866|
DDI-DrugBank.d669.s1.e3_DDI-DrugBank.d669.s1.e6 false polymyxin_24\NN\2716866| (r_compound) b_25\NN\1355326|polymyxin (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) cisplatin_32\NN\1740|
DDI-DrugBank.d669.s1.e3_DDI-DrugBank.d669.s1.e1 false polymyxin_24\NN\2716866| (r_compound) b_25\NN\1355326|polymyxin (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) aminoglycosides_20\NNS\1740|
DDI-DrugBank.d669.s1.e4_DDI-DrugBank.d669.s1.e5 false colistin_27\NN\1740| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) viomycin_29\NN\2716866|
DDI-DrugBank.d669.s1.e4_DDI-DrugBank.d669.s1.e6 false colistin_27\NN\1740| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) cisplatin_32\NN\1740|
DDI-DrugBank.d669.s1.e4_DDI-DrugBank.d669.s1.e1 false colistin_27\NN\1740| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) aminoglycosides_20\NNS\1740|
DDI-DrugBank.d669.s1.e5_DDI-DrugBank.d669.s1.e6 false viomycin_29\NN\2716866| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) cisplatin_32\NN\1740|
DDI-DrugBank.d669.s1.e5_DDI-DrugBank.d669.s1.e1 false viomycin_29\NN\2716866| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) aminoglycosides_20\NNS\1740|
DDI-DrugBank.d669.s1.e6_DDI-DrugBank.d669.s1.e1 false cisplatin_32\NN\1740| (r_conj) b_18\NN\1355326|such|amphotericin|,|aminoglycosides|,|bacitracin|,|b|,|colistin|,|viomycin|,|or|cisplatin (l_conj) aminoglycosides_20\NNS\1740|
DDI-DrugBank.d781.s10
DDI-DrugBank.d781.s10.e1_DDI-DrugBank.d781.s10.e0 false lithium_10\NN\14625458| (r_compound) toxicity_11\NN\13576101|of|lithium (r_nmod) risk_8\NN\14541044|the|toxicity (r_dobj) increase_6\VB\169651|use|may|further|risk|. (l_nsubj) use_0\NN\407535|diuretic (l_nmod) diuretic_3\NN\3247620|of|a
DDI-DrugBank.d585.s7
DDI-DrugBank.d761.s9
DDI-DrugBank.d761.s9.e0_DDI-DrugBank.d761.s9.e3 false phenytoin_0\NN\3550533| (r_dep) alter_21\VB\126264|phenytoin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_23\NNS\6054892|the|dose (l_nmod) dose_28\NN\3740161|of|a|single|300-mg|phenytoin (l_nmod) phenytoin_30\NN\3550533|of
DDI-DrugBank.d761.s9.e0_DDI-DrugBank.d761.s9.e1 false phenytoin_0\NN\3550533| (r_dep) alter_21\VB\126264|phenytoin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nmod) subjects_5\NNS\6598915|in|12|normal-weight|receiving (l_acl) receiving_6\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_7\NN\1740|
DDI-DrugBank.d761.s9.e0_DDI-DrugBank.d761.s9.e2 false phenytoin_0\NN\3550533| (r_dep) alter_21\VB\126264|phenytoin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_18\NN\1740|
DDI-DrugBank.d761.s9.e3_DDI-DrugBank.d761.s9.e1 false phenytoin_30\NN\3550533|of (r_nmod) dose_28\NN\3740161|of|a|single|300-mg|phenytoin (r_nmod) pharmacokinetics_23\NNS\6054892|the|dose (r_dobj) alter_21\VB\126264|phenytoin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nmod) subjects_5\NNS\6598915|in|12|normal-weight|receiving (l_acl) receiving_6\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_7\NN\1740|
DDI-DrugBank.d761.s9.e3_DDI-DrugBank.d761.s9.e2 false phenytoin_30\NN\3550533|of (r_nmod) dose_28\NN\3740161|of|a|single|300-mg|phenytoin (r_nmod) pharmacokinetics_23\NNS\6054892|the|dose (r_dobj) alter_21\VB\126264|phenytoin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_18\NN\1740|
DDI-DrugBank.d761.s9.e1_DDI-DrugBank.d761.s9.e2 false xenical_7\NN\1740| (r_dobj) receiving_6\VBG\2210855|xenical|mg|times|days (r_acl) subjects_5\NNS\6598915|in|12|normal-weight|receiving (r_nmod) alter_21\VB\126264|phenytoin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_18\NN\1740|
DDI-DrugBank.d690.s0
DDI-DrugBank.d690.s0.e0_DDI-DrugBank.d690.s0.e2 true propoxyphene_4\NN\2707683|of (r_nmod) effect_2\NN\34213|the|cns-depressant|propoxyphene (r_nsubj) additive_6\JJ\1740|effect|is|that|. (l_nmod) that_8\DT\1740|with|depressants (l_nmod) depressants_12\NNS\3248958|of|other|cns|,|alcohol (l_nmod) alcohol_15\NN\7881800|including
DDI-DrugBank.d690.s0.e0_DDI-DrugBank.d690.s0.e1 true propoxyphene_4\NN\2707683|of (r_nmod) effect_2\NN\34213|the|cns-depressant|propoxyphene (r_nsubj) additive_6\JJ\1740|effect|is|that|. (l_nmod) that_8\DT\1740|with|depressants (l_nmod) depressants_12\NNS\3248958|of|other|cns|,|alcohol
DDI-DrugBank.d690.s0.e2_DDI-DrugBank.d690.s0.e1 false alcohol_15\NN\7881800|including (r_nmod) depressants_12\NNS\3248958|of|other|cns|,|alcohol
DDI-DrugBank.d640.s7
DDI-DrugBank.d738.s0
DDI-DrugBank.d738.s0.e1_DDI-DrugBank.d738.s0.e0 false ketoconazole_16\NN\1740|of|or|inhibitors (r_nmod) doses_14\NNS\3740161|with|therapeutic|ketoconazole (r_nmod) administered_11\VBN\2436349|when|doses (r_advcl) exceed_2\VB\2673965|do|not|dose|administered|. (l_dobj) dose_7\NN\3740161|a|mg|daily|vesicare (l_nmod) vesicare_9\NN\1740|of
DDI-DrugBank.d633.s5
DDI-DrugBank.d633.s5.e0_DDI-DrugBank.d633.s5.e1 false mexiletine_2\NN\2715941|of (r_nmod) addition_0\NN\3081021|mexiletine|propafenone (l_nmod) propafenone_4\NN\1740|to
DDI-DrugBank.d633.s5.e0_DDI-DrugBank.d633.s5.e2 false mexiletine_2\NN\2715941|of (r_nmod) addition_0\NN\3081021|mexiletine|propafenone (r_nsubj) lead_7\VB\1752884|addition|did|not|changes|. (l_nmod) changes_12\NNS\7283608|to|further|parameters|intervals|propafenone (l_nmod) propafenone_24\NN\1740|than|alone
DDI-DrugBank.d633.s5.e1_DDI-DrugBank.d633.s5.e2 false propafenone_4\NN\1740|to (r_nmod) addition_0\NN\3081021|mexiletine|propafenone (r_nsubj) lead_7\VB\1752884|addition|did|not|changes|. (l_nmod) changes_12\NNS\7283608|to|further|parameters|intervals|propafenone (l_nmod) propafenone_24\NN\1740|than|alone
DDI-DrugBank.d658.s0
DDI-DrugBank.d658.s0.e0_DDI-DrugBank.d658.s0.e1 true testolactone_4\NN\1740| (r_nsubj) increase_6\VB\169651|administered|,|testolactone|may|effects|; (l_dobj) effects_8\NNS\13245626|the|anticoagulants (l_nmod) anticoagulants_11\NNS\3740161|of|oral
DDI-DrugBank.d591.s2
DDI-DrugBank.d591.s2.e0_DDI-DrugBank.d591.s2.e1 true ropivacaine_7\NN\1740|of (r_nmod) clearance_5\NN\5089947|the|plasma|ropivacaine (r_nsubjpass) reduced_9\VBN\441445|vivo|,|clearance|was|%|coadministration|. (l_nmod) coadministration_14\NN\1740|during|fluvoxamine (l_nmod) fluvoxamine_16\NN\1740|of|bid|days|)|,|inhibitor
DDI-DrugBank.d735.s5
DDI-DrugBank.d735.s5.e0_DDI-DrugBank.d735.s5.e1 false sirolimus_2\NN\1740|or|nifedipine (l_conj) nifedipine_4\NN\2938514|
DDI-DrugBank.d735.s5.e0_DDI-DrugBank.d735.s5.e3 false sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nmod) toxicity_16\NN\13576101|for|sirolimus (l_compound) sirolimus_13\NN\1740|or|nifedipine
DDI-DrugBank.d735.s5.e0_DDI-DrugBank.d735.s5.e4 false sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nmod) toxicity_16\NN\13576101|for|sirolimus (l_compound) sirolimus_13\NN\1740|or|nifedipine (l_conj) nifedipine_15\NN\2938514|
DDI-DrugBank.d735.s5.e0_DDI-DrugBank.d735.s5.e5 false sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine
DDI-DrugBank.d735.s5.e0_DDI-DrugBank.d735.s5.e6 false sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine (l_conj) nifedipine_20\NN\2938514|
DDI-DrugBank.d735.s5.e0_DDI-DrugBank.d735.s5.e2 true sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (l_nmod) combination_6\NN\7951464|in|mycamine (l_nmod) mycamine_8\NN\1740|with
DDI-DrugBank.d735.s5.e1_DDI-DrugBank.d735.s5.e3 false nifedipine_4\NN\2938514| (r_conj) sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nmod) toxicity_16\NN\13576101|for|sirolimus (l_compound) sirolimus_13\NN\1740|or|nifedipine
DDI-DrugBank.d735.s5.e1_DDI-DrugBank.d735.s5.e4 false nifedipine_4\NN\2938514| (r_conj) sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nmod) toxicity_16\NN\13576101|for|sirolimus (l_compound) sirolimus_13\NN\1740|or|nifedipine (l_conj) nifedipine_15\NN\2938514|
DDI-DrugBank.d735.s5.e1_DDI-DrugBank.d735.s5.e5 false nifedipine_4\NN\2938514| (r_conj) sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine
DDI-DrugBank.d735.s5.e1_DDI-DrugBank.d735.s5.e6 false nifedipine_4\NN\2938514| (r_conj) sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine (l_conj) nifedipine_20\NN\2938514|
DDI-DrugBank.d735.s5.e1_DDI-DrugBank.d735.s5.e2 true nifedipine_4\NN\2938514| (r_conj) sirolimus_2\NN\1740|or|nifedipine (r_dobj) receiving_1\VBG\2210855|sirolimus|combination (l_nmod) combination_6\NN\7951464|in|mycamine (l_nmod) mycamine_8\NN\1740|with
DDI-DrugBank.d735.s5.e3_DDI-DrugBank.d735.s5.e4 false sirolimus_13\NN\1740|or|nifedipine (l_conj) nifedipine_15\NN\2938514|
DDI-DrugBank.d735.s5.e3_DDI-DrugBank.d735.s5.e5 false sirolimus_13\NN\1740|or|nifedipine (r_compound) toxicity_16\NN\13576101|for|sirolimus (r_nmod) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine
DDI-DrugBank.d735.s5.e3_DDI-DrugBank.d735.s5.e6 false sirolimus_13\NN\1740|or|nifedipine (r_compound) toxicity_16\NN\13576101|for|sirolimus (r_nmod) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine (l_conj) nifedipine_20\NN\2938514|
DDI-DrugBank.d735.s5.e3_DDI-DrugBank.d735.s5.e2 false sirolimus_13\NN\1740|or|nifedipine (r_compound) toxicity_16\NN\13576101|for|sirolimus (r_nmod) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nsubjpass) patients_0\NNS\9898892|receiving (l_acl) receiving_1\VBG\2210855|sirolimus|combination (l_nmod) combination_6\NN\7951464|in|mycamine (l_nmod) mycamine_8\NN\1740|with
DDI-DrugBank.d735.s5.e4_DDI-DrugBank.d735.s5.e5 false nifedipine_15\NN\2938514| (r_conj) sirolimus_13\NN\1740|or|nifedipine (r_compound) toxicity_16\NN\13576101|for|sirolimus (r_nmod) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine
DDI-DrugBank.d735.s5.e4_DDI-DrugBank.d735.s5.e6 false nifedipine_15\NN\2938514| (r_conj) sirolimus_13\NN\1740|or|nifedipine (r_compound) toxicity_16\NN\13576101|for|sirolimus (r_nmod) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_conj) reduced_24\VBN\441445|dosage|should|be|necessary|. (l_nsubjpass) dosage_21\NN\13576355|sirolimus (l_compound) sirolimus_18\NN\1740|or|nifedipine (l_conj) nifedipine_20\NN\2938514|
DDI-DrugBank.d735.s5.e4_DDI-DrugBank.d735.s5.e2 false nifedipine_15\NN\2938514| (r_conj) sirolimus_13\NN\1740|or|nifedipine (r_compound) toxicity_16\NN\13576101|for|sirolimus (r_nmod) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nsubjpass) patients_0\NNS\9898892|receiving (l_acl) receiving_1\VBG\2210855|sirolimus|combination (l_nmod) combination_6\NN\7951464|in|mycamine (l_nmod) mycamine_8\NN\1740|with
DDI-DrugBank.d735.s5.e5_DDI-DrugBank.d735.s5.e6 false sirolimus_18\NN\1740|or|nifedipine (l_conj) nifedipine_20\NN\2938514|
DDI-DrugBank.d735.s5.e5_DDI-DrugBank.d735.s5.e2 false sirolimus_18\NN\1740|or|nifedipine (r_compound) dosage_21\NN\13576355|sirolimus (r_nsubjpass) reduced_24\VBN\441445|dosage|should|be|necessary|. (r_conj) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nsubjpass) patients_0\NNS\9898892|receiving (l_acl) receiving_1\VBG\2210855|sirolimus|combination (l_nmod) combination_6\NN\7951464|in|mycamine (l_nmod) mycamine_8\NN\1740|with
DDI-DrugBank.d735.s5.e6_DDI-DrugBank.d735.s5.e2 false nifedipine_20\NN\2938514| (r_conj) sirolimus_18\NN\1740|or|nifedipine (r_compound) dosage_21\NN\13576355|sirolimus (r_nsubjpass) reduced_24\VBN\441445|dosage|should|be|necessary|. (r_conj) monitored_11\VBN\2169352|patients|should|be|toxicity|and|reduced (l_nsubjpass) patients_0\NNS\9898892|receiving (l_acl) receiving_1\VBG\2210855|sirolimus|combination (l_nmod) combination_6\NN\7951464|in|mycamine (l_nmod) mycamine_8\NN\1740|with
DDI-DrugBank.d732.s3
DDI-DrugBank.d756.s11
DDI-DrugBank.d742.s11
DDI-DrugBank.d742.s11.e0_DDI-DrugBank.d742.s11.e1 true diazepam_8\NN\2830852|and|drugs (r_dobj) avoid_7\VB\2452885|to|diazepam|taking (l_advcl) taking_14\VBG\2367363|while|soltab (l_dobj) soltab_16\NN\1740|remeron
DDI-DrugBank.d728.s0
DDI-DrugBank.d659.s2
DDI-DrugBank.d659.s2.e1_DDI-DrugBank.d659.s2.e2 false theophylline-containing_5\NN\1740| (r_amod) drugs_6\NNS\14778436|theophylline-containing (r_conj) trental_3\NN\3247620|of|and|drugs (r_nmod) administration_1\NN\1133281|concomitant|trental (r_nsubj) leads_7\VBZ\1752884|administration|levels|. (l_nmod) levels_11\NNS\4916342|to|increased|theophylline|and|toxicity|individuals (l_compound) theophylline_10\NN\2905612|
DDI-DrugBank.d659.s2.e1_DDI-DrugBank.d659.s2.e3 false theophylline-containing_5\NN\1740| (r_amod) drugs_6\NNS\14778436|theophylline-containing (r_conj) trental_3\NN\3247620|of|and|drugs (r_nmod) administration_1\NN\1133281|concomitant|trental (r_nsubj) leads_7\VBZ\1752884|administration|levels|. (l_nmod) levels_11\NNS\4916342|to|increased|theophylline|and|toxicity|individuals (l_conj) toxicity_14\NN\13576101|theophylline (l_compound) theophylline_13\NN\2905612|
DDI-DrugBank.d659.s2.e1_DDI-DrugBank.d659.s2.e0 false theophylline-containing_5\NN\1740| (r_amod) drugs_6\NNS\14778436|theophylline-containing (r_conj) trental_3\NN\3247620|of|and|drugs
DDI-DrugBank.d659.s2.e2_DDI-DrugBank.d659.s2.e3 false theophylline_10\NN\2905612| (r_compound) levels_11\NNS\4916342|to|increased|theophylline|and|toxicity|individuals (l_conj) toxicity_14\NN\13576101|theophylline (l_compound) theophylline_13\NN\2905612|
DDI-DrugBank.d659.s2.e2_DDI-DrugBank.d659.s2.e0 false theophylline_10\NN\2905612| (r_compound) levels_11\NNS\4916342|to|increased|theophylline|and|toxicity|individuals (r_nmod) leads_7\VBZ\1752884|administration|levels|. (l_nsubj) administration_1\NN\1133281|concomitant|trental (l_nmod) trental_3\NN\3247620|of|and|drugs
DDI-DrugBank.d659.s2.e3_DDI-DrugBank.d659.s2.e0 false theophylline_13\NN\2905612| (r_compound) toxicity_14\NN\13576101|theophylline (r_conj) levels_11\NNS\4916342|to|increased|theophylline|and|toxicity|individuals (r_nmod) leads_7\VBZ\1752884|administration|levels|. (l_nsubj) administration_1\NN\1133281|concomitant|trental (l_nmod) trental_3\NN\3247620|of|and|drugs
DDI-DrugBank.d779.s13
DDI-DrugBank.d780.s8
DDI-DrugBank.d780.s8.e0_DDI-DrugBank.d780.s8.e1 false acetazolamide_0\NN\1740| (r_dep) extend_10\VB\153263|acetazolamide|:|use|may|half-life|. (l_nsubj) use_3\NN\407535|concurrent|acetazolamide (l_nmod) acetazolamide_5\NN\1740|of|and|hydrochloride
DDI-DrugBank.d780.s8.e0_DDI-DrugBank.d780.s8.e2 false acetazolamide_0\NN\1740| (r_dep) extend_10\VB\153263|acetazolamide|:|use|may|half-life|. (l_nsubj) use_3\NN\407535|concurrent|acetazolamide (l_nmod) acetazolamide_5\NN\1740|of|and|hydrochloride (l_conj) hydrochloride_8\NN\14817592|procaine
DDI-DrugBank.d780.s8.e0_DDI-DrugBank.d780.s8.e3 false acetazolamide_0\NN\1740| (r_dep) extend_10\VB\153263|acetazolamide|:|use|may|half-life|. (l_dobj) half-life_13\NN\15113229|the|plasma|procaine (l_nmod) procaine_15\NN\3681148|of
DDI-DrugBank.d780.s8.e1_DDI-DrugBank.d780.s8.e2 true acetazolamide_5\NN\1740|of|and|hydrochloride (l_conj) hydrochloride_8\NN\14817592|procaine
DDI-DrugBank.d780.s8.e1_DDI-DrugBank.d780.s8.e3 false acetazolamide_5\NN\1740|of|and|hydrochloride (r_nmod) use_3\NN\407535|concurrent|acetazolamide (r_nsubj) extend_10\VB\153263|acetazolamide|:|use|may|half-life|. (l_dobj) half-life_13\NN\15113229|the|plasma|procaine (l_nmod) procaine_15\NN\3681148|of
DDI-DrugBank.d780.s8.e2_DDI-DrugBank.d780.s8.e3 false hydrochloride_8\NN\14817592|procaine (r_conj) acetazolamide_5\NN\1740|of|and|hydrochloride (r_nmod) use_3\NN\407535|concurrent|acetazolamide (r_nsubj) extend_10\VB\153263|acetazolamide|:|use|may|half-life|. (l_dobj) half-life_13\NN\15113229|the|plasma|procaine (l_nmod) procaine_15\NN\3681148|of
DDI-DrugBank.d739.s15
DDI-DrugBank.d739.s15.e0_DDI-DrugBank.d739.s15.e1 false phenobarbital_17\NN\2792049|such|or|rifampin (l_conj) rifampin_19\NN\2716205|
DDI-DrugBank.d739.s15.e0_DDI-DrugBank.d739.s15.e2 true phenobarbital_17\NN\2792049|such|or|rifampin (r_nmod) inducers_13\NNS\14778436|potent|enzyme|,|phenobarbital|, (r_nsubjpass) co-administered_22\VBN\1740|when|inducers|are|montelukast (l_nmod) montelukast_24\NN\1740|with
DDI-DrugBank.d739.s15.e1_DDI-DrugBank.d739.s15.e2 true rifampin_19\NN\2716205| (r_conj) phenobarbital_17\NN\2792049|such|or|rifampin (r_nmod) inducers_13\NNS\14778436|potent|enzyme|,|phenobarbital|, (r_nsubjpass) co-administered_22\VBN\1740|when|inducers|are|montelukast (l_nmod) montelukast_24\NN\1740|with
DDI-DrugBank.d578.s2
DDI-DrugBank.d584.s10
DDI-DrugBank.d584.s10.e1_DDI-DrugBank.d584.s10.e3 false acth_3\NN\5407119| (r_conj) steroids_1\NNS\14727670|adrenal|or|acth (r_nsubj) increase_18\VB\169651|steroids|patients|,|administration|may|edema|. (l_nsubj) administration_10\NN\1133281|concomitant|steroids (l_nmod) steroids_14\NNS\14727670|with|adrenal|cortical|or|acth (l_conj) acth_16\NN\5407119|
DDI-DrugBank.d584.s10.e1_DDI-DrugBank.d584.s10.e0 false acth_3\NN\5407119| (r_conj) steroids_1\NNS\14727670|adrenal|or|acth
DDI-DrugBank.d584.s10.e1_DDI-DrugBank.d584.s10.e2 false acth_3\NN\5407119| (r_conj) steroids_1\NNS\14727670|adrenal|or|acth (r_nsubj) increase_18\VB\169651|steroids|patients|,|administration|may|edema|. (l_nsubj) administration_10\NN\1133281|concomitant|steroids (l_nmod) steroids_14\NNS\14727670|with|adrenal|cortical|or|acth
DDI-DrugBank.d584.s10.e3_DDI-DrugBank.d584.s10.e0 false acth_16\NN\5407119| (r_conj) steroids_14\NNS\14727670|with|adrenal|cortical|or|acth (r_nmod) administration_10\NN\1133281|concomitant|steroids (r_nsubj) increase_18\VB\169651|steroids|patients|,|administration|may|edema|. (l_nsubj) steroids_1\NNS\14727670|adrenal|or|acth
DDI-DrugBank.d584.s10.e3_DDI-DrugBank.d584.s10.e2 false acth_16\NN\5407119| (r_conj) steroids_14\NNS\14727670|with|adrenal|cortical|or|acth
DDI-DrugBank.d584.s10.e0_DDI-DrugBank.d584.s10.e2 false steroids_1\NNS\14727670|adrenal|or|acth (r_nsubj) increase_18\VB\169651|steroids|patients|,|administration|may|edema|. (l_nsubj) administration_10\NN\1133281|concomitant|steroids (l_nmod) steroids_14\NNS\14727670|with|adrenal|cortical|or|acth
DDI-DrugBank.d779.s0
DDI-DrugBank.d779.s0.e0_DDI-DrugBank.d779.s0.e1 true methyldopa_1\NN\2721160| (r_nsubjpass) used_3\VBN\1156834|when|methyldopa|is|drugs (l_nmod) drugs_7\NNS\14778436|with|other|antihypertensive
DDI-DrugBank.d743.s5
DDI-DrugBank.d743.s5.e0_DDI-DrugBank.d743.s5.e1 false itraconazole_0\NN\2720201| (r_dep) reported_12\VBN\831651|itraconazole|:|pointes|have|been|use|. (l_nsubjpass) pointes_4\NNS\1740|torsades|de|and|levels (l_conj) levels_9\NNS\4916342|elevated|parent|terfenadine (l_compound) terfenadine_8\NN\1740|
DDI-DrugBank.d743.s5.e0_DDI-DrugBank.d743.s5.e2 false itraconazole_0\NN\2720201| (r_dep) reported_12\VBN\831651|itraconazole|:|pointes|have|been|use|. (l_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) terfenadine_17\NN\1740|of|and|itraconazole
DDI-DrugBank.d743.s5.e0_DDI-DrugBank.d743.s5.e3 false itraconazole_0\NN\2720201| (r_dep) reported_12\VBN\831651|itraconazole|:|pointes|have|been|use|. (l_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) terfenadine_17\NN\1740|of|and|itraconazole (l_conj) itraconazole_19\NN\2720201|
DDI-DrugBank.d743.s5.e0_DDI-DrugBank.d743.s5.e4 false itraconazole_0\NN\2720201| (r_dep) reported_12\VBN\831651|itraconazole|:|pointes|have|been|use|. (l_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) trials_22\NNS\786195|in|clinical|itraconazole|and|sources (l_nmod) itraconazole_24\NN\2720201|of
DDI-DrugBank.d743.s5.e1_DDI-DrugBank.d743.s5.e2 false terfenadine_8\NN\1740| (r_compound) levels_9\NNS\4916342|elevated|parent|terfenadine (r_conj) pointes_4\NNS\1740|torsades|de|and|levels (r_nsubjpass) reported_12\VBN\831651|itraconazole|:|pointes|have|been|use|. (l_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) terfenadine_17\NN\1740|of|and|itraconazole
DDI-DrugBank.d743.s5.e1_DDI-DrugBank.d743.s5.e3 false terfenadine_8\NN\1740| (r_compound) levels_9\NNS\4916342|elevated|parent|terfenadine (r_conj) pointes_4\NNS\1740|torsades|de|and|levels (r_nsubjpass) reported_12\VBN\831651|itraconazole|:|pointes|have|been|use|. (l_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) terfenadine_17\NN\1740|of|and|itraconazole (l_conj) itraconazole_19\NN\2720201|
DDI-DrugBank.d743.s5.e1_DDI-DrugBank.d743.s5.e4 false terfenadine_8\NN\1740| (r_compound) levels_9\NNS\4916342|elevated|parent|terfenadine (r_conj) pointes_4\NNS\1740|torsades|de|and|levels (r_nsubjpass) reported_12\VBN\831651|itraconazole|:|pointes|have|been|use|. (l_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) trials_22\NNS\786195|in|clinical|itraconazole|and|sources (l_nmod) itraconazole_24\NN\2720201|of
DDI-DrugBank.d743.s5.e2_DDI-DrugBank.d743.s5.e3 true terfenadine_17\NN\1740|of|and|itraconazole (l_conj) itraconazole_19\NN\2720201|
DDI-DrugBank.d743.s5.e2_DDI-DrugBank.d743.s5.e4 false terfenadine_17\NN\1740|of|and|itraconazole (r_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) trials_22\NNS\786195|in|clinical|itraconazole|and|sources (l_nmod) itraconazole_24\NN\2720201|of
DDI-DrugBank.d743.s5.e3_DDI-DrugBank.d743.s5.e4 false itraconazole_19\NN\2720201| (r_conj) terfenadine_17\NN\1740|of|and|itraconazole (r_nmod) use_15\NN\407535|during|concomitant|terfenadine|trials (l_nmod) trials_22\NNS\786195|in|clinical|itraconazole|and|sources (l_nmod) itraconazole_24\NN\2720201|of
DDI-DrugBank.d709.s0
DDI-DrugBank.d578.s4
DDI-DrugBank.d578.s4.e0_DDI-DrugBank.d578.s4.e1 false phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (l_conj) phenytoin_9\NN\3550533|
DDI-DrugBank.d578.s4.e0_DDI-DrugBank.d578.s4.e2 false phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (l_conj) rifampin_12\NN\2716205|
DDI-DrugBank.d578.s4.e0_DDI-DrugBank.d578.s4.e3 true phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_14\VB\169651|drugs|may|clearance|and|require|. (l_dobj) clearance_16\NN\5089947|the|methylprednisolone (l_nmod) methylprednisolone_18\NN\1740|of
DDI-DrugBank.d578.s4.e0_DDI-DrugBank.d578.s4.e4 true phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_14\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_21\VB\754942|may|increased|achieve (l_dobj) increased_22\VBN\169651|dose (l_nmod) dose_25\NN\3740161|in|methylprednisolone (l_compound) methylprednisolone_24\NN\1740|
DDI-DrugBank.d578.s4.e1_DDI-DrugBank.d578.s4.e2 false phenytoin_9\NN\3550533| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (l_conj) rifampin_12\NN\2716205|
DDI-DrugBank.d578.s4.e1_DDI-DrugBank.d578.s4.e3 true phenytoin_9\NN\3550533| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_14\VB\169651|drugs|may|clearance|and|require|. (l_dobj) clearance_16\NN\5089947|the|methylprednisolone (l_nmod) methylprednisolone_18\NN\1740|of
DDI-DrugBank.d578.s4.e1_DDI-DrugBank.d578.s4.e4 true phenytoin_9\NN\3550533| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_14\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_21\VB\754942|may|increased|achieve (l_dobj) increased_22\VBN\169651|dose (l_nmod) dose_25\NN\3740161|in|methylprednisolone (l_compound) methylprednisolone_24\NN\1740|
DDI-DrugBank.d578.s4.e2_DDI-DrugBank.d578.s4.e3 true rifampin_12\NN\2716205| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_14\VB\169651|drugs|may|clearance|and|require|. (l_dobj) clearance_16\NN\5089947|the|methylprednisolone (l_nmod) methylprednisolone_18\NN\1740|of
DDI-DrugBank.d578.s4.e2_DDI-DrugBank.d578.s4.e4 true rifampin_12\NN\2716205| (r_conj) phenobarbital_7\NN\2792049|such|,|phenytoin|,|and|rifampin (r_nmod) drugs_0\NNS\14778436|induce|phenobarbital (r_nsubj) increase_14\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_21\VB\754942|may|increased|achieve (l_dobj) increased_22\VBN\169651|dose (l_nmod) dose_25\NN\3740161|in|methylprednisolone (l_compound) methylprednisolone_24\NN\1740|
DDI-DrugBank.d578.s4.e3_DDI-DrugBank.d578.s4.e4 false methylprednisolone_18\NN\1740|of (r_nmod) clearance_16\NN\5089947|the|methylprednisolone (r_dobj) increase_14\VB\169651|drugs|may|clearance|and|require|. (l_conj) require_21\VB\754942|may|increased|achieve (l_dobj) increased_22\VBN\169651|dose (l_nmod) dose_25\NN\3740161|in|methylprednisolone (l_compound) methylprednisolone_24\NN\1740|
DDI-DrugBank.d780.s6
DDI-DrugBank.d780.s6.e1_DDI-DrugBank.d780.s6.e2 false chloride_7\NNP\14818238|such|suxamethonium (r_nmod) agents_2\NNS\7347|neuromuscular|blocking|(|chloride|): (r_nsubj) result_19\VB\2633881|agents|use|may|prolongation|. (l_nsubj) use_10\NN\407535|concurrent|hydrochloride (l_nmod) hydrochloride_13\NN\14817592|of|procaine|and|agents
DDI-DrugBank.d780.s6.e1_DDI-DrugBank.d780.s6.e0 false chloride_7\NNP\14818238|such|suxamethonium (r_nmod) agents_2\NNS\7347|neuromuscular|blocking|(|chloride|):
DDI-DrugBank.d780.s6.e1_DDI-DrugBank.d780.s6.e3 false chloride_7\NNP\14818238|such|suxamethonium (r_nmod) agents_2\NNS\7347|neuromuscular|blocking|(|chloride|): (r_nsubj) result_19\VB\2633881|agents|use|may|prolongation|. (l_nsubj) use_10\NN\407535|concurrent|hydrochloride (l_nmod) hydrochloride_13\NN\14817592|of|procaine|and|agents (l_conj) agents_17\NNS\7347|neuromuscular|blocking
DDI-DrugBank.d780.s6.e2_DDI-DrugBank.d780.s6.e0 false hydrochloride_13\NN\14817592|of|procaine|and|agents (r_nmod) use_10\NN\407535|concurrent|hydrochloride (r_nsubj) result_19\VB\2633881|agents|use|may|prolongation|. (l_nsubj) agents_2\NNS\7347|neuromuscular|blocking|(|chloride|):
DDI-DrugBank.d780.s6.e2_DDI-DrugBank.d780.s6.e3 true hydrochloride_13\NN\14817592|of|procaine|and|agents (l_conj) agents_17\NNS\7347|neuromuscular|blocking
DDI-DrugBank.d780.s6.e0_DDI-DrugBank.d780.s6.e3 false agents_2\NNS\7347|neuromuscular|blocking|(|chloride|): (r_nsubj) result_19\VB\2633881|agents|use|may|prolongation|. (l_nsubj) use_10\NN\407535|concurrent|hydrochloride (l_nmod) hydrochloride_13\NN\14817592|of|procaine|and|agents (l_conj) agents_17\NNS\7347|neuromuscular|blocking
DDI-DrugBank.d572.s4
DDI-DrugBank.d761.s5
DDI-DrugBank.d761.s5.e0_DDI-DrugBank.d761.s5.e1 false orlistat_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|orlistat|absorption (l_nmod) absorption_6\NN\13558490|on|the|d (l_nmod) d_10\NN\15089472|of|supplemental|vitamin|,|a|,|and|k (l_compound) vitamin_9\NN\7570720|
DDI-DrugBank.d761.s5.e0_DDI-DrugBank.d761.s5.e2 false orlistat_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|orlistat|absorption (l_nmod) absorption_6\NN\13558490|on|the|d (l_nmod) d_10\NN\15089472|of|supplemental|vitamin|,|a|,|and|k (l_conj) a_13\NN\13649268|vitamin (l_compound) vitamin_12\NN\7570720|
DDI-DrugBank.d761.s5.e0_DDI-DrugBank.d761.s5.e3 false orlistat_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|orlistat|absorption (l_nmod) absorption_6\NN\13558490|on|the|d (l_nmod) d_10\NN\15089472|of|supplemental|vitamin|,|a|,|and|k (l_conj) k_18\NN\13608598|nutritionally-derived|vitamin (l_compound) vitamin_17\NN\7570720|
DDI-DrugBank.d761.s5.e1_DDI-DrugBank.d761.s5.e2 false vitamin_9\NN\7570720| (r_compound) d_10\NN\15089472|of|supplemental|vitamin|,|a|,|and|k (l_conj) a_13\NN\13649268|vitamin (l_compound) vitamin_12\NN\7570720|
DDI-DrugBank.d761.s5.e1_DDI-DrugBank.d761.s5.e3 false vitamin_9\NN\7570720| (r_compound) d_10\NN\15089472|of|supplemental|vitamin|,|a|,|and|k (l_conj) k_18\NN\13608598|nutritionally-derived|vitamin (l_compound) vitamin_17\NN\7570720|
DDI-DrugBank.d761.s5.e2_DDI-DrugBank.d761.s5.e3 false vitamin_12\NN\7570720| (r_compound) a_13\NN\13649268|vitamin (r_conj) d_10\NN\15089472|of|supplemental|vitamin|,|a|,|and|k (l_conj) k_18\NN\13608598|nutritionally-derived|vitamin (l_compound) vitamin_17\NN\7570720|
DDI-DrugBank.d743.s3
DDI-DrugBank.d710.s3
DDI-DrugBank.d752.s6
DDI-DrugBank.d752.s6.e0_DDI-DrugBank.d752.s6.e1 false rifampin_11\NN\2716205|such|,|carbamazepine|,|and|phenytoin (l_conj) carbamazepine_13\NN\1740|
DDI-DrugBank.d752.s6.e0_DDI-DrugBank.d752.s6.e2 false rifampin_11\NN\2716205|such|,|carbamazepine|,|and|phenytoin (l_conj) phenytoin_16\NN\3550533|
DDI-DrugBank.d752.s6.e0_DDI-DrugBank.d752.s6.e3 true rifampin_11\NN\2716205|such|,|carbamazepine|,|and|phenytoin (r_nmod) inducers_7\NNS\14778436|p450|,|rifampin|, (r_nsubj) induce_18\VBP\1627355|inducers|metabolism|and|caused|. (l_conj) caused_21\VBD\1617192|max|studies (l_dobj) max_26\NN\3414814|a|decreased|c|and|auc|midazolam (l_nmod) midazolam_31\NN\2830852|of|oral
DDI-DrugBank.d752.s6.e1_DDI-DrugBank.d752.s6.e2 false carbamazepine_13\NN\1740| (r_conj) rifampin_11\NN\2716205|such|,|carbamazepine|,|and|phenytoin (l_conj) phenytoin_16\NN\3550533|
DDI-DrugBank.d752.s6.e1_DDI-DrugBank.d752.s6.e3 true carbamazepine_13\NN\1740| (r_conj) rifampin_11\NN\2716205|such|,|carbamazepine|,|and|phenytoin (r_nmod) inducers_7\NNS\14778436|p450|,|rifampin|, (r_nsubj) induce_18\VBP\1627355|inducers|metabolism|and|caused|. (l_conj) caused_21\VBD\1617192|max|studies (l_dobj) max_26\NN\3414814|a|decreased|c|and|auc|midazolam (l_nmod) midazolam_31\NN\2830852|of|oral
DDI-DrugBank.d752.s6.e2_DDI-DrugBank.d752.s6.e3 true phenytoin_16\NN\3550533| (r_conj) rifampin_11\NN\2716205|such|,|carbamazepine|,|and|phenytoin (r_nmod) inducers_7\NNS\14778436|p450|,|rifampin|, (r_nsubj) induce_18\VBP\1627355|inducers|metabolism|and|caused|. (l_conj) caused_21\VBD\1617192|max|studies (l_dobj) max_26\NN\3414814|a|decreased|c|and|auc|midazolam (l_nmod) midazolam_31\NN\2830852|of|oral
DDI-DrugBank.d584.s13
DDI-DrugBank.d588.s9
DDI-DrugBank.d677.s0
DDI-DrugBank.d677.s0.e5_DDI-DrugBank.d677.s0.e0 false alcohol_16\NN\7881800|,|etc (r_conj) opiates_14\NNS\3808564|,|alcohol (r_conj) anesthetics_12\NNS\3247620|,|opiates (r_conj) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (r_appos) depressants_6\NNS\3248958|cns|barbiturates (r_dobj) potentiating_4\VBG\229605|of|depressants (r_advcl) capable_2\JJ\1740|phenothiazines|are|potentiating (l_nsubj) phenothiazines_0\NNS\14771088|
DDI-DrugBank.d677.s0.e5_DDI-DrugBank.d677.s0.e1 false alcohol_16\NN\7881800|,|etc (r_conj) opiates_14\NNS\3808564|,|alcohol (r_conj) anesthetics_12\NNS\3247620|,|opiates (r_conj) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (r_appos) depressants_6\NNS\3248958|cns|barbiturates
DDI-DrugBank.d677.s0.e5_DDI-DrugBank.d677.s0.e2 false alcohol_16\NN\7881800|,|etc (r_conj) opiates_14\NNS\3808564|,|alcohol (r_conj) anesthetics_12\NNS\3247620|,|opiates (r_conj) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|)
DDI-DrugBank.d677.s0.e5_DDI-DrugBank.d677.s0.e3 false alcohol_16\NN\7881800|,|etc (r_conj) opiates_14\NNS\3808564|,|alcohol (r_conj) anesthetics_12\NNS\3247620|,|opiates
DDI-DrugBank.d677.s0.e5_DDI-DrugBank.d677.s0.e4 false alcohol_16\NN\7881800|,|etc (r_conj) opiates_14\NNS\3808564|,|alcohol
DDI-DrugBank.d677.s0.e0_DDI-DrugBank.d677.s0.e1 true phenothiazines_0\NNS\14771088| (r_nsubj) capable_2\JJ\1740|phenothiazines|are|potentiating (l_advcl) potentiating_4\VBG\229605|of|depressants (l_dobj) depressants_6\NNS\3248958|cns|barbiturates
DDI-DrugBank.d677.s0.e0_DDI-DrugBank.d677.s0.e2 true phenothiazines_0\NNS\14771088| (r_nsubj) capable_2\JJ\1740|phenothiazines|are|potentiating (l_advcl) potentiating_4\VBG\229605|of|depressants (l_dobj) depressants_6\NNS\3248958|cns|barbiturates (l_appos) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|)
DDI-DrugBank.d677.s0.e0_DDI-DrugBank.d677.s0.e3 true phenothiazines_0\NNS\14771088| (r_nsubj) capable_2\JJ\1740|phenothiazines|are|potentiating (l_advcl) potentiating_4\VBG\229605|of|depressants (l_dobj) depressants_6\NNS\3248958|cns|barbiturates (l_appos) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (l_conj) anesthetics_12\NNS\3247620|,|opiates
DDI-DrugBank.d677.s0.e0_DDI-DrugBank.d677.s0.e4 true phenothiazines_0\NNS\14771088| (r_nsubj) capable_2\JJ\1740|phenothiazines|are|potentiating (l_advcl) potentiating_4\VBG\229605|of|depressants (l_dobj) depressants_6\NNS\3248958|cns|barbiturates (l_appos) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (l_conj) anesthetics_12\NNS\3247620|,|opiates (l_conj) opiates_14\NNS\3808564|,|alcohol
DDI-DrugBank.d677.s0.e1_DDI-DrugBank.d677.s0.e2 false depressants_6\NNS\3248958|cns|barbiturates (l_appos) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|)
DDI-DrugBank.d677.s0.e1_DDI-DrugBank.d677.s0.e3 false depressants_6\NNS\3248958|cns|barbiturates (l_appos) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (l_conj) anesthetics_12\NNS\3247620|,|opiates
DDI-DrugBank.d677.s0.e1_DDI-DrugBank.d677.s0.e4 false depressants_6\NNS\3248958|cns|barbiturates (l_appos) barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (l_conj) anesthetics_12\NNS\3247620|,|opiates (l_conj) opiates_14\NNS\3808564|,|alcohol
DDI-DrugBank.d677.s0.e2_DDI-DrugBank.d677.s0.e3 false barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (l_conj) anesthetics_12\NNS\3247620|,|opiates
DDI-DrugBank.d677.s0.e2_DDI-DrugBank.d677.s0.e4 false barbiturates_10\NNS\4166841|(|e.g.|,|,|anesthetics|) (l_conj) anesthetics_12\NNS\3247620|,|opiates (l_conj) opiates_14\NNS\3808564|,|alcohol
DDI-DrugBank.d677.s0.e3_DDI-DrugBank.d677.s0.e4 false anesthetics_12\NNS\3247620|,|opiates (l_conj) opiates_14\NNS\3808564|,|alcohol
DDI-DrugBank.d776.s20
DDI-DrugBank.d776.s20.e2_DDI-DrugBank.d776.s20.e1 false terfenadine_24\NN\1740|with (r_nmod) conjunction_22\NN\5048123|in|terfenadine (r_nmod) receiving_18\VBG\2210855|antifungals|conjunction (l_dobj) antifungals_20\NNS\14778436|azole
DDI-DrugBank.d722.s1
DDI-DrugBank.d722.s1.e1_DDI-DrugBank.d722.s1.e2 false olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (l_conj) mesalazine_14\NN\1740|
DDI-DrugBank.d722.s1.e1_DDI-DrugBank.d722.s1.e3 false olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (l_conj) sulphasalazine_17\NN\1740|
DDI-DrugBank.d722.s1.e1_DDI-DrugBank.d722.s1.e4 true olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (r_appos) derivatives_8\NNS\5802185|aminosalicylate|(|olsalazine (r_nsubj) inhibit_19\VBP\2510337|that|derivatives|enzyme (r_ccomp) evidence_5\NN\5816287|in|inhibit (r_nsubj) is_2\VBZ\836236|as|there|evidence (r_advcl) administered_27\VBN\2436349|is|,|they|should|be|caution|patients|. (l_nmod) patients_31\NNS\9898892|to|receiving (l_acl) receiving_32\VBG\2210855|therapy (l_dobj) therapy_35\NN\657604|concurrent|thioguanine (l_compound) thioguanine_34\NN\2722458|
DDI-DrugBank.d722.s1.e1_DDI-DrugBank.d722.s1.e0 false olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (r_appos) derivatives_8\NNS\5802185|aminosalicylate|(|olsalazine
DDI-DrugBank.d722.s1.e2_DDI-DrugBank.d722.s1.e3 false mesalazine_14\NN\1740| (r_conj) olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (l_conj) sulphasalazine_17\NN\1740|
DDI-DrugBank.d722.s1.e2_DDI-DrugBank.d722.s1.e4 true mesalazine_14\NN\1740| (r_conj) olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (r_appos) derivatives_8\NNS\5802185|aminosalicylate|(|olsalazine (r_nsubj) inhibit_19\VBP\2510337|that|derivatives|enzyme (r_ccomp) evidence_5\NN\5816287|in|inhibit (r_nsubj) is_2\VBZ\836236|as|there|evidence (r_advcl) administered_27\VBN\2436349|is|,|they|should|be|caution|patients|. (l_nmod) patients_31\NNS\9898892|to|receiving (l_acl) receiving_32\VBG\2210855|therapy (l_dobj) therapy_35\NN\657604|concurrent|thioguanine (l_compound) thioguanine_34\NN\2722458|
DDI-DrugBank.d722.s1.e2_DDI-DrugBank.d722.s1.e0 false mesalazine_14\NN\1740| (r_conj) olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (r_appos) derivatives_8\NNS\5802185|aminosalicylate|(|olsalazine
DDI-DrugBank.d722.s1.e3_DDI-DrugBank.d722.s1.e4 true sulphasalazine_17\NN\1740| (r_conj) olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (r_appos) derivatives_8\NNS\5802185|aminosalicylate|(|olsalazine (r_nsubj) inhibit_19\VBP\2510337|that|derivatives|enzyme (r_ccomp) evidence_5\NN\5816287|in|inhibit (r_nsubj) is_2\VBZ\836236|as|there|evidence (r_advcl) administered_27\VBN\2436349|is|,|they|should|be|caution|patients|. (l_nmod) patients_31\NNS\9898892|to|receiving (l_acl) receiving_32\VBG\2210855|therapy (l_dobj) therapy_35\NN\657604|concurrent|thioguanine (l_compound) thioguanine_34\NN\2722458|
DDI-DrugBank.d722.s1.e3_DDI-DrugBank.d722.s1.e0 false sulphasalazine_17\NN\1740| (r_conj) olsalazine_12\NN\1740|e.g.|,|,|mesalazine|,|or|sulphasalazine|) (r_appos) derivatives_8\NNS\5802185|aminosalicylate|(|olsalazine
DDI-DrugBank.d722.s1.e4_DDI-DrugBank.d722.s1.e0 false thioguanine_34\NN\2722458| (r_compound) therapy_35\NN\657604|concurrent|thioguanine (r_dobj) receiving_32\VBG\2210855|therapy (r_acl) patients_31\NNS\9898892|to|receiving (r_nmod) administered_27\VBN\2436349|is|,|they|should|be|caution|patients|. (l_advcl) is_2\VBZ\836236|as|there|evidence (l_nsubj) evidence_5\NN\5816287|in|inhibit (l_ccomp) inhibit_19\VBP\2510337|that|derivatives|enzyme (l_nsubj) derivatives_8\NNS\5802185|aminosalicylate|(|olsalazine
DDI-DrugBank.d716.s2
DDI-DrugBank.d716.s2.e0_DDI-DrugBank.d716.s2.e1 true mazindol_0\NN\1740| (r_nsubj) reduce_2\VB\441445|mazindol|may|effects|. (l_dobj) effects_4\NNS\13245626|the|guanethidine (l_nmod) guanethidine_6\NN\1740|of|(|ismelin|)
DDI-DrugBank.d716.s2.e0_DDI-DrugBank.d716.s2.e2 true mazindol_0\NN\1740| (r_nsubj) reduce_2\VB\441445|mazindol|may|effects|. (l_dobj) effects_4\NNS\13245626|the|guanethidine (l_nmod) guanethidine_6\NN\1740|of|(|ismelin|) (l_appos) ismelin_8\NN\1740|
DDI-DrugBank.d716.s2.e1_DDI-DrugBank.d716.s2.e2 false guanethidine_6\NN\1740|of|(|ismelin|) (l_appos) ismelin_8\NN\1740|
DDI-DrugBank.d572.s19
DDI-DrugBank.d682.s1
DDI-DrugBank.d682.s1.e1_DDI-DrugBank.d682.s1.e3 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) warfarin_25\NN\2718259|effect
DDI-DrugBank.d682.s1.e1_DDI-DrugBank.d682.s1.e4 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion
DDI-DrugBank.d682.s1.e1_DDI-DrugBank.d682.s1.e5 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion (l_dep) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (l_nmod) methotrexate_38\NN\2722166|of
DDI-DrugBank.d682.s1.e1_DDI-DrugBank.d682.s1.e6 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d682.s1.e1_DDI-DrugBank.d682.s1.e7 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d682.s1.e1_DDI-DrugBank.d682.s1.e0 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d682.s1.e1_DDI-DrugBank.d682.s1.e2 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d682.s1.e3_DDI-DrugBank.d682.s1.e4 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion
DDI-DrugBank.d682.s1.e3_DDI-DrugBank.d682.s1.e5 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion (l_dep) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (l_nmod) methotrexate_38\NN\2722166|of
DDI-DrugBank.d682.s1.e3_DDI-DrugBank.d682.s1.e6 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d682.s1.e3_DDI-DrugBank.d682.s1.e7 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d682.s1.e3_DDI-DrugBank.d682.s1.e0 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d682.s1.e3_DDI-DrugBank.d682.s1.e2 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d682.s1.e4_DDI-DrugBank.d682.s1.e5 false methotrexate_32\NN\2722166|excretion (l_dep) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (l_nmod) methotrexate_38\NN\2722166|of
DDI-DrugBank.d682.s1.e4_DDI-DrugBank.d682.s1.e6 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d682.s1.e4_DDI-DrugBank.d682.s1.e7 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d682.s1.e4_DDI-DrugBank.d682.s1.e0 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d682.s1.e4_DDI-DrugBank.d682.s1.e2 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d682.s1.e5_DDI-DrugBank.d682.s1.e6 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d682.s1.e5_DDI-DrugBank.d682.s1.e7 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d682.s1.e5_DDI-DrugBank.d682.s1.e0 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d682.s1.e5_DDI-DrugBank.d682.s1.e2 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d682.s1.e6_DDI-DrugBank.d682.s1.e7 false phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d682.s1.e6_DDI-DrugBank.d682.s1.e0 false phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d682.s1.e6_DDI-DrugBank.d682.s1.e2 false phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d682.s1.e7_DDI-DrugBank.d682.s1.e0 false phenytoin_47\NN\3550533|of (r_nmod) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (r_dep) phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d682.s1.e7_DDI-DrugBank.d682.s1.e2 false phenytoin_47\NN\3550533|of (r_nmod) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (r_dep) phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d682.s1.e0_DDI-DrugBank.d682.s1.e2 false thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d776.s25
DDI-DrugBank.d776.s25.e0_DDI-DrugBank.d776.s25.e1 false cisapride_0\NN\1740| (r_dep) been_4\VBN\836236|cisapride|:|there|have|reports|. (l_attr) reports_5\NNS\6470073|events (l_nmod) events_8\NNS\23100|of|cardiac|,|pointes (l_nmod) pointes_13\NNS\1740|including|torsade|de|patients (l_nmod) patients_15\NNS\9898892|in|coadministered (l_acl:relcl) coadministered_22\VBN\1740|whom|fluconazole|were (l_nsubjpass) fluconazole_18\NN\1740|and|cisapride
DDI-DrugBank.d776.s25.e0_DDI-DrugBank.d776.s25.e2 false cisapride_0\NN\1740| (r_dep) been_4\VBN\836236|cisapride|:|there|have|reports|. (l_attr) reports_5\NNS\6470073|events (l_nmod) events_8\NNS\23100|of|cardiac|,|pointes (l_nmod) pointes_13\NNS\1740|including|torsade|de|patients (l_nmod) patients_15\NNS\9898892|in|coadministered (l_acl:relcl) coadministered_22\VBN\1740|whom|fluconazole|were (l_nsubjpass) fluconazole_18\NN\1740|and|cisapride (l_conj) cisapride_20\NN\1740|
DDI-DrugBank.d776.s25.e1_DDI-DrugBank.d776.s25.e2 true fluconazole_18\NN\1740|and|cisapride (l_conj) cisapride_20\NN\1740|
DDI-DrugBank.d572.s28
DDI-DrugBank.d784.s7
DDI-DrugBank.d784.s7.e2_DDI-DrugBank.d784.s7.e3 false hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (l_conj) hydroxide_14\NN\14818238|magnesium
DDI-DrugBank.d784.s7.e2_DDI-DrugBank.d784.s7.e4 false hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (l_conj) simethicone_17\NN\1740|
DDI-DrugBank.d784.s7.e2_DDI-DrugBank.d784.s7.e5 false hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml (r_nmod) ingestion_1\NN\13440063|concurrent|antacid (r_nsubj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_dobj) exposure_24\NN\5042871|the|oxybutynin (l_nmod) oxybutynin_26\NN\1740|of|or|desethyloxybutynin
DDI-DrugBank.d784.s7.e2_DDI-DrugBank.d784.s7.e6 false hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml (r_nmod) ingestion_1\NN\13440063|concurrent|antacid (r_nsubj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_dobj) exposure_24\NN\5042871|the|oxybutynin (l_nmod) oxybutynin_26\NN\1740|of|or|desethyloxybutynin (l_conj) desethyloxybutynin_28\NN\1740|
DDI-DrugBank.d784.s7.e2_DDI-DrugBank.d784.s7.e0 false hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml
DDI-DrugBank.d784.s7.e2_DDI-DrugBank.d784.s7.e1 false hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing
DDI-DrugBank.d784.s7.e3_DDI-DrugBank.d784.s7.e4 false hydroxide_14\NN\14818238|magnesium (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (l_conj) simethicone_17\NN\1740|
DDI-DrugBank.d784.s7.e3_DDI-DrugBank.d784.s7.e5 false hydroxide_14\NN\14818238|magnesium (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml (r_nmod) ingestion_1\NN\13440063|concurrent|antacid (r_nsubj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_dobj) exposure_24\NN\5042871|the|oxybutynin (l_nmod) oxybutynin_26\NN\1740|of|or|desethyloxybutynin
DDI-DrugBank.d784.s7.e3_DDI-DrugBank.d784.s7.e6 false hydroxide_14\NN\14818238|magnesium (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml (r_nmod) ingestion_1\NN\13440063|concurrent|antacid (r_nsubj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_dobj) exposure_24\NN\5042871|the|oxybutynin (l_nmod) oxybutynin_26\NN\1740|of|or|desethyloxybutynin (l_conj) desethyloxybutynin_28\NN\1740|
DDI-DrugBank.d784.s7.e3_DDI-DrugBank.d784.s7.e0 false hydroxide_14\NN\14818238|magnesium (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml
DDI-DrugBank.d784.s7.e3_DDI-DrugBank.d784.s7.e1 false hydroxide_14\NN\14818238|magnesium (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing
DDI-DrugBank.d784.s7.e4_DDI-DrugBank.d784.s7.e5 false simethicone_17\NN\1740| (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml (r_nmod) ingestion_1\NN\13440063|concurrent|antacid (r_nsubj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_dobj) exposure_24\NN\5042871|the|oxybutynin (l_nmod) oxybutynin_26\NN\1740|of|or|desethyloxybutynin
DDI-DrugBank.d784.s7.e4_DDI-DrugBank.d784.s7.e6 false simethicone_17\NN\1740| (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml (r_nmod) ingestion_1\NN\13440063|concurrent|antacid (r_nsubj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_dobj) exposure_24\NN\5042871|the|oxybutynin (l_nmod) oxybutynin_26\NN\1740|of|or|desethyloxybutynin (l_conj) desethyloxybutynin_28\NN\1740|
DDI-DrugBank.d784.s7.e4_DDI-DrugBank.d784.s7.e0 false simethicone_17\NN\1740| (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing (r_nmod) ml_6\NN\13616054|(|20|antacid|) (r_dep) antacid_3\NN\14778436|of|ml
DDI-DrugBank.d784.s7.e4_DDI-DrugBank.d784.s7.e1 false simethicone_17\NN\1740| (r_conj) hydroxide_11\NN\14818238|aluminum|,|hydroxide|,|and|simethicone (r_dobj) containing_9\VBG\2632940|hydroxide (r_acl) antacid_8\NN\14778436|of|containing
DDI-DrugBank.d784.s7.e5_DDI-DrugBank.d784.s7.e6 false oxybutynin_26\NN\1740|of|or|desethyloxybutynin (l_conj) desethyloxybutynin_28\NN\1740|
DDI-DrugBank.d784.s7.e5_DDI-DrugBank.d784.s7.e0 false oxybutynin_26\NN\1740|of|or|desethyloxybutynin (r_nmod) exposure_24\NN\5042871|the|oxybutynin (r_dobj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_nsubj) ingestion_1\NN\13440063|concurrent|antacid (l_nmod) antacid_3\NN\14778436|of|ml
DDI-DrugBank.d784.s7.e5_DDI-DrugBank.d784.s7.e1 false oxybutynin_26\NN\1740|of|or|desethyloxybutynin (r_nmod) exposure_24\NN\5042871|the|oxybutynin (r_dobj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_nsubj) ingestion_1\NN\13440063|concurrent|antacid (l_nmod) antacid_3\NN\14778436|of|ml (l_dep) ml_6\NN\13616054|(|20|antacid|) (l_nmod) antacid_8\NN\14778436|of|containing
DDI-DrugBank.d784.s7.e6_DDI-DrugBank.d784.s7.e0 false desethyloxybutynin_28\NN\1740| (r_conj) oxybutynin_26\NN\1740|of|or|desethyloxybutynin (r_nmod) exposure_24\NN\5042871|the|oxybutynin (r_dobj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_nsubj) ingestion_1\NN\13440063|concurrent|antacid (l_nmod) antacid_3\NN\14778436|of|ml
DDI-DrugBank.d784.s7.e6_DDI-DrugBank.d784.s7.e1 false desethyloxybutynin_28\NN\1740| (r_conj) oxybutynin_26\NN\1740|of|or|desethyloxybutynin (r_nmod) exposure_24\NN\5042871|the|oxybutynin (r_dobj) affect_22\VB\126264|ingestion|did|not|significantly|exposure|. (l_nsubj) ingestion_1\NN\13440063|concurrent|antacid (l_nmod) antacid_3\NN\14778436|of|ml (l_dep) ml_6\NN\13616054|(|20|antacid|) (l_nmod) antacid_8\NN\14778436|of|containing
DDI-DrugBank.d784.s7.e0_DDI-DrugBank.d784.s7.e1 false antacid_3\NN\14778436|of|ml (l_dep) ml_6\NN\13616054|(|20|antacid|) (l_nmod) antacid_8\NN\14778436|of|containing
DDI-DrugBank.d776.s2
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e3 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) cyclosporine_16\NN\1740|
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e4 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifampin_18\NN\2716205|
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e5 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) theophylline_20\NN\2905612|
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e6 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) terfenadine_22\NN\1740|
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e7 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) cisapride_24\NN\1740|
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e8 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) astemizole_26\NN\1740|
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e9 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifabutin_28\NN\1740|
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e0 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e2_DDI-DrugBank.d776.s2.e1 false phenytoin_14\NN\3550533| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e4 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifampin_18\NN\2716205|
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e5 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) theophylline_20\NN\2905612|
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e6 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) terfenadine_22\NN\1740|
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e7 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) cisapride_24\NN\1740|
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e8 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) astemizole_26\NN\1740|
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e9 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifabutin_28\NN\1740|
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e0 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e3_DDI-DrugBank.d776.s2.e1 false cyclosporine_16\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e4_DDI-DrugBank.d776.s2.e5 false rifampin_18\NN\2716205| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) theophylline_20\NN\2905612|
DDI-DrugBank.d776.s2.e4_DDI-DrugBank.d776.s2.e6 false rifampin_18\NN\2716205| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) terfenadine_22\NN\1740|
DDI-DrugBank.d776.s2.e4_DDI-DrugBank.d776.s2.e7 false rifampin_18\NN\2716205| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) cisapride_24\NN\1740|
DDI-DrugBank.d776.s2.e4_DDI-DrugBank.d776.s2.e8 false rifampin_18\NN\2716205| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) astemizole_26\NN\1740|
DDI-DrugBank.d776.s2.e4_DDI-DrugBank.d776.s2.e9 false rifampin_18\NN\2716205| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifabutin_28\NN\1740|
DDI-DrugBank.d776.s2.e4_DDI-DrugBank.d776.s2.e0 false rifampin_18\NN\2716205| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e4_DDI-DrugBank.d776.s2.e1 false rifampin_18\NN\2716205| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e5_DDI-DrugBank.d776.s2.e6 false theophylline_20\NN\2905612| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) terfenadine_22\NN\1740|
DDI-DrugBank.d776.s2.e5_DDI-DrugBank.d776.s2.e7 false theophylline_20\NN\2905612| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) cisapride_24\NN\1740|
DDI-DrugBank.d776.s2.e5_DDI-DrugBank.d776.s2.e8 false theophylline_20\NN\2905612| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) astemizole_26\NN\1740|
DDI-DrugBank.d776.s2.e5_DDI-DrugBank.d776.s2.e9 false theophylline_20\NN\2905612| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifabutin_28\NN\1740|
DDI-DrugBank.d776.s2.e5_DDI-DrugBank.d776.s2.e0 false theophylline_20\NN\2905612| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e5_DDI-DrugBank.d776.s2.e1 false theophylline_20\NN\2905612| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e6_DDI-DrugBank.d776.s2.e7 false terfenadine_22\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) cisapride_24\NN\1740|
DDI-DrugBank.d776.s2.e6_DDI-DrugBank.d776.s2.e8 false terfenadine_22\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) astemizole_26\NN\1740|
DDI-DrugBank.d776.s2.e6_DDI-DrugBank.d776.s2.e9 false terfenadine_22\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifabutin_28\NN\1740|
DDI-DrugBank.d776.s2.e6_DDI-DrugBank.d776.s2.e0 false terfenadine_22\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e6_DDI-DrugBank.d776.s2.e1 false terfenadine_22\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e7_DDI-DrugBank.d776.s2.e8 false cisapride_24\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) astemizole_26\NN\1740|
DDI-DrugBank.d776.s2.e7_DDI-DrugBank.d776.s2.e9 false cisapride_24\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifabutin_28\NN\1740|
DDI-DrugBank.d776.s2.e7_DDI-DrugBank.d776.s2.e0 false cisapride_24\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e7_DDI-DrugBank.d776.s2.e1 false cisapride_24\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e8_DDI-DrugBank.d776.s2.e9 false astemizole_26\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) rifabutin_28\NN\1740|
DDI-DrugBank.d776.s2.e8_DDI-DrugBank.d776.s2.e0 false astemizole_26\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e8_DDI-DrugBank.d776.s2.e1 false astemizole_26\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e9_DDI-DrugBank.d776.s2.e0 false rifabutin_28\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|;
DDI-DrugBank.d776.s2.e9_DDI-DrugBank.d776.s2.e1 false rifabutin_28\NN\1740| (r_appos) hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s2.e0_DDI-DrugBank.d776.s2.e1 false hypoglycemics_9\NNS\1740|oral|,|anticoagulants|,|phenytoin|,|cyclosporine|,|rifampin|,|theophylline|,|terfenadine|,|cisapride|,|astemizole|,|rifabutin|,|tacrolimus|,|benzodiazepines|,|hypoglycemics|:|precipitated|; (l_appos) anticoagulants_12\NNS\3740161|coumarin-type
DDI-DrugBank.d607.s0
DDI-DrugBank.d581.s2
DDI-DrugBank.d581.s2.e0_DDI-DrugBank.d581.s2.e1 true lithium_2\NN\14625458|and|neulasta (l_conj) neulasta_4\NN\1740|
DDI-DrugBank.d640.s0
DDI-DrugBank.d640.s0.e0_DDI-DrugBank.d640.s0.e1 false diuretics_0\NNS\3247620| (r_dep) occur_8\VB\2623529|diuretics|:|reductions|may|patients|started|. (l_advcl) started_18\VBN\2009433|when|inhibitors|are (l_nsubjpass) inhibitors_16\NNS\20090|ace
DDI-DrugBank.d775.s12
DDI-DrugBank.d775.s12.e0_DDI-DrugBank.d775.s12.e1 false phenytoin_5\NN\3550533|or|carbamazepine (l_conj) carbamazepine_7\NN\1740|
DDI-DrugBank.d775.s12.e0_DDI-DrugBank.d775.s12.e2 true phenytoin_5\NN\3550533|or|carbamazepine (r_compound) therapy_8\NN\657604|of|chronic|phenytoin (r_nmod) effects_2\NNS\13245626|the|therapy|action (l_nmod) action_11\NN\30358|on|the|mivacron (l_nmod) mivacron_13\NN\1740|of
DDI-DrugBank.d775.s12.e1_DDI-DrugBank.d775.s12.e2 true carbamazepine_7\NN\1740| (r_conj) phenytoin_5\NN\3550533|or|carbamazepine (r_compound) therapy_8\NN\657604|of|chronic|phenytoin (r_nmod) effects_2\NNS\13245626|the|therapy|action (l_nmod) action_11\NN\30358|on|the|mivacron (l_nmod) mivacron_13\NN\1740|of
DDI-DrugBank.d680.s0
DDI-DrugBank.d776.s29
DDI-DrugBank.d715.s0
DDI-DrugBank.d715.s0.e2_DDI-DrugBank.d715.s0.e0 false haloperidol_12\NN\3713736| (r_conj) phenothiazines_10\NNS\14771088|or|haloperidol (r_dobj) receiving_9\VBG\2210855|phenothiazines (r_acl) patients_8\NNS\9898892|to|receiving (r_nmod) administering_5\VBG\2436349|in|demser|patients (l_dobj) demser_6\NN\1740|
DDI-DrugBank.d715.s0.e2_DDI-DrugBank.d715.s0.e1 false haloperidol_12\NN\3713736| (r_conj) phenothiazines_10\NNS\14771088|or|haloperidol
DDI-DrugBank.d715.s0.e0_DDI-DrugBank.d715.s0.e1 true demser_6\NN\1740| (r_dobj) administering_5\VBG\2436349|in|demser|patients (l_nmod) patients_8\NNS\9898892|to|receiving (l_acl) receiving_9\VBG\2210855|phenothiazines (l_dobj) phenothiazines_10\NNS\14771088|or|haloperidol
DDI-DrugBank.d709.s3
DDI-DrugBank.d709.s3.e0_DDI-DrugBank.d709.s3.e1 false roxithromycin_9\NN\1740|with (r_nmod) demonstrated_7\VBN\2137132|although|reaction|has|not|been|roxithromycin (r_advcl) recommended_21\VBN\875394|demonstrated|,|administration|is|not|. (l_nsubjpass) administration_12\NN\1133281|concomitant|roxithromycin|terfenadine (l_nmod) roxithromycin_14\NN\1740|of
DDI-DrugBank.d709.s3.e0_DDI-DrugBank.d709.s3.e2 false roxithromycin_9\NN\1740|with (r_nmod) demonstrated_7\VBN\2137132|although|reaction|has|not|been|roxithromycin (r_advcl) recommended_21\VBN\875394|demonstrated|,|administration|is|not|. (l_nsubjpass) administration_12\NN\1133281|concomitant|roxithromycin|terfenadine (l_nmod) terfenadine_16\NN\1740|with|or|astemizole
DDI-DrugBank.d709.s3.e0_DDI-DrugBank.d709.s3.e3 false roxithromycin_9\NN\1740|with (r_nmod) demonstrated_7\VBN\2137132|although|reaction|has|not|been|roxithromycin (r_advcl) recommended_21\VBN\875394|demonstrated|,|administration|is|not|. (l_nsubjpass) administration_12\NN\1133281|concomitant|roxithromycin|terfenadine (l_nmod) terfenadine_16\NN\1740|with|or|astemizole (l_conj) astemizole_18\NN\1740|
DDI-DrugBank.d709.s3.e1_DDI-DrugBank.d709.s3.e2 true roxithromycin_14\NN\1740|of (r_nmod) administration_12\NN\1133281|concomitant|roxithromycin|terfenadine (l_nmod) terfenadine_16\NN\1740|with|or|astemizole
DDI-DrugBank.d709.s3.e1_DDI-DrugBank.d709.s3.e3 true roxithromycin_14\NN\1740|of (r_nmod) administration_12\NN\1133281|concomitant|roxithromycin|terfenadine (l_nmod) terfenadine_16\NN\1740|with|or|astemizole (l_conj) astemizole_18\NN\1740|
DDI-DrugBank.d709.s3.e2_DDI-DrugBank.d709.s3.e3 false terfenadine_16\NN\1740|with|or|astemizole (l_conj) astemizole_18\NN\1740|
DDI-DrugBank.d633.s9
DDI-DrugBank.d633.s9.e0_DDI-DrugBank.d633.s9.e1 false phenytoin_1\NN\3550533|or|inducers (l_conj) inducers_6\NNS\14778436|other|hepatic|enzyme|rifampin (l_nmod) rifampin_9\NN\2716205|such|and|phenobarbital
DDI-DrugBank.d633.s9.e0_DDI-DrugBank.d633.s9.e2 false phenytoin_1\NN\3550533|or|inducers (l_conj) inducers_6\NNS\14778436|other|hepatic|enzyme|rifampin (l_nmod) rifampin_9\NN\2716205|such|and|phenobarbital (l_conj) phenobarbital_11\NN\2792049|
DDI-DrugBank.d633.s9.e0_DDI-DrugBank.d633.s9.e3 true phenytoin_1\NN\3550533|or|inducers (r_nsubjpass) taken_14\VBN\2367363|when|phenytoin|have|been|mexitil (l_nmod) mexitil_17\NN\2715941|concurrently|with
DDI-DrugBank.d633.s9.e0_DDI-DrugBank.d633.s9.e4 false phenytoin_1\NN\3550533|or|inducers (r_nsubjpass) taken_14\VBN\2367363|when|phenytoin|have|been|mexitil (r_advcl) reported_25\VBN\831651|taken|,|levels|have|been|. (l_nsubjpass) levels_22\NNS\4916342|lowered|mexitil|plasma (l_compound) mexitil_20\NN\2715941|
DDI-DrugBank.d633.s9.e1_DDI-DrugBank.d633.s9.e2 false rifampin_9\NN\2716205|such|and|phenobarbital (l_conj) phenobarbital_11\NN\2792049|
DDI-DrugBank.d633.s9.e1_DDI-DrugBank.d633.s9.e3 true rifampin_9\NN\2716205|such|and|phenobarbital (r_nmod) inducers_6\NNS\14778436|other|hepatic|enzyme|rifampin (r_conj) phenytoin_1\NN\3550533|or|inducers (r_nsubjpass) taken_14\VBN\2367363|when|phenytoin|have|been|mexitil (l_nmod) mexitil_17\NN\2715941|concurrently|with
DDI-DrugBank.d633.s9.e1_DDI-DrugBank.d633.s9.e4 false rifampin_9\NN\2716205|such|and|phenobarbital (r_nmod) inducers_6\NNS\14778436|other|hepatic|enzyme|rifampin (r_conj) phenytoin_1\NN\3550533|or|inducers (r_nsubjpass) taken_14\VBN\2367363|when|phenytoin|have|been|mexitil (r_advcl) reported_25\VBN\831651|taken|,|levels|have|been|. (l_nsubjpass) levels_22\NNS\4916342|lowered|mexitil|plasma (l_compound) mexitil_20\NN\2715941|
DDI-DrugBank.d633.s9.e2_DDI-DrugBank.d633.s9.e3 true phenobarbital_11\NN\2792049| (r_conj) rifampin_9\NN\2716205|such|and|phenobarbital (r_nmod) inducers_6\NNS\14778436|other|hepatic|enzyme|rifampin (r_conj) phenytoin_1\NN\3550533|or|inducers (r_nsubjpass) taken_14\VBN\2367363|when|phenytoin|have|been|mexitil (l_nmod) mexitil_17\NN\2715941|concurrently|with
DDI-DrugBank.d633.s9.e2_DDI-DrugBank.d633.s9.e4 false phenobarbital_11\NN\2792049| (r_conj) rifampin_9\NN\2716205|such|and|phenobarbital (r_nmod) inducers_6\NNS\14778436|other|hepatic|enzyme|rifampin (r_conj) phenytoin_1\NN\3550533|or|inducers (r_nsubjpass) taken_14\VBN\2367363|when|phenytoin|have|been|mexitil (r_advcl) reported_25\VBN\831651|taken|,|levels|have|been|. (l_nsubjpass) levels_22\NNS\4916342|lowered|mexitil|plasma (l_compound) mexitil_20\NN\2715941|
DDI-DrugBank.d633.s9.e3_DDI-DrugBank.d633.s9.e4 false mexitil_17\NN\2715941|concurrently|with (r_nmod) taken_14\VBN\2367363|when|phenytoin|have|been|mexitil (r_advcl) reported_25\VBN\831651|taken|,|levels|have|been|. (l_nsubjpass) levels_22\NNS\4916342|lowered|mexitil|plasma (l_compound) mexitil_20\NN\2715941|
DDI-DrugBank.d588.s11
DDI-DrugBank.d588.s11.e1_DDI-DrugBank.d588.s11.e2 true metolazone_2\NN\1740| (r_nsubj) decrease_4\VB\169651|metolazone|may|responsiveness|,|but|sufficient (l_dobj) responsiveness_6\NN\5652926|arterial|norepinephrine (l_nmod) norepinephrine_8\NN\14807929|to
DDI-DrugBank.d588.s11.e1_DDI-DrugBank.d588.s11.e0 false metolazone_2\NN\1740| (r_nsubj) decrease_4\VB\169651|metolazone|may|responsiveness|,|but|sufficient (r_dep) sympathomimetics_0\NNS\1740|:|decrease|.
DDI-DrugBank.d588.s11.e2_DDI-DrugBank.d588.s11.e0 false norepinephrine_8\NN\14807929|to (r_nmod) responsiveness_6\NN\5652926|arterial|norepinephrine (r_dobj) decrease_4\VB\169651|metolazone|may|responsiveness|,|but|sufficient (r_dep) sympathomimetics_0\NNS\1740|:|decrease|.
DDI-DrugBank.d572.s26
DDI-DrugBank.d645.s1
DDI-DrugBank.d783.s1
DDI-DrugBank.d710.s5
DDI-DrugBank.d710.s5.e0_DDI-DrugBank.d710.s5.e1 true acetaminophen_2\NN\2707683|with (r_nmod) coadministration_0\NN\1740|acetaminophen (r_nsubj) reduced_3\VBD\441445|coadministration|concentration|%|. (l_dobj) concentration_6\NN\4916342|the|peak|and|auc|values|rimantadine (l_nmod) rimantadine_11\NN\1740|for
DDI-DrugBank.d727.s4
DDI-DrugBank.d653.s0
DDI-DrugBank.d632.s1
DDI-DrugBank.d572.s17
DDI-DrugBank.d572.s17.e0_DDI-DrugBank.d572.s17.e1 false ezetimibe_8\NN\1740|of (r_nmod) studies_6\NNS\635850|in|oral|fertility|ezetimibe|conducted (r_nmod) was_14\VBD\836236|studies|,|there|evidence|rats|exposure|. (l_dep) exposure_36\NN\5042871|times|the|human|mg|24hr|ezetimibe|) (l_nmod) ezetimibe_48\NN\1740|for|total
DDI-DrugBank.d575.s1
DDI-DrugBank.d668.s2
DDI-DrugBank.d668.s2.e1_DDI-DrugBank.d668.s2.e2 false phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (l_appos) phenobarbital_10\NN\2792049|
DDI-DrugBank.d668.s2.e1_DDI-DrugBank.d668.s2.e3 false phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (l_appos) carbamazepine_12\NN\1740|
DDI-DrugBank.d668.s2.e1_DDI-DrugBank.d668.s2.e4 true phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin (r_nsubj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_dobj) metabolism_17\NN\13526110|mifepristone (l_compound) mifepristone_16\NN\2667906|
DDI-DrugBank.d668.s2.e1_DDI-DrugBank.d668.s2.e5 false phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin (r_nsubj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_advcl) lowering_19\VBG\1850315|levels|) (l_dobj) levels_21\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_23\NN\2667906|of
DDI-DrugBank.d668.s2.e1_DDI-DrugBank.d668.s2.e0 false phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin
DDI-DrugBank.d668.s2.e2_DDI-DrugBank.d668.s2.e3 false phenobarbital_10\NN\2792049| (r_appos) phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (l_appos) carbamazepine_12\NN\1740|
DDI-DrugBank.d668.s2.e2_DDI-DrugBank.d668.s2.e4 false phenobarbital_10\NN\2792049| (r_appos) phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin (r_nsubj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_dobj) metabolism_17\NN\13526110|mifepristone (l_compound) mifepristone_16\NN\2667906|
DDI-DrugBank.d668.s2.e2_DDI-DrugBank.d668.s2.e5 false phenobarbital_10\NN\2792049| (r_appos) phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin (r_nsubj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_advcl) lowering_19\VBG\1850315|levels|) (l_dobj) levels_21\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_23\NN\2667906|of
DDI-DrugBank.d668.s2.e2_DDI-DrugBank.d668.s2.e0 false phenobarbital_10\NN\2792049| (r_appos) phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin
DDI-DrugBank.d668.s2.e3_DDI-DrugBank.d668.s2.e4 false carbamazepine_12\NN\1740| (r_appos) phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin (r_nsubj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_dobj) metabolism_17\NN\13526110|mifepristone (l_compound) mifepristone_16\NN\2667906|
DDI-DrugBank.d668.s2.e3_DDI-DrugBank.d668.s2.e5 false carbamazepine_12\NN\1740| (r_appos) phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin (r_nsubj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_advcl) lowering_19\VBG\1850315|levels|) (l_dobj) levels_21\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_23\NN\2667906|of
DDI-DrugBank.d668.s2.e3_DDI-DrugBank.d668.s2.e0 false carbamazepine_12\NN\1740| (r_appos) phenytoin_8\NN\3550533|(|,|phenobarbital|,|carbamazepine|) (r_dep) anticonvulsants_6\NNS\3740161|certain|phenytoin
DDI-DrugBank.d668.s2.e4_DDI-DrugBank.d668.s2.e5 false mifepristone_16\NN\2667906| (r_compound) metabolism_17\NN\13526110|mifepristone (r_dobj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_advcl) lowering_19\VBG\1850315|levels|) (l_dobj) levels_21\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_23\NN\2667906|of
DDI-DrugBank.d668.s2.e4_DDI-DrugBank.d668.s2.e0 false mifepristone_16\NN\2667906| (r_compound) metabolism_17\NN\13526110|mifepristone (r_dobj) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_nsubj) anticonvulsants_6\NNS\3740161|certain|phenytoin
DDI-DrugBank.d668.s2.e5_DDI-DrugBank.d668.s2.e0 false mifepristone_23\NN\2667906|of (r_nmod) levels_21\NNS\4916342|serum|mifepristone (r_dobj) lowering_19\VBG\1850315|levels|) (r_advcl) induce_15\VB\1627355|anticonvulsants|may|metabolism|(|lowering|. (l_nsubj) anticonvulsants_6\NNS\3740161|certain|phenytoin
DDI-DrugBank.d704.s0
DDI-DrugBank.d704.s0.e0_DDI-DrugBank.d704.s0.e1 false flomax_7\NNP\1740| (r_compound) capsules_8\NNS\3094503|between|flomax|and|agents (l_conj) agents_13\NNS\7347|other|alpha-adrenergic|blocking
DDI-DrugBank.d619.s0
DDI-DrugBank.d619.s0.e0_DDI-DrugBank.d619.s0.e1 true selegiline_24\NN\1740|of|and|meperidine (l_conj) meperidine_26\NN\3808564|
DDI-DrugBank.d576.s2
DDI-DrugBank.d622.s3
DDI-DrugBank.d622.s3.e0_DDI-DrugBank.d622.s3.e1 false morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) theophylline_2\NN\2905612|
DDI-DrugBank.d622.s3.e0_DDI-DrugBank.d622.s3.e2 false morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) aminophylline_4\NN\2905612|
DDI-DrugBank.d622.s3.e0_DDI-DrugBank.d622.s3.e3 false morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) succinylcholine_6\NN\3800001|
DDI-DrugBank.d622.s3.e0_DDI-DrugBank.d622.s3.e4 false morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) reserpine_8\NN\2721160|
DDI-DrugBank.d622.s3.e0_DDI-DrugBank.d622.s3.e5 false morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) tranquilizers_12\NNS\4017429|phenothiazine-type
DDI-DrugBank.d622.s3.e1_DDI-DrugBank.d622.s3.e2 false theophylline_2\NN\2905612| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) aminophylline_4\NN\2905612|
DDI-DrugBank.d622.s3.e1_DDI-DrugBank.d622.s3.e3 false theophylline_2\NN\2905612| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) succinylcholine_6\NN\3800001|
DDI-DrugBank.d622.s3.e1_DDI-DrugBank.d622.s3.e4 false theophylline_2\NN\2905612| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) reserpine_8\NN\2721160|
DDI-DrugBank.d622.s3.e1_DDI-DrugBank.d622.s3.e5 false theophylline_2\NN\2905612| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) tranquilizers_12\NNS\4017429|phenothiazine-type
DDI-DrugBank.d622.s3.e2_DDI-DrugBank.d622.s3.e3 false aminophylline_4\NN\2905612| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) succinylcholine_6\NN\3800001|
DDI-DrugBank.d622.s3.e2_DDI-DrugBank.d622.s3.e4 false aminophylline_4\NN\2905612| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) reserpine_8\NN\2721160|
DDI-DrugBank.d622.s3.e2_DDI-DrugBank.d622.s3.e5 false aminophylline_4\NN\2905612| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) tranquilizers_12\NNS\4017429|phenothiazine-type
DDI-DrugBank.d622.s3.e3_DDI-DrugBank.d622.s3.e4 false succinylcholine_6\NN\3800001| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) reserpine_8\NN\2721160|
DDI-DrugBank.d622.s3.e3_DDI-DrugBank.d622.s3.e5 false succinylcholine_6\NN\3800001| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) tranquilizers_12\NNS\4017429|phenothiazine-type
DDI-DrugBank.d622.s3.e4_DDI-DrugBank.d622.s3.e5 false reserpine_8\NN\2721160| (r_conj) morphine_0\NN\2707683|,|theophylline|,|aminophylline|,|succinylcholine|,|reserpine|,|and|tranquilizers (l_conj) tranquilizers_12\NNS\4017429|phenothiazine-type
DDI-DrugBank.d711.s3
DDI-DrugBank.d711.s3.e1_DDI-DrugBank.d711.s3.e0 false methoxyflurane_6\NN\1740| (r_conj) tetracycline_4\NN\2716205|of|and|methoxyflurane
DDI-DrugBank.d776.s24
DDI-DrugBank.d776.s24.e0_DDI-DrugBank.d776.s24.e1 true fluconazole_3\NN\1740|of (r_nmod) coadministration_1\NN\1740|the|fluconazole|doses|terfenadine (l_nmod) terfenadine_11\NN\1740|with
DDI-DrugBank.d661.s3
DDI-DrugBank.d590.s2
DDI-DrugBank.d590.s2.e1_DDI-DrugBank.d590.s2.e2 false ranitidine_21\NN\14778019|of (r_nmod) concentrations_19\NNS\4916342|in|plasma|ranitidine (r_nmod) decrease_16\NN\7296428|in|a|%|concentrations (r_nmod) results_11\VBZ\2633881|coadministration|decrease|and|decrease|. (l_conj) decrease_24\VB\169651|may|concentrations|tritec (l_nmod) tritec_30\NN\1740|from
DDI-DrugBank.d590.s2.e1_DDI-DrugBank.d590.s2.e0 false ranitidine_21\NN\14778019|of (r_nmod) concentrations_19\NNS\4916342|in|plasma|ranitidine (r_nmod) decrease_16\NN\7296428|in|a|%|concentrations (r_nmod) results_11\VBZ\2633881|coadministration|decrease|and|decrease|. (l_nsubj) coadministration_0\NN\1740|dose (l_nmod) dose_4\NN\3740161|with|a|high|antacid (l_nmod) antacid_6\NN\14778436|of|meq
DDI-DrugBank.d590.s2.e2_DDI-DrugBank.d590.s2.e0 false tritec_30\NN\1740|from (r_nmod) decrease_24\VB\169651|may|concentrations|tritec (r_conj) results_11\VBZ\2633881|coadministration|decrease|and|decrease|. (l_nsubj) coadministration_0\NN\1740|dose (l_nmod) dose_4\NN\3740161|with|a|high|antacid (l_nmod) antacid_6\NN\14778436|of|meq
DDI-DrugBank.d652.s0
DDI-DrugBank.d652.s0.e0_DDI-DrugBank.d652.s0.e1 true metoclopramide_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|metoclopramide|motility (r_nsubjpass) antagonized_8\VBN\1787955|effects|are|drugs|. (l_nmod) drugs_11\NNS\14778436|by|anticholinergic|and|analgesics
DDI-DrugBank.d652.s0.e0_DDI-DrugBank.d652.s0.e2 true metoclopramide_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|metoclopramide|motility (r_nsubjpass) antagonized_8\VBN\1787955|effects|are|drugs|. (l_nmod) drugs_11\NNS\14778436|by|anticholinergic|and|analgesics (l_conj) analgesics_14\NNS\3740161|narcotic
DDI-DrugBank.d652.s0.e1_DDI-DrugBank.d652.s0.e2 false drugs_11\NNS\14778436|by|anticholinergic|and|analgesics (l_conj) analgesics_14\NNS\3740161|narcotic
DDI-DrugBank.d765.s0
DDI-DrugBank.d765.s0.e0_DDI-DrugBank.d765.s0.e1 true ketoconazole_3\NN\1740|,|inhibitor|, (r_nsubj) increased_15\VBD\169651|ketoconazole|significantly|concentrations|coadministered|see|. (l_dobj) concentrations_17\NNS\4916342|plasma|tolterodine (l_nmod) tolterodine_19\NN\1740|of
DDI-DrugBank.d781.s16
DDI-DrugBank.d781.s16.e0_DDI-DrugBank.d781.s16.e1 false perindopril_7\NN\1740|of (r_nmod) biotransformation_5\NN\1740|of|perindopril|metabolite (l_nmod) metabolite_11\NN\20090|to|the|active|,|perindoprilat|, (l_appos) perindoprilat_13\NN\1740|
DDI-DrugBank.d572.s20
DDI-DrugBank.d606.s1
DDI-DrugBank.d606.s1.e1_DDI-DrugBank.d606.s1.e2 false methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (l_conj) mecamylamine_9\NN\1740|
DDI-DrugBank.d606.s1.e1_DDI-DrugBank.d606.s1.e3 false methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (l_conj) reserpine_11\NN\2721160|
DDI-DrugBank.d606.s1.e1_DDI-DrugBank.d606.s1.e0 false methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (r_nmod) effects_5\NNS\13245626|the|antihypertensive|methyldopa (r_dobj) reduce_2\VB\441445|sympathomimetics|may|effects|. (l_nsubj) sympathomimetics_0\NNS\1740|
DDI-DrugBank.d606.s1.e1_DDI-DrugBank.d606.s1.e4 false methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (l_conj) alkaloids_14\NNS\14727670|veratrum
DDI-DrugBank.d606.s1.e2_DDI-DrugBank.d606.s1.e3 false mecamylamine_9\NN\1740| (r_conj) methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (l_conj) reserpine_11\NN\2721160|
DDI-DrugBank.d606.s1.e2_DDI-DrugBank.d606.s1.e0 false mecamylamine_9\NN\1740| (r_conj) methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (r_nmod) effects_5\NNS\13245626|the|antihypertensive|methyldopa (r_dobj) reduce_2\VB\441445|sympathomimetics|may|effects|. (l_nsubj) sympathomimetics_0\NNS\1740|
DDI-DrugBank.d606.s1.e2_DDI-DrugBank.d606.s1.e4 false mecamylamine_9\NN\1740| (r_conj) methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (l_conj) alkaloids_14\NNS\14727670|veratrum
DDI-DrugBank.d606.s1.e3_DDI-DrugBank.d606.s1.e0 false reserpine_11\NN\2721160| (r_conj) methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (r_nmod) effects_5\NNS\13245626|the|antihypertensive|methyldopa (r_dobj) reduce_2\VB\441445|sympathomimetics|may|effects|. (l_nsubj) sympathomimetics_0\NNS\1740|
DDI-DrugBank.d606.s1.e3_DDI-DrugBank.d606.s1.e4 false reserpine_11\NN\2721160| (r_conj) methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (l_conj) alkaloids_14\NNS\14727670|veratrum
DDI-DrugBank.d606.s1.e0_DDI-DrugBank.d606.s1.e4 true sympathomimetics_0\NNS\1740| (r_nsubj) reduce_2\VB\441445|sympathomimetics|may|effects|. (l_dobj) effects_5\NNS\13245626|the|antihypertensive|methyldopa (l_nmod) methyldopa_7\NN\2721160|of|,|mecamylamine|,|reserpine|and|alkaloids (l_conj) alkaloids_14\NNS\14727670|veratrum
DDI-DrugBank.d597.s27
DDI-DrugBank.d597.s27.e0_DDI-DrugBank.d597.s27.e1 false meloxicam_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|meloxicam|effect (l_nmod) effect_7\NN\34213|on|the|anticoagulant|warfarin (l_nmod) warfarin_9\NN\2718259|of
DDI-DrugBank.d597.s27.e0_DDI-DrugBank.d597.s27.e2 false meloxicam_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|meloxicam|effect (r_nsubjpass) studied_11\VBN\630380|effect|was|group|. (l_nmod) group_14\NN\2137|in|a|subjects (l_nmod) subjects_17\NNS\6598915|of|healthy|receiving (l_acl) receiving_18\VBG\2210855|doses (l_dobj) doses_20\NNS\3740161|daily|warfarin|produced (l_nmod) warfarin_22\NN\2718259|of
DDI-DrugBank.d597.s27.e1_DDI-DrugBank.d597.s27.e2 false warfarin_9\NN\2718259|of (r_nmod) effect_7\NN\34213|on|the|anticoagulant|warfarin (r_nmod) effect_1\NN\34213|the|meloxicam|effect (r_nsubjpass) studied_11\VBN\630380|effect|was|group|. (l_nmod) group_14\NN\2137|in|a|subjects (l_nmod) subjects_17\NNS\6598915|of|healthy|receiving (l_acl) receiving_18\VBG\2210855|doses (l_dobj) doses_20\NNS\3740161|daily|warfarin|produced (l_nmod) warfarin_22\NN\2718259|of
DDI-DrugBank.d572.s14
DDI-DrugBank.d665.s1
DDI-DrugBank.d703.s0
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e0 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (r_dep) interaction_0\NN\37396|depressants|:|used (l_nmod) depressants_6\NNS\3248958|with|other|central|nervous|system
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e2 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e3 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) anesthetics_30\NNS\3247620|general
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e4 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) phenothiazines_32\NNS\14771088|
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e5 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) tranquilizers_35\NNS\4017429|other|,
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e6 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e7 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_nmod) barbiturates_40\NNS\4166841|including|)
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e8 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e1_DDI-DrugBank.d703.s0.e9 false meperidine_8\NN\3808564| (r_nsubjpass) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e2 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e3 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) anesthetics_30\NNS\3247620|general
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e4 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) phenothiazines_32\NNS\14771088|
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e5 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) tranquilizers_35\NNS\4017429|other|,
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e6 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e7 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_nmod) barbiturates_40\NNS\4166841|including|)
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e8 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e0_DDI-DrugBank.d703.s0.e9 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) interaction_0\NN\37396|depressants|:|used (l_dep) used_11\VBN\1156834|meperidine|should|be|caution|. (l_nmod) caution_14\NN\4662951|with|great|and|dosage (l_conj) dosage_18\NN\13576355|in|reduced|patients (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl:relcl) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e2_DDI-DrugBank.d703.s0.e3 false analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) anesthetics_30\NNS\3247620|general
DDI-DrugBank.d703.s0.e2_DDI-DrugBank.d703.s0.e4 false analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) phenothiazines_32\NNS\14771088|
DDI-DrugBank.d703.s0.e2_DDI-DrugBank.d703.s0.e5 false analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) tranquilizers_35\NNS\4017429|other|,
DDI-DrugBank.d703.s0.e2_DDI-DrugBank.d703.s0.e6 false analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants
DDI-DrugBank.d703.s0.e2_DDI-DrugBank.d703.s0.e7 false analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_nmod) barbiturates_40\NNS\4166841|including|)
DDI-DrugBank.d703.s0.e2_DDI-DrugBank.d703.s0.e8 false analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e2_DDI-DrugBank.d703.s0.e9 false analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e3_DDI-DrugBank.d703.s0.e4 false anesthetics_30\NNS\3247620|general (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) phenothiazines_32\NNS\14771088|
DDI-DrugBank.d703.s0.e3_DDI-DrugBank.d703.s0.e5 false anesthetics_30\NNS\3247620|general (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) tranquilizers_35\NNS\4017429|other|,
DDI-DrugBank.d703.s0.e3_DDI-DrugBank.d703.s0.e6 false anesthetics_30\NNS\3247620|general (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants
DDI-DrugBank.d703.s0.e3_DDI-DrugBank.d703.s0.e7 false anesthetics_30\NNS\3247620|general (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_nmod) barbiturates_40\NNS\4166841|including|)
DDI-DrugBank.d703.s0.e3_DDI-DrugBank.d703.s0.e8 false anesthetics_30\NNS\3247620|general (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e3_DDI-DrugBank.d703.s0.e9 false anesthetics_30\NNS\3247620|general (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e4_DDI-DrugBank.d703.s0.e5 false phenothiazines_32\NNS\14771088| (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (l_conj) tranquilizers_35\NNS\4017429|other|,
DDI-DrugBank.d703.s0.e4_DDI-DrugBank.d703.s0.e6 false phenothiazines_32\NNS\14771088| (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants
DDI-DrugBank.d703.s0.e4_DDI-DrugBank.d703.s0.e7 false phenothiazines_32\NNS\14771088| (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_nmod) barbiturates_40\NNS\4166841|including|)
DDI-DrugBank.d703.s0.e4_DDI-DrugBank.d703.s0.e8 false phenothiazines_32\NNS\14771088| (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e4_DDI-DrugBank.d703.s0.e9 false phenothiazines_32\NNS\14771088| (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e5_DDI-DrugBank.d703.s0.e6 false tranquilizers_35\NNS\4017429|other|, (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants
DDI-DrugBank.d703.s0.e5_DDI-DrugBank.d703.s0.e7 false tranquilizers_35\NNS\4017429|other|, (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_nmod) barbiturates_40\NNS\4166841|including|)
DDI-DrugBank.d703.s0.e5_DDI-DrugBank.d703.s0.e8 false tranquilizers_35\NNS\4017429|other|, (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e5_DDI-DrugBank.d703.s0.e9 false tranquilizers_35\NNS\4017429|other|, (r_conj) analgesics_27\NNS\3740161|other|narcotic|,|anesthetics|,|phenothiazines|,|tranquilizers (r_dobj) receiving_24\VBG\2210855|who|are|concurrently|analgesics|sedative-hypnotics (l_dobj) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e6_DDI-DrugBank.d703.s0.e7 false sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_nmod) barbiturates_40\NNS\4166841|including|)
DDI-DrugBank.d703.s0.e6_DDI-DrugBank.d703.s0.e8 false sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e6_DDI-DrugBank.d703.s0.e9 false sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e7_DDI-DrugBank.d703.s0.e8 false barbiturates_40\NNS\4166841|including|) (r_nmod) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants
DDI-DrugBank.d703.s0.e7_DDI-DrugBank.d703.s0.e9 false barbiturates_40\NNS\4166841|including|) (r_nmod) sedative-hypnotics_37\NNS\4166553|(|barbiturates|,|antidepressants (l_conj) antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d703.s0.e8_DDI-DrugBank.d703.s0.e9 false antidepressants_44\NNS\3740161|tricyclic|and|depressants (l_conj) depressants_48\NNS\3248958|other|cns|(|alcohol
DDI-DrugBank.d597.s21
DDI-DrugBank.d608.s6
DDI-DrugBank.d688.s1
DDI-DrugBank.d688.s1.e0_DDI-DrugBank.d688.s1.e1 true acetate_8\NN\15010703|of|megestrol|and|indinavir (l_conj) indinavir_10\NN\4013993|
DDI-DrugBank.d688.s1.e0_DDI-DrugBank.d688.s1.e2 false acetate_8\NN\15010703|of|megestrol|and|indinavir (r_nmod) coadministration_5\NN\1740|acetate (r_nsubj) results_11\VBZ\2633881|that|coadministration|decrease (l_nmod) decrease_15\NN\7296428|in|a|significant|parameters|% (l_dep) %_22\NN\1740|(|~36|cmax|and|%|)|indinavir (l_nmod) indinavir_32\NN\4013993|of
DDI-DrugBank.d688.s1.e1_DDI-DrugBank.d688.s1.e2 false indinavir_10\NN\4013993| (r_conj) acetate_8\NN\15010703|of|megestrol|and|indinavir (r_nmod) coadministration_5\NN\1740|acetate (r_nsubj) results_11\VBZ\2633881|that|coadministration|decrease (l_nmod) decrease_15\NN\7296428|in|a|significant|parameters|% (l_dep) %_22\NN\1740|(|~36|cmax|and|%|)|indinavir (l_nmod) indinavir_32\NN\4013993|of
DDI-DrugBank.d638.s0
DDI-DrugBank.d638.s0.e1_DDI-DrugBank.d638.s0.e0 false guanethidine_7\NN\1740|of (r_nmod) effect_5\NN\34213|the|hypotensive|guanethidine (r_dobj) decrease_2\VB\169651|ritalin|may|effect|. (l_nsubj) ritalin_0\NN\4320126|
DDI-DrugBank.d604.s5
DDI-DrugBank.d604.s5.e0_DDI-DrugBank.d604.s5.e1 true wort_2\VBN\1740|john|agents (l_nmod) agents_6\NNS\7347|with|hormonal|contraceptive
DDI-DrugBank.d687.s2
DDI-DrugBank.d578.s6
DDI-DrugBank.d630.s1
DDI-DrugBank.d630.s1.e1_DDI-DrugBank.d630.s1.e0 false methazolamide_9\NN\1740| (r_conj) aspirin_7\NN\2707683|high-dose|and|methazolamide
DDI-DrugBank.d630.s1.e1_DDI-DrugBank.d630.s1.e2 false methazolamide_9\NN\1740| (r_conj) aspirin_7\NN\2707683|high-dose|and|methazolamide (r_dobj) receiving_5\VBG\2210855|aspirin|concomitantly (r_acl) patients_4\NNS\9898892|for|receiving (r_nmod) advised_2\VBN\813978|caution|is|patients|,|reported|. (l_advcl) reported_24\VBN\831651|as|anorexia|have|been|use (l_nmod) use_27\NN\407535|with|concomitant|aspirin (l_nmod) aspirin_30\NN\2707683|of|high-dose|and|inhibitors
DDI-DrugBank.d630.s1.e1_DDI-DrugBank.d630.s1.e3 false methazolamide_9\NN\1740| (r_conj) aspirin_7\NN\2707683|high-dose|and|methazolamide (r_dobj) receiving_5\VBG\2210855|aspirin|concomitantly (r_acl) patients_4\NNS\9898892|for|receiving (r_nmod) advised_2\VBN\813978|caution|is|patients|,|reported|. (l_advcl) reported_24\VBN\831651|as|anorexia|have|been|use (l_nmod) use_27\NN\407535|with|concomitant|aspirin (l_nmod) aspirin_30\NN\2707683|of|high-dose|and|inhibitors (l_conj) inhibitors_34\NNS\20090|anhydrase
DDI-DrugBank.d630.s1.e0_DDI-DrugBank.d630.s1.e2 false aspirin_7\NN\2707683|high-dose|and|methazolamide (r_dobj) receiving_5\VBG\2210855|aspirin|concomitantly (r_acl) patients_4\NNS\9898892|for|receiving (r_nmod) advised_2\VBN\813978|caution|is|patients|,|reported|. (l_advcl) reported_24\VBN\831651|as|anorexia|have|been|use (l_nmod) use_27\NN\407535|with|concomitant|aspirin (l_nmod) aspirin_30\NN\2707683|of|high-dose|and|inhibitors
DDI-DrugBank.d630.s1.e0_DDI-DrugBank.d630.s1.e3 false aspirin_7\NN\2707683|high-dose|and|methazolamide (r_dobj) receiving_5\VBG\2210855|aspirin|concomitantly (r_acl) patients_4\NNS\9898892|for|receiving (r_nmod) advised_2\VBN\813978|caution|is|patients|,|reported|. (l_advcl) reported_24\VBN\831651|as|anorexia|have|been|use (l_nmod) use_27\NN\407535|with|concomitant|aspirin (l_nmod) aspirin_30\NN\2707683|of|high-dose|and|inhibitors (l_conj) inhibitors_34\NNS\20090|anhydrase
DDI-DrugBank.d630.s1.e2_DDI-DrugBank.d630.s1.e3 true aspirin_30\NN\2707683|of|high-dose|and|inhibitors (l_conj) inhibitors_34\NNS\20090|anhydrase
DDI-DrugBank.d698.s2
DDI-DrugBank.d698.s2.e0_DDI-DrugBank.d698.s2.e1 true riboflavin_2\NN\15090742|for (r_nmod) requirements_0\NNS\1129920|riboflavin (r_nsubjpass) increased_5\VBN\169651|requirements|may|be|patients|. (l_nmod) patients_7\NNS\9898892|in|receiving (l_acl) receiving_8\VBG\2210855|probenecid (l_dobj) probenecid_9\NN\3740161|
DDI-DrugBank.d702.s1
DDI-DrugBank.d702.s1.e0_DDI-DrugBank.d702.s1.e1 false bronchodilators_3\NNS\3740161|sympathomimetic|,|methylxanthines (l_conj) methylxanthines_5\NNS\1740|,|and|steroids
DDI-DrugBank.d702.s1.e0_DDI-DrugBank.d702.s1.e2 false bronchodilators_3\NNS\3740161|sympathomimetic|,|methylxanthines (l_conj) methylxanthines_5\NNS\1740|,|and|steroids (l_conj) steroids_11\NNS\14727670|oral
DDI-DrugBank.d702.s1.e1_DDI-DrugBank.d702.s1.e2 false methylxanthines_5\NNS\1740|,|and|steroids (l_conj) steroids_11\NNS\14727670|oral
DDI-DrugBank.d623.s0
DDI-DrugBank.d648.s6
DDI-DrugBank.d648.s6.e1_DDI-DrugBank.d648.s6.e2 false clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) indomethacin_18\NN\3828465|
DDI-DrugBank.d648.s6.e1_DDI-DrugBank.d648.s6.e3 false clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) naproxen_20\NN\3828465|
DDI-DrugBank.d648.s6.e1_DDI-DrugBank.d648.s6.e4 false clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) ibuprofen_22\NN\3828465|
DDI-DrugBank.d648.s6.e1_DDI-DrugBank.d648.s6.e5 false clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazepam_24\NN\2830852|
DDI-DrugBank.d648.s6.e1_DDI-DrugBank.d648.s6.e6 false clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazoxide_27\NN\4522904|
DDI-DrugBank.d648.s6.e1_DDI-DrugBank.d648.s6.e0 false clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (r_nmod) drugs_12\NNS\14778436|with|other|protein-bound|,|clofibrate (r_nmod) coadministered_7\VBN\1740|when|evista|is|drugs (l_nsubjpass) evista_5\NNP\1740|
DDI-DrugBank.d648.s6.e2_DDI-DrugBank.d648.s6.e3 false indomethacin_18\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) naproxen_20\NN\3828465|
DDI-DrugBank.d648.s6.e2_DDI-DrugBank.d648.s6.e4 false indomethacin_18\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) ibuprofen_22\NN\3828465|
DDI-DrugBank.d648.s6.e2_DDI-DrugBank.d648.s6.e5 false indomethacin_18\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazepam_24\NN\2830852|
DDI-DrugBank.d648.s6.e2_DDI-DrugBank.d648.s6.e6 false indomethacin_18\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazoxide_27\NN\4522904|
DDI-DrugBank.d648.s6.e2_DDI-DrugBank.d648.s6.e0 false indomethacin_18\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (r_nmod) drugs_12\NNS\14778436|with|other|protein-bound|,|clofibrate (r_nmod) coadministered_7\VBN\1740|when|evista|is|drugs (l_nsubjpass) evista_5\NNP\1740|
DDI-DrugBank.d648.s6.e3_DDI-DrugBank.d648.s6.e4 false naproxen_20\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) ibuprofen_22\NN\3828465|
DDI-DrugBank.d648.s6.e3_DDI-DrugBank.d648.s6.e5 false naproxen_20\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazepam_24\NN\2830852|
DDI-DrugBank.d648.s6.e3_DDI-DrugBank.d648.s6.e6 false naproxen_20\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazoxide_27\NN\4522904|
DDI-DrugBank.d648.s6.e3_DDI-DrugBank.d648.s6.e0 false naproxen_20\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (r_nmod) drugs_12\NNS\14778436|with|other|protein-bound|,|clofibrate (r_nmod) coadministered_7\VBN\1740|when|evista|is|drugs (l_nsubjpass) evista_5\NNP\1740|
DDI-DrugBank.d648.s6.e4_DDI-DrugBank.d648.s6.e5 false ibuprofen_22\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazepam_24\NN\2830852|
DDI-DrugBank.d648.s6.e4_DDI-DrugBank.d648.s6.e6 false ibuprofen_22\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazoxide_27\NN\4522904|
DDI-DrugBank.d648.s6.e4_DDI-DrugBank.d648.s6.e0 false ibuprofen_22\NN\3828465| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (r_nmod) drugs_12\NNS\14778436|with|other|protein-bound|,|clofibrate (r_nmod) coadministered_7\VBN\1740|when|evista|is|drugs (l_nsubjpass) evista_5\NNP\1740|
DDI-DrugBank.d648.s6.e5_DDI-DrugBank.d648.s6.e6 false diazepam_24\NN\2830852| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (l_conj) diazoxide_27\NN\4522904|
DDI-DrugBank.d648.s6.e5_DDI-DrugBank.d648.s6.e0 false diazepam_24\NN\2830852| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (r_nmod) drugs_12\NNS\14778436|with|other|protein-bound|,|clofibrate (r_nmod) coadministered_7\VBN\1740|when|evista|is|drugs (l_nsubjpass) evista_5\NNP\1740|
DDI-DrugBank.d648.s6.e6_DDI-DrugBank.d648.s6.e0 false diazoxide_27\NN\4522904| (r_conj) clofibrate_16\NN\3740161|such|,|indomethacin|,|naproxen|,|ibuprofen|,|diazepam|,|and|diazoxide (r_nmod) drugs_12\NNS\14778436|with|other|protein-bound|,|clofibrate (r_nmod) coadministered_7\VBN\1740|when|evista|is|drugs (l_nsubjpass) evista_5\NNP\1740|
DDI-DrugBank.d669.s0
DDI-DrugBank.d669.s0.e0_DDI-DrugBank.d669.s0.e1 true vancomycin_3\NN\2716866|of|and|agents (l_conj) agents_6\NNS\7347|anesthetic
DDI-DrugBank.d576.s4
DDI-DrugBank.d576.s4.e0_DDI-DrugBank.d576.s4.e1 true salicylates_0\NNS\3828465|given (l_acl) given_1\VBN\2327200|drugs (l_nmod) drugs_5\NNS\14778436|concomitantly|with|anticoagulant
DDI-DrugBank.d668.s1
DDI-DrugBank.d668.s1.e0_DDI-DrugBank.d668.s1.e1 false rifampin_2\NN\2716205|,|dexamethasone|, (l_appos) dexamethasone_4\NN\2721538|
DDI-DrugBank.d697.s0
DDI-DrugBank.d697.s0.e0_DDI-DrugBank.d697.s0.e1 false b1_3\NN\1740|for|vitamin|thiamine (l_appos) thiamine_5\NN\15090742|(|):
DDI-DrugBank.d697.s0.e0_DDI-DrugBank.d697.s0.e4 true b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_appos) stavudine_13\NN\1740|
DDI-DrugBank.d697.s0.e0_DDI-DrugBank.d697.s0.e2 true b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants
DDI-DrugBank.d697.s0.e0_DDI-DrugBank.d697.s0.e3 true b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_conj) contraceptives_11\NNS\3183080|oral
DDI-DrugBank.d697.s0.e0_DDI-DrugBank.d697.s0.e5 true b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_appos) antidepressants_16\NNS\3740161|tricyclic
DDI-DrugBank.d697.s0.e1_DDI-DrugBank.d697.s0.e4 true thiamine_5\NN\15090742|(|): (r_appos) b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_appos) stavudine_13\NN\1740|
DDI-DrugBank.d697.s0.e1_DDI-DrugBank.d697.s0.e2 true thiamine_5\NN\15090742|(|): (r_appos) b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants
DDI-DrugBank.d697.s0.e1_DDI-DrugBank.d697.s0.e3 true thiamine_5\NN\15090742|(|): (r_appos) b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_conj) contraceptives_11\NNS\3183080|oral
DDI-DrugBank.d697.s0.e1_DDI-DrugBank.d697.s0.e5 true thiamine_5\NN\15090742|(|): (r_appos) b1_3\NN\1740|for|vitamin|thiamine (r_nmod) interactions_0\NNS\37396|b1|diuretics (l_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_appos) antidepressants_16\NNS\3740161|tricyclic
DDI-DrugBank.d697.s0.e4_DDI-DrugBank.d697.s0.e2 false stavudine_13\NN\1740| (r_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants
DDI-DrugBank.d697.s0.e4_DDI-DrugBank.d697.s0.e3 false stavudine_13\NN\1740| (r_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_conj) contraceptives_11\NNS\3183080|oral
DDI-DrugBank.d697.s0.e4_DDI-DrugBank.d697.s0.e5 false stavudine_13\NN\1740| (r_appos) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_appos) antidepressants_16\NNS\3740161|tricyclic
DDI-DrugBank.d697.s0.e2_DDI-DrugBank.d697.s0.e3 false diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_conj) contraceptives_11\NNS\3183080|oral
DDI-DrugBank.d697.s0.e2_DDI-DrugBank.d697.s0.e5 false diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_appos) antidepressants_16\NNS\3740161|tricyclic
DDI-DrugBank.d697.s0.e3_DDI-DrugBank.d697.s0.e5 false contraceptives_11\NNS\3183080|oral (r_conj) diuretics_8\NNS\3247620|loop|,|contraceptives|,|stavudine|,|antidepressants (l_appos) antidepressants_16\NNS\3740161|tricyclic
DDI-DrugBank.d726.s3
DDI-DrugBank.d726.s3.e1_DDI-DrugBank.d726.s3.e2 true cholestyramine_11\NN\1740|such (r_nmod) drugs_0\NNS\14778436|impair|,|cholestyramine|, (r_nsubj) interfere_14\VB\2451370|drugs|may|absorption|. (l_nmod) absorption_17\NN\13558490|with|the|capsules (l_nmod) capsules_20\NNS\3094503|of|zemplar (l_amod) zemplar_19\JJ\1740|
DDI-DrugBank.d726.s3.e1_DDI-DrugBank.d726.s3.e0 false cholestyramine_11\NN\1740|such (r_nmod) drugs_0\NNS\14778436|impair|,|cholestyramine|, (l_acl:relcl) impair_2\VBP\258857|that|absorption (l_dobj) absorption_4\NN\13558490|intestinal|vitamins (l_nmod) vitamins_7\NNS\7570720|of|fat-soluble
DDI-DrugBank.d726.s3.e2_DDI-DrugBank.d726.s3.e0 false zemplar_19\JJ\1740| (r_amod) capsules_20\NNS\3094503|of|zemplar (r_nmod) absorption_17\NN\13558490|with|the|capsules (r_nmod) interfere_14\VB\2451370|drugs|may|absorption|. (l_nsubj) drugs_0\NNS\14778436|impair|,|cholestyramine|, (l_acl:relcl) impair_2\VBP\258857|that|absorption (l_dobj) absorption_4\NN\13558490|intestinal|vitamins (l_nmod) vitamins_7\NNS\7570720|of|fat-soluble
DDI-DrugBank.d703.s1
DDI-DrugBank.d597.s29
DDI-DrugBank.d746.s2
DDI-DrugBank.d713.s2
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e3 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) procainamide_41\NN\1740|
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e4 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) pancuronium_43\NN\1740|
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e5 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) morphine_45\NN\2707683|
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e6 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) vancomycin_47\NN\2716866|
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e7 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) metformin_49\NN\2719105|
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e8 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) tenofovir_51\NN\1740|
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e0 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_advcl) conducted_18\VBN\2436349|although|studies|have|not|been (l_nsubjpass) studies_8\NNS\635850|assess (l_acl) assess_10\VB\670261|to|interactions (l_dobj) interactions_12\NNS\37396|drug-drug|sanctura (l_nmod) sanctura_14\NN\1740|with
DDI-DrugBank.d713.s2.e2_DDI-DrugBank.d713.s2.e1 false digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d713.s2.e3_DDI-DrugBank.d713.s2.e4 false procainamide_41\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) pancuronium_43\NN\1740|
DDI-DrugBank.d713.s2.e3_DDI-DrugBank.d713.s2.e5 false procainamide_41\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) morphine_45\NN\2707683|
DDI-DrugBank.d713.s2.e3_DDI-DrugBank.d713.s2.e6 false procainamide_41\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) vancomycin_47\NN\2716866|
DDI-DrugBank.d713.s2.e3_DDI-DrugBank.d713.s2.e7 false procainamide_41\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) metformin_49\NN\2719105|
DDI-DrugBank.d713.s2.e3_DDI-DrugBank.d713.s2.e8 false procainamide_41\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) tenofovir_51\NN\1740|
DDI-DrugBank.d713.s2.e3_DDI-DrugBank.d713.s2.e0 false procainamide_41\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_advcl) conducted_18\VBN\2436349|although|studies|have|not|been (l_nsubjpass) studies_8\NNS\635850|assess (l_acl) assess_10\VB\670261|to|interactions (l_dobj) interactions_12\NNS\37396|drug-drug|sanctura (l_nmod) sanctura_14\NN\1740|with
DDI-DrugBank.d713.s2.e3_DDI-DrugBank.d713.s2.e1 false procainamide_41\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d713.s2.e4_DDI-DrugBank.d713.s2.e5 false pancuronium_43\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) morphine_45\NN\2707683|
DDI-DrugBank.d713.s2.e4_DDI-DrugBank.d713.s2.e6 false pancuronium_43\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) vancomycin_47\NN\2716866|
DDI-DrugBank.d713.s2.e4_DDI-DrugBank.d713.s2.e7 false pancuronium_43\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) metformin_49\NN\2719105|
DDI-DrugBank.d713.s2.e4_DDI-DrugBank.d713.s2.e8 false pancuronium_43\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) tenofovir_51\NN\1740|
DDI-DrugBank.d713.s2.e4_DDI-DrugBank.d713.s2.e0 false pancuronium_43\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_advcl) conducted_18\VBN\2436349|although|studies|have|not|been (l_nsubjpass) studies_8\NNS\635850|assess (l_acl) assess_10\VB\670261|to|interactions (l_dobj) interactions_12\NNS\37396|drug-drug|sanctura (l_nmod) sanctura_14\NN\1740|with
DDI-DrugBank.d713.s2.e4_DDI-DrugBank.d713.s2.e1 false pancuronium_43\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d713.s2.e5_DDI-DrugBank.d713.s2.e6 false morphine_45\NN\2707683| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) vancomycin_47\NN\2716866|
DDI-DrugBank.d713.s2.e5_DDI-DrugBank.d713.s2.e7 false morphine_45\NN\2707683| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) metformin_49\NN\2719105|
DDI-DrugBank.d713.s2.e5_DDI-DrugBank.d713.s2.e8 false morphine_45\NN\2707683| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) tenofovir_51\NN\1740|
DDI-DrugBank.d713.s2.e5_DDI-DrugBank.d713.s2.e0 false morphine_45\NN\2707683| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_advcl) conducted_18\VBN\2436349|although|studies|have|not|been (l_nsubjpass) studies_8\NNS\635850|assess (l_acl) assess_10\VB\670261|to|interactions (l_dobj) interactions_12\NNS\37396|drug-drug|sanctura (l_nmod) sanctura_14\NN\1740|with
DDI-DrugBank.d713.s2.e5_DDI-DrugBank.d713.s2.e1 false morphine_45\NN\2707683| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d713.s2.e6_DDI-DrugBank.d713.s2.e7 false vancomycin_47\NN\2716866| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) metformin_49\NN\2719105|
DDI-DrugBank.d713.s2.e6_DDI-DrugBank.d713.s2.e8 false vancomycin_47\NN\2716866| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) tenofovir_51\NN\1740|
DDI-DrugBank.d713.s2.e6_DDI-DrugBank.d713.s2.e0 false vancomycin_47\NN\2716866| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_advcl) conducted_18\VBN\2436349|although|studies|have|not|been (l_nsubjpass) studies_8\NNS\635850|assess (l_acl) assess_10\VB\670261|to|interactions (l_dobj) interactions_12\NNS\37396|drug-drug|sanctura (l_nmod) sanctura_14\NN\1740|with
DDI-DrugBank.d713.s2.e6_DDI-DrugBank.d713.s2.e1 false vancomycin_47\NN\2716866| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d713.s2.e7_DDI-DrugBank.d713.s2.e8 false metformin_49\NN\2719105| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (l_conj) tenofovir_51\NN\1740|
DDI-DrugBank.d713.s2.e7_DDI-DrugBank.d713.s2.e0 false metformin_49\NN\2719105| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_advcl) conducted_18\VBN\2436349|although|studies|have|not|been (l_nsubjpass) studies_8\NNS\635850|assess (l_acl) assess_10\VB\670261|to|interactions (l_dobj) interactions_12\NNS\37396|drug-drug|sanctura (l_nmod) sanctura_14\NN\1740|with
DDI-DrugBank.d713.s2.e7_DDI-DrugBank.d713.s2.e1 false metformin_49\NN\2719105| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d713.s2.e8_DDI-DrugBank.d713.s2.e0 false tenofovir_51\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_advcl) conducted_18\VBN\2436349|although|studies|have|not|been (l_nsubjpass) studies_8\NNS\635850|assess (l_acl) assess_10\VB\670261|to|interactions (l_dobj) interactions_12\NNS\37396|drug-drug|sanctura (l_nmod) sanctura_14\NN\1740|with
DDI-DrugBank.d713.s2.e8_DDI-DrugBank.d713.s2.e1 false tenofovir_51\NN\1740| (r_conj) digoxin_39\NN\15060131|(|e.g.|,|procainamide|,|pancuronium|,|morphine|,|vancomycin|,|metformin|and|tenofovir|) (r_nmod) eliminated_32\VBN\1619929|that|are|secretion|digoxin (r_acl:relcl) drugs_29\NNS\14778436|with|other|eliminated (r_nmod) interactions_26\NNS\37396|for|pharmacokinetic|drugs (r_nmod) potential_23\NN\14481929|the|interactions (r_dobj) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d713.s2.e0_DDI-DrugBank.d713.s2.e1 false sanctura_14\NN\1740|with (r_nmod) interactions_12\NNS\37396|drug-drug|sanctura (r_dobj) assess_10\VB\670261|to|interactions (r_acl) studies_8\NNS\635850|assess (r_nsubjpass) conducted_18\VBN\2436349|although|studies|have|not|been (r_advcl) has_21\VBZ\2108377|conducted|,|sanctura|potential|. (l_nsubj) sanctura_20\NN\1740|
DDI-DrugBank.d572.s11
DDI-DrugBank.d572.s11.e0_DDI-DrugBank.d572.s11.e1 false ezetimibe_6\NN\1740|with (r_nmod) study_4\NN\635850|a|104-week|dietary|carcinogenicity|ezetimibe (r_nsubjpass) conducted_8\VBN\2436349|study|was|rats|doses|. (l_nmod) doses_12\NNS\3740161|at|mg/kg/day (l_nmod) mg/kg/day_16\NN\1740|up|to|1500|males|and|mg/kg/day|exposure (l_dep) exposure_31\NN\5042871|(|times|the|human|mg|based|ezetimibe|) (l_nmod) ezetimibe_43\NN\1740|for|total
DDI-DrugBank.d572.s3
DDI-DrugBank.d743.s0
DDI-DrugBank.d743.s0.e0_DDI-DrugBank.d743.s0.e1 false ketoconazole_0\NN\1740| (r_dep) demonstrate_16\VBP\2137132|ketoconazole|:|reports|prolongation (l_nsubj) reports_5\NNS\6470073|spontaneous|adverse|reaction|patients (l_nmod) patients_7\NNS\9898892|of|taking (l_acl) taking_8\VBG\2367363|ketoconazole|doses (l_dobj) ketoconazole_10\NN\1740|concomitant
DDI-DrugBank.d743.s0.e0_DDI-DrugBank.d743.s0.e2 false ketoconazole_0\NN\1740| (r_dep) demonstrate_16\VBP\2137132|ketoconazole|:|reports|prolongation (l_nsubj) reports_5\NNS\6470073|spontaneous|adverse|reaction|patients (l_nmod) patients_7\NNS\9898892|of|taking (l_acl) taking_8\VBG\2367363|ketoconazole|doses (l_nmod) doses_13\NNS\3740161|with|recommended|terfenadine (l_nmod) terfenadine_15\NN\1740|of
DDI-DrugBank.d743.s0.e1_DDI-DrugBank.d743.s0.e2 true ketoconazole_10\NN\1740|concomitant (r_dobj) taking_8\VBG\2367363|ketoconazole|doses (l_nmod) doses_13\NNS\3740161|with|recommended|terfenadine (l_nmod) terfenadine_15\NN\1740|of
DDI-DrugBank.d652.s3
DDI-DrugBank.d652.s3.e0_DDI-DrugBank.d652.s3.e1 true digoxin_12\NN\15060131|e.g.|,|) (r_dep) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_nmod) metoclopramide_15\NN\1740|by
DDI-DrugBank.d652.s3.e0_DDI-DrugBank.d652.s3.e2 false digoxin_12\NN\15060131|e.g.|,|) (r_dep) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|)
DDI-DrugBank.d652.s3.e0_DDI-DrugBank.d652.s3.e3 false digoxin_12\NN\15060131|e.g.|,|) (r_dep) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) tetracycline_38\NN\2716205|
DDI-DrugBank.d652.s3.e0_DDI-DrugBank.d652.s3.e4 false digoxin_12\NN\15060131|e.g.|,|) (r_dep) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) levodopa_40\NN\14604959|
DDI-DrugBank.d652.s3.e0_DDI-DrugBank.d652.s3.e5 false digoxin_12\NN\15060131|e.g.|,|) (r_dep) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) ethanol_42\NN\14708720|
DDI-DrugBank.d652.s3.e0_DDI-DrugBank.d652.s3.e6 false digoxin_12\NN\15060131|e.g.|,|) (r_dep) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) cyclosporine_44\NN\1740|
DDI-DrugBank.d652.s3.e1_DDI-DrugBank.d652.s3.e2 true metoclopramide_15\NN\1740|by (r_nmod) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|)
DDI-DrugBank.d652.s3.e1_DDI-DrugBank.d652.s3.e3 false metoclopramide_15\NN\1740|by (r_nmod) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) tetracycline_38\NN\2716205|
DDI-DrugBank.d652.s3.e1_DDI-DrugBank.d652.s3.e4 false metoclopramide_15\NN\1740|by (r_nmod) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) levodopa_40\NN\14604959|
DDI-DrugBank.d652.s3.e1_DDI-DrugBank.d652.s3.e5 false metoclopramide_15\NN\1740|by (r_nmod) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) ethanol_42\NN\14708720|
DDI-DrugBank.d652.s3.e1_DDI-DrugBank.d652.s3.e6 false metoclopramide_15\NN\1740|by (r_nmod) diminished_8\VBN\169651|absorption|may|be|(|digoxin|metoclopramide|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|rate|may|be|acetaminophen (l_dobj) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) cyclosporine_44\NN\1740|
DDI-DrugBank.d652.s3.e2_DDI-DrugBank.d652.s3.e3 false acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) tetracycline_38\NN\2716205|
DDI-DrugBank.d652.s3.e2_DDI-DrugBank.d652.s3.e4 false acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) levodopa_40\NN\14604959|
DDI-DrugBank.d652.s3.e2_DDI-DrugBank.d652.s3.e5 false acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) ethanol_42\NN\14708720|
DDI-DrugBank.d652.s3.e2_DDI-DrugBank.d652.s3.e6 false acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) cyclosporine_44\NN\1740|
DDI-DrugBank.d652.s3.e3_DDI-DrugBank.d652.s3.e4 false tetracycline_38\NN\2716205| (r_appos) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) levodopa_40\NN\14604959|
DDI-DrugBank.d652.s3.e3_DDI-DrugBank.d652.s3.e5 false tetracycline_38\NN\2716205| (r_appos) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) ethanol_42\NN\14708720|
DDI-DrugBank.d652.s3.e3_DDI-DrugBank.d652.s3.e6 false tetracycline_38\NN\2716205| (r_appos) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) cyclosporine_44\NN\1740|
DDI-DrugBank.d652.s3.e4_DDI-DrugBank.d652.s3.e5 false levodopa_40\NN\14604959| (r_appos) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) ethanol_42\NN\14708720|
DDI-DrugBank.d652.s3.e4_DDI-DrugBank.d652.s3.e6 false levodopa_40\NN\14604959| (r_appos) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) cyclosporine_44\NN\1740|
DDI-DrugBank.d652.s3.e5_DDI-DrugBank.d652.s3.e6 false ethanol_42\NN\14708720| (r_appos) acetaminophen_36\NN\2707683|(|e.g.|,|,|tetracycline|,|levodopa|,|ethanol|,|cyclosporine|) (l_appos) cyclosporine_44\NN\1740|
DDI-DrugBank.d678.s0
DDI-DrugBank.d640.s4
DDI-DrugBank.d763.s4
DDI-DrugBank.d763.s4.e0_DDI-DrugBank.d763.s4.e1 false ondansetron_13\NN\1740|for (r_nmod) adjustment_11\NN\7357388|no|dosage|ondansetron (r_nsubjpass) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) tramadol_21\NN\1740|
DDI-DrugBank.d763.s4.e0_DDI-DrugBank.d763.s4.e2 false ondansetron_13\NN\1740|for (r_nmod) adjustment_11\NN\7357388|no|dosage|ondansetron (r_nsubjpass) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_advcl) observed_34\VBN\2163746|although|interaction|has|been (l_nsubjpass) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (l_nmod) ondansetron_29\NN\1740|between|and|tramadol
DDI-DrugBank.d763.s4.e0_DDI-DrugBank.d763.s4.e3 false ondansetron_13\NN\1740|for (r_nmod) adjustment_11\NN\7357388|no|dosage|ondansetron (r_nsubjpass) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_advcl) observed_34\VBN\2163746|although|interaction|has|been (l_nsubjpass) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (l_nmod) ondansetron_29\NN\1740|between|and|tramadol (l_conj) tramadol_31\NN\1740|
DDI-DrugBank.d763.s4.e0_DDI-DrugBank.d763.s4.e4 false ondansetron_13\NN\1740|for (r_nmod) adjustment_11\NN\7357388|no|dosage|ondansetron (r_nsubjpass) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nsubjpass) ondansetron_43\NN\1740|
DDI-DrugBank.d763.s4.e0_DDI-DrugBank.d763.s4.e5 false ondansetron_13\NN\1740|for (r_nmod) adjustment_11\NN\7357388|no|dosage|ondansetron (r_nsubjpass) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nmod) increase_49\NN\13576355|with|an|administration (l_nmod) administration_53\NN\1133281|in|controlled|tramadol.4,5 (l_nmod) tramadol.4,5_55\NN\1740|of
DDI-DrugBank.d763.s4.e0_DDI-DrugBank.d763.s4.e6 false ondansetron_13\NN\1740|for (r_nmod) adjustment_11\NN\7357388|no|dosage|ondansetron (r_nsubjpass) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) affected_71\VBN\126264|response|is|not|ondansetron|. (l_nmod) ondansetron_73\NN\1740|by
DDI-DrugBank.d763.s4.e1_DDI-DrugBank.d763.s4.e2 false tramadol_21\NN\1740| (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_advcl) observed_34\VBN\2163746|although|interaction|has|been (l_nsubjpass) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (l_nmod) ondansetron_29\NN\1740|between|and|tramadol
DDI-DrugBank.d763.s4.e1_DDI-DrugBank.d763.s4.e3 false tramadol_21\NN\1740| (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_advcl) observed_34\VBN\2163746|although|interaction|has|been (l_nsubjpass) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (l_nmod) ondansetron_29\NN\1740|between|and|tramadol (l_conj) tramadol_31\NN\1740|
DDI-DrugBank.d763.s4.e1_DDI-DrugBank.d763.s4.e4 false tramadol_21\NN\1740| (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nsubjpass) ondansetron_43\NN\1740|
DDI-DrugBank.d763.s4.e1_DDI-DrugBank.d763.s4.e5 false tramadol_21\NN\1740| (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nmod) increase_49\NN\13576355|with|an|administration (l_nmod) administration_53\NN\1133281|in|controlled|tramadol.4,5 (l_nmod) tramadol.4,5_55\NN\1740|of
DDI-DrugBank.d763.s4.e1_DDI-DrugBank.d763.s4.e6 false tramadol_21\NN\1740| (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) affected_71\VBN\126264|response|is|not|ondansetron|. (l_nmod) ondansetron_73\NN\1740|by
DDI-DrugBank.d763.s4.e2_DDI-DrugBank.d763.s4.e3 false ondansetron_29\NN\1740|between|and|tramadol (l_conj) tramadol_31\NN\1740|
DDI-DrugBank.d763.s4.e2_DDI-DrugBank.d763.s4.e4 false ondansetron_29\NN\1740|between|and|tramadol (r_nmod) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (r_nsubjpass) observed_34\VBN\2163746|although|interaction|has|been (r_advcl) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nsubjpass) ondansetron_43\NN\1740|
DDI-DrugBank.d763.s4.e2_DDI-DrugBank.d763.s4.e5 false ondansetron_29\NN\1740|between|and|tramadol (r_nmod) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (r_nsubjpass) observed_34\VBN\2163746|although|interaction|has|been (r_advcl) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nmod) increase_49\NN\13576355|with|an|administration (l_nmod) administration_53\NN\1133281|in|controlled|tramadol.4,5 (l_nmod) tramadol.4,5_55\NN\1740|of
DDI-DrugBank.d763.s4.e2_DDI-DrugBank.d763.s4.e6 false ondansetron_29\NN\1740|between|and|tramadol (r_nmod) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (r_nsubjpass) observed_34\VBN\2163746|although|interaction|has|been (r_advcl) indicate_41\VBP\952524|observed|,|data|associated (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) affected_71\VBN\126264|response|is|not|ondansetron|. (l_nmod) ondansetron_73\NN\1740|by
DDI-DrugBank.d763.s4.e3_DDI-DrugBank.d763.s4.e4 false tramadol_31\NN\1740| (r_conj) ondansetron_29\NN\1740|between|and|tramadol (r_nmod) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (r_nsubjpass) observed_34\VBN\2163746|although|interaction|has|been (r_advcl) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nsubjpass) ondansetron_43\NN\1740|
DDI-DrugBank.d763.s4.e3_DDI-DrugBank.d763.s4.e5 false tramadol_31\NN\1740| (r_conj) ondansetron_29\NN\1740|between|and|tramadol (r_nmod) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (r_nsubjpass) observed_34\VBN\2163746|although|interaction|has|been (r_advcl) indicate_41\VBP\952524|observed|,|data|associated (l_ccomp) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nmod) increase_49\NN\13576355|with|an|administration (l_nmod) administration_53\NN\1133281|in|controlled|tramadol.4,5 (l_nmod) tramadol.4,5_55\NN\1740|of
DDI-DrugBank.d763.s4.e3_DDI-DrugBank.d763.s4.e6 false tramadol_31\NN\1740| (r_conj) ondansetron_29\NN\1740|between|and|tramadol (r_nmod) interaction_27\NN\37396|no|pharmacokinetic|drug|ondansetron (r_nsubjpass) observed_34\VBN\2163746|although|interaction|has|been (r_advcl) indicate_41\VBP\952524|observed|,|data|associated (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) affected_71\VBN\126264|response|is|not|ondansetron|. (l_nmod) ondansetron_73\NN\1740|by
DDI-DrugBank.d763.s4.e4_DDI-DrugBank.d763.s4.e5 false ondansetron_43\NN\1740| (r_nsubjpass) associated_46\VBN\628491|that|ondansetron|may|be|increase (l_nmod) increase_49\NN\13576355|with|an|administration (l_nmod) administration_53\NN\1133281|in|controlled|tramadol.4,5 (l_nmod) tramadol.4,5_55\NN\1740|of
DDI-DrugBank.d763.s4.e4_DDI-DrugBank.d763.s4.e6 false ondansetron_43\NN\1740| (r_nsubjpass) associated_46\VBN\628491|that|ondansetron|may|be|increase (r_ccomp) indicate_41\VBP\952524|observed|,|data|associated (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) affected_71\VBN\126264|response|is|not|ondansetron|. (l_nmod) ondansetron_73\NN\1740|by
DDI-DrugBank.d763.s4.e5_DDI-DrugBank.d763.s4.e6 false tramadol.4,5_55\NN\1740|of (r_nmod) administration_53\NN\1133281|in|controlled|tramadol.4,5 (r_nmod) increase_49\NN\13576355|with|an|administration (r_nmod) associated_46\VBN\628491|that|ondansetron|may|be|increase (r_ccomp) indicate_41\VBP\952524|observed|,|data|associated (r_dep) recommended_15\VBN\875394|however|,|data|,|adjustment|is|patients|drugs.1,3|tramadol|:|indicate|chemotherapy|:|affected (l_dep) affected_71\VBN\126264|response|is|not|ondansetron|. (l_nmod) ondansetron_73\NN\1740|by
DDI-DrugBank.d781.s1
DDI-DrugBank.d781.s1.e1_DDI-DrugBank.d781.s1.e0 false perindopril_24\NN\1740|with (r_nmod) treatment_22\NN\654885|of|perindopril (r_nmod) initiation_20\NN\7450842|to|treatment (r_nmod) prior_18\RB\1740|initiation (r_advmod) increasing_14\VBG\169651|intake|prior (r_conj) discontinuing_10\VBG\2609764|by|either|diuretic|or|increasing (l_dobj) diuretic_12\NN\3247620|the
DDI-DrugBank.d680.s7
DDI-DrugBank.d680.s7.e1_DDI-DrugBank.d680.s7.e0 false warfarin_7\NN\2718259| (r_conj) inhibitors_5\NNS\20090|with|proton|pump|and|warfarin
DDI-DrugBank.d670.s8
DDI-DrugBank.d588.s10
DDI-DrugBank.d588.s10.e2_DDI-DrugBank.d588.s10.e0 false mykrox_13\NN\1740| (r_compound) tablets_14\NNS\4233405|of|mykrox (r_nmod) effects_11\NNS\13245626|the|antihypertensive|tablets (r_dobj) decrease_8\VB\169651|salicylates|may|effects|. (l_nsubj) salicylates_0\NNS\3828465|and|drugs|:
DDI-DrugBank.d588.s10.e2_DDI-DrugBank.d588.s10.e1 false mykrox_13\NN\1740| (r_compound) tablets_14\NNS\4233405|of|mykrox (r_nmod) effects_11\NNS\13245626|the|antihypertensive|tablets (r_dobj) decrease_8\VB\169651|salicylates|may|effects|. (l_nsubj) salicylates_0\NNS\3828465|and|drugs|: (l_conj) drugs_5\NNS\14778436|other|non-steroidal|anti-inflammatory
DDI-DrugBank.d588.s10.e0_DDI-DrugBank.d588.s10.e1 false salicylates_0\NNS\3828465|and|drugs|: (l_conj) drugs_5\NNS\14778436|other|non-steroidal|anti-inflammatory
DDI-DrugBank.d670.s10
DDI-DrugBank.d603.s0
DDI-DrugBank.d603.s0.e0_DDI-DrugBank.d603.s0.e1 true proamatine_4\NN\1740|with (r_nmod) administered_1\VBN\2436349|when|concomitantly|proamatine (r_advcl) enhance_9\VB\227165|administered|,|glycosides|may|or|precipitate|a.v. (l_nsubj) glycosides_7\NNS\14727670|cardiac
DDI-DrugBank.d735.s0
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e2 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) cyclosporine_25\NN\1740|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e3 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) tacrolimus_27\NN\1740|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e4 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) prednisolone_29\NN\2721538|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e5 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) sirolimus_31\NN\1740|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e6 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) nifedipine_33\NN\2938514|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e7 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) fluconazole_35\NN\1740|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e8 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) ritonavir_37\NN\4013993|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e9 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e1_DDI-DrugBank.d735.s0.e0 false mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e3 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) tacrolimus_27\NN\1740|
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e4 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) prednisolone_29\NN\2721538|
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e5 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) sirolimus_31\NN\1740|
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e6 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) nifedipine_33\NN\2938514|
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e7 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) fluconazole_35\NN\1740|
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e8 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) ritonavir_37\NN\4013993|
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e9 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e2_DDI-DrugBank.d735.s0.e0 false cyclosporine_25\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e3_DDI-DrugBank.d735.s0.e4 false tacrolimus_27\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) prednisolone_29\NN\2721538|
DDI-DrugBank.d735.s0.e3_DDI-DrugBank.d735.s0.e5 false tacrolimus_27\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) sirolimus_31\NN\1740|
DDI-DrugBank.d735.s0.e3_DDI-DrugBank.d735.s0.e6 false tacrolimus_27\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) nifedipine_33\NN\2938514|
DDI-DrugBank.d735.s0.e3_DDI-DrugBank.d735.s0.e7 false tacrolimus_27\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) fluconazole_35\NN\1740|
DDI-DrugBank.d735.s0.e3_DDI-DrugBank.d735.s0.e8 false tacrolimus_27\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) ritonavir_37\NN\4013993|
DDI-DrugBank.d735.s0.e3_DDI-DrugBank.d735.s0.e9 false tacrolimus_27\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e3_DDI-DrugBank.d735.s0.e0 false tacrolimus_27\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e4_DDI-DrugBank.d735.s0.e5 false prednisolone_29\NN\2721538| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) sirolimus_31\NN\1740|
DDI-DrugBank.d735.s0.e4_DDI-DrugBank.d735.s0.e6 false prednisolone_29\NN\2721538| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) nifedipine_33\NN\2938514|
DDI-DrugBank.d735.s0.e4_DDI-DrugBank.d735.s0.e7 false prednisolone_29\NN\2721538| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) fluconazole_35\NN\1740|
DDI-DrugBank.d735.s0.e4_DDI-DrugBank.d735.s0.e8 false prednisolone_29\NN\2721538| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) ritonavir_37\NN\4013993|
DDI-DrugBank.d735.s0.e4_DDI-DrugBank.d735.s0.e9 false prednisolone_29\NN\2721538| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e4_DDI-DrugBank.d735.s0.e0 false prednisolone_29\NN\2721538| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e5_DDI-DrugBank.d735.s0.e6 false sirolimus_31\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) nifedipine_33\NN\2938514|
DDI-DrugBank.d735.s0.e5_DDI-DrugBank.d735.s0.e7 false sirolimus_31\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) fluconazole_35\NN\1740|
DDI-DrugBank.d735.s0.e5_DDI-DrugBank.d735.s0.e8 false sirolimus_31\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) ritonavir_37\NN\4013993|
DDI-DrugBank.d735.s0.e5_DDI-DrugBank.d735.s0.e9 false sirolimus_31\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e5_DDI-DrugBank.d735.s0.e0 false sirolimus_31\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e6_DDI-DrugBank.d735.s0.e7 false nifedipine_33\NN\2938514| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) fluconazole_35\NN\1740|
DDI-DrugBank.d735.s0.e6_DDI-DrugBank.d735.s0.e8 false nifedipine_33\NN\2938514| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) ritonavir_37\NN\4013993|
DDI-DrugBank.d735.s0.e6_DDI-DrugBank.d735.s0.e9 false nifedipine_33\NN\2938514| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e6_DDI-DrugBank.d735.s0.e0 false nifedipine_33\NN\2938514| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e7_DDI-DrugBank.d735.s0.e8 false fluconazole_35\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) ritonavir_37\NN\4013993|
DDI-DrugBank.d735.s0.e7_DDI-DrugBank.d735.s0.e9 false fluconazole_35\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e7_DDI-DrugBank.d735.s0.e0 false fluconazole_35\NN\1740| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e8_DDI-DrugBank.d735.s0.e9 false ritonavir_37\NN\4013993| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (l_conj) rifampin_40\NN\2716205|
DDI-DrugBank.d735.s0.e8_DDI-DrugBank.d735.s0.e0 false ritonavir_37\NN\4013993| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d735.s0.e9_DDI-DrugBank.d735.s0.e0 false rifampin_40\NN\2716205| (r_conj) mofetil_23\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|sirolimus|,|nifedipine|,|fluconazole|,|ritonavir|,|and|rifampin (r_conj) mycamine_20\NN\1740|between|and|mofetil
DDI-DrugBank.d775.s10
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e5 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) bacitracin_25\NN\2716866|
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e7 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) lincomycin_29\NN\2716866|
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e8 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) clindamycin_31\NN\1740|
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e9 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) colistin_33\NN\1740|
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e1 false agents_11\NNS\7347|of|nondepolarizing|mivacron (l_nmod) mivacron_14\NN\1740|such
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e2 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e3 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|)
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e4 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e0_DDI-DrugBank.d775.s10.e6 true agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e7 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) lincomycin_29\NN\2716866|
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e8 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) clindamycin_31\NN\1740|
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e9 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) colistin_33\NN\1740|
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e1 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (r_dobj) include_15\VBP\690614|drugs|antibiotics|. (l_nsubj) drugs_1\NNS\14778436|other|enhance (l_acl:relcl) enhance_4\VB\227165|which|may|action (l_dobj) action_8\NN\30358|the|neuromuscular|blocking|agents (l_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (l_nmod) mivacron_14\NN\1740|such
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e2 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e3 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|)
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e4 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e5_DDI-DrugBank.d775.s10.e6 false bacitracin_25\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e7_DDI-DrugBank.d775.s10.e8 false lincomycin_29\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) clindamycin_31\NN\1740|
DDI-DrugBank.d775.s10.e7_DDI-DrugBank.d775.s10.e9 false lincomycin_29\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) colistin_33\NN\1740|
DDI-DrugBank.d775.s10.e7_DDI-DrugBank.d775.s10.e1 false lincomycin_29\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (r_dobj) include_15\VBP\690614|drugs|antibiotics|. (l_nsubj) drugs_1\NNS\14778436|other|enhance (l_acl:relcl) enhance_4\VB\227165|which|may|action (l_dobj) action_8\NN\30358|the|neuromuscular|blocking|agents (l_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (l_nmod) mivacron_14\NN\1740|such
DDI-DrugBank.d775.s10.e7_DDI-DrugBank.d775.s10.e2 false lincomycin_29\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine
DDI-DrugBank.d775.s10.e7_DDI-DrugBank.d775.s10.e3 false lincomycin_29\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|)
DDI-DrugBank.d775.s10.e7_DDI-DrugBank.d775.s10.e4 false lincomycin_29\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e7_DDI-DrugBank.d775.s10.e6 false lincomycin_29\NN\2716866| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e8_DDI-DrugBank.d775.s10.e9 false clindamycin_31\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) colistin_33\NN\1740|
DDI-DrugBank.d775.s10.e8_DDI-DrugBank.d775.s10.e1 false clindamycin_31\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (r_dobj) include_15\VBP\690614|drugs|antibiotics|. (l_nsubj) drugs_1\NNS\14778436|other|enhance (l_acl:relcl) enhance_4\VB\227165|which|may|action (l_dobj) action_8\NN\30358|the|neuromuscular|blocking|agents (l_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (l_nmod) mivacron_14\NN\1740|such
DDI-DrugBank.d775.s10.e8_DDI-DrugBank.d775.s10.e2 false clindamycin_31\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine
DDI-DrugBank.d775.s10.e8_DDI-DrugBank.d775.s10.e3 false clindamycin_31\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|)
DDI-DrugBank.d775.s10.e8_DDI-DrugBank.d775.s10.e4 false clindamycin_31\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e8_DDI-DrugBank.d775.s10.e6 false clindamycin_31\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e9_DDI-DrugBank.d775.s10.e1 false colistin_33\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (r_dobj) include_15\VBP\690614|drugs|antibiotics|. (l_nsubj) drugs_1\NNS\14778436|other|enhance (l_acl:relcl) enhance_4\VB\227165|which|may|action (l_dobj) action_8\NN\30358|the|neuromuscular|blocking|agents (l_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (l_nmod) mivacron_14\NN\1740|such
DDI-DrugBank.d775.s10.e9_DDI-DrugBank.d775.s10.e2 false colistin_33\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (r_dep) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine
DDI-DrugBank.d775.s10.e9_DDI-DrugBank.d775.s10.e3 false colistin_33\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|)
DDI-DrugBank.d775.s10.e9_DDI-DrugBank.d775.s10.e4 false colistin_33\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e9_DDI-DrugBank.d775.s10.e6 false colistin_33\NN\1740| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e1_DDI-DrugBank.d775.s10.e2 false mivacron_14\NN\1740|such (r_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine
DDI-DrugBank.d775.s10.e1_DDI-DrugBank.d775.s10.e3 false mivacron_14\NN\1740|such (r_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|)
DDI-DrugBank.d775.s10.e1_DDI-DrugBank.d775.s10.e4 false mivacron_14\NN\1740|such (r_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e1_DDI-DrugBank.d775.s10.e6 false mivacron_14\NN\1740|such (r_nmod) agents_11\NNS\7347|of|nondepolarizing|mivacron (r_nmod) action_8\NN\30358|the|neuromuscular|blocking|agents (r_dobj) enhance_4\VB\227165|which|may|action (r_acl:relcl) drugs_1\NNS\14778436|other|enhance (r_nsubj) include_15\VBP\690614|drugs|antibiotics|. (l_dobj) antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e2_DDI-DrugBank.d775.s10.e3 false antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|)
DDI-DrugBank.d775.s10.e2_DDI-DrugBank.d775.s10.e4 false antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e2_DDI-DrugBank.d775.s10.e6 false antibiotics_17\NNS\2716205|certain|aminoglycosides|,|salts|,|procainamide|,|and|quinidine (l_dep) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e3_DDI-DrugBank.d775.s10.e4 false aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) tetracyclines_23\NNS\2716205|
DDI-DrugBank.d775.s10.e3_DDI-DrugBank.d775.s10.e6 false aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d775.s10.e4_DDI-DrugBank.d775.s10.e6 false tetracyclines_23\NNS\2716205| (r_conj) aminoglycosides_21\NNS\1740|(|e.g.|,|,|tetracyclines|,|bacitracin|,|polymyxins|,|lincomycin|,|clindamycin|,|colistin|,|and|colistimethate|) (l_conj) polymyxins_27\NNS\2716866|
DDI-DrugBank.d610.s0
DDI-DrugBank.d610.s0.e0_DDI-DrugBank.d610.s0.e1 false abacavir_3\NN\1740|of (r_nmod) properties_1\NNS\32613|pharmacokinetic|abacavir (r_nsubjpass) altered_6\VBN\126264|properties|were|not|addition|. (l_nmod) addition_9\NN\3081021|by|the|lamivudine (l_nmod) lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination
DDI-DrugBank.d610.s0.e0_DDI-DrugBank.d610.s0.e2 false abacavir_3\NN\1740|of (r_nmod) properties_1\NNS\32613|pharmacokinetic|abacavir (r_nsubjpass) altered_6\VBN\126264|properties|were|not|addition|. (l_nmod) addition_9\NN\3081021|by|the|lamivudine (l_nmod) lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) zidovudine_14\NN\3834836|
DDI-DrugBank.d610.s0.e0_DDI-DrugBank.d610.s0.e3 false abacavir_3\NN\1740|of (r_nmod) properties_1\NNS\32613|pharmacokinetic|abacavir (r_nsubjpass) altered_6\VBN\126264|properties|were|not|addition|. (l_nmod) addition_9\NN\3081021|by|the|lamivudine (l_nmod) lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) combination_17\NN\7951464|the|lamivudine (l_nmod) lamivudine_19\NN\3834836|of|and|zidovudine
DDI-DrugBank.d610.s0.e0_DDI-DrugBank.d610.s0.e4 false abacavir_3\NN\1740|of (r_nmod) properties_1\NNS\32613|pharmacokinetic|abacavir (r_nsubjpass) altered_6\VBN\126264|properties|were|not|addition|. (l_nmod) addition_9\NN\3081021|by|the|lamivudine (l_nmod) lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) combination_17\NN\7951464|the|lamivudine (l_nmod) lamivudine_19\NN\3834836|of|and|zidovudine (l_conj) zidovudine_21\NN\3834836|
DDI-DrugBank.d610.s0.e1_DDI-DrugBank.d610.s0.e2 false lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) zidovudine_14\NN\3834836|
DDI-DrugBank.d610.s0.e1_DDI-DrugBank.d610.s0.e3 false lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) combination_17\NN\7951464|the|lamivudine (l_nmod) lamivudine_19\NN\3834836|of|and|zidovudine
DDI-DrugBank.d610.s0.e1_DDI-DrugBank.d610.s0.e4 false lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) combination_17\NN\7951464|the|lamivudine (l_nmod) lamivudine_19\NN\3834836|of|and|zidovudine (l_conj) zidovudine_21\NN\3834836|
DDI-DrugBank.d610.s0.e2_DDI-DrugBank.d610.s0.e3 false zidovudine_14\NN\3834836| (r_conj) lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) combination_17\NN\7951464|the|lamivudine (l_nmod) lamivudine_19\NN\3834836|of|and|zidovudine
DDI-DrugBank.d610.s0.e2_DDI-DrugBank.d610.s0.e4 false zidovudine_14\NN\3834836| (r_conj) lamivudine_12\NN\3834836|of|either|or|zidovudine|or|combination (l_conj) combination_17\NN\7951464|the|lamivudine (l_nmod) lamivudine_19\NN\3834836|of|and|zidovudine (l_conj) zidovudine_21\NN\3834836|
DDI-DrugBank.d610.s0.e3_DDI-DrugBank.d610.s0.e4 false lamivudine_19\NN\3834836|of|and|zidovudine (l_conj) zidovudine_21\NN\3834836|
DDI-DrugBank.d781.s14
DDI-DrugBank.d779.s5
DDI-DrugBank.d779.s5.e0_DDI-DrugBank.d779.s5.e1 true methyldopa_1\NN\2721160|and|lithium (l_conj) lithium_3\NN\14625458|
DDI-DrugBank.d779.s5.e0_DDI-DrugBank.d779.s5.e2 false methyldopa_1\NN\2721160|and|lithium (r_nsubjpass) given_5\VBN\2327200|when|methyldopa|are|concomitantly (r_advcl) monitored_12\VBN\2169352|given|patient|should|be|carefully|symptoms|. (l_nmod) symptoms_14\NNS\5823932|for|toxicity (l_nmod) toxicity_17\NN\13576101|of|lithium (l_compound) lithium_16\NN\14625458|
DDI-DrugBank.d779.s5.e1_DDI-DrugBank.d779.s5.e2 false lithium_3\NN\14625458| (r_conj) methyldopa_1\NN\2721160|and|lithium (r_nsubjpass) given_5\VBN\2327200|when|methyldopa|are|concomitantly (r_advcl) monitored_12\VBN\2169352|given|patient|should|be|carefully|symptoms|. (l_nmod) symptoms_14\NNS\5823932|for|toxicity (l_nmod) toxicity_17\NN\13576101|of|lithium (l_compound) lithium_16\NN\14625458|
DDI-DrugBank.d572.s22
DDI-DrugBank.d572.s22.e0_DDI-DrugBank.d572.s22.e1 false ezetimibe_4\NN\1740|with (r_nmod) treated_2\VBN\2376958|ezetimibe (r_acl) rabbits_1\NNS\2323902|in|treated (r_nmod) observed_14\VBN\2163746|rabbits|,|incidence|was|mg/kg/day|exposure|. (l_dobj) exposure_23\NN\5042871|150|times|the|human|mg|24hr|ezetimibe|) (l_nmod) ezetimibe_35\NN\1740|for|total
DDI-DrugBank.d597.s7
DDI-DrugBank.d597.s7.e0_DDI-DrugBank.d597.s7.e1 false cholestyramine_0\NN\1740| (r_dep) increased_9\VBD\169651|cholestyramine|:|pretreatment|significantly|clearance|%|. (l_nsubj) pretreatment_2\NN\1740|days|cholestyramine (l_nmod) cholestyramine_7\NN\1740|with
DDI-DrugBank.d597.s7.e0_DDI-DrugBank.d597.s7.e2 false cholestyramine_0\NN\1740| (r_dep) increased_9\VBD\169651|cholestyramine|:|pretreatment|significantly|clearance|%|. (l_dobj) clearance_11\NN\5089947|the|meloxicam (l_nmod) meloxicam_13\NN\1740|of
DDI-DrugBank.d597.s7.e1_DDI-DrugBank.d597.s7.e2 true cholestyramine_7\NN\1740|with (r_nmod) pretreatment_2\NN\1740|days|cholestyramine (r_nsubj) increased_9\VBD\169651|cholestyramine|:|pretreatment|significantly|clearance|%|. (l_dobj) clearance_11\NN\5089947|the|meloxicam (l_nmod) meloxicam_13\NN\1740|of
DDI-DrugBank.d779.s3
DDI-DrugBank.d739.s13
DDI-DrugBank.d739.s13.e0_DDI-DrugBank.d739.s13.e1 false phenobarbital_0\NN\2792049|,|induces|, (r_nsubj) decreased_7\VBD\169651|phenobarbital|auc|%|dose|. (l_dobj) auc_9\NN\1740|the|montelukast (l_nmod) montelukast_11\NN\1740|of
DDI-DrugBank.d739.s13.e0_DDI-DrugBank.d739.s13.e2 false phenobarbital_0\NN\2792049|,|induces|, (r_nsubj) decreased_7\VBD\169651|phenobarbital|auc|%|dose|. (l_nmod) dose_19\NN\3740161|following|a|single|10-mg|montelukast (l_nmod) montelukast_21\NN\1740|of
DDI-DrugBank.d739.s13.e1_DDI-DrugBank.d739.s13.e2 false montelukast_11\NN\1740|of (r_nmod) auc_9\NN\1740|the|montelukast (r_dobj) decreased_7\VBD\169651|phenobarbital|auc|%|dose|. (l_nmod) dose_19\NN\3740161|following|a|single|10-mg|montelukast (l_nmod) montelukast_21\NN\1740|of
DDI-DrugBank.d761.s7
DDI-DrugBank.d761.s7.e0_DDI-DrugBank.d761.s7.e3 false nifedipine_0\NN\2938514|tablets (r_dep) alter_24\VB\126264|nifedipine|subjects|,|xenical|did|not|bioavailability|. (l_dobj) bioavailability_26\NN\1740|the|nifedipine (l_nmod) nifedipine_28\NN\2938514|of|tablets
DDI-DrugBank.d761.s7.e0_DDI-DrugBank.d761.s7.e1 false nifedipine_0\NN\2938514|tablets (r_dep) alter_24\VB\126264|nifedipine|subjects|,|xenical|did|not|bioavailability|. (l_nmod) subjects_8\NNS\6598915|in|17|normal-weight|receiving (l_acl) receiving_9\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_10\NN\1740|
DDI-DrugBank.d761.s7.e0_DDI-DrugBank.d761.s7.e2 false nifedipine_0\NN\2938514|tablets (r_dep) alter_24\VB\126264|nifedipine|subjects|,|xenical|did|not|bioavailability|. (l_nsubj) xenical_21\NN\1740|
DDI-DrugBank.d761.s7.e3_DDI-DrugBank.d761.s7.e1 false nifedipine_28\NN\2938514|of|tablets (r_nmod) bioavailability_26\NN\1740|the|nifedipine (r_dobj) alter_24\VB\126264|nifedipine|subjects|,|xenical|did|not|bioavailability|. (l_nmod) subjects_8\NNS\6598915|in|17|normal-weight|receiving (l_acl) receiving_9\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_10\NN\1740|
DDI-DrugBank.d761.s7.e3_DDI-DrugBank.d761.s7.e2 false nifedipine_28\NN\2938514|of|tablets (r_nmod) bioavailability_26\NN\1740|the|nifedipine (r_dobj) alter_24\VB\126264|nifedipine|subjects|,|xenical|did|not|bioavailability|. (l_nsubj) xenical_21\NN\1740|
DDI-DrugBank.d761.s7.e1_DDI-DrugBank.d761.s7.e2 false xenical_10\NN\1740| (r_dobj) receiving_9\VBG\2210855|xenical|mg|times|days (r_acl) subjects_8\NNS\6598915|in|17|normal-weight|receiving (r_nmod) alter_24\VB\126264|nifedipine|subjects|,|xenical|did|not|bioavailability|. (l_nsubj) xenical_21\NN\1740|
DDI-DrugBank.d580.s1
DDI-DrugBank.d580.s1.e0_DDI-DrugBank.d580.s1.e1 true ketoconazole_2\NN\1740|,|inhibitor|, (r_nsubj) increase_13\VB\169651|however|,|ketoconazole|may|levels|dosing|. (l_dobj) levels_15\NNS\4916342|plasma|furoate (l_nmod) furoate_18\NN\1740|of|mometasone
DDI-DrugBank.d759.s0
DDI-DrugBank.d759.s0.e0_DDI-DrugBank.d759.s0.e1 true acid_5\NN\14818238|ascorbic (r_nsubj) influence_7\VB\137313|that|acid|may|intensity (l_dobj) intensity_9\NN\5090441|the|and|duration|action|bishydroxycoumarin (l_nmod) bishydroxycoumarin_15\NN\1740|of
DDI-DrugBank.d776.s39
DDI-DrugBank.d776.s39.e0_DDI-DrugBank.d776.s39.e1 false estradiol_17\NN\14749794|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_19\NN\1740|
DDI-DrugBank.d640.s2
DDI-DrugBank.d640.s2.e0_DDI-DrugBank.d640.s2.e2 false potassium_0\NN\14625458| (r_compound) supplements_1\NNS\6365467|potassium|and|diuretics|:|increase|. (l_dep) increase_8\VB\169651|univasc|can|potassium|decreases (l_nsubj) univasc_6\NNP\1740|
DDI-DrugBank.d640.s2.e0_DDI-DrugBank.d640.s2.e1 false potassium_0\NN\14625458| (r_compound) supplements_1\NNS\6365467|potassium|and|diuretics|:|increase|. (l_conj) diuretics_4\NNS\3247620|potassium-sparing
DDI-DrugBank.d640.s2.e2_DDI-DrugBank.d640.s2.e1 false univasc_6\NNP\1740| (r_nsubj) increase_8\VB\169651|univasc|can|potassium|decreases (r_dep) supplements_1\NNS\6365467|potassium|and|diuretics|:|increase|. (l_conj) diuretics_4\NNS\3247620|potassium-sparing
DDI-DrugBank.d632.s5
DDI-DrugBank.d632.s5.e0_DDI-DrugBank.d632.s5.e1 false symlin_12\NNP\1740|of (r_nmod) effect_10\NN\34213|the|symlin|kinetics (l_nmod) kinetics_15\NNS\6100236|on|the|agents (l_nmod) agents_19\NNS\7347|of|oral|antidiabetic
DDI-DrugBank.d762.s3
DDI-DrugBank.d762.s3.e0_DDI-DrugBank.d762.s3.e1 true meropenem_4\NN\1740| (r_nsubj) reduce_6\VB\441445|that|meropenem|may|levels|levels|range (l_dobj) levels_8\NNS\4916342|serum|acid (l_nmod) acid_11\NN\14818238|of|valproic
DDI-DrugBank.d762.s3.e0_DDI-DrugBank.d762.s3.e2 false meropenem_4\NN\1740| (r_nsubj) reduce_6\VB\441445|that|meropenem|may|levels|levels|range (l_nmod) range_17\NN\5123416|(|therapeutic|considered (l_acl) considered_18\VBN\689344|valproate|) (l_xcomp) valproate_26\NN\1740|to|be|g/ml|total
DDI-DrugBank.d762.s3.e1_DDI-DrugBank.d762.s3.e2 false acid_11\NN\14818238|of|valproic (r_nmod) levels_8\NNS\4916342|serum|acid (r_dobj) reduce_6\VB\441445|that|meropenem|may|levels|levels|range (l_nmod) range_17\NN\5123416|(|therapeutic|considered (l_acl) considered_18\VBN\689344|valproate|) (l_xcomp) valproate_26\NN\1740|to|be|g/ml|total
DDI-DrugBank.d576.s8
DDI-DrugBank.d637.s3
DDI-DrugBank.d665.s3
DDI-DrugBank.d666.s4
DDI-DrugBank.d736.s6
DDI-DrugBank.d736.s6.e0_DDI-DrugBank.d736.s6.e2 false lithium_0\NN\14625458| (r_compound) clearance_2\NN\5089947|lithium|renal (r_nsubjpass) reduced_4\VBN\441445|clearance|is|thiazides|,|increasing|. (l_advcl) increasing_8\VBG\169651|risk (l_dobj) risk_10\NN\14541044|the|toxicity (l_nmod) toxicity_13\NN\13576101|of|lithium (l_compound) lithium_12\NN\14625458|
DDI-DrugBank.d736.s6.e0_DDI-DrugBank.d736.s6.e1 true lithium_0\NN\14625458| (r_compound) clearance_2\NN\5089947|lithium|renal (r_nsubjpass) reduced_4\VBN\441445|clearance|is|thiazides|,|increasing|. (l_nmod) thiazides_6\NNS\3214670|by
DDI-DrugBank.d736.s6.e2_DDI-DrugBank.d736.s6.e1 false lithium_12\NN\14625458| (r_compound) toxicity_13\NN\13576101|of|lithium (r_nmod) risk_10\NN\14541044|the|toxicity (r_dobj) increasing_8\VBG\169651|risk (r_advcl) reduced_4\VBN\441445|clearance|is|thiazides|,|increasing|. (l_nmod) thiazides_6\NNS\3214670|by
DDI-DrugBank.d682.s0
DDI-DrugBank.d682.s0.e0_DDI-DrugBank.d682.s0.e2 true sulfoxone_0\NN\1740| (r_nsubj) increase_2\VB\169651|sulfoxone|may|effects|. (l_dobj) effects_4\NNS\13245626|the|barbiturates (l_nmod) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) tolbutamide_8\NN\14914301|
DDI-DrugBank.d682.s0.e0_DDI-DrugBank.d682.s0.e1 true sulfoxone_0\NN\1740| (r_nsubj) increase_2\VB\169651|sulfoxone|may|effects|. (l_dobj) effects_4\NNS\13245626|the|barbiturates (l_nmod) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics
DDI-DrugBank.d682.s0.e0_DDI-DrugBank.d682.s0.e3 true sulfoxone_0\NN\1740| (r_nsubj) increase_2\VB\169651|sulfoxone|may|effects|. (l_dobj) effects_4\NNS\13245626|the|barbiturates (l_nmod) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) uricosurics_11\NNS\1740|
DDI-DrugBank.d682.s0.e2_DDI-DrugBank.d682.s0.e1 false tolbutamide_8\NN\14914301| (r_conj) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics
DDI-DrugBank.d682.s0.e2_DDI-DrugBank.d682.s0.e3 false tolbutamide_8\NN\14914301| (r_conj) barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) uricosurics_11\NNS\1740|
DDI-DrugBank.d682.s0.e1_DDI-DrugBank.d682.s0.e3 false barbiturates_6\NNS\4166841|of|,|tolbutamide|,|and|uricosurics (l_conj) uricosurics_11\NNS\1740|
DDI-DrugBank.d702.s0
DDI-DrugBank.d585.s6
DDI-DrugBank.d585.s6.e0_DDI-DrugBank.d585.s6.e1 true antacids_1\NNS\14778436| (r_nsubj) interfere_3\VB\2451370|because|antacids|may|absorption (l_nmod) absorption_6\NN\13558490|with|the|agents (l_nmod) agents_9\NNS\7347|of|anticholinergic
DDI-DrugBank.d648.s7
DDI-DrugBank.d680.s8
DDI-DrugBank.d680.s8.e0_DDI-DrugBank.d680.s8.e1 true pantoprazole_12\NN\1740| (r_nsubj) interfere_14\VB\2451370|inhibition|,|pantoprazole|may|absorption|ketoconazole|. (l_nmod) ketoconazole_32\NN\1740|(|eg|,|,|esters|,|and|salts|)
DDI-DrugBank.d680.s8.e0_DDI-DrugBank.d680.s8.e2 true pantoprazole_12\NN\1740| (r_nsubj) interfere_14\VB\2451370|inhibition|,|pantoprazole|may|absorption|ketoconazole|. (l_nmod) ketoconazole_32\NN\1740|(|eg|,|,|esters|,|and|salts|) (l_conj) esters_35\NNS\14727670|ampicillin (l_compound) ampicillin_34\NN\3910033|
DDI-DrugBank.d680.s8.e0_DDI-DrugBank.d680.s8.e3 true pantoprazole_12\NN\1740| (r_nsubj) interfere_14\VB\2451370|inhibition|,|pantoprazole|may|absorption|ketoconazole|. (l_nmod) ketoconazole_32\NN\1740|(|eg|,|,|esters|,|and|salts|) (l_conj) salts_39\NNS\14818238|iron (l_compound) iron_38\NN\14625458|
DDI-DrugBank.d680.s8.e1_DDI-DrugBank.d680.s8.e2 false ketoconazole_32\NN\1740|(|eg|,|,|esters|,|and|salts|) (l_conj) esters_35\NNS\14727670|ampicillin (l_compound) ampicillin_34\NN\3910033|
DDI-DrugBank.d680.s8.e1_DDI-DrugBank.d680.s8.e3 false ketoconazole_32\NN\1740|(|eg|,|,|esters|,|and|salts|) (l_conj) salts_39\NNS\14818238|iron (l_compound) iron_38\NN\14625458|
DDI-DrugBank.d680.s8.e2_DDI-DrugBank.d680.s8.e3 false ampicillin_34\NN\3910033| (r_compound) esters_35\NNS\14727670|ampicillin (r_conj) ketoconazole_32\NN\1740|(|eg|,|,|esters|,|and|salts|) (l_conj) salts_39\NNS\14818238|iron (l_compound) iron_38\NN\14625458|
DDI-DrugBank.d608.s4
DDI-DrugBank.d608.s4.e1_DDI-DrugBank.d608.s4.e0 false methotrexate_10\NN\2722166|with (r_nmod) administered_7\VBN\2436349|if|tolectin|is|concomitantly|methotrexate (l_nsubjpass) tolectin_5\NN\3828465|
DDI-DrugBank.d581.s1
DDI-DrugBank.d665.s0
DDI-DrugBank.d665.s0.e1_DDI-DrugBank.d665.s0.e2 false erythromycin_8\NN\2716866|e.g.|,|,|tetracycline|) (l_appos) tetracycline_10\NN\2716205|
DDI-DrugBank.d665.s0.e1_DDI-DrugBank.d665.s0.e0 false erythromycin_8\NN\2716866|e.g.|,|,|tetracycline|) (r_appos) antibiotics_4\NNS\2716205|of|bacteriostatic|(|erythromycin
DDI-DrugBank.d665.s0.e1_DDI-DrugBank.d665.s0.e3 true erythromycin_8\NN\2716866|e.g.|,|,|tetracycline|) (r_appos) antibiotics_4\NNS\2716205|of|bacteriostatic|(|erythromycin (r_nmod) administration_1\NN\1133281|concurrent|antibiotics (r_nsubj) diminish_13\VB\169651|administration|may|effects|slowing|. (l_dobj) effects_16\NNS\13245626|the|bactericidal|penicillins (l_nmod) penicillins_18\NNS\2716866|of
DDI-DrugBank.d665.s0.e2_DDI-DrugBank.d665.s0.e0 false tetracycline_10\NN\2716205| (r_appos) erythromycin_8\NN\2716866|e.g.|,|,|tetracycline|) (r_appos) antibiotics_4\NNS\2716205|of|bacteriostatic|(|erythromycin
DDI-DrugBank.d665.s0.e2_DDI-DrugBank.d665.s0.e3 true tetracycline_10\NN\2716205| (r_appos) erythromycin_8\NN\2716866|e.g.|,|,|tetracycline|) (r_appos) antibiotics_4\NNS\2716205|of|bacteriostatic|(|erythromycin (r_nmod) administration_1\NN\1133281|concurrent|antibiotics (r_nsubj) diminish_13\VB\169651|administration|may|effects|slowing|. (l_dobj) effects_16\NNS\13245626|the|bactericidal|penicillins (l_nmod) penicillins_18\NNS\2716866|of
DDI-DrugBank.d665.s0.e0_DDI-DrugBank.d665.s0.e3 true antibiotics_4\NNS\2716205|of|bacteriostatic|(|erythromycin (r_nmod) administration_1\NN\1133281|concurrent|antibiotics (r_nsubj) diminish_13\VB\169651|administration|may|effects|slowing|. (l_dobj) effects_16\NNS\13245626|the|bactericidal|penicillins (l_nmod) penicillins_18\NNS\2716866|of
DDI-DrugBank.d688.s0
DDI-DrugBank.d688.s0.e0_DDI-DrugBank.d688.s0.e1 false zidovudine_13\NN\3834836|of|or|rifabutin (l_conj) rifabutin_15\NN\1740|
DDI-DrugBank.d688.s0.e0_DDI-DrugBank.d688.s0.e2 false zidovudine_13\NN\3834836|of|or|rifabutin (r_nmod) parameters_11\NNS\5858936|in|pharmacokinetic|zidovudine (r_nmod) are_5\VBP\836236|that|there|alterations|parameters|warrant (l_xcomp) warrant_17\VB\1012073|to|adjustment|administered (l_advcl) administered_24\VBN\2436349|when|acetate|is|drugs (l_nsubjpass) acetate_22\NN\15010703|megestrol
DDI-DrugBank.d688.s0.e1_DDI-DrugBank.d688.s0.e2 false rifabutin_15\NN\1740| (r_conj) zidovudine_13\NN\3834836|of|or|rifabutin (r_nmod) parameters_11\NNS\5858936|in|pharmacokinetic|zidovudine (r_nmod) are_5\VBP\836236|that|there|alterations|parameters|warrant (l_xcomp) warrant_17\VB\1012073|to|adjustment|administered (l_advcl) administered_24\VBN\2436349|when|acetate|is|drugs (l_nsubjpass) acetate_22\NN\15010703|megestrol
DDI-DrugBank.d713.s0
DDI-DrugBank.d713.s0.e0_DDI-DrugBank.d713.s0.e1 true sanctura_4\NN\1740|of (r_nmod) use_2\NN\407535|the|concomitant|sanctura|agents (l_nmod) agents_8\NNS\7347|with|other|anticholinergic|produce
DDI-DrugBank.d700.s15
DDI-DrugBank.d742.s0
DDI-DrugBank.d680.s4
DDI-DrugBank.d773.s3
DDI-DrugBank.d763.s3
DDI-DrugBank.d763.s3.e0_DDI-DrugBank.d763.s3.e1 false phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_conj) carbamazepine_2\NN\1740|
DDI-DrugBank.d763.s3.e0_DDI-DrugBank.d763.s3.e2 false phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_conj) rifampicin_5\NN\1740|
DDI-DrugBank.d763.s3.e0_DDI-DrugBank.d763.s3.e3 false phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|)
DDI-DrugBank.d763.s3.e0_DDI-DrugBank.d763.s3.e4 false phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) carbamazepine_20\NN\1740|
DDI-DrugBank.d763.s3.e0_DDI-DrugBank.d763.s3.e5 false phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) rifampicin_23\NN\1740|
DDI-DrugBank.d763.s3.e0_DDI-DrugBank.d763.s3.e6 false phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nsubjpass) clearance_27\NN\5089947|the|ondansetron (l_nmod) ondansetron_29\NN\1740|of
DDI-DrugBank.d763.s3.e0_DDI-DrugBank.d763.s3.e7 false phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_conj) decreased_38\VBN\169651|concentrations|were (l_nsubjpass) concentrations_36\NNS\4916342|ondansetron|blood (l_compound) ondansetron_34\NN\1740|
DDI-DrugBank.d763.s3.e1_DDI-DrugBank.d763.s3.e2 false carbamazepine_2\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_conj) rifampicin_5\NN\1740|
DDI-DrugBank.d763.s3.e1_DDI-DrugBank.d763.s3.e3 false carbamazepine_2\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|)
DDI-DrugBank.d763.s3.e1_DDI-DrugBank.d763.s3.e4 false carbamazepine_2\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) carbamazepine_20\NN\1740|
DDI-DrugBank.d763.s3.e1_DDI-DrugBank.d763.s3.e5 false carbamazepine_2\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) rifampicin_23\NN\1740|
DDI-DrugBank.d763.s3.e1_DDI-DrugBank.d763.s3.e6 false carbamazepine_2\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nsubjpass) clearance_27\NN\5089947|the|ondansetron (l_nmod) ondansetron_29\NN\1740|of
DDI-DrugBank.d763.s3.e1_DDI-DrugBank.d763.s3.e7 false carbamazepine_2\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_conj) decreased_38\VBN\169651|concentrations|were (l_nsubjpass) concentrations_36\NNS\4916342|ondansetron|blood (l_compound) ondansetron_34\NN\1740|
DDI-DrugBank.d763.s3.e2_DDI-DrugBank.d763.s3.e3 false rifampicin_5\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|)
DDI-DrugBank.d763.s3.e2_DDI-DrugBank.d763.s3.e4 false rifampicin_5\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) carbamazepine_20\NN\1740|
DDI-DrugBank.d763.s3.e2_DDI-DrugBank.d763.s3.e5 false rifampicin_5\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nmod) patients_8\NNS\9898892|in|treated (l_acl) treated_9\VBN\2376958|inducers (l_nmod) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (l_dep) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) rifampicin_23\NN\1740|
DDI-DrugBank.d763.s3.e2_DDI-DrugBank.d763.s3.e6 false rifampicin_5\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nsubjpass) clearance_27\NN\5089947|the|ondansetron (l_nmod) ondansetron_29\NN\1740|of
DDI-DrugBank.d763.s3.e2_DDI-DrugBank.d763.s3.e7 false rifampicin_5\NN\1740| (r_conj) phenytoin_0\NN\3550533|,|carbamazepine|,|and|rifampicin|:|increased (l_dep) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_conj) decreased_38\VBN\169651|concentrations|were (l_nsubjpass) concentrations_36\NNS\4916342|ondansetron|blood (l_compound) ondansetron_34\NN\1740|
DDI-DrugBank.d763.s3.e3_DDI-DrugBank.d763.s3.e4 false phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) carbamazepine_20\NN\1740|
DDI-DrugBank.d763.s3.e3_DDI-DrugBank.d763.s3.e5 false phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) rifampicin_23\NN\1740|
DDI-DrugBank.d763.s3.e3_DDI-DrugBank.d763.s3.e6 false phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (r_dep) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (r_nmod) treated_9\VBN\2376958|inducers (r_acl) patients_8\NNS\9898892|in|treated (r_nmod) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nsubjpass) clearance_27\NN\5089947|the|ondansetron (l_nmod) ondansetron_29\NN\1740|of
DDI-DrugBank.d763.s3.e3_DDI-DrugBank.d763.s3.e7 false phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (r_dep) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (r_nmod) treated_9\VBN\2376958|inducers (r_acl) patients_8\NNS\9898892|in|treated (r_nmod) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_conj) decreased_38\VBN\169651|concentrations|were (l_nsubjpass) concentrations_36\NNS\4916342|ondansetron|blood (l_compound) ondansetron_34\NN\1740|
DDI-DrugBank.d763.s3.e4_DDI-DrugBank.d763.s3.e5 false carbamazepine_20\NN\1740| (r_conj) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (l_conj) rifampicin_23\NN\1740|
DDI-DrugBank.d763.s3.e4_DDI-DrugBank.d763.s3.e6 false carbamazepine_20\NN\1740| (r_conj) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (r_dep) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (r_nmod) treated_9\VBN\2376958|inducers (r_acl) patients_8\NNS\9898892|in|treated (r_nmod) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nsubjpass) clearance_27\NN\5089947|the|ondansetron (l_nmod) ondansetron_29\NN\1740|of
DDI-DrugBank.d763.s3.e4_DDI-DrugBank.d763.s3.e7 false carbamazepine_20\NN\1740| (r_conj) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (r_dep) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (r_nmod) treated_9\VBN\2376958|inducers (r_acl) patients_8\NNS\9898892|in|treated (r_nmod) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_conj) decreased_38\VBN\169651|concentrations|were (l_nsubjpass) concentrations_36\NNS\4916342|ondansetron|blood (l_compound) ondansetron_34\NN\1740|
DDI-DrugBank.d763.s3.e5_DDI-DrugBank.d763.s3.e6 false rifampicin_23\NN\1740| (r_conj) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (r_dep) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (r_nmod) treated_9\VBN\2376958|inducers (r_acl) patients_8\NNS\9898892|in|treated (r_nmod) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_nsubjpass) clearance_27\NN\5089947|the|ondansetron (l_nmod) ondansetron_29\NN\1740|of
DDI-DrugBank.d763.s3.e5_DDI-DrugBank.d763.s3.e7 false rifampicin_23\NN\1740| (r_conj) phenytoin_18\NN\3550533|(|i.e.|,|,|carbamazepine|,|and|rifampicin|) (r_dep) inducers_12\NNS\14778436|with|potent|cyp3a4|phenytoin (r_nmod) treated_9\VBN\2376958|inducers (r_acl) patients_8\NNS\9898892|in|treated (r_nmod) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_conj) decreased_38\VBN\169651|concentrations|were (l_nsubjpass) concentrations_36\NNS\4916342|ondansetron|blood (l_compound) ondansetron_34\NN\1740|
DDI-DrugBank.d763.s3.e6_DDI-DrugBank.d763.s3.e7 false ondansetron_29\NN\1740|of (r_nmod) clearance_27\NN\5089947|the|ondansetron (r_nsubjpass) increased_32\VBN\169651|patients|,|clearance|was|significantly|and|decreased|. (l_conj) decreased_38\VBN\169651|concentrations|were (l_nsubjpass) concentrations_36\NNS\4916342|ondansetron|blood (l_compound) ondansetron_34\NN\1740|
DDI-DrugBank.d647.s2
DDI-DrugBank.d647.s2.e0_DDI-DrugBank.d647.s2.e1 true doxorubicin_4\NN\2716866| (r_compound) dosage_5\NN\13576355|of|the|doxorubicin (r_nmod) reduction_1\NN\351485|a|dosage (r_nsubjpass) considered_8\VBN\689344|reduction|should|be|patients|. (l_nmod) patients_10\NNS\9898892|in|receiving (l_acl) receiving_11\VBG\2210855|zanosar|concurrently (l_dobj) zanosar_12\NNP\1740|
DDI-DrugBank.d654.s1
DDI-DrugBank.d654.s1.e0_DDI-DrugBank.d654.s1.e1 false retapamulin_6\NN\1740|to (r_nmod) exposure_4\NN\5042871|due|low|systemic|retapamulin|application (r_nmod) unnecessary_18\JJ\1740|exposure|,|adjustments|are|co-administered|. (l_nsubj) adjustments_14\NNS\7357388|dosage|retapamulin (l_nmod) retapamulin_16\NN\1740|for
DDI-DrugBank.d654.s1.e0_DDI-DrugBank.d654.s1.e2 false retapamulin_6\NN\1740|to (r_nmod) exposure_4\NN\5042871|due|low|systemic|retapamulin|application (r_nmod) unnecessary_18\JJ\1740|exposure|,|adjustments|are|co-administered|. (l_advcl) co-administered_20\VBN\1740|when|inhibitors (l_nmod) inhibitors_23\NNS\20090|with|cyp3a4|,|ketoconazole (l_nmod) ketoconazole_27\NN\1740|such
DDI-DrugBank.d654.s1.e1_DDI-DrugBank.d654.s1.e2 false retapamulin_16\NN\1740|for (r_nmod) adjustments_14\NNS\7357388|dosage|retapamulin (r_nsubj) unnecessary_18\JJ\1740|exposure|,|adjustments|are|co-administered|. (l_advcl) co-administered_20\VBN\1740|when|inhibitors (l_nmod) inhibitors_23\NNS\20090|with|cyp3a4|,|ketoconazole (l_nmod) ketoconazole_27\NN\1740|such
DDI-DrugBank.d572.s10
DDI-DrugBank.d572.s10.e0_DDI-DrugBank.d572.s10.e1 true ezetimibe_4\NN\1740|both|and|cyclosporine (l_conj) cyclosporine_6\NN\1740|
DDI-DrugBank.d638.s3
DDI-DrugBank.d752.s11
DDI-DrugBank.d596.s3
DDI-DrugBank.d596.s3.e0_DDI-DrugBank.d596.s3.e1 false rivastigmine_6\NN\1740|between|and|digoxin (l_conj) digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine
DDI-DrugBank.d596.s3.e0_DDI-DrugBank.d596.s3.e2 false rivastigmine_6\NN\1740|between|and|digoxin (l_conj) digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) warfarin_10\NN\2718259|
DDI-DrugBank.d596.s3.e0_DDI-DrugBank.d596.s3.e3 false rivastigmine_6\NN\1740|between|and|digoxin (l_conj) digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) diazepam_12\NN\2830852|
DDI-DrugBank.d596.s3.e0_DDI-DrugBank.d596.s3.e4 false rivastigmine_6\NN\1740|between|and|digoxin (l_conj) digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_15\NN\4169152|
DDI-DrugBank.d596.s3.e1_DDI-DrugBank.d596.s3.e2 false digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) warfarin_10\NN\2718259|
DDI-DrugBank.d596.s3.e1_DDI-DrugBank.d596.s3.e3 false digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) diazepam_12\NN\2830852|
DDI-DrugBank.d596.s3.e1_DDI-DrugBank.d596.s3.e4 false digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_15\NN\4169152|
DDI-DrugBank.d596.s3.e2_DDI-DrugBank.d596.s3.e3 false warfarin_10\NN\2718259| (r_conj) digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) diazepam_12\NN\2830852|
DDI-DrugBank.d596.s3.e2_DDI-DrugBank.d596.s3.e4 false warfarin_10\NN\2718259| (r_conj) digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_15\NN\4169152|
DDI-DrugBank.d596.s3.e3_DDI-DrugBank.d596.s3.e4 false diazepam_12\NN\2830852| (r_conj) digoxin_8\NN\15060131|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_15\NN\4169152|
DDI-DrugBank.d776.s13
DDI-DrugBank.d776.s13.e0_DDI-DrugBank.d776.s13.e2 false cyclosporine_0\NN\1740| (r_compound) diflucan_2\NN\1740|cyclosporine|: (r_nsubj) increase_5\VB\169651|diflucan|may|significantly|levels|. (l_dobj) levels_7\NNS\4916342|cyclosporine|patients (l_compound) cyclosporine_6\NN\1740|
DDI-DrugBank.d776.s13.e0_DDI-DrugBank.d776.s13.e1 false cyclosporine_0\NN\1740| (r_compound) diflucan_2\NN\1740|cyclosporine|:
DDI-DrugBank.d776.s13.e2_DDI-DrugBank.d776.s13.e1 false cyclosporine_6\NN\1740| (r_compound) levels_7\NNS\4916342|cyclosporine|patients (r_dobj) increase_5\VB\169651|diflucan|may|significantly|levels|. (l_nsubj) diflucan_2\NN\1740|cyclosporine|:
DDI-DrugBank.d695.s0
DDI-DrugBank.d695.s0.e0_DDI-DrugBank.d695.s0.e1 true zavesca_3\NN\1740|of (r_nmod) co-administration_1\NN\1740|zavesca (r_nsubj) appeared_4\VBD\2604760|while|co-administration|increase (l_xcomp) increase_6\VB\169651|to|clearance|% (l_dobj) clearance_8\NN\5089947|the|cerezyme (l_nmod) cerezyme_10\NN\1740|of
DDI-DrugBank.d695.s0.e0_DDI-DrugBank.d695.s0.e2 false zavesca_3\NN\1740|of (r_nmod) co-administration_1\NN\1740|zavesca (r_nsubj) appeared_4\VBD\2604760|while|co-administration|increase (r_advcl) conclusive_19\JJ\1740|appeared|,|results|are|not|number|. (l_nmod) number_24\NN\5107765|because|the|small|subjects|and|took (l_conj) took_31\VBD\2367363|because|patients|doses (l_dobj) doses_33\NNS\3740161|variable|cerezyme (l_nmod) cerezyme_35\NN\1740|of
DDI-DrugBank.d695.s0.e1_DDI-DrugBank.d695.s0.e2 false cerezyme_10\NN\1740|of (r_nmod) clearance_8\NN\5089947|the|cerezyme (r_dobj) increase_6\VB\169651|to|clearance|% (r_xcomp) appeared_4\VBD\2604760|while|co-administration|increase (r_advcl) conclusive_19\JJ\1740|appeared|,|results|are|not|number|. (l_nmod) number_24\NN\5107765|because|the|small|subjects|and|took (l_conj) took_31\VBD\2367363|because|patients|doses (l_dobj) doses_33\NNS\3740161|variable|cerezyme (l_nmod) cerezyme_35\NN\1740|of
DDI-DrugBank.d776.s27
DDI-DrugBank.d776.s27.e0_DDI-DrugBank.d776.s27.e1 true fluconazole_4\NN\1740|of (r_nmod) use_2\NN\407535|the|combined|fluconazole|cisapride (l_nmod) cisapride_6\NN\1740|with
DDI-DrugBank.d597.s13
DDI-DrugBank.d597.s13.e0_DDI-DrugBank.d597.s13.e1 false digoxin_10\NN\15060131|between|and|meloxicam (l_conj) meloxicam_12\NN\1740|
DDI-DrugBank.d661.s6
DDI-DrugBank.d598.s0
DDI-DrugBank.d598.s0.e0_DDI-DrugBank.d598.s0.e1 true trimethoprim_0\NN\1740| (r_nsubj) inhibit_2\VB\2510337|trimethoprim|may|metabolism|. (l_dobj) metabolism_5\NN\13526110|the|hepatic|phenytoin (l_nmod) phenytoin_7\NN\3550533|of
DDI-DrugBank.d599.s3
DDI-DrugBank.d741.s1
DDI-DrugBank.d656.s3
DDI-DrugBank.d656.s3.e0_DDI-DrugBank.d656.s3.e1 true lithium_5\NN\14625458| (r_compound) levels_6\NNS\4916342|plasma|lithium (r_nsubjpass) monitored_8\VBN\2169352|that|levels|be|initiating (l_advcl) initiating_10\VBG\1617192|when|,|adjusting (l_conj) adjusting_12\VBG\126264|and|discontinuing (l_conj) discontinuing_14\VBG\2609764|feldene (l_dobj) feldene_15\NNP\3828465|
DDI-DrugBank.d775.s8
DDI-DrugBank.d775.s8.e1_DDI-DrugBank.d775.s8.e2 false enflurane_17\NN\3299929|of|or|isoflurane (l_conj) isoflurane_19\NN\3570838|
DDI-DrugBank.d775.s8.e1_DDI-DrugBank.d775.s8.e0 false enflurane_17\NN\3299929|of|or|isoflurane (r_nmod) concentrations_15\NNS\4916342|with|higher|enflurane (r_nmod) expected_12\VBN\670261|potentiation|may|be|concentrations|. (l_nsubjpass) potentiation_2\NN\13564910|a|greater|effects (l_nmod) effects_7\NNS\13245626|of|the|neuromuscular|blocking|mivacron (l_nmod) mivacron_9\NN\1740|of
DDI-DrugBank.d775.s8.e2_DDI-DrugBank.d775.s8.e0 false isoflurane_19\NN\3570838| (r_conj) enflurane_17\NN\3299929|of|or|isoflurane (r_nmod) concentrations_15\NNS\4916342|with|higher|enflurane (r_nmod) expected_12\VBN\670261|potentiation|may|be|concentrations|. (l_nsubjpass) potentiation_2\NN\13564910|a|greater|effects (l_nmod) effects_7\NNS\13245626|of|the|neuromuscular|blocking|mivacron (l_nmod) mivacron_9\NN\1740|of
DDI-DrugBank.d632.s0
DDI-DrugBank.d632.s0.e2_DDI-DrugBank.d632.s0.e0 false atropine_29\NN\14712692|such (r_nmod) agents_26\NNS\7347|(|e.g.|,|anticholinergic|atropine|) (r_nmod) patients_15\NNS\9898892|for|taking|agents|and|agents|inhibitors (r_nmod) considered_13\VBN\689344|effects|,|therapy|should|not|be|patients|. (l_nsubjpass) therapy_9\NN\657604|symlin (l_compound) symlin_8\NN\1740|
DDI-DrugBank.d632.s0.e2_DDI-DrugBank.d632.s0.e1 false atropine_29\NN\14712692|such (r_nmod) agents_26\NNS\7347|(|e.g.|,|anticholinergic|atropine|)
DDI-DrugBank.d632.s0.e2_DDI-DrugBank.d632.s0.e3 false atropine_29\NN\14712692|such (r_nmod) agents_26\NNS\7347|(|e.g.|,|anticholinergic|atropine|) (r_nmod) patients_15\NNS\9898892|for|taking|agents|and|agents|inhibitors (l_appos) inhibitors_45\NNS\20090|(|e.g.|,|alpha|glucosidase|)
DDI-DrugBank.d632.s0.e0_DDI-DrugBank.d632.s0.e1 true symlin_8\NN\1740| (r_compound) therapy_9\NN\657604|symlin (r_nsubjpass) considered_13\VBN\689344|effects|,|therapy|should|not|be|patients|. (l_nmod) patients_15\NNS\9898892|for|taking|agents|and|agents|inhibitors (l_nmod) agents_26\NNS\7347|(|e.g.|,|anticholinergic|atropine|)
DDI-DrugBank.d632.s0.e0_DDI-DrugBank.d632.s0.e3 true symlin_8\NN\1740| (r_compound) therapy_9\NN\657604|symlin (r_nsubjpass) considered_13\VBN\689344|effects|,|therapy|should|not|be|patients|. (l_nmod) patients_15\NNS\9898892|for|taking|agents|and|agents|inhibitors (l_appos) inhibitors_45\NNS\20090|(|e.g.|,|alpha|glucosidase|)
DDI-DrugBank.d632.s0.e1_DDI-DrugBank.d632.s0.e3 false agents_26\NNS\7347|(|e.g.|,|anticholinergic|atropine|) (r_nmod) patients_15\NNS\9898892|for|taking|agents|and|agents|inhibitors (l_appos) inhibitors_45\NNS\20090|(|e.g.|,|alpha|glucosidase|)
DDI-DrugBank.d761.s10
DDI-DrugBank.d761.s10.e0_DDI-DrugBank.d761.s10.e3 false pravastatin_0\NN\3676175| (r_dep) affect_29\VB\126264|pravastatin|:|study|,|xenical|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_31\NNS\6054892|the|pravastatin (l_nmod) pravastatin_33\NN\3676175|of
DDI-DrugBank.d761.s10.e0_DDI-DrugBank.d761.s10.e1 false pravastatin_0\NN\3676175| (r_dep) affect_29\VB\126264|pravastatin|:|study|,|xenical|did|not|pharmacokinetics|. (l_nmod) study_6\NN\635850|in|a|2-way|crossover|patients (l_nmod) patients_13\NNS\9898892|of|24|hypercholesterolemic|receiving (l_acl) receiving_14\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_15\NN\1740|
DDI-DrugBank.d761.s10.e0_DDI-DrugBank.d761.s10.e2 false pravastatin_0\NN\3676175| (r_dep) affect_29\VB\126264|pravastatin|:|study|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_26\NN\1740|
DDI-DrugBank.d761.s10.e3_DDI-DrugBank.d761.s10.e1 false pravastatin_33\NN\3676175|of (r_nmod) pharmacokinetics_31\NNS\6054892|the|pravastatin (r_dobj) affect_29\VB\126264|pravastatin|:|study|,|xenical|did|not|pharmacokinetics|. (l_nmod) study_6\NN\635850|in|a|2-way|crossover|patients (l_nmod) patients_13\NNS\9898892|of|24|hypercholesterolemic|receiving (l_acl) receiving_14\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_15\NN\1740|
DDI-DrugBank.d761.s10.e3_DDI-DrugBank.d761.s10.e2 false pravastatin_33\NN\3676175|of (r_nmod) pharmacokinetics_31\NNS\6054892|the|pravastatin (r_dobj) affect_29\VB\126264|pravastatin|:|study|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_26\NN\1740|
DDI-DrugBank.d761.s10.e1_DDI-DrugBank.d761.s10.e2 false xenical_15\NN\1740| (r_dobj) receiving_14\VBG\2210855|xenical|mg|times|days (r_acl) patients_13\NNS\9898892|of|24|hypercholesterolemic|receiving (r_nmod) study_6\NN\635850|in|a|2-way|crossover|patients (r_nmod) affect_29\VB\126264|pravastatin|:|study|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_26\NN\1740|
DDI-DrugBank.d736.s0
DDI-DrugBank.d595.s0
DDI-DrugBank.d706.s0
DDI-DrugBank.d706.s0.e0_DDI-DrugBank.d706.s0.e1 true reserpine_5\NN\2721160|e.g.|,|) (r_appos) drugs_1\NNS\14778436|catecholamine-depleting|(|reserpine (r_nsubj) have_8\VB\2108377|drugs|may|effect|given|. (l_advcl) given_13\VBN\2327200|when|agents (l_nmod) agents_16\NNS\7347|with|beta-blocking
DDI-DrugBank.d638.s2
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e4 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_appos) diphenylhydantoin_19\NN\3550533|
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e5 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_appos) primidone_21\NN\2718469|
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e6 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) phenylbutazone_24\NN\2721538|
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e8 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|)
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e9 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (l_appos) clomipramine_32\NN\4482543|
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e0 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (r_nmod) metabolism_10\NN\13526110|the|anticoagulants (r_dobj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_nsubj) ritalin_6\NN\4320126|
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e1 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e2 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e3_DDI-DrugBank.d638.s2.e7 false phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e5 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_appos) primidone_21\NN\2718469|
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e6 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) phenylbutazone_24\NN\2721538|
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e8 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|)
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e9 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (l_appos) clomipramine_32\NN\4482543|
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e0 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (r_nmod) metabolism_10\NN\13526110|the|anticoagulants (r_dobj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_nsubj) ritalin_6\NN\4320126|
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e1 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e2 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e4_DDI-DrugBank.d638.s2.e7 false diphenylhydantoin_19\NN\3550533| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e5_DDI-DrugBank.d638.s2.e6 false primidone_21\NN\2718469| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) phenylbutazone_24\NN\2721538|
DDI-DrugBank.d638.s2.e5_DDI-DrugBank.d638.s2.e8 false primidone_21\NN\2718469| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|)
DDI-DrugBank.d638.s2.e5_DDI-DrugBank.d638.s2.e9 false primidone_21\NN\2718469| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (l_appos) clomipramine_32\NN\4482543|
DDI-DrugBank.d638.s2.e5_DDI-DrugBank.d638.s2.e0 false primidone_21\NN\2718469| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (r_nmod) metabolism_10\NN\13526110|the|anticoagulants (r_dobj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_nsubj) ritalin_6\NN\4320126|
DDI-DrugBank.d638.s2.e5_DDI-DrugBank.d638.s2.e1 false primidone_21\NN\2718469| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants
DDI-DrugBank.d638.s2.e5_DDI-DrugBank.d638.s2.e2 false primidone_21\NN\2718469| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e5_DDI-DrugBank.d638.s2.e7 false primidone_21\NN\2718469| (r_appos) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e6_DDI-DrugBank.d638.s2.e8 false phenylbutazone_24\NN\2721538| (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|)
DDI-DrugBank.d638.s2.e6_DDI-DrugBank.d638.s2.e9 false phenylbutazone_24\NN\2721538| (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine (l_dep) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (l_appos) clomipramine_32\NN\4482543|
DDI-DrugBank.d638.s2.e6_DDI-DrugBank.d638.s2.e0 false phenylbutazone_24\NN\2721538| (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (r_nmod) metabolism_10\NN\13526110|the|anticoagulants (r_dobj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_nsubj) ritalin_6\NN\4320126|
DDI-DrugBank.d638.s2.e6_DDI-DrugBank.d638.s2.e1 false phenylbutazone_24\NN\2721538| (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants
DDI-DrugBank.d638.s2.e6_DDI-DrugBank.d638.s2.e2 false phenylbutazone_24\NN\2721538| (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e6_DDI-DrugBank.d638.s2.e7 false phenylbutazone_24\NN\2721538| (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e8_DDI-DrugBank.d638.s2.e9 false imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (l_appos) clomipramine_32\NN\4482543|
DDI-DrugBank.d638.s2.e8_DDI-DrugBank.d638.s2.e0 false imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (r_nmod) metabolism_10\NN\13526110|the|anticoagulants (r_dobj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_nsubj) ritalin_6\NN\4320126|
DDI-DrugBank.d638.s2.e8_DDI-DrugBank.d638.s2.e1 false imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants
DDI-DrugBank.d638.s2.e8_DDI-DrugBank.d638.s2.e2 false imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e8_DDI-DrugBank.d638.s2.e7 false imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e9_DDI-DrugBank.d638.s2.e0 false clomipramine_32\NN\4482543| (r_appos) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (r_nmod) metabolism_10\NN\13526110|the|anticoagulants (r_dobj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_nsubj) ritalin_6\NN\4320126|
DDI-DrugBank.d638.s2.e9_DDI-DrugBank.d638.s2.e1 false clomipramine_32\NN\4482543| (r_appos) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital (r_conj) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants
DDI-DrugBank.d638.s2.e9_DDI-DrugBank.d638.s2.e2 false clomipramine_32\NN\4482543| (r_appos) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine (r_conj) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (r_dep) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e9_DDI-DrugBank.d638.s2.e7 false clomipramine_32\NN\4482543| (r_appos) imipramine_30\NN\4482543|(|,|clomipramine|,|desipramine|) (r_dep) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e0_DDI-DrugBank.d638.s2.e1 true ritalin_6\NN\4320126| (r_nsubj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_dobj) metabolism_10\NN\13526110|the|anticoagulants (l_nmod) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants
DDI-DrugBank.d638.s2.e0_DDI-DrugBank.d638.s2.e2 true ritalin_6\NN\4320126| (r_nsubj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_dobj) metabolism_10\NN\13526110|the|anticoagulants (l_nmod) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (l_conj) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e0_DDI-DrugBank.d638.s2.e7 true ritalin_6\NN\4320126| (r_nsubj) inhibit_8\VB\2510337|that|ritalin|may|metabolism (l_dobj) metabolism_10\NN\13526110|the|anticoagulants (l_nmod) anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (l_conj) anticonvulsants_15\NNS\3740161|phenobarbital (l_dep) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e1_DDI-DrugBank.d638.s2.e2 false anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (l_conj) anticonvulsants_15\NNS\3740161|phenobarbital
DDI-DrugBank.d638.s2.e1_DDI-DrugBank.d638.s2.e7 false anticoagulants_13\NNS\3740161|of|coumarin|,|anticonvulsants (l_conj) anticonvulsants_15\NNS\3740161|phenobarbital (l_dep) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d638.s2.e2_DDI-DrugBank.d638.s2.e7 false anticonvulsants_15\NNS\3740161|phenobarbital (l_dep) phenobarbital_17\NN\2792049|(|,|diphenylhydantoin|,|primidone|)|,|phenylbutazone|,|and|drugs (l_conj) drugs_28\NNS\14778436|tricyclic|imipramine
DDI-DrugBank.d780.s2
DDI-DrugBank.d596.s8
DDI-DrugBank.d596.s8.e0_DDI-DrugBank.d596.s8.e1 false anticholinergics_2\NNS\3740161|with (r_nmod) use_0\NN\407535|anticholinergics (r_dep) have_13\VBP\2108377|use|:|mechanism|,|inhibitors|potential (l_nsubj) inhibitors_12\NNS\20090|cholinesterase
DDI-DrugBank.d596.s8.e0_DDI-DrugBank.d596.s8.e2 false anticholinergics_2\NNS\3740161|with (r_nmod) use_0\NN\407535|anticholinergics (r_dep) have_13\VBP\2108377|use|:|mechanism|,|inhibitors|potential (l_dobj) potential_15\NN\14481929|the|interfere (l_acl) interfere_17\VB\2451370|to|activity (l_nmod) activity_20\NN\30358|with|the|medications. (l_nmod) medications._23\NNS\1740|of|anticholinergic
DDI-DrugBank.d596.s8.e1_DDI-DrugBank.d596.s8.e2 true inhibitors_12\NNS\20090|cholinesterase (r_nsubj) have_13\VBP\2108377|use|:|mechanism|,|inhibitors|potential (l_dobj) potential_15\NN\14481929|the|interfere (l_acl) interfere_17\VB\2451370|to|activity (l_nmod) activity_20\NN\30358|with|the|medications. (l_nmod) medications._23\NNS\1740|of|anticholinergic
DDI-DrugBank.d610.s2
DDI-DrugBank.d610.s2.e0_DDI-DrugBank.d610.s2.e1 false abacavir_0\NN\1740| (r_nsubj) has_1\VBZ\2108377|abacavir|effect|. (l_dobj) effect_3\NN\34213|no|properties (l_nmod) properties_7\NNS\32613|on|the|pharmacokinetic|ethanol (l_nmod) ethanol_9\NN\14708720|of
DDI-DrugBank.d700.s4
DDI-DrugBank.d761.s6
DDI-DrugBank.d761.s6.e0_DDI-DrugBank.d761.s6.e1 false glyburide_0\NN\2719105| (r_dep) alter_21\VB\126264|glyburide|:|subjects|,|orlistat|did|not|pharmacokinetics|. (l_nmod) subjects_5\NNS\6598915|in|12|normal-weight|receiving (l_acl) receiving_6\VBG\2210855|orlistat|mg|times|days (l_dobj) orlistat_7\NN\1740|
DDI-DrugBank.d761.s6.e0_DDI-DrugBank.d761.s6.e2 false glyburide_0\NN\2719105| (r_dep) alter_21\VB\126264|glyburide|:|subjects|,|orlistat|did|not|pharmacokinetics|. (l_nsubj) orlistat_18\NN\1740|
DDI-DrugBank.d761.s6.e0_DDI-DrugBank.d761.s6.e3 false glyburide_0\NN\2719105| (r_dep) alter_21\VB\126264|glyburide|:|subjects|,|orlistat|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_23\NNS\6054892|the|or|pharmacodynamics|glucose-lowering|glyburide (l_nmod) glyburide_31\NN\2719105|of
DDI-DrugBank.d761.s6.e1_DDI-DrugBank.d761.s6.e2 false orlistat_7\NN\1740| (r_dobj) receiving_6\VBG\2210855|orlistat|mg|times|days (r_acl) subjects_5\NNS\6598915|in|12|normal-weight|receiving (r_nmod) alter_21\VB\126264|glyburide|:|subjects|,|orlistat|did|not|pharmacokinetics|. (l_nsubj) orlistat_18\NN\1740|
DDI-DrugBank.d761.s6.e1_DDI-DrugBank.d761.s6.e3 false orlistat_7\NN\1740| (r_dobj) receiving_6\VBG\2210855|orlistat|mg|times|days (r_acl) subjects_5\NNS\6598915|in|12|normal-weight|receiving (r_nmod) alter_21\VB\126264|glyburide|:|subjects|,|orlistat|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_23\NNS\6054892|the|or|pharmacodynamics|glucose-lowering|glyburide (l_nmod) glyburide_31\NN\2719105|of
DDI-DrugBank.d761.s6.e2_DDI-DrugBank.d761.s6.e3 false orlistat_18\NN\1740| (r_nsubj) alter_21\VB\126264|glyburide|:|subjects|,|orlistat|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_23\NNS\6054892|the|or|pharmacodynamics|glucose-lowering|glyburide (l_nmod) glyburide_31\NN\2719105|of
DDI-DrugBank.d638.s4
DDI-DrugBank.d665.s2
DDI-DrugBank.d700.s1
DDI-DrugBank.d700.s1.e0_DDI-DrugBank.d700.s1.e1 true myfortic_4\JJ\1740|and|antacids (l_conj) antacids_6\NNS\14778436|
DDI-DrugBank.d756.s6
DDI-DrugBank.d653.s7
DDI-DrugBank.d653.s7.e0_DDI-DrugBank.d653.s7.e1 true corticosteroids_3\NNS\14745635|of (r_nmod) effect_1\NN\34213|the|corticosteroids|anticoagulants (l_nmod) anticoagulants_6\NNS\3740161|on|oral
DDI-DrugBank.d678.s1
DDI-DrugBank.d678.s1.e1_DDI-DrugBank.d678.s1.e0 false phenytoin_7\NN\3550533|by (r_nmod) accelerated_5\VBN\226566|metabolism|is|phenytoin|; (l_nsubjpass) metabolism_1\NN\13526110|the|metopirone (l_nmod) metopirone_3\NN\1740|of
DDI-DrugBank.d578.s1
DDI-DrugBank.d578.s1.e0_DDI-DrugBank.d578.s1.e1 true cyclosporin_9\NN\1740|of|and|methylprednisolone (l_conj) methylprednisolone_11\NN\1740|
DDI-DrugBank.d739.s6
DDI-DrugBank.d739.s6.e0_DDI-DrugBank.d739.s6.e1 false phenobarbital_0\NN\2792049|,|induces|, (r_nsubj) decreased_7\VBD\169651|phenobarbital|auc|%|dose|. (l_dobj) auc_9\NN\1740|the|montelukast (l_nmod) montelukast_11\NN\1740|of
DDI-DrugBank.d739.s6.e0_DDI-DrugBank.d739.s6.e2 false phenobarbital_0\NN\2792049|,|induces|, (r_nsubj) decreased_7\VBD\169651|phenobarbital|auc|%|dose|. (l_nmod) dose_19\NN\3740161|following|a|single|10-mg|montelukast (l_nmod) montelukast_21\NN\1740|of
DDI-DrugBank.d739.s6.e1_DDI-DrugBank.d739.s6.e2 false montelukast_11\NN\1740|of (r_nmod) auc_9\NN\1740|the|montelukast (r_dobj) decreased_7\VBD\169651|phenobarbital|auc|%|dose|. (l_nmod) dose_19\NN\3740161|following|a|single|10-mg|montelukast (l_nmod) montelukast_21\NN\1740|of
DDI-DrugBank.d668.s0
DDI-DrugBank.d668.s0.e0_DDI-DrugBank.d668.s0.e1 false mifepristone_7\NN\2667906|with (r_nmod) interactions_5\NNS\37396|drug|mifepristone (r_nsubjpass) studied_11\VBN\630380|although|interactions|have|not|been (r_advcl) possible_27\JJ\1740|studied|,|basis|metabolism|,|it|is|inhibit|. (l_ccomp) inhibit_39\VB\2510337|that|ketoconazole|may|metabolism|(|increasing (l_nsubj) ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice
DDI-DrugBank.d668.s0.e0_DDI-DrugBank.d668.s0.e2 false mifepristone_7\NN\2667906|with (r_nmod) interactions_5\NNS\37396|drug|mifepristone (r_nsubjpass) studied_11\VBN\630380|although|interactions|have|not|been (r_advcl) possible_27\JJ\1740|studied|,|basis|metabolism|,|it|is|inhibit|. (l_ccomp) inhibit_39\VB\2510337|that|ketoconazole|may|metabolism|(|increasing (l_nsubj) ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (l_conj) itraconazole_31\NN\2720201|
DDI-DrugBank.d668.s0.e0_DDI-DrugBank.d668.s0.e3 false mifepristone_7\NN\2667906|with (r_nmod) interactions_5\NNS\37396|drug|mifepristone (r_nsubjpass) studied_11\VBN\630380|although|interactions|have|not|been (r_advcl) possible_27\JJ\1740|studied|,|basis|metabolism|,|it|is|inhibit|. (l_ccomp) inhibit_39\VB\2510337|that|ketoconazole|may|metabolism|(|increasing (l_nsubj) ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (l_conj) erythromycin_33\NN\2716866|
DDI-DrugBank.d668.s0.e0_DDI-DrugBank.d668.s0.e4 false mifepristone_7\NN\2667906|with (r_nmod) interactions_5\NNS\37396|drug|mifepristone (r_nsubjpass) studied_11\VBN\630380|although|interactions|have|not|been (r_advcl) possible_27\JJ\1740|studied|,|basis|metabolism|,|it|is|inhibit|. (l_ccomp) inhibit_39\VB\2510337|that|ketoconazole|may|metabolism|(|increasing (l_advcl) increasing_43\VBG\169651|levels|) (l_dobj) levels_45\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_47\NN\2667906|of
DDI-DrugBank.d668.s0.e1_DDI-DrugBank.d668.s0.e2 false ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (l_conj) itraconazole_31\NN\2720201|
DDI-DrugBank.d668.s0.e1_DDI-DrugBank.d668.s0.e3 false ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (l_conj) erythromycin_33\NN\2716866|
DDI-DrugBank.d668.s0.e1_DDI-DrugBank.d668.s0.e4 true ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (r_nsubj) inhibit_39\VB\2510337|that|ketoconazole|may|metabolism|(|increasing (l_advcl) increasing_43\VBG\169651|levels|) (l_dobj) levels_45\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_47\NN\2667906|of
DDI-DrugBank.d668.s0.e2_DDI-DrugBank.d668.s0.e3 false itraconazole_31\NN\2720201| (r_conj) ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (l_conj) erythromycin_33\NN\2716866|
DDI-DrugBank.d668.s0.e2_DDI-DrugBank.d668.s0.e4 true itraconazole_31\NN\2720201| (r_conj) ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (r_nsubj) inhibit_39\VB\2510337|that|ketoconazole|may|metabolism|(|increasing (l_advcl) increasing_43\VBG\169651|levels|) (l_dobj) levels_45\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_47\NN\2667906|of
DDI-DrugBank.d668.s0.e3_DDI-DrugBank.d668.s0.e4 true erythromycin_33\NN\2716866| (r_conj) ketoconazole_29\NN\1740|,|itraconazole|,|erythromycin|,|and|juice (r_nsubj) inhibit_39\VB\2510337|that|ketoconazole|may|metabolism|(|increasing (l_advcl) increasing_43\VBG\169651|levels|) (l_dobj) levels_45\NNS\4916342|serum|mifepristone (l_nmod) mifepristone_47\NN\2667906|of
DDI-DrugBank.d700.s13
DDI-DrugBank.d777.s0
DDI-DrugBank.d777.s0.e1_DDI-DrugBank.d777.s0.e0 false streptokinase_5\NN\14732946| (r_appos) streptase_3\NN\1740|of|,|streptokinase|,
DDI-DrugBank.d610.s3
DDI-DrugBank.d610.s3.e0_DDI-DrugBank.d610.s3.e1 true ethanol_0\NN\14708720| (r_nsubj) decreases_1\VBZ\169651|ethanol|elimination|causing|. (l_dobj) elimination_3\NN\391599|the|abacavir (l_nmod) abacavir_5\NN\1740|of
DDI-DrugBank.d610.s3.e2_DDI-DrugBank.d610.s3.e3 false methadone_3\NN\3808564|of (r_nmod) addition_1\NN\3081021|the|methadone (r_nsubj) has_4\VBZ\2108377|addition|effect|. (l_dobj) effect_8\NN\34213|no|significant|properties (l_nmod) properties_12\NNS\32613|on|the|pharmacokinetic|abacavir (l_nmod) abacavir_14\NN\1740|of
DDI-DrugBank.d572.s36
DDI-DrugBank.d666.s0
DDI-DrugBank.d666.s0.e0_DDI-DrugBank.d666.s0.e1 true reserpine_5\NN\2721160|e.g.|,|) (r_appos) drugs_1\NNS\14778436|catecholamine-depleting|(|reserpine (r_nsubj) have_8\VB\2108377|drugs|may|effect|given|. (l_advcl) given_13\VBN\2327200|when|agents (l_nmod) agents_16\NNS\7347|with|beta-blocking
DDI-DrugBank.d739.s9
DDI-DrugBank.d737.s0
DDI-DrugBank.d737.s0.e0_DDI-DrugBank.d737.s0.e1 false carbidopa/levodopa_0\NN\1740|:|influence
DDI-DrugBank.d737.s0.e0_DDI-DrugBank.d737.s0.e2 false carbidopa/levodopa_0\NN\1740|:|influence (l_dep) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_nsubj) carbidopa/levodopa_2\NN\1740|
DDI-DrugBank.d737.s0.e0_DDI-DrugBank.d737.s0.e3 false carbidopa/levodopa_0\NN\1740|:|influence (l_dep) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_nsubj) carbidopa/levodopa_2\NN\1740|
DDI-DrugBank.d737.s0.e0_DDI-DrugBank.d737.s0.e4 false carbidopa/levodopa_0\NN\1740|:|influence (l_dep) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_dobj) pharmacokinetics_7\NNS\6054892|the|pramipexole|volunteers (l_nmod) pramipexole_9\NN\1740|of
DDI-DrugBank.d737.s0.e1_DDI-DrugBank.d737.s0.e2 false carbidopa/levodopa_0\NN\1740|:|influence (l_dep) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_nsubj) carbidopa/levodopa_2\NN\1740|
DDI-DrugBank.d737.s0.e1_DDI-DrugBank.d737.s0.e3 false carbidopa/levodopa_0\NN\1740|:|influence (l_dep) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_nsubj) carbidopa/levodopa_2\NN\1740|
DDI-DrugBank.d737.s0.e1_DDI-DrugBank.d737.s0.e4 false carbidopa/levodopa_0\NN\1740|:|influence (l_dep) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_dobj) pharmacokinetics_7\NNS\6054892|the|pramipexole|volunteers (l_nmod) pramipexole_9\NN\1740|of
DDI-DrugBank.d737.s0.e2_DDI-DrugBank.d737.s0.e3 false carbidopa/levodopa_2\NN\1740|
DDI-DrugBank.d737.s0.e2_DDI-DrugBank.d737.s0.e4 false carbidopa/levodopa_2\NN\1740| (r_nsubj) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_dobj) pharmacokinetics_7\NNS\6054892|the|pramipexole|volunteers (l_nmod) pramipexole_9\NN\1740|of
DDI-DrugBank.d737.s0.e3_DDI-DrugBank.d737.s0.e4 false carbidopa/levodopa_2\NN\1740| (r_nsubj) influence_5\VB\137313|carbidopa/levodopa|does|not|pharmacokinetics|. (l_dobj) pharmacokinetics_7\NNS\6054892|the|pramipexole|volunteers (l_nmod) pramipexole_9\NN\1740|of
DDI-DrugBank.d761.s2
DDI-DrugBank.d761.s2.e0_DDI-DrugBank.d761.s2.e3 false digoxin_0\NN\15060131| (r_dep) alter_21\VB\126264|digoxin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_23\NNS\6054892|the|dose (l_nmod) dose_27\NN\3740161|of|a|single|digoxin (l_nmod) digoxin_29\NN\15060131|of
DDI-DrugBank.d761.s2.e0_DDI-DrugBank.d761.s2.e1 false digoxin_0\NN\15060131| (r_dep) alter_21\VB\126264|digoxin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nmod) subjects_5\NNS\6598915|in|12|normal-weight|receiving (l_acl) receiving_6\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_7\NN\1740|
DDI-DrugBank.d761.s2.e0_DDI-DrugBank.d761.s2.e2 false digoxin_0\NN\15060131| (r_dep) alter_21\VB\126264|digoxin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_18\NN\1740|
DDI-DrugBank.d761.s2.e3_DDI-DrugBank.d761.s2.e1 false digoxin_29\NN\15060131|of (r_nmod) dose_27\NN\3740161|of|a|single|digoxin (r_nmod) pharmacokinetics_23\NNS\6054892|the|dose (r_dobj) alter_21\VB\126264|digoxin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nmod) subjects_5\NNS\6598915|in|12|normal-weight|receiving (l_acl) receiving_6\VBG\2210855|xenical|mg|times|days (l_dobj) xenical_7\NN\1740|
DDI-DrugBank.d761.s2.e3_DDI-DrugBank.d761.s2.e2 false digoxin_29\NN\15060131|of (r_nmod) dose_27\NN\3740161|of|a|single|digoxin (r_nmod) pharmacokinetics_23\NNS\6054892|the|dose (r_dobj) alter_21\VB\126264|digoxin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_18\NN\1740|
DDI-DrugBank.d761.s2.e1_DDI-DrugBank.d761.s2.e2 false xenical_7\NN\1740| (r_dobj) receiving_6\VBG\2210855|xenical|mg|times|days (r_acl) subjects_5\NNS\6598915|in|12|normal-weight|receiving (r_nmod) alter_21\VB\126264|digoxin|:|subjects|,|xenical|did|not|pharmacokinetics|. (l_nsubj) xenical_18\NN\1740|
DDI-DrugBank.d704.s5
DDI-DrugBank.d704.s5.e0_DDI-DrugBank.d704.s5.e1 false hci_13\NN\1740|between|tamsulosin|and|warfarin (l_conj) warfarin_15\NN\2718259|
DDI-DrugBank.d737.s6
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e1 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) ranitidine_28\NN\14778019|
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e2 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) diltiazem_30\NN\2938514|
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e3 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) triamterene_32\NN\1740|
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e4 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) verapamil_34\NN\2938514|
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e5 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinidine_36\NN\2715941|
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e6 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinine_39\NN\2721948|
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e7 true cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_dobj) clearance_44\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_46\NN\1740|of
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e8 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e0_DDI-DrugBank.d737.s6.e9 false cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e2 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) diltiazem_30\NN\2938514|
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e3 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) triamterene_32\NN\1740|
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e4 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) verapamil_34\NN\2938514|
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e5 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinidine_36\NN\2715941|
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e6 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinine_39\NN\2721948|
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e7 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_dobj) clearance_44\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_46\NN\1740|of
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e8 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e1_DDI-DrugBank.d737.s6.e9 false ranitidine_28\NN\14778019| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e2_DDI-DrugBank.d737.s6.e3 false diltiazem_30\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) triamterene_32\NN\1740|
DDI-DrugBank.d737.s6.e2_DDI-DrugBank.d737.s6.e4 false diltiazem_30\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) verapamil_34\NN\2938514|
DDI-DrugBank.d737.s6.e2_DDI-DrugBank.d737.s6.e5 false diltiazem_30\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinidine_36\NN\2715941|
DDI-DrugBank.d737.s6.e2_DDI-DrugBank.d737.s6.e6 false diltiazem_30\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinine_39\NN\2721948|
DDI-DrugBank.d737.s6.e2_DDI-DrugBank.d737.s6.e7 false diltiazem_30\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_dobj) clearance_44\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_46\NN\1740|of
DDI-DrugBank.d737.s6.e2_DDI-DrugBank.d737.s6.e8 false diltiazem_30\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e2_DDI-DrugBank.d737.s6.e9 false diltiazem_30\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e3_DDI-DrugBank.d737.s6.e4 false triamterene_32\NN\1740| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) verapamil_34\NN\2938514|
DDI-DrugBank.d737.s6.e3_DDI-DrugBank.d737.s6.e5 false triamterene_32\NN\1740| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinidine_36\NN\2715941|
DDI-DrugBank.d737.s6.e3_DDI-DrugBank.d737.s6.e6 false triamterene_32\NN\1740| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinine_39\NN\2721948|
DDI-DrugBank.d737.s6.e3_DDI-DrugBank.d737.s6.e7 false triamterene_32\NN\1740| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_dobj) clearance_44\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_46\NN\1740|of
DDI-DrugBank.d737.s6.e3_DDI-DrugBank.d737.s6.e8 false triamterene_32\NN\1740| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e3_DDI-DrugBank.d737.s6.e9 false triamterene_32\NN\1740| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e4_DDI-DrugBank.d737.s6.e5 false verapamil_34\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinidine_36\NN\2715941|
DDI-DrugBank.d737.s6.e4_DDI-DrugBank.d737.s6.e6 false verapamil_34\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinine_39\NN\2721948|
DDI-DrugBank.d737.s6.e4_DDI-DrugBank.d737.s6.e7 false verapamil_34\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_dobj) clearance_44\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_46\NN\1740|of
DDI-DrugBank.d737.s6.e4_DDI-DrugBank.d737.s6.e8 false verapamil_34\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e4_DDI-DrugBank.d737.s6.e9 false verapamil_34\NN\2938514| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e5_DDI-DrugBank.d737.s6.e6 false quinidine_36\NN\2715941| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (l_conj) quinine_39\NN\2721948|
DDI-DrugBank.d737.s6.e5_DDI-DrugBank.d737.s6.e7 false quinidine_36\NN\2715941| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_dobj) clearance_44\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_46\NN\1740|of
DDI-DrugBank.d737.s6.e5_DDI-DrugBank.d737.s6.e8 false quinidine_36\NN\2715941| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e5_DDI-DrugBank.d737.s6.e9 false quinidine_36\NN\2715941| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e6_DDI-DrugBank.d737.s6.e7 false quinine_39\NN\2721948| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_dobj) clearance_44\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_46\NN\1740|of
DDI-DrugBank.d737.s6.e6_DDI-DrugBank.d737.s6.e8 false quinine_39\NN\2721948| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e6_DDI-DrugBank.d737.s6.e9 false quinine_39\NN\2721948| (r_conj) cimetidine_26\NN\14778019|(|e.g.|,|,|ranitidine|,|diltiazem|,|triamterene|,|verapamil|,|quinidine|,|and|quinine|) (r_nmod) secreted_17\VBN\67999|that|are|system|cimetidine (r_acl:relcl) drugs_14\NNS\14778436|of|secreted (r_nmod) coadministration_12\NN\1740|drugs (r_nsubj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e7_DDI-DrugBank.d737.s6.e8 false pramipexole_46\NN\1740|of (r_nmod) clearance_44\NN\5089947|the|oral|pramipexole (r_dobj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|)
DDI-DrugBank.d737.s6.e7_DDI-DrugBank.d737.s6.e9 false pramipexole_46\NN\1740|of (r_nmod) clearance_44\NN\5089947|the|oral|pramipexole (r_dobj) decreases_41\VBZ\169651|that|coadministration|clearance|%|,|likely (l_advcl) likely_75\JJ\1740|while|those|are|have (l_nsubj) those_53\DT\1740|secreted|cephalosporins (l_dep) cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d737.s6.e8_DDI-DrugBank.d737.s6.e9 false cephalosporins_63\NNS\2716866|(|e.g.|,|,|penicillins|,|indomethacin|,|hydrochlorothiazide|,|and|chlorpropamide|) (l_conj) penicillins_65\NNS\2716866|
DDI-DrugBank.d629.s0
DDI-DrugBank.d629.s0.e0_DDI-DrugBank.d629.s0.e2 true metronidazole_1\NN\2723292|oral (r_nsubjpass) reported_4\VBN\831651|metronidazole|has|been|potentiate|. (l_xcomp) potentiate_6\VB\229605|to|effect|,|resulting (l_dobj) effect_9\NN\34213|the|anticoagulant|coumarin (l_nmod) coumarin_11\NN\1740|of|and|warfarin (l_conj) warfarin_13\NN\2718259|
DDI-DrugBank.d629.s0.e0_DDI-DrugBank.d629.s0.e1 true metronidazole_1\NN\2723292|oral (r_nsubjpass) reported_4\VBN\831651|metronidazole|has|been|potentiate|. (l_xcomp) potentiate_6\VB\229605|to|effect|,|resulting (l_dobj) effect_9\NN\34213|the|anticoagulant|coumarin (l_nmod) coumarin_11\NN\1740|of|and|warfarin
DDI-DrugBank.d629.s0.e2_DDI-DrugBank.d629.s0.e1 false warfarin_13\NN\2718259| (r_conj) coumarin_11\NN\1740|of|and|warfarin
DDI-DrugBank.d725.s2
DDI-DrugBank.d632.s2
DDI-DrugBank.d584.s6
DDI-DrugBank.d584.s6.e0_DDI-DrugBank.d584.s6.e1 true oxandrolone_1\NN\1740| (r_compound) therapy_2\NN\657604|oxandrolone (r_nsubjpass) initiated_4\VBN\1617192|when|therapy|is|patient (l_nmod) patient_7\NN\9898892|in|a|receiving (l_acl) receiving_9\VBG\2210855|already|treatment (l_dobj) treatment_10\NN\654885|warfarin (l_nmod) warfarin_12\NN\2718259|with
DDI-DrugBank.d584.s6.e0_DDI-DrugBank.d584.s6.e2 false oxandrolone_1\NN\1740| (r_compound) therapy_2\NN\657604|oxandrolone (r_nsubjpass) initiated_4\VBN\1617192|when|therapy|is|patient (r_advcl) monitored_24\VBN\2169352|initiated|,|inr|should|be|closely|and|adjusted|. (l_conj) adjusted_31\VBN\126264|dose|as|achieved (l_nsubj) dose_28\NN\3740161|the|warfarin (l_nmod) warfarin_30\NN\2718259|of
DDI-DrugBank.d584.s6.e1_DDI-DrugBank.d584.s6.e2 false warfarin_12\NN\2718259|with (r_nmod) treatment_10\NN\654885|warfarin (r_dobj) receiving_9\VBG\2210855|already|treatment (r_acl) patient_7\NN\9898892|in|a|receiving (r_nmod) initiated_4\VBN\1617192|when|therapy|is|patient (r_advcl) monitored_24\VBN\2169352|initiated|,|inr|should|be|closely|and|adjusted|. (l_conj) adjusted_31\VBN\126264|dose|as|achieved (l_nsubj) dose_28\NN\3740161|the|warfarin (l_nmod) warfarin_30\NN\2718259|of
DDI-DrugBank.d776.s1
DDI-DrugBank.d628.s7
DDI-DrugBank.d628.s7.e0_DDI-DrugBank.d628.s7.e1 false relaxants_21\NNS\3247620|of|muscle|,|agents|) (l_conj) agents_24\NNS\7347|inhalational|,|agents (l_conj) agents_27\NNS\7347|analgesic|,|and|agents
DDI-DrugBank.d628.s7.e0_DDI-DrugBank.d628.s7.e2 false relaxants_21\NNS\3247620|of|muscle|,|agents|) (l_conj) agents_24\NNS\7347|inhalational|,|agents (l_conj) agents_27\NNS\7347|analgesic|,|and|agents (l_conj) agents_32\NNS\7347|local|anesthetic
DDI-DrugBank.d628.s7.e1_DDI-DrugBank.d628.s7.e2 false agents_27\NNS\7347|analgesic|,|and|agents (l_conj) agents_32\NNS\7347|local|anesthetic
DDI-DrugBank.d572.s7
DDI-DrugBank.d572.s7.e0_DDI-DrugBank.d572.s7.e1 false gemfibrozil_0\NN\3740161| (r_dep) increased_10\VBD\169651|gemfibrozil|:|study|,|administration|concentrations|1.7-fold|. (l_nsubj) administration_9\NN\1133281|concomitant|gemfibrozil (l_compound) gemfibrozil_8\NN\3740161|
DDI-DrugBank.d572.s7.e0_DDI-DrugBank.d572.s7.e2 false gemfibrozil_0\NN\3740161| (r_dep) increased_10\VBD\169651|gemfibrozil|:|study|,|administration|concentrations|1.7-fold|. (l_dobj) concentrations_13\NNS\4916342|total|ezetimibe (l_compound) ezetimibe_12\NN\1740|
DDI-DrugBank.d572.s7.e1_DDI-DrugBank.d572.s7.e2 false gemfibrozil_8\NN\3740161| (r_compound) administration_9\NN\1133281|concomitant|gemfibrozil (r_nsubj) increased_10\VBD\169651|gemfibrozil|:|study|,|administration|concentrations|1.7-fold|. (l_dobj) concentrations_13\NNS\4916342|total|ezetimibe (l_compound) ezetimibe_12\NN\1740|
DDI-DrugBank.d578.s0
DDI-DrugBank.d721.s4
DDI-DrugBank.d721.s4.e0_DDI-DrugBank.d721.s4.e1 false tiludronate_5\NNP\1740| (r_nsubj) displace_8\VB\1850315|that|tiludronate|does|not|warfarin|site (l_dobj) warfarin_9\NNP\2718259|
DDI-DrugBank.d645.s5
DDI-DrugBank.d645.s5.e0_DDI-DrugBank.d645.s5.e1 true terbinafine_0\NN\2720201| (r_nsubj) increases_1\VBZ\169651|terbinafine|clearance|%|. (l_dobj) clearance_3\NN\5089947|the|cyclosporine (l_nmod) cyclosporine_5\NN\1740|of
DDI-DrugBank.d693.s3
DDI-DrugBank.d665.s6
DDI-DrugBank.d665.s6.e1_DDI-DrugBank.d665.s6.e0 false probenecid_10\NN\3740161|of|blocks (r_nmod) administration_8\NN\1133281|by|concurrent|probenecid (r_nmod) prolonged_5\VBN\317700|levels|may|be|administration|. (l_nsubjpass) levels_2\NNS\4916342|penicillin|blood (l_compound) penicillin_0\NN\2716866|
DDI-DrugBank.d665.s6.e1_DDI-DrugBank.d665.s6.e2 false probenecid_10\NN\3740161|of|blocks (l_acl:relcl) blocks_12\VBZ\1476483|which|secretion (l_dobj) secretion_16\NN\13526110|the|renal|tubular|penicillins (l_nmod) penicillins_18\NNS\2716866|of
DDI-DrugBank.d665.s6.e0_DDI-DrugBank.d665.s6.e2 false penicillin_0\NN\2716866| (r_compound) levels_2\NNS\4916342|penicillin|blood (r_nsubjpass) prolonged_5\VBN\317700|levels|may|be|administration|. (l_nmod) administration_8\NN\1133281|by|concurrent|probenecid (l_nmod) probenecid_10\NN\3740161|of|blocks (l_acl:relcl) blocks_12\VBZ\1476483|which|secretion (l_dobj) secretion_16\NN\13526110|the|renal|tubular|penicillins (l_nmod) penicillins_18\NNS\2716866|of
DDI-DrugBank.d615.s2
DDI-DrugBank.d753.s4
DDI-DrugBank.d753.s4.e0_DDI-DrugBank.d753.s4.e1 true cimetidine_23\NN\14778019|of (r_nmod) coadministration_21\NN\1740|following|cimetidine|analgesics (l_nmod) analgesics_26\NNS\3740161|with|opioid
DDI-DrugBank.d680.s2
DDI-DrugBank.d597.s17
DDI-DrugBank.d597.s17.e0_DDI-DrugBank.d597.s17.e1 false furosemide_0\NN\3214670|:|affected (l_dep) affected_11\VBN\126264|pharmacodynamics|are|not|doses|. (l_nmod) doses_14\NNS\3740161|by|multiple|meloxicam (l_nmod) meloxicam_16\NN\1740|of
DDI-DrugBank.d596.s1
DDI-DrugBank.d597.s1
DDI-DrugBank.d597.s1.e0_DDI-DrugBank.d597.s1.e1 true nsaids_9\NNS\2721538| (r_dobj) taking_8\VBG\2367363|nsaids|inhibitors (l_nmod) inhibitors_13\NNS\20090|with|ace
DDI-DrugBank.d638.s5
DDI-DrugBank.d638.s5.e0_DDI-DrugBank.d638.s5.e1 false methylphenidate_4\NN\4320126| (r_dobj) using_3\VBG\1156834|of|methylphenidate|combination (l_nmod) combination_6\NN\7951464|in|clonidine (l_nmod) clonidine_8\NN\2721160|with|or|agonists
DDI-DrugBank.d638.s5.e0_DDI-DrugBank.d638.s5.e2 false methylphenidate_4\NN\4320126| (r_dobj) using_3\VBG\1156834|of|methylphenidate|combination (l_nmod) combination_6\NN\7951464|in|clonidine (l_nmod) clonidine_8\NN\2721160|with|or|agonists (l_conj) agonists_14\NNS\9613191|other|acting|alpha-2
DDI-DrugBank.d638.s5.e1_DDI-DrugBank.d638.s5.e2 false clonidine_8\NN\2721160|with|or|agonists (l_conj) agonists_14\NNS\9613191|other|acting|alpha-2
DDI-DrugBank.d675.s6
DDI-DrugBank.d689.s2
DDI-DrugBank.d746.s1
DDI-DrugBank.d746.s1.e0_DDI-DrugBank.d746.s1.e1 false inhibitors_2\NNS\20090|monoamine|oxidase|or|antidepressants (l_conj) antidepressants_5\NNS\3740161|tricyclic
DDI-DrugBank.d746.s1.e0_DDI-DrugBank.d746.s1.e2 true inhibitors_2\NNS\20090|monoamine|oxidase|or|antidepressants (r_nsubj) potentiate_7\VB\229605|inhibitors|may|action|. (l_dobj) action_9\NN\30358|the|amines (l_nmod) amines_12\NNS\14951377|of|sympathomimetic
DDI-DrugBank.d746.s1.e1_DDI-DrugBank.d746.s1.e2 true antidepressants_5\NNS\3740161|tricyclic (r_conj) inhibitors_2\NNS\20090|monoamine|oxidase|or|antidepressants (r_nsubj) potentiate_7\VB\229605|inhibitors|may|action|. (l_dobj) action_9\NN\30358|the|amines (l_nmod) amines_12\NNS\14951377|of|sympathomimetic
DDI-DrugBank.d763.s1
DDI-DrugBank.d763.s1.e0_DDI-DrugBank.d763.s1.e1 false ondansetron_1\NN\1740| (r_nsubjpass) metabolized_3\VBN\1740|because|ondansetron|is|enzymes (r_advcl) change_25\VB\46534|metabolized|,|inducers|may|clearance|. (l_dobj) clearance_27\NN\5089947|the|and|,|hence|,|half-life (l_conj) half-life_33\NN\15113229|the|ondansetron (l_nmod) ondansetron_35\NN\1740|of
DDI-DrugBank.d742.s8
DDI-DrugBank.d742.s8.e1_DDI-DrugBank.d742.s8.e0 false alcohol_21\NN\7881800|by (r_nmod) produced_19\VBN\1617192|alcohol (r_acl) those_18\DT\1740|with|produced (r_nmod) additive_16\JJ\1740|to|be|those (r_xcomp) shown_13\VBN\2137132|however|,|impairment|were|additive|. (l_nsubjpass) impairment_3\NN\7296428|the|skills (l_nmod) skills_8\NNS\5616246|of|cognitive|produced (l_acl) produced_9\VBN\1617192|remeron (l_nmod) remeron_11\NNP\1740|by
DDI-DrugBank.d752.s8
DDI-DrugBank.d597.s3
DDI-DrugBank.d746.s0
DDI-DrugBank.d746.s0.e0_DDI-DrugBank.d746.s0.e1 false aramine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|aramine|should|be|caution|patients|,|cause|. (l_advcl) cause_19\VB\1617192|since|combination|may|arrhythmias (l_nsubj) combination_12\NN\7951464|the|digitalis (l_nmod) digitalis_14\NN\15059939|of|and|amines
DDI-DrugBank.d746.s0.e0_DDI-DrugBank.d746.s0.e2 false aramine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|aramine|should|be|caution|patients|,|cause|. (l_advcl) cause_19\VB\1617192|since|combination|may|arrhythmias (l_nsubj) combination_12\NN\7951464|the|digitalis (l_nmod) digitalis_14\NN\15059939|of|and|amines (l_conj) amines_17\NNS\14951377|sympathomimetic
DDI-DrugBank.d746.s0.e1_DDI-DrugBank.d746.s0.e2 true digitalis_14\NN\15059939|of|and|amines (l_conj) amines_17\NNS\14951377|sympathomimetic
DDI-DrugBank.d752.s1
DDI-DrugBank.d752.s1.e0_DDI-DrugBank.d752.s1.e1 false erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) diltiazem_5\NN\2938514|
DDI-DrugBank.d752.s1.e0_DDI-DrugBank.d752.s1.e2 false erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) verapamil_7\NN\2938514|
DDI-DrugBank.d752.s1.e0_DDI-DrugBank.d752.s1.e3 false erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) ketoconazole_9\NN\1740|
DDI-DrugBank.d752.s1.e0_DDI-DrugBank.d752.s1.e4 false erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) fluconazole_11\NN\1740|
DDI-DrugBank.d752.s1.e0_DDI-DrugBank.d752.s1.e5 false erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) itraconazole_13\NN\2720201|
DDI-DrugBank.d752.s1.e0_DDI-DrugBank.d752.s1.e6 true erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (r_nmod) drugs_0\NNS\14778436|erythromycin (r_nsubjpass) shown_15\VBN\2137132|drugs|were|increase|. (l_xcomp) increase_18\VB\169651|to|significantly|max (l_dobj) max_21\NN\3414814|the|c|and|auc|midazolam (l_nmod) midazolam_27\NN\2830852|of|administered
DDI-DrugBank.d752.s1.e1_DDI-DrugBank.d752.s1.e2 false diltiazem_5\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) verapamil_7\NN\2938514|
DDI-DrugBank.d752.s1.e1_DDI-DrugBank.d752.s1.e3 false diltiazem_5\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) ketoconazole_9\NN\1740|
DDI-DrugBank.d752.s1.e1_DDI-DrugBank.d752.s1.e4 false diltiazem_5\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) fluconazole_11\NN\1740|
DDI-DrugBank.d752.s1.e1_DDI-DrugBank.d752.s1.e5 false diltiazem_5\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) itraconazole_13\NN\2720201|
DDI-DrugBank.d752.s1.e1_DDI-DrugBank.d752.s1.e6 false diltiazem_5\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (r_nmod) drugs_0\NNS\14778436|erythromycin (r_nsubjpass) shown_15\VBN\2137132|drugs|were|increase|. (l_xcomp) increase_18\VB\169651|to|significantly|max (l_dobj) max_21\NN\3414814|the|c|and|auc|midazolam (l_nmod) midazolam_27\NN\2830852|of|administered
DDI-DrugBank.d752.s1.e2_DDI-DrugBank.d752.s1.e3 false verapamil_7\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) ketoconazole_9\NN\1740|
DDI-DrugBank.d752.s1.e2_DDI-DrugBank.d752.s1.e4 false verapamil_7\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) fluconazole_11\NN\1740|
DDI-DrugBank.d752.s1.e2_DDI-DrugBank.d752.s1.e5 false verapamil_7\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) itraconazole_13\NN\2720201|
DDI-DrugBank.d752.s1.e2_DDI-DrugBank.d752.s1.e6 false verapamil_7\NN\2938514| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (r_nmod) drugs_0\NNS\14778436|erythromycin (r_nsubjpass) shown_15\VBN\2137132|drugs|were|increase|. (l_xcomp) increase_18\VB\169651|to|significantly|max (l_dobj) max_21\NN\3414814|the|c|and|auc|midazolam (l_nmod) midazolam_27\NN\2830852|of|administered
DDI-DrugBank.d752.s1.e3_DDI-DrugBank.d752.s1.e4 false ketoconazole_9\NN\1740| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) fluconazole_11\NN\1740|
DDI-DrugBank.d752.s1.e3_DDI-DrugBank.d752.s1.e5 false ketoconazole_9\NN\1740| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) itraconazole_13\NN\2720201|
DDI-DrugBank.d752.s1.e3_DDI-DrugBank.d752.s1.e6 false ketoconazole_9\NN\1740| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (r_nmod) drugs_0\NNS\14778436|erythromycin (r_nsubjpass) shown_15\VBN\2137132|drugs|were|increase|. (l_xcomp) increase_18\VB\169651|to|significantly|max (l_dobj) max_21\NN\3414814|the|c|and|auc|midazolam (l_nmod) midazolam_27\NN\2830852|of|administered
DDI-DrugBank.d752.s1.e4_DDI-DrugBank.d752.s1.e5 false fluconazole_11\NN\1740| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (l_conj) itraconazole_13\NN\2720201|
DDI-DrugBank.d752.s1.e4_DDI-DrugBank.d752.s1.e6 false fluconazole_11\NN\1740| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (r_nmod) drugs_0\NNS\14778436|erythromycin (r_nsubjpass) shown_15\VBN\2137132|drugs|were|increase|. (l_xcomp) increase_18\VB\169651|to|significantly|max (l_dobj) max_21\NN\3414814|the|c|and|auc|midazolam (l_nmod) midazolam_27\NN\2830852|of|administered
DDI-DrugBank.d752.s1.e5_DDI-DrugBank.d752.s1.e6 false itraconazole_13\NN\2720201| (r_conj) erythromycin_3\NN\2716866|such|,|diltiazem|,|verapamil|,|ketoconazole|,|fluconazole|and|itraconazole (r_nmod) drugs_0\NNS\14778436|erythromycin (r_nsubjpass) shown_15\VBN\2137132|drugs|were|increase|. (l_xcomp) increase_18\VB\169651|to|significantly|max (l_dobj) max_21\NN\3414814|the|c|and|auc|midazolam (l_nmod) midazolam_27\NN\2830852|of|administered
DDI-DrugBank.d633.s14
DDI-DrugBank.d572.s37
DDI-DrugBank.d588.s13
DDI-DrugBank.d588.s13.e1_DDI-DrugBank.d588.s13.e0 false metolazone_2\NN\1740|,|as|diuretics|, (r_nsubj) affect_12\VB\126264|anticoagulants|:|metolazone|may|response|; (l_nsubj) anticoagulants_0\NNS\3740161|
DDI-DrugBank.d588.s13.e1_DDI-DrugBank.d588.s13.e2 false metolazone_2\NN\1740|,|as|diuretics|, (l_conj) diuretics_9\NNS\3247620|other|thiazide-like
DDI-DrugBank.d588.s13.e1_DDI-DrugBank.d588.s13.e3 true metolazone_2\NN\1740|,|as|diuretics|, (r_nsubj) affect_12\VB\126264|anticoagulants|:|metolazone|may|response|; (l_dobj) response_15\NN\11410625|the|hypoprothrombinemic|anticoagulants (l_nmod) anticoagulants_17\NNS\3740161|to
DDI-DrugBank.d588.s13.e0_DDI-DrugBank.d588.s13.e2 false anticoagulants_0\NNS\3740161| (r_nsubj) affect_12\VB\126264|anticoagulants|:|metolazone|may|response|; (l_nsubj) metolazone_2\NN\1740|,|as|diuretics|, (l_conj) diuretics_9\NNS\3247620|other|thiazide-like
DDI-DrugBank.d588.s13.e0_DDI-DrugBank.d588.s13.e3 false anticoagulants_0\NNS\3740161| (r_nsubj) affect_12\VB\126264|anticoagulants|:|metolazone|may|response|; (l_dobj) response_15\NN\11410625|the|hypoprothrombinemic|anticoagulants (l_nmod) anticoagulants_17\NNS\3740161|to
DDI-DrugBank.d588.s13.e2_DDI-DrugBank.d588.s13.e3 false diuretics_9\NNS\3247620|other|thiazide-like (r_conj) metolazone_2\NN\1740|,|as|diuretics|, (r_nsubj) affect_12\VB\126264|anticoagulants|:|metolazone|may|response|; (l_dobj) response_15\NN\11410625|the|hypoprothrombinemic|anticoagulants (l_nmod) anticoagulants_17\NNS\3740161|to
DDI-DrugBank.d741.s0
DDI-DrugBank.d741.s0.e0_DDI-DrugBank.d741.s0.e2 false methadone_12\NN\3808564| (r_dobj) receiving_11\VBG\2210855|concomitantly|methadone (r_acl) patients_9\NNS\9898892|of|18|chronic|c|receiving (r_nmod) study_3\NN\635850|in|a|pharmacokinetic|patients (r_nmod) associated_23\VBN\628491|study|,|treatment|was|increase|; (l_nmod) increase_27\NN\13576355|with|a|mean|%|auc (l_nmod) auc_33\NN\1740|in|methadone (l_compound) methadone_32\NN\3808564|
DDI-DrugBank.d741.s0.e0_DDI-DrugBank.d741.s0.e1 true methadone_12\NN\3808564| (r_dobj) receiving_11\VBG\2210855|concomitantly|methadone (r_acl) patients_9\NNS\9898892|of|18|chronic|c|receiving (r_nmod) study_3\NN\635850|in|a|pharmacokinetic|patients (r_nmod) associated_23\VBN\628491|study|,|treatment|was|increase|; (l_nsubjpass) treatment_14\NN\654885|peg-intron|weeks (l_nmod) peg-intron_16\NN\1740|with|weekly
DDI-DrugBank.d741.s0.e2_DDI-DrugBank.d741.s0.e1 false methadone_32\NN\3808564| (r_compound) auc_33\NN\1740|in|methadone (r_nmod) increase_27\NN\13576355|with|a|mean|%|auc (r_nmod) associated_23\VBN\628491|study|,|treatment|was|increase|; (l_nsubjpass) treatment_14\NN\654885|peg-intron|weeks (l_nmod) peg-intron_16\NN\1740|with|weekly
DDI-DrugBank.d645.s7
DDI-DrugBank.d645.s7.e0_DDI-DrugBank.d645.s7.e1 true terbinafine_0\NN\2720201| (r_compound) clearance_1\NN\5089947|terbinafine (r_nsubjpass) increased_3\VBN\169651|clearance|is|%|rifampin|,|and|decreased|. (l_nmod) rifampin_7\NN\2716205|by|,|inducer
DDI-DrugBank.d645.s7.e0_DDI-DrugBank.d645.s7.e2 true terbinafine_0\NN\2720201| (r_compound) clearance_1\NN\5089947|terbinafine (r_nsubjpass) increased_3\VBN\169651|clearance|is|%|rifampin|,|and|decreased|. (l_conj) decreased_15\VBN\169651|%|cimetidine (l_nmod) cimetidine_19\NN\14778019|by|,|inhibitor
DDI-DrugBank.d645.s7.e1_DDI-DrugBank.d645.s7.e2 false rifampin_7\NN\2716205|by|,|inducer (r_nmod) increased_3\VBN\169651|clearance|is|%|rifampin|,|and|decreased|. (l_conj) decreased_15\VBN\169651|%|cimetidine (l_nmod) cimetidine_19\NN\14778019|by|,|inhibitor
DDI-DrugBank.d756.s3
DDI-DrugBank.d591.s1
DDI-DrugBank.d769.s2
DDI-DrugBank.d769.s2.e3_DDI-DrugBank.d769.s2.e1 false acid_24\NN\14818238|e.g.|,|valproic|) (r_nmod) inhibitors_19\NNS\20090|other|hdac|(|acid (r_conj) zolinza_15\NN\1740|of|and|inhibitors
DDI-DrugBank.d769.s2.e3_DDI-DrugBank.d769.s2.e0 false acid_24\NN\14818238|e.g.|,|valproic|) (r_nmod) inhibitors_19\NNS\20090|other|hdac|(|acid (r_conj) zolinza_15\NN\1740|of|and|inhibitors (r_nmod) use_13\NN\407535|with|concomitant|zolinza (r_nmod) reported_10\VBN\831651|inhibitors|have|been|use|. (l_nsubjpass) inhibitors_2\NNS\20090|other|hdac|thrombocytopenia
DDI-DrugBank.d769.s2.e3_DDI-DrugBank.d769.s2.e2 false acid_24\NN\14818238|e.g.|,|valproic|) (r_nmod) inhibitors_19\NNS\20090|other|hdac|(|acid
DDI-DrugBank.d769.s2.e1_DDI-DrugBank.d769.s2.e0 false zolinza_15\NN\1740|of|and|inhibitors (r_nmod) use_13\NN\407535|with|concomitant|zolinza (r_nmod) reported_10\VBN\831651|inhibitors|have|been|use|. (l_nsubjpass) inhibitors_2\NNS\20090|other|hdac|thrombocytopenia
DDI-DrugBank.d769.s2.e1_DDI-DrugBank.d769.s2.e2 true zolinza_15\NN\1740|of|and|inhibitors (l_conj) inhibitors_19\NNS\20090|other|hdac|(|acid
DDI-DrugBank.d769.s2.e0_DDI-DrugBank.d769.s2.e2 false inhibitors_2\NNS\20090|other|hdac|thrombocytopenia (r_nsubjpass) reported_10\VBN\831651|inhibitors|have|been|use|. (l_nmod) use_13\NN\407535|with|concomitant|zolinza (l_nmod) zolinza_15\NN\1740|of|and|inhibitors (l_conj) inhibitors_19\NNS\20090|other|hdac|(|acid
DDI-DrugBank.d647.s1
DDI-DrugBank.d647.s1.e0_DDI-DrugBank.d647.s1.e1 true streptozocin_0\NN\1740| (r_nsubjpass) reported_3\VBN\831651|streptozocin|has|been|prolong|; (l_xcomp) prolong_5\VB\317700|to|half-life|and|lead (l_dobj) half-life_8\NN\15113229|the|elimination|doxorubicin (l_nmod) doxorubicin_10\NN\2716866|of
DDI-DrugBank.d597.s20
DDI-DrugBank.d597.s20.e0_DDI-DrugBank.d597.s20.e1 false lithium_10\NN\14625458| (r_compound) concentration_11\NN\4916342|mean|pre-dose|lithium|and|auc (r_nsubjpass) increased_15\VBN\169651|study|,|concentration|were|%|subjects|compared|. (l_nmod) subjects_20\NNS\6598915|in|receiving (l_acl) receiving_21\VBG\2210855|doses (l_dobj) doses_23\NNS\3740161|lithium|ranging (l_compound) lithium_22\NN\14625458|
DDI-DrugBank.d597.s20.e0_DDI-DrugBank.d597.s20.e2 false lithium_10\NN\14625458| (r_compound) concentration_11\NN\4916342|mean|pre-dose|lithium|and|auc (r_nsubjpass) increased_15\VBN\169651|study|,|concentration|were|%|subjects|compared|. (l_nmod) subjects_20\NNS\6598915|in|receiving (l_acl) receiving_21\VBG\2210855|doses (l_dobj) doses_23\NNS\3740161|lithium|ranging (l_acl) ranging_24\VBG\2604760|mg|qd (l_nmod) qd_35\NN\1740|with|meloxicam|mg (l_compound) meloxicam_32\NN\1740|
DDI-DrugBank.d597.s20.e0_DDI-DrugBank.d597.s20.e3 false lithium_10\NN\14625458| (r_compound) concentration_11\NN\4916342|mean|pre-dose|lithium|and|auc (r_nsubjpass) increased_15\VBN\169651|study|,|concentration|were|%|subjects|compared|. (l_advcl) compared_37\VBN\644583|as|subjects (l_nmod) subjects_39\NNS\6598915|to|receiving (l_acl) receiving_40\VBG\2210855|lithium (l_dobj) lithium_41\NN\14625458|alone
DDI-DrugBank.d597.s20.e1_DDI-DrugBank.d597.s20.e2 true lithium_22\NN\14625458| (r_compound) doses_23\NNS\3740161|lithium|ranging (l_acl) ranging_24\VBG\2604760|mg|qd (l_nmod) qd_35\NN\1740|with|meloxicam|mg (l_compound) meloxicam_32\NN\1740|
DDI-DrugBank.d597.s20.e1_DDI-DrugBank.d597.s20.e3 false lithium_22\NN\14625458| (r_compound) doses_23\NNS\3740161|lithium|ranging (r_dobj) receiving_21\VBG\2210855|doses (r_acl) subjects_20\NNS\6598915|in|receiving (r_nmod) increased_15\VBN\169651|study|,|concentration|were|%|subjects|compared|. (l_advcl) compared_37\VBN\644583|as|subjects (l_nmod) subjects_39\NNS\6598915|to|receiving (l_acl) receiving_40\VBG\2210855|lithium (l_dobj) lithium_41\NN\14625458|alone
DDI-DrugBank.d597.s20.e2_DDI-DrugBank.d597.s20.e3 false meloxicam_32\NN\1740| (r_compound) qd_35\NN\1740|with|meloxicam|mg (r_nmod) ranging_24\VBG\2604760|mg|qd (r_acl) doses_23\NNS\3740161|lithium|ranging (r_dobj) receiving_21\VBG\2210855|doses (r_acl) subjects_20\NNS\6598915|in|receiving (r_nmod) increased_15\VBN\169651|study|,|concentration|were|%|subjects|compared|. (l_advcl) compared_37\VBN\644583|as|subjects (l_nmod) subjects_39\NNS\6598915|to|receiving (l_acl) receiving_40\VBG\2210855|lithium (l_dobj) lithium_41\NN\14625458|alone
DDI-DrugBank.d572.s13
DDI-DrugBank.d631.s3
DDI-DrugBank.d631.s3.e0_DDI-DrugBank.d631.s3.e1 true lorazepam_9\NN\2830852|and|pyrimethamine (l_conj) pyrimethamine_11\NN\1740|
DDI-DrugBank.d780.s0
DDI-DrugBank.d780.s0.e1_DDI-DrugBank.d780.s0.e4 false hydrochloride_6\NN\14817592|of|procaine|and|agents (r_nmod) use_3\NN\407535|concurrent|hydrochloride (r_nsubj) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_advcl) inhibit_18\VBP\2510337|since|anticholinesterases|breakdown (l_dobj) breakdown_20\NN\553173|the|hydrochloride (l_nmod) hydrochloride_23\NN\14817592|of|procaine
DDI-DrugBank.d780.s0.e1_DDI-DrugBank.d780.s0.e0 false hydrochloride_6\NN\14817592|of|procaine|and|agents (r_nmod) use_3\NN\407535|concurrent|hydrochloride (r_nsubj) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_dep) anticholinesterases_0\NNS\3740161|
DDI-DrugBank.d780.s0.e1_DDI-DrugBank.d780.s0.e2 true hydrochloride_6\NN\14817592|of|procaine|and|agents (l_conj) agents_9\NNS\7347|anticholinesterase
DDI-DrugBank.d780.s0.e1_DDI-DrugBank.d780.s0.e3 false hydrochloride_6\NN\14817592|of|procaine|and|agents (r_nmod) use_3\NN\407535|concurrent|hydrochloride (r_nsubj) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_advcl) inhibit_18\VBP\2510337|since|anticholinesterases|breakdown (l_nsubj) anticholinesterases_17\NNS\3740161|
DDI-DrugBank.d780.s0.e4_DDI-DrugBank.d780.s0.e0 false hydrochloride_23\NN\14817592|of|procaine (r_nmod) breakdown_20\NN\553173|the|hydrochloride (r_dobj) inhibit_18\VBP\2510337|since|anticholinesterases|breakdown (r_advcl) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_dep) anticholinesterases_0\NNS\3740161|
DDI-DrugBank.d780.s0.e4_DDI-DrugBank.d780.s0.e2 false hydrochloride_23\NN\14817592|of|procaine (r_nmod) breakdown_20\NN\553173|the|hydrochloride (r_dobj) inhibit_18\VBP\2510337|since|anticholinesterases|breakdown (r_advcl) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_nsubj) use_3\NN\407535|concurrent|hydrochloride (l_nmod) hydrochloride_6\NN\14817592|of|procaine|and|agents (l_conj) agents_9\NNS\7347|anticholinesterase
DDI-DrugBank.d780.s0.e4_DDI-DrugBank.d780.s0.e3 false hydrochloride_23\NN\14817592|of|procaine (r_nmod) breakdown_20\NN\553173|the|hydrochloride (r_dobj) inhibit_18\VBP\2510337|since|anticholinesterases|breakdown (l_nsubj) anticholinesterases_17\NNS\3740161|
DDI-DrugBank.d780.s0.e0_DDI-DrugBank.d780.s0.e2 false anticholinesterases_0\NNS\3740161| (r_dep) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_nsubj) use_3\NN\407535|concurrent|hydrochloride (l_nmod) hydrochloride_6\NN\14817592|of|procaine|and|agents (l_conj) agents_9\NNS\7347|anticholinesterase
DDI-DrugBank.d780.s0.e0_DDI-DrugBank.d780.s0.e3 false anticholinesterases_0\NNS\3740161| (r_dep) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_advcl) inhibit_18\VBP\2510337|since|anticholinesterases|breakdown (l_nsubj) anticholinesterases_17\NNS\3740161|
DDI-DrugBank.d780.s0.e2_DDI-DrugBank.d780.s0.e3 false agents_9\NNS\7347|anticholinesterase (r_conj) hydrochloride_6\NN\14817592|of|procaine|and|agents (r_nmod) use_3\NN\407535|concurrent|hydrochloride (r_nsubj) result_11\VB\2633881|anticholinesterases|:|use|may|toxicity|inhibit|. (l_advcl) inhibit_18\VBP\2510337|since|anticholinesterases|breakdown (l_nsubj) anticholinesterases_17\NNS\3740161|
DDI-DrugBank.d627.s2
DDI-DrugBank.d613.s1
DDI-DrugBank.d613.s1.e0_DDI-DrugBank.d613.s1.e1 true vigabatrin_15\NN\1740| (r_dobj) administering_14\VBG\2436349|vigabatrin|phenytoin (l_nmod) phenytoin_17\NN\3550533|with
DDI-DrugBank.d613.s1.e0_DDI-DrugBank.d613.s1.e2 false vigabatrin_15\NN\1740| (r_dobj) administering_14\VBG\2436349|vigabatrin|phenytoin (r_csubj) lowered_18\VBD\1850315|that|administering|concentration (l_dobj) concentration_22\NN\4916342|the|serum|phenytoin|patients (l_compound) phenytoin_21\NN\3550533|
DDI-DrugBank.d613.s1.e1_DDI-DrugBank.d613.s1.e2 false phenytoin_17\NN\3550533|with (r_nmod) administering_14\VBG\2436349|vigabatrin|phenytoin (r_csubj) lowered_18\VBD\1850315|that|administering|concentration (l_dobj) concentration_22\NN\4916342|the|serum|phenytoin|patients (l_compound) phenytoin_21\NN\3550533|
DDI-DrugBank.d738.s1
DDI-DrugBank.d738.s1.e0_DDI-DrugBank.d738.s1.e1 false solifenacin_14\NN\1740|of (r_nmod) effect_12\NN\34213|of|the|solifenacin|interval (r_nmod) study_9\NN\635850|in|a|effect (r_nmod) appeared_28\VBD\2604760|patients|study|,|effect|less|,|and|appear|. (l_advmod) less_29\RBR\1740|solifenacin|mg|mg (l_nmod) solifenacin_31\NN\1740|with
DDI-DrugBank.d738.s1.e0_DDI-DrugBank.d738.s1.e2 false solifenacin_14\NN\1740|of (r_nmod) effect_12\NN\34213|of|the|solifenacin|interval (r_nmod) study_9\NN\635850|in|a|effect (r_nmod) appeared_28\VBD\2604760|patients|study|,|effect|less|,|and|appear|. (l_conj) appear_56\VB\2604760|effect|did|not|large (l_nsubj) effect_49\NN\34213|the|solifenacin|mg (l_nmod) solifenacin_51\NN\1740|of
DDI-DrugBank.d738.s1.e0_DDI-DrugBank.d738.s1.e3 false solifenacin_14\NN\1740|of (r_nmod) effect_12\NN\34213|of|the|solifenacin|interval (r_nmod) study_9\NN\635850|in|a|effect (r_nmod) appeared_28\VBD\2604760|patients|study|,|effect|less|,|and|appear|. (l_conj) appear_56\VB\2604760|effect|did|not|large (l_xcomp) large_58\JJ\1740|as|that (l_nmod) that_60\DT\1740|as|moxifloxacin (l_nmod) moxifloxacin_65\NN\1740|of|the|positive|control|dose
DDI-DrugBank.d738.s1.e1_DDI-DrugBank.d738.s1.e2 false solifenacin_31\NN\1740|with (r_nmod) less_29\RBR\1740|solifenacin|mg|mg (r_advmod) appeared_28\VBD\2604760|patients|study|,|effect|less|,|and|appear|. (l_conj) appear_56\VB\2604760|effect|did|not|large (l_nsubj) effect_49\NN\34213|the|solifenacin|mg (l_nmod) solifenacin_51\NN\1740|of
DDI-DrugBank.d738.s1.e1_DDI-DrugBank.d738.s1.e3 false solifenacin_31\NN\1740|with (r_nmod) less_29\RBR\1740|solifenacin|mg|mg (r_advmod) appeared_28\VBD\2604760|patients|study|,|effect|less|,|and|appear|. (l_conj) appear_56\VB\2604760|effect|did|not|large (l_xcomp) large_58\JJ\1740|as|that (l_nmod) that_60\DT\1740|as|moxifloxacin (l_nmod) moxifloxacin_65\NN\1740|of|the|positive|control|dose
DDI-DrugBank.d738.s1.e2_DDI-DrugBank.d738.s1.e3 false solifenacin_51\NN\1740|of (r_nmod) effect_49\NN\34213|the|solifenacin|mg (r_nsubj) appear_56\VB\2604760|effect|did|not|large (l_xcomp) large_58\JJ\1740|as|that (l_nmod) that_60\DT\1740|as|moxifloxacin (l_nmod) moxifloxacin_65\NN\1740|of|the|positive|control|dose
DDI-DrugBank.d721.s0
DDI-DrugBank.d721.s0.e1_DDI-DrugBank.d721.s0.e2 false calcium_9\NN\14625458|by (r_nmod) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_advcl) administered_16\VBN\2436349|when|calcium|are|time (l_nsubjpass) calcium_12\NN\14625458|and|skelid
DDI-DrugBank.d721.s0.e1_DDI-DrugBank.d721.s0.e4 false calcium_9\NN\14625458|by (r_nmod) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_nmod) antacids_30\NNS\14778436|by|some|magnesium-containing (l_det) some_26\DT\1740|aluminum- (l_punct) aluminum-_27\NN\1740|or
DDI-DrugBank.d721.s0.e1_DDI-DrugBank.d721.s0.e5 false calcium_9\NN\14625458|by (r_nmod) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_nmod) antacids_30\NNS\14778436|by|some|magnesium-containing (l_amod) magnesium-containing_29\NN\1740|
DDI-DrugBank.d721.s0.e1_DDI-DrugBank.d721.s0.e6 false calcium_9\NN\14625458|by (r_nmod) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_nmod) antacids_30\NNS\14778436|by|some|magnesium-containing
DDI-DrugBank.d721.s0.e1_DDI-DrugBank.d721.s0.e0 false calcium_9\NN\14625458|by (r_nmod) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_nsubjpass) bioavailability_1\NN\1740|the|skelid (l_nmod) skelid_3\NN\1740|of
DDI-DrugBank.d721.s0.e1_DDI-DrugBank.d721.s0.e3 false calcium_9\NN\14625458|by (r_nmod) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_advcl) administered_16\VBN\2436349|when|calcium|are|time (l_nsubjpass) calcium_12\NN\14625458|and|skelid (l_conj) skelid_14\NN\1740|
DDI-DrugBank.d721.s0.e1_DDI-DrugBank.d721.s0.e7 false calcium_9\NN\14625458|by (r_nmod) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_advcl) administered_33\VBN\2436349|when|skelid (l_nmod) skelid_37\NN\1740|hour|before
DDI-DrugBank.d721.s0.e2_DDI-DrugBank.d721.s0.e4 false calcium_12\NN\14625458|and|skelid (r_nsubjpass) administered_16\VBN\2436349|when|calcium|are|time (r_advcl) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_nmod) antacids_30\NNS\14778436|by|some|magnesium-containing (l_det) some_26\DT\1740|aluminum- (l_punct) aluminum-_27\NN\1740|or
DDI-DrugBank.d721.s0.e2_DDI-DrugBank.d721.s0.e5 false calcium_12\NN\14625458|and|skelid (r_nsubjpass) administered_16\VBN\2436349|when|calcium|are|time (r_advcl) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_nmod) antacids_30\NNS\14778436|by|some|magnesium-containing (l_amod) magnesium-containing_29\NN\1740|
DDI-DrugBank.d721.s0.e2_DDI-DrugBank.d721.s0.e6 false calcium_12\NN\14625458|and|skelid (r_nsubjpass) administered_16\VBN\2436349|when|calcium|are|time (r_advcl) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_nmod) antacids_30\NNS\14778436|by|some|magnesium-containing
DDI-DrugBank.d721.s0.e2_DDI-DrugBank.d721.s0.e0 false calcium_12\NN\14625458|and|skelid (r_nsubjpass) administered_16\VBN\2436349|when|calcium|are|time (r_advcl) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_nsubjpass) bioavailability_1\NN\1740|the|skelid (l_nmod) skelid_3\NN\1740|of
DDI-DrugBank.d721.s0.e2_DDI-DrugBank.d721.s0.e3 false calcium_12\NN\14625458|and|skelid (l_conj) skelid_14\NN\1740|
DDI-DrugBank.d721.s0.e2_DDI-DrugBank.d721.s0.e7 false calcium_12\NN\14625458|and|skelid (r_nsubjpass) administered_16\VBN\2436349|when|calcium|are|time (r_advcl) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_advcl) administered_33\VBN\2436349|when|skelid (l_nmod) skelid_37\NN\1740|hour|before
DDI-DrugBank.d721.s0.e4_DDI-DrugBank.d721.s0.e5 false aluminum-_27\NN\1740|or (r_punct) some_26\DT\1740|aluminum- (r_det) antacids_30\NNS\14778436|by|some|magnesium-containing (l_amod) magnesium-containing_29\NN\1740|
DDI-DrugBank.d721.s0.e4_DDI-DrugBank.d721.s0.e6 false aluminum-_27\NN\1740|or (r_punct) some_26\DT\1740|aluminum- (r_det) antacids_30\NNS\14778436|by|some|magnesium-containing
DDI-DrugBank.d721.s0.e4_DDI-DrugBank.d721.s0.e0 false aluminum-_27\NN\1740|or (r_punct) some_26\DT\1740|aluminum- (r_det) antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (r_conj) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_nsubjpass) bioavailability_1\NN\1740|the|skelid (l_nmod) skelid_3\NN\1740|of
DDI-DrugBank.d721.s0.e4_DDI-DrugBank.d721.s0.e3 false aluminum-_27\NN\1740|or (r_punct) some_26\DT\1740|aluminum- (r_det) antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (r_conj) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_advcl) administered_16\VBN\2436349|when|calcium|are|time (l_nsubjpass) calcium_12\NN\14625458|and|skelid (l_conj) skelid_14\NN\1740|
DDI-DrugBank.d721.s0.e4_DDI-DrugBank.d721.s0.e7 false aluminum-_27\NN\1740|or (r_punct) some_26\DT\1740|aluminum- (r_det) antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (l_advcl) administered_33\VBN\2436349|when|skelid (l_nmod) skelid_37\NN\1740|hour|before
DDI-DrugBank.d721.s0.e5_DDI-DrugBank.d721.s0.e6 false magnesium-containing_29\NN\1740| (r_amod) antacids_30\NNS\14778436|by|some|magnesium-containing
DDI-DrugBank.d721.s0.e5_DDI-DrugBank.d721.s0.e0 false magnesium-containing_29\NN\1740| (r_amod) antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (r_conj) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_nsubjpass) bioavailability_1\NN\1740|the|skelid (l_nmod) skelid_3\NN\1740|of
DDI-DrugBank.d721.s0.e5_DDI-DrugBank.d721.s0.e3 false magnesium-containing_29\NN\1740| (r_amod) antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (r_conj) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_advcl) administered_16\VBN\2436349|when|calcium|are|time (l_nsubjpass) calcium_12\NN\14625458|and|skelid (l_conj) skelid_14\NN\1740|
DDI-DrugBank.d721.s0.e5_DDI-DrugBank.d721.s0.e7 false magnesium-containing_29\NN\1740| (r_amod) antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (l_advcl) administered_33\VBN\2436349|when|skelid (l_nmod) skelid_37\NN\1740|hour|before
DDI-DrugBank.d721.s0.e6_DDI-DrugBank.d721.s0.e0 false antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (r_conj) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_nsubjpass) bioavailability_1\NN\1740|the|skelid (l_nmod) skelid_3\NN\1740|of
DDI-DrugBank.d721.s0.e6_DDI-DrugBank.d721.s0.e3 false antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (r_conj) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_advcl) administered_16\VBN\2436349|when|calcium|are|time (l_nsubjpass) calcium_12\NN\14625458|and|skelid (l_conj) skelid_14\NN\1740|
DDI-DrugBank.d721.s0.e6_DDI-DrugBank.d721.s0.e7 false antacids_30\NNS\14778436|by|some|magnesium-containing (r_nmod) %_24\NN\1740|60|antacids|,|administered (l_advcl) administered_33\VBN\2436349|when|skelid (l_nmod) skelid_37\NN\1740|hour|before
DDI-DrugBank.d721.s0.e0_DDI-DrugBank.d721.s0.e3 false skelid_3\NN\1740|of (r_nmod) bioavailability_1\NN\1740|the|skelid (r_nsubjpass) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_advcl) administered_16\VBN\2436349|when|calcium|are|time (l_nsubjpass) calcium_12\NN\14625458|and|skelid (l_conj) skelid_14\NN\1740|
DDI-DrugBank.d721.s0.e0_DDI-DrugBank.d721.s0.e7 false skelid_3\NN\1740|of (r_nmod) bioavailability_1\NN\1740|the|skelid (r_nsubjpass) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_advcl) administered_33\VBN\2436349|when|skelid (l_nmod) skelid_37\NN\1740|hour|before
DDI-DrugBank.d721.s0.e3_DDI-DrugBank.d721.s0.e7 false skelid_14\NN\1740| (r_conj) calcium_12\NN\14625458|and|skelid (r_nsubjpass) administered_16\VBN\2436349|when|calcium|are|time (r_advcl) decreased_5\VBN\169651|bioavailability|is|%|calcium|,|administered|,|and|%|. (l_conj) %_24\NN\1740|60|antacids|,|administered (l_advcl) administered_33\VBN\2436349|when|skelid (l_nmod) skelid_37\NN\1740|hour|before
DDI-DrugBank.d704.s6
DDI-DrugBank.d704.s6.e0_DDI-DrugBank.d704.s6.e1 true warfarin_10\NN\2718259|of|and|capsules (l_conj) capsules_13\NNS\3094503|flomax (l_compound) flomax_12\NN\1740|
DDI-DrugBank.d591.s4
DDI-DrugBank.d687.s0
DDI-DrugBank.d687.s0.e0_DDI-DrugBank.d687.s0.e1 true acid_3\NN\14818238|of|valproic (r_nmod) administration_0\NN\1133281|acid (r_nsubj) decreases_4\VBZ\169651|administration|clearance|%|. (l_dobj) clearance_6\NN\5089947|oral|temozolomide (l_nmod) temozolomide_8\NN\1740|of
DDI-DrugBank.d743.s8
DDI-DrugBank.d743.s8.e1_DDI-DrugBank.d743.s8.e2 false fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (l_conj) metronidazole_14\NN\2723292|
DDI-DrugBank.d743.s8.e1_DDI-DrugBank.d743.s8.e3 false fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (l_conj) miconazole_17\NN\2720201|
DDI-DrugBank.d743.s8.e1_DDI-DrugBank.d743.s8.e4 false fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) ketoconazole_20\NN\1740|to|,|and|itraconazole
DDI-DrugBank.d743.s8.e1_DDI-DrugBank.d743.s8.e5 false fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) ketoconazole_20\NN\1740|to|,|and|itraconazole (l_conj) itraconazole_23\NN\2720201|
DDI-DrugBank.d743.s8.e1_DDI-DrugBank.d743.s8.e6 false fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (r_nmod) recommended_34\VBN\875394|similarity|,|use|is|not|examination|. (l_nsubjpass) use_26\NN\407535|concomitant|products|terfenadine (l_nmod) terfenadine_31\NN\1740|with
DDI-DrugBank.d743.s8.e1_DDI-DrugBank.d743.s8.e0 false fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole
DDI-DrugBank.d743.s8.e2_DDI-DrugBank.d743.s8.e3 false metronidazole_14\NN\2723292| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (l_conj) miconazole_17\NN\2720201|
DDI-DrugBank.d743.s8.e2_DDI-DrugBank.d743.s8.e4 false metronidazole_14\NN\2723292| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) ketoconazole_20\NN\1740|to|,|and|itraconazole
DDI-DrugBank.d743.s8.e2_DDI-DrugBank.d743.s8.e5 false metronidazole_14\NN\2723292| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) ketoconazole_20\NN\1740|to|,|and|itraconazole (l_conj) itraconazole_23\NN\2720201|
DDI-DrugBank.d743.s8.e2_DDI-DrugBank.d743.s8.e6 false metronidazole_14\NN\2723292| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (r_nmod) recommended_34\VBN\875394|similarity|,|use|is|not|examination|. (l_nsubjpass) use_26\NN\407535|concomitant|products|terfenadine (l_nmod) terfenadine_31\NN\1740|with
DDI-DrugBank.d743.s8.e2_DDI-DrugBank.d743.s8.e0 false metronidazole_14\NN\2723292| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole
DDI-DrugBank.d743.s8.e3_DDI-DrugBank.d743.s8.e4 false miconazole_17\NN\2720201| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) ketoconazole_20\NN\1740|to|,|and|itraconazole
DDI-DrugBank.d743.s8.e3_DDI-DrugBank.d743.s8.e5 false miconazole_17\NN\2720201| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) ketoconazole_20\NN\1740|to|,|and|itraconazole (l_conj) itraconazole_23\NN\2720201|
DDI-DrugBank.d743.s8.e3_DDI-DrugBank.d743.s8.e6 false miconazole_17\NN\2720201| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (r_nmod) recommended_34\VBN\875394|similarity|,|use|is|not|examination|. (l_nsubjpass) use_26\NN\407535|concomitant|products|terfenadine (l_nmod) terfenadine_31\NN\1740|with
DDI-DrugBank.d743.s8.e3_DDI-DrugBank.d743.s8.e0 false miconazole_17\NN\2720201| (r_conj) fluconazole_12\NN\1740|including|,|metronidazole|,|and|miconazole|) (r_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole
DDI-DrugBank.d743.s8.e4_DDI-DrugBank.d743.s8.e5 false ketoconazole_20\NN\1740|to|,|and|itraconazole (l_conj) itraconazole_23\NN\2720201|
DDI-DrugBank.d743.s8.e4_DDI-DrugBank.d743.s8.e6 false ketoconazole_20\NN\1740|to|,|and|itraconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (r_nmod) recommended_34\VBN\875394|similarity|,|use|is|not|examination|. (l_nsubjpass) use_26\NN\407535|concomitant|products|terfenadine (l_nmod) terfenadine_31\NN\1740|with
DDI-DrugBank.d743.s8.e4_DDI-DrugBank.d743.s8.e0 false ketoconazole_20\NN\1740|to|,|and|itraconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole
DDI-DrugBank.d743.s8.e5_DDI-DrugBank.d743.s8.e6 false itraconazole_23\NN\2720201| (r_conj) ketoconazole_20\NN\1740|to|,|and|itraconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (r_nmod) recommended_34\VBN\875394|similarity|,|use|is|not|examination|. (l_nsubjpass) use_26\NN\407535|concomitant|products|terfenadine (l_nmod) terfenadine_31\NN\1740|with
DDI-DrugBank.d743.s8.e5_DDI-DrugBank.d743.s8.e0 false itraconazole_23\NN\2720201| (r_conj) ketoconazole_20\NN\1740|to|,|and|itraconazole (r_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole
DDI-DrugBank.d743.s8.e6_DDI-DrugBank.d743.s8.e0 false terfenadine_31\NN\1740|with (r_nmod) use_26\NN\407535|concomitant|products|terfenadine (r_nsubjpass) recommended_34\VBN\875394|similarity|,|use|is|not|examination|. (l_nmod) similarity_4\NN\4742535|due|the|chemical|agents|ketoconazole (l_nmod) agents_9\NNS\7347|of|other|azole-type|antifungal|(|fluconazole
DDI-DrugBank.d637.s1
DDI-DrugBank.d637.s1.e1_DDI-DrugBank.d637.s1.e0 false morphine_7\NN\2707683|with|oral (r_nmod) conjunction_4\NN\5048123|in|morphine (r_nmod) use_0\NN\407535|neuroleptics|conjunction (l_nmod) neuroleptics_2\NNS\4470232|of
DDI-DrugBank.d597.s8
DDI-DrugBank.d577.s1
DDI-DrugBank.d577.s1.e0_DDI-DrugBank.d577.s1.e2 true sulfamethoxazole_5\NN\4352070| (r_nsubj) prolong_7\VB\317700|that|sulfamethoxazole|may|time (l_dobj) time_10\NN\7308889|the|prothrombin|patients (l_nmod) patients_12\NNS\9898892|in|receiving (l_acl:relcl) receiving_15\VBG\2210855|who|are|warfarin (l_dobj) warfarin_18\NN\2718259|the|anticoagulant
DDI-DrugBank.d577.s1.e0_DDI-DrugBank.d577.s1.e1 false sulfamethoxazole_5\NN\4352070| (r_nsubj) prolong_7\VB\317700|that|sulfamethoxazole|may|time (l_dobj) time_10\NN\7308889|the|prothrombin|patients (l_nmod) patients_12\NNS\9898892|in|receiving (l_acl:relcl) receiving_15\VBG\2210855|who|are|warfarin (l_dobj) warfarin_18\NN\2718259|the|anticoagulant (l_amod) anticoagulant_17\JJ\1740|
DDI-DrugBank.d577.s1.e2_DDI-DrugBank.d577.s1.e1 false warfarin_18\NN\2718259|the|anticoagulant (l_amod) anticoagulant_17\JJ\1740|
DDI-DrugBank.d596.s6
DDI-DrugBank.d596.s6.e0_DDI-DrugBank.d596.s6.e1 false rivastigmine_9\NN\1740|of (r_nmod) metabolism_7\NN\13526110|the|rivastigmine (r_nsubjpass) affected_13\VBN\126264|that|metabolism|is|not|significantly|administration (l_nmod) administration_16\NN\1133281|by|concurrent|digoxin (l_nmod) digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine
DDI-DrugBank.d596.s6.e0_DDI-DrugBank.d596.s6.e2 false rivastigmine_9\NN\1740|of (r_nmod) metabolism_7\NN\13526110|the|rivastigmine (r_nsubjpass) affected_13\VBN\126264|that|metabolism|is|not|significantly|administration (l_nmod) administration_16\NN\1133281|by|concurrent|digoxin (l_nmod) digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) warfarin_20\NN\2718259|
DDI-DrugBank.d596.s6.e0_DDI-DrugBank.d596.s6.e3 false rivastigmine_9\NN\1740|of (r_nmod) metabolism_7\NN\13526110|the|rivastigmine (r_nsubjpass) affected_13\VBN\126264|that|metabolism|is|not|significantly|administration (l_nmod) administration_16\NN\1133281|by|concurrent|digoxin (l_nmod) digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) diazepam_22\NN\2830852|
DDI-DrugBank.d596.s6.e0_DDI-DrugBank.d596.s6.e4 false rivastigmine_9\NN\1740|of (r_nmod) metabolism_7\NN\13526110|the|rivastigmine (r_nsubjpass) affected_13\VBN\126264|that|metabolism|is|not|significantly|administration (l_nmod) administration_16\NN\1133281|by|concurrent|digoxin (l_nmod) digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_25\NN\4169152|
DDI-DrugBank.d596.s6.e1_DDI-DrugBank.d596.s6.e2 false digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) warfarin_20\NN\2718259|
DDI-DrugBank.d596.s6.e1_DDI-DrugBank.d596.s6.e3 false digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) diazepam_22\NN\2830852|
DDI-DrugBank.d596.s6.e1_DDI-DrugBank.d596.s6.e4 false digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_25\NN\4169152|
DDI-DrugBank.d596.s6.e2_DDI-DrugBank.d596.s6.e3 false warfarin_20\NN\2718259| (r_conj) digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) diazepam_22\NN\2830852|
DDI-DrugBank.d596.s6.e2_DDI-DrugBank.d596.s6.e4 false warfarin_20\NN\2718259| (r_conj) digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_25\NN\4169152|
DDI-DrugBank.d596.s6.e3_DDI-DrugBank.d596.s6.e4 false diazepam_22\NN\2830852| (r_conj) digoxin_18\NN\15060131|of|,|warfarin|,|diazepam|,|or|fluoxetine (l_conj) fluoxetine_25\NN\4169152|
DDI-DrugBank.d700.s7
DDI-DrugBank.d700.s7.e0_DDI-DrugBank.d700.s7.e1 false cholestyramine_0\NN\1740|and|drugs|: (r_nsubj) interrupt_10\VBP\362348|cholestyramine|drugs|recirculation|and|reduce|. (l_conj) reduce_14\VBP\441445|exposure|coadministered (l_dobj) exposure_16\NN\5042871|mpa (l_compound) mpa_15\NN\1740|
DDI-DrugBank.d700.s7.e0_DDI-DrugBank.d700.s7.e2 false cholestyramine_0\NN\1740|and|drugs|: (r_nsubj) interrupt_10\VBP\362348|cholestyramine|drugs|recirculation|and|reduce|. (l_conj) reduce_14\VBP\441445|exposure|coadministered (l_advcl) coadministered_18\VBN\1740|when|mofetil (l_nmod) mofetil_21\NN\1740|with|mycophenolate
DDI-DrugBank.d700.s7.e1_DDI-DrugBank.d700.s7.e2 false mpa_15\NN\1740| (r_compound) exposure_16\NN\5042871|mpa (r_dobj) reduce_14\VBP\441445|exposure|coadministered (l_advcl) coadministered_18\VBN\1740|when|mofetil (l_nmod) mofetil_21\NN\1740|with|mycophenolate
DDI-DrugBank.d658.s2
DDI-DrugBank.d608.s1
DDI-DrugBank.d608.s1.e1_DDI-DrugBank.d608.s1.e0 false warfarin_16\NN\2718259| (r_conj) tolectin_14\NN\3828465|on|concomitant|and|warfarin
DDI-DrugBank.d597.s11
DDI-DrugBank.d597.s11.e0_DDI-DrugBank.d597.s11.e1 false cimetidine_0\NN\14778019| (r_dep) alter_11\VB\126264|cimetidine|:|administration|did|not|pharmacokinetics|. (l_nsubj) administration_3\NN\1133281|concomitant|qid (l_nmod) qid_8\NN\1740|of|mg|cimetidine (l_compound) cimetidine_7\NN\14778019|
DDI-DrugBank.d597.s11.e0_DDI-DrugBank.d597.s11.e2 false cimetidine_0\NN\14778019| (r_dep) alter_11\VB\126264|cimetidine|:|administration|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_14\NNS\6054892|the|single-dose|meloxicam (l_nmod) meloxicam_18\NN\1740|of|mg
DDI-DrugBank.d597.s11.e1_DDI-DrugBank.d597.s11.e2 false cimetidine_7\NN\14778019| (r_compound) qid_8\NN\1740|of|mg|cimetidine (r_nmod) administration_3\NN\1133281|concomitant|qid (r_nsubj) alter_11\VB\126264|cimetidine|:|administration|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_14\NNS\6054892|the|single-dose|meloxicam (l_nmod) meloxicam_18\NN\1740|of|mg
DDI-DrugBank.d776.s9
DDI-DrugBank.d676.s2
DDI-DrugBank.d676.s2.e3_DDI-DrugBank.d676.s2.e4 false hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (l_appos) hcl_22\NN\1740|imipramine
DDI-DrugBank.d676.s2.e3_DDI-DrugBank.d676.s2.e5 false hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (l_conj) drugs_26\NNS\14778436|other|and|foods|content|,|wine|, (l_nmod) content_33\NN\7951464|with|known|high|tyramine (l_compound) tyramine_32\NN\14601829|
DDI-DrugBank.d676.s2.e3_DDI-DrugBank.d676.s2.e0 false hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (r_conj) drugs_10\NNS\14778436|sympathomimetic|,|drugs (r_nsubjpass) avoided_48\VBN\2452885|exhibits|,|drugs|should|be|. (l_advcl) exhibits_2\VBZ\2632167|because|matulane|activity (l_nsubj) matulane_1\NN\1740|
DDI-DrugBank.d676.s2.e3_DDI-DrugBank.d676.s2.e1 false hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (r_conj) drugs_10\NNS\14778436|sympathomimetic|,|drugs
DDI-DrugBank.d676.s2.e3_DDI-DrugBank.d676.s2.e2 false hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (l_amod) antidepressant_13\JJ\1740|
DDI-DrugBank.d676.s2.e4_DDI-DrugBank.d676.s2.e5 false hcl_22\NN\1740|imipramine (r_appos) hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (l_conj) drugs_26\NNS\14778436|other|and|foods|content|,|wine|, (l_nmod) content_33\NN\7951464|with|known|high|tyramine (l_compound) tyramine_32\NN\14601829|
DDI-DrugBank.d676.s2.e4_DDI-DrugBank.d676.s2.e0 false hcl_22\NN\1740|imipramine (r_appos) hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (r_conj) drugs_10\NNS\14778436|sympathomimetic|,|drugs (r_nsubjpass) avoided_48\VBN\2452885|exhibits|,|drugs|should|be|. (l_advcl) exhibits_2\VBZ\2632167|because|matulane|activity (l_nsubj) matulane_1\NN\1740|
DDI-DrugBank.d676.s2.e4_DDI-DrugBank.d676.s2.e1 false hcl_22\NN\1740|imipramine (r_appos) hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (r_conj) drugs_10\NNS\14778436|sympathomimetic|,|drugs
DDI-DrugBank.d676.s2.e4_DDI-DrugBank.d676.s2.e2 false hcl_22\NN\1740|imipramine (r_appos) hcl_19\NN\1740|e.g.|,|amitriptyline|,|hcl|) (r_nmod) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (l_amod) antidepressant_13\JJ\1740|
DDI-DrugBank.d676.s2.e5_DDI-DrugBank.d676.s2.e0 false tyramine_32\NN\14601829| (r_compound) content_33\NN\7951464|with|known|high|tyramine (r_nmod) drugs_26\NNS\14778436|other|and|foods|content|,|wine|, (r_conj) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (r_conj) drugs_10\NNS\14778436|sympathomimetic|,|drugs (r_nsubjpass) avoided_48\VBN\2452885|exhibits|,|drugs|should|be|. (l_advcl) exhibits_2\VBZ\2632167|because|matulane|activity (l_nsubj) matulane_1\NN\1740|
DDI-DrugBank.d676.s2.e5_DDI-DrugBank.d676.s2.e1 false tyramine_32\NN\14601829| (r_compound) content_33\NN\7951464|with|known|high|tyramine (r_nmod) drugs_26\NNS\14778436|other|and|foods|content|,|wine|, (r_conj) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (r_conj) drugs_10\NNS\14778436|sympathomimetic|,|drugs
DDI-DrugBank.d676.s2.e5_DDI-DrugBank.d676.s2.e2 false tyramine_32\NN\14601829| (r_compound) content_33\NN\7951464|with|known|high|tyramine (r_nmod) drugs_26\NNS\14778436|other|and|foods|content|,|wine|, (r_conj) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (l_amod) antidepressant_13\JJ\1740|
DDI-DrugBank.d676.s2.e0_DDI-DrugBank.d676.s2.e1 true matulane_1\NN\1740| (r_nsubj) exhibits_2\VBZ\2632167|because|matulane|activity (r_advcl) avoided_48\VBN\2452885|exhibits|,|drugs|should|be|. (l_nsubjpass) drugs_10\NNS\14778436|sympathomimetic|,|drugs
DDI-DrugBank.d676.s2.e0_DDI-DrugBank.d676.s2.e2 true matulane_1\NN\1740| (r_nsubj) exhibits_2\VBZ\2632167|because|matulane|activity (r_advcl) avoided_48\VBN\2452885|exhibits|,|drugs|should|be|. (l_nsubjpass) drugs_10\NNS\14778436|sympathomimetic|,|drugs (l_conj) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (l_amod) antidepressant_13\JJ\1740|
DDI-DrugBank.d676.s2.e1_DDI-DrugBank.d676.s2.e2 false drugs_10\NNS\14778436|sympathomimetic|,|drugs (l_conj) drugs_14\NNS\14778436|tricyclic|antidepressant|(|hcl|and|drugs (l_amod) antidepressant_13\JJ\1740|
DDI-DrugBank.d763.s7
DDI-DrugBank.d763.s7.e0_DDI-DrugBank.d763.s7.e1 false ondansetron_0\NN\1740| (r_nsubj) increase_3\VB\169651|ondansetron|did|not|levels|. (l_dobj) levels_5\NNS\4916342|blood|methotrexate (l_nmod) methotrexate_8\NN\2722166|of|high-dose
DDI-DrugBank.d758.s0
DDI-DrugBank.d758.s0.e0_DDI-DrugBank.d758.s0.e1 true hydrochloride_6\NN\14817592|of|oxycodone (r_nmod) effects_3\NNS\13245626|the|cns|depressant|hydrochloride (r_nsubj) additive_9\JJ\1740|effects|may|be|that|.. (l_nmod) that_11\DT\1740|with|depressants (l_nmod) depressants_15\NNS\3248958|of|other|cns
DDI-DrugBank.d666.s1
DDI-DrugBank.d693.s7
DDI-DrugBank.d709.s2
DDI-DrugBank.d710.s2
DDI-DrugBank.d710.s2.e0_DDI-DrugBank.d710.s2.e1 false acetaminophen_0\NN\2707683|:|given (l_dep) given_9\VBN\2327200|hcl|was|daily|days|volunteers|. (l_nsubjpass) hcl_3\NN\1740|rimantadine|,|mg|,
DDI-DrugBank.d743.s11
DDI-DrugBank.d743.s11.e0_DDI-DrugBank.d743.s11.e1 false erythromycin_22\NN\2716866|or|troleandomycin (l_conj) troleandomycin_24\NN\1740|
DDI-DrugBank.d783.s0
DDI-DrugBank.d783.s0.e1_DDI-DrugBank.d783.s0.e2 false terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) astemizole_16\NN\1740|
DDI-DrugBank.d783.s0.e1_DDI-DrugBank.d783.s0.e3 false terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) cisapride_18\NN\1740|
DDI-DrugBank.d783.s0.e1_DDI-DrugBank.d783.s0.e4 false terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) cyclosporine_20\NN\1740|
DDI-DrugBank.d783.s0.e1_DDI-DrugBank.d783.s0.e0 false terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (r_appos) drugs_12\NNS\14778436|some|other|-|terfenadine (r_dobj) metabolize_9\VB\1740|to|drugs (r_acl) ability_7\NN\4723816|of|liver|metabolize (r_nmod) some_2\DT\1740|ability (r_dobj) inhibits_1\VBZ\2510337|posicor|some|. (l_nsubj) posicor_0\NN\1740|
DDI-DrugBank.d783.s0.e1_DDI-DrugBank.d783.s0.e5 false terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) antidepressants_24\NNS\3740161|tricyclic
DDI-DrugBank.d783.s0.e2_DDI-DrugBank.d783.s0.e3 false astemizole_16\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) cisapride_18\NN\1740|
DDI-DrugBank.d783.s0.e2_DDI-DrugBank.d783.s0.e4 false astemizole_16\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) cyclosporine_20\NN\1740|
DDI-DrugBank.d783.s0.e2_DDI-DrugBank.d783.s0.e0 false astemizole_16\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (r_appos) drugs_12\NNS\14778436|some|other|-|terfenadine (r_dobj) metabolize_9\VB\1740|to|drugs (r_acl) ability_7\NN\4723816|of|liver|metabolize (r_nmod) some_2\DT\1740|ability (r_dobj) inhibits_1\VBZ\2510337|posicor|some|. (l_nsubj) posicor_0\NN\1740|
DDI-DrugBank.d783.s0.e2_DDI-DrugBank.d783.s0.e5 false astemizole_16\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) antidepressants_24\NNS\3740161|tricyclic
DDI-DrugBank.d783.s0.e3_DDI-DrugBank.d783.s0.e4 false cisapride_18\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) cyclosporine_20\NN\1740|
DDI-DrugBank.d783.s0.e3_DDI-DrugBank.d783.s0.e0 false cisapride_18\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (r_appos) drugs_12\NNS\14778436|some|other|-|terfenadine (r_dobj) metabolize_9\VB\1740|to|drugs (r_acl) ability_7\NN\4723816|of|liver|metabolize (r_nmod) some_2\DT\1740|ability (r_dobj) inhibits_1\VBZ\2510337|posicor|some|. (l_nsubj) posicor_0\NN\1740|
DDI-DrugBank.d783.s0.e3_DDI-DrugBank.d783.s0.e5 false cisapride_18\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) antidepressants_24\NNS\3740161|tricyclic
DDI-DrugBank.d783.s0.e4_DDI-DrugBank.d783.s0.e0 false cyclosporine_20\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (r_appos) drugs_12\NNS\14778436|some|other|-|terfenadine (r_dobj) metabolize_9\VB\1740|to|drugs (r_acl) ability_7\NN\4723816|of|liver|metabolize (r_nmod) some_2\DT\1740|ability (r_dobj) inhibits_1\VBZ\2510337|posicor|some|. (l_nsubj) posicor_0\NN\1740|
DDI-DrugBank.d783.s0.e4_DDI-DrugBank.d783.s0.e5 false cyclosporine_20\NN\1740| (r_conj) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) antidepressants_24\NNS\3740161|tricyclic
DDI-DrugBank.d783.s0.e0_DDI-DrugBank.d783.s0.e5 true posicor_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|posicor|some|. (l_dobj) some_2\DT\1740|ability (l_nmod) ability_7\NN\4723816|of|liver|metabolize (l_acl) metabolize_9\VB\1740|to|drugs (l_dobj) drugs_12\NNS\14778436|some|other|-|terfenadine (l_appos) terfenadine_14\NN\1740|,|astemizole|,|cisapride|,|cyclosporine|,|and|antidepressants (l_conj) antidepressants_24\NNS\3740161|tricyclic
DDI-DrugBank.d649.s1
DDI-DrugBank.d649.s1.e1_DDI-DrugBank.d649.s1.e3 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) warfarin_25\NN\2718259|effect
DDI-DrugBank.d649.s1.e1_DDI-DrugBank.d649.s1.e4 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion
DDI-DrugBank.d649.s1.e1_DDI-DrugBank.d649.s1.e5 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion (l_dep) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (l_nmod) methotrexate_38\NN\2722166|of
DDI-DrugBank.d649.s1.e1_DDI-DrugBank.d649.s1.e6 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d649.s1.e1_DDI-DrugBank.d649.s1.e7 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d649.s1.e1_DDI-DrugBank.d649.s1.e0 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d649.s1.e1_DDI-DrugBank.d649.s1.e2 false cyclosporine_11\NN\1740|nephrotoxicity (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d649.s1.e3_DDI-DrugBank.d649.s1.e4 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion
DDI-DrugBank.d649.s1.e3_DDI-DrugBank.d649.s1.e5 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) methotrexate_32\NN\2722166|excretion (l_dep) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (l_nmod) methotrexate_38\NN\2722166|of
DDI-DrugBank.d649.s1.e3_DDI-DrugBank.d649.s1.e6 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d649.s1.e3_DDI-DrugBank.d649.s1.e7 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d649.s1.e3_DDI-DrugBank.d649.s1.e0 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d649.s1.e3_DDI-DrugBank.d649.s1.e2 false warfarin_25\NN\2718259|effect (r_conj) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d649.s1.e4_DDI-DrugBank.d649.s1.e5 false methotrexate_32\NN\2722166|excretion (l_dep) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (l_nmod) methotrexate_38\NN\2722166|of
DDI-DrugBank.d649.s1.e4_DDI-DrugBank.d649.s1.e6 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d649.s1.e4_DDI-DrugBank.d649.s1.e7 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d649.s1.e4_DDI-DrugBank.d649.s1.e0 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d649.s1.e4_DDI-DrugBank.d649.s1.e2 false methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d649.s1.e5_DDI-DrugBank.d649.s1.e6 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance
DDI-DrugBank.d649.s1.e5_DDI-DrugBank.d649.s1.e7 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_appos) phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d649.s1.e5_DDI-DrugBank.d649.s1.e0 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d649.s1.e5_DDI-DrugBank.d649.s1.e2 false methotrexate_38\NN\2722166|of (r_nmod) excretion_36\NN\13466586|(|decreased|renal|methotrexate|) (r_dep) methotrexate_32\NN\2722166|excretion (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d649.s1.e6_DDI-DrugBank.d649.s1.e7 false phenytoin_41\NN\3550533|clearance (l_dep) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (l_nmod) phenytoin_47\NN\3550533|of
DDI-DrugBank.d649.s1.e6_DDI-DrugBank.d649.s1.e0 false phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d649.s1.e6_DDI-DrugBank.d649.s1.e2 false phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d649.s1.e7_DDI-DrugBank.d649.s1.e0 false phenytoin_47\NN\3550533|of (r_nmod) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (r_dep) phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin
DDI-DrugBank.d649.s1.e7_DDI-DrugBank.d649.s1.e2 false phenytoin_47\NN\3550533|of (r_nmod) clearance_45\NN\5089947|(|decreased|hepatic|phenytoin|) (r_dep) phenytoin_41\NN\3550533|clearance (r_appos) thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d649.s1.e0_DDI-DrugBank.d649.s1.e2 false thiazides_5\NNS\3214670|with|thrombocytopenia|,|cyclosporine|,|agents|,|warfarin|,|methotrexate|,|phenytoin (l_conj) agents_18\NNS\7347|sulfonylurea|response
DDI-DrugBank.d763.s0
DDI-DrugBank.d771.s1
DDI-DrugBank.d771.s1.e0_DDI-DrugBank.d771.s1.e3 true scopolamine_0\NN\14712692| (r_nsubjpass) used_3\VBN\1156834|scopolamine|should|be|care|patients|. (l_nmod) patients_7\NNS\9898892|in|taking (l_acl) taking_8\VBG\2367363|drugs (l_dobj) drugs_10\NNS\14778436|other|capable (l_acl:relcl) capable_13\JJ\1740|that|are|causing (l_advcl) causing_15\VBG\1617192|of|effects (l_dobj) effects_17\NNS\13245626|cns|sedatives (l_nmod) sedatives_20\NNS\3248958|such|,|tranquilizers (l_conj) tranquilizers_22\NNS\4017429|,|or|alcohol (l_conj) alcohol_25\NN\7881800|
DDI-DrugBank.d771.s1.e0_DDI-DrugBank.d771.s1.e1 true scopolamine_0\NN\14712692| (r_nsubjpass) used_3\VBN\1156834|scopolamine|should|be|care|patients|. (l_nmod) patients_7\NNS\9898892|in|taking (l_acl) taking_8\VBG\2367363|drugs (l_dobj) drugs_10\NNS\14778436|other|capable (l_acl:relcl) capable_13\JJ\1740|that|are|causing (l_advcl) causing_15\VBG\1617192|of|effects (l_dobj) effects_17\NNS\13245626|cns|sedatives (l_nmod) sedatives_20\NNS\3248958|such|,|tranquilizers
DDI-DrugBank.d771.s1.e0_DDI-DrugBank.d771.s1.e2 true scopolamine_0\NN\14712692| (r_nsubjpass) used_3\VBN\1156834|scopolamine|should|be|care|patients|. (l_nmod) patients_7\NNS\9898892|in|taking (l_acl) taking_8\VBG\2367363|drugs (l_dobj) drugs_10\NNS\14778436|other|capable (l_acl:relcl) capable_13\JJ\1740|that|are|causing (l_advcl) causing_15\VBG\1617192|of|effects (l_dobj) effects_17\NNS\13245626|cns|sedatives (l_nmod) sedatives_20\NNS\3248958|such|,|tranquilizers (l_conj) tranquilizers_22\NNS\4017429|,|or|alcohol
DDI-DrugBank.d771.s1.e3_DDI-DrugBank.d771.s1.e1 false alcohol_25\NN\7881800| (r_conj) tranquilizers_22\NNS\4017429|,|or|alcohol (r_conj) sedatives_20\NNS\3248958|such|,|tranquilizers
DDI-DrugBank.d771.s1.e3_DDI-DrugBank.d771.s1.e2 false alcohol_25\NN\7881800| (r_conj) tranquilizers_22\NNS\4017429|,|or|alcohol
DDI-DrugBank.d771.s1.e1_DDI-DrugBank.d771.s1.e2 false sedatives_20\NNS\3248958|such|,|tranquilizers (l_conj) tranquilizers_22\NNS\4017429|,|or|alcohol
DDI-DrugBank.d739.s2
DDI-DrugBank.d661.s0
DDI-DrugBank.d661.s0.e1_DDI-DrugBank.d661.s0.e2 false bromide_7\NN\14904359|(|rocuronium|) (r_appos) zemuron_4\NN\1740|bromide (r_compound) injection_9\NN\320852|of|zemuron|succinylcholine (l_nmod) succinylcholine_11\NN\3800001|before
DDI-DrugBank.d661.s0.e1_DDI-DrugBank.d661.s0.e3 false bromide_7\NN\14904359|(|rocuronium|) (r_appos) zemuron_4\NN\1740|bromide (r_compound) injection_9\NN\320852|of|zemuron|succinylcholine (r_nmod) use_2\NN\407535|the|injection|,|purpose (l_nmod) purpose_15\NN\5980875|for|the|attenuating (l_advcl) attenuating_17\VBG\224901|of|some (l_dobj) some_18\DT\1740|effects (l_nmod) effects_22\NNS\13245626|of|the|side|succinylcholine (l_nmod) succinylcholine_24\NN\3800001|of
DDI-DrugBank.d661.s0.e1_DDI-DrugBank.d661.s0.e0 false bromide_7\NN\14904359|(|rocuronium|) (r_appos) zemuron_4\NN\1740|bromide
DDI-DrugBank.d661.s0.e2_DDI-DrugBank.d661.s0.e3 false succinylcholine_11\NN\3800001|before (r_nmod) injection_9\NN\320852|of|zemuron|succinylcholine (r_nmod) use_2\NN\407535|the|injection|,|purpose (l_nmod) purpose_15\NN\5980875|for|the|attenuating (l_advcl) attenuating_17\VBG\224901|of|some (l_dobj) some_18\DT\1740|effects (l_nmod) effects_22\NNS\13245626|of|the|side|succinylcholine (l_nmod) succinylcholine_24\NN\3800001|of
DDI-DrugBank.d661.s0.e2_DDI-DrugBank.d661.s0.e0 false succinylcholine_11\NN\3800001|before (r_nmod) injection_9\NN\320852|of|zemuron|succinylcholine (l_compound) zemuron_4\NN\1740|bromide
DDI-DrugBank.d661.s0.e3_DDI-DrugBank.d661.s0.e0 false succinylcholine_24\NN\3800001|of (r_nmod) effects_22\NNS\13245626|of|the|side|succinylcholine (r_nmod) some_18\DT\1740|effects (r_dobj) attenuating_17\VBG\224901|of|some (r_advcl) purpose_15\NN\5980875|for|the|attenuating (r_nmod) use_2\NN\407535|the|injection|,|purpose (l_nmod) injection_9\NN\320852|of|zemuron|succinylcholine (l_compound) zemuron_4\NN\1740|bromide
DDI-DrugBank.d720.s4
DDI-DrugBank.d720.s4.e0_DDI-DrugBank.d720.s4.e1 true sumatriptan_4\NN\1740|with|and|ssri (l_conj) ssri_7\NN\2718811|an
DDI-DrugBank.d602.s4
DDI-DrugBank.d776.s34
DDI-DrugBank.d776.s34.e0_DDI-DrugBank.d776.s34.e1 true tacrolimus_2\NN\1740|and|fluconazole (l_conj) fluconazole_4\NN\1740|
DDI-DrugBank.d720.s1
DDI-DrugBank.d720.s1.e0_DDI-DrugBank.d720.s1.e2 false ergotamine-containing_15\NN\1740|or|ergot-type (r_amod) medications_18\NNS\3247620|of|ergotamine-containing|(|dihydroergotamine|hours (l_nmod) dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan
DDI-DrugBank.d720.s1.e0_DDI-DrugBank.d720.s1.e3 false ergotamine-containing_15\NN\1740|or|ergot-type (r_amod) medications_18\NNS\3247620|of|ergotamine-containing|(|dihydroergotamine|hours (l_nmod) dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (l_conj) methysergide_23\NN\1740|
DDI-DrugBank.d720.s1.e0_DDI-DrugBank.d720.s1.e4 true ergotamine-containing_15\NN\1740|or|ergot-type (r_amod) medications_18\NNS\3247620|of|ergotamine-containing|(|dihydroergotamine|hours (l_nmod) dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (l_conj) sumatriptan_26\NN\1740|
DDI-DrugBank.d720.s1.e0_DDI-DrugBank.d720.s1.e1 false ergotamine-containing_15\NN\1740|or|ergot-type (r_amod) medications_18\NNS\3247620|of|ergotamine-containing|(|dihydroergotamine|hours
DDI-DrugBank.d720.s1.e2_DDI-DrugBank.d720.s1.e3 false dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (l_conj) methysergide_23\NN\1740|
DDI-DrugBank.d720.s1.e2_DDI-DrugBank.d720.s1.e4 true dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (l_conj) sumatriptan_26\NN\1740|
DDI-DrugBank.d720.s1.e2_DDI-DrugBank.d720.s1.e1 false dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (r_nmod) medications_18\NNS\3247620|of|ergotamine-containing|(|dihydroergotamine|hours
DDI-DrugBank.d720.s1.e3_DDI-DrugBank.d720.s1.e4 true methysergide_23\NN\1740| (r_conj) dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (l_conj) sumatriptan_26\NN\1740|
DDI-DrugBank.d720.s1.e3_DDI-DrugBank.d720.s1.e1 false methysergide_23\NN\1740| (r_conj) dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (r_nmod) medications_18\NNS\3247620|of|ergotamine-containing|(|dihydroergotamine|hours
DDI-DrugBank.d720.s1.e4_DDI-DrugBank.d720.s1.e1 false sumatriptan_26\NN\1740| (r_conj) dihydroergotamine_21\NN\1740|like|or|methysergide|)|and|sumatriptan (r_nmod) medications_18\NNS\3247620|of|ergotamine-containing|(|dihydroergotamine|hours
DDI-DrugBank.d780.s1
DDI-DrugBank.d721.s1
DDI-DrugBank.d721.s1.e0_DDI-DrugBank.d721.s1.e1 true aspirin_0\NN\2707683| (r_nsubj) decrease_2\VB\169651|aspirin|may|bioavailability|%|taken|. (l_dobj) bioavailability_3\NN\1740|skelid (l_nmod) skelid_5\NN\1740|of
DDI-DrugBank.d721.s1.e0_DDI-DrugBank.d721.s1.e2 false aspirin_0\NN\2707683| (r_nsubj) decrease_2\VB\169651|aspirin|may|bioavailability|%|taken|. (l_advcl) taken_12\VBN\2367363|when|skelid (l_nmod) skelid_16\NN\1740|after
DDI-DrugBank.d721.s1.e1_DDI-DrugBank.d721.s1.e2 false skelid_5\NN\1740|of (r_nmod) bioavailability_3\NN\1740|skelid (r_dobj) decrease_2\VB\169651|aspirin|may|bioavailability|%|taken|. (l_advcl) taken_12\VBN\2367363|when|skelid (l_nmod) skelid_16\NN\1740|after
DDI-DrugBank.d595.s6
DDI-DrugBank.d623.s2
DDI-DrugBank.d776.s43
DDI-DrugBank.d650.s1
DDI-DrugBank.d597.s22
DDI-DrugBank.d597.s22.e0_DDI-DrugBank.d597.s22.e1 true lithium_2\NN\14625458| (r_compound) treatment_3\NN\654885|on|lithium (r_nmod) patients_0\NNS\9898892|treatment (r_nsubjpass) monitored_7\VBN\2169352|patients|should|be|closely|introduced|. (l_advcl) introduced_11\VBN\831651|when|mobic|is|or|withdrawn (l_nsubjpass) mobic_9\NNP\1740|
DDI-DrugBank.d781.s8
DDI-DrugBank.d781.s8.e0_DDI-DrugBank.d781.s8.e1 false lithium_0\NN\14625458| (r_dep) reported_12\VBN\831651|lithium|:|lithium|have|been|patients|. (l_nsubjpass) lithium_4\NN\14625458|increased|serum|and|symptoms
DDI-DrugBank.d781.s8.e0_DDI-DrugBank.d781.s8.e2 false lithium_0\NN\14625458| (r_dep) reported_12\VBN\831651|lithium|:|lithium|have|been|patients|. (l_nsubjpass) lithium_4\NN\14625458|increased|serum|and|symptoms (l_conj) symptoms_6\NNS\5823932|toxicity (l_nmod) toxicity_9\NN\13576101|of|lithium (l_compound) lithium_8\NN\14625458|
DDI-DrugBank.d781.s8.e0_DDI-DrugBank.d781.s8.e3 false lithium_0\NN\14625458| (r_dep) reported_12\VBN\831651|lithium|:|lithium|have|been|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|therapy (l_dobj) therapy_21\NN\657604|lithium (l_compound) lithium_17\NN\14625458|concomitant|and|inhibitor
DDI-DrugBank.d781.s8.e1_DDI-DrugBank.d781.s8.e2 false lithium_4\NN\14625458|increased|serum|and|symptoms (l_conj) symptoms_6\NNS\5823932|toxicity (l_nmod) toxicity_9\NN\13576101|of|lithium (l_compound) lithium_8\NN\14625458|
DDI-DrugBank.d781.s8.e1_DDI-DrugBank.d781.s8.e3 false lithium_4\NN\14625458|increased|serum|and|symptoms (r_nsubjpass) reported_12\VBN\831651|lithium|:|lithium|have|been|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|therapy (l_dobj) therapy_21\NN\657604|lithium (l_compound) lithium_17\NN\14625458|concomitant|and|inhibitor
DDI-DrugBank.d781.s8.e2_DDI-DrugBank.d781.s8.e3 false lithium_8\NN\14625458| (r_compound) toxicity_9\NN\13576101|of|lithium (r_nmod) symptoms_6\NNS\5823932|toxicity (r_conj) lithium_4\NN\14625458|increased|serum|and|symptoms (r_nsubjpass) reported_12\VBN\831651|lithium|:|lithium|have|been|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|therapy (l_dobj) therapy_21\NN\657604|lithium (l_compound) lithium_17\NN\14625458|concomitant|and|inhibitor
DDI-DrugBank.d756.s7
DDI-DrugBank.d756.s7.e0_DDI-DrugBank.d756.s7.e1 false caffeine_0\NN\14712692|and/or|stimulantes (l_conj) stimulantes_2\NNS\1740|type (l_nmod) type_6\NN\5839024|of|the|ephedrine/amphetamine (l_compound) ephedrine/amphetamine_5\NN\1740|
DDI-DrugBank.d756.s7.e0_DDI-DrugBank.d756.s7.e2 false caffeine_0\NN\14712692|and/or|stimulantes (l_conj) stimulantes_2\NNS\1740|type (l_nmod) type_6\NN\5839024|of|the|ephedrine/amphetamine (l_compound) ephedrine/amphetamine_5\NN\1740|
DDI-DrugBank.d756.s7.e0_DDI-DrugBank.d756.s7.e3 true caffeine_0\NN\14712692|and/or|stimulantes (r_nsubj) counteract_8\VB\2367363|caffeine|may|actions|. (l_dobj) actions_11\NNS\30358|the|specific|levomepromazine (l_nmod) levomepromazine_13\NN\1740|of
DDI-DrugBank.d756.s7.e1_DDI-DrugBank.d756.s7.e2 false ephedrine/amphetamine_5\NN\1740|
DDI-DrugBank.d756.s7.e1_DDI-DrugBank.d756.s7.e3 true ephedrine/amphetamine_5\NN\1740| (r_compound) type_6\NN\5839024|of|the|ephedrine/amphetamine (r_nmod) stimulantes_2\NNS\1740|type (r_conj) caffeine_0\NN\14712692|and/or|stimulantes (r_nsubj) counteract_8\VB\2367363|caffeine|may|actions|. (l_dobj) actions_11\NNS\30358|the|specific|levomepromazine (l_nmod) levomepromazine_13\NN\1740|of
DDI-DrugBank.d756.s7.e2_DDI-DrugBank.d756.s7.e3 true ephedrine/amphetamine_5\NN\1740| (r_compound) type_6\NN\5839024|of|the|ephedrine/amphetamine (r_nmod) stimulantes_2\NNS\1740|type (r_conj) caffeine_0\NN\14712692|and/or|stimulantes (r_nsubj) counteract_8\VB\2367363|caffeine|may|actions|. (l_dobj) actions_11\NNS\30358|the|specific|levomepromazine (l_nmod) levomepromazine_13\NN\1740|of
DDI-DrugBank.d642.s1
DDI-DrugBank.d642.s1.e0_DDI-DrugBank.d642.s1.e1 true drugs_4\NNS\14778436|of|antibacterial (r_nmod) use_1\NN\407535|concurrent|drugs|contraceptives (l_nmod) contraceptives_7\NNS\3183080|with|oral
DDI-DrugBank.d642.s1.e0_DDI-DrugBank.d642.s1.e2 false drugs_4\NNS\14778436|of|antibacterial (r_nmod) use_1\NN\407535|concurrent|drugs|contraceptives (r_nsubj) render_9\VB\120316|use|may|effective|. (l_ccomp) effective_13\JJ\1740|contraceptives|less (l_nsubj) contraceptives_11\NNS\3183080|oral
DDI-DrugBank.d642.s1.e1_DDI-DrugBank.d642.s1.e2 false contraceptives_7\NNS\3183080|with|oral (r_nmod) use_1\NN\407535|concurrent|drugs|contraceptives (r_nsubj) render_9\VB\120316|use|may|effective|. (l_ccomp) effective_13\JJ\1740|contraceptives|less (l_nsubj) contraceptives_11\NNS\3183080|oral
DDI-DrugBank.d766.s3
DDI-DrugBank.d766.s3.e1_DDI-DrugBank.d766.s3.e2 false clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (l_appos) ketoconazole_16\NN\1740|
DDI-DrugBank.d766.s3.e1_DDI-DrugBank.d766.s3.e3 false clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (l_appos) miconazole_18\NN\2720201|
DDI-DrugBank.d766.s3.e1_DDI-DrugBank.d766.s3.e4 true clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (r_appos) drugs_12\NNS\14778436|substituted|imidazole|clotrimazole (r_nsubj) inhibitors_24\NNS\20090|model|,|drugs|were|potent|non-competitive|metabolism|. (l_nmod) metabolism_27\NN\13526110|of|trimetrexate (l_compound) trimetrexate_26\NN\1740|
DDI-DrugBank.d766.s3.e1_DDI-DrugBank.d766.s3.e0 false clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (r_appos) drugs_12\NNS\14778436|substituted|imidazole|clotrimazole
DDI-DrugBank.d766.s3.e2_DDI-DrugBank.d766.s3.e3 false ketoconazole_16\NN\1740| (r_appos) clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (l_appos) miconazole_18\NN\2720201|
DDI-DrugBank.d766.s3.e2_DDI-DrugBank.d766.s3.e4 true ketoconazole_16\NN\1740| (r_appos) clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (r_appos) drugs_12\NNS\14778436|substituted|imidazole|clotrimazole (r_nsubj) inhibitors_24\NNS\20090|model|,|drugs|were|potent|non-competitive|metabolism|. (l_nmod) metabolism_27\NN\13526110|of|trimetrexate (l_compound) trimetrexate_26\NN\1740|
DDI-DrugBank.d766.s3.e2_DDI-DrugBank.d766.s3.e0 false ketoconazole_16\NN\1740| (r_appos) clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (r_appos) drugs_12\NNS\14778436|substituted|imidazole|clotrimazole
DDI-DrugBank.d766.s3.e3_DDI-DrugBank.d766.s3.e4 true miconazole_18\NN\2720201| (r_appos) clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (r_appos) drugs_12\NNS\14778436|substituted|imidazole|clotrimazole (r_nsubj) inhibitors_24\NNS\20090|model|,|drugs|were|potent|non-competitive|metabolism|. (l_nmod) metabolism_27\NN\13526110|of|trimetrexate (l_compound) trimetrexate_26\NN\1740|
DDI-DrugBank.d766.s3.e3_DDI-DrugBank.d766.s3.e0 false miconazole_18\NN\2720201| (r_appos) clotrimazole_14\NN\1740|(|,|ketoconazole|,|miconazole|) (r_appos) drugs_12\NNS\14778436|substituted|imidazole|clotrimazole
DDI-DrugBank.d766.s3.e4_DDI-DrugBank.d766.s3.e0 false trimetrexate_26\NN\1740| (r_compound) metabolism_27\NN\13526110|of|trimetrexate (r_nmod) inhibitors_24\NNS\20090|model|,|drugs|were|potent|non-competitive|metabolism|. (l_nsubj) drugs_12\NNS\14778436|substituted|imidazole|clotrimazole
DDI-DrugBank.d776.s30
DDI-DrugBank.d693.s1
DDI-DrugBank.d693.s1.e0_DDI-DrugBank.d693.s1.e1 false sulfasalazine_4\NN\1740| (r_compound) g_6\NN\13717155|of|sulfasalazine|2 (r_nmod) doses_2\NNS\3740161|daily|g|and|doses (l_conj) doses_9\NNS\3740161|weekly|methotrexate (l_nmod) methotrexate_11\NN\2722166|of|mg
DDI-DrugBank.d654.s2
DDI-DrugBank.d654.s2.e1_DDI-DrugBank.d654.s2.e0 false retapamulin_19\NN\1740| (r_nsubj) unlikely_21\JJ\1740|studies|,|retapamulin|is|affect|. (l_nmod) studies_6\NNS\635850|based|on|in|p450|inhibition|and|exposure (l_conj) exposure_11\NN\5042871|the|low|systemic|observed (l_acl) observed_12\VBN\2163746|application (l_nmod) application_15\NN\947128|following|topical|altabax (l_nmod) altabax_17\NN\1740|of
DDI-DrugBank.d737.s11
DDI-DrugBank.d622.s2
DDI-DrugBank.d622.s2.e0_DDI-DrugBank.d622.s2.e1 false pralidoxime_28\NN\1740|of (r_nmod) use_26\NN\407535|on|the|pralidoxime (r_nmod) bear_22\VB\2630189|although|they|do|not|directly|use (r_advcl) kept_8\VBN\2367363|2|precautions|should|be|mind|treatment|,|bear (r_ccomp) used_41\VBN\1156834|kept|:|potentiated|,|they|should|be|cautiously|treatment|; (l_advcl) potentiated_33\VBN\229605|since|barbiturates|are|anticholinesterases (l_nsubjpass) barbiturates_31\NNS\4166841|
DDI-DrugBank.d622.s2.e0_DDI-DrugBank.d622.s2.e2 false pralidoxime_28\NN\1740|of (r_nmod) use_26\NN\407535|on|the|pralidoxime (r_nmod) bear_22\VB\2630189|although|they|do|not|directly|use (r_advcl) kept_8\VBN\2367363|2|precautions|should|be|mind|treatment|,|bear (r_ccomp) used_41\VBN\1156834|kept|:|potentiated|,|they|should|be|cautiously|treatment|; (l_advcl) potentiated_33\VBN\229605|since|barbiturates|are|anticholinesterases (l_nmod) anticholinesterases_36\NNS\3740161|by|the
DDI-DrugBank.d622.s2.e1_DDI-DrugBank.d622.s2.e2 true barbiturates_31\NNS\4166841| (r_nsubjpass) potentiated_33\VBN\229605|since|barbiturates|are|anticholinesterases (l_nmod) anticholinesterases_36\NNS\3740161|by|the
DDI-DrugBank.d572.s12
DDI-DrugBank.d572.s12.e0_DDI-DrugBank.d572.s12.e1 false ezetimibe_6\NN\1740|with (r_nmod) study_4\NN\635850|a|104-week|dietary|carcinogenicity|ezetimibe (r_nsubjpass) conducted_9\VBN\2436349|study|was|also|mice|doses|. (l_nmod) doses_13\NNS\3740161|at|mg/kg/day|exposure (l_dep) exposure_24\NN\5042871|(|150|times|the|human|mg|24hr|ezetimibe|) (l_nmod) ezetimibe_36\NN\1740|for|total
DDI-DrugBank.d732.s1
DDI-DrugBank.d640.s5
DDI-DrugBank.d640.s5.e1_DDI-DrugBank.d640.s5.e0 false warfarin_6\NN\2718259|with (r_nmod) studies_4\NNS\635850|interaction|warfarin (r_nsubj) failed_7\VBD\1798936|anticoagulants|:|studies|identify|. (l_nsubj) anticoagulants_1\NNS\3740161|oral
DDI-DrugBank.d640.s5.e1_DDI-DrugBank.d640.s5.e2 false warfarin_6\NN\2718259|with (r_nmod) studies_4\NNS\635850|interaction|warfarin (r_nsubj) failed_7\VBD\1798936|anticoagulants|:|studies|identify|. (l_xcomp) identify_9\VB\699815|to|effect (l_dobj) effect_13\NN\34213|any|important|concentrations (l_nmod) concentrations_17\NNS\4916342|on|the|serum|anticoagulant|or|effect (l_nmod) anticoagulant_20\NN\3740161|of|the
DDI-DrugBank.d640.s5.e0_DDI-DrugBank.d640.s5.e2 false anticoagulants_1\NNS\3740161|oral (r_nsubj) failed_7\VBD\1798936|anticoagulants|:|studies|identify|. (l_xcomp) identify_9\VB\699815|to|effect (l_dobj) effect_13\NN\34213|any|important|concentrations (l_nmod) concentrations_17\NNS\4916342|on|the|serum|anticoagulant|or|effect (l_nmod) anticoagulant_20\NN\3740161|of|the
DDI-DrugBank.d776.s38
DDI-DrugBank.d776.s38.e0_DDI-DrugBank.d776.s38.e1 true fluconazole_0\NN\1740| (r_compound) tablets_1\NNS\4233405|fluconazole|coadministered (l_acl) coadministered_2\VBN\1740|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|estradiol-|oral (l_amod) estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing
DDI-DrugBank.d776.s38.e0_DDI-DrugBank.d776.s38.e2 true fluconazole_0\NN\1740| (r_compound) tablets_1\NNS\4233405|fluconazole|coadministered (l_acl) coadministered_2\VBN\1740|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|estradiol-|oral (l_amod) estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (l_conj) levonorgestrel-containing_7\NN\1740|
DDI-DrugBank.d776.s38.e0_DDI-DrugBank.d776.s38.e4 false fluconazole_0\NN\1740| (r_compound) tablets_1\NNS\4233405|fluconazole|coadministered (r_nsubj) produced_10\VBD\1617192|tablets|increase|; (l_dobj) increase_14\NN\13576355|an|overall|mean|levels (l_nmod) levels_20\NNS\4916342|in|estradiol (l_compound) estradiol_17\NN\14749794|ethinyl|and|levonorgestrel
DDI-DrugBank.d776.s38.e0_DDI-DrugBank.d776.s38.e5 false fluconazole_0\NN\1740| (r_compound) tablets_1\NNS\4233405|fluconazole|coadministered (r_nsubj) produced_10\VBD\1617192|tablets|increase|; (l_dobj) increase_14\NN\13576355|an|overall|mean|levels (l_nmod) levels_20\NNS\4916342|in|estradiol (l_compound) estradiol_17\NN\14749794|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_19\NN\1740|
DDI-DrugBank.d776.s38.e0_DDI-DrugBank.d776.s38.e3 false fluconazole_0\NN\1740| (r_compound) tablets_1\NNS\4233405|fluconazole|coadministered (l_acl) coadministered_2\VBN\1740|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|estradiol-|oral
DDI-DrugBank.d776.s38.e1_DDI-DrugBank.d776.s38.e2 false estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (l_conj) levonorgestrel-containing_7\NN\1740|
DDI-DrugBank.d776.s38.e1_DDI-DrugBank.d776.s38.e4 false estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (r_amod) contraceptives_9\NNS\3183080|with|estradiol-|oral (r_nmod) coadministered_2\VBN\1740|contraceptives (r_acl) tablets_1\NNS\4233405|fluconazole|coadministered (r_nsubj) produced_10\VBD\1617192|tablets|increase|; (l_dobj) increase_14\NN\13576355|an|overall|mean|levels (l_nmod) levels_20\NNS\4916342|in|estradiol (l_compound) estradiol_17\NN\14749794|ethinyl|and|levonorgestrel
DDI-DrugBank.d776.s38.e1_DDI-DrugBank.d776.s38.e5 false estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (r_amod) contraceptives_9\NNS\3183080|with|estradiol-|oral (r_nmod) coadministered_2\VBN\1740|contraceptives (r_acl) tablets_1\NNS\4233405|fluconazole|coadministered (r_nsubj) produced_10\VBD\1617192|tablets|increase|; (l_dobj) increase_14\NN\13576355|an|overall|mean|levels (l_nmod) levels_20\NNS\4916342|in|estradiol (l_compound) estradiol_17\NN\14749794|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_19\NN\1740|
DDI-DrugBank.d776.s38.e1_DDI-DrugBank.d776.s38.e3 false estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (r_amod) contraceptives_9\NNS\3183080|with|estradiol-|oral
DDI-DrugBank.d776.s38.e2_DDI-DrugBank.d776.s38.e4 false levonorgestrel-containing_7\NN\1740| (r_conj) estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (r_amod) contraceptives_9\NNS\3183080|with|estradiol-|oral (r_nmod) coadministered_2\VBN\1740|contraceptives (r_acl) tablets_1\NNS\4233405|fluconazole|coadministered (r_nsubj) produced_10\VBD\1617192|tablets|increase|; (l_dobj) increase_14\NN\13576355|an|overall|mean|levels (l_nmod) levels_20\NNS\4916342|in|estradiol (l_compound) estradiol_17\NN\14749794|ethinyl|and|levonorgestrel
DDI-DrugBank.d776.s38.e2_DDI-DrugBank.d776.s38.e5 false levonorgestrel-containing_7\NN\1740| (r_conj) estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (r_amod) contraceptives_9\NNS\3183080|with|estradiol-|oral (r_nmod) coadministered_2\VBN\1740|contraceptives (r_acl) tablets_1\NNS\4233405|fluconazole|coadministered (r_nsubj) produced_10\VBD\1617192|tablets|increase|; (l_dobj) increase_14\NN\13576355|an|overall|mean|levels (l_nmod) levels_20\NNS\4916342|in|estradiol (l_compound) estradiol_17\NN\14749794|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_19\NN\1740|
DDI-DrugBank.d776.s38.e2_DDI-DrugBank.d776.s38.e3 false levonorgestrel-containing_7\NN\1740| (r_conj) estradiol-_5\NN\1740|ethinyl|and|levonorgestrel-containing (r_amod) contraceptives_9\NNS\3183080|with|estradiol-|oral
DDI-DrugBank.d776.s38.e4_DDI-DrugBank.d776.s38.e5 false estradiol_17\NN\14749794|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_19\NN\1740|
DDI-DrugBank.d776.s38.e4_DDI-DrugBank.d776.s38.e3 false estradiol_17\NN\14749794|ethinyl|and|levonorgestrel (r_compound) levels_20\NNS\4916342|in|estradiol (r_nmod) increase_14\NN\13576355|an|overall|mean|levels (r_dobj) produced_10\VBD\1617192|tablets|increase|; (l_nsubj) tablets_1\NNS\4233405|fluconazole|coadministered (l_acl) coadministered_2\VBN\1740|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|estradiol-|oral
DDI-DrugBank.d776.s38.e5_DDI-DrugBank.d776.s38.e3 false levonorgestrel_19\NN\1740| (r_conj) estradiol_17\NN\14749794|ethinyl|and|levonorgestrel (r_compound) levels_20\NNS\4916342|in|estradiol (r_nmod) increase_14\NN\13576355|an|overall|mean|levels (r_dobj) produced_10\VBD\1617192|tablets|increase|; (l_nsubj) tablets_1\NNS\4233405|fluconazole|coadministered (l_acl) coadministered_2\VBN\1740|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|estradiol-|oral
DDI-DrugBank.d604.s4
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e3 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e4 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) modafinil_19\NN\1740|
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e6 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e7 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e8 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) phenytoin_27\NN\3550533|
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e9 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) carbamazepine_29\NN\1740|
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e1 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_appos) drugs_4\NNS\14778436|interfere (l_acl:relcl) interfere_6\VBP\2451370|that|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|hormonal
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e2 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e0_DDI-DrugBank.d604.s4.e5 false non-thalidomide_1\JJ\1740| (r_amod) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e4 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) modafinil_19\NN\1740|
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e6 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e7 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e8 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) phenytoin_27\NN\3550533|
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e9 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) carbamazepine_29\NN\1740|
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e1 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (r_nmod) use_12\NN\407535|concomitant|inhibitors (r_dep) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_appos) drugs_4\NNS\14778436|interfere (l_acl:relcl) interfere_6\VBP\2451370|that|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|hormonal
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e2 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e3_DDI-DrugBank.d604.s4.e5 false griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e4_DDI-DrugBank.d604.s4.e6 false modafinil_19\NN\1740| (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin
DDI-DrugBank.d604.s4.e4_DDI-DrugBank.d604.s4.e7 false modafinil_19\NN\1740| (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine
DDI-DrugBank.d604.s4.e4_DDI-DrugBank.d604.s4.e8 false modafinil_19\NN\1740| (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) phenytoin_27\NN\3550533|
DDI-DrugBank.d604.s4.e4_DDI-DrugBank.d604.s4.e9 false modafinil_19\NN\1740| (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin (l_conj) rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) carbamazepine_29\NN\1740|
DDI-DrugBank.d604.s4.e4_DDI-DrugBank.d604.s4.e1 false modafinil_19\NN\1740| (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (r_nmod) use_12\NN\407535|concomitant|inhibitors (r_dep) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_appos) drugs_4\NNS\14778436|interfere (l_acl:relcl) interfere_6\VBP\2451370|that|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|hormonal
DDI-DrugBank.d604.s4.e4_DDI-DrugBank.d604.s4.e2 false modafinil_19\NN\1740| (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e4_DDI-DrugBank.d604.s4.e5 false modafinil_19\NN\1740| (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e6_DDI-DrugBank.d604.s4.e7 false rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine
DDI-DrugBank.d604.s4.e6_DDI-DrugBank.d604.s4.e8 false rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) phenytoin_27\NN\3550533|
DDI-DrugBank.d604.s4.e6_DDI-DrugBank.d604.s4.e9 false rifampin_23\NN\2716205|,|rifabutin (l_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) carbamazepine_29\NN\1740|
DDI-DrugBank.d604.s4.e6_DDI-DrugBank.d604.s4.e1 false rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (r_nmod) use_12\NN\407535|concomitant|inhibitors (r_dep) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_appos) drugs_4\NNS\14778436|interfere (l_acl:relcl) interfere_6\VBP\2451370|that|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|hormonal
DDI-DrugBank.d604.s4.e6_DDI-DrugBank.d604.s4.e2 false rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e6_DDI-DrugBank.d604.s4.e5 false rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e7_DDI-DrugBank.d604.s4.e8 false rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) phenytoin_27\NN\3550533|
DDI-DrugBank.d604.s4.e7_DDI-DrugBank.d604.s4.e9 false rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) carbamazepine_29\NN\1740|
DDI-DrugBank.d604.s4.e7_DDI-DrugBank.d604.s4.e1 false rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (r_nmod) use_12\NN\407535|concomitant|inhibitors (r_dep) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_appos) drugs_4\NNS\14778436|interfere (l_acl:relcl) interfere_6\VBP\2451370|that|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|hormonal
DDI-DrugBank.d604.s4.e7_DDI-DrugBank.d604.s4.e2 false rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e7_DDI-DrugBank.d604.s4.e5 false rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e8_DDI-DrugBank.d604.s4.e9 false phenytoin_27\NN\3550533| (r_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (l_conj) carbamazepine_29\NN\1740|
DDI-DrugBank.d604.s4.e8_DDI-DrugBank.d604.s4.e1 false phenytoin_27\NN\3550533| (r_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (r_nmod) use_12\NN\407535|concomitant|inhibitors (r_dep) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_appos) drugs_4\NNS\14778436|interfere (l_acl:relcl) interfere_6\VBP\2451370|that|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|hormonal
DDI-DrugBank.d604.s4.e8_DDI-DrugBank.d604.s4.e2 false phenytoin_27\NN\3550533| (r_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e8_DDI-DrugBank.d604.s4.e5 false phenytoin_27\NN\3550533| (r_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e9_DDI-DrugBank.d604.s4.e1 false carbamazepine_29\NN\1740| (r_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (r_nmod) use_12\NN\407535|concomitant|inhibitors (r_dep) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_appos) drugs_4\NNS\14778436|interfere (l_acl:relcl) interfere_6\VBP\2451370|that|contraceptives (l_nmod) contraceptives_9\NNS\3183080|with|hormonal
DDI-DrugBank.d604.s4.e9_DDI-DrugBank.d604.s4.e2 false carbamazepine_29\NN\1740| (r_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin (r_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (r_conj) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e9_DDI-DrugBank.d604.s4.e5 false carbamazepine_29\NN\1740| (r_conj) rifabutin_25\NN\1740|,|phenytoin|,|carbamazepine (r_conj) rifampin_23\NN\2716205|,|rifabutin (r_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e1_DDI-DrugBank.d604.s4.e2 false contraceptives_9\NNS\3183080|with|hormonal (r_nmod) interfere_6\VBP\2451370|that|contraceptives (r_acl:relcl) drugs_4\NNS\14778436|interfere (r_appos) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements
DDI-DrugBank.d604.s4.e1_DDI-DrugBank.d604.s4.e5 false contraceptives_9\NNS\3183080|with|hormonal (r_nmod) interfere_6\VBP\2451370|that|contraceptives (r_acl:relcl) drugs_4\NNS\14778436|interfere (r_appos) interactions_3\NNS\37396|important|non-thalidomide|drug|drugs|:|use (l_dep) use_12\NN\407535|concomitant|inhibitors (l_nmod) inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d604.s4.e2_DDI-DrugBank.d604.s4.e5 false inhibitors_15\NNS\20090|of|hiv-protease|,|griseofulvin|,|or|supplements (l_conj) griseofulvin_17\NN\2720201|,|modafinil|,|penicillins (l_conj) penicillins_21\NNS\2716866|,|rifampin
DDI-DrugBank.d578.s10
DDI-DrugBank.d578.s10.e0_DDI-DrugBank.d578.s10.e1 false methylprednisolone_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|methylprednisolone|anticoagulants (l_nmod) anticoagulants_6\NNS\3740161|on|oral
DDI-DrugBank.d779.s18
DDI-DrugBank.d584.s5
DDI-DrugBank.d584.s5.e0_DDI-DrugBank.d584.s5.e1 false warfarin_6\NN\2718259| (r_compound) dose_7\NN\3740161|in|the|mean|warfarin (r_nmod) decrease_2\NN\7296428|a|5.5-fold|dose|mg/day|mg/day|reduction|, (l_appos) reduction_20\NN\351485|(|%|dose|) (l_nmod) dose_23\NN\3740161|of|warfarin (l_compound) warfarin_22\NN\2718259|
DDI-DrugBank.d572.s6
DDI-DrugBank.d572.s6.e0_DDI-DrugBank.d572.s6.e1 false fenofibrate_0\NN\1740| (r_dep) increased_10\VBD\169651|fenofibrate|:|study|,|administration|concentrations|1.5-fold|. (l_nsubj) administration_9\NN\1133281|concomitant|fenofibrate (l_compound) fenofibrate_8\NN\1740|
DDI-DrugBank.d572.s6.e0_DDI-DrugBank.d572.s6.e2 false fenofibrate_0\NN\1740| (r_dep) increased_10\VBD\169651|fenofibrate|:|study|,|administration|concentrations|1.5-fold|. (l_dobj) concentrations_13\NNS\4916342|total|ezetimibe (l_compound) ezetimibe_12\NN\1740|
DDI-DrugBank.d572.s6.e1_DDI-DrugBank.d572.s6.e2 true fenofibrate_8\NN\1740| (r_compound) administration_9\NN\1133281|concomitant|fenofibrate (r_nsubj) increased_10\VBD\169651|fenofibrate|:|study|,|administration|concentrations|1.5-fold|. (l_dobj) concentrations_13\NNS\4916342|total|ezetimibe (l_compound) ezetimibe_12\NN\1740|
DDI-DrugBank.d670.s6
DDI-DrugBank.d670.s6.e0_DDI-DrugBank.d670.s6.e3 true paliperidone_6\NN\1740|of (r_nmod) effects_4\NNS\13245626|given|the|primary|cns|paliperidone (r_nmod) used_11\VBN\1156834|effects|,|invega|should|be|caution|combination|. (l_nmod) combination_15\NN\7951464|in|drugs (l_nmod) drugs_20\NNS\14778436|with|other|acting|and|alcohol (l_conj) alcohol_22\NN\7881800|
DDI-DrugBank.d670.s6.e0_DDI-DrugBank.d670.s6.e1 false paliperidone_6\NN\1740|of (r_nmod) effects_4\NNS\13245626|given|the|primary|cns|paliperidone (r_nmod) used_11\VBN\1156834|effects|,|invega|should|be|caution|combination|. (l_nsubjpass) invega_8\NNP\1740|
DDI-DrugBank.d670.s6.e0_DDI-DrugBank.d670.s6.e2 true paliperidone_6\NN\1740|of (r_nmod) effects_4\NNS\13245626|given|the|primary|cns|paliperidone (r_nmod) used_11\VBN\1156834|effects|,|invega|should|be|caution|combination|. (l_nmod) combination_15\NN\7951464|in|drugs (l_nmod) drugs_20\NNS\14778436|with|other|acting|and|alcohol
DDI-DrugBank.d670.s6.e3_DDI-DrugBank.d670.s6.e1 false alcohol_22\NN\7881800| (r_conj) drugs_20\NNS\14778436|with|other|acting|and|alcohol (r_nmod) combination_15\NN\7951464|in|drugs (r_nmod) used_11\VBN\1156834|effects|,|invega|should|be|caution|combination|. (l_nsubjpass) invega_8\NNP\1740|
DDI-DrugBank.d670.s6.e3_DDI-DrugBank.d670.s6.e2 false alcohol_22\NN\7881800| (r_conj) drugs_20\NNS\14778436|with|other|acting|and|alcohol
DDI-DrugBank.d670.s6.e1_DDI-DrugBank.d670.s6.e2 true invega_8\NNP\1740| (r_nsubjpass) used_11\VBN\1156834|effects|,|invega|should|be|caution|combination|. (l_nmod) combination_15\NN\7951464|in|drugs (l_nmod) drugs_20\NNS\14778436|with|other|acting|and|alcohol
DDI-DrugBank.d634.s4
DDI-DrugBank.d720.s3
DDI-DrugBank.d720.s3.e0_DDI-DrugBank.d720.s3.e1 true succinate_6\NN\1740|sumatriptan (r_compound) tablets_7\NNS\4233405|of|succinate (r_nmod) use_3\NN\407535|the|tablets|patients (l_nmod) patients_9\NNS\9898892|in|receiving (l_acl) receiving_10\VBG\2210855|inhibitors (l_dobj) inhibitors_12\NNS\20090|mao-a
DDI-DrugBank.d720.s3.e4_DDI-DrugBank.d720.s3.e5 false fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (l_conj) fluvoxamine_12\NN\1740|
DDI-DrugBank.d720.s3.e4_DDI-DrugBank.d720.s3.e6 false fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (l_conj) paroxetine_14\NN\1740|
DDI-DrugBank.d720.s3.e4_DDI-DrugBank.d720.s3.e7 false fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (l_appos) sertraline_16\NN\4169152|
DDI-DrugBank.d720.s3.e4_DDI-DrugBank.d720.s3.e8 false fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris (r_nsubjpass) reported_20\VBN\831651|inhibitors|have|been|,|rarely|,|cause|. (l_xcomp) cause_25\VB\1617192|to|weakness|coadministered (l_advcl) coadministered_33\VBN\1740|when|sumatriptan (l_nmod) sumatriptan_35\NN\1740|with
DDI-DrugBank.d720.s3.e4_DDI-DrugBank.d720.s3.e2 false fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris
DDI-DrugBank.d720.s3.e4_DDI-DrugBank.d720.s3.e3 false fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine
DDI-DrugBank.d720.s3.e5_DDI-DrugBank.d720.s3.e6 false fluvoxamine_12\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (l_conj) paroxetine_14\NN\1740|
DDI-DrugBank.d720.s3.e5_DDI-DrugBank.d720.s3.e7 false fluvoxamine_12\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (l_appos) sertraline_16\NN\4169152|
DDI-DrugBank.d720.s3.e5_DDI-DrugBank.d720.s3.e8 false fluvoxamine_12\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris (r_nsubjpass) reported_20\VBN\831651|inhibitors|have|been|,|rarely|,|cause|. (l_xcomp) cause_25\VB\1617192|to|weakness|coadministered (l_advcl) coadministered_33\VBN\1740|when|sumatriptan (l_nmod) sumatriptan_35\NN\1740|with
DDI-DrugBank.d720.s3.e5_DDI-DrugBank.d720.s3.e2 false fluvoxamine_12\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris
DDI-DrugBank.d720.s3.e5_DDI-DrugBank.d720.s3.e3 false fluvoxamine_12\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine
DDI-DrugBank.d720.s3.e6_DDI-DrugBank.d720.s3.e7 false paroxetine_14\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (l_appos) sertraline_16\NN\4169152|
DDI-DrugBank.d720.s3.e6_DDI-DrugBank.d720.s3.e8 false paroxetine_14\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris (r_nsubjpass) reported_20\VBN\831651|inhibitors|have|been|,|rarely|,|cause|. (l_xcomp) cause_25\VB\1617192|to|weakness|coadministered (l_advcl) coadministered_33\VBN\1740|when|sumatriptan (l_nmod) sumatriptan_35\NN\1740|with
DDI-DrugBank.d720.s3.e6_DDI-DrugBank.d720.s3.e2 false paroxetine_14\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris
DDI-DrugBank.d720.s3.e6_DDI-DrugBank.d720.s3.e3 false paroxetine_14\NN\1740| (r_conj) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine
DDI-DrugBank.d720.s3.e7_DDI-DrugBank.d720.s3.e8 false sertraline_16\NN\4169152| (r_appos) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris (r_nsubjpass) reported_20\VBN\831651|inhibitors|have|been|,|rarely|,|cause|. (l_xcomp) cause_25\VB\1617192|to|weakness|coadministered (l_advcl) coadministered_33\VBN\1740|when|sumatriptan (l_nmod) sumatriptan_35\NN\1740|with
DDI-DrugBank.d720.s3.e7_DDI-DrugBank.d720.s3.e2 false sertraline_16\NN\4169152| (r_appos) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine (r_appos) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris
DDI-DrugBank.d720.s3.e7_DDI-DrugBank.d720.s3.e3 false sertraline_16\NN\4169152| (r_appos) fluoxetine_10\NN\4169152|e.g.|,|,|fluvoxamine|,|paroxetine|,|sertraline|) (r_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine
DDI-DrugBank.d720.s3.e8_DDI-DrugBank.d720.s3.e2 false sumatriptan_35\NN\1740|with (r_nmod) coadministered_33\VBN\1740|when|sumatriptan (r_advcl) cause_25\VB\1617192|to|weakness|coadministered (r_xcomp) reported_20\VBN\831651|inhibitors|have|been|,|rarely|,|cause|. (l_nsubjpass) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris
DDI-DrugBank.d720.s3.e8_DDI-DrugBank.d720.s3.e3 false sumatriptan_35\NN\1740|with (r_nmod) coadministered_33\VBN\1740|when|sumatriptan (r_advcl) cause_25\VB\1617192|to|weakness|coadministered (r_xcomp) reported_20\VBN\831651|inhibitors|have|been|,|rarely|,|cause|. (l_nsubjpass) inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris (l_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine
DDI-DrugBank.d720.s3.e2_DDI-DrugBank.d720.s3.e3 false inhibitors_3\NNS\20090|selective|serotonin|reuptake|ssris (l_appos) ssris_5\NNS\2718811|(|)|(|fluoxetine
DDI-DrugBank.d770.s1
DDI-DrugBank.d599.s7
DDI-DrugBank.d599.s7.e0_DDI-DrugBank.d599.s7.e4 true gh_4\NN\1740| (r_compound) administration_5\NN\1133281|gh (r_nsubj) alter_7\VB\126264|that|administration|may|clearance (l_dobj) clearance_9\NN\5089947|the|compounds (l_nmod) compounds_11\NNS\5869584|of|known|(|corticosteroids (l_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) cyclosporin_30\NN\1740|
DDI-DrugBank.d599.s7.e0_DDI-DrugBank.d599.s7.e1 true gh_4\NN\1740| (r_compound) administration_5\NN\1133281|gh (r_nsubj) alter_7\VB\126264|that|administration|may|clearance (l_dobj) clearance_9\NN\5089947|the|compounds (l_nmod) compounds_11\NNS\5869584|of|known|(|corticosteroids (l_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|)
DDI-DrugBank.d599.s7.e0_DDI-DrugBank.d599.s7.e2 true gh_4\NN\1740| (r_compound) administration_5\NN\1133281|gh (r_nsubj) alter_7\VB\126264|that|administration|may|clearance (l_dobj) clearance_9\NN\5089947|the|compounds (l_nmod) compounds_11\NNS\5869584|of|known|(|corticosteroids (l_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) steroids_26\NNS\14727670|sex
DDI-DrugBank.d599.s7.e0_DDI-DrugBank.d599.s7.e3 true gh_4\NN\1740| (r_compound) administration_5\NN\1133281|gh (r_nsubj) alter_7\VB\126264|that|administration|may|clearance (l_dobj) clearance_9\NN\5089947|the|compounds (l_nmod) compounds_11\NNS\5869584|of|known|(|corticosteroids (l_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) anticonvulsants_28\NNS\3740161|
DDI-DrugBank.d599.s7.e4_DDI-DrugBank.d599.s7.e1 false cyclosporin_30\NN\1740| (r_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|)
DDI-DrugBank.d599.s7.e4_DDI-DrugBank.d599.s7.e2 false cyclosporin_30\NN\1740| (r_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) steroids_26\NNS\14727670|sex
DDI-DrugBank.d599.s7.e4_DDI-DrugBank.d599.s7.e3 false cyclosporin_30\NN\1740| (r_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) anticonvulsants_28\NNS\3740161|
DDI-DrugBank.d599.s7.e1_DDI-DrugBank.d599.s7.e2 false corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) steroids_26\NNS\14727670|sex
DDI-DrugBank.d599.s7.e1_DDI-DrugBank.d599.s7.e3 false corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) anticonvulsants_28\NNS\3740161|
DDI-DrugBank.d599.s7.e2_DDI-DrugBank.d599.s7.e3 false steroids_26\NNS\14727670|sex (r_appos) corticosteroids_23\NNS\14745635|e.g.|,|,|steroids|,|anticonvulsants|,|cyclosporin|) (l_appos) anticonvulsants_28\NNS\3740161|
DDI-DrugBank.d572.s24
DDI-DrugBank.d572.s24.e0_DDI-DrugBank.d572.s24.e3 false ezetimibe_4\NN\1740|of|given (r_nmod) studies_2\NNS\635850|multiple|dose|ezetimibe (r_nsubj) result_21\VBP\2633881|studies|exposures|. (l_nmod) exposures_27\NNS\5042871|in|ezetimibe (l_compound) ezetimibe_24\NN\1740|higher|and|statin
DDI-DrugBank.d572.s24.e0_DDI-DrugBank.d572.s24.e1 false ezetimibe_4\NN\1740|of|given (l_acl) given_5\VBN\2327200|combination|rats|organogenesis (l_nmod) combination_7\NN\7951464|in|inhibitors (l_nmod) inhibitors_11\NNS\20090|with|hmg-coa|reductase|statins
DDI-DrugBank.d572.s24.e0_DDI-DrugBank.d572.s24.e2 false ezetimibe_4\NN\1740|of|given (l_acl) given_5\VBN\2327200|combination|rats|organogenesis (l_nmod) combination_7\NN\7951464|in|inhibitors (l_nmod) inhibitors_11\NNS\20090|with|hmg-coa|reductase|statins (l_appos) statins_13\NNS\3740161|(|)
DDI-DrugBank.d572.s24.e3_DDI-DrugBank.d572.s24.e1 false ezetimibe_24\NN\1740|higher|and|statin (r_compound) exposures_27\NNS\5042871|in|ezetimibe (r_nmod) result_21\VBP\2633881|studies|exposures|. (l_nsubj) studies_2\NNS\635850|multiple|dose|ezetimibe (l_nmod) ezetimibe_4\NN\1740|of|given (l_acl) given_5\VBN\2327200|combination|rats|organogenesis (l_nmod) combination_7\NN\7951464|in|inhibitors (l_nmod) inhibitors_11\NNS\20090|with|hmg-coa|reductase|statins
DDI-DrugBank.d572.s24.e3_DDI-DrugBank.d572.s24.e2 false ezetimibe_24\NN\1740|higher|and|statin (r_compound) exposures_27\NNS\5042871|in|ezetimibe (r_nmod) result_21\VBP\2633881|studies|exposures|. (l_nsubj) studies_2\NNS\635850|multiple|dose|ezetimibe (l_nmod) ezetimibe_4\NN\1740|of|given (l_acl) given_5\VBN\2327200|combination|rats|organogenesis (l_nmod) combination_7\NN\7951464|in|inhibitors (l_nmod) inhibitors_11\NNS\20090|with|hmg-coa|reductase|statins (l_appos) statins_13\NNS\3740161|(|)
DDI-DrugBank.d572.s24.e1_DDI-DrugBank.d572.s24.e2 false inhibitors_11\NNS\20090|with|hmg-coa|reductase|statins (l_appos) statins_13\NNS\3740161|(|)
DDI-DrugBank.d779.s2
DDI-DrugBank.d779.s2.e1_DDI-DrugBank.d779.s2.e0 false methyldopa_9\NN\2721160|on (r_nmod) require_2\VB\754942|patients|may|doses|methyldopa|. (l_dobj) doses_4\NNS\3740161|reduced|anesthetics (l_nmod) anesthetics_6\NNS\3247620|of
DDI-DrugBank.d641.s5
DDI-DrugBank.d641.s5.e0_DDI-DrugBank.d641.s5.e3 false alimta_9\NN\1740|between|and|nsaids (r_nmod) interaction_7\NN\37396|regarding|potential|alimta (r_nmod) data_4\NNS\7951464|of|interaction (r_nmod) absence_2\NN\14449405|in|the|data (r_nmod) interrupt_22\VB\362348|absence|,|patients|should|dosing|days|day|. (l_nmod) day_32\NN\15154774|before|,|the|of|,|and|days|following|administration (l_appos) administration_40\NN\1133281|alimta (l_compound) alimta_39\NN\1740|
DDI-DrugBank.d641.s5.e0_DDI-DrugBank.d641.s5.e1 false alimta_9\NN\1740|between|and|nsaids (l_conj) nsaids_11\NNS\2721538|half-lives
DDI-DrugBank.d641.s5.e0_DDI-DrugBank.d641.s5.e2 false alimta_9\NN\1740|between|and|nsaids (r_nmod) interaction_7\NN\37396|regarding|potential|alimta (r_nmod) data_4\NNS\7951464|of|interaction (r_nmod) absence_2\NN\14449405|in|the|data (r_nmod) interrupt_22\VB\362348|absence|,|patients|should|dosing|days|day|. (l_nsubj) patients_17\NNS\9898892|all|taking (l_acl) taking_18\VBG\2367363|nsaids (l_dobj) nsaids_20\NNS\2721538|these
DDI-DrugBank.d641.s5.e3_DDI-DrugBank.d641.s5.e1 false alimta_39\NN\1740| (r_compound) administration_40\NN\1133281|alimta (r_appos) day_32\NN\15154774|before|,|the|of|,|and|days|following|administration (r_nmod) interrupt_22\VB\362348|absence|,|patients|should|dosing|days|day|. (l_nmod) absence_2\NN\14449405|in|the|data (l_nmod) data_4\NNS\7951464|of|interaction (l_nmod) interaction_7\NN\37396|regarding|potential|alimta (l_nmod) alimta_9\NN\1740|between|and|nsaids (l_conj) nsaids_11\NNS\2721538|half-lives
DDI-DrugBank.d641.s5.e3_DDI-DrugBank.d641.s5.e2 false alimta_39\NN\1740| (r_compound) administration_40\NN\1133281|alimta (r_appos) day_32\NN\15154774|before|,|the|of|,|and|days|following|administration (r_nmod) interrupt_22\VB\362348|absence|,|patients|should|dosing|days|day|. (l_nsubj) patients_17\NNS\9898892|all|taking (l_acl) taking_18\VBG\2367363|nsaids (l_dobj) nsaids_20\NNS\2721538|these
DDI-DrugBank.d641.s5.e1_DDI-DrugBank.d641.s5.e2 false nsaids_11\NNS\2721538|half-lives (r_conj) alimta_9\NN\1740|between|and|nsaids (r_nmod) interaction_7\NN\37396|regarding|potential|alimta (r_nmod) data_4\NNS\7951464|of|interaction (r_nmod) absence_2\NN\14449405|in|the|data (r_nmod) interrupt_22\VB\362348|absence|,|patients|should|dosing|days|day|. (l_nsubj) patients_17\NNS\9898892|all|taking (l_acl) taking_18\VBG\2367363|nsaids (l_dobj) nsaids_20\NNS\2721538|these
DDI-DrugBank.d639.s1
DDI-DrugBank.d579.s1
DDI-DrugBank.d579.s1.e0_DDI-DrugBank.d579.s1.e2 true mecamylamine_3\NN\1740|of (r_nmod) action_1\NN\30358|the|mecamylamine (r_nsubjpass) potentiated_6\VBN\229605|action|may|be|anesthesia|. (l_nmod) anesthesia_8\NN\14034177|by|,|drugs (l_conj) drugs_12\NNS\14778436|other|antihypertensive|and|alcohol (l_conj) alcohol_14\NN\7881800|
DDI-DrugBank.d579.s1.e0_DDI-DrugBank.d579.s1.e1 true mecamylamine_3\NN\1740|of (r_nmod) action_1\NN\30358|the|mecamylamine (r_nsubjpass) potentiated_6\VBN\229605|action|may|be|anesthesia|. (l_nmod) anesthesia_8\NN\14034177|by|,|drugs (l_conj) drugs_12\NNS\14778436|other|antihypertensive|and|alcohol
DDI-DrugBank.d579.s1.e2_DDI-DrugBank.d579.s1.e1 false alcohol_14\NN\7881800| (r_conj) drugs_12\NNS\14778436|other|antihypertensive|and|alcohol
DDI-DrugBank.d737.s10
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e9 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_dobj) effectiveness_34\NN\5190804|the|mirapex (l_nmod) mirapex_36\NN\1740|of
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e0 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (r_dep) antagonists_1\NNS\7846|dopamine|:|possible|.
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e2 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e3 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|,
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e4 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e5 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|)
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e6 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) butyrophenones_24\NNS\1740|
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e7 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e1_DDI-DrugBank.d737.s10.e8 false pramipexole_4\NN\1740| (r_nsubj) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e0 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (r_ccomp) possible_12\JJ\1740|agonist|,|it|is|diminish (r_dep) antagonists_1\NNS\7846|dopamine|:|possible|.
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e2 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (r_ccomp) possible_12\JJ\1740|agonist|,|it|is|diminish (l_advcl) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e3 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|,
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e4 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e5 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|)
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e6 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) butyrophenones_24\NNS\1740|
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e7 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e9_DDI-DrugBank.d737.s10.e8 false mirapex_36\NN\1740|of (r_nmod) effectiveness_34\NN\5190804|the|mirapex (r_dobj) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e0_DDI-DrugBank.d737.s10.e2 false antagonists_1\NNS\7846|dopamine|:|possible|. (l_dep) possible_12\JJ\1740|agonist|,|it|is|diminish (l_advcl) agonist_8\NN\9613191|since|pramipexole|is|a|dopamine
DDI-DrugBank.d737.s10.e0_DDI-DrugBank.d737.s10.e3 false antagonists_1\NNS\7846|dopamine|:|possible|. (l_dep) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|,
DDI-DrugBank.d737.s10.e0_DDI-DrugBank.d737.s10.e4 false antagonists_1\NNS\7846|dopamine|:|possible|. (l_dep) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d737.s10.e0_DDI-DrugBank.d737.s10.e5 false antagonists_1\NNS\7846|dopamine|:|possible|. (l_dep) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|)
DDI-DrugBank.d737.s10.e0_DDI-DrugBank.d737.s10.e6 false antagonists_1\NNS\7846|dopamine|:|possible|. (l_dep) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) butyrophenones_24\NNS\1740|
DDI-DrugBank.d737.s10.e0_DDI-DrugBank.d737.s10.e7 false antagonists_1\NNS\7846|dopamine|:|possible|. (l_dep) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e0_DDI-DrugBank.d737.s10.e8 false antagonists_1\NNS\7846|dopamine|:|possible|. (l_dep) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e2_DDI-DrugBank.d737.s10.e3 false agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|,
DDI-DrugBank.d737.s10.e2_DDI-DrugBank.d737.s10.e4 false agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d737.s10.e2_DDI-DrugBank.d737.s10.e5 false agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|)
DDI-DrugBank.d737.s10.e2_DDI-DrugBank.d737.s10.e6 false agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) butyrophenones_24\NNS\1740|
DDI-DrugBank.d737.s10.e2_DDI-DrugBank.d737.s10.e7 false agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e2_DDI-DrugBank.d737.s10.e8 false agonist_8\NN\9613191|since|pramipexole|is|a|dopamine (r_advcl) possible_12\JJ\1740|agonist|,|it|is|diminish (l_ccomp) diminish_32\VB\169651|that|antagonists|may|effectiveness (l_nsubj) antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e3_DDI-DrugBank.d737.s10.e4 false antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d737.s10.e3_DDI-DrugBank.d737.s10.e5 false antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|)
DDI-DrugBank.d737.s10.e3_DDI-DrugBank.d737.s10.e6 false antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) butyrophenones_24\NNS\1740|
DDI-DrugBank.d737.s10.e3_DDI-DrugBank.d737.s10.e7 false antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e3_DDI-DrugBank.d737.s10.e8 false antagonists_15\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e4_DDI-DrugBank.d737.s10.e5 false neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|)
DDI-DrugBank.d737.s10.e4_DDI-DrugBank.d737.s10.e6 false neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) butyrophenones_24\NNS\1740|
DDI-DrugBank.d737.s10.e4_DDI-DrugBank.d737.s10.e7 false neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e4_DDI-DrugBank.d737.s10.e8 false neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e5_DDI-DrugBank.d737.s10.e6 false phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) butyrophenones_24\NNS\1740|
DDI-DrugBank.d737.s10.e5_DDI-DrugBank.d737.s10.e7 false phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e5_DDI-DrugBank.d737.s10.e8 false phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (r_dep) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e6_DDI-DrugBank.d737.s10.e7 false butyrophenones_24\NNS\1740| (r_appos) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (l_appos) thioxanthenes_26\NNS\1740|
DDI-DrugBank.d737.s10.e6_DDI-DrugBank.d737.s10.e8 false butyrophenones_24\NNS\1740| (r_appos) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (r_dep) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d737.s10.e7_DDI-DrugBank.d737.s10.e8 false thioxanthenes_26\NNS\1740| (r_appos) phenothiazines_22\NNS\14771088|(|,|butyrophenones|,|thioxanthenes|) (r_dep) neuroleptics_20\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_conj) metoclopramide_29\NN\1740|
DDI-DrugBank.d641.s1
DDI-DrugBank.d653.s8
DDI-DrugBank.d653.s8.e0_DDI-DrugBank.d653.s8.e1 true anticoagulants_11\NNS\3740161|of (r_nmod) effects_9\NNS\13245626|of|enhanced|diminished|anticoagulants (r_nmod) reports_2\NNS\6470073|effects (r_attr) are_1\VBP\836236|there|reports|given|. (l_advcl) given_13\VBN\2327200|when|concurrently|corticosteroids (l_nmod) corticosteroids_16\NNS\14745635|with
DDI-DrugBank.d576.s5
DDI-DrugBank.d576.s5.e0_DDI-DrugBank.d576.s5.e1 true salicylates_0\NNS\3828465| (r_nsubj) enhance_2\VB\227165|salicylates|may|effect|. (l_dobj) effect_5\NN\34213|the|hypoglycemic|drugs (l_nmod) drugs_9\NNS\14778436|of|oral|antidiabetic|class
DDI-DrugBank.d742.s3
DDI-DrugBank.d633.s6
DDI-DrugBank.d633.s6.e0_DDI-DrugBank.d633.s6.e1 false mexiletine_10\NN\2715941|with (r_nmod) administration_2\NN\1133281|concomitant|either|mexiletine (r_nsubjpass) initiated_12\VBN\1617192|when|administration|is (r_advcl) titrated_21\VBN\489837|initiated|,|dose|should|be|slowly|effect|. (l_nsubjpass) dose_15\NN\3740161|the|mexiletine (l_nmod) mexiletine_17\NN\2715941|of
DDI-DrugBank.d659.s6
DDI-DrugBank.d700.s10
DDI-DrugBank.d700.s10.e0_DDI-DrugBank.d700.s10.e1 true levonorgesterol_9\NN\1740| (r_compound) auc_10\NN\1740|mean|levonorgesterol (r_nsubjpass) decreased_12\VBN\169651|however|,|study|,|auc|was|%|coadministered|. (l_advcl) coadministered_17\VBN\1740|when|mofetil (l_nmod) mofetil_20\NN\1740|with|mycophenolate
DDI-DrugBank.d572.s33
DDI-DrugBank.d595.s3
DDI-DrugBank.d591.s0
DDI-DrugBank.d591.s0.e0_DDI-DrugBank.d591.s0.e1 true ropivacaine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|ropivacaine|should|be|caution|patients|,|additive|. (l_nmod) patients_7\NNS\9898892|in|receiving (l_acl) receiving_8\VBG\2210855|anesthetics (l_dobj) anesthetics_11\NNS\3247620|other|local|or|agents
DDI-DrugBank.d591.s0.e0_DDI-DrugBank.d591.s0.e2 false ropivacaine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|ropivacaine|should|be|caution|patients|,|additive|. (l_nmod) patients_7\NNS\9898892|in|receiving (l_acl) receiving_8\VBG\2210855|anesthetics (l_dobj) anesthetics_11\NNS\3247620|other|local|or|agents (l_conj) agents_13\NNS\7347|related (l_amod) related_15\JJ\1740|structurally|anesthetics (l_nmod) anesthetics_19\NNS\3247620|to|amide-type|local
DDI-DrugBank.d591.s0.e1_DDI-DrugBank.d591.s0.e2 false anesthetics_11\NNS\3247620|other|local|or|agents (l_conj) agents_13\NNS\7347|related (l_amod) related_15\JJ\1740|structurally|anesthetics (l_nmod) anesthetics_19\NNS\3247620|to|amide-type|local
DDI-DrugBank.d636.s3
DDI-DrugBank.d636.s3.e0_DDI-DrugBank.d636.s3.e2 true mephenytoin_0\NN\2718469| (r_nsubj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_dobj) effects_5\NNS\13245626|the|drugs (l_nmod) drugs_8\NNS\14778436|of|other|,|include (l_acl:relcl) include_11\VBP\690614|which|medications (l_dobj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) warfarin_16\NN\2718259|
DDI-DrugBank.d636.s3.e0_DDI-DrugBank.d636.s3.e4 true mephenytoin_0\NN\2718469| (r_nsubj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_dobj) effects_5\NNS\13245626|the|drugs (l_nmod) drugs_8\NNS\14778436|of|other|,|include (l_acl:relcl) include_11\VBP\690614|which|medications (l_dobj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) furosemide_29\NN\3214670|and|theophylline
DDI-DrugBank.d636.s3.e0_DDI-DrugBank.d636.s3.e5 true mephenytoin_0\NN\2718469| (r_nsubj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_dobj) effects_5\NNS\13245626|the|drugs (l_nmod) drugs_8\NNS\14778436|of|other|,|include (l_acl:relcl) include_11\VBP\690614|which|medications (l_dobj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) furosemide_29\NN\3214670|and|theophylline (l_conj) theophylline_31\NN\2905612|
DDI-DrugBank.d636.s3.e0_DDI-DrugBank.d636.s3.e6 false mephenytoin_0\NN\2718469| (r_nsubj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_xcomp) note_33\VB\1009240|please|interact (l_ccomp) interact_37\VB\2367363|that|mephenytoin|may|drugs (l_nsubj) mephenytoin_35\NN\2718469|
DDI-DrugBank.d636.s3.e0_DDI-DrugBank.d636.s3.e1 true mephenytoin_0\NN\2718469| (r_nsubj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_dobj) effects_5\NNS\13245626|the|drugs (l_nmod) drugs_8\NNS\14778436|of|other|,|include (l_acl:relcl) include_11\VBP\690614|which|medications (l_dobj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide
DDI-DrugBank.d636.s3.e0_DDI-DrugBank.d636.s3.e3 true mephenytoin_0\NN\2718469| (r_nsubj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_dobj) effects_5\NNS\13245626|the|drugs (l_nmod) drugs_8\NNS\14778436|of|other|,|include (l_acl:relcl) include_11\VBP\690614|which|medications (l_dobj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) medicines_27\NNS\6045562|anti-infective
DDI-DrugBank.d636.s3.e2_DDI-DrugBank.d636.s3.e4 false warfarin_16\NN\2718259| (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) furosemide_29\NN\3214670|and|theophylline
DDI-DrugBank.d636.s3.e2_DDI-DrugBank.d636.s3.e5 false warfarin_16\NN\2718259| (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) furosemide_29\NN\3214670|and|theophylline (l_conj) theophylline_31\NN\2905612|
DDI-DrugBank.d636.s3.e2_DDI-DrugBank.d636.s3.e6 false warfarin_16\NN\2718259| (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (r_dobj) include_11\VBP\690614|which|medications (r_acl:relcl) drugs_8\NNS\14778436|of|other|,|include (r_nmod) effects_5\NNS\13245626|the|drugs (r_dobj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_xcomp) note_33\VB\1009240|please|interact (l_ccomp) interact_37\VB\2367363|that|mephenytoin|may|drugs (l_nsubj) mephenytoin_35\NN\2718469|
DDI-DrugBank.d636.s3.e2_DDI-DrugBank.d636.s3.e1 false warfarin_16\NN\2718259| (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide
DDI-DrugBank.d636.s3.e2_DDI-DrugBank.d636.s3.e3 false warfarin_16\NN\2718259| (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) medicines_27\NNS\6045562|anti-infective
DDI-DrugBank.d636.s3.e4_DDI-DrugBank.d636.s3.e5 false furosemide_29\NN\3214670|and|theophylline (l_conj) theophylline_31\NN\2905612|
DDI-DrugBank.d636.s3.e4_DDI-DrugBank.d636.s3.e6 false furosemide_29\NN\3214670|and|theophylline (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (r_dobj) include_11\VBP\690614|which|medications (r_acl:relcl) drugs_8\NNS\14778436|of|other|,|include (r_nmod) effects_5\NNS\13245626|the|drugs (r_dobj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_xcomp) note_33\VB\1009240|please|interact (l_ccomp) interact_37\VB\2367363|that|mephenytoin|may|drugs (l_nsubj) mephenytoin_35\NN\2718469|
DDI-DrugBank.d636.s3.e4_DDI-DrugBank.d636.s3.e1 false furosemide_29\NN\3214670|and|theophylline (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide
DDI-DrugBank.d636.s3.e4_DDI-DrugBank.d636.s3.e3 false furosemide_29\NN\3214670|and|theophylline (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) medicines_27\NNS\6045562|anti-infective
DDI-DrugBank.d636.s3.e5_DDI-DrugBank.d636.s3.e6 false theophylline_31\NN\2905612| (r_conj) furosemide_29\NN\3214670|and|theophylline (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (r_dobj) include_11\VBP\690614|which|medications (r_acl:relcl) drugs_8\NNS\14778436|of|other|,|include (r_nmod) effects_5\NNS\13245626|the|drugs (r_dobj) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_xcomp) note_33\VB\1009240|please|interact (l_ccomp) interact_37\VB\2367363|that|mephenytoin|may|drugs (l_nsubj) mephenytoin_35\NN\2718469|
DDI-DrugBank.d636.s3.e5_DDI-DrugBank.d636.s3.e1 false theophylline_31\NN\2905612| (r_conj) furosemide_29\NN\3214670|and|theophylline (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide
DDI-DrugBank.d636.s3.e5_DDI-DrugBank.d636.s3.e3 false theophylline_31\NN\2905612| (r_conj) furosemide_29\NN\3214670|and|theophylline (r_conj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) medicines_27\NNS\6045562|anti-infective
DDI-DrugBank.d636.s3.e6_DDI-DrugBank.d636.s3.e1 false mephenytoin_35\NN\2718469| (r_nsubj) interact_37\VB\2367363|that|mephenytoin|may|drugs (r_ccomp) note_33\VB\1009240|please|interact (r_xcomp) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_dobj) effects_5\NNS\13245626|the|drugs (l_nmod) drugs_8\NNS\14778436|of|other|,|include (l_acl:relcl) include_11\VBP\690614|which|medications (l_dobj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide
DDI-DrugBank.d636.s3.e6_DDI-DrugBank.d636.s3.e3 false mephenytoin_35\NN\2718469| (r_nsubj) interact_37\VB\2367363|that|mephenytoin|may|drugs (r_ccomp) note_33\VB\1009240|please|interact (r_xcomp) affect_3\VB\126264|mephenytoin|may|also|effects|note|. (l_dobj) effects_5\NNS\13245626|the|drugs (l_nmod) drugs_8\NNS\14778436|of|other|,|include (l_acl:relcl) include_11\VBP\690614|which|medications (l_dobj) medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) medicines_27\NNS\6045562|anti-infective
DDI-DrugBank.d636.s3.e1_DDI-DrugBank.d636.s3.e3 false medications_14\NNS\3247620|some|steroid|,|warfarin|,|medicines|,|pills|,|medicines|,|furosemide (l_conj) medicines_27\NNS\6045562|anti-infective
DDI-DrugBank.d597.s24
DDI-DrugBank.d597.s24.e0_DDI-DrugBank.d597.s24.e1 false meloxicam_0\NN\1740| (r_nsubj) have_3\VB\2108377|meloxicam|did|not|effect|pharmacokinetics|. (l_nmod) pharmacokinetics_9\NNS\6054892|on|the|doses (l_nmod) doses_12\NNS\3740161|of|single|methotrexate (l_nmod) methotrexate_14\NN\2722166|of
DDI-DrugBank.d588.s6
DDI-DrugBank.d588.s6.e1_DDI-DrugBank.d588.s6.e0 false acth_2\NN\5407119| (r_conj) corticosteroids_0\NNS\14745635|or|acth|:
DDI-DrugBank.d756.s4
DDI-DrugBank.d756.s4.e0_DDI-DrugBank.d756.s4.e1 true levomepromazine_5\NN\1740| (r_dobj) combining_4\VBG\2630189|in|levomepromazine|drugs (l_nmod) drugs_9\NNS\14778436|with|other|anticholinergic|antidepressants
DDI-DrugBank.d756.s4.e0_DDI-DrugBank.d756.s4.e2 true levomepromazine_5\NN\1740| (r_dobj) combining_4\VBG\2630189|in|levomepromazine|drugs (l_nmod) drugs_9\NNS\14778436|with|other|anticholinergic|antidepressants (l_dep) antidepressants_12\NNS\3740161|(|tricyclic|and|antiparkinsonian-agents
DDI-DrugBank.d756.s4.e0_DDI-DrugBank.d756.s4.e3 true levomepromazine_5\NN\1740| (r_dobj) combining_4\VBG\2630189|in|levomepromazine|drugs (l_nmod) drugs_9\NNS\14778436|with|other|anticholinergic|antidepressants (l_dep) antidepressants_12\NNS\3740161|(|tricyclic|and|antiparkinsonian-agents (l_conj) antiparkinsonian-agents_14\JJ\1740|
DDI-DrugBank.d756.s4.e1_DDI-DrugBank.d756.s4.e2 false drugs_9\NNS\14778436|with|other|anticholinergic|antidepressants (l_dep) antidepressants_12\NNS\3740161|(|tricyclic|and|antiparkinsonian-agents
DDI-DrugBank.d756.s4.e1_DDI-DrugBank.d756.s4.e3 false drugs_9\NNS\14778436|with|other|anticholinergic|antidepressants (l_dep) antidepressants_12\NNS\3740161|(|tricyclic|and|antiparkinsonian-agents (l_conj) antiparkinsonian-agents_14\JJ\1740|
DDI-DrugBank.d756.s4.e2_DDI-DrugBank.d756.s4.e3 false antidepressants_12\NNS\3740161|(|tricyclic|and|antiparkinsonian-agents (l_conj) antiparkinsonian-agents_14\JJ\1740|
DDI-DrugBank.d728.s1
DDI-DrugBank.d728.s1.e1_DDI-DrugBank.d728.s1.e0 false 5-fu_9\NN\1740|infusional (r_conj) eloxatin_6\NN\1740|between|85|mg/m2|and|5-fu
DDI-DrugBank.d640.s10
DDI-DrugBank.d640.s10.e4_DDI-DrugBank.d640.s10.e0 false digoxin_17\NN\15060131|,|agents (r_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (r_conj) agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics (r_nmod) used_3\VBN\1156834|univasc|has|been|trials|concomitantly|agents|. (l_nsubjpass) univasc_0\NNP\1740|
DDI-DrugBank.d640.s10.e4_DDI-DrugBank.d640.s10.e1 false digoxin_17\NN\15060131|,|agents (r_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (r_conj) agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics
DDI-DrugBank.d640.s10.e4_DDI-DrugBank.d640.s10.e2 false digoxin_17\NN\15060131|,|agents (r_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin
DDI-DrugBank.d640.s10.e4_DDI-DrugBank.d640.s10.e3 false digoxin_17\NN\15060131|,|agents (r_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) blockers_15\NNS\10101634|h2
DDI-DrugBank.d640.s10.e4_DDI-DrugBank.d640.s10.e5 false digoxin_17\NN\15060131|,|agents (l_conj) agents_21\NNS\7347|oral|hypoglycemic|,|and|agents
DDI-DrugBank.d640.s10.e0_DDI-DrugBank.d640.s10.e1 false univasc_0\NNP\1740| (r_nsubjpass) used_3\VBN\1156834|univasc|has|been|trials|concomitantly|agents|. (l_nmod) agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics
DDI-DrugBank.d640.s10.e0_DDI-DrugBank.d640.s10.e2 false univasc_0\NNP\1740| (r_nsubjpass) used_3\VBN\1156834|univasc|has|been|trials|concomitantly|agents|. (l_nmod) agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics (l_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin
DDI-DrugBank.d640.s10.e0_DDI-DrugBank.d640.s10.e3 false univasc_0\NNP\1740| (r_nsubjpass) used_3\VBN\1156834|univasc|has|been|trials|concomitantly|agents|. (l_nmod) agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics (l_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) blockers_15\NNS\10101634|h2
DDI-DrugBank.d640.s10.e0_DDI-DrugBank.d640.s10.e5 false univasc_0\NNP\1740| (r_nsubjpass) used_3\VBN\1156834|univasc|has|been|trials|concomitantly|agents|. (l_nmod) agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics (l_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) digoxin_17\NN\15060131|,|agents (l_conj) agents_21\NNS\7347|oral|hypoglycemic|,|and|agents
DDI-DrugBank.d640.s10.e1_DDI-DrugBank.d640.s10.e2 false agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics (l_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin
DDI-DrugBank.d640.s10.e1_DDI-DrugBank.d640.s10.e3 false agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics (l_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) blockers_15\NNS\10101634|h2
DDI-DrugBank.d640.s10.e1_DDI-DrugBank.d640.s10.e5 false agents_10\NNS\7347|with|calcium-channel-blocking|,|diuretics (l_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) digoxin_17\NN\15060131|,|agents (l_conj) agents_21\NNS\7347|oral|hypoglycemic|,|and|agents
DDI-DrugBank.d640.s10.e2_DDI-DrugBank.d640.s10.e3 false diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) blockers_15\NNS\10101634|h2
DDI-DrugBank.d640.s10.e2_DDI-DrugBank.d640.s10.e5 false diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) digoxin_17\NN\15060131|,|agents (l_conj) agents_21\NNS\7347|oral|hypoglycemic|,|and|agents
DDI-DrugBank.d640.s10.e3_DDI-DrugBank.d640.s10.e5 false blockers_15\NNS\10101634|h2 (r_conj) diuretics_12\NNS\3247620|,|blockers|,|digoxin (l_conj) digoxin_17\NN\15060131|,|agents (l_conj) agents_21\NNS\7347|oral|hypoglycemic|,|and|agents
DDI-DrugBank.d641.s2
DDI-DrugBank.d641.s2.e0_DDI-DrugBank.d641.s2.e1 true probenecid_12\NN\3740161|(|e.g.|,|) (r_appos) substances_3\NNS\20827|of|secreted|probenecid (r_nmod) administration_1\NN\1133281|concomitant|substances (r_nsubj) result_16\VB\2633881|administration|could|potentially|clearance|. (l_nmod) clearance_19\NN\5089947|in|delayed|alimta (l_nmod) alimta_21\NN\1740|of
DDI-DrugBank.d736.s1
DDI-DrugBank.d736.s1.e1_DDI-DrugBank.d736.s1.e0 false acth_9\NN\5407119| (r_conj) steroids_7\NNS\14727670|of|or|acth
DDI-DrugBank.d756.s8
DDI-DrugBank.d696.s1
DDI-DrugBank.d696.s1.e2_DDI-DrugBank.d696.s1.e3 false sumatriptan_9\NN\1740| (r_conj) alkaloids_7\NNS\14727670|including|ergot|,|sumatriptan|,|and|nicotine (l_conj) nicotine_12\NN\14712692|(|smoking
DDI-DrugBank.d696.s1.e2_DDI-DrugBank.d696.s1.e0 false sumatriptan_9\NN\1740| (r_conj) alkaloids_7\NNS\14727670|including|ergot|,|sumatriptan|,|and|nicotine (r_nmod) agents_4\NNS\7347|with|vasoconstrictor|alkaloids
DDI-DrugBank.d696.s1.e2_DDI-DrugBank.d696.s1.e1 false sumatriptan_9\NN\1740| (r_conj) alkaloids_7\NNS\14727670|including|ergot|,|sumatriptan|,|and|nicotine
DDI-DrugBank.d696.s1.e3_DDI-DrugBank.d696.s1.e0 false nicotine_12\NN\14712692|(|smoking (r_conj) alkaloids_7\NNS\14727670|including|ergot|,|sumatriptan|,|and|nicotine (r_nmod) agents_4\NNS\7347|with|vasoconstrictor|alkaloids
DDI-DrugBank.d696.s1.e3_DDI-DrugBank.d696.s1.e1 false nicotine_12\NN\14712692|(|smoking (r_conj) alkaloids_7\NNS\14727670|including|ergot|,|sumatriptan|,|and|nicotine
DDI-DrugBank.d696.s1.e0_DDI-DrugBank.d696.s1.e1 false agents_4\NNS\7347|with|vasoconstrictor|alkaloids (l_nmod) alkaloids_7\NNS\14727670|including|ergot|,|sumatriptan|,|and|nicotine
DDI-DrugBank.d633.s12
DDI-DrugBank.d633.s12.e1_DDI-DrugBank.d633.s12.e3 false digoxin_17\NN\15060131|,|diuretics|,|or|propranolol (l_conj) propranolol_22\NN\1740|
DDI-DrugBank.d633.s12.e1_DDI-DrugBank.d633.s12.e0 false digoxin_17\NN\15060131|,|diuretics|,|or|propranolol (r_conj) mexitil_15\NN\2715941|by|concurrent|and|digoxin
DDI-DrugBank.d633.s12.e1_DDI-DrugBank.d633.s12.e2 false digoxin_17\NN\15060131|,|diuretics|,|or|propranolol (l_conj) diuretics_19\NNS\3247620|
DDI-DrugBank.d633.s12.e3_DDI-DrugBank.d633.s12.e0 false propranolol_22\NN\1740| (r_conj) digoxin_17\NN\15060131|,|diuretics|,|or|propranolol (r_conj) mexitil_15\NN\2715941|by|concurrent|and|digoxin
DDI-DrugBank.d633.s12.e3_DDI-DrugBank.d633.s12.e2 false propranolol_22\NN\1740| (r_conj) digoxin_17\NN\15060131|,|diuretics|,|or|propranolol (l_conj) diuretics_19\NNS\3247620|
DDI-DrugBank.d633.s12.e0_DDI-DrugBank.d633.s12.e2 false mexitil_15\NN\2715941|by|concurrent|and|digoxin (l_conj) digoxin_17\NN\15060131|,|diuretics|,|or|propranolol (l_conj) diuretics_19\NNS\3247620|
DDI-DrugBank.d752.s4
DDI-DrugBank.d623.s1
DDI-DrugBank.d623.s1.e0_DDI-DrugBank.d623.s1.e2 false aminoglutethimide_0\NN\1740|administered (r_nsubj) decrease_9\VB\169651|aminoglutethimide|may|significantly|concentrations|. (l_dobj) concentrations_12\NNS\4916342|the|serum|mpa (l_nmod) mpa_14\NN\1740|of
DDI-DrugBank.d623.s1.e0_DDI-DrugBank.d623.s1.e1 true aminoglutethimide_0\NN\1740|administered (l_acl) administered_1\VBN\2436349|provera (l_nmod) provera_5\NN\14747338|concomitantly|with|depo-subq|104 (l_nummod) 104_6\CD\1740|
DDI-DrugBank.d623.s1.e2_DDI-DrugBank.d623.s1.e1 false mpa_14\NN\1740|of (r_nmod) concentrations_12\NNS\4916342|the|serum|mpa (r_dobj) decrease_9\VB\169651|aminoglutethimide|may|significantly|concentrations|. (l_nsubj) aminoglutethimide_0\NN\1740|administered (l_acl) administered_1\VBN\2436349|provera (l_nmod) provera_5\NN\14747338|concomitantly|with|depo-subq|104 (l_nummod) 104_6\CD\1740|
DDI-DrugBank.d776.s35
DDI-DrugBank.d776.s35.e1_DDI-DrugBank.d776.s35.e2 true midazolam_7\NN\2830852|of (r_nmod) administration_5\NN\1133281|following|oral|midazolam (r_nmod) resulted_10\VBD\2633881|benzodiazepines|:|administration|,|fluconazole|increases|. (l_nsubj) fluconazole_9\NN\1740|
DDI-DrugBank.d776.s35.e1_DDI-DrugBank.d776.s35.e3 false midazolam_7\NN\2830852|of (r_nmod) administration_5\NN\1133281|following|oral|midazolam (r_nmod) resulted_10\VBD\2633881|benzodiazepines|:|administration|,|fluconazole|increases|. (l_nmod) increases_13\NNS\13576355|in|substantial|concentrations (l_nmod) concentrations_16\NNS\4916342|in|midazolam|and|effects (l_compound) midazolam_15\NN\2830852|
DDI-DrugBank.d776.s35.e1_DDI-DrugBank.d776.s35.e0 false midazolam_7\NN\2830852|of (r_nmod) administration_5\NN\1133281|following|oral|midazolam (r_nmod) resulted_10\VBD\2633881|benzodiazepines|:|administration|,|fluconazole|increases|. (l_dep) benzodiazepines_1\NNS\3771443|short-acting
DDI-DrugBank.d776.s35.e2_DDI-DrugBank.d776.s35.e3 false fluconazole_9\NN\1740| (r_nsubj) resulted_10\VBD\2633881|benzodiazepines|:|administration|,|fluconazole|increases|. (l_nmod) increases_13\NNS\13576355|in|substantial|concentrations (l_nmod) concentrations_16\NNS\4916342|in|midazolam|and|effects (l_compound) midazolam_15\NN\2830852|
DDI-DrugBank.d776.s35.e2_DDI-DrugBank.d776.s35.e0 false fluconazole_9\NN\1740| (r_nsubj) resulted_10\VBD\2633881|benzodiazepines|:|administration|,|fluconazole|increases|. (l_dep) benzodiazepines_1\NNS\3771443|short-acting
DDI-DrugBank.d776.s35.e3_DDI-DrugBank.d776.s35.e0 false midazolam_15\NN\2830852| (r_compound) concentrations_16\NNS\4916342|in|midazolam|and|effects (r_nmod) increases_13\NNS\13576355|in|substantial|concentrations (r_nmod) resulted_10\VBD\2633881|benzodiazepines|:|administration|,|fluconazole|increases|. (l_dep) benzodiazepines_1\NNS\3771443|short-acting
DDI-DrugBank.d576.s3
DDI-DrugBank.d597.s0
DDI-DrugBank.d597.s0.e0_DDI-DrugBank.d597.s0.e1 false inhibitors_1\NNS\20090|ace (r_compound) reports_2\NNS\6470073|inhibitors (r_nsubj) suggest_3\VBP\1010118|reports|diminish|. (l_ccomp) diminish_7\VB\169651|that|nsaids|may|effect (l_nsubj) nsaids_5\NNS\2721538|
DDI-DrugBank.d597.s0.e0_DDI-DrugBank.d597.s0.e2 false inhibitors_1\NNS\20090|ace (r_compound) reports_2\NNS\6470073|inhibitors (r_nsubj) suggest_3\VBP\1010118|reports|diminish|. (l_ccomp) diminish_7\VB\169651|that|nsaids|may|effect (l_dobj) effect_10\NN\34213|the|antihypertensive|inhibitors (l_nmod) inhibitors_17\NNS\20090|of|enzyme
DDI-DrugBank.d597.s0.e1_DDI-DrugBank.d597.s0.e2 true nsaids_5\NNS\2721538| (r_nsubj) diminish_7\VB\169651|that|nsaids|may|effect (l_dobj) effect_10\NN\34213|the|antihypertensive|inhibitors (l_nmod) inhibitors_17\NNS\20090|of|enzyme
DDI-DrugBank.d607.s1
DDI-DrugBank.d607.s1.e1_DDI-DrugBank.d607.s1.e0 false lithium_12\NN\14625458|such|and|corticosteroids (r_nmod) drugs_0\NNS\14778436|potentiate|,|lithium|, (l_acl:relcl) potentiate_3\VB\229605|which|may|effects (l_dobj) effects_6\NNS\13245626|the|myeloproliferative|leukine (l_nmod) leukine_8\NN\1740|of
DDI-DrugBank.d607.s1.e1_DDI-DrugBank.d607.s1.e2 false lithium_12\NN\14625458|such|and|corticosteroids (l_conj) corticosteroids_14\NNS\14745635|
DDI-DrugBank.d607.s1.e0_DDI-DrugBank.d607.s1.e2 true leukine_8\NN\1740|of (r_nmod) effects_6\NNS\13245626|the|myeloproliferative|leukine (r_dobj) potentiate_3\VB\229605|which|may|effects (r_acl:relcl) drugs_0\NNS\14778436|potentiate|,|lithium|, (l_nmod) lithium_12\NN\14625458|such|and|corticosteroids (l_conj) corticosteroids_14\NNS\14745635|
DDI-DrugBank.d609.s1
DDI-DrugBank.d602.s5
DDI-DrugBank.d781.s0
DDI-DrugBank.d781.s0.e2_DDI-DrugBank.d781.s0.e0 false aceon_24\NN\1740| (r_compound) tablets_25\NNS\4233405|aceon (r_compound) therapy_26\NN\657604|of|tablets (r_nmod) initiation_22\NN\7450842|after|therapy (r_nmod) experience_14\VB\2108377|diuretics|:|patients|may|occasionally|reduction|initiation|. (l_nsubj) diuretics_0\NNS\3247620|
DDI-DrugBank.d781.s0.e2_DDI-DrugBank.d781.s0.e1 false aceon_24\NN\1740| (r_compound) tablets_25\NNS\4233405|aceon (r_compound) therapy_26\NN\657604|of|tablets (r_nmod) initiation_22\NN\7450842|after|therapy (r_nmod) experience_14\VB\2108377|diuretics|:|patients|may|occasionally|reduction|initiation|. (l_nsubj) patients_2\NNS\9898892|diuretics|,|and|those|, (l_nmod) diuretics_4\NNS\3247620|on
DDI-DrugBank.d781.s0.e0_DDI-DrugBank.d781.s0.e1 false diuretics_0\NNS\3247620| (r_nsubj) experience_14\VB\2108377|diuretics|:|patients|may|occasionally|reduction|initiation|. (l_nsubj) patients_2\NNS\9898892|diuretics|,|and|those|, (l_nmod) diuretics_4\NNS\3247620|on
DDI-DrugBank.d717.s2
DDI-DrugBank.d680.s6
DDI-DrugBank.d753.s3
DDI-DrugBank.d753.s3.e0_DDI-DrugBank.d753.s3.e1 true oxymorphone_12\NN\1740| (r_nsubjpass) combined_14\VBN\2630189|when|oxymorphone|was|propofol|induction (l_nmod) propofol_16\NN\1740|with
DDI-DrugBank.d572.s9
DDI-DrugBank.d572.s9.e0_DDI-DrugBank.d572.s9.e1 false cyclosporine_0\NN\1740| (r_nsubj) increased_6\VBD\169651|cyclosporine|:|level|12-fold|patient|. (l_nsubj) level_5\NN\4916342|the|total|ezetimibe (l_compound) ezetimibe_4\NN\1740|
DDI-DrugBank.d572.s9.e0_DDI-DrugBank.d572.s9.e2 false cyclosporine_0\NN\1740| (r_nsubj) increased_6\VBD\169651|cyclosporine|:|level|12-fold|patient|. (l_nmod) patient_12\NN\9898892|in|one|renal|transplant|receiving (l_acl) receiving_13\VBG\2210855|medications (l_dobj) medications_15\NNS\3247620|multiple|,|cyclosporine (l_nmod) cyclosporine_18\NN\1740|including
DDI-DrugBank.d572.s9.e1_DDI-DrugBank.d572.s9.e2 true ezetimibe_4\NN\1740| (r_compound) level_5\NN\4916342|the|total|ezetimibe (r_nsubj) increased_6\VBD\169651|cyclosporine|:|level|12-fold|patient|. (l_nmod) patient_12\NN\9898892|in|one|renal|transplant|receiving (l_acl) receiving_13\VBG\2210855|medications (l_dobj) medications_15\NNS\3247620|multiple|,|cyclosporine (l_nmod) cyclosporine_18\NN\1740|including
DDI-DrugBank.d734.s1
DDI-DrugBank.d734.s1.e0_DDI-DrugBank.d734.s1.e1 true guanethidine_3\NN\1740|of|and|compounds (r_nmod) effects_1\NNS\13245626|antihypertensive|guanethidine (r_nsubjpass) counteracted_9\VBN\2367363|effects|may|be|used|. (l_advcl) used_13\VBN\1156834|when|phenothiazines|are|concomitantly (l_nsubjpass) phenothiazines_11\NNS\14771088|
DDI-DrugBank.d732.s0
DDI-DrugBank.d732.s0.e1_DDI-DrugBank.d732.s0.e0 false iron_10\NN\14625458| (r_compound) supplements_11\NNS\6365467|including|iron (r_nmod) drugs_8\NNS\14778436|with|other|supplements (r_nmod) interact_5\VB\2367363|to|drugs (r_xcomp) known_3\VBN\2110220|chemet|is|not|interact|; (l_nsubjpass) chemet_0\NNP\1740|
DDI-DrugBank.d633.s8
DDI-DrugBank.d633.s8.e1_DDI-DrugBank.d633.s8.e2 false quinidine_6\NN\2715941|such|or|propranolol (l_conj) propranolol_8\NN\1740|
DDI-DrugBank.d633.s8.e1_DDI-DrugBank.d633.s8.e0 false quinidine_6\NN\2715941|such|or|propranolol (r_nmod) antiarrhythmics_3\NNS\3740161|of|quinidine
DDI-DrugBank.d633.s8.e2_DDI-DrugBank.d633.s8.e0 false propranolol_8\NN\1740| (r_conj) quinidine_6\NN\2715941|such|or|propranolol (r_nmod) antiarrhythmics_3\NNS\3740161|of|quinidine
DDI-DrugBank.d578.s12
DDI-DrugBank.d776.s16
DDI-DrugBank.d776.s16.e0_DDI-DrugBank.d776.s16.e1 false rifampin_0\NN\2716205| (r_compound) rifampin_2\NN\2716205|rifampin|:
DDI-DrugBank.d776.s16.e0_DDI-DrugBank.d776.s16.e2 false rifampin_0\NN\2716205| (r_compound) rifampin_2\NN\2716205|rifampin|: (r_nsubj) enhances_3\VBZ\227165|rifampin|metabolism|. (l_dobj) metabolism_5\NN\13526110|the|diflucan (l_nmod) diflucan_9\NN\1740|of|administered
DDI-DrugBank.d776.s16.e1_DDI-DrugBank.d776.s16.e2 true rifampin_2\NN\2716205|rifampin|: (r_nsubj) enhances_3\VBZ\227165|rifampin|metabolism|. (l_dobj) metabolism_5\NN\13526110|the|diflucan (l_nmod) diflucan_9\NN\1740|of|administered
DDI-DrugBank.d633.s11
DDI-DrugBank.d633.s11.e1_DDI-DrugBank.d633.s11.e0 false mexitil_11\NN\2715941| (r_amod) concentrations_13\NNS\4916342|mexitil|plasma (r_dobj) affect_10\VB\126264|not|to|concentrations (r_xcomp) shown_7\VBN\2137132|study|,|benzodiazepines|were|affect|. (l_nsubjpass) benzodiazepines_5\NNS\3771443|
DDI-DrugBank.d769.s0
DDI-DrugBank.d769.s0.e1_DDI-DrugBank.d769.s0.e0 false zolinza_22\NN\1740| (r_dobj) receiving_21\VBG\2210855|zolinza|anticoagulants (r_acl) patients_20\NNS\9898892|in|receiving (r_nmod) observed_18\VBN\2163746|anticoagulants|:|prolongation|were|patients|. (l_nsubjpass) anticoagulants_1\NNS\3740161|coumarin-derivative
DDI-DrugBank.d769.s0.e1_DDI-DrugBank.d769.s0.e2 true zolinza_22\NN\1740| (r_dobj) receiving_21\VBG\2210855|zolinza|anticoagulants (l_nmod) anticoagulants_26\NNS\3740161|concomitantly|with|coumarin-derivative
DDI-DrugBank.d769.s0.e0_DDI-DrugBank.d769.s0.e2 false anticoagulants_1\NNS\3740161|coumarin-derivative (r_nsubjpass) observed_18\VBN\2163746|anticoagulants|:|prolongation|were|patients|. (l_nmod) patients_20\NNS\9898892|in|receiving (l_acl) receiving_21\VBG\2210855|zolinza|anticoagulants (l_nmod) anticoagulants_26\NNS\3740161|concomitantly|with|coumarin-derivative
DDI-DrugBank.d757.s0
DDI-DrugBank.d757.s0.e0_DDI-DrugBank.d757.s0.e1 false alcohol_2\NN\7881800|with (r_nmod) usage_0\NN\407535|alcohol|:|used (l_dep) used_17\VBN\1156834|potential|,|alcohol|should|be|caution|patients|. (l_nsubjpass) alcohol_14\NN\7881800|
DDI-DrugBank.d757.s0.e0_DDI-DrugBank.d757.s0.e2 false alcohol_2\NN\7881800|with (r_nmod) usage_0\NN\407535|alcohol|:|used (l_dep) used_17\VBN\1156834|potential|,|alcohol|should|be|caution|patients|. (l_nmod) patients_21\NNS\9898892|in|receiving (l_acl:relcl) receiving_25\VBG\2210855|who|are|currently|pentazocine (l_dobj) pentazocine_26\NN\2707683|
DDI-DrugBank.d757.s0.e1_DDI-DrugBank.d757.s0.e2 true alcohol_14\NN\7881800| (r_nsubjpass) used_17\VBN\1156834|potential|,|alcohol|should|be|caution|patients|. (l_nmod) patients_21\NNS\9898892|in|receiving (l_acl:relcl) receiving_25\VBG\2210855|who|are|currently|pentazocine (l_dobj) pentazocine_26\NN\2707683|
DDI-DrugBank.d643.s0
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e3 false melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_dep) lower_14\VB\1850315|(|may|levels|) (l_dobj) levels_16\NNS\4916342|melatonin (l_compound) melatonin_15\NN\5407119|
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e4 true melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluvoxamine_19\NN\1740|increased
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e5 false melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluvoxamine_19\NN\1740|increased (l_dep) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (l_nsubjpass) bioavailability_21\NN\1740|melatonin (l_nmod) melatonin_24\NN\5407119|of|oral
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e7 false melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease (l_dep) decrease_35\VB\169651|(|may|levels|) (l_dobj) levels_37\NNS\4916342|melatonin (l_compound) melatonin_36\NN\5407119|
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e8 true melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluoxetine_40\NN\4169152|reports
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e1 true melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e2 true melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) nsaids_11\NNS\2721538|other
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e6 true melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e0_DDI-DrugBank.d643.s0.e9 true melatonin_0\NN\5407119| (r_nsubj) interact_2\VB\2367363|melatonin|may|drugs|aspirin|. (l_punct) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e4 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluvoxamine_19\NN\1740|increased
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e5 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluvoxamine_19\NN\1740|increased (l_dep) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (l_nsubjpass) bioavailability_21\NN\1740|melatonin (l_nmod) melatonin_24\NN\5407119|of|oral
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e7 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease (l_dep) decrease_35\VB\169651|(|may|levels|) (l_dobj) levels_37\NNS\4916342|melatonin (l_compound) melatonin_36\NN\5407119|
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e8 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluoxetine_40\NN\4169152|reports
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e1 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e2 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) nsaids_11\NNS\2721538|other
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e6 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e3_DDI-DrugBank.d643.s0.e9 false melatonin_15\NN\5407119| (r_compound) levels_16\NNS\4916342|melatonin (r_dobj) lower_14\VB\1850315|(|may|levels|) (r_dep) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e4_DDI-DrugBank.d643.s0.e5 false fluvoxamine_19\NN\1740|increased (l_dep) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (l_nsubjpass) bioavailability_21\NN\1740|melatonin (l_nmod) melatonin_24\NN\5407119|of|oral
DDI-DrugBank.d643.s0.e4_DDI-DrugBank.d643.s0.e7 false fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease (l_dep) decrease_35\VB\169651|(|may|levels|) (l_dobj) levels_37\NNS\4916342|melatonin (l_compound) melatonin_36\NN\5407119|
DDI-DrugBank.d643.s0.e4_DDI-DrugBank.d643.s0.e8 false fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluoxetine_40\NN\4169152|reports
DDI-DrugBank.d643.s0.e4_DDI-DrugBank.d643.s0.e1 false fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids
DDI-DrugBank.d643.s0.e4_DDI-DrugBank.d643.s0.e2 false fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) nsaids_11\NNS\2721538|other
DDI-DrugBank.d643.s0.e4_DDI-DrugBank.d643.s0.e6 false fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e4_DDI-DrugBank.d643.s0.e9 false fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e5_DDI-DrugBank.d643.s0.e7 false melatonin_24\NN\5407119|of|oral (r_nmod) bioavailability_21\NN\1740|melatonin (r_nsubjpass) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (r_dep) fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease (l_dep) decrease_35\VB\169651|(|may|levels|) (l_dobj) levels_37\NNS\4916342|melatonin (l_compound) melatonin_36\NN\5407119|
DDI-DrugBank.d643.s0.e5_DDI-DrugBank.d643.s0.e8 false melatonin_24\NN\5407119|of|oral (r_nmod) bioavailability_21\NN\1740|melatonin (r_nsubjpass) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (r_dep) fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluoxetine_40\NN\4169152|reports
DDI-DrugBank.d643.s0.e5_DDI-DrugBank.d643.s0.e1 false melatonin_24\NN\5407119|of|oral (r_nmod) bioavailability_21\NN\1740|melatonin (r_nsubjpass) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (r_dep) fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids
DDI-DrugBank.d643.s0.e5_DDI-DrugBank.d643.s0.e2 false melatonin_24\NN\5407119|of|oral (r_nmod) bioavailability_21\NN\1740|melatonin (r_nsubjpass) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (r_dep) fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) nsaids_11\NNS\2721538|other
DDI-DrugBank.d643.s0.e5_DDI-DrugBank.d643.s0.e6 false melatonin_24\NN\5407119|of|oral (r_nmod) bioavailability_21\NN\1740|melatonin (r_nsubjpass) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (r_dep) fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e5_DDI-DrugBank.d643.s0.e9 false melatonin_24\NN\5407119|of|oral (r_nmod) bioavailability_21\NN\1740|melatonin (r_nsubjpass) increased_26\VBN\169651|(|bioavailability|is|coadministration|) (r_dep) fluvoxamine_19\NN\1740|increased (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e7_DDI-DrugBank.d643.s0.e8 false melatonin_36\NN\5407119| (r_compound) levels_37\NNS\4916342|melatonin (r_dobj) decrease_35\VB\169651|(|may|levels|) (r_dep) blockers_32\NNS\10101634|beta|decrease (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) fluoxetine_40\NN\4169152|reports
DDI-DrugBank.d643.s0.e7_DDI-DrugBank.d643.s0.e1 false melatonin_36\NN\5407119| (r_compound) levels_37\NNS\4916342|melatonin (r_dobj) decrease_35\VB\169651|(|may|levels|) (r_dep) blockers_32\NNS\10101634|beta|decrease (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids
DDI-DrugBank.d643.s0.e7_DDI-DrugBank.d643.s0.e2 false melatonin_36\NN\5407119| (r_compound) levels_37\NNS\4916342|melatonin (r_dobj) decrease_35\VB\169651|(|may|levels|) (r_dep) blockers_32\NNS\10101634|beta|decrease (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) nsaids_11\NNS\2721538|other
DDI-DrugBank.d643.s0.e7_DDI-DrugBank.d643.s0.e6 false melatonin_36\NN\5407119| (r_compound) levels_37\NNS\4916342|melatonin (r_dobj) decrease_35\VB\169651|(|may|levels|) (r_dep) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e7_DDI-DrugBank.d643.s0.e9 false melatonin_36\NN\5407119| (r_compound) levels_37\NNS\4916342|melatonin (r_dobj) decrease_35\VB\169651|(|may|levels|) (r_dep) blockers_32\NNS\10101634|beta|decrease (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e8_DDI-DrugBank.d643.s0.e1 false fluoxetine_40\NN\4169152|reports (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids
DDI-DrugBank.d643.s0.e8_DDI-DrugBank.d643.s0.e2 false fluoxetine_40\NN\4169152|reports (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) nsaids_11\NNS\2721538|other
DDI-DrugBank.d643.s0.e8_DDI-DrugBank.d643.s0.e6 false fluoxetine_40\NN\4169152|reports (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e8_DDI-DrugBank.d643.s0.e9 false fluoxetine_40\NN\4169152|reports (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e1_DDI-DrugBank.d643.s0.e2 false aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) nsaids_11\NNS\2721538|other
DDI-DrugBank.d643.s0.e1_DDI-DrugBank.d643.s0.e6 false aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e1_DDI-DrugBank.d643.s0.e9 false aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e2_DDI-DrugBank.d643.s0.e6 false nsaids_11\NNS\2721538|other (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) blockers_32\NNS\10101634|beta|decrease
DDI-DrugBank.d643.s0.e2_DDI-DrugBank.d643.s0.e9 false nsaids_11\NNS\2721538|other (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d643.s0.e6_DDI-DrugBank.d643.s0.e9 false blockers_32\NNS\10101634|beta|decrease (r_conj) aspirin_8\NN\2707683|and|nsaids|lower|,|fluvoxamine|,|blockers|,|fluoxetine|,|progestin|,|benzodiazepenes|,|and|corticosteroids (l_conj) progestin_50\NN\14745635|inhibit
DDI-DrugBank.d573.s2
DDI-DrugBank.d633.s1
DDI-DrugBank.d633.s1.e0_DDI-DrugBank.d633.s1.e1 true mexiletine_16\NN\2715941|of (r_nmod) clearance_14\NN\5089947|the|mexiletine (r_nsubjpass) decreased_18\VBN\169651|study|clearance|was|%|coadministration|. (l_nmod) coadministration_24\NN\1740|following|the|fluvoxamine (l_nmod) fluvoxamine_26\NN\1740|of|,|inhibitor
DDI-DrugBank.d771.s3
DDI-DrugBank.d771.s3.e2_DDI-DrugBank.d771.s3.e0 false meclizine_9\NN\2720725|including (r_nmod) antihistamines_6\NNS\3740161|(|meclizine|) (r_conj) alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|.
DDI-DrugBank.d771.s3.e2_DDI-DrugBank.d771.s3.e1 false meclizine_9\NN\2720725|including (r_nmod) antihistamines_6\NNS\3740161|(|meclizine|)
DDI-DrugBank.d771.s3.e2_DDI-DrugBank.d771.s3.e3 false meclizine_9\NN\2720725|including (r_nmod) antihistamines_6\NNS\3740161|(|meclizine|) (r_conj) alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|. (l_conj) antidepressants_13\NNS\3740161|tricyclic|,|and|relaxants
DDI-DrugBank.d771.s3.e2_DDI-DrugBank.d771.s3.e4 false meclizine_9\NN\2720725|including (r_nmod) antihistamines_6\NNS\3740161|(|meclizine|) (r_conj) alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|. (l_conj) antidepressants_13\NNS\3740161|tricyclic|,|and|relaxants (l_conj) relaxants_17\NNS\3247620|muscle
DDI-DrugBank.d771.s3.e0_DDI-DrugBank.d771.s3.e1 false alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|. (l_conj) antihistamines_6\NNS\3740161|(|meclizine|)
DDI-DrugBank.d771.s3.e0_DDI-DrugBank.d771.s3.e3 false alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|. (l_conj) antidepressants_13\NNS\3740161|tricyclic|,|and|relaxants
DDI-DrugBank.d771.s3.e0_DDI-DrugBank.d771.s3.e4 false alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|. (l_conj) antidepressants_13\NNS\3740161|tricyclic|,|and|relaxants (l_conj) relaxants_17\NNS\3247620|muscle
DDI-DrugBank.d771.s3.e1_DDI-DrugBank.d771.s3.e3 false antihistamines_6\NNS\3740161|(|meclizine|) (r_conj) alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|. (l_conj) antidepressants_13\NNS\3740161|tricyclic|,|and|relaxants
DDI-DrugBank.d771.s3.e1_DDI-DrugBank.d771.s3.e4 false antihistamines_6\NNS\3740161|(|meclizine|) (r_conj) alkaloids_4\NNS\14727670|e.g.|,|other|belladonna|,|antihistamines|,|antidepressants|. (l_conj) antidepressants_13\NNS\3740161|tricyclic|,|and|relaxants (l_conj) relaxants_17\NNS\3247620|muscle
DDI-DrugBank.d771.s3.e3_DDI-DrugBank.d771.s3.e4 false antidepressants_13\NNS\3740161|tricyclic|,|and|relaxants (l_conj) relaxants_17\NNS\3247620|muscle
DDI-DrugBank.d608.s3
DDI-DrugBank.d608.s3.e1_DDI-DrugBank.d608.s3.e2 false insulin_10\NN\5407119| (r_conj) sulfonylureas_8\NNS\2719105|with|either|or|insulin (r_nmod) treatment_5\NN\654885|under|sulfonylureas (r_nmod) patients_3\NNS\9898892|in|adult|diabetic|treatment (r_nmod) is_12\VBZ\836236|patients|there|change|. (l_attr) change_14\NN\7283608|no|effects (l_nmod) effects_18\NNS\13245626|in|the|clinical|tolectin (l_nmod) tolectin_21\NN\3828465|of|either|or|agents
DDI-DrugBank.d608.s3.e1_DDI-DrugBank.d608.s3.e0 false insulin_10\NN\5407119| (r_conj) sulfonylureas_8\NNS\2719105|with|either|or|insulin
DDI-DrugBank.d608.s3.e1_DDI-DrugBank.d608.s3.e3 false insulin_10\NN\5407119| (r_conj) sulfonylureas_8\NNS\2719105|with|either|or|insulin (r_nmod) treatment_5\NN\654885|under|sulfonylureas (r_nmod) patients_3\NNS\9898892|in|adult|diabetic|treatment (r_nmod) is_12\VBZ\836236|patients|there|change|. (l_attr) change_14\NN\7283608|no|effects (l_nmod) effects_18\NNS\13245626|in|the|clinical|tolectin (l_nmod) tolectin_21\NN\3828465|of|either|or|agents (l_conj) agents_25\NNS\7347|the|hypoglycemic
DDI-DrugBank.d608.s3.e2_DDI-DrugBank.d608.s3.e0 false tolectin_21\NN\3828465|of|either|or|agents (r_nmod) effects_18\NNS\13245626|in|the|clinical|tolectin (r_nmod) change_14\NN\7283608|no|effects (r_attr) is_12\VBZ\836236|patients|there|change|. (l_nmod) patients_3\NNS\9898892|in|adult|diabetic|treatment (l_nmod) treatment_5\NN\654885|under|sulfonylureas (l_nmod) sulfonylureas_8\NNS\2719105|with|either|or|insulin
DDI-DrugBank.d608.s3.e2_DDI-DrugBank.d608.s3.e3 false tolectin_21\NN\3828465|of|either|or|agents (l_conj) agents_25\NNS\7347|the|hypoglycemic
DDI-DrugBank.d608.s3.e0_DDI-DrugBank.d608.s3.e3 false sulfonylureas_8\NNS\2719105|with|either|or|insulin (r_nmod) treatment_5\NN\654885|under|sulfonylureas (r_nmod) patients_3\NNS\9898892|in|adult|diabetic|treatment (r_nmod) is_12\VBZ\836236|patients|there|change|. (l_attr) change_14\NN\7283608|no|effects (l_nmod) effects_18\NNS\13245626|in|the|clinical|tolectin (l_nmod) tolectin_21\NN\3828465|of|either|or|agents (l_conj) agents_25\NNS\7347|the|hypoglycemic
DDI-DrugBank.d599.s4
DDI-DrugBank.d599.s4.e0_DDI-DrugBank.d599.s4.e1 false glucocorticoid_1\NN\14751417| (r_compound) replacement_2\NN\196485|glucocorticoid (r_nsubjpass) required_4\VBN\754942|if|replacement|is (r_advcl) adjusted_12\VBN\126264|required|,|dose|should|be|carefully|. (l_nsubjpass) dose_8\NN\3740161|the|glucocorticoid (l_compound) glucocorticoid_7\NN\14751417|
DDI-DrugBank.d775.s0
DDI-DrugBank.d775.s0.e2_DDI-DrugBank.d775.s0.e0 false succinylcholine_23\NN\3800001| (r_conj) mivacron_21\NN\1740|between|and|succinylcholine (r_nmod) interaction_19\NN\37396|the|mivacron (r_nsubjpass) studied_28\VBN\630380|administered|,|interaction|has|not|been|systematically|. (l_advcl) administered_11\VBN\2436349|although|mivacron|has|been|safely|intubation (l_nsubjpass) mivacron_1\NNP\1740|mixture
DDI-DrugBank.d775.s0.e2_DDI-DrugBank.d775.s0.e1 false succinylcholine_23\NN\3800001| (r_conj) mivacron_21\NN\1740|between|and|succinylcholine
DDI-DrugBank.d775.s0.e0_DDI-DrugBank.d775.s0.e1 false mivacron_1\NNP\1740|mixture (r_nsubjpass) administered_11\VBN\2436349|although|mivacron|has|been|safely|intubation (r_advcl) studied_28\VBN\630380|administered|,|interaction|has|not|been|systematically|. (l_nsubjpass) interaction_19\NN\37396|the|mivacron (l_nmod) mivacron_21\NN\1740|between|and|succinylcholine
DDI-DrugBank.d598.s2
DDI-DrugBank.d634.s3
DDI-DrugBank.d634.s3.e0_DDI-DrugBank.d634.s3.e1 false glycosides_1\NNS\14727670|digitalis (r_nsubjpass) increased_8\VBN\169651|glycosides|:|levels|may|be|become|; (l_advcl) become_18\VBP\146138|when|patients|euthyroid (l_nsubj) patients_11\NNS\9898892|hyperthyroid|regimen (l_nmod) regimen_17\NN\5898568|on|a|stable|glycoside (l_compound) glycoside_16\NN\14727670|digitalis
DDI-DrugBank.d773.s5
DDI-DrugBank.d597.s16
DDI-DrugBank.d597.s16.e0_DDI-DrugBank.d597.s16.e1 false furosemide_2\NN\3214670| (r_compound) agents_3\NNS\7347|with|furosemide|and|meloxicam (l_conj) meloxicam_5\NN\1740|
DDI-DrugBank.d590.s3
DDI-DrugBank.d641.s6
DDI-DrugBank.d572.s2
DDI-DrugBank.d572.s2.e1_DDI-DrugBank.d572.s2.e2 false ezetimibe_6\NN\1740|of|administered (l_acl) administered_7\VBN\2436349|fibrates (l_nmod) fibrates_9\NNS\1740|with
DDI-DrugBank.d588.s7
DDI-DrugBank.d588.s7.e0_DDI-DrugBank.d588.s7.e1 false lithium_0\NN\14625458| (r_compound) levels_4\NNS\4916342|lithium|:|serum|lithium (l_compound) lithium_3\NN\14625458|
DDI-DrugBank.d645.s2
DDI-DrugBank.d645.s2.e0_DDI-DrugBank.d645.s2.e1 false antidepressants_17\NNS\3740161|such|tricyclic|,|-blockers|,|inhibitors|,|and|type (l_conj) inhibitors_24\NNS\20090|selective|serotonin|reuptake|ssris
DDI-DrugBank.d645.s2.e0_DDI-DrugBank.d645.s2.e2 false antidepressants_17\NNS\3740161|such|tricyclic|,|-blockers|,|inhibitors|,|and|type (l_conj) inhibitors_24\NNS\20090|selective|serotonin|reuptake|ssris (l_appos) ssris_26\NNS\2718811|(|)
DDI-DrugBank.d645.s2.e0_DDI-DrugBank.d645.s2.e3 false antidepressants_17\NNS\3740161|such|tricyclic|,|-blockers|,|inhibitors|,|and|type (l_conj) type_36\NN\5839024|inhibitors|b
DDI-DrugBank.d645.s2.e1_DDI-DrugBank.d645.s2.e2 false inhibitors_24\NNS\20090|selective|serotonin|reuptake|ssris (l_appos) ssris_26\NNS\2718811|(|)
DDI-DrugBank.d645.s2.e1_DDI-DrugBank.d645.s2.e3 false inhibitors_24\NNS\20090|selective|serotonin|reuptake|ssris (r_conj) antidepressants_17\NNS\3740161|such|tricyclic|,|-blockers|,|inhibitors|,|and|type (l_conj) type_36\NN\5839024|inhibitors|b
DDI-DrugBank.d645.s2.e2_DDI-DrugBank.d645.s2.e3 false ssris_26\NNS\2718811|(|) (r_appos) inhibitors_24\NNS\20090|selective|serotonin|reuptake|ssris (r_conj) antidepressants_17\NNS\3740161|such|tricyclic|,|-blockers|,|inhibitors|,|and|type (l_conj) type_36\NN\5839024|inhibitors|b
DDI-DrugBank.d608.s5
DDI-DrugBank.d608.s5.e2_DDI-DrugBank.d608.s5.e3 false methotrexate_15\NN\2722166|of (r_nmod) secretion_13\NN\13526110|the|tubular|methotrexate (r_dobj) reduce_10\VB\441445|to|secretion|model|,|enhancing (l_advcl) enhancing_22\VBG\227165|possibly|toxicity (l_dobj) toxicity_24\NN\13576101|the|methotrexate (l_nmod) methotrexate_26\NN\2722166|of
DDI-DrugBank.d608.s5.e2_DDI-DrugBank.d608.s5.e0 false methotrexate_15\NN\2722166|of (r_nmod) secretion_13\NN\13526110|the|tubular|methotrexate (r_dobj) reduce_10\VB\441445|to|secretion|model|,|enhancing (r_xcomp) reported_8\VBN\831651|tolectin|have|been|reduce|. (l_nsubjpass) tolectin_0\NN\3828465|and|drugs
DDI-DrugBank.d608.s5.e2_DDI-DrugBank.d608.s5.e1 false methotrexate_15\NN\2722166|of (r_nmod) secretion_13\NN\13526110|the|tubular|methotrexate (r_dobj) reduce_10\VB\441445|to|secretion|model|,|enhancing (r_xcomp) reported_8\VBN\831651|tolectin|have|been|reduce|. (l_nsubjpass) tolectin_0\NN\3828465|and|drugs (l_conj) drugs_5\NNS\14778436|other|nonsteroidal|anti-inflammatory
DDI-DrugBank.d608.s5.e3_DDI-DrugBank.d608.s5.e0 false methotrexate_26\NN\2722166|of (r_nmod) toxicity_24\NN\13576101|the|methotrexate (r_dobj) enhancing_22\VBG\227165|possibly|toxicity (r_advcl) reduce_10\VB\441445|to|secretion|model|,|enhancing (r_xcomp) reported_8\VBN\831651|tolectin|have|been|reduce|. (l_nsubjpass) tolectin_0\NN\3828465|and|drugs
DDI-DrugBank.d608.s5.e3_DDI-DrugBank.d608.s5.e1 false methotrexate_26\NN\2722166|of (r_nmod) toxicity_24\NN\13576101|the|methotrexate (r_dobj) enhancing_22\VBG\227165|possibly|toxicity (r_advcl) reduce_10\VB\441445|to|secretion|model|,|enhancing (r_xcomp) reported_8\VBN\831651|tolectin|have|been|reduce|. (l_nsubjpass) tolectin_0\NN\3828465|and|drugs (l_conj) drugs_5\NNS\14778436|other|nonsteroidal|anti-inflammatory
DDI-DrugBank.d608.s5.e0_DDI-DrugBank.d608.s5.e1 false tolectin_0\NN\3828465|and|drugs (l_conj) drugs_5\NNS\14778436|other|nonsteroidal|anti-inflammatory
DDI-DrugBank.d645.s0
DDI-DrugBank.d645.s0.e0_DDI-DrugBank.d645.s0.e1 false terbinafine_9\NN\2720201| (r_nsubj) inhibit_12\VB\2510337|that|terbinafine|does|not|metabolism (l_dobj) metabolism_14\NN\13526110|the|tolbutamide (l_nmod) tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine
DDI-DrugBank.d645.s0.e0_DDI-DrugBank.d645.s0.e2 false terbinafine_9\NN\2720201| (r_nsubj) inhibit_12\VB\2510337|that|terbinafine|does|not|metabolism (l_dobj) metabolism_14\NN\13526110|the|tolbutamide (l_nmod) tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) ethinylestradiol_18\NN\1740|
DDI-DrugBank.d645.s0.e0_DDI-DrugBank.d645.s0.e3 false terbinafine_9\NN\2720201| (r_nsubj) inhibit_12\VB\2510337|that|terbinafine|does|not|metabolism (l_dobj) metabolism_14\NN\13526110|the|tolbutamide (l_nmod) tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) ethoxycoumarin_20\NN\1740|
DDI-DrugBank.d645.s0.e0_DDI-DrugBank.d645.s0.e4 false terbinafine_9\NN\2720201| (r_nsubj) inhibit_12\VB\2510337|that|terbinafine|does|not|metabolism (l_dobj) metabolism_14\NN\13526110|the|tolbutamide (l_nmod) tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) cyclosporine_23\NN\1740|
DDI-DrugBank.d645.s0.e1_DDI-DrugBank.d645.s0.e2 false tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) ethinylestradiol_18\NN\1740|
DDI-DrugBank.d645.s0.e1_DDI-DrugBank.d645.s0.e3 false tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) ethoxycoumarin_20\NN\1740|
DDI-DrugBank.d645.s0.e1_DDI-DrugBank.d645.s0.e4 false tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) cyclosporine_23\NN\1740|
DDI-DrugBank.d645.s0.e2_DDI-DrugBank.d645.s0.e3 false ethinylestradiol_18\NN\1740| (r_conj) tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) ethoxycoumarin_20\NN\1740|
DDI-DrugBank.d645.s0.e2_DDI-DrugBank.d645.s0.e4 false ethinylestradiol_18\NN\1740| (r_conj) tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) cyclosporine_23\NN\1740|
DDI-DrugBank.d645.s0.e3_DDI-DrugBank.d645.s0.e4 false ethoxycoumarin_20\NN\1740| (r_conj) tolbutamide_16\NN\14914301|of|,|ethinylestradiol|,|ethoxycoumarin|,|and|cyclosporine (l_conj) cyclosporine_23\NN\1740|
DDI-DrugBank.d693.s6
DDI-DrugBank.d743.s2
DDI-DrugBank.d743.s2.e0_DDI-DrugBank.d743.s2.e1 true ketoconazole_4\NN\1740| (r_nsubj) inhibits_6\VBZ\2510337|that|ketoconazole|markedly|metabolism|,|resulting (l_dobj) metabolism_8\NN\13526110|the|terfenadine (l_nmod) terfenadine_10\NN\1740|of
DDI-DrugBank.d743.s2.e0_DDI-DrugBank.d743.s2.e2 false ketoconazole_4\NN\1740| (r_nsubj) inhibits_6\VBZ\2510337|that|ketoconazole|markedly|metabolism|,|resulting (l_advcl) resulting_12\VBG\2633881|levels (l_nmod) levels_17\NNS\4916342|in|elevated|plasma|terfenadine (l_compound) terfenadine_16\NN\1740|
DDI-DrugBank.d743.s2.e1_DDI-DrugBank.d743.s2.e2 false terfenadine_10\NN\1740|of (r_nmod) metabolism_8\NN\13526110|the|terfenadine (r_dobj) inhibits_6\VBZ\2510337|that|ketoconazole|markedly|metabolism|,|resulting (l_advcl) resulting_12\VBG\2633881|levels (l_nmod) levels_17\NNS\4916342|in|elevated|plasma|terfenadine (l_compound) terfenadine_16\NN\1740|
DDI-DrugBank.d725.s0
DDI-DrugBank.d725.s0.e1_DDI-DrugBank.d725.s0.e2 true metaraminol_3\NN\1740|particularly (r_appos) vasopressors_0\NNS\4522421|,|metaraminol|, (r_nsubj) cause_6\VB\1617192|vasopressors|may|arrhythmias|anesthesia|and|used|. (l_nmod) anesthesia_12\NN\14034177|during|halothane (l_compound) halothane_11\NN\3570838|
DDI-DrugBank.d725.s0.e1_DDI-DrugBank.d725.s0.e0 false metaraminol_3\NN\1740|particularly (r_appos) vasopressors_0\NNS\4522421|,|metaraminol|,
DDI-DrugBank.d725.s0.e2_DDI-DrugBank.d725.s0.e0 false halothane_11\NN\3570838| (r_compound) anesthesia_12\NN\14034177|during|halothane (r_nmod) cause_6\VB\1617192|vasopressors|may|arrhythmias|anesthesia|and|used|. (l_nsubj) vasopressors_0\NNS\4522421|,|metaraminol|,
DDI-DrugBank.d781.s17
DDI-DrugBank.d752.s0
DDI-DrugBank.d752.s0.e0_DDI-DrugBank.d752.s0.e1 true midazolam_12\NN\2830852| (r_nsubjpass) administered_14\VBN\2436349|when|midazolam|is|drugs (r_advcl) advised_10\VBN\813978|caution|is|administered|drugs|. (l_parataxis) drugs_33\NNS\14778436|(|ie|,|some|classes (l_nmod) classes_37\NNS\7951464|in|the|drug|antimycotics (l_nmod) antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|)
DDI-DrugBank.d752.s0.e0_DDI-DrugBank.d752.s0.e2 true midazolam_12\NN\2830852| (r_nsubjpass) administered_14\VBN\2436349|when|midazolam|is|drugs (r_advcl) advised_10\VBN\813978|caution|is|administered|drugs|. (l_parataxis) drugs_33\NNS\14778436|(|ie|,|some|classes (l_nmod) classes_37\NNS\7951464|in|the|drug|antimycotics (l_nmod) antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) inhibitors_43\NNS\20090|protease
DDI-DrugBank.d752.s0.e0_DDI-DrugBank.d752.s0.e3 true midazolam_12\NN\2830852| (r_nsubjpass) administered_14\VBN\2436349|when|midazolam|is|drugs (r_advcl) advised_10\VBN\813978|caution|is|administered|drugs|. (l_parataxis) drugs_33\NNS\14778436|(|ie|,|some|classes (l_nmod) classes_37\NNS\7951464|in|the|drug|antimycotics (l_nmod) antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) antagonists_47\NNS\7846|calcium|channel
DDI-DrugBank.d752.s0.e0_DDI-DrugBank.d752.s0.e4 true midazolam_12\NN\2830852| (r_nsubjpass) administered_14\VBN\2436349|when|midazolam|is|drugs (r_advcl) advised_10\VBN\813978|caution|is|administered|drugs|. (l_parataxis) drugs_33\NNS\14778436|(|ie|,|some|classes (l_nmod) classes_37\NNS\7951464|in|the|drug|antimycotics (l_nmod) antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) antibiotics_51\NNS\2716205|macrolide
DDI-DrugBank.d752.s0.e1_DDI-DrugBank.d752.s0.e2 false antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) inhibitors_43\NNS\20090|protease
DDI-DrugBank.d752.s0.e1_DDI-DrugBank.d752.s0.e3 false antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) antagonists_47\NNS\7846|calcium|channel
DDI-DrugBank.d752.s0.e1_DDI-DrugBank.d752.s0.e4 false antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) antibiotics_51\NNS\2716205|macrolide
DDI-DrugBank.d752.s0.e2_DDI-DrugBank.d752.s0.e3 false inhibitors_43\NNS\20090|protease (r_conj) antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) antagonists_47\NNS\7846|calcium|channel
DDI-DrugBank.d752.s0.e2_DDI-DrugBank.d752.s0.e4 false inhibitors_43\NNS\20090|protease (r_conj) antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) antibiotics_51\NNS\2716205|macrolide
DDI-DrugBank.d752.s0.e3_DDI-DrugBank.d752.s0.e4 false antagonists_47\NNS\7846|calcium|channel (r_conj) antimycotics_40\NNS\14778436|of|azole|,|inhibitors|,|antagonists|,|and|antibiotics|) (l_conj) antibiotics_51\NNS\2716205|macrolide
DDI-DrugBank.d700.s8
DDI-DrugBank.d700.s8.e0_DDI-DrugBank.d700.s8.e1 true myfortic_5\JJ\1740| (r_dobj) administer_4\VB\2436349|therefore|,|do|not|myfortic|cholestyramine|. (l_nmod) cholestyramine_7\NN\1740|with|or|agents
DDI-DrugBank.d700.s8.e0_DDI-DrugBank.d700.s8.e2 true myfortic_5\JJ\1740| (r_dobj) administer_4\VB\2436349|therefore|,|do|not|myfortic|cholestyramine|. (l_nmod) cholestyramine_7\NN\1740|with|or|agents (l_conj) agents_10\NNS\7347|other|interfere (l_acl:relcl) interfere_13\VB\2451370|that|may|recirculation|,|potential (l_nmod) recirculation_16\NN\368302|with|enterohepatic|or|drugs (l_conj) drugs_18\NNS\14778436|bind (l_acl:relcl) bind_21\VB\1290422|that|may|acids|sequestrates (l_nmod) sequestrates_29\NNS\1740|bile|acid|or|charcoal (l_conj) charcoal_33\NN\14633206|oral|activated
DDI-DrugBank.d700.s8.e0_DDI-DrugBank.d700.s8.e3 false myfortic_5\JJ\1740| (r_dobj) administer_4\VB\2436349|therefore|,|do|not|myfortic|cholestyramine|. (l_nmod) cholestyramine_7\NN\1740|with|or|agents (l_conj) agents_10\NNS\7347|other|interfere (l_acl:relcl) interfere_13\VB\2451370|that|may|recirculation|,|potential (l_nmod) potential_38\NN\14481929|because|the|reduce (l_acl) reduce_40\VB\441445|to|efficacy (l_dobj) efficacy_42\NN\5199286|the|myfortic (l_nmod) myfortic_44\NN\1740|of
DDI-DrugBank.d700.s8.e1_DDI-DrugBank.d700.s8.e2 false cholestyramine_7\NN\1740|with|or|agents (l_conj) agents_10\NNS\7347|other|interfere (l_acl:relcl) interfere_13\VB\2451370|that|may|recirculation|,|potential (l_nmod) recirculation_16\NN\368302|with|enterohepatic|or|drugs (l_conj) drugs_18\NNS\14778436|bind (l_acl:relcl) bind_21\VB\1290422|that|may|acids|sequestrates (l_nmod) sequestrates_29\NNS\1740|bile|acid|or|charcoal (l_conj) charcoal_33\NN\14633206|oral|activated
DDI-DrugBank.d700.s8.e1_DDI-DrugBank.d700.s8.e3 false cholestyramine_7\NN\1740|with|or|agents (l_conj) agents_10\NNS\7347|other|interfere (l_acl:relcl) interfere_13\VB\2451370|that|may|recirculation|,|potential (l_nmod) potential_38\NN\14481929|because|the|reduce (l_acl) reduce_40\VB\441445|to|efficacy (l_dobj) efficacy_42\NN\5199286|the|myfortic (l_nmod) myfortic_44\NN\1740|of
DDI-DrugBank.d700.s8.e2_DDI-DrugBank.d700.s8.e3 false charcoal_33\NN\14633206|oral|activated (r_conj) sequestrates_29\NNS\1740|bile|acid|or|charcoal (r_nmod) bind_21\VB\1290422|that|may|acids|sequestrates (r_acl:relcl) drugs_18\NNS\14778436|bind (r_conj) recirculation_16\NN\368302|with|enterohepatic|or|drugs (r_nmod) interfere_13\VB\2451370|that|may|recirculation|,|potential (l_nmod) potential_38\NN\14481929|because|the|reduce (l_acl) reduce_40\VB\441445|to|efficacy (l_dobj) efficacy_42\NN\5199286|the|myfortic (l_nmod) myfortic_44\NN\1740|of
DDI-DrugBank.d600.s0
DDI-DrugBank.d784.s6
DDI-DrugBank.d776.s28
DDI-DrugBank.d776.s28.e0_DDI-DrugBank.d776.s28.e1 false astemizole_0\NN\1740| (r_nsubjpass) associated_22\VBN\628491|astemizole|:|use|may|be|elevations|. (l_nsubjpass) use_3\NN\407535|the|fluconazole|patients (l_nmod) fluconazole_5\NN\1740|of
DDI-DrugBank.d776.s28.e0_DDI-DrugBank.d776.s28.e2 false astemizole_0\NN\1740| (r_nsubjpass) associated_22\VBN\628491|astemizole|:|use|may|be|elevations|. (l_nsubjpass) use_3\NN\407535|the|fluconazole|patients (l_nmod) patients_7\NNS\9898892|in|taking (l_acl) taking_9\VBG\2367363|concurrently|astemizole (l_dobj) astemizole_10\NN\1740|or|drugs
DDI-DrugBank.d776.s28.e1_DDI-DrugBank.d776.s28.e2 true fluconazole_5\NN\1740|of (r_nmod) use_3\NN\407535|the|fluconazole|patients (l_nmod) patients_7\NNS\9898892|in|taking (l_acl) taking_9\VBG\2367363|concurrently|astemizole (l_dobj) astemizole_10\NN\1740|or|drugs
DDI-DrugBank.d584.s7
DDI-DrugBank.d584.s7.e0_DDI-DrugBank.d584.s7.e1 true warfarin_20\NN\2718259| (r_compound) dosage_21\NN\13576355|of|the|warfarin (r_nmod) adjustment_17\NN\7357388|dosage|indicated (r_conj) monitoring_9\NN\879759|careful|inr|,|and|adjustment (r_nsubjpass) recommended_25\VBN\875394|furthermore|,|patients|,|monitoring|are|changed|. (l_advcl) changed_31\VBN\46534|dose|is|or|discontinued (l_nsubjpass) dose_29\NN\3740161|the|oxandrolone (l_compound) oxandrolone_28\NN\1740|
DDI-DrugBank.d618.s1
DDI-DrugBank.d618.s1.e0_DDI-DrugBank.d618.s1.e3 false heparin_6\NN\2718259|with|and|antagonists (r_nmod) associated_4\VBN\628491|heparin (r_acl) bleeding_3\NN\14285662|to|associated (r_nmod) addition_1\NN\3081021|in|bleeding (r_nmod) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_nsubj) drugs_12\NNS\14778436|alter|(|aspirin (l_nmod) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (l_conj) dipyridamole_22\NN\1740|
DDI-DrugBank.d618.s1.e0_DDI-DrugBank.d618.s1.e4 false heparin_6\NN\2718259|with|and|antagonists (r_nmod) associated_4\VBN\628491|heparin (r_acl) bleeding_3\NN\14285662|to|associated (r_nmod) addition_1\NN\3081021|in|bleeding (r_nmod) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_nsubj) drugs_12\NNS\14778436|alter|(|aspirin (l_nmod) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (l_conj) abciximab_25\NN\1740|
DDI-DrugBank.d618.s1.e0_DDI-DrugBank.d618.s1.e2 false heparin_6\NN\2718259|with|and|antagonists (r_nmod) associated_4\VBN\628491|heparin (r_acl) bleeding_3\NN\14285662|to|associated (r_nmod) addition_1\NN\3081021|in|bleeding (r_nmod) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_nsubj) drugs_12\NNS\14778436|alter|(|aspirin (l_nmod) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|)
DDI-DrugBank.d618.s1.e0_DDI-DrugBank.d618.s1.e5 true heparin_6\NN\2718259|with|and|antagonists (r_nmod) associated_4\VBN\628491|heparin (r_acl) bleeding_3\NN\14285662|to|associated (r_nmod) addition_1\NN\3081021|in|bleeding (r_nmod) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_advcl) administered_34\VBN\2436349|if|therapy (l_nmod) therapy_40\NN\657604|prior|retavase (l_compound) retavase_39\NN\1740|
DDI-DrugBank.d618.s1.e0_DDI-DrugBank.d618.s1.e1 false heparin_6\NN\2718259|with|and|antagonists (l_conj) antagonists_10\NNS\7846|k
DDI-DrugBank.d618.s1.e3_DDI-DrugBank.d618.s1.e4 false dipyridamole_22\NN\1740| (r_conj) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (l_conj) abciximab_25\NN\1740|
DDI-DrugBank.d618.s1.e3_DDI-DrugBank.d618.s1.e2 false dipyridamole_22\NN\1740| (r_conj) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|)
DDI-DrugBank.d618.s1.e3_DDI-DrugBank.d618.s1.e5 false dipyridamole_22\NN\1740| (r_conj) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (r_nmod) drugs_12\NNS\14778436|alter|(|aspirin (r_nsubj) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_advcl) administered_34\VBN\2436349|if|therapy (l_nmod) therapy_40\NN\657604|prior|retavase (l_compound) retavase_39\NN\1740|
DDI-DrugBank.d618.s1.e3_DDI-DrugBank.d618.s1.e1 false dipyridamole_22\NN\1740| (r_conj) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (r_nmod) drugs_12\NNS\14778436|alter|(|aspirin (r_nsubj) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_nmod) addition_1\NN\3081021|in|bleeding (l_nmod) bleeding_3\NN\14285662|to|associated (l_acl) associated_4\VBN\628491|heparin (l_nmod) heparin_6\NN\2718259|with|and|antagonists (l_conj) antagonists_10\NNS\7846|k
DDI-DrugBank.d618.s1.e4_DDI-DrugBank.d618.s1.e2 false abciximab_25\NN\1740| (r_conj) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|)
DDI-DrugBank.d618.s1.e4_DDI-DrugBank.d618.s1.e5 false abciximab_25\NN\1740| (r_conj) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (r_nmod) drugs_12\NNS\14778436|alter|(|aspirin (r_nsubj) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_advcl) administered_34\VBN\2436349|if|therapy (l_nmod) therapy_40\NN\657604|prior|retavase (l_compound) retavase_39\NN\1740|
DDI-DrugBank.d618.s1.e4_DDI-DrugBank.d618.s1.e1 false abciximab_25\NN\1740| (r_conj) aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (r_nmod) drugs_12\NNS\14778436|alter|(|aspirin (r_nsubj) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_nmod) addition_1\NN\3081021|in|bleeding (l_nmod) bleeding_3\NN\14285662|to|associated (l_acl) associated_4\VBN\628491|heparin (l_nmod) heparin_6\NN\2718259|with|and|antagonists (l_conj) antagonists_10\NNS\7846|k
DDI-DrugBank.d618.s1.e2_DDI-DrugBank.d618.s1.e5 false aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (r_nmod) drugs_12\NNS\14778436|alter|(|aspirin (r_nsubj) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_advcl) administered_34\VBN\2436349|if|therapy (l_nmod) therapy_40\NN\657604|prior|retavase (l_compound) retavase_39\NN\1740|
DDI-DrugBank.d618.s1.e2_DDI-DrugBank.d618.s1.e1 false aspirin_20\NN\2707683|such|,|dipyridamole|,|and|abciximab|) (r_nmod) drugs_12\NNS\14778436|alter|(|aspirin (r_nsubj) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_nmod) addition_1\NN\3081021|in|bleeding (l_nmod) bleeding_3\NN\14285662|to|associated (l_acl) associated_4\VBN\628491|heparin (l_nmod) heparin_6\NN\2718259|with|and|antagonists (l_conj) antagonists_10\NNS\7846|k
DDI-DrugBank.d618.s1.e5_DDI-DrugBank.d618.s1.e1 false retavase_39\NN\1740| (r_compound) therapy_40\NN\657604|prior|retavase (r_nmod) administered_34\VBN\2436349|if|therapy (r_advcl) increase_28\VB\169651|addition|,|drugs|may|risk|administered|. (l_nmod) addition_1\NN\3081021|in|bleeding (l_nmod) bleeding_3\NN\14285662|to|associated (l_acl) associated_4\VBN\628491|heparin (l_nmod) heparin_6\NN\2718259|with|and|antagonists (l_conj) antagonists_10\NNS\7846|k
DDI-DrugBank.d675.s0
DDI-DrugBank.d675.s0.e3_DDI-DrugBank.d675.s0.e4 false dihydroergotamine_32\NN\1740|(|e.g.|and|ergotamine|) (l_conj) ergotamine_34\NN\14712692|
DDI-DrugBank.d675.s0.e3_DDI-DrugBank.d675.s0.e0 false dihydroergotamine_32\NN\1740|(|e.g.|and|ergotamine|) (r_dep) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors (r_nmod) coadministration_24\NN\1740|with|the|drugs|,|resulting (r_nmod) connection_21\NN\31921|in|coadministration (r_nmod) reports_15\NNS\6470073|rare|events|connection (r_attr) been_13\VBN\836236|inhibitors|there|have|reports|. (l_nsubj) inhibitors_2\NNS\20090|cyp|3a4|(|antibiotics|) (l_appos) antibiotics_6\NNS\2716205|e.g.|macrolide|and|inhibitors
DDI-DrugBank.d675.s0.e3_DDI-DrugBank.d675.s0.e1 false dihydroergotamine_32\NN\1740|(|e.g.|and|ergotamine|) (r_dep) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors (r_nmod) coadministration_24\NN\1740|with|the|drugs|,|resulting (r_nmod) connection_21\NN\31921|in|coadministration (r_nmod) reports_15\NNS\6470073|rare|events|connection (r_attr) been_13\VBN\836236|inhibitors|there|have|reports|. (l_nsubj) inhibitors_2\NNS\20090|cyp|3a4|(|antibiotics|) (l_appos) antibiotics_6\NNS\2716205|e.g.|macrolide|and|inhibitors (l_conj) inhibitors_9\NNS\20090|protease
DDI-DrugBank.d675.s0.e3_DDI-DrugBank.d675.s0.e2 false dihydroergotamine_32\NN\1740|(|e.g.|and|ergotamine|) (r_dep) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors
DDI-DrugBank.d675.s0.e4_DDI-DrugBank.d675.s0.e0 false ergotamine_34\NN\14712692| (r_conj) dihydroergotamine_32\NN\1740|(|e.g.|and|ergotamine|) (r_dep) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors (r_nmod) coadministration_24\NN\1740|with|the|drugs|,|resulting (r_nmod) connection_21\NN\31921|in|coadministration (r_nmod) reports_15\NNS\6470073|rare|events|connection (r_attr) been_13\VBN\836236|inhibitors|there|have|reports|. (l_nsubj) inhibitors_2\NNS\20090|cyp|3a4|(|antibiotics|) (l_appos) antibiotics_6\NNS\2716205|e.g.|macrolide|and|inhibitors
DDI-DrugBank.d675.s0.e4_DDI-DrugBank.d675.s0.e1 false ergotamine_34\NN\14712692| (r_conj) dihydroergotamine_32\NN\1740|(|e.g.|and|ergotamine|) (r_dep) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors (r_nmod) coadministration_24\NN\1740|with|the|drugs|,|resulting (r_nmod) connection_21\NN\31921|in|coadministration (r_nmod) reports_15\NNS\6470073|rare|events|connection (r_attr) been_13\VBN\836236|inhibitors|there|have|reports|. (l_nsubj) inhibitors_2\NNS\20090|cyp|3a4|(|antibiotics|) (l_appos) antibiotics_6\NNS\2716205|e.g.|macrolide|and|inhibitors (l_conj) inhibitors_9\NNS\20090|protease
DDI-DrugBank.d675.s0.e4_DDI-DrugBank.d675.s0.e2 false ergotamine_34\NN\14712692| (r_conj) dihydroergotamine_32\NN\1740|(|e.g.|and|ergotamine|) (r_dep) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors
DDI-DrugBank.d675.s0.e0_DDI-DrugBank.d675.s0.e1 false antibiotics_6\NNS\2716205|e.g.|macrolide|and|inhibitors (l_conj) inhibitors_9\NNS\20090|protease
DDI-DrugBank.d675.s0.e0_DDI-DrugBank.d675.s0.e2 false antibiotics_6\NNS\2716205|e.g.|macrolide|and|inhibitors (r_appos) inhibitors_2\NNS\20090|cyp|3a4|(|antibiotics|) (r_nsubj) been_13\VBN\836236|inhibitors|there|have|reports|. (l_attr) reports_15\NNS\6470073|rare|events|connection (l_nmod) connection_21\NN\31921|in|coadministration (l_nmod) coadministration_24\NN\1740|with|the|drugs|,|resulting (l_nmod) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors
DDI-DrugBank.d675.s0.e1_DDI-DrugBank.d675.s0.e2 false inhibitors_9\NNS\20090|protease (r_conj) antibiotics_6\NNS\2716205|e.g.|macrolide|and|inhibitors (r_appos) inhibitors_2\NNS\20090|cyp|3a4|(|antibiotics|) (r_nsubj) been_13\VBN\836236|inhibitors|there|have|reports|. (l_attr) reports_15\NNS\6470073|rare|events|connection (l_nmod) connection_21\NN\31921|in|coadministration (l_nmod) coadministration_24\NN\1740|with|the|drugs|,|resulting (l_nmod) drugs_29\NNS\14778436|of|certain|ergot|alkaloid|dihydroergotamine|and|inhibitors
DDI-DrugBank.d578.s7
DDI-DrugBank.d578.s7.e0_DDI-DrugBank.d578.s7.e1 true methylprednisolone_0\NN\1740| (r_nsubj) increase_2\VB\169651|methylprednisolone|may|clearance|. (l_dobj) clearance_4\NN\5089947|the|aspirin (l_nmod) aspirin_9\NN\2707683|of|chronic|dose
DDI-DrugBank.d751.s0
DDI-DrugBank.d751.s0.e2_DDI-DrugBank.d751.s0.e0 false heparin_10\NN\2718259| (r_conj) aspirin_8\NN\2707683|of|and|heparin (r_nmod) background_6\NN\4921011|on|a|aspirin (r_nmod) studied_3\VBN\630380|aggrastat|has|been|background|. (l_nsubjpass) aggrastat_0\NN\1740|
DDI-DrugBank.d751.s0.e2_DDI-DrugBank.d751.s0.e1 false heparin_10\NN\2718259| (r_conj) aspirin_8\NN\2707683|of|and|heparin
DDI-DrugBank.d751.s0.e0_DDI-DrugBank.d751.s0.e1 false aggrastat_0\NN\1740| (r_nsubjpass) studied_3\VBN\630380|aggrastat|has|been|background|. (l_nmod) background_6\NN\4921011|on|a|aspirin (l_nmod) aspirin_8\NN\2707683|of|and|heparin
DDI-DrugBank.d737.s4
DDI-DrugBank.d737.s4.e0_DDI-DrugBank.d737.s4.e1 false cimetidine_0\NN\14778019|:|caused (l_dep) caused_20\VBD\1617192|cimetidine|increase|. (l_nsubj) cimetidine_2\NN\14778019|,|inhibitor|,
DDI-DrugBank.d737.s4.e0_DDI-DrugBank.d737.s4.e2 false cimetidine_0\NN\14778019|:|caused (l_dep) caused_20\VBD\1617192|cimetidine|increase|. (l_dobj) increase_24\NN\13576355|a|%|auc|and|increase|n= (l_nmod) auc_27\NN\1740|in|pramipexole (l_compound) pramipexole_26\NN\1740|
DDI-DrugBank.d737.s4.e1_DDI-DrugBank.d737.s4.e2 true cimetidine_2\NN\14778019|,|inhibitor|, (r_nsubj) caused_20\VBD\1617192|cimetidine|increase|. (l_dobj) increase_24\NN\13576355|a|%|auc|and|increase|n= (l_nmod) auc_27\NN\1740|in|pramipexole (l_compound) pramipexole_26\NN\1740|
DDI-DrugBank.d584.s1
DDI-DrugBank.d721.s3
DDI-DrugBank.d721.s3.e0_DDI-DrugBank.d721.s3.e1 false digoxin_4\NN\15060131|of (r_nmod) parameters_2\NNS\5858936|the|pharmacokinetic|digoxin (r_nsubjpass) modified_8\VBN\109660|parameters|are|not|significantly|coadministration|. (l_nmod) coadministration_11\NN\1740|by|skelid (l_compound) skelid_10\NN\1740|
DDI-DrugBank.d716.s4
DDI-DrugBank.d654.s0
DDI-DrugBank.d654.s0.e0_DDI-DrugBank.d654.s0.e1 false ketoconazole_3\NN\1740|of|oral (r_compound) mg_5\NN\13717155|ketoconazole|200 (r_nmod) co-administration_0\NN\1740|mg (r_nsubj) increased_8\VBD\169651|co-administration|daily|auc(0|and|cmax|%|application|,|%|skin|. (l_dobj) auc(0_12\NN\1740|mean|24 (l_compound) mean_11\NN\6021761|retapamulin|geometric (l_compound) retapamulin_9\NN\1740|
DDI-DrugBank.d654.s0.e0_DDI-DrugBank.d654.s0.e2 true ketoconazole_3\NN\1740|of|oral (r_compound) mg_5\NN\13717155|ketoconazole|200 (r_nmod) co-administration_0\NN\1740|mg (r_nsubj) increased_8\VBD\169651|co-administration|daily|auc(0|and|cmax|%|application|,|%|skin|. (l_nmod) application_23\NN\947128|after|topical|ointment (l_nmod) ointment_26\NN\4074482|of|retapamulin (l_compound) retapamulin_25\NN\1740|
DDI-DrugBank.d654.s0.e1_DDI-DrugBank.d654.s0.e2 false retapamulin_9\NN\1740| (r_compound) mean_11\NN\6021761|retapamulin|geometric (r_compound) auc(0_12\NN\1740|mean|24 (r_dobj) increased_8\VBD\169651|co-administration|daily|auc(0|and|cmax|%|application|,|%|skin|. (l_nmod) application_23\NN\947128|after|topical|ointment (l_nmod) ointment_26\NN\4074482|of|retapamulin (l_compound) retapamulin_25\NN\1740|
DDI-DrugBank.d761.s11
DDI-DrugBank.d761.s11.e0_DDI-DrugBank.d761.s11.e2 false warfarin_0\NNP\2718259|:|result (l_dep) result_21\VB\2633881|subjects|,|administration|did|not|change|. (l_nmod) change_24\NN\7283608|in|any|pharmacokinetics (l_nmod) pharmacokinetics_28\NNS\6054892|in|either|warfarin|r-|or|pharmacodynamics (l_compound) warfarin_27\NN\2718259|
DDI-DrugBank.d761.s11.e0_DDI-DrugBank.d761.s11.e1 false warfarin_0\NNP\2718259|:|result (l_dep) result_21\VB\2633881|subjects|,|administration|did|not|change|. (l_nsubj) administration_7\NN\1133281|mg|times|days (l_nmod) mg_11\NN\13717155|of|xenical|120 (l_amod) xenical_9\JJ\1740|
DDI-DrugBank.d761.s11.e2_DDI-DrugBank.d761.s11.e1 false warfarin_27\NN\2718259| (r_compound) pharmacokinetics_28\NNS\6054892|in|either|warfarin|r-|or|pharmacodynamics (r_nmod) change_24\NN\7283608|in|any|pharmacokinetics (r_nmod) result_21\VB\2633881|subjects|,|administration|did|not|change|. (l_nsubj) administration_7\NN\1133281|mg|times|days (l_nmod) mg_11\NN\13717155|of|xenical|120 (l_amod) xenical_9\JJ\1740|
DDI-DrugBank.d572.s25
DDI-DrugBank.d652.s5
DDI-DrugBank.d572.s15
DDI-DrugBank.d610.s6
DDI-DrugBank.d661.s4
DDI-DrugBank.d661.s4.e0_DDI-DrugBank.d661.s4.e1 false zemuron_9\NNP\1740|of (r_nmod) use_7\NN\407535|the|zemuron|relaxants (l_nmod) relaxants_16\NNS\3247620|before|other|nondepolarizing|muscle
DDI-DrugBank.d781.s2
DDI-DrugBank.d781.s2.e1_DDI-DrugBank.d781.s2.e0 false aceon_18\NN\1740| (r_compound) tablets_19\NNS\4233405|of|aceon (r_nmod) dose_16\NN\3740161|with|the|first|tablets (r_nmod) provided_12\VBN\2199590|interrupted|,|supervision|should|be|dose|,|hours|and|stabilized|. (l_advcl) interrupted_5\VBN\362348|if|diuretics|can|not|be (l_nsubjpass) diuretics_1\NNS\3247620|
DDI-DrugBank.d645.s8
DDI-DrugBank.d645.s8.e0_DDI-DrugBank.d645.s8.e1 false terbinafine_0\NN\2720201| (r_compound) clearance_1\NN\5089947|terbinafine (r_nsubj) unaffected_3\JJ\1740|clearance|is|cyclosporine|. (l_nmod) cyclosporine_5\NN\1740|by
DDI-DrugBank.d597.s2
DDI-DrugBank.d597.s2.e2_DDI-DrugBank.d597.s2.e0 false meloxicam_30\NN\1740|of (r_nmod) auc_18\NN\1740|the|%|and|cmax|meloxicam (r_dobj) increase_16\VB\169651|to|auc (r_xcomp) tended_14\VBD\2604760|aspirin|:|administration|increase|. (l_nsubj) aspirin_0\NN\2707683|
DDI-DrugBank.d597.s2.e2_DDI-DrugBank.d597.s2.e1 false meloxicam_30\NN\1740|of (r_nmod) auc_18\NN\1740|the|%|and|cmax|meloxicam (r_dobj) increase_16\VB\169651|to|auc (r_xcomp) tended_14\VBD\2604760|aspirin|:|administration|increase|. (l_nsubj) administration_3\NN\1133281|concomitant|aspirin|volunteers (l_nmod) aspirin_5\NN\2707683|of|tid
DDI-DrugBank.d597.s2.e0_DDI-DrugBank.d597.s2.e1 false aspirin_0\NN\2707683| (r_nsubj) tended_14\VBD\2604760|aspirin|:|administration|increase|. (l_nsubj) administration_3\NN\1133281|concomitant|aspirin|volunteers (l_nmod) aspirin_5\NN\2707683|of|tid
DDI-DrugBank.d616.s1
DDI-DrugBank.d616.s1.e0_DDI-DrugBank.d616.s1.e1 true zadaxin_6\NN\1740| (r_compound) therapy_7\NN\657604|zadaxin (r_dobj) administering_5\VBG\2436349|when|therapy|combination (l_nmod) combination_9\NN\7951464|in|drugs (l_nmod) drugs_13\NNS\14778436|with|other|immunomodulating
DDI-DrugBank.d597.s19
DDI-DrugBank.d597.s19.e0_DDI-DrugBank.d597.s19.e2 false lithium_0\NN\14625458| (r_dep) produced_8\VBN\1617192|lithium|:|trials|,|nsaids|have|elevation|. (l_dobj) elevation_10\NN\7445480|an|levels|and|reduction (l_nmod) levels_14\NNS\4916342|of|plasma|lithium (l_compound) lithium_13\NN\14625458|
DDI-DrugBank.d597.s19.e0_DDI-DrugBank.d597.s19.e3 false lithium_0\NN\14625458| (r_dep) produced_8\VBN\1617192|lithium|:|trials|,|nsaids|have|elevation|. (l_dobj) elevation_10\NN\7445480|an|levels|and|reduction (l_conj) reduction_17\NN\351485|a|clearance (l_nmod) clearance_21\NN\5089947|in|renal|lithium (l_compound) lithium_20\NN\14625458|
DDI-DrugBank.d597.s19.e0_DDI-DrugBank.d597.s19.e1 false lithium_0\NN\14625458| (r_dep) produced_8\VBN\1617192|lithium|:|trials|,|nsaids|have|elevation|. (l_nsubj) nsaids_6\NNS\2721538|
DDI-DrugBank.d597.s19.e2_DDI-DrugBank.d597.s19.e3 false lithium_13\NN\14625458| (r_compound) levels_14\NNS\4916342|of|plasma|lithium (r_nmod) elevation_10\NN\7445480|an|levels|and|reduction (l_conj) reduction_17\NN\351485|a|clearance (l_nmod) clearance_21\NN\5089947|in|renal|lithium (l_compound) lithium_20\NN\14625458|
DDI-DrugBank.d597.s19.e2_DDI-DrugBank.d597.s19.e1 false lithium_13\NN\14625458| (r_compound) levels_14\NNS\4916342|of|plasma|lithium (r_nmod) elevation_10\NN\7445480|an|levels|and|reduction (r_dobj) produced_8\VBN\1617192|lithium|:|trials|,|nsaids|have|elevation|. (l_nsubj) nsaids_6\NNS\2721538|
DDI-DrugBank.d597.s19.e3_DDI-DrugBank.d597.s19.e1 false lithium_20\NN\14625458| (r_compound) clearance_21\NN\5089947|in|renal|lithium (r_nmod) reduction_17\NN\351485|a|clearance (r_conj) elevation_10\NN\7445480|an|levels|and|reduction (r_dobj) produced_8\VBN\1617192|lithium|:|trials|,|nsaids|have|elevation|. (l_nsubj) nsaids_6\NNS\2721538|
DDI-DrugBank.d603.s6
DDI-DrugBank.d595.s2
DDI-DrugBank.d595.s2.e0_DDI-DrugBank.d595.s2.e1 false bicarbonate_4\NN\14798450|of|sodium (r_nmod) addition_1\NN\3081021|the|bicarbonate|solutions (l_nmod) solutions_7\NNS\14586258|to|parenteral|containing (l_acl) containing_8\VBG\2632940|calcium (l_dobj) calcium_9\NN\14625458|
DDI-DrugBank.d636.s2
DDI-DrugBank.d636.s2.e1_DDI-DrugBank.d636.s2.e2 false sodium_4\NN\14625458|divalproex|,|acid (l_conj) acid_7\NN\14818238|valproic|,|and|phenobarbital
DDI-DrugBank.d636.s2.e1_DDI-DrugBank.d636.s2.e3 false sodium_4\NN\14625458|divalproex|,|acid (l_conj) acid_7\NN\14818238|valproic|,|and|phenobarbital (l_conj) phenobarbital_10\NN\2792049|
DDI-DrugBank.d636.s2.e1_DDI-DrugBank.d636.s2.e0 false sodium_4\NN\14625458|divalproex|,|acid (r_dobj) include_2\VBP\690614|anticonvulsants|sodium|. (l_nsubj) anticonvulsants_1\NNS\3740161|those
DDI-DrugBank.d636.s2.e2_DDI-DrugBank.d636.s2.e3 false acid_7\NN\14818238|valproic|,|and|phenobarbital (l_conj) phenobarbital_10\NN\2792049|
DDI-DrugBank.d636.s2.e2_DDI-DrugBank.d636.s2.e0 false acid_7\NN\14818238|valproic|,|and|phenobarbital (r_conj) sodium_4\NN\14625458|divalproex|,|acid (r_dobj) include_2\VBP\690614|anticonvulsants|sodium|. (l_nsubj) anticonvulsants_1\NNS\3740161|those
DDI-DrugBank.d636.s2.e3_DDI-DrugBank.d636.s2.e0 false phenobarbital_10\NN\2792049| (r_conj) acid_7\NN\14818238|valproic|,|and|phenobarbital (r_conj) sodium_4\NN\14625458|divalproex|,|acid (r_dobj) include_2\VBP\690614|anticonvulsants|sodium|. (l_nsubj) anticonvulsants_1\NNS\3740161|those
DDI-DrugBank.d717.s1
DDI-DrugBank.d717.s1.e1_DDI-DrugBank.d717.s1.e0 false mitotane_16\NN\1740| (r_dobj) administering_15\VBG\2436349|when|mitotane|patients (r_advcl) monitor_5\VB\2169352|therefore|,|physicians|should|closely|patients|change|administering|. (l_nmod) change_9\NN\7283608|for|a|requirements (l_nmod) requirements_13\NNS\1129920|in|anticoagulant|dosage (l_amod) anticoagulant_11\JJ\1740|
DDI-DrugBank.d717.s1.e1_DDI-DrugBank.d717.s1.e2 true mitotane_16\NN\1740| (r_dobj) administering_15\VBG\2436349|when|mitotane|patients (l_nmod) patients_18\NNS\9898892|to|anticoagulants (l_nmod) anticoagulants_21\NNS\3740161|on|coumarin-type
DDI-DrugBank.d717.s1.e0_DDI-DrugBank.d717.s1.e2 false anticoagulant_11\JJ\1740| (r_amod) requirements_13\NNS\1129920|in|anticoagulant|dosage (r_nmod) change_9\NN\7283608|for|a|requirements (r_nmod) monitor_5\VB\2169352|therefore|,|physicians|should|closely|patients|change|administering|. (l_advcl) administering_15\VBG\2436349|when|mitotane|patients (l_nmod) patients_18\NNS\9898892|to|anticoagulants (l_nmod) anticoagulants_21\NNS\3740161|on|coumarin-type
DDI-DrugBank.d728.s3
DDI-DrugBank.d633.s4
DDI-DrugBank.d633.s4.e0_DDI-DrugBank.d633.s4.e1 false propafenone_10\NN\1740|of (r_nmod) pharmacokinetics_8\NNS\6054892|the|propafenone (r_nsubj) unaffected_12\JJ\1740|study|,|pharmacokinetics|were|phenotype|coadministration|. (l_nmod) coadministration_18\NN\1740|by|the|mexiletine (l_nmod) mexiletine_20\NN\2715941|of
DDI-DrugBank.d633.s10
DDI-DrugBank.d602.s2
DDI-DrugBank.d602.s2.e0_DDI-DrugBank.d602.s2.e1 true doxorubicin_5\NN\2716866| (r_dobj) administering_4\VBG\2436349|when|doxorubicin|nexavar (l_nmod) nexavar_7\NNP\1740|with
DDI-DrugBank.d623.s6
DDI-DrugBank.d774.s0
DDI-DrugBank.d774.s0.e0_DDI-DrugBank.d774.s0.e1 true trilostane_0\NN\1740| (r_nsubj) interact_2\VB\2367363|trilostane|may|aminoglutethimide|(|causing|. (l_nmod) aminoglutethimide_4\NN\1740|with|or|mitotane
DDI-DrugBank.d774.s0.e0_DDI-DrugBank.d774.s0.e2 true trilostane_0\NN\1740| (r_nsubj) interact_2\VB\2367363|trilostane|may|aminoglutethimide|(|causing|. (l_nmod) aminoglutethimide_4\NN\1740|with|or|mitotane (l_conj) mitotane_6\NN\1740|
DDI-DrugBank.d774.s0.e1_DDI-DrugBank.d774.s0.e2 false aminoglutethimide_4\NN\1740|with|or|mitotane (l_conj) mitotane_6\NN\1740|
DDI-DrugBank.d781.s4
DDI-DrugBank.d781.s4.e0_DDI-DrugBank.d781.s4.e1 false perindoprilat_3\NN\1740|of (r_nmod) bioavailability_1\NN\1740|the|perindoprilat (r_nsubjpass) reduced_5\VBN\441445|bioavailability|was|diuretics|,|however|,|and|associated (l_nmod) diuretics_7\NNS\3247620|by
DDI-DrugBank.d678.s4
DDI-DrugBank.d678.s4.e1_DDI-DrugBank.d678.s4.e2 false acetaminophen_5\NN\2707683|of (r_nmod) glucuronidation_3\NN\1740|the|acetaminophen (r_dobj) inhibits_1\VBZ\2510337|metopirone|glucuronidation|and|potentiate|. (l_conj) potentiate_9\VB\229605|could|possibly|toxicity (l_dobj) toxicity_11\NN\13576101|acetaminophen (l_compound) acetaminophen_10\NN\2707683|
DDI-DrugBank.d678.s4.e1_DDI-DrugBank.d678.s4.e0 false acetaminophen_5\NN\2707683|of (r_nmod) glucuronidation_3\NN\1740|the|acetaminophen (r_dobj) inhibits_1\VBZ\2510337|metopirone|glucuronidation|and|potentiate|. (l_nsubj) metopirone_0\NN\1740|
DDI-DrugBank.d678.s4.e2_DDI-DrugBank.d678.s4.e0 false acetaminophen_10\NN\2707683| (r_compound) toxicity_11\NN\13576101|acetaminophen (r_dobj) potentiate_9\VB\229605|could|possibly|toxicity (r_conj) inhibits_1\VBZ\2510337|metopirone|glucuronidation|and|potentiate|. (l_nsubj) metopirone_0\NN\1740|
DDI-DrugBank.d597.s30
DDI-DrugBank.d597.s30.e1_DDI-DrugBank.d597.s30.e2 false warfarin_8\NN\2718259|with (r_nmod) administering_5\VBG\2436349|when|mobic|warfarin (r_advcl) used_3\VBN\1156834|caution|should|be|administering|experience|. (l_advcl) experience_14\VB\2108377|since|patients|may|changes|introduced (l_nsubj) patients_10\NNS\9898892|warfarin (l_nmod) warfarin_12\NN\2718259|on
DDI-DrugBank.d597.s30.e1_DDI-DrugBank.d597.s30.e0 false warfarin_8\NN\2718259|with (r_nmod) administering_5\VBG\2436349|when|mobic|warfarin (l_dobj) mobic_6\NN\1740|
DDI-DrugBank.d597.s30.e2_DDI-DrugBank.d597.s30.e0 false warfarin_12\NN\2718259|on (r_nmod) patients_10\NNS\9898892|warfarin (r_nsubj) experience_14\VB\2108377|since|patients|may|changes|introduced (r_advcl) used_3\VBN\1156834|caution|should|be|administering|experience|. (l_advcl) administering_5\VBG\2436349|when|mobic|warfarin (l_dobj) mobic_6\NN\1740|
DDI-DrugBank.d648.s2
DDI-DrugBank.d713.s5
DDI-DrugBank.d743.s4
DDI-DrugBank.d743.s4.e0_DDI-DrugBank.d743.s4.e1 true ketoconazole_3\NN\1740|of|and|terfenadine (l_conj) terfenadine_5\NN\1740|
DDI-DrugBank.d686.s2
DDI-DrugBank.d648.s1
DDI-DrugBank.d648.s1.e0_DDI-DrugBank.d648.s1.e2 false warfarin_0\NNP\2718259| (r_dep) assessed_11\VBN\670261|warfarin|:|coadministration|has|not|been|conditions|. (l_nsubjpass) coadministration_3\NN\1740|the|evista (l_nmod) evista_5\NNP\1740|of|and|warfarin (l_conj) warfarin_7\NN\2718259|
DDI-DrugBank.d648.s1.e0_DDI-DrugBank.d648.s1.e1 false warfarin_0\NNP\2718259| (r_dep) assessed_11\VBN\670261|warfarin|:|coadministration|has|not|been|conditions|. (l_nsubjpass) coadministration_3\NN\1740|the|evista (l_nmod) evista_5\NNP\1740|of|and|warfarin
DDI-DrugBank.d648.s1.e2_DDI-DrugBank.d648.s1.e1 false warfarin_7\NN\2718259| (r_conj) evista_5\NNP\1740|of|and|warfarin
DDI-DrugBank.d645.s4
DDI-DrugBank.d645.s4.e0_DDI-DrugBank.d645.s4.e1 true terbinafine_0\NN\2720201| (r_nsubj) decreases_1\VBZ\169651|terbinafine|clearance|%|. (l_dobj) clearance_3\NN\5089947|the|caffeine (l_nmod) caffeine_5\NN\14712692|of
DDI-DrugBank.d775.s3
DDI-DrugBank.d775.s3.e1_DDI-DrugBank.d775.s3.e2 false succinylcholine_5\NN\3800001|before (r_nmod) use_1\NN\407535|the|mivacron|succinylcholine|attenuate (l_acl) attenuate_7\VB\224901|to|some (l_dobj) some_8\DT\1740|effects (l_nmod) effects_12\NNS\13245626|of|the|side|succinylcholine (l_nmod) succinylcholine_14\NN\3800001|of
DDI-DrugBank.d775.s3.e1_DDI-DrugBank.d775.s3.e0 false succinylcholine_5\NN\3800001|before (r_nmod) use_1\NN\407535|the|mivacron|succinylcholine|attenuate (l_nmod) mivacron_3\NN\1740|of
DDI-DrugBank.d775.s3.e2_DDI-DrugBank.d775.s3.e0 false succinylcholine_14\NN\3800001|of (r_nmod) effects_12\NNS\13245626|of|the|side|succinylcholine (r_nmod) some_8\DT\1740|effects (r_dobj) attenuate_7\VB\224901|to|some (r_acl) use_1\NN\407535|the|mivacron|succinylcholine|attenuate (l_nmod) mivacron_3\NN\1740|of
DDI-DrugBank.d676.s4
DDI-DrugBank.d676.s4.e0_DDI-DrugBank.d676.s4.e1 false agents_5\NNS\7347|with|other|chemotherapeutic|,|radiotherapy (l_conj) radiotherapy_7\NN\661091|or|steroids (l_conj) steroids_9\NNS\14727670|
DDI-DrugBank.d628.s3
DDI-DrugBank.d628.s3.e2_DDI-DrugBank.d628.s3.e0 false oxide_41\NN\14818238|eg|,|nitrous|or|opioids|) (r_appos) agents_36\NNS\7347|of|supplemental|analgesic|(|oxide (r_nmod) presence_32\NN\13954253|in|the|agents (r_nmod) reduced_29\VBN\441445|may|be|presence (r_conj) adjusted_16\VBN\126264|maintenance|,|rate|should|be|level|and|reduced|. (l_nsubjpass) rate_8\NN\13815152|the|administration (l_nmod) administration_13\NN\1133281|of|injectable|emulsion (l_amod) injectable_11\JJ\1740|diprivan (l_nmod:npmod) diprivan_10\NN\1740|
DDI-DrugBank.d628.s3.e2_DDI-DrugBank.d628.s3.e1 false oxide_41\NN\14818238|eg|,|nitrous|or|opioids|) (r_appos) agents_36\NNS\7347|of|supplemental|analgesic|(|oxide
DDI-DrugBank.d628.s3.e2_DDI-DrugBank.d628.s3.e3 false oxide_41\NN\14818238|eg|,|nitrous|or|opioids|) (l_conj) opioids_43\NNS\1740|
DDI-DrugBank.d628.s3.e0_DDI-DrugBank.d628.s3.e1 true diprivan_10\NN\1740| (r_nmod:npmod) injectable_11\JJ\1740|diprivan (r_amod) administration_13\NN\1133281|of|injectable|emulsion (r_nmod) rate_8\NN\13815152|the|administration (r_nsubjpass) adjusted_16\VBN\126264|maintenance|,|rate|should|be|level|and|reduced|. (l_conj) reduced_29\VBN\441445|may|be|presence (l_nmod) presence_32\NN\13954253|in|the|agents (l_nmod) agents_36\NNS\7347|of|supplemental|analgesic|(|oxide
DDI-DrugBank.d628.s3.e0_DDI-DrugBank.d628.s3.e3 true diprivan_10\NN\1740| (r_nmod:npmod) injectable_11\JJ\1740|diprivan (r_amod) administration_13\NN\1133281|of|injectable|emulsion (r_nmod) rate_8\NN\13815152|the|administration (r_nsubjpass) adjusted_16\VBN\126264|maintenance|,|rate|should|be|level|and|reduced|. (l_conj) reduced_29\VBN\441445|may|be|presence (l_nmod) presence_32\NN\13954253|in|the|agents (l_nmod) agents_36\NNS\7347|of|supplemental|analgesic|(|oxide (l_appos) oxide_41\NN\14818238|eg|,|nitrous|or|opioids|) (l_conj) opioids_43\NNS\1740|
DDI-DrugBank.d628.s3.e1_DDI-DrugBank.d628.s3.e3 false agents_36\NNS\7347|of|supplemental|analgesic|(|oxide (l_appos) oxide_41\NN\14818238|eg|,|nitrous|or|opioids|) (l_conj) opioids_43\NNS\1740|
DDI-DrugBank.d736.s5
DDI-DrugBank.d736.s5.e1_DDI-DrugBank.d736.s5.e0 false tubocurarine_7\NN\14712692|of (r_nmod) responsiveness_5\NN\5652926|the|tubocurarine (r_dobj) increase_3\VB\169651|drugs|may|responsiveness|. (l_nsubj) drugs_1\NNS\14778436|thiazide
DDI-DrugBank.d688.s2
DDI-DrugBank.d688.s2.e0_DDI-DrugBank.d688.s2.e1 true indinavir_6\NN\4013993|of (r_nmod) dose_4\NN\3740161|of|a|higher|indinavir (r_nmod) administration_0\NN\1133281|dose (r_nsubjpass) considered_9\VBN\689344|administration|should|be|coadministering|. (l_advcl) coadministering_11\VBG\1740|when|acetate (l_nmod) acetate_14\NN\15010703|with|megestrol
DDI-DrugBank.d633.s7
DDI-DrugBank.d633.s7.e0_DDI-DrugBank.d633.s7.e1 false mexitil_6\NNP\2715941| (r_nsubjpass) used_9\VBN\1156834|program|mexitil|has|been|concurrently|drugs|interactions|. (l_nmod) drugs_20\NNS\14778436|with|employed|antianginal (l_amod) antianginal_14\JJ\1740|,|antihypertensive (l_conj) antihypertensive_16\JJ\1740|,|and|anticoagulant
DDI-DrugBank.d633.s7.e0_DDI-DrugBank.d633.s7.e2 false mexitil_6\NNP\2715941| (r_nsubjpass) used_9\VBN\1156834|program|mexitil|has|been|concurrently|drugs|interactions|. (l_nmod) drugs_20\NNS\14778436|with|employed|antianginal
DDI-DrugBank.d633.s7.e1_DDI-DrugBank.d633.s7.e2 false antihypertensive_16\JJ\1740|,|and|anticoagulant (r_conj) antianginal_14\JJ\1740|,|antihypertensive (r_amod) drugs_20\NNS\14778436|with|employed|antianginal
DDI-DrugBank.d781.s7
DDI-DrugBank.d625.s1
DDI-DrugBank.d625.s1.e0_DDI-DrugBank.d625.s1.e1 true melphalan_17\NN\2722458|with|high-dose|intravenous (r_nmod) conditioned_13\JJ\1740|who|were|melphalan|and|received (l_conj) received_21\VBD\2210855|who|subsequently|cyclosporin|prevent (l_dobj) cyclosporin_22\NN\1740|
DDI-DrugBank.d781.s6
DDI-DrugBank.d781.s6.e1_DDI-DrugBank.d781.s6.e2 false spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) amiloride_7\NN\1740|
DDI-DrugBank.d781.s6.e1_DDI-DrugBank.d781.s6.e3 false spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) triamterene_9\NN\1740|and|others
DDI-DrugBank.d781.s6.e1_DDI-DrugBank.d781.s6.e4 false spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_compound) potassium_14\NN\14625458|
DDI-DrugBank.d781.s6.e1_DDI-DrugBank.d781.s6.e5 false spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|)
DDI-DrugBank.d781.s6.e1_DDI-DrugBank.d781.s6.e6 false spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) heparin_27\NN\2718259|
DDI-DrugBank.d781.s6.e1_DDI-DrugBank.d781.s6.e7 false spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) cyclosporine_29\NN\1740|and|others
DDI-DrugBank.d781.s6.e1_DDI-DrugBank.d781.s6.e0 false spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone
DDI-DrugBank.d781.s6.e2_DDI-DrugBank.d781.s6.e3 false amiloride_7\NN\1740| (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) triamterene_9\NN\1740|and|others
DDI-DrugBank.d781.s6.e2_DDI-DrugBank.d781.s6.e4 false amiloride_7\NN\1740| (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_compound) potassium_14\NN\14625458|
DDI-DrugBank.d781.s6.e2_DDI-DrugBank.d781.s6.e5 false amiloride_7\NN\1740| (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|)
DDI-DrugBank.d781.s6.e2_DDI-DrugBank.d781.s6.e6 false amiloride_7\NN\1740| (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) heparin_27\NN\2718259|
DDI-DrugBank.d781.s6.e2_DDI-DrugBank.d781.s6.e7 false amiloride_7\NN\1740| (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) cyclosporine_29\NN\1740|and|others
DDI-DrugBank.d781.s6.e2_DDI-DrugBank.d781.s6.e0 false amiloride_7\NN\1740| (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone
DDI-DrugBank.d781.s6.e3_DDI-DrugBank.d781.s6.e4 false triamterene_9\NN\1740|and|others (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_compound) potassium_14\NN\14625458|
DDI-DrugBank.d781.s6.e3_DDI-DrugBank.d781.s6.e5 false triamterene_9\NN\1740|and|others (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|)
DDI-DrugBank.d781.s6.e3_DDI-DrugBank.d781.s6.e6 false triamterene_9\NN\1740|and|others (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) heparin_27\NN\2718259|
DDI-DrugBank.d781.s6.e3_DDI-DrugBank.d781.s6.e7 false triamterene_9\NN\1740|and|others (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (l_conj) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) cyclosporine_29\NN\1740|and|others
DDI-DrugBank.d781.s6.e3_DDI-DrugBank.d781.s6.e0 false triamterene_9\NN\1740|and|others (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone
DDI-DrugBank.d781.s6.e4_DDI-DrugBank.d781.s6.e5 false potassium_14\NN\14625458| (r_compound) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|)
DDI-DrugBank.d781.s6.e4_DDI-DrugBank.d781.s6.e6 false potassium_14\NN\14625458| (r_compound) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) heparin_27\NN\2718259|
DDI-DrugBank.d781.s6.e4_DDI-DrugBank.d781.s6.e7 false potassium_14\NN\14625458| (r_compound) supplements_15\NNS\6365467|potassium|or|drugs (l_conj) drugs_18\NNS\14778436|other|capable|indomethacin (l_dep) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) cyclosporine_29\NN\1740|and|others
DDI-DrugBank.d781.s6.e4_DDI-DrugBank.d781.s6.e0 false potassium_14\NN\14625458| (r_compound) supplements_15\NNS\6365467|potassium|or|drugs (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone
DDI-DrugBank.d781.s6.e5_DDI-DrugBank.d781.s6.e6 false indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) heparin_27\NN\2718259|
DDI-DrugBank.d781.s6.e5_DDI-DrugBank.d781.s6.e7 false indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) cyclosporine_29\NN\1740|and|others
DDI-DrugBank.d781.s6.e5_DDI-DrugBank.d781.s6.e0 false indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (r_dep) drugs_18\NNS\14778436|other|capable|indomethacin (r_conj) supplements_15\NNS\6365467|potassium|or|drugs (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone
DDI-DrugBank.d781.s6.e6_DDI-DrugBank.d781.s6.e7 false heparin_27\NN\2718259| (r_conj) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (l_conj) cyclosporine_29\NN\1740|and|others
DDI-DrugBank.d781.s6.e6_DDI-DrugBank.d781.s6.e0 false heparin_27\NN\2718259| (r_conj) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (r_dep) drugs_18\NNS\14778436|other|capable|indomethacin (r_conj) supplements_15\NNS\6365467|potassium|or|drugs (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone
DDI-DrugBank.d781.s6.e7_DDI-DrugBank.d781.s6.e0 false cyclosporine_29\NN\1740|and|others (r_conj) indomethacin_25\NN\3828465|(|,|heparin|,|cyclosporine|) (r_dep) drugs_18\NNS\14778436|other|capable|indomethacin (r_conj) supplements_15\NNS\6365467|potassium|or|drugs (r_conj) spironolactone_5\NN\2721160|(|,|amiloride|,|triamterene|)|,|supplements (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone
DDI-DrugBank.d700.s6
DDI-DrugBank.d700.s6.e0_DDI-DrugBank.d700.s6.e1 false azathioprine/mycophenolate_0\NN\1740| (r_compound) mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended
DDI-DrugBank.d700.s6.e0_DDI-DrugBank.d700.s6.e2 false azathioprine/mycophenolate_0\NN\1740| (r_compound) mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_advcl) inhibit_9\VBP\2510337|that|azathioprine|metabolism (l_nsubj) azathioprine_5\NN\3740161|and|mofetil
DDI-DrugBank.d700.s6.e0_DDI-DrugBank.d700.s6.e3 false azathioprine/mycophenolate_0\NN\1740| (r_compound) mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_advcl) inhibit_9\VBP\2510337|that|azathioprine|metabolism (l_nsubj) azathioprine_5\NN\3740161|and|mofetil (l_conj) mofetil_8\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e0_DDI-DrugBank.d700.s6.e5 false azathioprine/mycophenolate_0\NN\1740| (r_compound) mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil
DDI-DrugBank.d700.s6.e0_DDI-DrugBank.d700.s6.e6 false azathioprine/mycophenolate_0\NN\1740| (r_compound) mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil (l_conj) mofetil_26\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e0_DDI-DrugBank.d700.s6.e4 false azathioprine/mycophenolate_0\NN\1740| (r_compound) mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nsubjpass) myfortic_17\NN\1740|
DDI-DrugBank.d700.s6.e1_DDI-DrugBank.d700.s6.e2 false mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_advcl) inhibit_9\VBP\2510337|that|azathioprine|metabolism (l_nsubj) azathioprine_5\NN\3740161|and|mofetil
DDI-DrugBank.d700.s6.e1_DDI-DrugBank.d700.s6.e3 false mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_advcl) inhibit_9\VBP\2510337|that|azathioprine|metabolism (l_nsubj) azathioprine_5\NN\3740161|and|mofetil (l_conj) mofetil_8\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e1_DDI-DrugBank.d700.s6.e5 false mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil
DDI-DrugBank.d700.s6.e1_DDI-DrugBank.d700.s6.e6 false mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil (l_conj) mofetil_26\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e1_DDI-DrugBank.d700.s6.e4 false mofetil_1\NN\1740|azathioprine/mycophenolate|:|recommended (l_acl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nsubjpass) myfortic_17\NN\1740|
DDI-DrugBank.d700.s6.e2_DDI-DrugBank.d700.s6.e3 false azathioprine_5\NN\3740161|and|mofetil (l_conj) mofetil_8\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e2_DDI-DrugBank.d700.s6.e5 false azathioprine_5\NN\3740161|and|mofetil (r_nsubj) inhibit_9\VBP\2510337|that|azathioprine|metabolism (r_advcl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil
DDI-DrugBank.d700.s6.e2_DDI-DrugBank.d700.s6.e6 false azathioprine_5\NN\3740161|and|mofetil (r_nsubj) inhibit_9\VBP\2510337|that|azathioprine|metabolism (r_advcl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil (l_conj) mofetil_26\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e2_DDI-DrugBank.d700.s6.e4 false azathioprine_5\NN\3740161|and|mofetil (r_nsubj) inhibit_9\VBP\2510337|that|azathioprine|metabolism (r_advcl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nsubjpass) myfortic_17\NN\1740|
DDI-DrugBank.d700.s6.e3_DDI-DrugBank.d700.s6.e5 false mofetil_8\NN\1740|mycophenolate (r_conj) azathioprine_5\NN\3740161|and|mofetil (r_nsubj) inhibit_9\VBP\2510337|that|azathioprine|metabolism (r_advcl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil
DDI-DrugBank.d700.s6.e3_DDI-DrugBank.d700.s6.e6 false mofetil_8\NN\1740|mycophenolate (r_conj) azathioprine_5\NN\3740161|and|mofetil (r_nsubj) inhibit_9\VBP\2510337|that|azathioprine|metabolism (r_advcl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nmod) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil (l_conj) mofetil_26\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e3_DDI-DrugBank.d700.s6.e4 false mofetil_8\NN\1740|mycophenolate (r_conj) azathioprine_5\NN\3740161|and|mofetil (r_nsubj) inhibit_9\VBP\2510337|that|azathioprine|metabolism (r_advcl) recommended_15\VBN\875394|given|inhibit|,|it|is|administered|. (l_ccomp) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nsubjpass) myfortic_17\NN\1740|
DDI-DrugBank.d700.s6.e5_DDI-DrugBank.d700.s6.e6 false azathioprine_23\NN\3740161|concomitantly|with|or|mofetil (l_conj) mofetil_26\NN\1740|mycophenolate
DDI-DrugBank.d700.s6.e5_DDI-DrugBank.d700.s6.e4 false azathioprine_23\NN\3740161|concomitantly|with|or|mofetil (r_nmod) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nsubjpass) myfortic_17\NN\1740|
DDI-DrugBank.d700.s6.e6_DDI-DrugBank.d700.s6.e4 false mofetil_26\NN\1740|mycophenolate (r_conj) azathioprine_23\NN\3740161|concomitantly|with|or|mofetil (r_nmod) administered_20\VBN\2436349|that|myfortic|not|be|azathioprine (l_nsubjpass) myfortic_17\NN\1740|
DDI-DrugBank.d656.s1
DDI-DrugBank.d656.s1.e2_DDI-DrugBank.d656.s1.e3 false feldene_21\NN\3828465|with (r_nmod) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_parataxis) monitor_30\VB\2169352|,|physicians|should|closely|patients|change|administering (l_advcl) administering_39\VBG\2436349|when|feldene|patients|anticoagulants (l_dobj) feldene_40\NNP\3828465|
DDI-DrugBank.d656.s1.e2_DDI-DrugBank.d656.s1.e0 false feldene_21\NN\3828465|with (r_nmod) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_advcl) occurred_4\VBN\2623529|although|this|has|not|studies (l_nmod) studies_8\NNS\635850|in|in|anticoagulants (l_nmod) anticoagulants_11\NNS\3740161|with|coumarin-type
DDI-DrugBank.d656.s1.e2_DDI-DrugBank.d656.s1.e1 false feldene_21\NN\3828465|with (r_nmod) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_nsubjpass) interactions_13\NNS\37396|anticoagulants (l_nmod) anticoagulants_16\NNS\3740161|with|coumarin-type
DDI-DrugBank.d656.s1.e2_DDI-DrugBank.d656.s1.e4 false feldene_21\NN\3828465|with (r_nmod) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_parataxis) monitor_30\VB\2169352|,|physicians|should|closely|patients|change|administering (l_advcl) administering_39\VBG\2436349|when|feldene|patients|anticoagulants (l_nmod) anticoagulants_45\NNS\3740161|on|coumarin-type|and|drugs
DDI-DrugBank.d656.s1.e3_DDI-DrugBank.d656.s1.e0 false feldene_40\NNP\3828465| (r_dobj) administering_39\VBG\2436349|when|feldene|patients|anticoagulants (r_advcl) monitor_30\VB\2169352|,|physicians|should|closely|patients|change|administering (r_parataxis) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_advcl) occurred_4\VBN\2623529|although|this|has|not|studies (l_nmod) studies_8\NNS\635850|in|in|anticoagulants (l_nmod) anticoagulants_11\NNS\3740161|with|coumarin-type
DDI-DrugBank.d656.s1.e3_DDI-DrugBank.d656.s1.e1 false feldene_40\NNP\3828465| (r_dobj) administering_39\VBG\2436349|when|feldene|patients|anticoagulants (r_advcl) monitor_30\VB\2169352|,|physicians|should|closely|patients|change|administering (r_parataxis) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_nsubjpass) interactions_13\NNS\37396|anticoagulants (l_nmod) anticoagulants_16\NNS\3740161|with|coumarin-type
DDI-DrugBank.d656.s1.e3_DDI-DrugBank.d656.s1.e4 true feldene_40\NNP\3828465| (r_dobj) administering_39\VBG\2436349|when|feldene|patients|anticoagulants (l_nmod) anticoagulants_45\NNS\3740161|on|coumarin-type|and|drugs
DDI-DrugBank.d656.s1.e0_DDI-DrugBank.d656.s1.e1 false anticoagulants_11\NNS\3740161|with|coumarin-type (r_nmod) studies_8\NNS\635850|in|in|anticoagulants (r_nmod) occurred_4\VBN\2623529|although|this|has|not|studies (r_advcl) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_nsubjpass) interactions_13\NNS\37396|anticoagulants (l_nmod) anticoagulants_16\NNS\3740161|with|coumarin-type
DDI-DrugBank.d656.s1.e0_DDI-DrugBank.d656.s1.e4 false anticoagulants_11\NNS\3740161|with|coumarin-type (r_nmod) studies_8\NNS\635850|in|in|anticoagulants (r_nmod) occurred_4\VBN\2623529|although|this|has|not|studies (r_advcl) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_parataxis) monitor_30\VB\2169352|,|physicians|should|closely|patients|change|administering (l_advcl) administering_39\VBG\2436349|when|feldene|patients|anticoagulants (l_nmod) anticoagulants_45\NNS\3740161|on|coumarin-type|and|drugs
DDI-DrugBank.d656.s1.e1_DDI-DrugBank.d656.s1.e4 false anticoagulants_16\NNS\3740161|with|coumarin-type (r_nmod) interactions_13\NNS\37396|anticoagulants (r_nsubjpass) reported_19\VBN\831651|occurred|,|interactions|have|been|feldene|marketing|,|therefore|monitor|. (l_parataxis) monitor_30\VB\2169352|,|physicians|should|closely|patients|change|administering (l_advcl) administering_39\VBG\2436349|when|feldene|patients|anticoagulants (l_nmod) anticoagulants_45\NNS\3740161|on|coumarin-type|and|drugs
DDI-DrugBank.d577.s7
DDI-DrugBank.d640.s11
DDI-DrugBank.d717.s0
DDI-DrugBank.d717.s0.e0_DDI-DrugBank.d717.s0.e1 true mitotane_0\NN\1740| (r_nsubjpass) reported_3\VBN\831651|mitotane|has|been|accelerate|. (l_xcomp) accelerate_5\VB\226566|to|metabolism|mechanism|,|leading (l_dobj) metabolism_7\NN\13526110|the|warfarin (l_nmod) warfarin_9\NN\2718259|of
DDI-DrugBank.d717.s0.e0_DDI-DrugBank.d717.s0.e2 false mitotane_0\NN\1740| (r_nsubjpass) reported_3\VBN\831651|mitotane|has|been|accelerate|. (l_xcomp) accelerate_5\VB\226566|to|metabolism|mechanism|,|leading (l_advcl) leading_19\VBG\1752884|increase (l_nmod) increase_22\NN\13576355|to|an|requirements (l_nmod) requirements_25\NNS\1129920|in|dosage|warfarin (l_nmod) warfarin_27\NN\2718259|for
DDI-DrugBank.d717.s0.e1_DDI-DrugBank.d717.s0.e2 false warfarin_9\NN\2718259|of (r_nmod) metabolism_7\NN\13526110|the|warfarin (r_dobj) accelerate_5\VB\226566|to|metabolism|mechanism|,|leading (l_advcl) leading_19\VBG\1752884|increase (l_nmod) increase_22\NN\13576355|to|an|requirements (l_nmod) requirements_25\NNS\1129920|in|dosage|warfarin (l_nmod) warfarin_27\NN\2718259|for
DDI-DrugBank.d776.s26
DDI-DrugBank.d776.s26.e0_DDI-DrugBank.d776.s26.e1 true fluconazole_6\NN\1740|concomitant (r_compound) mg_8\NN\13717155|fluconazole|200|daily|and|mg (l_conj) mg_14\NN\13717155|cisapride|20|times (l_compound) cisapride_12\NN\1740|
DDI-DrugBank.d776.s26.e0_DDI-DrugBank.d776.s26.e2 false fluconazole_6\NN\1740|concomitant (r_compound) mg_8\NN\13717155|fluconazole|200|daily|and|mg (r_nsubj) yielded_19\VBD\2327200|that|mg|increase (l_dobj) increase_22\NN\13576355|a|significant|levels|and|prolongation (l_nmod) levels_26\NNS\4916342|in|cisapride|plasma (l_compound) cisapride_24\NN\1740|
DDI-DrugBank.d776.s26.e1_DDI-DrugBank.d776.s26.e2 false cisapride_12\NN\1740| (r_compound) mg_14\NN\13717155|cisapride|20|times (r_conj) mg_8\NN\13717155|fluconazole|200|daily|and|mg (r_nsubj) yielded_19\VBD\2327200|that|mg|increase (l_dobj) increase_22\NN\13576355|a|significant|levels|and|prolongation (l_nmod) levels_26\NNS\4916342|in|cisapride|plasma (l_compound) cisapride_24\NN\1740|
DDI-DrugBank.d631.s0
DDI-DrugBank.d631.s0.e0_DDI-DrugBank.d631.s0.e2 false pyrimethamine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|pyrimethamine|may|be|sulfonamides|. (l_nmod) sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics (l_conj) quinine_7\NN\2721948|and|antimalarials
DDI-DrugBank.d631.s0.e0_DDI-DrugBank.d631.s0.e1 false pyrimethamine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|pyrimethamine|may|be|sulfonamides|. (l_nmod) sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics
DDI-DrugBank.d631.s0.e0_DDI-DrugBank.d631.s0.e3 false pyrimethamine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|pyrimethamine|may|be|sulfonamides|. (l_nmod) sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics (l_conj) quinine_7\NN\2721948|and|antimalarials (l_conj) antimalarials_10\NNS\2723292|other
DDI-DrugBank.d631.s0.e0_DDI-DrugBank.d631.s0.e4 false pyrimethamine_0\NN\1740| (r_nsubjpass) used_3\VBN\1156834|pyrimethamine|may|be|sulfonamides|. (l_nmod) sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics (l_conj) antibiotics_15\NNS\2716205|with|other
DDI-DrugBank.d631.s0.e2_DDI-DrugBank.d631.s0.e1 false quinine_7\NN\2721948|and|antimalarials (r_conj) sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics
DDI-DrugBank.d631.s0.e2_DDI-DrugBank.d631.s0.e3 false quinine_7\NN\2721948|and|antimalarials (l_conj) antimalarials_10\NNS\2723292|other
DDI-DrugBank.d631.s0.e2_DDI-DrugBank.d631.s0.e4 false quinine_7\NN\2721948|and|antimalarials (r_conj) sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics (l_conj) antibiotics_15\NNS\2716205|with|other
DDI-DrugBank.d631.s0.e1_DDI-DrugBank.d631.s0.e3 false sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics (l_conj) quinine_7\NN\2721948|and|antimalarials (l_conj) antimalarials_10\NNS\2723292|other
DDI-DrugBank.d631.s0.e1_DDI-DrugBank.d631.s0.e4 false sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics (l_conj) antibiotics_15\NNS\2716205|with|other
DDI-DrugBank.d631.s0.e3_DDI-DrugBank.d631.s0.e4 false antimalarials_10\NNS\2723292|other (r_conj) quinine_7\NN\2721948|and|antimalarials (r_conj) sulfonamides_5\NNS\2716205|with|,|quinine|and|antibiotics (l_conj) antibiotics_15\NNS\2716205|with|other
DDI-DrugBank.d659.s0
DDI-DrugBank.d659.s0.e0_DDI-DrugBank.d659.s0.e1 true trental_23\NNP\3247620|with (r_nmod) treated_21\VBN\2376958|trental|anticoagulants (l_nmod) anticoagulants_27\NNS\3740161|with|or|inhibitors
DDI-DrugBank.d659.s0.e0_DDI-DrugBank.d659.s0.e2 true trental_23\NNP\3247620|with (r_nmod) treated_21\VBN\2376958|trental|anticoagulants (l_nmod) anticoagulants_27\NNS\3740161|with|or|inhibitors (l_conj) inhibitors_31\NNS\20090|platelet|aggregation
DDI-DrugBank.d659.s0.e1_DDI-DrugBank.d659.s0.e2 false anticoagulants_27\NNS\3740161|with|or|inhibitors (l_conj) inhibitors_31\NNS\20090|platelet|aggregation
DDI-DrugBank.d715.s1
DDI-DrugBank.d715.s1.e1_DDI-DrugBank.d715.s1.e2 false alcohol_5\NN\7881800|with|or|depressants (l_conj) depressants_9\NNS\3248958|other|cns
DDI-DrugBank.d715.s1.e1_DDI-DrugBank.d715.s1.e0 false alcohol_5\NN\7881800|with|or|depressants (r_nmod) use_1\NN\407535|concurrent|demser|alcohol (l_nmod) demser_3\NN\1740|of
DDI-DrugBank.d715.s1.e2_DDI-DrugBank.d715.s1.e0 false depressants_9\NNS\3248958|other|cns (r_conj) alcohol_5\NN\7881800|with|or|depressants (r_nmod) use_1\NN\407535|concurrent|demser|alcohol (l_nmod) demser_3\NN\1740|of
DDI-DrugBank.d765.s1
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e2 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_dep) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|)
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e3 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_dep) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (l_appos) miconazole_19\NN\2720201|
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e5 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|)
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e6 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (l_appos) clarithromycin_29\NN\1740|
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e7 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e8 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine (l_conj) vinblastine_34\NN\3917455|
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e9 true ketoconazole_3\NN\1740|or|inhibitors (r_dobj) receiving_2\VBG\2210855|ketoconazole (r_acl) patients_1\NNS\9898892|for|receiving (r_nmod) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nsubj) dose_38\NN\3740161|the|recommended|la (l_nmod) la_41\NNP\14625458|of|detrol
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e1 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e0_DDI-DrugBank.d765.s1.e4 false ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e3 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (l_appos) miconazole_19\NN\2720201|
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e5 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|)
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e6 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (l_appos) clarithromycin_29\NN\1740|
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e7 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e8 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine (l_conj) vinblastine_34\NN\3917455|
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e9 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (r_nmod) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (r_conj) ketoconazole_3\NN\1740|or|inhibitors (r_dobj) receiving_2\VBG\2210855|ketoconazole (r_acl) patients_1\NNS\9898892|for|receiving (r_nmod) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nsubj) dose_38\NN\3740161|the|recommended|la (l_nmod) la_41\NNP\14625458|of|detrol
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e1 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e2_DDI-DrugBank.d765.s1.e4 false itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e3_DDI-DrugBank.d765.s1.e5 false miconazole_19\NN\2720201| (r_appos) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|)
DDI-DrugBank.d765.s1.e3_DDI-DrugBank.d765.s1.e6 false miconazole_19\NN\2720201| (r_appos) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (l_appos) clarithromycin_29\NN\1740|
DDI-DrugBank.d765.s1.e3_DDI-DrugBank.d765.s1.e7 false miconazole_19\NN\2720201| (r_appos) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine
DDI-DrugBank.d765.s1.e3_DDI-DrugBank.d765.s1.e8 false miconazole_19\NN\2720201| (r_appos) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine (l_conj) vinblastine_34\NN\3917455|
DDI-DrugBank.d765.s1.e3_DDI-DrugBank.d765.s1.e9 false miconazole_19\NN\2720201| (r_appos) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (r_nmod) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (r_conj) ketoconazole_3\NN\1740|or|inhibitors (r_dobj) receiving_2\VBG\2210855|ketoconazole (r_acl) patients_1\NNS\9898892|for|receiving (r_nmod) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nsubj) dose_38\NN\3740161|the|recommended|la (l_nmod) la_41\NNP\14625458|of|detrol
DDI-DrugBank.d765.s1.e3_DDI-DrugBank.d765.s1.e1 false miconazole_19\NN\2720201| (r_appos) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e3_DDI-DrugBank.d765.s1.e4 false miconazole_19\NN\2720201| (r_appos) itraconazole_17\NN\2720201|(|eg|,|,|miconazole|) (r_dep) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e5_DDI-DrugBank.d765.s1.e6 false erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (l_appos) clarithromycin_29\NN\1740|
DDI-DrugBank.d765.s1.e5_DDI-DrugBank.d765.s1.e7 false erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine
DDI-DrugBank.d765.s1.e5_DDI-DrugBank.d765.s1.e8 false erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine (l_conj) vinblastine_34\NN\3917455|
DDI-DrugBank.d765.s1.e5_DDI-DrugBank.d765.s1.e9 false erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (r_nmod) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (r_conj) ketoconazole_3\NN\1740|or|inhibitors (r_dobj) receiving_2\VBG\2210855|ketoconazole (r_acl) patients_1\NNS\9898892|for|receiving (r_nmod) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nsubj) dose_38\NN\3740161|the|recommended|la (l_nmod) la_41\NNP\14625458|of|detrol
DDI-DrugBank.d765.s1.e5_DDI-DrugBank.d765.s1.e1 false erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e5_DDI-DrugBank.d765.s1.e4 false erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e6_DDI-DrugBank.d765.s1.e7 false clarithromycin_29\NN\1740| (r_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine
DDI-DrugBank.d765.s1.e6_DDI-DrugBank.d765.s1.e8 false clarithromycin_29\NN\1740| (r_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (l_conj) cyclosporine_32\NN\1740|or|vinblastine (l_conj) vinblastine_34\NN\3917455|
DDI-DrugBank.d765.s1.e6_DDI-DrugBank.d765.s1.e9 false clarithromycin_29\NN\1740| (r_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (r_nmod) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (r_conj) ketoconazole_3\NN\1740|or|inhibitors (r_dobj) receiving_2\VBG\2210855|ketoconazole (r_acl) patients_1\NNS\9898892|for|receiving (r_nmod) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nsubj) dose_38\NN\3740161|the|recommended|la (l_nmod) la_41\NNP\14625458|of|detrol
DDI-DrugBank.d765.s1.e6_DDI-DrugBank.d765.s1.e1 false clarithromycin_29\NN\1740| (r_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e6_DDI-DrugBank.d765.s1.e4 false clarithromycin_29\NN\1740| (r_appos) erythromycin_27\NN\2716866|(|eg|,|,|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e7_DDI-DrugBank.d765.s1.e8 false cyclosporine_32\NN\1740|or|vinblastine (l_conj) vinblastine_34\NN\3917455|
DDI-DrugBank.d765.s1.e7_DDI-DrugBank.d765.s1.e9 false cyclosporine_32\NN\1740|or|vinblastine (r_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (r_nmod) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (r_conj) ketoconazole_3\NN\1740|or|inhibitors (r_dobj) receiving_2\VBG\2210855|ketoconazole (r_acl) patients_1\NNS\9898892|for|receiving (r_nmod) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nsubj) dose_38\NN\3740161|the|recommended|la (l_nmod) la_41\NNP\14625458|of|detrol
DDI-DrugBank.d765.s1.e7_DDI-DrugBank.d765.s1.e1 false cyclosporine_32\NN\1740|or|vinblastine (r_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e7_DDI-DrugBank.d765.s1.e4 false cyclosporine_32\NN\1740|or|vinblastine (r_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e8_DDI-DrugBank.d765.s1.e9 false vinblastine_34\NN\3917455| (r_conj) cyclosporine_32\NN\1740|or|vinblastine (r_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (r_nmod) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (r_conj) ketoconazole_3\NN\1740|or|inhibitors (r_dobj) receiving_2\VBG\2210855|ketoconazole (r_acl) patients_1\NNS\9898892|for|receiving (r_nmod) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nsubj) dose_38\NN\3740161|the|recommended|la (l_nmod) la_41\NNP\14625458|of|detrol
DDI-DrugBank.d765.s1.e8_DDI-DrugBank.d765.s1.e1 false vinblastine_34\NN\3917455| (r_conj) cyclosporine_32\NN\1740|or|vinblastine (r_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine (r_conj) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e8_DDI-DrugBank.d765.s1.e4 false vinblastine_34\NN\3917455| (r_conj) cyclosporine_32\NN\1740|or|vinblastine (r_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e9_DDI-DrugBank.d765.s1.e1 false la_41\NNP\14625458|of|detrol (r_nmod) dose_38\NN\3740161|the|recommended|la (r_nsubj) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nmod) patients_1\NNS\9898892|for|receiving (l_acl) receiving_2\VBG\2210855|ketoconazole (l_dobj) ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics
DDI-DrugBank.d765.s1.e9_DDI-DrugBank.d765.s1.e4 false la_41\NNP\14625458|of|detrol (r_nmod) dose_38\NN\3740161|the|recommended|la (r_nsubj) mg_44\NN\13717155|patients|,|dose|is|2|daily|. (l_nmod) patients_1\NNS\9898892|for|receiving (l_acl) receiving_2\VBG\2210855|ketoconazole (l_dobj) ketoconazole_3\NN\1740|or|inhibitors (l_conj) inhibitors_8\NNS\20090|other|potent|cyp3a4|antifungals (l_nmod) antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d765.s1.e1_DDI-DrugBank.d765.s1.e4 false antifungals_13\NNS\14778436|such|other|azole|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|erythromycin|or|cyclosporine
DDI-DrugBank.d670.s2
DDI-DrugBank.d743.s13
DDI-DrugBank.d743.s13.e0_DDI-DrugBank.d743.s13.e1 false terfenadine_6\NN\1740|of (r_nmod) interactions_4\NNS\37396|potential|terfenadine|azithromycin (l_nmod) azithromycin_8\NN\2716205|with
DDI-DrugBank.d631.s2
DDI-DrugBank.d631.s2.e0_DDI-DrugBank.d631.s2.e1 false acid_1\NN\14818238|folinic|leucovorin (l_appos) leucovorin_3\NNP\1740|(|)
DDI-DrugBank.d700.s0
DDI-DrugBank.d700.s0.e2_DDI-DrugBank.d700.s0.e3 false magnesium-aluminum_21\NN\1740|
DDI-DrugBank.d700.s0.e2_DDI-DrugBank.d700.s0.e1 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing (r_dobj) taking_20\VBG\2367363|also|antacids (r_acl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (r_nmod) administered_12\VBN\2436349|when|patients (r_advcl) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_nsubjpass) absorption_2\NN\13558490|dose (l_nmod) dose_6\NN\3740161|of|a|single|myfortic (l_nmod) myfortic_8\NN\1740|of
DDI-DrugBank.d700.s0.e2_DDI-DrugBank.d700.s0.e5 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing (r_dobj) taking_20\VBG\2367363|also|antacids (r_acl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (l_acl:relcl) lower_43\JJR\1740|cmax|were|%|,|respectively|,|administered (l_advcl) administered_51\VBN\2436349|than|when|myfortic|was|alone|conditions (l_nsubjpass) myfortic_49\NN\1740|
DDI-DrugBank.d700.s0.e2_DDI-DrugBank.d700.s0.e0 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing (r_dobj) taking_20\VBG\2367363|also|antacids (r_acl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (r_nmod) administered_12\VBN\2436349|when|patients (r_advcl) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_nsubjpass) antacids_0\NNS\14778436|
DDI-DrugBank.d700.s0.e2_DDI-DrugBank.d700.s0.e4 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing
DDI-DrugBank.d700.s0.e3_DDI-DrugBank.d700.s0.e1 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing (r_dobj) taking_20\VBG\2367363|also|antacids (r_acl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (r_nmod) administered_12\VBN\2436349|when|patients (r_advcl) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_nsubjpass) absorption_2\NN\13558490|dose (l_nmod) dose_6\NN\3740161|of|a|single|myfortic (l_nmod) myfortic_8\NN\1740|of
DDI-DrugBank.d700.s0.e3_DDI-DrugBank.d700.s0.e5 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing (r_dobj) taking_20\VBG\2367363|also|antacids (r_acl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (l_acl:relcl) lower_43\JJR\1740|cmax|were|%|,|respectively|,|administered (l_advcl) administered_51\VBN\2436349|than|when|myfortic|was|alone|conditions (l_nsubjpass) myfortic_49\NN\1740|
DDI-DrugBank.d700.s0.e3_DDI-DrugBank.d700.s0.e0 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing (r_dobj) taking_20\VBG\2367363|also|antacids (r_acl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (r_nmod) administered_12\VBN\2436349|when|patients (r_advcl) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_nsubjpass) antacids_0\NNS\14778436|
DDI-DrugBank.d700.s0.e3_DDI-DrugBank.d700.s0.e4 false magnesium-aluminum_21\NN\1740| (r_compound) antacids_23\NNS\14778436|magnesium-aluminum|containing
DDI-DrugBank.d700.s0.e1_DDI-DrugBank.d700.s0.e5 false myfortic_8\NN\1740|of (r_nmod) dose_6\NN\3740161|of|a|single|myfortic (r_nmod) absorption_2\NN\13558490|dose (r_nsubjpass) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_advcl) administered_12\VBN\2436349|when|patients (l_nmod) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (l_acl:relcl) lower_43\JJR\1740|cmax|were|%|,|respectively|,|administered (l_advcl) administered_51\VBN\2436349|than|when|myfortic|was|alone|conditions (l_nsubjpass) myfortic_49\NN\1740|
DDI-DrugBank.d700.s0.e1_DDI-DrugBank.d700.s0.e0 false myfortic_8\NN\1740|of (r_nmod) dose_6\NN\3740161|of|a|single|myfortic (r_nmod) absorption_2\NN\13558490|dose (r_nsubjpass) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_nsubjpass) antacids_0\NNS\14778436|
DDI-DrugBank.d700.s0.e1_DDI-DrugBank.d700.s0.e4 false myfortic_8\NN\1740|of (r_nmod) dose_6\NN\3740161|of|a|single|myfortic (r_nmod) absorption_2\NN\13558490|dose (r_nsubjpass) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_advcl) administered_12\VBN\2436349|when|patients (l_nmod) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (l_acl) taking_20\VBG\2367363|also|antacids (l_dobj) antacids_23\NNS\14778436|magnesium-aluminum|containing
DDI-DrugBank.d700.s0.e5_DDI-DrugBank.d700.s0.e0 false myfortic_49\NN\1740| (r_nsubjpass) administered_51\VBN\2436349|than|when|myfortic|was|alone|conditions (r_advcl) lower_43\JJR\1740|cmax|were|%|,|respectively|,|administered (r_acl:relcl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (r_nmod) administered_12\VBN\2436349|when|patients (r_advcl) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_nsubjpass) antacids_0\NNS\14778436|
DDI-DrugBank.d700.s0.e5_DDI-DrugBank.d700.s0.e4 false myfortic_49\NN\1740| (r_nsubjpass) administered_51\VBN\2436349|than|when|myfortic|was|alone|conditions (r_advcl) lower_43\JJR\1740|cmax|were|%|,|respectively|,|administered (r_acl:relcl) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (l_acl) taking_20\VBG\2367363|also|antacids (l_dobj) antacids_23\NNS\14778436|magnesium-aluminum|containing
DDI-DrugBank.d700.s0.e0_DDI-DrugBank.d700.s0.e4 false antacids_0\NNS\14778436| (r_nsubjpass) decreased_10\VBN\169651|antacids|:|absorption|was|administered|. (l_advcl) administered_12\VBN\2436349|when|patients (l_nmod) patients_18\NNS\9898892|to|12|stable|renal|transplant|taking|ml|lower (l_acl) taking_20\VBG\2367363|also|antacids (l_dobj) antacids_23\NNS\14778436|magnesium-aluminum|containing
DDI-DrugBank.d734.s0
DDI-DrugBank.d734.s0.e0_DDI-DrugBank.d734.s0.e1 true diuretics_1\NNS\3247620|thiazide (r_nsubj) accentuate_3\VB\943837|diuretics|may|hypotension|. (l_dobj) hypotension_6\NN\14057371|the|orthostatic|occur (l_acl:relcl) occur_9\VB\2623529|that|may|phenothiazines (l_nmod) phenothiazines_11\NNS\14771088|with
DDI-DrugBank.d623.s9
DDI-DrugBank.d650.s0
DDI-DrugBank.d650.s0.e5_DDI-DrugBank.d650.s0.e6 false metoclopramide_15\NN\1740| (r_conj) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (r_nmod) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (r_nsubjpass) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nmod) permax_24\NN\1740|concurrently|with|(|agonist
DDI-DrugBank.d650.s0.e5_DDI-DrugBank.d650.s0.e0 false metoclopramide_15\NN\1740| (r_conj) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (r_nmod) antagonists_1\NNS\7846|dopamine|,|neuroleptics|,
DDI-DrugBank.d650.s0.e5_DDI-DrugBank.d650.s0.e1 false metoclopramide_15\NN\1740| (r_conj) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d650.s0.e5_DDI-DrugBank.d650.s0.e2 false metoclopramide_15\NN\1740| (r_conj) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|)
DDI-DrugBank.d650.s0.e5_DDI-DrugBank.d650.s0.e3 false metoclopramide_15\NN\1740| (r_conj) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) butyrophenones_10\NNS\1740|
DDI-DrugBank.d650.s0.e5_DDI-DrugBank.d650.s0.e4 false metoclopramide_15\NN\1740| (r_conj) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) thioxanthines_12\NNS\1740|
DDI-DrugBank.d650.s0.e5_DDI-DrugBank.d650.s0.e7 false metoclopramide_15\NN\1740| (r_conj) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (r_nmod) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (r_nsubjpass) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nmod) permax_24\NN\1740|concurrently|with|(|agonist (l_appos) agonist_28\NN\9613191|a|dopamine|)
DDI-DrugBank.d650.s0.e6_DDI-DrugBank.d650.s0.e0 false permax_24\NN\1740|concurrently|with|(|agonist (r_nmod) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nsubjpass) antagonists_1\NNS\7846|dopamine|,|neuroleptics|,
DDI-DrugBank.d650.s0.e6_DDI-DrugBank.d650.s0.e1 false permax_24\NN\1740|concurrently|with|(|agonist (r_nmod) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nsubjpass) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d650.s0.e6_DDI-DrugBank.d650.s0.e2 false permax_24\NN\1740|concurrently|with|(|agonist (r_nmod) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nsubjpass) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|)
DDI-DrugBank.d650.s0.e6_DDI-DrugBank.d650.s0.e3 false permax_24\NN\1740|concurrently|with|(|agonist (r_nmod) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nsubjpass) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) butyrophenones_10\NNS\1740|
DDI-DrugBank.d650.s0.e6_DDI-DrugBank.d650.s0.e4 false permax_24\NN\1740|concurrently|with|(|agonist (r_nmod) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nsubjpass) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) thioxanthines_12\NNS\1740|
DDI-DrugBank.d650.s0.e6_DDI-DrugBank.d650.s0.e7 false permax_24\NN\1740|concurrently|with|(|agonist (l_appos) agonist_28\NN\9613191|a|dopamine|)
DDI-DrugBank.d650.s0.e0_DDI-DrugBank.d650.s0.e1 false antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide
DDI-DrugBank.d650.s0.e0_DDI-DrugBank.d650.s0.e2 false antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|)
DDI-DrugBank.d650.s0.e0_DDI-DrugBank.d650.s0.e3 false antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) butyrophenones_10\NNS\1740|
DDI-DrugBank.d650.s0.e0_DDI-DrugBank.d650.s0.e4 false antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (l_nmod) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) thioxanthines_12\NNS\1740|
DDI-DrugBank.d650.s0.e0_DDI-DrugBank.d650.s0.e7 false antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (r_nsubjpass) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nmod) permax_24\NN\1740|concurrently|with|(|agonist (l_appos) agonist_28\NN\9613191|a|dopamine|)
DDI-DrugBank.d650.s0.e1_DDI-DrugBank.d650.s0.e2 false neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|)
DDI-DrugBank.d650.s0.e1_DDI-DrugBank.d650.s0.e3 false neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) butyrophenones_10\NNS\1740|
DDI-DrugBank.d650.s0.e1_DDI-DrugBank.d650.s0.e4 false neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (l_dep) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) thioxanthines_12\NNS\1740|
DDI-DrugBank.d650.s0.e1_DDI-DrugBank.d650.s0.e7 false neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (r_nmod) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (r_nsubjpass) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nmod) permax_24\NN\1740|concurrently|with|(|agonist (l_appos) agonist_28\NN\9613191|a|dopamine|)
DDI-DrugBank.d650.s0.e2_DDI-DrugBank.d650.s0.e3 false phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) butyrophenones_10\NNS\1740|
DDI-DrugBank.d650.s0.e2_DDI-DrugBank.d650.s0.e4 false phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) thioxanthines_12\NNS\1740|
DDI-DrugBank.d650.s0.e2_DDI-DrugBank.d650.s0.e7 false phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (r_dep) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (r_nmod) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (r_nsubjpass) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nmod) permax_24\NN\1740|concurrently|with|(|agonist (l_appos) agonist_28\NN\9613191|a|dopamine|)
DDI-DrugBank.d650.s0.e3_DDI-DrugBank.d650.s0.e4 false butyrophenones_10\NNS\1740| (r_appos) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (l_appos) thioxanthines_12\NNS\1740|
DDI-DrugBank.d650.s0.e3_DDI-DrugBank.d650.s0.e7 false butyrophenones_10\NNS\1740| (r_appos) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (r_dep) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (r_nmod) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (r_nsubjpass) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nmod) permax_24\NN\1740|concurrently|with|(|agonist (l_appos) agonist_28\NN\9613191|a|dopamine|)
DDI-DrugBank.d650.s0.e4_DDI-DrugBank.d650.s0.e7 false thioxanthines_12\NNS\1740| (r_appos) phenothiazines_8\NNS\14771088|(|,|butyrophenones|,|thioxanthines|) (r_dep) neuroleptics_6\NNS\4470232|such|the|phenothiazines|or|metoclopramide (r_nmod) antagonists_1\NNS\7846|dopamine|,|neuroleptics|, (r_nsubjpass) administered_21\VBN\2436349|antagonists|ordinarily|should|not|be|permax|; (l_nmod) permax_24\NN\1740|concurrently|with|(|agonist (l_appos) agonist_28\NN\9613191|a|dopamine|)
DDI-DrugBank.d597.s6
DDI-DrugBank.d597.s6.e0_DDI-DrugBank.d597.s6.e1 false mobic_0\NNP\1740| (r_nsubj) substitute_4\NN\5695554|mobic|is|not|a|aspirin|prophylaxis|. (l_nmod) aspirin_6\NN\2707683|for
DDI-DrugBank.d753.s2
DDI-DrugBank.d753.s2.e0_DDI-DrugBank.d753.s2.e1 true anticholinergics_0\NNS\3740161|or|medications|used (l_advcl) used_8\VBN\1156834|when|concurrently|analgesics (l_nmod) analgesics_12\NNS\3740161|with|opioid
DDI-DrugBank.d670.s3
DDI-DrugBank.d711.s0
DDI-DrugBank.d711.s0.e0_DDI-DrugBank.d711.s0.e1 true tetracyclines_1\NNS\2716205| (r_nsubjpass) shown_4\VBN\2137132|because|tetracyclines|have|been|depress (r_advcl) require_18\VB\754942|shown|,|patients|may|adjustment|. (l_nsubj) patients_11\NNS\9898892|therapy (l_acl:relcl) therapy_16\NN\657604|who|are|on|anticoagulant (l_compound) anticoagulant_15\NN\3740161|
DDI-DrugBank.d711.s0.e0_DDI-DrugBank.d711.s0.e2 false tetracyclines_1\NNS\2716205| (r_nsubjpass) shown_4\VBN\2137132|because|tetracyclines|have|been|depress (r_advcl) require_18\VB\754942|shown|,|patients|may|adjustment|. (l_dobj) adjustment_20\NN\7357388|downward|dosage (l_nmod) dosage_24\NN\13576355|of|their|anticoagulant (l_amod) anticoagulant_23\JJ\1740|
DDI-DrugBank.d711.s0.e1_DDI-DrugBank.d711.s0.e2 false anticoagulant_15\NN\3740161| (r_compound) therapy_16\NN\657604|who|are|on|anticoagulant (r_acl:relcl) patients_11\NNS\9898892|therapy (r_nsubj) require_18\VB\754942|shown|,|patients|may|adjustment|. (l_dobj) adjustment_20\NN\7357388|downward|dosage (l_nmod) dosage_24\NN\13576355|of|their|anticoagulant (l_amod) anticoagulant_23\JJ\1740|
DDI-DrugBank.d771.s0
DDI-DrugBank.d588.s4
DDI-DrugBank.d588.s4.e0_DDI-DrugBank.d588.s4.e1 false glycosides_1\NNS\14727670|digitalis (r_dep) increase_6\VB\169651|glycosides|:|hypokalemia|can|sensitivity|. (l_nsubj) hypokalemia_4\NN\14299637|diuretic-induced (l_amod) diuretic-induced_3\JJ\1740|
DDI-DrugBank.d588.s4.e0_DDI-DrugBank.d588.s4.e2 false glycosides_1\NNS\14727670|digitalis (r_dep) increase_6\VB\169651|glycosides|:|hypokalemia|can|sensitivity|. (l_dobj) sensitivity_8\NN\5651971|the|myocardium|digitalis (l_nmod) digitalis_13\NNS\15059939|to
DDI-DrugBank.d588.s4.e1_DDI-DrugBank.d588.s4.e2 true diuretic-induced_3\JJ\1740| (r_amod) hypokalemia_4\NN\14299637|diuretic-induced (r_nsubj) increase_6\VB\169651|glycosides|:|hypokalemia|can|sensitivity|. (l_dobj) sensitivity_8\NN\5651971|the|myocardium|digitalis (l_nmod) digitalis_13\NNS\15059939|to
DDI-DrugBank.d710.s9
DDI-DrugBank.d710.s9.e0_DDI-DrugBank.d710.s9.e1 true rimantadine_6\NN\1740|of (r_nmod) auc_4\NN\1740|rimantadine (r_conj) concentrations_2\NNS\4916342|peak|plasma|and|auc (r_nsubjpass) reduced_8\VBN\441445|concentrations|were|%|presence|. (l_nmod) presence_14\NN\13954253|in|the|aspirin (l_nmod) aspirin_16\NN\2707683|of
DDI-DrugBank.d588.s3
DDI-DrugBank.d588.s3.e0_DDI-DrugBank.d588.s3.e3 false alcohol_0\NN\7881800|,|barbiturates|,|and|narcotics|: (r_nsubjpass) potentiated_15\VBN\229605|alcohol|effects|may|be|contraction|. (l_nmod) contraction_19\NN\358931|by|the|volume|associated (l_acl:relcl) associated_23\VBN\628491|that|may|be|therapy (l_nmod) therapy_26\NN\657604|with|metolazone (l_compound) metolazone_25\NN\1740|
DDI-DrugBank.d588.s3.e0_DDI-DrugBank.d588.s3.e1 false alcohol_0\NN\7881800|,|barbiturates|,|and|narcotics|: (l_conj) barbiturates_2\NNS\4166841|
DDI-DrugBank.d588.s3.e0_DDI-DrugBank.d588.s3.e2 false alcohol_0\NN\7881800|,|barbiturates|,|and|narcotics|: (l_conj) narcotics_5\NNS\3247620|
DDI-DrugBank.d588.s3.e3_DDI-DrugBank.d588.s3.e1 false metolazone_25\NN\1740| (r_compound) therapy_26\NN\657604|with|metolazone (r_nmod) associated_23\VBN\628491|that|may|be|therapy (r_acl:relcl) contraction_19\NN\358931|by|the|volume|associated (r_nmod) potentiated_15\VBN\229605|alcohol|effects|may|be|contraction|. (l_nsubjpass) alcohol_0\NN\7881800|,|barbiturates|,|and|narcotics|: (l_conj) barbiturates_2\NNS\4166841|
DDI-DrugBank.d588.s3.e3_DDI-DrugBank.d588.s3.e2 false metolazone_25\NN\1740| (r_compound) therapy_26\NN\657604|with|metolazone (r_nmod) associated_23\VBN\628491|that|may|be|therapy (r_acl:relcl) contraction_19\NN\358931|by|the|volume|associated (r_nmod) potentiated_15\VBN\229605|alcohol|effects|may|be|contraction|. (l_nsubjpass) alcohol_0\NN\7881800|,|barbiturates|,|and|narcotics|: (l_conj) narcotics_5\NNS\3247620|
DDI-DrugBank.d588.s3.e1_DDI-DrugBank.d588.s3.e2 false barbiturates_2\NNS\4166841| (r_conj) alcohol_0\NN\7881800|,|barbiturates|,|and|narcotics|: (l_conj) narcotics_5\NNS\3247620|
DDI-DrugBank.d641.s0
DDI-DrugBank.d743.s6
DDI-DrugBank.d627.s1
DDI-DrugBank.d627.s4
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e1 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) calcium_38\NN\14625458|
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e2 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) estrogens_41\NNS\14745635|conjugated
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e3 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sulfate_44\NN\15010703|hydroxychloroquine
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e4 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) ibuprofen_46\NN\3828465|
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e5 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sodium_49\NN\14625458|levothyroxine
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e6 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) acetate_52\NN\15010703|medroxyprogesterone
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e7 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) methotrexate_54\NN\2722166|
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e9 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e0_DDI-DrugBank.d627.s4.e8 false acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e2 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) estrogens_41\NNS\14745635|conjugated
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e3 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sulfate_44\NN\15010703|hydroxychloroquine
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e4 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) ibuprofen_46\NN\3828465|
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e5 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sodium_49\NN\14625458|levothyroxine
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e6 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) acetate_52\NN\15010703|medroxyprogesterone
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e7 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) methotrexate_54\NN\2722166|
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e9 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e1_DDI-DrugBank.d627.s4.e8 false calcium_38\NN\14625458| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e2_DDI-DrugBank.d627.s4.e3 false estrogens_41\NNS\14745635|conjugated (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sulfate_44\NN\15010703|hydroxychloroquine
DDI-DrugBank.d627.s4.e2_DDI-DrugBank.d627.s4.e4 false estrogens_41\NNS\14745635|conjugated (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) ibuprofen_46\NN\3828465|
DDI-DrugBank.d627.s4.e2_DDI-DrugBank.d627.s4.e5 false estrogens_41\NNS\14745635|conjugated (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sodium_49\NN\14625458|levothyroxine
DDI-DrugBank.d627.s4.e2_DDI-DrugBank.d627.s4.e6 false estrogens_41\NNS\14745635|conjugated (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) acetate_52\NN\15010703|medroxyprogesterone
DDI-DrugBank.d627.s4.e2_DDI-DrugBank.d627.s4.e7 false estrogens_41\NNS\14745635|conjugated (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) methotrexate_54\NN\2722166|
DDI-DrugBank.d627.s4.e2_DDI-DrugBank.d627.s4.e9 false estrogens_41\NNS\14745635|conjugated (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e2_DDI-DrugBank.d627.s4.e8 false estrogens_41\NNS\14745635|conjugated (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e3_DDI-DrugBank.d627.s4.e4 false sulfate_44\NN\15010703|hydroxychloroquine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) ibuprofen_46\NN\3828465|
DDI-DrugBank.d627.s4.e3_DDI-DrugBank.d627.s4.e5 false sulfate_44\NN\15010703|hydroxychloroquine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sodium_49\NN\14625458|levothyroxine
DDI-DrugBank.d627.s4.e3_DDI-DrugBank.d627.s4.e6 false sulfate_44\NN\15010703|hydroxychloroquine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) acetate_52\NN\15010703|medroxyprogesterone
DDI-DrugBank.d627.s4.e3_DDI-DrugBank.d627.s4.e7 false sulfate_44\NN\15010703|hydroxychloroquine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) methotrexate_54\NN\2722166|
DDI-DrugBank.d627.s4.e3_DDI-DrugBank.d627.s4.e9 false sulfate_44\NN\15010703|hydroxychloroquine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e3_DDI-DrugBank.d627.s4.e8 false sulfate_44\NN\15010703|hydroxychloroquine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e4_DDI-DrugBank.d627.s4.e5 false ibuprofen_46\NN\3828465| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) sodium_49\NN\14625458|levothyroxine
DDI-DrugBank.d627.s4.e4_DDI-DrugBank.d627.s4.e6 false ibuprofen_46\NN\3828465| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) acetate_52\NN\15010703|medroxyprogesterone
DDI-DrugBank.d627.s4.e4_DDI-DrugBank.d627.s4.e7 false ibuprofen_46\NN\3828465| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) methotrexate_54\NN\2722166|
DDI-DrugBank.d627.s4.e4_DDI-DrugBank.d627.s4.e9 false ibuprofen_46\NN\3828465| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e4_DDI-DrugBank.d627.s4.e8 false ibuprofen_46\NN\3828465| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e5_DDI-DrugBank.d627.s4.e6 false sodium_49\NN\14625458|levothyroxine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) acetate_52\NN\15010703|medroxyprogesterone
DDI-DrugBank.d627.s4.e5_DDI-DrugBank.d627.s4.e7 false sodium_49\NN\14625458|levothyroxine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) methotrexate_54\NN\2722166|
DDI-DrugBank.d627.s4.e5_DDI-DrugBank.d627.s4.e9 false sodium_49\NN\14625458|levothyroxine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e5_DDI-DrugBank.d627.s4.e8 false sodium_49\NN\14625458|levothyroxine (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e6_DDI-DrugBank.d627.s4.e7 false acetate_52\NN\15010703|medroxyprogesterone (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) methotrexate_54\NN\2722166|
DDI-DrugBank.d627.s4.e6_DDI-DrugBank.d627.s4.e9 false acetate_52\NN\15010703|medroxyprogesterone (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e6_DDI-DrugBank.d627.s4.e8 false acetate_52\NN\15010703|medroxyprogesterone (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e7_DDI-DrugBank.d627.s4.e9 false methotrexate_54\NN\2722166| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) naproxen_58\NN\3828465|
DDI-DrugBank.d627.s4.e7_DDI-DrugBank.d627.s4.e8 false methotrexate_54\NN\2722166| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d627.s4.e9_DDI-DrugBank.d627.s4.e8 false naproxen_58\NN\3828465| (r_conj) acid_33\NN\14818238|acetylsalicylic|,|tears|,|calcium|,|estrogens|,|sulfate|,|ibuprofen|,|sodium|,|acetate|,|methotrexate|,|multivitamins|,|naproxen|,|omeprazole|,|paracetamol|,|and|prednisone (l_conj) multivitamins_56\NNS\7938149|
DDI-DrugBank.d771.s2
DDI-DrugBank.d779.s14
DDI-DrugBank.d737.s3
DDI-DrugBank.d737.s3.e0_DDI-DrugBank.d737.s3.e1 false amantadine_0\NN\1740| (r_dep) suggests_5\VBZ\1010118|amantadine|:|analysis|unlikely|. (l_ccomp) unlikely_9\JJ\1740|that|amantadine|is|alter|n= (l_nsubj) amantadine_7\NN\1740|
DDI-DrugBank.d737.s3.e0_DDI-DrugBank.d737.s3.e2 false amantadine_0\NN\1740| (r_dep) suggests_5\VBZ\1010118|amantadine|:|analysis|unlikely|. (l_ccomp) unlikely_9\JJ\1740|that|amantadine|is|alter|n= (l_xcomp) alter_11\VB\126264|to|clearance (l_dobj) clearance_14\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_16\NN\1740|of
DDI-DrugBank.d737.s3.e1_DDI-DrugBank.d737.s3.e2 false amantadine_7\NN\1740| (r_nsubj) unlikely_9\JJ\1740|that|amantadine|is|alter|n= (l_xcomp) alter_11\VB\126264|to|clearance (l_dobj) clearance_14\NN\5089947|the|oral|pramipexole (l_nmod) pramipexole_16\NN\1740|of
DDI-DrugBank.d709.s4
DDI-DrugBank.d709.s4.e0_DDI-DrugBank.d709.s4.e1 false cisapride_1\NN\1740|-|,|pimozide|:|associated (l_appos) pimozide_3\NN\3203641|
DDI-DrugBank.d709.s4.e0_DDI-DrugBank.d709.s4.e2 false cisapride_1\NN\1740|-|,|pimozide|:|associated (l_dep) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nsubjpass) drugs_6\NNS\14778436|other|cisapride|,|metabolised (l_nmod) cisapride_9\NN\1740|such|or|pimozide
DDI-DrugBank.d709.s4.e0_DDI-DrugBank.d709.s4.e3 false cisapride_1\NN\1740|-|,|pimozide|:|associated (l_dep) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nsubjpass) drugs_6\NNS\14778436|other|cisapride|,|metabolised (l_nmod) cisapride_9\NN\1740|such|or|pimozide (l_conj) pimozide_11\NN\3203641|
DDI-DrugBank.d709.s4.e0_DDI-DrugBank.d709.s4.e4 false cisapride_1\NN\1740|-|,|pimozide|:|associated (l_dep) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nmod) result_38\NN\34213|as|a|increase (l_nmod) increase_40\NN\13576355|of|level|subsequent (l_amod) subsequent_45\JJ\1740|interaction (l_nmod) interaction_47\NN\37396|to|inhibitors (l_nmod) inhibitors_50\NNS\20090|with|significant|isozyme|,|antibacterials (l_nmod) antibacterials_58\NNS\3740161|including|some|macrolide
DDI-DrugBank.d709.s4.e1_DDI-DrugBank.d709.s4.e2 false pimozide_3\NN\3203641| (r_appos) cisapride_1\NN\1740|-|,|pimozide|:|associated (l_dep) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nsubjpass) drugs_6\NNS\14778436|other|cisapride|,|metabolised (l_nmod) cisapride_9\NN\1740|such|or|pimozide
DDI-DrugBank.d709.s4.e1_DDI-DrugBank.d709.s4.e3 false pimozide_3\NN\3203641| (r_appos) cisapride_1\NN\1740|-|,|pimozide|:|associated (l_dep) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nsubjpass) drugs_6\NNS\14778436|other|cisapride|,|metabolised (l_nmod) cisapride_9\NN\1740|such|or|pimozide (l_conj) pimozide_11\NN\3203641|
DDI-DrugBank.d709.s4.e1_DDI-DrugBank.d709.s4.e4 true pimozide_3\NN\3203641| (r_appos) cisapride_1\NN\1740|-|,|pimozide|:|associated (l_dep) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nmod) result_38\NN\34213|as|a|increase (l_nmod) increase_40\NN\13576355|of|level|subsequent (l_amod) subsequent_45\JJ\1740|interaction (l_nmod) interaction_47\NN\37396|to|inhibitors (l_nmod) inhibitors_50\NNS\20090|with|significant|isozyme|,|antibacterials (l_nmod) antibacterials_58\NNS\3740161|including|some|macrolide
DDI-DrugBank.d709.s4.e2_DDI-DrugBank.d709.s4.e3 false cisapride_9\NN\1740|such|or|pimozide (l_conj) pimozide_11\NN\3203641|
DDI-DrugBank.d709.s4.e2_DDI-DrugBank.d709.s4.e4 true cisapride_9\NN\1740|such|or|pimozide (r_nmod) drugs_6\NNS\14778436|other|cisapride|,|metabolised (r_nsubjpass) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nmod) result_38\NN\34213|as|a|increase (l_nmod) increase_40\NN\13576355|of|level|subsequent (l_amod) subsequent_45\JJ\1740|interaction (l_nmod) interaction_47\NN\37396|to|inhibitors (l_nmod) inhibitors_50\NNS\20090|with|significant|isozyme|,|antibacterials (l_nmod) antibacterials_58\NNS\3740161|including|some|macrolide
DDI-DrugBank.d709.s4.e3_DDI-DrugBank.d709.s4.e4 false pimozide_11\NN\3203641| (r_conj) cisapride_9\NN\1740|such|or|pimozide (r_nmod) drugs_6\NNS\14778436|other|cisapride|,|metabolised (r_nsubjpass) associated_22\VBN\628491|drugs|have|been|prolongation|result (l_nmod) result_38\NN\34213|as|a|increase (l_nmod) increase_40\NN\13576355|of|level|subsequent (l_amod) subsequent_45\JJ\1740|interaction (l_nmod) interaction_47\NN\37396|to|inhibitors (l_nmod) inhibitors_50\NNS\20090|with|significant|isozyme|,|antibacterials (l_nmod) antibacterials_58\NNS\3740161|including|some|macrolide
DDI-DrugBank.d668.s5
DDI-DrugBank.d763.s5
DDI-DrugBank.d763.s5.e0_DDI-DrugBank.d763.s5.e1 false carmustine_3\NN\1740|,|etoposide|,|and|cisplatin (l_conj) etoposide_5\NN\1740|
DDI-DrugBank.d763.s5.e0_DDI-DrugBank.d763.s5.e2 false carmustine_3\NN\1740|,|etoposide|,|and|cisplatin (l_conj) cisplatin_8\NN\1740|
DDI-DrugBank.d763.s5.e0_DDI-DrugBank.d763.s5.e3 false carmustine_3\NN\1740|,|etoposide|,|and|cisplatin (r_nsubj) affect_11\VB\126264|humans|,|carmustine|do|not|pharmacokinetics|. (l_dobj) pharmacokinetics_13\NNS\6054892|the|ondansetron (l_nmod) ondansetron_15\NN\1740|of
DDI-DrugBank.d763.s5.e1_DDI-DrugBank.d763.s5.e2 false etoposide_5\NN\1740| (r_conj) carmustine_3\NN\1740|,|etoposide|,|and|cisplatin (l_conj) cisplatin_8\NN\1740|
DDI-DrugBank.d763.s5.e1_DDI-DrugBank.d763.s5.e3 false etoposide_5\NN\1740| (r_conj) carmustine_3\NN\1740|,|etoposide|,|and|cisplatin (r_nsubj) affect_11\VB\126264|humans|,|carmustine|do|not|pharmacokinetics|. (l_dobj) pharmacokinetics_13\NNS\6054892|the|ondansetron (l_nmod) ondansetron_15\NN\1740|of
DDI-DrugBank.d763.s5.e2_DDI-DrugBank.d763.s5.e3 false cisplatin_8\NN\1740| (r_conj) carmustine_3\NN\1740|,|etoposide|,|and|cisplatin (r_nsubj) affect_11\VB\126264|humans|,|carmustine|do|not|pharmacokinetics|. (l_dobj) pharmacokinetics_13\NNS\6054892|the|ondansetron (l_nmod) ondansetron_15\NN\1740|of
DDI-DrugBank.d590.s4
DDI-DrugBank.d590.s4.e0_DDI-DrugBank.d590.s4.e1 false ranitidine_7\NN\14778019|with (r_nmod) associated_5\VBN\628491|ranitidine (r_acl) interactions_4\NNS\37396|on|drug|associated (r_nmod) information_1\NN\6598915|for|interactions (r_nmod) refer_9\VB\730052|information|,|insert|. (l_nmod) insert_14\NN\6392001|to|the|zantac|package (l_compound) zantac_12\NNP\14778019|
DDI-DrugBank.d779.s10
DDI-DrugBank.d739.s0
DDI-DrugBank.d739.s0.e0_DDI-DrugBank.d739.s0.e1 false montelukast_0\NN\1740|dose|- (r_nsubj) cause_17\VB\1617192|montelukast|did|not|changes|kinetics|. (l_nmod) kinetics_23\NNS\6100236|in|the|dose (l_nmod) dose_28\NN\3740161|of|a|single|intravenous|theophylline (l_nmod) theophylline_30\NN\2905612|of|substrate
DDI-DrugBank.d704.s2
DDI-DrugBank.d704.s2.e0_DDI-DrugBank.d704.s2.e1 false cimetidine_4\NN\14778019|between|and|capsules (l_conj) capsules_7\NNS\3094503|flomax (l_compound) flomax_6\NN\1740|
DDI-DrugBank.d710.s1
DDI-DrugBank.d710.s1.e0_DDI-DrugBank.d710.s1.e1 true hcl_8\NN\1740|of|rimantadine (r_nmod) dose_5\NN\3740161|a|single|mg|hcl (r_nsubjpass) administered_10\VBN\2436349|when|dose|was|hour (l_nmod) hour_12\NN\15154774|one|after|initiation|mg|times|) (l_dep) initiation_15\NN\7450842|the|cimetidine (l_nmod) cimetidine_17\NN\14778019|of
DDI-DrugBank.d710.s1.e0_DDI-DrugBank.d710.s1.e2 false hcl_8\NN\1740|of|rimantadine (r_nmod) dose_5\NN\3740161|a|single|mg|hcl (r_nsubjpass) administered_10\VBN\2436349|when|dose|was|hour (r_advcl) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_nsubjpass) clearance_31\NN\5089947|the|apparent|total|rimantadine|dose (l_compound) rimantadine_30\NN\1740|
DDI-DrugBank.d710.s1.e0_DDI-DrugBank.d710.s1.e3 false hcl_8\NN\1740|of|rimantadine (r_nmod) dose_5\NN\3740161|a|single|mg|hcl (r_nsubjpass) administered_10\VBN\2436349|when|dose|was|hour (r_advcl) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_parataxis) compared_46\VBN\644583|(|clearance (l_nmod) clearance_52\NN\5089947|to|the|apparent|total|rimantadine|subjects|absence|) (l_compound) rimantadine_51\NN\1740|
DDI-DrugBank.d710.s1.e0_DDI-DrugBank.d710.s1.e4 false hcl_8\NN\1740|of|rimantadine (r_nmod) dose_5\NN\3740161|a|single|mg|hcl (r_nsubjpass) administered_10\VBN\2436349|when|dose|was|hour (r_advcl) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_parataxis) compared_46\VBN\644583|(|clearance (l_nmod) clearance_52\NN\5089947|to|the|apparent|total|rimantadine|subjects|absence|) (l_nmod) absence_59\NN\14449405|in|the|cimetidine (l_nmod) cimetidine_61\NN\14778019|of
DDI-DrugBank.d710.s1.e1_DDI-DrugBank.d710.s1.e2 false cimetidine_17\NN\14778019|of (r_nmod) initiation_15\NN\7450842|the|cimetidine (r_dep) hour_12\NN\15154774|one|after|initiation|mg|times|) (r_nmod) administered_10\VBN\2436349|when|dose|was|hour (r_advcl) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_nsubjpass) clearance_31\NN\5089947|the|apparent|total|rimantadine|dose (l_compound) rimantadine_30\NN\1740|
DDI-DrugBank.d710.s1.e1_DDI-DrugBank.d710.s1.e3 false cimetidine_17\NN\14778019|of (r_nmod) initiation_15\NN\7450842|the|cimetidine (r_dep) hour_12\NN\15154774|one|after|initiation|mg|times|) (r_nmod) administered_10\VBN\2436349|when|dose|was|hour (r_advcl) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_parataxis) compared_46\VBN\644583|(|clearance (l_nmod) clearance_52\NN\5089947|to|the|apparent|total|rimantadine|subjects|absence|) (l_compound) rimantadine_51\NN\1740|
DDI-DrugBank.d710.s1.e1_DDI-DrugBank.d710.s1.e4 false cimetidine_17\NN\14778019|of (r_nmod) initiation_15\NN\7450842|the|cimetidine (r_dep) hour_12\NN\15154774|one|after|initiation|mg|times|) (r_nmod) administered_10\VBN\2436349|when|dose|was|hour (r_advcl) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_parataxis) compared_46\VBN\644583|(|clearance (l_nmod) clearance_52\NN\5089947|to|the|apparent|total|rimantadine|subjects|absence|) (l_nmod) absence_59\NN\14449405|in|the|cimetidine (l_nmod) cimetidine_61\NN\14778019|of
DDI-DrugBank.d710.s1.e2_DDI-DrugBank.d710.s1.e3 false rimantadine_30\NN\1740| (r_compound) clearance_31\NN\5089947|the|apparent|total|rimantadine|dose (r_nsubjpass) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_parataxis) compared_46\VBN\644583|(|clearance (l_nmod) clearance_52\NN\5089947|to|the|apparent|total|rimantadine|subjects|absence|) (l_compound) rimantadine_51\NN\1740|
DDI-DrugBank.d710.s1.e2_DDI-DrugBank.d710.s1.e4 false rimantadine_30\NN\1740| (r_compound) clearance_31\NN\5089947|the|apparent|total|rimantadine|dose (r_nsubjpass) reduced_41\VBN\441445|administered|,|clearance|was|%|compared|. (l_parataxis) compared_46\VBN\644583|(|clearance (l_nmod) clearance_52\NN\5089947|to|the|apparent|total|rimantadine|subjects|absence|) (l_nmod) absence_59\NN\14449405|in|the|cimetidine (l_nmod) cimetidine_61\NN\14778019|of
DDI-DrugBank.d710.s1.e3_DDI-DrugBank.d710.s1.e4 false rimantadine_51\NN\1740| (r_compound) clearance_52\NN\5089947|to|the|apparent|total|rimantadine|subjects|absence|) (l_nmod) absence_59\NN\14449405|in|the|cimetidine (l_nmod) cimetidine_61\NN\14778019|of
DDI-DrugBank.d659.s1
DDI-DrugBank.d775.s1
DDI-DrugBank.d775.s1.e0_DDI-DrugBank.d775.s1.e1 true succinylcholine_3\NN\3800001|of (r_nmod) administration_1\NN\1133281|prior|succinylcholine (r_nsubj) potentiate_5\VB\229605|administration|can|effects|. (l_dobj) effects_9\NNS\13245626|the|neuromuscular|blocking|agents (l_nmod) agents_12\NNS\7347|of|nondepolarizing
DDI-DrugBank.d761.s8
DDI-DrugBank.d761.s8.e1_DDI-DrugBank.d761.s8.e0 false xenical_12\JJ\1740| (r_amod) mg_14\NN\13717155|of|xenical|120|times (r_nmod) treatment_10\NN\654885|the|mg|days (r_nsubj) resulted_22\VBD\2633881|contraceptives|:|subjects|,|treatment|changes|. (l_dep) contraceptives_1\NNS\3183080|oral
DDI-DrugBank.d761.s8.e1_DDI-DrugBank.d761.s8.e2 false xenical_12\JJ\1740| (r_amod) mg_14\NN\13717155|of|xenical|120|times (r_nmod) treatment_10\NN\654885|the|mg|days (r_nsubj) resulted_22\VBD\2633881|contraceptives|:|subjects|,|treatment|changes|. (l_nmod) changes_25\NNS\7283608|in|no|action (l_nmod) action_29\NN\30358|in|the|ovulation-suppressing|contraceptives (l_nmod) contraceptives_32\NNS\3183080|of|oral
DDI-DrugBank.d761.s8.e0_DDI-DrugBank.d761.s8.e2 false contraceptives_1\NNS\3183080|oral (r_dep) resulted_22\VBD\2633881|contraceptives|:|subjects|,|treatment|changes|. (l_nmod) changes_25\NNS\7283608|in|no|action (l_nmod) action_29\NN\30358|in|the|ovulation-suppressing|contraceptives (l_nmod) contraceptives_32\NNS\3183080|of|oral
DDI-DrugBank.d776.s23
DDI-DrugBank.d776.s23.e0_DDI-DrugBank.d776.s23.e1 true fluconazole_4\NN\1740|of (r_nmod) use_2\NN\407535|the|combined|fluconazole|doses|terfenadine (l_nmod) terfenadine_13\NN\1740|with
DDI-DrugBank.d639.s5
DDI-DrugBank.d698.s1
DDI-DrugBank.d698.s1.e0_DDI-DrugBank.d698.s1.e1 true probenecid_0\NN\3740161| (r_nmod:npmod) concurrent_2\JJ\1740|probenecid|- (r_amod) use_3\NN\407535|concurrent (r_nsubj) decreases_4\VBZ\169651|use|absorption|; (l_dobj) absorption_6\NN\13558490|gastrointestinal|riboflavin (l_nmod) riboflavin_8\NN\15090742|of
DDI-DrugBank.d739.s5
DDI-DrugBank.d739.s5.e0_DDI-DrugBank.d739.s5.e1 false prednisone_12\NN\2721538|of|or|prednisolone (l_conj) prednisolone_14\NN\2721538|
DDI-DrugBank.d739.s5.e0_DDI-DrugBank.d739.s5.e2 false prednisone_12\NN\2721538|of|or|prednisolone (r_nmod) profiles_10\NNS\6999802|in|plasma|prednisone (r_nmod) change_7\NN\7283608|any|significant|profiles (r_dobj) cause_3\VB\1617192|-|did|not|change|administration|. (l_nmod) administration_16\NN\1133281|following|prednisone (l_nmod) prednisone_20\NN\2721538|of|either|oral|or|prednisolone
DDI-DrugBank.d739.s5.e0_DDI-DrugBank.d739.s5.e3 false prednisone_12\NN\2721538|of|or|prednisolone (r_nmod) profiles_10\NNS\6999802|in|plasma|prednisone (r_nmod) change_7\NN\7283608|any|significant|profiles (r_dobj) cause_3\VB\1617192|-|did|not|change|administration|. (l_nmod) administration_16\NN\1133281|following|prednisone (l_nmod) prednisone_20\NN\2721538|of|either|oral|or|prednisolone (l_conj) prednisolone_23\NN\2721538|intravenous
DDI-DrugBank.d739.s5.e1_DDI-DrugBank.d739.s5.e2 false prednisolone_14\NN\2721538| (r_conj) prednisone_12\NN\2721538|of|or|prednisolone (r_nmod) profiles_10\NNS\6999802|in|plasma|prednisone (r_nmod) change_7\NN\7283608|any|significant|profiles (r_dobj) cause_3\VB\1617192|-|did|not|change|administration|. (l_nmod) administration_16\NN\1133281|following|prednisone (l_nmod) prednisone_20\NN\2721538|of|either|oral|or|prednisolone
DDI-DrugBank.d739.s5.e1_DDI-DrugBank.d739.s5.e3 false prednisolone_14\NN\2721538| (r_conj) prednisone_12\NN\2721538|of|or|prednisolone (r_nmod) profiles_10\NNS\6999802|in|plasma|prednisone (r_nmod) change_7\NN\7283608|any|significant|profiles (r_dobj) cause_3\VB\1617192|-|did|not|change|administration|. (l_nmod) administration_16\NN\1133281|following|prednisone (l_nmod) prednisone_20\NN\2721538|of|either|oral|or|prednisolone (l_conj) prednisolone_23\NN\2721538|intravenous
DDI-DrugBank.d739.s5.e2_DDI-DrugBank.d739.s5.e3 false prednisone_20\NN\2721538|of|either|oral|or|prednisolone (l_conj) prednisolone_23\NN\2721538|intravenous
DDI-DrugBank.d670.s0
DDI-DrugBank.d670.s0.e1_DDI-DrugBank.d670.s0.e0 false paliperidone_7\NN\1740| (r_dep) drugs_6\NNS\14778436|other|paliperidone (r_dobj) affect_4\VB\126264|for|invega|to|drugs (l_nsubj) invega_2\NN\1740|
DDI-DrugBank.d572.s16
DDI-DrugBank.d633.s3
DDI-DrugBank.d763.s2
DDI-DrugBank.d779.s1
DDI-DrugBank.d776.s11
DDI-DrugBank.d776.s11.e0_DDI-DrugBank.d776.s11.e2 false phenytoin_3\NN\3550533| (r_compound) concentrations_4\NNS\4916342|of|phenytoin|patients (l_nmod) patients_6\NNS\9898892|in|receiving (l_acl) receiving_7\VBG\2210855|diflucan (l_dobj) diflucan_8\NN\1740|and|phenytoin (l_conj) phenytoin_10\NN\3550533|
DDI-DrugBank.d776.s11.e0_DDI-DrugBank.d776.s11.e1 false phenytoin_3\NN\3550533| (r_compound) concentrations_4\NNS\4916342|of|phenytoin|patients (l_nmod) patients_6\NNS\9898892|in|receiving (l_acl) receiving_7\VBG\2210855|diflucan (l_dobj) diflucan_8\NN\1740|and|phenytoin
DDI-DrugBank.d776.s11.e2_DDI-DrugBank.d776.s11.e1 false phenytoin_10\NN\3550533| (r_conj) diflucan_8\NN\1740|and|phenytoin
DDI-DrugBank.d572.s5
DDI-DrugBank.d572.s5.e0_DDI-DrugBank.d572.s5.e1 true zetia_2\NNP\1740|of (r_nmod) co-administration_0\NN\1740|zetia|fibrates (l_nmod) fibrates_4\NNS\1740|with
DDI-DrugBank.d704.s1
DDI-DrugBank.d704.s1.e0_DDI-DrugBank.d704.s1.e1 true flomax_7\NNP\1740| (r_compound) capsules_8\NNS\3094503|flomax (r_nsubjpass) used_12\VBN\1156834|capsules|should|not|be|combination|. (l_nmod) combination_14\NN\7951464|in|agents (l_nmod) agents_19\NNS\7347|with|other|alpha-adrenergic|blocking
DDI-DrugBank.d572.s0
DDI-DrugBank.d572.s0.e0_DDI-DrugBank.d572.s0.e1 false cholestyramine_0\NN\1740| (r_dep) decreased_5\VBD\169651|cholestyramine|:|administration|auc|%|. (l_nsubj) administration_4\NN\1133281|concomitant|cholestyramine (l_compound) cholestyramine_3\NN\1740|
DDI-DrugBank.d572.s0.e0_DDI-DrugBank.d572.s0.e2 false cholestyramine_0\NN\1740| (r_dep) decreased_5\VBD\169651|cholestyramine|:|administration|auc|%|. (l_dobj) auc_8\NN\1740|the|mean|ezetimibe (l_nmod) ezetimibe_11\NN\1740|of|total
DDI-DrugBank.d572.s0.e1_DDI-DrugBank.d572.s0.e2 true cholestyramine_3\NN\1740| (r_compound) administration_4\NN\1133281|concomitant|cholestyramine (r_nsubj) decreased_5\VBD\169651|cholestyramine|:|administration|auc|%|. (l_dobj) auc_8\NN\1740|the|mean|ezetimibe (l_nmod) ezetimibe_11\NN\1740|of|total
DDI-DrugBank.d693.s4
DDI-DrugBank.d584.s12
DDI-DrugBank.d604.s3
DDI-DrugBank.d572.s35
DDI-DrugBank.d668.s3
DDI-DrugBank.d585.s2
DDI-DrugBank.d585.s2.e0_DDI-DrugBank.d585.s2.e1 true drugs_1\NNS\14778436|anticholinergic (r_nsubj) hazardous_11\JJ\1740|drugs|presence|may|be|taken|. (l_advcl) taken_13\VBN\2367363|when|concurrently|agents (l_nmod) agents_16\NNS\7347|with|corticosteroids (l_nmod) corticosteroids_19\NNS\14745635|such
DDI-DrugBank.d734.s2
DDI-DrugBank.d734.s2.e0_DDI-DrugBank.d734.s2.e1 true propranolol_3\NN\1740|of (r_nmod) administration_1\NN\1133281|concomitant|propranolol|phenothiazines (l_nmod) phenothiazines_5\NNS\14771088|with
DDI-DrugBank.d580.s0
DDI-DrugBank.d700.s14
DDI-DrugBank.d585.s1
DDI-DrugBank.d585.s1.e0_DDI-DrugBank.d585.s1.e1 true anticholinergics_0\NNS\3740161| (r_nsubj) antagonize_1\VBP\1787955|anticholinergics|effects|. (l_dobj) effects_3\NNS\13245626|the|agents (l_nmod) agents_6\NNS\7347|of|antiglaucoma
DDI-DrugBank.d599.s8
DDI-DrugBank.d623.s3
DDI-DrugBank.d766.s1
DDI-DrugBank.d766.s1.e0_DDI-DrugBank.d766.s1.e1 true trimetrexate_6\NN\1740|with (r_nmod) coadministered_4\VBN\1740|that|might|be|trimetrexate|patients|indications (r_acl:relcl) agents_0\NNS\7347|coadministered (r_nsubj) include_18\VBP\690614|agents|erythromycin|. (l_dobj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole
DDI-DrugBank.d766.s1.e0_DDI-DrugBank.d766.s1.e2 true trimetrexate_6\NN\1740|with (r_nmod) coadministered_4\VBN\1740|that|might|be|trimetrexate|patients|indications (r_acl:relcl) agents_0\NNS\7347|coadministered (r_nsubj) include_18\VBP\690614|agents|erythromycin|. (l_dobj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) rifampin_21\NN\2716205|
DDI-DrugBank.d766.s1.e0_DDI-DrugBank.d766.s1.e3 true trimetrexate_6\NN\1740|with (r_nmod) coadministered_4\VBN\1740|that|might|be|trimetrexate|patients|indications (r_acl:relcl) agents_0\NNS\7347|coadministered (r_nsubj) include_18\VBP\690614|agents|erythromycin|. (l_dobj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) rifabutin_23\NN\1740|
DDI-DrugBank.d766.s1.e0_DDI-DrugBank.d766.s1.e4 true trimetrexate_6\NN\1740|with (r_nmod) coadministered_4\VBN\1740|that|might|be|trimetrexate|patients|indications (r_acl:relcl) agents_0\NNS\7347|coadministered (r_nsubj) include_18\VBP\690614|agents|erythromycin|. (l_dobj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) ketoconazole_25\NN\1740|
DDI-DrugBank.d766.s1.e0_DDI-DrugBank.d766.s1.e5 true trimetrexate_6\NN\1740|with (r_nmod) coadministered_4\VBN\1740|that|might|be|trimetrexate|patients|indications (r_acl:relcl) agents_0\NNS\7347|coadministered (r_nsubj) include_18\VBP\690614|agents|erythromycin|. (l_dobj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) fluconazole_28\NN\1740|
DDI-DrugBank.d766.s1.e1_DDI-DrugBank.d766.s1.e2 false erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) rifampin_21\NN\2716205|
DDI-DrugBank.d766.s1.e1_DDI-DrugBank.d766.s1.e3 false erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) rifabutin_23\NN\1740|
DDI-DrugBank.d766.s1.e1_DDI-DrugBank.d766.s1.e4 false erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) ketoconazole_25\NN\1740|
DDI-DrugBank.d766.s1.e1_DDI-DrugBank.d766.s1.e5 false erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) fluconazole_28\NN\1740|
DDI-DrugBank.d766.s1.e2_DDI-DrugBank.d766.s1.e3 false rifampin_21\NN\2716205| (r_conj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) rifabutin_23\NN\1740|
DDI-DrugBank.d766.s1.e2_DDI-DrugBank.d766.s1.e4 false rifampin_21\NN\2716205| (r_conj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) ketoconazole_25\NN\1740|
DDI-DrugBank.d766.s1.e2_DDI-DrugBank.d766.s1.e5 false rifampin_21\NN\2716205| (r_conj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) fluconazole_28\NN\1740|
DDI-DrugBank.d766.s1.e3_DDI-DrugBank.d766.s1.e4 false rifabutin_23\NN\1740| (r_conj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) ketoconazole_25\NN\1740|
DDI-DrugBank.d766.s1.e3_DDI-DrugBank.d766.s1.e5 false rifabutin_23\NN\1740| (r_conj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) fluconazole_28\NN\1740|
DDI-DrugBank.d766.s1.e4_DDI-DrugBank.d766.s1.e5 false ketoconazole_25\NN\1740| (r_conj) erythromycin_19\NN\2716866|,|rifampin|,|rifabutin|,|ketoconazole|,|and|fluconazole (l_conj) fluconazole_28\NN\1740|
DDI-DrugBank.d742.s7
DDI-DrugBank.d742.s7.e0_DDI-DrugBank.d742.s7.e1 false alcohol_0\NN\7881800| (r_dep) had_12\VBD\2108377|alcohol|:|administration|effect|. (l_nsubj) administration_3\NN\1133281|concomitant|alcohol (l_nmod) alcohol_5\NN\7881800|of|(|equivalent|)
DDI-DrugBank.d742.s7.e0_DDI-DrugBank.d742.s7.e2 false alcohol_0\NN\7881800| (r_dep) had_12\VBD\2108377|alcohol|:|administration|effect|. (l_dobj) effect_15\NN\34213|a|minimal|levels (l_nmod) levels_18\NNS\4916342|on|plasma|mirtazapine|subjects (l_nmod) mirtazapine_20\NN\1740|of|mg
DDI-DrugBank.d742.s7.e1_DDI-DrugBank.d742.s7.e2 true alcohol_5\NN\7881800|of|(|equivalent|) (r_nmod) administration_3\NN\1133281|concomitant|alcohol (r_nsubj) had_12\VBD\2108377|alcohol|:|administration|effect|. (l_dobj) effect_15\NN\34213|a|minimal|levels (l_nmod) levels_18\NNS\4916342|on|plasma|mirtazapine|subjects (l_nmod) mirtazapine_20\NN\1740|of|mg
DDI-DrugBank.d637.s0
DDI-DrugBank.d637.s0.e1_DDI-DrugBank.d637.s0.e3 true morphine_12\NN\2707683|of (r_nmod) effects_10\NNS\13245626|the|depressant|morphine (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives
DDI-DrugBank.d637.s0.e1_DDI-DrugBank.d637.s0.e0 false morphine_12\NN\2707683|of (r_nmod) effects_10\NNS\13245626|the|depressant|morphine (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nsubjpass) use_0\NN\407535|depressants (l_nmod) depressants_6\NNS\3248958|with|other|central|nervous|system
DDI-DrugBank.d637.s0.e1_DDI-DrugBank.d637.s0.e2 true morphine_12\NN\2707683|of (r_nmod) effects_10\NNS\13245626|the|depressant|morphine (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol
DDI-DrugBank.d637.s0.e1_DDI-DrugBank.d637.s0.e4 true morphine_12\NN\2707683|of (r_nmod) effects_10\NNS\13245626|the|depressant|morphine (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs
DDI-DrugBank.d637.s0.e1_DDI-DrugBank.d637.s0.e5 true morphine_12\NN\2707683|of (r_nmod) effects_10\NNS\13245626|the|depressant|morphine (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) antihistaminics_28\NNS\1740|
DDI-DrugBank.d637.s0.e1_DDI-DrugBank.d637.s0.e6 false morphine_12\NN\2707683|of (r_nmod) effects_10\NNS\13245626|the|depressant|morphine (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) drugs_32\NNS\14778436|psychotropic
DDI-DrugBank.d637.s0.e3_DDI-DrugBank.d637.s0.e0 false alcohol_24\NN\7881800|such|,|sedatives (r_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (r_nmod) presence_17\NN\13954253|by|the|depressants (r_nmod) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nsubjpass) use_0\NN\407535|depressants (l_nmod) depressants_6\NNS\3248958|with|other|central|nervous|system
DDI-DrugBank.d637.s0.e3_DDI-DrugBank.d637.s0.e2 false alcohol_24\NN\7881800|such|,|sedatives (r_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol
DDI-DrugBank.d637.s0.e3_DDI-DrugBank.d637.s0.e4 false alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs
DDI-DrugBank.d637.s0.e3_DDI-DrugBank.d637.s0.e5 false alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) antihistaminics_28\NNS\1740|
DDI-DrugBank.d637.s0.e3_DDI-DrugBank.d637.s0.e6 false alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) drugs_32\NNS\14778436|psychotropic
DDI-DrugBank.d637.s0.e0_DDI-DrugBank.d637.s0.e2 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) use_0\NN\407535|depressants (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol
DDI-DrugBank.d637.s0.e0_DDI-DrugBank.d637.s0.e4 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) use_0\NN\407535|depressants (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs
DDI-DrugBank.d637.s0.e0_DDI-DrugBank.d637.s0.e5 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) use_0\NN\407535|depressants (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) antihistaminics_28\NNS\1740|
DDI-DrugBank.d637.s0.e0_DDI-DrugBank.d637.s0.e6 false depressants_6\NNS\3248958|with|other|central|nervous|system (r_nmod) use_0\NN\407535|depressants (r_nsubjpass) potentiated_14\VBN\229605|use|:|effects|are|presence|. (l_nmod) presence_17\NN\13954253|by|the|depressants (l_nmod) depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) drugs_32\NNS\14778436|psychotropic
DDI-DrugBank.d637.s0.e2_DDI-DrugBank.d637.s0.e4 false depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs
DDI-DrugBank.d637.s0.e2_DDI-DrugBank.d637.s0.e5 false depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) antihistaminics_28\NNS\1740|
DDI-DrugBank.d637.s0.e2_DDI-DrugBank.d637.s0.e6 false depressants_21\NNS\3248958|of|other|cns|alcohol (l_nmod) alcohol_24\NN\7881800|such|,|sedatives (l_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) drugs_32\NNS\14778436|psychotropic
DDI-DrugBank.d637.s0.e4_DDI-DrugBank.d637.s0.e5 false sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) antihistaminics_28\NNS\1740|
DDI-DrugBank.d637.s0.e4_DDI-DrugBank.d637.s0.e6 false sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) drugs_32\NNS\14778436|psychotropic
DDI-DrugBank.d637.s0.e5_DDI-DrugBank.d637.s0.e6 false antihistaminics_28\NNS\1740| (r_conj) sedatives_26\NNS\3248958|,|antihistaminics|,|or|drugs (l_conj) drugs_32\NNS\14778436|psychotropic
DDI-DrugBank.d761.s4
DDI-DrugBank.d761.s4.e1_DDI-DrugBank.d761.s4.e0 false acetate_7\NN\15010703| (r_compound) supplement_8\NN\6365467|of|a|vitamin|e|acetate (r_nmod) absorption_2\NN\13558490|supplement (r_dobj) inhibited_1\VBD\2510337|xenical|absorption|%|. (l_nsubj) xenical_0\NN\1740|
DDI-DrugBank.d688.s3
DDI-DrugBank.d688.s3.e0_DDI-DrugBank.d688.s3.e1 false indinavir_3\NN\4013993|of|,|zidovudine (l_conj) zidovudine_5\NN\3834836|or|rifabutin
DDI-DrugBank.d688.s3.e0_DDI-DrugBank.d688.s3.e2 false indinavir_3\NN\4013993|of|,|zidovudine (l_conj) zidovudine_5\NN\3834836|or|rifabutin (l_conj) rifabutin_7\NN\1740|
DDI-DrugBank.d688.s3.e0_DDI-DrugBank.d688.s3.e3 false indinavir_3\NN\4013993|of|,|zidovudine (r_nmod) effects_1\NNS\13245626|the|indinavir|pharmacokinetics (l_nmod) pharmacokinetics_10\NNS\6054892|on|the|acetate (l_nmod) acetate_13\NN\15010703|of|megestrol
DDI-DrugBank.d688.s3.e1_DDI-DrugBank.d688.s3.e2 false zidovudine_5\NN\3834836|or|rifabutin (l_conj) rifabutin_7\NN\1740|
DDI-DrugBank.d688.s3.e1_DDI-DrugBank.d688.s3.e3 false zidovudine_5\NN\3834836|or|rifabutin (r_conj) indinavir_3\NN\4013993|of|,|zidovudine (r_nmod) effects_1\NNS\13245626|the|indinavir|pharmacokinetics (l_nmod) pharmacokinetics_10\NNS\6054892|on|the|acetate (l_nmod) acetate_13\NN\15010703|of|megestrol
DDI-DrugBank.d688.s3.e2_DDI-DrugBank.d688.s3.e3 false rifabutin_7\NN\1740| (r_conj) zidovudine_5\NN\3834836|or|rifabutin (r_conj) indinavir_3\NN\4013993|of|,|zidovudine (r_nmod) effects_1\NNS\13245626|the|indinavir|pharmacokinetics (l_nmod) pharmacokinetics_10\NNS\6054892|on|the|acetate (l_nmod) acetate_13\NN\15010703|of|megestrol
DDI-DrugBank.d753.s1
DDI-DrugBank.d735.s4
DDI-DrugBank.d735.s4.e0_DDI-DrugBank.d735.s4.e2 false nifedipine_0\NN\2938514| (r_compound) auc_1\NN\1740|nifedipine|and|cmax (r_nsubjpass) increased_5\VBN\169651|auc|were|%|,|respectively|,|presence|nifedipine|. (l_nmod) nifedipine_23\NN\2938514|compared|with|alone
DDI-DrugBank.d735.s4.e0_DDI-DrugBank.d735.s4.e1 true nifedipine_0\NN\2938514| (r_compound) auc_1\NN\1740|nifedipine|and|cmax (r_nsubjpass) increased_5\VBN\169651|auc|were|%|,|respectively|,|presence|nifedipine|. (l_nmod) presence_17\NN\13954253|in|the|mycamine (l_nmod) mycamine_20\NN\1740|of|steady-state
DDI-DrugBank.d735.s4.e2_DDI-DrugBank.d735.s4.e1 false nifedipine_23\NN\2938514|compared|with|alone (r_nmod) increased_5\VBN\169651|auc|were|%|,|respectively|,|presence|nifedipine|. (l_nmod) presence_17\NN\13954253|in|the|mycamine (l_nmod) mycamine_20\NN\1740|of|steady-state
DDI-DrugBank.d588.s12
DDI-DrugBank.d588.s12.e0_DDI-DrugBank.d588.s12.e1 true methenamine_0\NN\2716205| (r_dep) decreased_5\VBN\169651|methenamine|:|efficacy|may|be|effect|. (l_nmod) effect_10\NN\34213|due|urinary|alkalizing|metolazone (l_nmod) metolazone_12\NN\1740|of
DDI-DrugBank.d779.s11
DDI-DrugBank.d642.s0
DDI-DrugBank.d642.s0.e0_DDI-DrugBank.d642.s0.e1 true tigecycline_11\NN\1740| (r_nsubjpass) administered_13\VBN\2436349|if|tigecycline|is|warfarin (l_nmod) warfarin_15\NN\2718259|with
DDI-DrugBank.d721.s2
DDI-DrugBank.d721.s2.e1_DDI-DrugBank.d721.s2.e2 false indomethacin_11\NN\3828465|by (r_nmod) increased_5\VBN\169651|bioavailability|is|fold|indomethacin|but|altered|. (l_conj) altered_16\VBN\126264|is|not|significantly|coadministration (l_nmod) coadministration_18\NN\1740|by|diclofenac (l_nmod) diclofenac_20\NN\1740|of
DDI-DrugBank.d721.s2.e1_DDI-DrugBank.d721.s2.e0 false indomethacin_11\NN\3828465|by (r_nmod) increased_5\VBN\169651|bioavailability|is|fold|indomethacin|but|altered|. (l_nsubjpass) bioavailability_1\NN\1740|the|skelid (l_nmod) skelid_3\NN\1740|of
DDI-DrugBank.d721.s2.e2_DDI-DrugBank.d721.s2.e0 false diclofenac_20\NN\1740|of (r_nmod) coadministration_18\NN\1740|by|diclofenac (r_nmod) altered_16\VBN\126264|is|not|significantly|coadministration (r_conj) increased_5\VBN\169651|bioavailability|is|fold|indomethacin|but|altered|. (l_nsubjpass) bioavailability_1\NN\1740|the|skelid (l_nmod) skelid_3\NN\1740|of
DDI-DrugBank.d599.s6
DDI-DrugBank.d599.s6.e0_DDI-DrugBank.d599.s6.e1 true gh_5\NN\1740| (r_compound) treatment_6\NN\654885|gh (r_nsubj) increases_7\VBZ\169651|that|treatment|clearance (l_dobj) clearance_15\NN\5089947|mediated|antipyrine|man (l_compound) antipyrine_14\NN\1740|
DDI-DrugBank.d584.s0
DDI-DrugBank.d584.s0.e0_DDI-DrugBank.d584.s0.e1 false anticoagulants_0\NNS\3740161| (r_compound) steroids_2\NNS\14727670|anticoagulants|anabolic
DDI-DrugBank.d584.s0.e0_DDI-DrugBank.d584.s0.e2 false anticoagulants_0\NNS\3740161| (r_compound) steroids_2\NNS\14727670|anticoagulants|anabolic (r_nsubj) increase_4\VB\169651|steroids|may|sensitivity|. (l_dobj) sensitivity_5\NN\5651971|anticoagulants (l_nmod) anticoagulants_8\NNS\3740161|to|oral
DDI-DrugBank.d584.s0.e1_DDI-DrugBank.d584.s0.e2 true steroids_2\NNS\14727670|anticoagulants|anabolic (r_nsubj) increase_4\VB\169651|steroids|may|sensitivity|. (l_dobj) sensitivity_5\NN\5651971|anticoagulants (l_nmod) anticoagulants_8\NNS\3740161|to|oral
DDI-DrugBank.d777.s4
DDI-DrugBank.d777.s4.e1_DDI-DrugBank.d777.s4.e0 false aspirin_20\NN\2707683|of (r_nmod) use_18\NN\407535|the|aspirin (r_nsubjpass) shown_23\VBN\2137132|anticoagulation|--|treatment|,|use|has|been|reduce|. (l_nsubjpass) anticoagulation_0\NN\657604|and|antiplatelets|treatment (l_conj) antiplatelets_2\NNS\1740|
DDI-DrugBank.d780.s3
DDI-DrugBank.d776.s36
DDI-DrugBank.d776.s36.e0_DDI-DrugBank.d776.s36.e1 true midazolam_3\NN\2830852|on (r_nmod) effect_1\NN\34213|this|midazolam (r_nsubj) appears_4\VBZ\2604760|effect|pronounced|. (l_xcomp) pronounced_8\JJ\1740|to|be|more|administration|fluconazole (l_nmod) administration_11\NN\1133281|following|oral|fluconazole (l_nmod) fluconazole_13\NN\1740|of
DDI-DrugBank.d776.s36.e0_DDI-DrugBank.d776.s36.e2 false midazolam_3\NN\2830852|on (r_nmod) effect_1\NN\34213|this|midazolam (r_nsubj) appears_4\VBZ\2604760|effect|pronounced|. (l_xcomp) pronounced_8\JJ\1740|to|be|more|administration|fluconazole (l_nmod) fluconazole_16\NN\1740|than|with|administered
DDI-DrugBank.d776.s36.e1_DDI-DrugBank.d776.s36.e2 false fluconazole_13\NN\1740|of (r_nmod) administration_11\NN\1133281|following|oral|fluconazole (r_nmod) pronounced_8\JJ\1740|to|be|more|administration|fluconazole (l_nmod) fluconazole_16\NN\1740|than|with|administered
DDI-DrugBank.d613.s0
DDI-DrugBank.d613.s0.e0_DDI-DrugBank.d613.s0.e1 true vigabatrin_7\NN\1740| (r_nsubj) causes_8\VBZ\1617192|that|vigabatrin|increase (l_dobj) increase_12\NN\13576355|a|significant|clearance (l_nmod) clearance_15\NN\5089947|in|plasma|carbamazepine (l_nmod) carbamazepine_17\NN\1740|of
DDI-DrugBank.d756.s9
DDI-DrugBank.d756.s5
DDI-DrugBank.d640.s6
DDI-DrugBank.d640.s6.e0_DDI-DrugBank.d640.s6.e1 false lithium_0\NN\14625458| (r_dep) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nsubjpass) levels_5\NNS\4916342|increased|serum|lithium|and|symptoms (l_compound) lithium_4\NN\14625458|
DDI-DrugBank.d640.s6.e0_DDI-DrugBank.d640.s6.e2 false lithium_0\NN\14625458| (r_dep) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nsubjpass) levels_5\NNS\4916342|increased|serum|lithium|and|symptoms (l_conj) symptoms_7\NNS\5823932|toxicity (l_nmod) toxicity_10\NN\13576101|of|lithium (l_compound) lithium_9\NN\14625458|
DDI-DrugBank.d640.s6.e0_DDI-DrugBank.d640.s6.e4 false lithium_0\NN\14625458| (r_dep) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nmod) patients_15\NNS\9898892|in|receiving (l_acl) receiving_16\VBG\2210855|inhibitors|therapy (l_nmod) therapy_20\NN\657604|during|lithium (l_nmod) lithium_22\NN\14625458|with
DDI-DrugBank.d640.s6.e0_DDI-DrugBank.d640.s6.e3 false lithium_0\NN\14625458| (r_dep) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nmod) patients_15\NNS\9898892|in|receiving (l_acl) receiving_16\VBG\2210855|inhibitors|therapy (l_dobj) inhibitors_18\NNS\20090|ace
DDI-DrugBank.d640.s6.e1_DDI-DrugBank.d640.s6.e2 false lithium_4\NN\14625458| (r_compound) levels_5\NNS\4916342|increased|serum|lithium|and|symptoms (l_conj) symptoms_7\NNS\5823932|toxicity (l_nmod) toxicity_10\NN\13576101|of|lithium (l_compound) lithium_9\NN\14625458|
DDI-DrugBank.d640.s6.e1_DDI-DrugBank.d640.s6.e4 false lithium_4\NN\14625458| (r_compound) levels_5\NNS\4916342|increased|serum|lithium|and|symptoms (r_nsubjpass) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nmod) patients_15\NNS\9898892|in|receiving (l_acl) receiving_16\VBG\2210855|inhibitors|therapy (l_nmod) therapy_20\NN\657604|during|lithium (l_nmod) lithium_22\NN\14625458|with
DDI-DrugBank.d640.s6.e1_DDI-DrugBank.d640.s6.e3 false lithium_4\NN\14625458| (r_compound) levels_5\NNS\4916342|increased|serum|lithium|and|symptoms (r_nsubjpass) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nmod) patients_15\NNS\9898892|in|receiving (l_acl) receiving_16\VBG\2210855|inhibitors|therapy (l_dobj) inhibitors_18\NNS\20090|ace
DDI-DrugBank.d640.s6.e2_DDI-DrugBank.d640.s6.e4 false lithium_9\NN\14625458| (r_compound) toxicity_10\NN\13576101|of|lithium (r_nmod) symptoms_7\NNS\5823932|toxicity (r_conj) levels_5\NNS\4916342|increased|serum|lithium|and|symptoms (r_nsubjpass) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nmod) patients_15\NNS\9898892|in|receiving (l_acl) receiving_16\VBG\2210855|inhibitors|therapy (l_nmod) therapy_20\NN\657604|during|lithium (l_nmod) lithium_22\NN\14625458|with
DDI-DrugBank.d640.s6.e2_DDI-DrugBank.d640.s6.e3 false lithium_9\NN\14625458| (r_compound) toxicity_10\NN\13576101|of|lithium (r_nmod) symptoms_7\NNS\5823932|toxicity (r_conj) levels_5\NNS\4916342|increased|serum|lithium|and|symptoms (r_nsubjpass) reported_13\VBN\831651|lithium|:|levels|have|been|patients|. (l_nmod) patients_15\NNS\9898892|in|receiving (l_acl) receiving_16\VBG\2210855|inhibitors|therapy (l_dobj) inhibitors_18\NNS\20090|ace
DDI-DrugBank.d640.s6.e4_DDI-DrugBank.d640.s6.e3 false lithium_22\NN\14625458|with (r_nmod) therapy_20\NN\657604|during|lithium (r_nmod) receiving_16\VBG\2210855|inhibitors|therapy (l_dobj) inhibitors_18\NNS\20090|ace
DDI-DrugBank.d781.s12
DDI-DrugBank.d781.s12.e0_DDI-DrugBank.d781.s12.e1 false gentamicin_0\NN\2716866| (r_dep) suggested_5\VBN\1010118|gentamicin|:|data|have|possibility|. (l_dobj) possibility_7\NN\5944958|the|interaction (l_nmod) interaction_9\NN\37396|of|perindopril (l_nmod) perindopril_11\NN\1740|between|and|gentamicin
DDI-DrugBank.d781.s12.e0_DDI-DrugBank.d781.s12.e2 false gentamicin_0\NN\2716866| (r_dep) suggested_5\VBN\1010118|gentamicin|:|data|have|possibility|. (l_dobj) possibility_7\NN\5944958|the|interaction (l_nmod) interaction_9\NN\37396|of|perindopril (l_nmod) perindopril_11\NN\1740|between|and|gentamicin (l_conj) gentamicin_13\NN\2716866|
DDI-DrugBank.d781.s12.e1_DDI-DrugBank.d781.s12.e2 true perindopril_11\NN\1740|between|and|gentamicin (l_conj) gentamicin_13\NN\2716866|
DDI-DrugBank.d665.s7
DDI-DrugBank.d665.s7.e0_DDI-DrugBank.d665.s7.e1 false penicillin_2\NN\2716866|of (r_nmod) displacement_0\NN\197772|penicillin|sites (r_nsubj) elevate_9\VB\2391803|displacement|will|level|. (l_dobj) level_11\NN\4916342|the|penicillin|serum (l_nmod) penicillin_14\NN\2716866|of|free
DDI-DrugBank.d670.s5
DDI-DrugBank.d610.s4
DDI-DrugBank.d610.s4.e0_DDI-DrugBank.d610.s4.e2 false methadone-maintenance_8\NN\1740| (r_compound) therapy_9\NN\657604|methadone-maintenance|mg (r_dobj) receiving_7\VBG\2210855|therapy|mg (r_acl) patients_6\NNS\9898892|of|11|hiv-infected|receiving (r_nmod) study_2\NN\635850|in|a|patients (r_nmod) increased_36\VBD\169651|study|,|clearance|%|ci|. (l_nsubj) clearance_35\NN\5089947|oral|methadone (l_compound) methadone_34\NN\3808564|
DDI-DrugBank.d610.s4.e0_DDI-DrugBank.d610.s4.e1 true methadone-maintenance_8\NN\1740| (r_compound) therapy_9\NN\657604|methadone-maintenance|mg (r_dobj) receiving_7\VBG\2210855|therapy|mg (l_nmod) mg_20\NN\13717155|with|600|ziagen|dose (l_nmod) ziagen_22\NN\1740|of
DDI-DrugBank.d610.s4.e2_DDI-DrugBank.d610.s4.e1 false methadone_34\NN\3808564| (r_compound) clearance_35\NN\5089947|oral|methadone (r_nsubj) increased_36\VBD\169651|study|,|clearance|%|ci|. (l_nmod) study_2\NN\635850|in|a|patients (l_nmod) patients_6\NNS\9898892|of|11|hiv-infected|receiving (l_acl) receiving_7\VBG\2210855|therapy|mg (l_nmod) mg_20\NN\13717155|with|600|ziagen|dose (l_nmod) ziagen_22\NN\1740|of
DDI-DrugBank.d601.s0
DDI-DrugBank.d601.s0.e4_DDI-DrugBank.d601.s0.e0 false theophylline_14\NN\2905612|,|corticosteroids (r_conj) quinidine_12\NN\2715941|,|theophylline (r_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (r_conj) contraceptives_7\NNS\3183080|of|oral|,|antibiotics (r_nmod) effectiveness_4\NN\5190804|the|contraceptives (r_dobj) decrease_2\VB\169651|barbiturates|may|effectiveness|. (l_nsubj) barbiturates_0\NNS\4166841|
DDI-DrugBank.d601.s0.e4_DDI-DrugBank.d601.s0.e1 false theophylline_14\NN\2905612|,|corticosteroids (r_conj) quinidine_12\NN\2715941|,|theophylline (r_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (r_conj) contraceptives_7\NNS\3183080|of|oral|,|antibiotics
DDI-DrugBank.d601.s0.e4_DDI-DrugBank.d601.s0.e2 false theophylline_14\NN\2905612|,|corticosteroids (r_conj) quinidine_12\NN\2715941|,|theophylline (r_conj) antibiotics_10\NNS\2716205|certain|,|quinidine
DDI-DrugBank.d601.s0.e4_DDI-DrugBank.d601.s0.e3 false theophylline_14\NN\2905612|,|corticosteroids (r_conj) quinidine_12\NN\2715941|,|theophylline
DDI-DrugBank.d601.s0.e4_DDI-DrugBank.d601.s0.e5 false theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants
DDI-DrugBank.d601.s0.e4_DDI-DrugBank.d601.s0.e6 false theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers
DDI-DrugBank.d601.s0.e4_DDI-DrugBank.d601.s0.e7 false theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers (l_conj) blockers_22\NNS\10101634|beta
DDI-DrugBank.d601.s0.e0_DDI-DrugBank.d601.s0.e1 true barbiturates_0\NNS\4166841| (r_nsubj) decrease_2\VB\169651|barbiturates|may|effectiveness|. (l_dobj) effectiveness_4\NN\5190804|the|contraceptives (l_nmod) contraceptives_7\NNS\3183080|of|oral|,|antibiotics
DDI-DrugBank.d601.s0.e0_DDI-DrugBank.d601.s0.e2 true barbiturates_0\NNS\4166841| (r_nsubj) decrease_2\VB\169651|barbiturates|may|effectiveness|. (l_dobj) effectiveness_4\NN\5190804|the|contraceptives (l_nmod) contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine
DDI-DrugBank.d601.s0.e0_DDI-DrugBank.d601.s0.e3 true barbiturates_0\NNS\4166841| (r_nsubj) decrease_2\VB\169651|barbiturates|may|effectiveness|. (l_dobj) effectiveness_4\NN\5190804|the|contraceptives (l_nmod) contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline
DDI-DrugBank.d601.s0.e0_DDI-DrugBank.d601.s0.e5 true barbiturates_0\NNS\4166841| (r_nsubj) decrease_2\VB\169651|barbiturates|may|effectiveness|. (l_dobj) effectiveness_4\NN\5190804|the|contraceptives (l_nmod) contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants
DDI-DrugBank.d601.s0.e0_DDI-DrugBank.d601.s0.e6 true barbiturates_0\NNS\4166841| (r_nsubj) decrease_2\VB\169651|barbiturates|may|effectiveness|. (l_dobj) effectiveness_4\NN\5190804|the|contraceptives (l_nmod) contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers
DDI-DrugBank.d601.s0.e0_DDI-DrugBank.d601.s0.e7 true barbiturates_0\NNS\4166841| (r_nsubj) decrease_2\VB\169651|barbiturates|may|effectiveness|. (l_dobj) effectiveness_4\NN\5190804|the|contraceptives (l_nmod) contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers (l_conj) blockers_22\NNS\10101634|beta
DDI-DrugBank.d601.s0.e1_DDI-DrugBank.d601.s0.e2 false contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine
DDI-DrugBank.d601.s0.e1_DDI-DrugBank.d601.s0.e3 false contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline
DDI-DrugBank.d601.s0.e1_DDI-DrugBank.d601.s0.e5 false contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants
DDI-DrugBank.d601.s0.e1_DDI-DrugBank.d601.s0.e6 false contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers
DDI-DrugBank.d601.s0.e1_DDI-DrugBank.d601.s0.e7 false contraceptives_7\NNS\3183080|of|oral|,|antibiotics (l_conj) antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers (l_conj) blockers_22\NNS\10101634|beta
DDI-DrugBank.d601.s0.e2_DDI-DrugBank.d601.s0.e3 false antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline
DDI-DrugBank.d601.s0.e2_DDI-DrugBank.d601.s0.e5 false antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants
DDI-DrugBank.d601.s0.e2_DDI-DrugBank.d601.s0.e6 false antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers
DDI-DrugBank.d601.s0.e2_DDI-DrugBank.d601.s0.e7 false antibiotics_10\NNS\2716205|certain|,|quinidine (l_conj) quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers (l_conj) blockers_22\NNS\10101634|beta
DDI-DrugBank.d601.s0.e3_DDI-DrugBank.d601.s0.e5 false quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants
DDI-DrugBank.d601.s0.e3_DDI-DrugBank.d601.s0.e6 false quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers
DDI-DrugBank.d601.s0.e3_DDI-DrugBank.d601.s0.e7 false quinidine_12\NN\2715941|,|theophylline (l_conj) theophylline_14\NN\2905612|,|corticosteroids (l_conj) corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers (l_conj) blockers_22\NNS\10101634|beta
DDI-DrugBank.d601.s0.e5_DDI-DrugBank.d601.s0.e6 false corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers
DDI-DrugBank.d601.s0.e5_DDI-DrugBank.d601.s0.e7 false corticosteroids_16\NNS\14745635|,|anticoagulants (l_conj) anticoagulants_18\NNS\3740161|,|and|blockers (l_conj) blockers_22\NNS\10101634|beta
DDI-DrugBank.d601.s0.e6_DDI-DrugBank.d601.s0.e7 false anticoagulants_18\NNS\3740161|,|and|blockers (l_conj) blockers_22\NNS\10101634|beta
DDI-DrugBank.d776.s14
DDI-DrugBank.d776.s14.e0_DDI-DrugBank.d776.s14.e2 false cyclosporine_3\NN\1740| (r_compound) concentrations_4\NNS\4916342|of|cyclosporine|and|creatinine (r_nmod) monitoring_1\NN\879759|careful|concentrations (r_nsubjpass) recommended_9\VBN\875394|monitoring|is|patients|. (l_nmod) patients_11\NNS\9898892|in|receiving (l_acl) receiving_12\VBG\2210855|diflucan (l_dobj) diflucan_13\NN\1740|and|cyclosporine (l_conj) cyclosporine_15\NN\1740|
DDI-DrugBank.d776.s14.e0_DDI-DrugBank.d776.s14.e1 false cyclosporine_3\NN\1740| (r_compound) concentrations_4\NNS\4916342|of|cyclosporine|and|creatinine (r_nmod) monitoring_1\NN\879759|careful|concentrations (r_nsubjpass) recommended_9\VBN\875394|monitoring|is|patients|. (l_nmod) patients_11\NNS\9898892|in|receiving (l_acl) receiving_12\VBG\2210855|diflucan (l_dobj) diflucan_13\NN\1740|and|cyclosporine
DDI-DrugBank.d776.s14.e2_DDI-DrugBank.d776.s14.e1 false cyclosporine_15\NN\1740| (r_conj) diflucan_13\NN\1740|and|cyclosporine
DDI-DrugBank.d653.s4
DDI-DrugBank.d653.s4.e1_DDI-DrugBank.d653.s4.e0 false aspirin_9\NN\2707683|of|chronic|dose (r_nmod) clearance_4\NN\5089947|the|aspirin (r_dobj) increase_2\VB\169651|corticosteroids|may|clearance|. (l_nsubj) corticosteroids_0\NNS\14745635|
DDI-DrugBank.d630.s0
DDI-DrugBank.d639.s2
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e2 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_conj) phenytoin_14\NN\3550533|
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e3 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) carbamazepine_16\NN\1740|
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e4 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifampin_18\NN\2716205|
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e5 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifabutin_20\NN\1740|
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e6 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifapentin_22\NN\1740|
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e7 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) phenobarbital_24\NN\2792049|
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e8 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (r_nsubj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_dobj) concentrations_33\NNS\4916342|sunitinib (l_compound) sunitinib_32\NN\1740|
DDI-DrugBank.d639.s2.e1_DDI-DrugBank.d639.s2.e0 false dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s2.e2_DDI-DrugBank.d639.s2.e3 false phenytoin_14\NN\3550533| (r_conj) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) carbamazepine_16\NN\1740|
DDI-DrugBank.d639.s2.e2_DDI-DrugBank.d639.s2.e4 false phenytoin_14\NN\3550533| (r_conj) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifampin_18\NN\2716205|
DDI-DrugBank.d639.s2.e2_DDI-DrugBank.d639.s2.e5 false phenytoin_14\NN\3550533| (r_conj) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifabutin_20\NN\1740|
DDI-DrugBank.d639.s2.e2_DDI-DrugBank.d639.s2.e6 false phenytoin_14\NN\3550533| (r_conj) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifapentin_22\NN\1740|
DDI-DrugBank.d639.s2.e2_DDI-DrugBank.d639.s2.e7 false phenytoin_14\NN\3550533| (r_conj) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) phenobarbital_24\NN\2792049|
DDI-DrugBank.d639.s2.e2_DDI-DrugBank.d639.s2.e8 false phenytoin_14\NN\3550533| (r_conj) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (r_nsubj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_dobj) concentrations_33\NNS\4916342|sunitinib (l_compound) sunitinib_32\NN\1740|
DDI-DrugBank.d639.s2.e2_DDI-DrugBank.d639.s2.e0 false phenytoin_14\NN\3550533| (r_conj) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s2.e3_DDI-DrugBank.d639.s2.e4 false carbamazepine_16\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifampin_18\NN\2716205|
DDI-DrugBank.d639.s2.e3_DDI-DrugBank.d639.s2.e5 false carbamazepine_16\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifabutin_20\NN\1740|
DDI-DrugBank.d639.s2.e3_DDI-DrugBank.d639.s2.e6 false carbamazepine_16\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifapentin_22\NN\1740|
DDI-DrugBank.d639.s2.e3_DDI-DrugBank.d639.s2.e7 false carbamazepine_16\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) phenobarbital_24\NN\2792049|
DDI-DrugBank.d639.s2.e3_DDI-DrugBank.d639.s2.e8 false carbamazepine_16\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (r_nsubj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_dobj) concentrations_33\NNS\4916342|sunitinib (l_compound) sunitinib_32\NN\1740|
DDI-DrugBank.d639.s2.e3_DDI-DrugBank.d639.s2.e0 false carbamazepine_16\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s2.e4_DDI-DrugBank.d639.s2.e5 false rifampin_18\NN\2716205| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifabutin_20\NN\1740|
DDI-DrugBank.d639.s2.e4_DDI-DrugBank.d639.s2.e6 false rifampin_18\NN\2716205| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifapentin_22\NN\1740|
DDI-DrugBank.d639.s2.e4_DDI-DrugBank.d639.s2.e7 false rifampin_18\NN\2716205| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) phenobarbital_24\NN\2792049|
DDI-DrugBank.d639.s2.e4_DDI-DrugBank.d639.s2.e8 false rifampin_18\NN\2716205| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (r_nsubj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_dobj) concentrations_33\NNS\4916342|sunitinib (l_compound) sunitinib_32\NN\1740|
DDI-DrugBank.d639.s2.e4_DDI-DrugBank.d639.s2.e0 false rifampin_18\NN\2716205| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s2.e5_DDI-DrugBank.d639.s2.e6 false rifabutin_20\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) rifapentin_22\NN\1740|
DDI-DrugBank.d639.s2.e5_DDI-DrugBank.d639.s2.e7 false rifabutin_20\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) phenobarbital_24\NN\2792049|
DDI-DrugBank.d639.s2.e5_DDI-DrugBank.d639.s2.e8 false rifabutin_20\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (r_nsubj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_dobj) concentrations_33\NNS\4916342|sunitinib (l_compound) sunitinib_32\NN\1740|
DDI-DrugBank.d639.s2.e5_DDI-DrugBank.d639.s2.e0 false rifabutin_20\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s2.e6_DDI-DrugBank.d639.s2.e7 false rifapentin_22\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (l_appos) phenobarbital_24\NN\2792049|
DDI-DrugBank.d639.s2.e6_DDI-DrugBank.d639.s2.e8 false rifapentin_22\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (r_nsubj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_dobj) concentrations_33\NNS\4916342|sunitinib (l_compound) sunitinib_32\NN\1740|
DDI-DrugBank.d639.s2.e6_DDI-DrugBank.d639.s2.e0 false rifapentin_22\NN\1740| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s2.e7_DDI-DrugBank.d639.s2.e8 false phenobarbital_24\NN\2792049| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (r_nsubj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_dobj) concentrations_33\NNS\4916342|sunitinib (l_compound) sunitinib_32\NN\1740|
DDI-DrugBank.d639.s2.e7_DDI-DrugBank.d639.s2.e0 false phenobarbital_24\NN\2792049| (r_appos) dexamethasone_12\NN\2721538|(|e.g.|,|,|phenytoin|,|carbamazepine|,|rifampin|,|rifabutin|,|rifapentin|,|phenobarbital|,|wort|) (r_dep) inducers_4\NNS\14778436|with|family|dexamethasone (r_nmod) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d639.s2.e8_DDI-DrugBank.d639.s2.e0 false sunitinib_32\NN\1740| (r_compound) concentrations_33\NNS\4916342|sunitinib (r_dobj) decrease_31\VB\169651|co-administration|may|concentrations|. (l_nsubj) co-administration_0\NN\1740|sutent|inducers (l_nmod) sutent_2\NN\1740|of
DDI-DrugBank.d752.s7
DDI-DrugBank.d585.s5
DDI-DrugBank.d585.s5.e1_DDI-DrugBank.d585.s5.e0 false metoclopramide_15\NN\1740|such (r_nmod) drugs_7\NNS\14778436|of|alter|,|metoclopramide (r_nmod) effects_5\NNS\13245626|the|drugs (r_dobj) antagonize_3\VB\1787955|drugs|may|effects|. (l_nsubj) drugs_1\NNS\14778436|anticholinergic
DDI-DrugBank.d666.s6
DDI-DrugBank.d776.s41
DDI-DrugBank.d776.s41.e0_DDI-DrugBank.d776.s41.e1 true fluconazole_5\NN\1740| (r_nsubj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (l_dobj) metabolism_9\NN\13526110|the|estradiol (l_nmod) estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel
DDI-DrugBank.d776.s41.e0_DDI-DrugBank.d776.s41.e2 true fluconazole_5\NN\1740| (r_nsubj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (l_dobj) metabolism_9\NN\13526110|the|estradiol (l_nmod) estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_14\NN\1740|
DDI-DrugBank.d776.s41.e0_DDI-DrugBank.d776.s41.e3 false fluconazole_5\NN\1740| (r_nsubj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nsubj) fluconazole_21\NN\1740|
DDI-DrugBank.d776.s41.e0_DDI-DrugBank.d776.s41.e4 false fluconazole_5\NN\1740| (r_nsubj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel
DDI-DrugBank.d776.s41.e0_DDI-DrugBank.d776.s41.e5 false fluconazole_5\NN\1740| (r_nsubj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel (l_conj) levonorgestrel_30\NN\1740|
DDI-DrugBank.d776.s41.e1_DDI-DrugBank.d776.s41.e2 false estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_14\NN\1740|
DDI-DrugBank.d776.s41.e1_DDI-DrugBank.d776.s41.e3 false estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (r_nmod) metabolism_9\NN\13526110|the|estradiol (r_dobj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nsubj) fluconazole_21\NN\1740|
DDI-DrugBank.d776.s41.e1_DDI-DrugBank.d776.s41.e4 false estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (r_nmod) metabolism_9\NN\13526110|the|estradiol (r_dobj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel
DDI-DrugBank.d776.s41.e1_DDI-DrugBank.d776.s41.e5 false estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (r_nmod) metabolism_9\NN\13526110|the|estradiol (r_dobj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel (l_conj) levonorgestrel_30\NN\1740|
DDI-DrugBank.d776.s41.e2_DDI-DrugBank.d776.s41.e3 false levonorgestrel_14\NN\1740| (r_conj) estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (r_nmod) metabolism_9\NN\13526110|the|estradiol (r_dobj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nsubj) fluconazole_21\NN\1740|
DDI-DrugBank.d776.s41.e2_DDI-DrugBank.d776.s41.e4 false levonorgestrel_14\NN\1740| (r_conj) estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (r_nmod) metabolism_9\NN\13526110|the|estradiol (r_dobj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel
DDI-DrugBank.d776.s41.e2_DDI-DrugBank.d776.s41.e5 false levonorgestrel_14\NN\1740| (r_conj) estradiol_12\NN\14749794|of|ethinyl|and|levonorgestrel (r_nmod) metabolism_9\NN\13526110|the|estradiol (r_dobj) inhibit_7\VB\2510337|that|fluconazole|can|metabolism (r_acl) evidence_3\NN\5816287|inhibit (r_nsubj) is_2\VBZ\836236|while|there|evidence (r_advcl) is_17\VBZ\836236|is|,|there|evidence|. (l_nsubj) evidence_19\NN\5816287|no|inducer (l_ccomp) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel (l_conj) levonorgestrel_30\NN\1740|
DDI-DrugBank.d776.s41.e3_DDI-DrugBank.d776.s41.e4 false fluconazole_21\NN\1740| (r_nsubj) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel
DDI-DrugBank.d776.s41.e3_DDI-DrugBank.d776.s41.e5 false fluconazole_21\NN\1740| (r_nsubj) inducer_25\NN\14778436|that|fluconazole|is|a|net|metabolism (l_nmod) metabolism_31\NN\13526110|of|estradiol (l_compound) estradiol_28\NN\14749794|ethinyl|or|levonorgestrel (l_conj) levonorgestrel_30\NN\1740|
DDI-DrugBank.d776.s41.e4_DDI-DrugBank.d776.s41.e5 false estradiol_28\NN\14749794|ethinyl|or|levonorgestrel (l_conj) levonorgestrel_30\NN\1740|
DDI-DrugBank.d716.s5
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e3 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) amoxapine_22\NN\1740|asendin
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e5 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e7 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e9 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) imipramine_37\NN\4482543|tofranil
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e2 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_appos) elavil_19\NN\4482543|(|)
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e4 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) amoxapine_22\NN\1740|asendin (l_appos) asendin_24\NN\1740|(|)
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e6 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan (l_appos) sinequan_29\NN\4482543|(|)
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e8 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e1_DDI-DrugBank.d716.s5.e0 false amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e5 false amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e7 false amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e9 false amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) imipramine_37\NN\4482543|tofranil
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e2 false amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_appos) elavil_19\NN\4482543|(|)
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e4 false amoxapine_22\NN\1740|asendin (l_appos) asendin_24\NN\1740|(|)
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e6 false amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan (l_appos) sinequan_29\NN\4482543|(|)
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e8 false amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e3_DDI-DrugBank.d716.s5.e0 false amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e5_DDI-DrugBank.d716.s5.e7 false doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor
DDI-DrugBank.d716.s5.e5_DDI-DrugBank.d716.s5.e9 false doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) imipramine_37\NN\4482543|tofranil
DDI-DrugBank.d716.s5.e5_DDI-DrugBank.d716.s5.e2 false doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_appos) elavil_19\NN\4482543|(|)
DDI-DrugBank.d716.s5.e5_DDI-DrugBank.d716.s5.e4 false doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) amoxapine_22\NN\1740|asendin (l_appos) asendin_24\NN\1740|(|)
DDI-DrugBank.d716.s5.e5_DDI-DrugBank.d716.s5.e6 false doxepin_27\NN\4482543|sinequan (l_appos) sinequan_29\NN\4482543|(|)
DDI-DrugBank.d716.s5.e5_DDI-DrugBank.d716.s5.e8 false doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e5_DDI-DrugBank.d716.s5.e0 false doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e7_DDI-DrugBank.d716.s5.e9 false nortriptyline_32\NN\4482543|pamelor (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) imipramine_37\NN\4482543|tofranil
DDI-DrugBank.d716.s5.e7_DDI-DrugBank.d716.s5.e2 false nortriptyline_32\NN\4482543|pamelor (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_appos) elavil_19\NN\4482543|(|)
DDI-DrugBank.d716.s5.e7_DDI-DrugBank.d716.s5.e4 false nortriptyline_32\NN\4482543|pamelor (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) amoxapine_22\NN\1740|asendin (l_appos) asendin_24\NN\1740|(|)
DDI-DrugBank.d716.s5.e7_DDI-DrugBank.d716.s5.e6 false nortriptyline_32\NN\4482543|pamelor (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan (l_appos) sinequan_29\NN\4482543|(|)
DDI-DrugBank.d716.s5.e7_DDI-DrugBank.d716.s5.e8 false nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e7_DDI-DrugBank.d716.s5.e0 false nortriptyline_32\NN\4482543|pamelor (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e9_DDI-DrugBank.d716.s5.e2 false imipramine_37\NN\4482543|tofranil (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_appos) elavil_19\NN\4482543|(|)
DDI-DrugBank.d716.s5.e9_DDI-DrugBank.d716.s5.e4 false imipramine_37\NN\4482543|tofranil (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) amoxapine_22\NN\1740|asendin (l_appos) asendin_24\NN\1740|(|)
DDI-DrugBank.d716.s5.e9_DDI-DrugBank.d716.s5.e6 false imipramine_37\NN\4482543|tofranil (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan (l_appos) sinequan_29\NN\4482543|(|)
DDI-DrugBank.d716.s5.e9_DDI-DrugBank.d716.s5.e8 false imipramine_37\NN\4482543|tofranil (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e9_DDI-DrugBank.d716.s5.e0 false imipramine_37\NN\4482543|tofranil (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e2_DDI-DrugBank.d716.s5.e4 false elavil_19\NN\4482543|(|) (r_appos) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) amoxapine_22\NN\1740|asendin (l_appos) asendin_24\NN\1740|(|)
DDI-DrugBank.d716.s5.e2_DDI-DrugBank.d716.s5.e6 false elavil_19\NN\4482543|(|) (r_appos) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan (l_appos) sinequan_29\NN\4482543|(|)
DDI-DrugBank.d716.s5.e2_DDI-DrugBank.d716.s5.e8 false elavil_19\NN\4482543|(|) (r_appos) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e2_DDI-DrugBank.d716.s5.e0 false elavil_19\NN\4482543|(|) (r_appos) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e4_DDI-DrugBank.d716.s5.e6 false asendin_24\NN\1740|(|) (r_appos) amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) doxepin_27\NN\4482543|sinequan (l_appos) sinequan_29\NN\4482543|(|)
DDI-DrugBank.d716.s5.e4_DDI-DrugBank.d716.s5.e8 false asendin_24\NN\1740|(|) (r_appos) amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e4_DDI-DrugBank.d716.s5.e0 false asendin_24\NN\1740|(|) (r_appos) amoxapine_22\NN\1740|asendin (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e6_DDI-DrugBank.d716.s5.e8 false sinequan_29\NN\4482543|(|) (r_appos) doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (l_conj) nortriptyline_32\NN\4482543|pamelor (l_appos) pamelor_34\NN\4482543|(|)
DDI-DrugBank.d716.s5.e6_DDI-DrugBank.d716.s5.e0 false sinequan_29\NN\4482543|(|) (r_appos) doxepin_27\NN\4482543|sinequan (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d716.s5.e8_DDI-DrugBank.d716.s5.e0 false pamelor_34\NN\4482543|(|) (r_appos) nortriptyline_32\NN\4482543|pamelor (r_conj) amitriptyline_17\NN\4482543|such|elavil|,|amoxapine|,|doxepin|,|nortriptyline|,|imipramine|,|clomipramine|,|protriptyline|,|or|desipramine (r_nmod) antidepressant_14\NN\3740161|a|tricyclic|amitriptyline
DDI-DrugBank.d776.s37
DDI-DrugBank.d776.s37.e1_DDI-DrugBank.d776.s37.e0 false fluconazole_17\NN\1740|with (r_nmod) administered_15\VBN\2436349|if|benzodiazepines|are|concomitantly|fluconazole (l_nsubjpass) benzodiazepines_2\NNS\3771443|short-acting|,|metabolized|,
DDI-DrugBank.d776.s37.e1_DDI-DrugBank.d776.s37.e2 false fluconazole_17\NN\1740|with (r_nmod) administered_15\VBN\2436349|if|benzodiazepines|are|concomitantly|fluconazole (r_advcl) given_22\VBN\2327200|administered|,|consideration|should|be|decreasing|,|and|monitored (l_advcl) decreasing_24\VBG\169651|to|dosage (l_dobj) dosage_27\NN\13576355|the|benzodiazepine (l_compound) benzodiazepine_26\NN\3771443|
DDI-DrugBank.d776.s37.e0_DDI-DrugBank.d776.s37.e2 false benzodiazepines_2\NNS\3771443|short-acting|,|metabolized|, (r_nsubjpass) administered_15\VBN\2436349|if|benzodiazepines|are|concomitantly|fluconazole (r_advcl) given_22\VBN\2327200|administered|,|consideration|should|be|decreasing|,|and|monitored (l_advcl) decreasing_24\VBG\169651|to|dosage (l_dobj) dosage_27\NN\13576355|the|benzodiazepine (l_compound) benzodiazepine_26\NN\3771443|
DDI-DrugBank.d587.s0
DDI-DrugBank.d587.s0.e1_DDI-DrugBank.d587.s0.e3 false methsuximide_3\NN\1740|(|) (r_appos) celontin_1\NNP\1740|methsuximide (r_nsubj) interact_6\VB\2367363|since|celontin|may|drugs (r_advcl) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_parataxis) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (l_nsubj) methsuximide_25\NN\1740|
DDI-DrugBank.d587.s0.e1_DDI-DrugBank.d587.s0.e4 false methsuximide_3\NN\1740|(|) (r_appos) celontin_1\NNP\1740|methsuximide (r_nsubj) interact_6\VB\2367363|since|celontin|may|drugs (r_advcl) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_parataxis) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (l_dobj) concentrations_30\NNS\4916342|the|plasma|phenytoin (l_nmod) phenytoin_32\NN\3550533|of|and|phenobarbital
DDI-DrugBank.d587.s0.e1_DDI-DrugBank.d587.s0.e5 false methsuximide_3\NN\1740|(|) (r_appos) celontin_1\NNP\1740|methsuximide (r_nsubj) interact_6\VB\2367363|since|celontin|may|drugs (r_advcl) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_parataxis) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (l_dobj) concentrations_30\NNS\4916342|the|plasma|phenytoin (l_nmod) phenytoin_32\NN\3550533|of|and|phenobarbital (l_conj) phenobarbital_34\NN\2792049|
DDI-DrugBank.d587.s0.e1_DDI-DrugBank.d587.s0.e0 false methsuximide_3\NN\1740|(|) (r_appos) celontin_1\NNP\1740|methsuximide
DDI-DrugBank.d587.s0.e1_DDI-DrugBank.d587.s0.e2 true methsuximide_3\NN\1740|(|) (r_appos) celontin_1\NNP\1740|methsuximide (r_nsubj) interact_6\VB\2367363|since|celontin|may|drugs (l_nmod) drugs_11\NNS\14778436|with|administered|antiepileptic
DDI-DrugBank.d587.s0.e3_DDI-DrugBank.d587.s0.e4 false methsuximide_25\NN\1740| (r_nsubj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (l_dobj) concentrations_30\NNS\4916342|the|plasma|phenytoin (l_nmod) phenytoin_32\NN\3550533|of|and|phenobarbital
DDI-DrugBank.d587.s0.e3_DDI-DrugBank.d587.s0.e5 false methsuximide_25\NN\1740| (r_nsubj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (l_dobj) concentrations_30\NNS\4916342|the|plasma|phenytoin (l_nmod) phenytoin_32\NN\3550533|of|and|phenobarbital (l_conj) phenobarbital_34\NN\2792049|
DDI-DrugBank.d587.s0.e3_DDI-DrugBank.d587.s0.e0 false methsuximide_25\NN\1740| (r_nsubj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (r_parataxis) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_advcl) interact_6\VB\2367363|since|celontin|may|drugs (l_nsubj) celontin_1\NNP\1740|methsuximide
DDI-DrugBank.d587.s0.e3_DDI-DrugBank.d587.s0.e2 false methsuximide_25\NN\1740| (r_nsubj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (r_parataxis) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_advcl) interact_6\VB\2367363|since|celontin|may|drugs (l_nmod) drugs_11\NNS\14778436|with|administered|antiepileptic
DDI-DrugBank.d587.s0.e4_DDI-DrugBank.d587.s0.e5 false phenytoin_32\NN\3550533|of|and|phenobarbital (l_conj) phenobarbital_34\NN\2792049|
DDI-DrugBank.d587.s0.e4_DDI-DrugBank.d587.s0.e0 false phenytoin_32\NN\3550533|of|and|phenobarbital (r_nmod) concentrations_30\NNS\4916342|the|plasma|phenytoin (r_dobj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (r_parataxis) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_advcl) interact_6\VB\2367363|since|celontin|may|drugs (l_nsubj) celontin_1\NNP\1740|methsuximide
DDI-DrugBank.d587.s0.e4_DDI-DrugBank.d587.s0.e2 false phenytoin_32\NN\3550533|of|and|phenobarbital (r_nmod) concentrations_30\NNS\4916342|the|plasma|phenytoin (r_dobj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (r_parataxis) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_advcl) interact_6\VB\2367363|since|celontin|may|drugs (l_nmod) drugs_11\NNS\14778436|with|administered|antiepileptic
DDI-DrugBank.d587.s0.e5_DDI-DrugBank.d587.s0.e0 false phenobarbital_34\NN\2792049| (r_conj) phenytoin_32\NN\3550533|of|and|phenobarbital (r_nmod) concentrations_30\NNS\4916342|the|plasma|phenytoin (r_dobj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (r_parataxis) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_advcl) interact_6\VB\2367363|since|celontin|may|drugs (l_nsubj) celontin_1\NNP\1740|methsuximide
DDI-DrugBank.d587.s0.e5_DDI-DrugBank.d587.s0.e2 false phenobarbital_34\NN\2792049| (r_conj) phenytoin_32\NN\3550533|of|and|phenobarbital (r_nmod) concentrations_30\NNS\4916342|the|plasma|phenytoin (r_dobj) increase_27\VB\169651|(|eg|methsuximide|may|concentrations|) (r_parataxis) necessary_22\JJ\1740|interact|,|determinations|may|be|increase|. (l_advcl) interact_6\VB\2367363|since|celontin|may|drugs (l_nmod) drugs_11\NNS\14778436|with|administered|antiepileptic
DDI-DrugBank.d587.s0.e0_DDI-DrugBank.d587.s0.e2 true celontin_1\NNP\1740|methsuximide (r_nsubj) interact_6\VB\2367363|since|celontin|may|drugs (l_nmod) drugs_11\NNS\14778436|with|administered|antiepileptic
DDI-DrugBank.d637.s2
DDI-DrugBank.d637.s2.e2_DDI-DrugBank.d637.s2.e3 false pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (l_conj) nalbuphine_14\NN\1740|
DDI-DrugBank.d637.s2.e2_DDI-DrugBank.d637.s2.e4 false pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (l_conj) butorphanol_16\NN\1740|
DDI-DrugBank.d637.s2.e2_DDI-DrugBank.d637.s2.e5 false pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (l_conj) buprenorphine_19\NN\1740|
DDI-DrugBank.d637.s2.e2_DDI-DrugBank.d637.s2.e0 false pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (r_dep) interaction_0\NN\37396|analgesics|:|administered (l_nmod) analgesics_5\NNS\3740161|with|mixed|agonist/antagonist|opioid
DDI-DrugBank.d637.s2.e2_DDI-DrugBank.d637.s2.e1 false pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine
DDI-DrugBank.d637.s2.e2_DDI-DrugBank.d637.s2.e6 false pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (l_nmod) patients_26\NNS\9898892|to|received (l_acl:relcl) received_29\VBN\2210855|who|have|or|receiving (l_conj) receiving_32\VBG\2210855|are|course (l_dobj) course_34\NN\883297|a|therapy (l_nmod) therapy_36\NN\657604|of|analgesic (l_nmod) analgesic_42\NN\3740161|with|a|proof|opioid|agonist
DDI-DrugBank.d637.s2.e3_DDI-DrugBank.d637.s2.e4 false nalbuphine_14\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (l_conj) butorphanol_16\NN\1740|
DDI-DrugBank.d637.s2.e3_DDI-DrugBank.d637.s2.e5 false nalbuphine_14\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (l_conj) buprenorphine_19\NN\1740|
DDI-DrugBank.d637.s2.e3_DDI-DrugBank.d637.s2.e0 false nalbuphine_14\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (r_dep) interaction_0\NN\37396|analgesics|:|administered (l_nmod) analgesics_5\NNS\3740161|with|mixed|agonist/antagonist|opioid
DDI-DrugBank.d637.s2.e3_DDI-DrugBank.d637.s2.e1 false nalbuphine_14\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine
DDI-DrugBank.d637.s2.e3_DDI-DrugBank.d637.s2.e6 false nalbuphine_14\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (l_nmod) patients_26\NNS\9898892|to|received (l_acl:relcl) received_29\VBN\2210855|who|have|or|receiving (l_conj) receiving_32\VBG\2210855|are|course (l_dobj) course_34\NN\883297|a|therapy (l_nmod) therapy_36\NN\657604|of|analgesic (l_nmod) analgesic_42\NN\3740161|with|a|proof|opioid|agonist
DDI-DrugBank.d637.s2.e4_DDI-DrugBank.d637.s2.e5 false butorphanol_16\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (l_conj) buprenorphine_19\NN\1740|
DDI-DrugBank.d637.s2.e4_DDI-DrugBank.d637.s2.e0 false butorphanol_16\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (r_dep) interaction_0\NN\37396|analgesics|:|administered (l_nmod) analgesics_5\NNS\3740161|with|mixed|agonist/antagonist|opioid
DDI-DrugBank.d637.s2.e4_DDI-DrugBank.d637.s2.e1 false butorphanol_16\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine
DDI-DrugBank.d637.s2.e4_DDI-DrugBank.d637.s2.e6 false butorphanol_16\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (l_nmod) patients_26\NNS\9898892|to|received (l_acl:relcl) received_29\VBN\2210855|who|have|or|receiving (l_conj) receiving_32\VBG\2210855|are|course (l_dobj) course_34\NN\883297|a|therapy (l_nmod) therapy_36\NN\657604|of|analgesic (l_nmod) analgesic_42\NN\3740161|with|a|proof|opioid|agonist
DDI-DrugBank.d637.s2.e5_DDI-DrugBank.d637.s2.e0 false buprenorphine_19\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (r_dep) interaction_0\NN\37396|analgesics|:|administered (l_nmod) analgesics_5\NNS\3740161|with|mixed|agonist/antagonist|opioid
DDI-DrugBank.d637.s2.e5_DDI-DrugBank.d637.s2.e1 false buprenorphine_19\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine
DDI-DrugBank.d637.s2.e5_DDI-DrugBank.d637.s2.e6 false buprenorphine_19\NN\1740| (r_conj) pentazocine_12\NN\2707683|i.e.|,|,|nalbuphine|,|butorphanol|,|or|buprenorphine|) (r_appos) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (l_nmod) patients_26\NNS\9898892|to|received (l_acl:relcl) received_29\VBN\2210855|who|have|or|receiving (l_conj) receiving_32\VBG\2210855|are|course (l_dobj) course_34\NN\883297|a|therapy (l_nmod) therapy_36\NN\657604|of|analgesic (l_nmod) analgesic_42\NN\3740161|with|a|proof|opioid|agonist
DDI-DrugBank.d637.s2.e0_DDI-DrugBank.d637.s2.e1 false analgesics_5\NNS\3740161|with|mixed|agonist/antagonist|opioid (r_nmod) interaction_0\NN\37396|analgesics|:|administered (l_dep) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (l_nsubjpass) analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine
DDI-DrugBank.d637.s2.e0_DDI-DrugBank.d637.s2.e6 false analgesics_5\NNS\3740161|with|mixed|agonist/antagonist|opioid (r_nmod) interaction_0\NN\37396|analgesics|:|administered (l_dep) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (l_nmod) patients_26\NNS\9898892|to|received (l_acl:relcl) received_29\VBN\2210855|who|have|or|receiving (l_conj) receiving_32\VBG\2210855|are|course (l_dobj) course_34\NN\883297|a|therapy (l_nmod) therapy_36\NN\657604|of|analgesic (l_nmod) analgesic_42\NN\3740161|with|a|proof|opioid|agonist
DDI-DrugBank.d637.s2.e1_DDI-DrugBank.d637.s2.e6 false analgesics_8\NNS\3740161|agonist/antagonist|(|pentazocine (r_nsubjpass) administered_24\VBN\2436349|analgesics|should|not|be|patients|. (l_nmod) patients_26\NNS\9898892|to|received (l_acl:relcl) received_29\VBN\2210855|who|have|or|receiving (l_conj) receiving_32\VBG\2210855|are|course (l_dobj) course_34\NN\883297|a|therapy (l_nmod) therapy_36\NN\657604|of|analgesic (l_nmod) analgesic_42\NN\3740161|with|a|proof|opioid|agonist
DDI-DrugBank.d739.s7
DDI-DrugBank.d700.s5
DDI-DrugBank.d700.s5.e0_DDI-DrugBank.d700.s5.e1 false acyclovir/ganciclovir_1\NN\1740|both|and|concentrations
DDI-DrugBank.d700.s5.e0_DDI-DrugBank.d700.s5.e2 false acyclovir/ganciclovir_1\NN\1740|both|and|concentrations (l_conj) concentrations_4\NNS\4916342|mpag (l_compound) mpag_3\NN\1740|
DDI-DrugBank.d700.s5.e1_DDI-DrugBank.d700.s5.e2 false acyclovir/ganciclovir_1\NN\1740|both|and|concentrations (l_conj) concentrations_4\NNS\4916342|mpag (l_compound) mpag_3\NN\1740|
DDI-DrugBank.d605.s0
DDI-DrugBank.d605.s0.e1_DDI-DrugBank.d605.s0.e0 false alcohol_6\NN\7881800|of|,|barbiturates (r_nmod) effects_4\NNS\13245626|the|alcohol (r_dobj) enhance_2\VB\227165|skelaxin|may|effects|. (l_nsubj) skelaxin_0\NN\1740|
DDI-DrugBank.d605.s0.e1_DDI-DrugBank.d605.s0.e2 false alcohol_6\NN\7881800|of|,|barbiturates (l_conj) barbiturates_8\NNS\4166841|and|depressants
DDI-DrugBank.d605.s0.e1_DDI-DrugBank.d605.s0.e3 false alcohol_6\NN\7881800|of|,|barbiturates (l_conj) barbiturates_8\NNS\4166841|and|depressants (l_conj) depressants_12\NNS\3248958|other|cns
DDI-DrugBank.d605.s0.e0_DDI-DrugBank.d605.s0.e2 true skelaxin_0\NN\1740| (r_nsubj) enhance_2\VB\227165|skelaxin|may|effects|. (l_dobj) effects_4\NNS\13245626|the|alcohol (l_nmod) alcohol_6\NN\7881800|of|,|barbiturates (l_conj) barbiturates_8\NNS\4166841|and|depressants
DDI-DrugBank.d605.s0.e0_DDI-DrugBank.d605.s0.e3 true skelaxin_0\NN\1740| (r_nsubj) enhance_2\VB\227165|skelaxin|may|effects|. (l_dobj) effects_4\NNS\13245626|the|alcohol (l_nmod) alcohol_6\NN\7881800|of|,|barbiturates (l_conj) barbiturates_8\NNS\4166841|and|depressants (l_conj) depressants_12\NNS\3248958|other|cns
DDI-DrugBank.d605.s0.e2_DDI-DrugBank.d605.s0.e3 false barbiturates_8\NNS\4166841|and|depressants (l_conj) depressants_12\NNS\3248958|other|cns
DDI-DrugBank.d628.s6
DDI-DrugBank.d628.s6.e2_DDI-DrugBank.d628.s6.e0 false succinylcholine_29\NN\3800001|(|eg|,|and|relaxants|) (r_nmod) cause_5\VB\1617192|emulsion|does|not|change|succinylcholine|. (l_nsubj) emulsion_2\NN\14588219|diprivan|injectable (l_compound) diprivan_0\NN\1740|
DDI-DrugBank.d628.s6.e2_DDI-DrugBank.d628.s6.e1 false succinylcholine_29\NN\3800001|(|eg|,|and|relaxants|) (r_nmod) cause_5\VB\1617192|emulsion|does|not|change|succinylcholine|. (l_dobj) change_9\NN\7283608|a|significant|onset (l_nmod) onset_11\NN\7325190|in|,|intensity|,|or|duration|action|agents (l_nmod) agents_25\NNS\7347|of|the|used|neuromuscular|blocking
DDI-DrugBank.d628.s6.e2_DDI-DrugBank.d628.s6.e3 false succinylcholine_29\NN\3800001|(|eg|,|and|relaxants|) (l_conj) relaxants_33\NNS\3247620|nondepolarizing|muscle
DDI-DrugBank.d628.s6.e0_DDI-DrugBank.d628.s6.e1 false diprivan_0\NN\1740| (r_compound) emulsion_2\NN\14588219|diprivan|injectable (r_nsubj) cause_5\VB\1617192|emulsion|does|not|change|succinylcholine|. (l_dobj) change_9\NN\7283608|a|significant|onset (l_nmod) onset_11\NN\7325190|in|,|intensity|,|or|duration|action|agents (l_nmod) agents_25\NNS\7347|of|the|used|neuromuscular|blocking
DDI-DrugBank.d628.s6.e0_DDI-DrugBank.d628.s6.e3 false diprivan_0\NN\1740| (r_compound) emulsion_2\NN\14588219|diprivan|injectable (r_nsubj) cause_5\VB\1617192|emulsion|does|not|change|succinylcholine|. (l_nmod) succinylcholine_29\NN\3800001|(|eg|,|and|relaxants|) (l_conj) relaxants_33\NNS\3247620|nondepolarizing|muscle
DDI-DrugBank.d628.s6.e1_DDI-DrugBank.d628.s6.e3 false agents_25\NNS\7347|of|the|used|neuromuscular|blocking (r_nmod) onset_11\NN\7325190|in|,|intensity|,|or|duration|action|agents (r_nmod) change_9\NN\7283608|a|significant|onset (r_dobj) cause_5\VB\1617192|emulsion|does|not|change|succinylcholine|. (l_nmod) succinylcholine_29\NN\3800001|(|eg|,|and|relaxants|) (l_conj) relaxants_33\NNS\3247620|nondepolarizing|muscle
DDI-DrugBank.d702.s2
DDI-DrugBank.d702.s2.e2_DDI-DrugBank.d702.s2.e0 false ipratropium_15\NN\1740|e.g.|,|) (r_appos) drugs_11\NNS\14778436|with|other|anticholinergic|containing|(|ipratropium (r_nmod) administration_4\NN\1133281|the|co|spiriva|drugs (l_nmod) spiriva_6\NNP\1740|of
DDI-DrugBank.d702.s2.e2_DDI-DrugBank.d702.s2.e1 false ipratropium_15\NN\1740|e.g.|,|) (r_appos) drugs_11\NNS\14778436|with|other|anticholinergic|containing|(|ipratropium (l_compound) anticholinergic_9\NN\3740161|
DDI-DrugBank.d702.s2.e0_DDI-DrugBank.d702.s2.e1 true spiriva_6\NNP\1740|of (r_nmod) administration_4\NN\1133281|the|co|spiriva|drugs (l_nmod) drugs_11\NNS\14778436|with|other|anticholinergic|containing|(|ipratropium (l_compound) anticholinergic_9\NN\3740161|
DDI-DrugBank.d770.s2
DDI-DrugBank.d727.s2
DDI-DrugBank.d727.s2.e0_DDI-DrugBank.d727.s2.e1 true stavudine_8\NN\1740|of (r_nmod) phosphorylation_6\NN\1740|the|stavudine (r_nsubjpass) inhibited_11\VBN\2510337|that|phosphorylation|is|also|concentrations|doxorubicin (l_nmod) doxorubicin_16\NN\2716866|by|and|ribavirin
DDI-DrugBank.d727.s2.e0_DDI-DrugBank.d727.s2.e2 true stavudine_8\NN\1740|of (r_nmod) phosphorylation_6\NN\1740|the|stavudine (r_nsubjpass) inhibited_11\VBN\2510337|that|phosphorylation|is|also|concentrations|doxorubicin (l_nmod) doxorubicin_16\NN\2716866|by|and|ribavirin (l_conj) ribavirin_18\NN\2725367|
DDI-DrugBank.d727.s2.e1_DDI-DrugBank.d727.s2.e2 false doxorubicin_16\NN\2716866|by|and|ribavirin (l_conj) ribavirin_18\NN\2725367|
DDI-DrugBank.d577.s6
DDI-DrugBank.d577.s6.e1_DDI-DrugBank.d577.s6.e2 false methotrexate_4\NN\2722166| (r_dobj) displace_3\VB\1850315|sulfonamides|can|also|methotrexate|sites|,|increasing|. (l_advcl) increasing_11\VBG\169651|thus|concentrations (l_dobj) concentrations_14\NNS\4916342|free|methotrexate (l_compound) methotrexate_13\NN\2722166|
DDI-DrugBank.d577.s6.e1_DDI-DrugBank.d577.s6.e0 false methotrexate_4\NN\2722166| (r_dobj) displace_3\VB\1850315|sulfonamides|can|also|methotrexate|sites|,|increasing|. (l_nsubj) sulfonamides_0\NNS\2716205|
DDI-DrugBank.d577.s6.e2_DDI-DrugBank.d577.s6.e0 false methotrexate_13\NN\2722166| (r_compound) concentrations_14\NNS\4916342|free|methotrexate (r_dobj) increasing_11\VBG\169651|thus|concentrations (r_advcl) displace_3\VB\1850315|sulfonamides|can|also|methotrexate|sites|,|increasing|. (l_nsubj) sulfonamides_0\NNS\2716205|
DDI-DrugBank.d727.s3
DDI-DrugBank.d576.s0
DDI-DrugBank.d652.s6
DDI-DrugBank.d652.s6.e0_DDI-DrugBank.d652.s6.e1 true metoclopramide_4\NN\1740|of (r_nmod) action_2\NN\30358|the|metoclopramide (r_nsubj) influence_6\VB\137313|because|action|will|delivery|. (l_dobj) delivery_8\NN\315986|the|food|intestines|and|thus|require (l_conj) require_28\VB\754942|rate|may|adjustment (l_nsubj) rate_17\NN\13815152|the|absorption|,|dosage (l_conj) dosage_22\NN\13576355|insulin|or|timing (l_compound) insulin_21\NN\5407119|
DDI-DrugBank.d761.s0
DDI-DrugBank.d761.s0.e0_DDI-DrugBank.d761.s0.e2 false alcohol_0\NN\7881800| (r_dep) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nsubj) coadministration_12\NN\1740|xenical (l_nmod) xenical_14\NN\1740|of|and|grams (l_conj) grams_17\NNS\13717155|40|alcohol|(|glasses|) (l_nmod) alcohol_19\NN\7881800|of
DDI-DrugBank.d761.s0.e0_DDI-DrugBank.d761.s0.e3 false alcohol_0\NN\7881800| (r_dep) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_nmod) pharmacokinetics_36\NNS\6054892|of|alcohol (l_compound) alcohol_35\NN\7881800|
DDI-DrugBank.d761.s0.e0_DDI-DrugBank.d761.s0.e4 false alcohol_0\NN\7881800| (r_dep) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_conj) pharmacodynamics_39\NNS\1740|orlistat|excretion (l_compound) orlistat_38\NN\1740|
DDI-DrugBank.d761.s0.e0_DDI-DrugBank.d761.s0.e5 false alcohol_0\NN\7881800| (r_dep) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_conj) exposure_48\NN\5042871|systemic|orlistat (l_nmod) orlistat_50\NN\1740|to
DDI-DrugBank.d761.s0.e0_DDI-DrugBank.d761.s0.e1 false alcohol_0\NN\7881800| (r_dep) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nsubj) coadministration_12\NN\1740|xenical (l_nmod) xenical_14\NN\1740|of|and|grams
DDI-DrugBank.d761.s0.e2_DDI-DrugBank.d761.s0.e3 false alcohol_19\NN\7881800|of (r_nmod) grams_17\NNS\13717155|40|alcohol|(|glasses|) (r_conj) xenical_14\NN\1740|of|and|grams (r_nmod) coadministration_12\NN\1740|xenical (r_nsubj) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_nmod) pharmacokinetics_36\NNS\6054892|of|alcohol (l_compound) alcohol_35\NN\7881800|
DDI-DrugBank.d761.s0.e2_DDI-DrugBank.d761.s0.e4 false alcohol_19\NN\7881800|of (r_nmod) grams_17\NNS\13717155|40|alcohol|(|glasses|) (r_conj) xenical_14\NN\1740|of|and|grams (r_nmod) coadministration_12\NN\1740|xenical (r_nsubj) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_conj) pharmacodynamics_39\NNS\1740|orlistat|excretion (l_compound) orlistat_38\NN\1740|
DDI-DrugBank.d761.s0.e2_DDI-DrugBank.d761.s0.e5 false alcohol_19\NN\7881800|of (r_nmod) grams_17\NNS\13717155|40|alcohol|(|glasses|) (r_conj) xenical_14\NN\1740|of|and|grams (r_nmod) coadministration_12\NN\1740|xenical (r_nsubj) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_conj) exposure_48\NN\5042871|systemic|orlistat (l_nmod) orlistat_50\NN\1740|to
DDI-DrugBank.d761.s0.e2_DDI-DrugBank.d761.s0.e1 false alcohol_19\NN\7881800|of (r_nmod) grams_17\NNS\13717155|40|alcohol|(|glasses|) (r_conj) xenical_14\NN\1740|of|and|grams
DDI-DrugBank.d761.s0.e3_DDI-DrugBank.d761.s0.e4 false alcohol_35\NN\7881800| (r_compound) pharmacokinetics_36\NNS\6054892|of|alcohol (r_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_conj) pharmacodynamics_39\NNS\1740|orlistat|excretion (l_compound) orlistat_38\NN\1740|
DDI-DrugBank.d761.s0.e3_DDI-DrugBank.d761.s0.e5 false alcohol_35\NN\7881800| (r_compound) pharmacokinetics_36\NNS\6054892|of|alcohol (r_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_conj) exposure_48\NN\5042871|systemic|orlistat (l_nmod) orlistat_50\NN\1740|to
DDI-DrugBank.d761.s0.e3_DDI-DrugBank.d761.s0.e1 false alcohol_35\NN\7881800| (r_compound) pharmacokinetics_36\NNS\6054892|of|alcohol (r_nmod) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (r_nmod) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nsubj) coadministration_12\NN\1740|xenical (l_nmod) xenical_14\NN\1740|of|and|grams
DDI-DrugBank.d761.s0.e4_DDI-DrugBank.d761.s0.e5 false orlistat_38\NN\1740| (r_compound) pharmacodynamics_39\NNS\1740|orlistat|excretion (r_conj) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (l_conj) exposure_48\NN\5042871|systemic|orlistat (l_nmod) orlistat_50\NN\1740|to
DDI-DrugBank.d761.s0.e4_DDI-DrugBank.d761.s0.e1 false orlistat_38\NN\1740| (r_compound) pharmacodynamics_39\NNS\1740|orlistat|excretion (r_conj) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (r_nmod) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nsubj) coadministration_12\NN\1740|xenical (l_nmod) xenical_14\NN\1740|of|and|grams
DDI-DrugBank.d761.s0.e5_DDI-DrugBank.d761.s0.e1 false orlistat_50\NN\1740|to (r_nmod) exposure_48\NN\5042871|systemic|orlistat (r_conj) alteration_33\NN\7283608|in|pharmacokinetics|,|pharmacodynamics|,|or|exposure (r_nmod) result_31\VB\2633881|alcohol|:|study|,|coadministration|did|not|alteration|. (l_nsubj) coadministration_12\NN\1740|xenical (l_nmod) xenical_14\NN\1740|of|and|grams
DDI-DrugBank.d775.s7
DDI-DrugBank.d735.s2
DDI-DrugBank.d735.s2.e1_DDI-DrugBank.d735.s2.e2 false mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) cyclosporine_17\NN\1740|
DDI-DrugBank.d735.s2.e1_DDI-DrugBank.d735.s2.e3 false mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) tacrolimus_19\NN\1740|
DDI-DrugBank.d735.s2.e1_DDI-DrugBank.d735.s2.e4 false mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) prednisolone_21\NN\2721538|
DDI-DrugBank.d735.s2.e1_DDI-DrugBank.d735.s2.e5 false mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) fluconazole_24\NN\1740|
DDI-DrugBank.d735.s2.e1_DDI-DrugBank.d735.s2.e0 false mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (r_compound) pharmacokinetics_25\NNS\6054892|on|mofetil (r_nmod) effect_3\NN\34213|no|dose|pharmacokinetics (l_nmod) dose_7\NN\3740161|of|a|single|or|doses|mycamine (l_nmod) mycamine_12\NN\1740|of
DDI-DrugBank.d735.s2.e2_DDI-DrugBank.d735.s2.e3 false cyclosporine_17\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) tacrolimus_19\NN\1740|
DDI-DrugBank.d735.s2.e2_DDI-DrugBank.d735.s2.e4 false cyclosporine_17\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) prednisolone_21\NN\2721538|
DDI-DrugBank.d735.s2.e2_DDI-DrugBank.d735.s2.e5 false cyclosporine_17\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) fluconazole_24\NN\1740|
DDI-DrugBank.d735.s2.e2_DDI-DrugBank.d735.s2.e0 false cyclosporine_17\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (r_compound) pharmacokinetics_25\NNS\6054892|on|mofetil (r_nmod) effect_3\NN\34213|no|dose|pharmacokinetics (l_nmod) dose_7\NN\3740161|of|a|single|or|doses|mycamine (l_nmod) mycamine_12\NN\1740|of
DDI-DrugBank.d735.s2.e3_DDI-DrugBank.d735.s2.e4 false tacrolimus_19\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) prednisolone_21\NN\2721538|
DDI-DrugBank.d735.s2.e3_DDI-DrugBank.d735.s2.e5 false tacrolimus_19\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) fluconazole_24\NN\1740|
DDI-DrugBank.d735.s2.e3_DDI-DrugBank.d735.s2.e0 false tacrolimus_19\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (r_compound) pharmacokinetics_25\NNS\6054892|on|mofetil (r_nmod) effect_3\NN\34213|no|dose|pharmacokinetics (l_nmod) dose_7\NN\3740161|of|a|single|or|doses|mycamine (l_nmod) mycamine_12\NN\1740|of
DDI-DrugBank.d735.s2.e4_DDI-DrugBank.d735.s2.e5 false prednisolone_21\NN\2721538| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (l_conj) fluconazole_24\NN\1740|
DDI-DrugBank.d735.s2.e4_DDI-DrugBank.d735.s2.e0 false prednisolone_21\NN\2721538| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (r_compound) pharmacokinetics_25\NNS\6054892|on|mofetil (r_nmod) effect_3\NN\34213|no|dose|pharmacokinetics (l_nmod) dose_7\NN\3740161|of|a|single|or|doses|mycamine (l_nmod) mycamine_12\NN\1740|of
DDI-DrugBank.d735.s2.e5_DDI-DrugBank.d735.s2.e0 false fluconazole_24\NN\1740| (r_conj) mofetil_15\NN\1740|mycophenolate|,|cyclosporine|,|tacrolimus|,|prednisolone|,|and|fluconazole (r_compound) pharmacokinetics_25\NNS\6054892|on|mofetil (r_nmod) effect_3\NN\34213|no|dose|pharmacokinetics (l_nmod) dose_7\NN\3740161|of|a|single|or|doses|mycamine (l_nmod) mycamine_12\NN\1740|of
DDI-DrugBank.d661.s5
DDI-DrugBank.d604.s1
DDI-DrugBank.d776.s3
DDI-DrugBank.d776.s3.e1_DDI-DrugBank.d776.s3.e0 false glyburide_13\NN\2719105| (r_conj) diflucan_11\NN\1740|and|glyburide
DDI-DrugBank.d675.s7
DDI-DrugBank.d675.s7.e1_DDI-DrugBank.d675.s7.e0 false maleate_8\NN\2718811|(|methylergonovine (r_appos) methergine_5\NN\1740|maleate|)
DDI-DrugBank.d675.s7.e1_DDI-DrugBank.d675.s7.e2 true maleate_8\NN\2718811|(|methylergonovine (r_appos) methergine_5\NN\1740|maleate|) (r_nsubjpass) used_11\VBN\1156834|when|methergine|is|concurrently|vasoconstrictors (l_nmod) vasoconstrictors_15\NNS\9190918|with|other|or|alkaloids
DDI-DrugBank.d675.s7.e1_DDI-DrugBank.d675.s7.e3 false maleate_8\NN\2718811|(|methylergonovine (r_appos) methergine_5\NN\1740|maleate|) (r_nsubjpass) used_11\VBN\1156834|when|methergine|is|concurrently|vasoconstrictors (l_nmod) vasoconstrictors_15\NNS\9190918|with|other|or|alkaloids (l_conj) alkaloids_18\NNS\14727670|ergot
DDI-DrugBank.d675.s7.e0_DDI-DrugBank.d675.s7.e2 true methergine_5\NN\1740|maleate|) (r_nsubjpass) used_11\VBN\1156834|when|methergine|is|concurrently|vasoconstrictors (l_nmod) vasoconstrictors_15\NNS\9190918|with|other|or|alkaloids
DDI-DrugBank.d675.s7.e0_DDI-DrugBank.d675.s7.e3 true methergine_5\NN\1740|maleate|) (r_nsubjpass) used_11\VBN\1156834|when|methergine|is|concurrently|vasoconstrictors (l_nmod) vasoconstrictors_15\NNS\9190918|with|other|or|alkaloids (l_conj) alkaloids_18\NNS\14727670|ergot
DDI-DrugBank.d675.s7.e2_DDI-DrugBank.d675.s7.e3 false vasoconstrictors_15\NNS\9190918|with|other|or|alkaloids (l_conj) alkaloids_18\NNS\14727670|ergot
DDI-DrugBank.d742.s2
DDI-DrugBank.d742.s2.e1_DDI-DrugBank.d742.s2.e0 false mirtazapine_12\NN\1740|(|) (r_appos) soltab_10\NNP\1740|of|remeron|mirtazapine
DDI-DrugBank.d763.s6
DDI-DrugBank.d751.s1
DDI-DrugBank.d751.s1.e1_DDI-DrugBank.d751.s1.e3 false heparin_8\NN\2718259|with|and|aspirin (r_nmod) combination_6\NN\7951464|in|heparin (r_nmod) aggrastat_3\NN\1740|of|,|combination (r_nmod) use_1\NN\407535|the|aggrastat|, (r_nsubjpass) associated_14\VBN\628491|use|has|been|increase|heparin|see (l_advcl) heparin_22\NN\2718259|compared|to|and|aspirin|alone
DDI-DrugBank.d751.s1.e1_DDI-DrugBank.d751.s1.e4 false heparin_8\NN\2718259|with|and|aspirin (r_nmod) combination_6\NN\7951464|in|heparin (r_nmod) aggrastat_3\NN\1740|of|,|combination (r_nmod) use_1\NN\407535|the|aggrastat|, (r_nsubjpass) associated_14\VBN\628491|use|has|been|increase|heparin|see (l_advcl) heparin_22\NN\2718259|compared|to|and|aspirin|alone (l_conj) aspirin_24\NN\2707683|
DDI-DrugBank.d751.s1.e1_DDI-DrugBank.d751.s1.e0 false heparin_8\NN\2718259|with|and|aspirin (r_nmod) combination_6\NN\7951464|in|heparin (r_nmod) aggrastat_3\NN\1740|of|,|combination
DDI-DrugBank.d751.s1.e1_DDI-DrugBank.d751.s1.e2 false heparin_8\NN\2718259|with|and|aspirin (l_conj) aspirin_10\NN\2707683|
DDI-DrugBank.d751.s1.e3_DDI-DrugBank.d751.s1.e4 false heparin_22\NN\2718259|compared|to|and|aspirin|alone (l_conj) aspirin_24\NN\2707683|
DDI-DrugBank.d751.s1.e3_DDI-DrugBank.d751.s1.e0 false heparin_22\NN\2718259|compared|to|and|aspirin|alone (r_advcl) associated_14\VBN\628491|use|has|been|increase|heparin|see (l_nsubjpass) use_1\NN\407535|the|aggrastat|, (l_nmod) aggrastat_3\NN\1740|of|,|combination
DDI-DrugBank.d751.s1.e3_DDI-DrugBank.d751.s1.e2 false heparin_22\NN\2718259|compared|to|and|aspirin|alone (r_advcl) associated_14\VBN\628491|use|has|been|increase|heparin|see (l_nsubjpass) use_1\NN\407535|the|aggrastat|, (l_nmod) aggrastat_3\NN\1740|of|,|combination (l_nmod) combination_6\NN\7951464|in|heparin (l_nmod) heparin_8\NN\2718259|with|and|aspirin (l_conj) aspirin_10\NN\2707683|
DDI-DrugBank.d751.s1.e4_DDI-DrugBank.d751.s1.e0 false aspirin_24\NN\2707683| (r_conj) heparin_22\NN\2718259|compared|to|and|aspirin|alone (r_advcl) associated_14\VBN\628491|use|has|been|increase|heparin|see (l_nsubjpass) use_1\NN\407535|the|aggrastat|, (l_nmod) aggrastat_3\NN\1740|of|,|combination
DDI-DrugBank.d751.s1.e4_DDI-DrugBank.d751.s1.e2 false aspirin_24\NN\2707683| (r_conj) heparin_22\NN\2718259|compared|to|and|aspirin|alone (r_advcl) associated_14\VBN\628491|use|has|been|increase|heparin|see (l_nsubjpass) use_1\NN\407535|the|aggrastat|, (l_nmod) aggrastat_3\NN\1740|of|,|combination (l_nmod) combination_6\NN\7951464|in|heparin (l_nmod) heparin_8\NN\2718259|with|and|aspirin (l_conj) aspirin_10\NN\2707683|
DDI-DrugBank.d751.s1.e0_DDI-DrugBank.d751.s1.e2 true aggrastat_3\NN\1740|of|,|combination (l_nmod) combination_6\NN\7951464|in|heparin (l_nmod) heparin_8\NN\2718259|with|and|aspirin (l_conj) aspirin_10\NN\2707683|
DDI-DrugBank.d632.s4
DDI-DrugBank.d632.s4.e2_DDI-DrugBank.d632.s4.e0 false symlin_19\NNP\1740|of (r_nmod) profile_17\NN\6999802|the|adverse|event|symlin (r_dobj) alter_13\VB\126264|trials|,|use|did|not|profile|. (l_nsubj) use_6\NN\407535|the|concomitant|sulfonylureas (l_nmod) sulfonylureas_8\NNS\2719105|of|or|biguanides
DDI-DrugBank.d632.s4.e2_DDI-DrugBank.d632.s4.e1 false symlin_19\NNP\1740|of (r_nmod) profile_17\NN\6999802|the|adverse|event|symlin (r_dobj) alter_13\VB\126264|trials|,|use|did|not|profile|. (l_nsubj) use_6\NN\407535|the|concomitant|sulfonylureas (l_nmod) sulfonylureas_8\NNS\2719105|of|or|biguanides (l_conj) biguanides_10\NNS\1740|
DDI-DrugBank.d632.s4.e0_DDI-DrugBank.d632.s4.e1 false sulfonylureas_8\NNS\2719105|of|or|biguanides (l_conj) biguanides_10\NNS\1740|
DDI-DrugBank.d572.s8
DDI-DrugBank.d572.s8.e1_DDI-DrugBank.d572.s8.e2 false ezetimibe_12\NN\1740| (r_nsubjpass) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (l_nmod) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin
DDI-DrugBank.d572.s8.e1_DDI-DrugBank.d572.s8.e3 false ezetimibe_12\NN\1740| (r_nsubjpass) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (l_nmod) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) simvastatin_18\NN\3676175|
DDI-DrugBank.d572.s8.e1_DDI-DrugBank.d572.s8.e4 false ezetimibe_12\NN\1740| (r_nsubjpass) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (l_nmod) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) pravastatin_20\NN\3676175|
DDI-DrugBank.d572.s8.e1_DDI-DrugBank.d572.s8.e5 false ezetimibe_12\NN\1740| (r_nsubjpass) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (l_nmod) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) lovastatin_22\NN\3676175|
DDI-DrugBank.d572.s8.e1_DDI-DrugBank.d572.s8.e6 false ezetimibe_12\NN\1740| (r_nsubjpass) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (l_nmod) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) fluvastatin_25\NN\3676175|
DDI-DrugBank.d572.s8.e1_DDI-DrugBank.d572.s8.e0 false ezetimibe_12\NN\1740| (r_nsubjpass) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (r_advcl) seen_10\VBN\2106506|inhibitors|:|interactions|were|co-administered|. (l_nsubjpass) inhibitors_2\NNS\20090|hmg-coa|reductase
DDI-DrugBank.d572.s8.e2_DDI-DrugBank.d572.s8.e3 false atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) simvastatin_18\NN\3676175|
DDI-DrugBank.d572.s8.e2_DDI-DrugBank.d572.s8.e4 false atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) pravastatin_20\NN\3676175|
DDI-DrugBank.d572.s8.e2_DDI-DrugBank.d572.s8.e5 false atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) lovastatin_22\NN\3676175|
DDI-DrugBank.d572.s8.e2_DDI-DrugBank.d572.s8.e6 false atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) fluvastatin_25\NN\3676175|
DDI-DrugBank.d572.s8.e2_DDI-DrugBank.d572.s8.e0 false atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (r_nmod) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (r_advcl) seen_10\VBN\2106506|inhibitors|:|interactions|were|co-administered|. (l_nsubjpass) inhibitors_2\NNS\20090|hmg-coa|reductase
DDI-DrugBank.d572.s8.e3_DDI-DrugBank.d572.s8.e4 false simvastatin_18\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) pravastatin_20\NN\3676175|
DDI-DrugBank.d572.s8.e3_DDI-DrugBank.d572.s8.e5 false simvastatin_18\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) lovastatin_22\NN\3676175|
DDI-DrugBank.d572.s8.e3_DDI-DrugBank.d572.s8.e6 false simvastatin_18\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) fluvastatin_25\NN\3676175|
DDI-DrugBank.d572.s8.e3_DDI-DrugBank.d572.s8.e0 false simvastatin_18\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (r_nmod) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (r_advcl) seen_10\VBN\2106506|inhibitors|:|interactions|were|co-administered|. (l_nsubjpass) inhibitors_2\NNS\20090|hmg-coa|reductase
DDI-DrugBank.d572.s8.e4_DDI-DrugBank.d572.s8.e5 false pravastatin_20\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) lovastatin_22\NN\3676175|
DDI-DrugBank.d572.s8.e4_DDI-DrugBank.d572.s8.e6 false pravastatin_20\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) fluvastatin_25\NN\3676175|
DDI-DrugBank.d572.s8.e4_DDI-DrugBank.d572.s8.e0 false pravastatin_20\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (r_nmod) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (r_advcl) seen_10\VBN\2106506|inhibitors|:|interactions|were|co-administered|. (l_nsubjpass) inhibitors_2\NNS\20090|hmg-coa|reductase
DDI-DrugBank.d572.s8.e5_DDI-DrugBank.d572.s8.e6 false lovastatin_22\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (l_conj) fluvastatin_25\NN\3676175|
DDI-DrugBank.d572.s8.e5_DDI-DrugBank.d572.s8.e0 false lovastatin_22\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (r_nmod) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (r_advcl) seen_10\VBN\2106506|inhibitors|:|interactions|were|co-administered|. (l_nsubjpass) inhibitors_2\NNS\20090|hmg-coa|reductase
DDI-DrugBank.d572.s8.e6_DDI-DrugBank.d572.s8.e0 false fluvastatin_25\NN\3676175| (r_conj) atorvastatin_16\NN\3676175|with|,|simvastatin|,|pravastatin|,|lovastatin|,|or|fluvastatin (r_nmod) co-administered_14\VBN\1740|when|ezetimibe|was|atorvastatin (r_advcl) seen_10\VBN\2106506|inhibitors|:|interactions|were|co-administered|. (l_nsubjpass) inhibitors_2\NNS\20090|hmg-coa|reductase
DDI-DrugBank.d659.s3
DDI-DrugBank.d752.s3
DDI-DrugBank.d752.s3.e0_DDI-DrugBank.d752.s3.e1 false ritonavir_10\NN\4013993|and|nelfinavir (l_conj) nelfinavir_12\NN\4013993|
DDI-DrugBank.d752.s3.e0_DDI-DrugBank.d752.s3.e2 true ritonavir_10\NN\4013993|and|nelfinavir (r_dep) inhibitors_9\NNS\20090|the|potent|3a4|ritonavir (r_nsubj) cause_14\VB\1617192|studied|,|inhibitors|may|sedation|decrease|. (l_nmod) decrease_25\NN\7296428|due|a|clearance (l_nmod) clearance_28\NN\5089947|in|plasma|midazolam (l_nmod) midazolam_30\NN\2830852|of
DDI-DrugBank.d752.s3.e1_DDI-DrugBank.d752.s3.e2 true nelfinavir_12\NN\4013993| (r_conj) ritonavir_10\NN\4013993|and|nelfinavir (r_dep) inhibitors_9\NNS\20090|the|potent|3a4|ritonavir (r_nsubj) cause_14\VB\1617192|studied|,|inhibitors|may|sedation|decrease|. (l_nmod) decrease_25\NN\7296428|due|a|clearance (l_nmod) clearance_28\NN\5089947|in|plasma|midazolam (l_nmod) midazolam_30\NN\2830852|of
DDI-DrugBank.d773.s1
DDI-DrugBank.d773.s1.e1_DDI-DrugBank.d773.s1.e0 false heparin_11\NN\2718259|with|and|aspirin (r_nmod) treated_9\VBN\2376958|patients|were|routinely|heparin|. (l_nsubjpass) patients_0\NNS\9898892|studied (l_acl) studied_1\VBN\630380|trials (l_nmod) trials_4\NNS\786195|in|clinical|tnkase (l_nmod) tnkase_6\NNP\1740|of
DDI-DrugBank.d773.s1.e1_DDI-DrugBank.d773.s1.e2 false heparin_11\NN\2718259|with|and|aspirin (l_conj) aspirin_13\NN\2707683|
DDI-DrugBank.d773.s1.e0_DDI-DrugBank.d773.s1.e2 false tnkase_6\NNP\1740|of (r_nmod) trials_4\NNS\786195|in|clinical|tnkase (r_nmod) studied_1\VBN\630380|trials (r_acl) patients_0\NNS\9898892|studied (r_nsubjpass) treated_9\VBN\2376958|patients|were|routinely|heparin|. (l_nmod) heparin_11\NN\2718259|with|and|aspirin (l_conj) aspirin_13\NN\2707683|
DDI-DrugBank.d742.s5
DDI-DrugBank.d742.s5.e0_DDI-DrugBank.d742.s5.e1 false mirtazapine_7\NN\1740| (r_nsubj) inhibitor_12\NN\20090|that|mirtazapine|is|not|a|potent|any|,|indication (l_dep) indication_20\NN\33020|an|likely (l_ccomp) likely_25\JJ\1740|that|mirtazapine|is|not|have (l_nsubj) mirtazapine_22\NN\1740|
DDI-DrugBank.d742.s5.e0_DDI-DrugBank.d742.s5.e2 false mirtazapine_7\NN\1740| (r_nsubj) inhibitor_12\NN\20090|that|mirtazapine|is|not|a|potent|any|,|indication (r_ccomp) shown_5\VBN\2137132|while|studies|have|inhibitor (r_advcl) studied_66\VBN\630380|shown|,|use|has|not|been|formally|. (l_nsubjpass) use_50\NN\407535|the|concomitant|soltab|drugs (l_nmod) soltab_53\NN\1740|of|remeron
DDI-DrugBank.d742.s5.e1_DDI-DrugBank.d742.s5.e2 false mirtazapine_22\NN\1740| (r_nsubj) likely_25\JJ\1740|that|mirtazapine|is|not|have (r_ccomp) indication_20\NN\33020|an|likely (r_dep) inhibitor_12\NN\20090|that|mirtazapine|is|not|a|potent|any|,|indication (r_ccomp) shown_5\VBN\2137132|while|studies|have|inhibitor (r_advcl) studied_66\VBN\630380|shown|,|use|has|not|been|formally|. (l_nsubjpass) use_50\NN\407535|the|concomitant|soltab|drugs (l_nmod) soltab_53\NN\1740|of|remeron
DDI-DrugBank.d633.s18
DDI-DrugBank.d633.s18.e1_DDI-DrugBank.d633.s18.e2 false theophylline_0\NN\2905612| (r_compound) levels_2\NNS\4916342|theophylline|plasma (r_nsubj) returned_3\VBD\1835496|levels|values|hours (l_nmod) values_6\NNS\5941423|to|pre-mexitil (l_amod) pre-mexitil_5\JJ\1740|
DDI-DrugBank.d633.s18.e1_DDI-DrugBank.d633.s18.e3 true theophylline_0\NN\2905612| (r_compound) levels_2\NNS\4916342|theophylline|plasma (r_nsubj) returned_3\VBD\1835496|levels|values|hours (l_nmod) hours_9\NNS\15118228|within|48|discontinuing (l_advcl) discontinuing_11\VBG\2609764|after|mexitil (l_dobj) mexitil_12\NN\2715941|
DDI-DrugBank.d633.s18.e2_DDI-DrugBank.d633.s18.e3 false pre-mexitil_5\JJ\1740| (r_amod) values_6\NNS\5941423|to|pre-mexitil (r_nmod) returned_3\VBD\1835496|levels|values|hours (l_nmod) hours_9\NNS\15118228|within|48|discontinuing (l_advcl) discontinuing_11\VBG\2609764|after|mexitil (l_dobj) mexitil_12\NN\2715941|
DDI-DrugBank.d633.s18.e5_DDI-DrugBank.d633.s18.e6 false theophylline_3\NN\2905612| (r_conj) mexitil_1\NN\2715941|and|theophylline (r_nsubj) if_0\IN\1740|mexitil|are|used (r_advcl) monitored_15\VBN\2169352|if|,|levels|should|be|,|changed|. (l_nsubjpass) levels_12\NNS\4916342|theophylline|blood (l_compound) theophylline_10\NN\2905612|
DDI-DrugBank.d633.s18.e5_DDI-DrugBank.d633.s18.e4 false theophylline_3\NN\2905612| (r_conj) mexitil_1\NN\2715941|and|theophylline
DDI-DrugBank.d633.s18.e5_DDI-DrugBank.d633.s18.e7 false theophylline_3\NN\2905612| (r_conj) mexitil_1\NN\2715941|and|theophylline (r_nsubj) if_0\IN\1740|mexitil|are|used (r_advcl) monitored_15\VBN\2169352|if|,|levels|should|be|,|changed|. (l_advcl) changed_23\VBN\46534|particularly|when|dose|is (l_nsubjpass) dose_21\NN\3740161|the|mexitil (l_compound) mexitil_20\NN\2715941|
DDI-DrugBank.d633.s18.e6_DDI-DrugBank.d633.s18.e4 false theophylline_10\NN\2905612| (r_compound) levels_12\NNS\4916342|theophylline|blood (r_nsubjpass) monitored_15\VBN\2169352|if|,|levels|should|be|,|changed|. (l_advcl) if_0\IN\1740|mexitil|are|used (l_nsubj) mexitil_1\NN\2715941|and|theophylline
DDI-DrugBank.d633.s18.e6_DDI-DrugBank.d633.s18.e7 false theophylline_10\NN\2905612| (r_compound) levels_12\NNS\4916342|theophylline|blood (r_nsubjpass) monitored_15\VBN\2169352|if|,|levels|should|be|,|changed|. (l_advcl) changed_23\VBN\46534|particularly|when|dose|is (l_nsubjpass) dose_21\NN\3740161|the|mexitil (l_compound) mexitil_20\NN\2715941|
DDI-DrugBank.d633.s18.e4_DDI-DrugBank.d633.s18.e7 false mexitil_1\NN\2715941|and|theophylline (r_nsubj) if_0\IN\1740|mexitil|are|used (r_advcl) monitored_15\VBN\2169352|if|,|levels|should|be|,|changed|. (l_advcl) changed_23\VBN\46534|particularly|when|dose|is (l_nsubjpass) dose_21\NN\3740161|the|mexitil (l_compound) mexitil_20\NN\2715941|
DDI-DrugBank.d766.s0
DDI-DrugBank.d766.s0.e0_DDI-DrugBank.d766.s0.e1 false trimetrexate_1\NN\1740| (r_nsubjpass) metabolized_3\VBN\1740|since|trimetrexate|is|system (r_advcl) elicit_21\VB\1617192|metabolized|,|drugs|may|interactions|. (l_dobj) interactions_24\NNS\37396|important|drug-drug|alter (l_acl:relcl) alter_27\VB\126264|that|may|concentrations (l_dobj) concentrations_30\NNS\4916342|trimetrexate|plasma (l_compound) trimetrexate_28\NN\1740|
DDI-DrugBank.d739.s4
DDI-DrugBank.d739.s4.e0_DDI-DrugBank.d739.s4.e2 false montelukast_0\NN\1740|doses|:|- (r_nsubj) alter_17\VB\126264|montelukast|did|not|significantly|concentrations|. (l_dobj) concentrations_20\NNS\4916342|the|plasma|component (l_nmod) component_23\NN\5867413|of|either|contraceptive (l_nmod) contraceptive_27\NN\3183080|of|an|oral|containing (l_acl) containing_28\VBG\2632940|norethindrone (l_dobj) norethindrone_29\NN\14747338|estradiol|mcg
DDI-DrugBank.d739.s4.e0_DDI-DrugBank.d739.s4.e3 false montelukast_0\NN\1740|doses|:|- (r_nsubj) alter_17\VB\126264|montelukast|did|not|significantly|concentrations|. (l_dobj) concentrations_20\NNS\4916342|the|plasma|component (l_nmod) component_23\NN\5867413|of|either|contraceptive (l_nmod) contraceptive_27\NN\3183080|of|an|oral|containing (l_acl) containing_28\VBG\2632940|norethindrone (l_dobj) norethindrone_29\NN\14747338|estradiol|mcg (l_appos) estradiol_32\NN\14749794|1|mg/ethinyl
DDI-DrugBank.d739.s4.e0_DDI-DrugBank.d739.s4.e1 false montelukast_0\NN\1740|doses|:|- (r_nsubj) alter_17\VB\126264|montelukast|did|not|significantly|concentrations|. (l_dobj) concentrations_20\NNS\4916342|the|plasma|component (l_nmod) component_23\NN\5867413|of|either|contraceptive (l_nmod) contraceptive_27\NN\3183080|of|an|oral|containing
DDI-DrugBank.d739.s4.e2_DDI-DrugBank.d739.s4.e3 false norethindrone_29\NN\14747338|estradiol|mcg (l_appos) estradiol_32\NN\14749794|1|mg/ethinyl
DDI-DrugBank.d739.s4.e2_DDI-DrugBank.d739.s4.e1 false norethindrone_29\NN\14747338|estradiol|mcg (r_dobj) containing_28\VBG\2632940|norethindrone (r_acl) contraceptive_27\NN\3183080|of|an|oral|containing
DDI-DrugBank.d739.s4.e3_DDI-DrugBank.d739.s4.e1 false estradiol_32\NN\14749794|1|mg/ethinyl (r_appos) norethindrone_29\NN\14747338|estradiol|mcg (r_dobj) containing_28\VBG\2632940|norethindrone (r_acl) contraceptive_27\NN\3183080|of|an|oral|containing
DDI-DrugBank.d585.s0
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e3 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) agents_17\NNS\7347|antiarrhythmic|class|quinidine (l_appos) quinidine_24\NN\2715941|(|e.g.|,|)
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e0 false amantadine_14\NN\1740|,|agents|,|antihistamines (r_dep) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dobj) actions_6\NNS\30358|certain|or|effects|drugs (l_nmod) drugs_12\NNS\14778436|of|anticholinergic
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e2 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) agents_17\NNS\7347|antiarrhythmic|class|quinidine (l_nmod) class_19\NN\7951464|of|i
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e4 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e5 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e6 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_appos) phenothiazines_34\NNS\14771088|e.g.|,|)
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e7 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e8 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e1_DDI-DrugBank.d585.s0.e9 false amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e0 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (r_dep) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dobj) actions_6\NNS\30358|certain|or|effects|drugs (l_nmod) drugs_12\NNS\14778436|of|anticholinergic
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e2 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (l_nmod) class_19\NN\7951464|of|i
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e4 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e5 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e6 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_appos) phenothiazines_34\NNS\14771088|e.g.|,|)
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e7 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e8 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e3_DDI-DrugBank.d585.s0.e9 false quinidine_24\NN\2715941|(|e.g.|,|) (r_appos) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e0_DDI-DrugBank.d585.s0.e2 true drugs_12\NNS\14778436|of|anticholinergic (r_nmod) actions_6\NNS\30358|certain|or|effects|drugs (r_dobj) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dep) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) agents_17\NNS\7347|antiarrhythmic|class|quinidine (l_nmod) class_19\NN\7951464|of|i
DDI-DrugBank.d585.s0.e0_DDI-DrugBank.d585.s0.e4 true drugs_12\NNS\14778436|of|anticholinergic (r_nmod) actions_6\NNS\30358|certain|or|effects|drugs (r_dobj) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dep) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents
DDI-DrugBank.d585.s0.e0_DDI-DrugBank.d585.s0.e5 true drugs_12\NNS\14778436|of|anticholinergic (r_nmod) actions_6\NNS\30358|certain|or|effects|drugs (r_dobj) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dep) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines
DDI-DrugBank.d585.s0.e0_DDI-DrugBank.d585.s0.e6 true drugs_12\NNS\14778436|of|anticholinergic (r_nmod) actions_6\NNS\30358|certain|or|effects|drugs (r_dobj) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dep) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_appos) phenothiazines_34\NNS\14771088|e.g.|,|)
DDI-DrugBank.d585.s0.e0_DDI-DrugBank.d585.s0.e7 true drugs_12\NNS\14778436|of|anticholinergic (r_nmod) actions_6\NNS\30358|certain|or|effects|drugs (r_dobj) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dep) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics
DDI-DrugBank.d585.s0.e0_DDI-DrugBank.d585.s0.e8 true drugs_12\NNS\14778436|of|anticholinergic (r_nmod) actions_6\NNS\30358|certain|or|effects|drugs (r_dobj) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dep) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e0_DDI-DrugBank.d585.s0.e9 true drugs_12\NNS\14778436|of|anticholinergic (r_nmod) actions_6\NNS\30358|certain|or|effects|drugs (r_dobj) increase_4\VB\169651|agents|may|actions|:|amantadine|. (l_dep) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e2_DDI-DrugBank.d585.s0.e4 false class_19\NN\7951464|of|i (r_nmod) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents
DDI-DrugBank.d585.s0.e2_DDI-DrugBank.d585.s0.e5 false class_19\NN\7951464|of|i (r_nmod) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines
DDI-DrugBank.d585.s0.e2_DDI-DrugBank.d585.s0.e6 false class_19\NN\7951464|of|i (r_nmod) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_appos) phenothiazines_34\NNS\14771088|e.g.|,|)
DDI-DrugBank.d585.s0.e2_DDI-DrugBank.d585.s0.e7 false class_19\NN\7951464|of|i (r_nmod) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics
DDI-DrugBank.d585.s0.e2_DDI-DrugBank.d585.s0.e8 false class_19\NN\7951464|of|i (r_nmod) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e2_DDI-DrugBank.d585.s0.e9 false class_19\NN\7951464|of|i (r_nmod) agents_17\NNS\7347|antiarrhythmic|class|quinidine (r_conj) amantadine_14\NN\1740|,|agents|,|antihistamines (l_conj) antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e4_DDI-DrugBank.d585.s0.e5 false antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines
DDI-DrugBank.d585.s0.e4_DDI-DrugBank.d585.s0.e6 false antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_appos) phenothiazines_34\NNS\14771088|e.g.|,|)
DDI-DrugBank.d585.s0.e4_DDI-DrugBank.d585.s0.e7 false antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics
DDI-DrugBank.d585.s0.e4_DDI-DrugBank.d585.s0.e8 false antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e4_DDI-DrugBank.d585.s0.e9 false antihistamines_27\NNS\3740161|,|agents (l_conj) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e5_DDI-DrugBank.d585.s0.e6 false agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_appos) phenothiazines_34\NNS\14771088|e.g.|,|)
DDI-DrugBank.d585.s0.e5_DDI-DrugBank.d585.s0.e7 false agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics
DDI-DrugBank.d585.s0.e5_DDI-DrugBank.d585.s0.e8 false agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e5_DDI-DrugBank.d585.s0.e9 false agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e6_DDI-DrugBank.d585.s0.e7 false phenothiazines_34\NNS\14771088|e.g.|,|) (r_appos) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics
DDI-DrugBank.d585.s0.e6_DDI-DrugBank.d585.s0.e8 false phenothiazines_34\NNS\14771088|e.g.|,|) (r_appos) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e6_DDI-DrugBank.d585.s0.e9 false phenothiazines_34\NNS\14771088|e.g.|,|) (r_appos) agents_30\NNS\7347|antipsychotic|(|phenothiazines|,|benzodiazepines (l_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e7_DDI-DrugBank.d585.s0.e8 false benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) inhibitors_40\NNS\20090|mao
DDI-DrugBank.d585.s0.e7_DDI-DrugBank.d585.s0.e9 false benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d585.s0.e8_DDI-DrugBank.d585.s0.e9 false inhibitors_40\NNS\20090|mao (r_conj) benzodiazepines_37\NNS\3771443|,|inhibitors|,|analgesics (l_conj) analgesics_43\NNS\3740161|narcotic|meperidine|,|nitrates
DDI-DrugBank.d633.s13
DDI-DrugBank.d633.s13.e0_DDI-DrugBank.d633.s13.e1 true cimetidine_3\NN\14778019|of|and|mexitil (l_conj) mexitil_5\NN\2715941|
DDI-DrugBank.d633.s13.e0_DDI-DrugBank.d633.s13.e2 false cimetidine_3\NN\14778019|of|and|mexitil (r_nmod) administration_1\NN\1133281|concurrent|cimetidine (r_nsubjpass) reported_8\VBN\831651|administration|has|been|increase|; (l_xcomp) increase_10\VB\169651|to|,|decrease|or|leave (l_conj) leave_15\VB\120316|levels (l_dobj) levels_19\NNS\4916342|unchanged|mexitil|plasma (l_compound) mexitil_17\NN\2715941|
DDI-DrugBank.d633.s13.e1_DDI-DrugBank.d633.s13.e2 false mexitil_5\NN\2715941| (r_conj) cimetidine_3\NN\14778019|of|and|mexitil (r_nmod) administration_1\NN\1133281|concurrent|cimetidine (r_nsubjpass) reported_8\VBN\831651|administration|has|been|increase|; (l_xcomp) increase_10\VB\169651|to|,|decrease|or|leave (l_conj) leave_15\VB\120316|levels (l_dobj) levels_19\NNS\4916342|unchanged|mexitil|plasma (l_compound) mexitil_17\NN\2715941|
DDI-DrugBank.d689.s1
DDI-DrugBank.d689.s1.e0_DDI-DrugBank.d689.s1.e1 false inhibitors_1\NNS\20090|mao (r_dep) potentiated_12\VBN\229605|inhibitors|-|effect|is|markedly|patients|. (l_nsubjpass) effect_5\NN\34213|the|pressor|amines (l_nmod) amines_9\NNS\14951377|of|sympathomimetic|pressor
DDI-DrugBank.d689.s1.e0_DDI-DrugBank.d689.s1.e2 false inhibitors_1\NNS\20090|mao (r_dep) potentiated_12\VBN\229605|inhibitors|-|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi
DDI-DrugBank.d689.s1.e0_DDI-DrugBank.d689.s1.e3 false inhibitors_1\NNS\20090|mao (r_dep) potentiated_12\VBN\229605|inhibitors|-|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi (l_appos) maoi_20\NNS\2718811|(|)
DDI-DrugBank.d689.s1.e1_DDI-DrugBank.d689.s1.e2 true amines_9\NNS\14951377|of|sympathomimetic|pressor (r_nmod) effect_5\NN\34213|the|pressor|amines (r_nsubjpass) potentiated_12\VBN\229605|inhibitors|-|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi
DDI-DrugBank.d689.s1.e1_DDI-DrugBank.d689.s1.e3 true amines_9\NNS\14951377|of|sympathomimetic|pressor (r_nmod) effect_5\NN\34213|the|pressor|amines (r_nsubjpass) potentiated_12\VBN\229605|inhibitors|-|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi (l_appos) maoi_20\NNS\2718811|(|)
DDI-DrugBank.d689.s1.e2_DDI-DrugBank.d689.s1.e3 false inhibitors_18\NNS\20090|monoamine|oxidase|maoi (l_appos) maoi_20\NNS\2718811|(|)
DDI-DrugBank.d596.s9
DDI-DrugBank.d596.s9.e3_DDI-DrugBank.d596.s9.e6 false succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (l_conj) agonists_29\NNS\9613191|cholinergic|bethanechol (l_nmod) bethanechol_32\NN\1740|such
DDI-DrugBank.d596.s9.e3_DDI-DrugBank.d596.s9.e0 false succinylcholine_21\NN\3800001|with|,|agents (r_nmod) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (r_advcl) expected_13\VBN\670261|effect|may|be|given (r_dep) use_0\NN\407535|cholinomimetics|:|expected (l_nmod) cholinomimetics_2\NNS\1740|with|and|inhibitors
DDI-DrugBank.d596.s9.e3_DDI-DrugBank.d596.s9.e1 false succinylcholine_21\NN\3800001|with|,|agents (r_nmod) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (r_advcl) expected_13\VBN\670261|effect|may|be|given (r_dep) use_0\NN\407535|cholinomimetics|:|expected (l_nmod) cholinomimetics_2\NNS\1740|with|and|inhibitors (l_conj) inhibitors_6\NNS\20090|other|cholinesterase
DDI-DrugBank.d596.s9.e3_DDI-DrugBank.d596.s9.e2 false succinylcholine_21\NN\3800001|with|,|agents (r_nmod) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nsubjpass) inhibitors_16\NNS\20090|cholinesterase
DDI-DrugBank.d596.s9.e3_DDI-DrugBank.d596.s9.e4 false succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists
DDI-DrugBank.d596.s9.e3_DDI-DrugBank.d596.s9.e5 false succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (l_conj) agonists_29\NNS\9613191|cholinergic|bethanechol
DDI-DrugBank.d596.s9.e6_DDI-DrugBank.d596.s9.e0 false bethanechol_32\NN\1740|such (r_nmod) agonists_29\NNS\9613191|cholinergic|bethanechol (r_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (r_conj) succinylcholine_21\NN\3800001|with|,|agents (r_nmod) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (r_advcl) expected_13\VBN\670261|effect|may|be|given (r_dep) use_0\NN\407535|cholinomimetics|:|expected (l_nmod) cholinomimetics_2\NNS\1740|with|and|inhibitors
DDI-DrugBank.d596.s9.e6_DDI-DrugBank.d596.s9.e1 false bethanechol_32\NN\1740|such (r_nmod) agonists_29\NNS\9613191|cholinergic|bethanechol (r_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (r_conj) succinylcholine_21\NN\3800001|with|,|agents (r_nmod) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (r_advcl) expected_13\VBN\670261|effect|may|be|given (r_dep) use_0\NN\407535|cholinomimetics|:|expected (l_nmod) cholinomimetics_2\NNS\1740|with|and|inhibitors (l_conj) inhibitors_6\NNS\20090|other|cholinesterase
DDI-DrugBank.d596.s9.e6_DDI-DrugBank.d596.s9.e2 false bethanechol_32\NN\1740|such (r_nmod) agonists_29\NNS\9613191|cholinergic|bethanechol (r_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (r_conj) succinylcholine_21\NN\3800001|with|,|agents (r_nmod) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nsubjpass) inhibitors_16\NNS\20090|cholinesterase
DDI-DrugBank.d596.s9.e6_DDI-DrugBank.d596.s9.e4 false bethanechol_32\NN\1740|such (r_nmod) agonists_29\NNS\9613191|cholinergic|bethanechol (r_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists
DDI-DrugBank.d596.s9.e6_DDI-DrugBank.d596.s9.e5 false bethanechol_32\NN\1740|such (r_nmod) agonists_29\NNS\9613191|cholinergic|bethanechol
DDI-DrugBank.d596.s9.e0_DDI-DrugBank.d596.s9.e1 false cholinomimetics_2\NNS\1740|with|and|inhibitors (l_conj) inhibitors_6\NNS\20090|other|cholinesterase
DDI-DrugBank.d596.s9.e0_DDI-DrugBank.d596.s9.e2 false cholinomimetics_2\NNS\1740|with|and|inhibitors (r_nmod) use_0\NN\407535|cholinomimetics|:|expected (l_dep) expected_13\VBN\670261|effect|may|be|given (l_advcl) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nsubjpass) inhibitors_16\NNS\20090|cholinesterase
DDI-DrugBank.d596.s9.e0_DDI-DrugBank.d596.s9.e4 false cholinomimetics_2\NNS\1740|with|and|inhibitors (r_nmod) use_0\NN\407535|cholinomimetics|:|expected (l_dep) expected_13\VBN\670261|effect|may|be|given (l_advcl) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nmod) succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists
DDI-DrugBank.d596.s9.e0_DDI-DrugBank.d596.s9.e5 false cholinomimetics_2\NNS\1740|with|and|inhibitors (r_nmod) use_0\NN\407535|cholinomimetics|:|expected (l_dep) expected_13\VBN\670261|effect|may|be|given (l_advcl) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nmod) succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (l_conj) agonists_29\NNS\9613191|cholinergic|bethanechol
DDI-DrugBank.d596.s9.e1_DDI-DrugBank.d596.s9.e2 false inhibitors_6\NNS\20090|other|cholinesterase (r_conj) cholinomimetics_2\NNS\1740|with|and|inhibitors (r_nmod) use_0\NN\407535|cholinomimetics|:|expected (l_dep) expected_13\VBN\670261|effect|may|be|given (l_advcl) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nsubjpass) inhibitors_16\NNS\20090|cholinesterase
DDI-DrugBank.d596.s9.e1_DDI-DrugBank.d596.s9.e4 false inhibitors_6\NNS\20090|other|cholinesterase (r_conj) cholinomimetics_2\NNS\1740|with|and|inhibitors (r_nmod) use_0\NN\407535|cholinomimetics|:|expected (l_dep) expected_13\VBN\670261|effect|may|be|given (l_advcl) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nmod) succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists
DDI-DrugBank.d596.s9.e1_DDI-DrugBank.d596.s9.e5 false inhibitors_6\NNS\20090|other|cholinesterase (r_conj) cholinomimetics_2\NNS\1740|with|and|inhibitors (r_nmod) use_0\NN\407535|cholinomimetics|:|expected (l_dep) expected_13\VBN\670261|effect|may|be|given (l_advcl) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nmod) succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (l_conj) agonists_29\NNS\9613191|cholinergic|bethanechol
DDI-DrugBank.d596.s9.e2_DDI-DrugBank.d596.s9.e4 false inhibitors_16\NNS\20090|cholinesterase (r_nsubjpass) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nmod) succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists
DDI-DrugBank.d596.s9.e2_DDI-DrugBank.d596.s9.e5 false inhibitors_16\NNS\20090|cholinesterase (r_nsubjpass) given_18\VBN\2327200|when|inhibitors|are|concurrently|succinylcholine (l_nmod) succinylcholine_21\NN\3800001|with|,|agents (l_conj) agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (l_conj) agonists_29\NNS\9613191|cholinergic|bethanechol
DDI-DrugBank.d596.s9.e4_DDI-DrugBank.d596.s9.e5 false agents_26\NNS\7347|similar|neuromuscular|blocking|or|agonists (l_conj) agonists_29\NNS\9613191|cholinergic|bethanechol
DDI-DrugBank.d670.s7
DDI-DrugBank.d670.s7.e0_DDI-DrugBank.d670.s7.e1 true paliperidone_0\NN\1740| (r_nsubj) antagonize_2\VB\1787955|paliperidone|may|effect|. (l_dobj) effect_4\NN\34213|the|levodopa (l_nmod) levodopa_6\NN\14604959|of|and|agonists
DDI-DrugBank.d670.s7.e0_DDI-DrugBank.d670.s7.e2 true paliperidone_0\NN\1740| (r_nsubj) antagonize_2\VB\1787955|paliperidone|may|effect|. (l_dobj) effect_4\NN\34213|the|levodopa (l_nmod) levodopa_6\NN\14604959|of|and|agonists (l_conj) agonists_10\NNS\9613191|other|dopamine
DDI-DrugBank.d670.s7.e1_DDI-DrugBank.d670.s7.e2 false levodopa_6\NN\14604959|of|and|agonists (l_conj) agonists_10\NNS\9613191|other|dopamine
DDI-DrugBank.d709.s5
DDI-DrugBank.d709.s5.e0_DDI-DrugBank.d709.s5.e1 false roxithromycin_8\NN\1740|for (r_nmod) verified_6\VBN\665886|although|risk|is|not|roxithromycin (r_advcl) recommended_18\VBN\875394|verified|,|combination|is|not|. (l_nsubjpass) combination_10\NN\7951464|roxithromycin|drugs (l_nmod) roxithromycin_12\NN\1740|of
DDI-DrugBank.d762.s2
DDI-DrugBank.d762.s2.e0_DDI-DrugBank.d762.s2.e1 true probenecid_5\NN\3740161|of (r_nmod) coadministration_3\NN\1740|the|probenecid|meropenem (l_nmod) meropenem_7\NNP\1740|with
DDI-DrugBank.d680.s9
DDI-DrugBank.d680.s9.e0_DDI-DrugBank.d680.s9.e1 false tetrahydrocannabinol_12\NN\4017137|for|thc|patients (l_appos) thc_14\NN\4017137|(|)
DDI-DrugBank.d680.s9.e0_DDI-DrugBank.d680.s9.e3 false tetrahydrocannabinol_12\NN\4017137|for|thc|patients (l_nmod) patients_17\NNS\9898892|in|receiving (l_acl) receiving_18\VBG\2210855|inhibitors (l_dobj) inhibitors_22\NNS\20090|most|pump|,|pantoprazole (l_nmod) pantoprazole_25\NN\1740|including
DDI-DrugBank.d680.s9.e0_DDI-DrugBank.d680.s9.e2 false tetrahydrocannabinol_12\NN\4017137|for|thc|patients (l_nmod) patients_17\NNS\9898892|in|receiving (l_acl) receiving_18\VBG\2210855|inhibitors (l_dobj) inhibitors_22\NNS\20090|most|pump|,|pantoprazole
DDI-DrugBank.d680.s9.e1_DDI-DrugBank.d680.s9.e3 false thc_14\NN\4017137|(|) (r_appos) tetrahydrocannabinol_12\NN\4017137|for|thc|patients (l_nmod) patients_17\NNS\9898892|in|receiving (l_acl) receiving_18\VBG\2210855|inhibitors (l_dobj) inhibitors_22\NNS\20090|most|pump|,|pantoprazole (l_nmod) pantoprazole_25\NN\1740|including
DDI-DrugBank.d680.s9.e1_DDI-DrugBank.d680.s9.e2 false thc_14\NN\4017137|(|) (r_appos) tetrahydrocannabinol_12\NN\4017137|for|thc|patients (l_nmod) patients_17\NNS\9898892|in|receiving (l_acl) receiving_18\VBG\2210855|inhibitors (l_dobj) inhibitors_22\NNS\20090|most|pump|,|pantoprazole
DDI-DrugBank.d680.s9.e3_DDI-DrugBank.d680.s9.e2 false pantoprazole_25\NN\1740|including (r_nmod) inhibitors_22\NNS\20090|most|pump|,|pantoprazole
DDI-DrugBank.d618.s0
DDI-DrugBank.d623.s7
DDI-DrugBank.d584.s3
DDI-DrugBank.d584.s3.e0_DDI-DrugBank.d584.s3.e1 false warfarin_0\NN\2718259|:|study (l_appos) study_4\NN\635850|a|multidose|oxandrolone|given|, (l_nmod) oxandrolone_6\NN\1740|of|,
DDI-DrugBank.d584.s3.e0_DDI-DrugBank.d584.s3.e2 false warfarin_0\NN\2718259|:|study (l_appos) study_4\NN\635850|a|multidose|oxandrolone|given|, (l_acl) given_8\VBN\2327200|bid|subjects (l_nmod) subjects_18\NNS\6598915|in|15|healthy|treated (l_acl) treated_20\VBN\2376958|concurrently|warfarin (l_nmod) warfarin_22\NN\2718259|with
DDI-DrugBank.d584.s3.e0_DDI-DrugBank.d584.s3.e3 false warfarin_0\NN\2718259|:|study (r_nsubj) resulted_24\VBD\2633881|warfarin|increase|:|detected|. (l_nmod) increase_28\NN\13576355|in|a|mean|half-life|ng*hr/ml (l_nmod) half-life_31\NN\15113229|in|s-warfarin|hours|and|auc (l_compound) s-warfarin_30\NN\1740|
DDI-DrugBank.d584.s3.e0_DDI-DrugBank.d584.s3.e4 false warfarin_0\NN\2718259|:|study (r_nsubj) resulted_24\VBD\2633881|warfarin|increase|:|detected|. (l_parataxis) detected_54\VBN\2163746|increases|were|also (l_nsubjpass) increases_46\NNS\13576355|similar|half-life (l_nmod) half-life_49\NN\15113229|in|r-warfarin|and|auc (l_compound) r-warfarin_48\NN\1740|
DDI-DrugBank.d584.s3.e1_DDI-DrugBank.d584.s3.e2 true oxandrolone_6\NN\1740|of|, (r_nmod) study_4\NN\635850|a|multidose|oxandrolone|given|, (l_acl) given_8\VBN\2327200|bid|subjects (l_nmod) subjects_18\NNS\6598915|in|15|healthy|treated (l_acl) treated_20\VBN\2376958|concurrently|warfarin (l_nmod) warfarin_22\NN\2718259|with
DDI-DrugBank.d584.s3.e1_DDI-DrugBank.d584.s3.e3 false oxandrolone_6\NN\1740|of|, (r_nmod) study_4\NN\635850|a|multidose|oxandrolone|given|, (r_appos) warfarin_0\NN\2718259|:|study (r_nsubj) resulted_24\VBD\2633881|warfarin|increase|:|detected|. (l_nmod) increase_28\NN\13576355|in|a|mean|half-life|ng*hr/ml (l_nmod) half-life_31\NN\15113229|in|s-warfarin|hours|and|auc (l_compound) s-warfarin_30\NN\1740|
DDI-DrugBank.d584.s3.e1_DDI-DrugBank.d584.s3.e4 false oxandrolone_6\NN\1740|of|, (r_nmod) study_4\NN\635850|a|multidose|oxandrolone|given|, (r_appos) warfarin_0\NN\2718259|:|study (r_nsubj) resulted_24\VBD\2633881|warfarin|increase|:|detected|. (l_parataxis) detected_54\VBN\2163746|increases|were|also (l_nsubjpass) increases_46\NNS\13576355|similar|half-life (l_nmod) half-life_49\NN\15113229|in|r-warfarin|and|auc (l_compound) r-warfarin_48\NN\1740|
DDI-DrugBank.d584.s3.e2_DDI-DrugBank.d584.s3.e3 false warfarin_22\NN\2718259|with (r_nmod) treated_20\VBN\2376958|concurrently|warfarin (r_acl) subjects_18\NNS\6598915|in|15|healthy|treated (r_nmod) given_8\VBN\2327200|bid|subjects (r_acl) study_4\NN\635850|a|multidose|oxandrolone|given|, (r_appos) warfarin_0\NN\2718259|:|study (r_nsubj) resulted_24\VBD\2633881|warfarin|increase|:|detected|. (l_nmod) increase_28\NN\13576355|in|a|mean|half-life|ng*hr/ml (l_nmod) half-life_31\NN\15113229|in|s-warfarin|hours|and|auc (l_compound) s-warfarin_30\NN\1740|
DDI-DrugBank.d584.s3.e2_DDI-DrugBank.d584.s3.e4 false warfarin_22\NN\2718259|with (r_nmod) treated_20\VBN\2376958|concurrently|warfarin (r_acl) subjects_18\NNS\6598915|in|15|healthy|treated (r_nmod) given_8\VBN\2327200|bid|subjects (r_acl) study_4\NN\635850|a|multidose|oxandrolone|given|, (r_appos) warfarin_0\NN\2718259|:|study (r_nsubj) resulted_24\VBD\2633881|warfarin|increase|:|detected|. (l_parataxis) detected_54\VBN\2163746|increases|were|also (l_nsubjpass) increases_46\NNS\13576355|similar|half-life (l_nmod) half-life_49\NN\15113229|in|r-warfarin|and|auc (l_compound) r-warfarin_48\NN\1740|
DDI-DrugBank.d584.s3.e3_DDI-DrugBank.d584.s3.e4 false s-warfarin_30\NN\1740| (r_compound) half-life_31\NN\15113229|in|s-warfarin|hours|and|auc (r_nmod) increase_28\NN\13576355|in|a|mean|half-life|ng*hr/ml (r_nmod) resulted_24\VBD\2633881|warfarin|increase|:|detected|. (l_parataxis) detected_54\VBN\2163746|increases|were|also (l_nsubjpass) increases_46\NNS\13576355|similar|half-life (l_nmod) half-life_49\NN\15113229|in|r-warfarin|and|auc (l_compound) r-warfarin_48\NN\1740|
DDI-DrugBank.d597.s10
DDI-DrugBank.d572.s34
DDI-DrugBank.d578.s11
DDI-DrugBank.d578.s11.e0_DDI-DrugBank.d578.s11.e1 true anticoagulant_11\NN\3740161|of (r_nmod) effects_9\NNS\13245626|of|enhanced|diminished|anticoagulant (r_nmod) reports_2\NNS\6470073|effects|given (l_advcl) given_13\VBN\2327200|when|corticosteroids (l_nmod) corticosteroids_16\NNS\14745635|concurrently|with
DDI-DrugBank.d752.s9
DDI-DrugBank.d752.s9.e1_DDI-DrugBank.d752.s9.e0 false methylphenidate_27\NN\4320126|of (r_nmod) effects_22\NNS\13245626|due|both|the|gastrointestinal|and|effects|methylphenidate (r_nmod) absorption_13\NN\13558490|of|decreased|sedatives|effects (l_nmod) sedatives_16\NNS\3248958|of|the
DDI-DrugBank.d776.s32
DDI-DrugBank.d776.s32.e0_DDI-DrugBank.d776.s32.e1 true rifabutin_2\NN\1740|and|fluconazole (l_conj) fluconazole_4\NN\1740|
DDI-DrugBank.d779.s9
DDI-DrugBank.d779.s9.e0_DDI-DrugBank.d779.s9.e1 true methyldopa_2\NN\2721160|of (r_nmod) coadministration_0\NN\1740|methyldopa|sulfate (l_nmod) sulfate_5\NN\15010703|with|ferrous|or|gluconate
DDI-DrugBank.d779.s9.e0_DDI-DrugBank.d779.s9.e2 true methyldopa_2\NN\2721160|of (r_nmod) coadministration_0\NN\1740|methyldopa|sulfate (l_nmod) sulfate_5\NN\15010703|with|ferrous|or|gluconate (l_conj) gluconate_8\NN\1740|ferrous
DDI-DrugBank.d779.s9.e1_DDI-DrugBank.d779.s9.e2 false sulfate_5\NN\15010703|with|ferrous|or|gluconate (l_conj) gluconate_8\NN\1740|ferrous
DDI-DrugBank.d648.s4
DDI-DrugBank.d690.s3
DDI-DrugBank.d690.s3.e0_DDI-DrugBank.d690.s3.e3 false propoxyphene_6\NN\2707683| (r_nsubjpass) administered_8\VBN\2436349|when|propoxyphene|was|patients|antidepressants (l_nmod) antidepressants_12\NNS\3740161|on|,|anticonvulsants|,|or|drugs (l_conj) drugs_18\NNS\14778436|warfarin-like (l_amod) warfarin-like_17\JJ\1740|
DDI-DrugBank.d690.s3.e0_DDI-DrugBank.d690.s3.e1 false propoxyphene_6\NN\2707683| (r_nsubjpass) administered_8\VBN\2436349|when|propoxyphene|was|patients|antidepressants (l_nmod) antidepressants_12\NNS\3740161|on|,|anticonvulsants|,|or|drugs
DDI-DrugBank.d690.s3.e0_DDI-DrugBank.d690.s3.e2 false propoxyphene_6\NN\2707683| (r_nsubjpass) administered_8\VBN\2436349|when|propoxyphene|was|patients|antidepressants (l_nmod) antidepressants_12\NNS\3740161|on|,|anticonvulsants|,|or|drugs (l_conj) anticonvulsants_14\NNS\3740161|
DDI-DrugBank.d690.s3.e3_DDI-DrugBank.d690.s3.e1 false warfarin-like_17\JJ\1740| (r_amod) drugs_18\NNS\14778436|warfarin-like (r_conj) antidepressants_12\NNS\3740161|on|,|anticonvulsants|,|or|drugs
DDI-DrugBank.d690.s3.e3_DDI-DrugBank.d690.s3.e2 false warfarin-like_17\JJ\1740| (r_amod) drugs_18\NNS\14778436|warfarin-like (r_conj) antidepressants_12\NNS\3740161|on|,|anticonvulsants|,|or|drugs (l_conj) anticonvulsants_14\NNS\3740161|
DDI-DrugBank.d690.s3.e1_DDI-DrugBank.d690.s3.e2 false antidepressants_12\NNS\3740161|on|,|anticonvulsants|,|or|drugs (l_conj) anticonvulsants_14\NNS\3740161|
DDI-DrugBank.d678.s2
DDI-DrugBank.d636.s0
DDI-DrugBank.d636.s0.e1_DDI-DrugBank.d636.s0.e0 false mephenytoin_5\NN\2718469|with (r_nmod) interact_3\VB\2367363|anticonvulsants|may|mephenytoin|. (l_nsubj) anticonvulsants_1\NNS\3740161|some
DDI-DrugBank.d777.s3
DDI-DrugBank.d777.s3.e1_DDI-DrugBank.d777.s3.e0 false streptokinase_18\NN\14732946|with (r_nmod) administered_16\VBN\2436349|treatment|,|aspirin|,|contraindicated|should|be|streptokinase|see|. (l_nsubjpass) aspirin_7\NN\2707683|
DDI-DrugBank.d634.s5
DDI-DrugBank.d634.s5.e0_DDI-DrugBank.d634.s5.e1 false theophylline_0\NN\2905612|: (r_dep) decrease_5\VB\169651|theophylline|clearance|may|become|; (l_nsubj) clearance_3\NN\5089947|theophylline (l_compound) theophylline_2\NN\2905612|
DDI-DrugBank.d634.s5.e0_DDI-DrugBank.d634.s5.e2 false theophylline_0\NN\2905612|: (r_dep) decrease_5\VB\169651|theophylline|clearance|may|become|; (l_advcl) become_14\VBP\146138|when|patients|euthyroid (l_nsubj) patients_8\NNS\9898892|hyperthyroid|regimen (l_nmod) regimen_13\NN\5898568|on|a|stable|theophylline (l_compound) theophylline_12\NN\2905612|
DDI-DrugBank.d634.s5.e1_DDI-DrugBank.d634.s5.e2 false theophylline_2\NN\2905612| (r_compound) clearance_3\NN\5089947|theophylline (r_nsubj) decrease_5\VB\169651|theophylline|clearance|may|become|; (l_advcl) become_14\VBP\146138|when|patients|euthyroid (l_nsubj) patients_8\NNS\9898892|hyperthyroid|regimen (l_nmod) regimen_13\NN\5898568|on|a|stable|theophylline (l_compound) theophylline_12\NN\2905612|
DDI-DrugBank.d629.s1
DDI-DrugBank.d629.s1.e1_DDI-DrugBank.d629.s1.e2 false metronidazole_10\NN\2723292| (r_compound) gel_11\NN\14588219|(|metronidazole (r_appos) metrogel_8\NN\1740|gel|)|,|% (r_nsubjpass) prescribed_17\VBN\748282|when|metrogel|is|patients|,|likely (l_advcl) likely_30\JJ\1740|although|they|are|less|occur|absorption (l_xcomp) occur_32\VB\2623529|to|administration (l_nmod) administration_36\NN\1133281|with|topical|metronidazole (l_compound) metronidazole_35\NN\2723292|
DDI-DrugBank.d629.s1.e1_DDI-DrugBank.d629.s1.e0 false metronidazole_10\NN\2723292| (r_compound) gel_11\NN\14588219|(|metronidazole (r_appos) metrogel_8\NN\1740|gel|)|,|%
DDI-DrugBank.d629.s1.e2_DDI-DrugBank.d629.s1.e0 false metronidazole_35\NN\2723292| (r_compound) administration_36\NN\1133281|with|topical|metronidazole (r_nmod) occur_32\VB\2623529|to|administration (r_xcomp) likely_30\JJ\1740|although|they|are|less|occur|absorption (r_advcl) prescribed_17\VBN\748282|when|metrogel|is|patients|,|likely (l_nsubjpass) metrogel_8\NN\1740|gel|)|,|%
DDI-DrugBank.d779.s4
DDI-DrugBank.d636.s1
DDI-DrugBank.d645.s3
DDI-DrugBank.d645.s3.e0_DDI-DrugBank.d645.s3.e1 false terbinafine_12\NN\2720201| (r_nsubj) affect_15\VB\126264|that|terbinafine|does|not|clearance (l_dobj) clearance_17\NN\5089947|the|antipyrine (l_nmod) antipyrine_19\NN\1740|of|or|digoxin
DDI-DrugBank.d645.s3.e0_DDI-DrugBank.d645.s3.e2 false terbinafine_12\NN\2720201| (r_nsubj) affect_15\VB\126264|that|terbinafine|does|not|clearance (l_dobj) clearance_17\NN\5089947|the|antipyrine (l_nmod) antipyrine_19\NN\1740|of|or|digoxin (l_conj) digoxin_21\NN\15060131|
DDI-DrugBank.d645.s3.e1_DDI-DrugBank.d645.s3.e2 false antipyrine_19\NN\1740|of|or|digoxin (l_conj) digoxin_21\NN\15060131|
DDI-DrugBank.d588.s1
DDI-DrugBank.d588.s1.e1_DDI-DrugBank.d588.s1.e0 false mykrox_4\NNP\1740| (r_compound) tablets_5\NNS\4233405|mykrox (r_nsubjpass) used_7\VBN\1156834|when|tablets|are|drugs (r_advcl) taken_16\VBN\2367363|antihypertensives|:|used|,|care|must|be|,|therapy|. (l_dep) antihypertensives_1\NNS\3740161|other
DDI-DrugBank.d588.s1.e1_DDI-DrugBank.d588.s1.e2 true mykrox_4\NNP\1740| (r_compound) tablets_5\NNS\4233405|mykrox (r_nsubjpass) used_7\VBN\1156834|when|tablets|are|drugs (l_nmod) drugs_11\NNS\14778436|with|other|antihypertensive
DDI-DrugBank.d588.s1.e0_DDI-DrugBank.d588.s1.e2 false antihypertensives_1\NNS\3740161|other (r_dep) taken_16\VBN\2367363|antihypertensives|:|used|,|care|must|be|,|therapy|. (l_advcl) used_7\VBN\1156834|when|tablets|are|drugs (l_nmod) drugs_11\NNS\14778436|with|other|antihypertensive
DDI-DrugBank.d784.s3
DDI-DrugBank.d784.s3.e0_DDI-DrugBank.d784.s3.e2 false chloride_2\NN\14818238|oxybutynin (r_compound) concentrations_4\NNS\4916342|mean|chloride|plasma (r_nsubj) higher_9\JJR\1740|concentrations|were|fold|administered|. (l_advcl) administered_14\VBN\2436349|when|xl|was|ketoconazole (l_nmod) ketoconazole_16\NN\1740|with|,|inhibitor
DDI-DrugBank.d784.s3.e0_DDI-DrugBank.d784.s3.e1 false chloride_2\NN\14818238|oxybutynin (r_compound) concentrations_4\NNS\4916342|mean|chloride|plasma (r_nsubj) higher_9\JJR\1740|concentrations|were|fold|administered|. (l_advcl) administered_14\VBN\2436349|when|xl|was|ketoconazole (l_nsubjpass) xl_12\NNP\13745420|ditropan
DDI-DrugBank.d784.s3.e2_DDI-DrugBank.d784.s3.e1 false ketoconazole_16\NN\1740|with|,|inhibitor (r_nmod) administered_14\VBN\2436349|when|xl|was|ketoconazole (l_nsubjpass) xl_12\NNP\13745420|ditropan
DDI-DrugBank.d578.s9
DDI-DrugBank.d578.s9.e0_DDI-DrugBank.d578.s9.e1 true aspirin_0\NN\2707683| (r_nsubjpass) used_3\VBN\1156834|aspirin|should|be|cautiously|conjunction|patients|. (l_nmod) conjunction_6\NN\5048123|in|corticosteroids (l_nmod) corticosteroids_8\NNS\14745635|with
DDI-DrugBank.d743.s7
DDI-DrugBank.d743.s7.e0_DDI-DrugBank.d743.s7.e1 true itraconazole_3\NN\2720201|of|and|terfenadine (l_conj) terfenadine_5\NN\1740|
DDI-DrugBank.d779.s8
DDI-DrugBank.d713.s1
DDI-DrugBank.d590.s1
DDI-DrugBank.d590.s1.e0_DDI-DrugBank.d590.s1.e1 false aspirin_2\NN\2707683|with (r_nmod) coadministration_0\NN\1740|aspirin (r_nsubj) results_3\VBZ\2633881|coadministration|decrease|. (l_nmod) decrease_7\NN\7296428|in|a|slight|rate|unimportant (l_nmod) rate_10\NN\13815152|in|the|absorption (l_nmod) absorption_13\NN\13558490|of|salicylate (l_compound) salicylate_12\NN\3828465|
DDI-DrugBank.d598.s1
DDI-DrugBank.d598.s1.e0_DDI-DrugBank.d598.s1.e1 true trimethoprim_0\NN\1740|,|given|, (r_nsubj) increased_9\VBD\169651|trimethoprim|half-life|%|and|decreased|. (l_dobj) half-life_12\NN\15113229|the|phenytoin (l_compound) phenytoin_11\NN\3550533|
DDI-DrugBank.d598.s1.e0_DDI-DrugBank.d598.s1.e2 true trimethoprim_0\NN\1740|,|given|, (r_nsubj) increased_9\VBD\169651|trimethoprim|half-life|%|and|decreased|. (l_conj) decreased_17\VBD\169651|rate|% (l_dobj) rate_22\NN\13815152|the|phenytoin|metabolic|clearance (l_compound) phenytoin_19\NN\3550533|
DDI-DrugBank.d598.s1.e1_DDI-DrugBank.d598.s1.e2 false phenytoin_11\NN\3550533| (r_compound) half-life_12\NN\15113229|the|phenytoin (r_dobj) increased_9\VBD\169651|trimethoprim|half-life|%|and|decreased|. (l_conj) decreased_17\VBD\169651|rate|% (l_dobj) rate_22\NN\13815152|the|phenytoin|metabolic|clearance (l_compound) phenytoin_19\NN\3550533|
DDI-DrugBank.d575.s3
DDI-DrugBank.d575.s3.e0_DDI-DrugBank.d575.s3.e1 false teniposide_9\NN\1740|of (r_nmod) kinetics_7\NNS\6100236|in|the|plasma|teniposide (r_nmod) was_1\VBD\836236|there|change|kinetics|coadministered|. (l_advcl) coadministered_11\VBN\1740|when|methotrexate (l_nmod) methotrexate_13\NN\2722166|with
DDI-DrugBank.d781.s15
DDI-DrugBank.d781.s15.e1_DDI-DrugBank.d781.s15.e0 false perindopril_17\NN\1740| (r_compound) absorption_18\NN\13558490|of|perindopril (r_nmod) rate_13\NN\13815152|the|or|extent|absorption (r_dobj) lower_11\VB\1850315|:|administration|does|not|significantly|rate|relative|. (l_nsubj) administration_2\NN\1133281|oral|tablets|food (l_nmod) tablets_5\NNS\4233405|of|aceon (l_compound) aceon_4\NN\1740|
DDI-DrugBank.d781.s3
DDI-DrugBank.d781.s3.e0_DDI-DrugBank.d781.s3.e1 false perindopril_5\NN\1740| (r_compound) absorption_6\NN\13558490|of|perindopril|and|elimination (r_nmod) rate_1\NN\13815152|the|and|extent|absorption (r_nsubjpass) affected_11\VBN\126264|rate|are|not|diuretics|. (l_nmod) diuretics_14\NNS\3247620|by|concomitant
DDI-DrugBank.d716.s1
DDI-DrugBank.d716.s1.e0_DDI-DrugBank.d716.s1.e1 true insulin_2\NN\5407119|in|and|therapies (r_nmod) changes_0\NNS\7283608|insulin (r_nsubj) necessary_10\JJ\1740|changes|may|be|treatment|. (l_nmod) treatment_12\NN\654885|during|mazindol (l_nmod) mazindol_14\NN\1740|with
DDI-DrugBank.d640.s1
DDI-DrugBank.d640.s1.e0_DDI-DrugBank.d640.s1.e1 false univasc_6\NNP\1740|with (r_nmod) effects_4\NNS\13245626|of|hypotensive|univasc (r_nmod) possibility_1\NN\5944958|the|effects (r_nsubjpass) minimized_9\VBN\441445|possibility|can|be|discontinuing (l_advcl) discontinuing_11\VBG\2609764|by|therapy|days|or|increasing (l_conj) increasing_19\VBG\169651|cautiously|intake|initiation (l_nmod) initiation_23\NN\7450842|before|treatment (l_nmod) treatment_25\NN\654885|of|univasc (l_nmod) univasc_27\NNP\1740|with
DDI-DrugBank.d726.s0
DDI-DrugBank.d584.s4
DDI-DrugBank.d659.s5
DDI-DrugBank.d739.s14
DDI-DrugBank.d610.s5
DDI-DrugBank.d694.s1
DDI-DrugBank.d769.s3
DDI-DrugBank.d611.s1
DDI-DrugBank.d611.s1.e0_DDI-DrugBank.d611.s1.e1 true agonists_2\NNS\9613191|beta|adrenergic (r_nsubjpass) administered_5\VBN\2436349|agonists|should|be|caution|patients|,|potentiated|. (l_nmod) patients_9\NNS\9898892|to|treated (l_acl) treated_11\VBN\2376958|being|inhibitors (l_nmod) inhibitors_15\NNS\20090|with|monoamine|oxidase|or|antidepressants
DDI-DrugBank.d611.s1.e0_DDI-DrugBank.d611.s1.e2 true agonists_2\NNS\9613191|beta|adrenergic (r_nsubjpass) administered_5\VBN\2436349|agonists|should|be|caution|patients|,|potentiated|. (l_nmod) patients_9\NNS\9898892|to|treated (l_acl) treated_11\VBN\2376958|being|inhibitors (l_nmod) inhibitors_15\NNS\20090|with|monoamine|oxidase|or|antidepressants (l_conj) antidepressants_18\NNS\3740161|tricyclic
DDI-DrugBank.d611.s1.e0_DDI-DrugBank.d611.s1.e3 false agonists_2\NNS\9613191|beta|adrenergic (r_nsubjpass) administered_5\VBN\2436349|agonists|should|be|caution|patients|,|potentiated|. (l_advcl) potentiated_33\VBN\229605|since|action|may|be (l_nsubjpass) action_22\NN\30358|the|agonists|system (l_nmod) agonists_26\NNS\9613191|of|beta|adrenergic
DDI-DrugBank.d611.s1.e1_DDI-DrugBank.d611.s1.e2 false inhibitors_15\NNS\20090|with|monoamine|oxidase|or|antidepressants (l_conj) antidepressants_18\NNS\3740161|tricyclic
DDI-DrugBank.d611.s1.e1_DDI-DrugBank.d611.s1.e3 false inhibitors_15\NNS\20090|with|monoamine|oxidase|or|antidepressants (r_nmod) treated_11\VBN\2376958|being|inhibitors (r_acl) patients_9\NNS\9898892|to|treated (r_nmod) administered_5\VBN\2436349|agonists|should|be|caution|patients|,|potentiated|. (l_advcl) potentiated_33\VBN\229605|since|action|may|be (l_nsubjpass) action_22\NN\30358|the|agonists|system (l_nmod) agonists_26\NNS\9613191|of|beta|adrenergic
DDI-DrugBank.d611.s1.e2_DDI-DrugBank.d611.s1.e3 false antidepressants_18\NNS\3740161|tricyclic (r_conj) inhibitors_15\NNS\20090|with|monoamine|oxidase|or|antidepressants (r_nmod) treated_11\VBN\2376958|being|inhibitors (r_acl) patients_9\NNS\9898892|to|treated (r_nmod) administered_5\VBN\2436349|agonists|should|be|caution|patients|,|potentiated|. (l_advcl) potentiated_33\VBN\229605|since|action|may|be (l_nsubjpass) action_22\NN\30358|the|agonists|system (l_nmod) agonists_26\NNS\9613191|of|beta|adrenergic
DDI-DrugBank.d775.s6
DDI-DrugBank.d741.s2
DDI-DrugBank.d596.s4
DDI-DrugBank.d596.s4.e0_DDI-DrugBank.d596.s4.e1 false warfarin_7\NN\2718259|by (r_nmod) induced_5\VBN\1627355|warfarin (r_acl) elevation_1\NN\7445480|the|time|induced (r_nsubjpass) affected_10\VBN\126264|elevation|is|not|administration|. (l_nmod) administration_12\NN\1133281|by|exelon (l_nmod) exelon_14\NN\1740|of
DDI-DrugBank.d633.s17
DDI-DrugBank.d700.s16
DDI-DrugBank.d700.s16.e0_DDI-DrugBank.d700.s16.e1 false mpag_2\NN\1740| (r_compound) hydrolysis_3\NN\13447361|of|mpag (r_nmod) interference_0\NN\6660942|hydrolysis (r_nsubj) lead_5\VB\1752884|interference|may|mpa|. (l_nmod) mpa_8\NN\1740|to|less|available
DDI-DrugBank.d737.s2
DDI-DrugBank.d737.s2.e0_DDI-DrugBank.d737.s2.e1 false selegiline_0\NN\1740| (r_dep) influence_13\VB\137313|selegiline|:|volunteers|,|selegiline|did|not|pharmacokinetics|. (l_nsubj) selegiline_10\NN\1740|
DDI-DrugBank.d737.s2.e0_DDI-DrugBank.d737.s2.e2 false selegiline_0\NN\1740| (r_dep) influence_13\VB\137313|selegiline|:|volunteers|,|selegiline|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_15\NNS\6054892|the|pramipexole (l_nmod) pramipexole_17\NN\1740|of
DDI-DrugBank.d737.s2.e1_DDI-DrugBank.d737.s2.e2 false selegiline_10\NN\1740| (r_nsubj) influence_13\VB\137313|selegiline|:|volunteers|,|selegiline|did|not|pharmacokinetics|. (l_dobj) pharmacokinetics_15\NNS\6054892|the|pramipexole (l_nmod) pramipexole_17\NN\1740|of
DDI-DrugBank.d678.s3
DDI-DrugBank.d585.s4
DDI-DrugBank.d659.s7
DDI-DrugBank.d756.s2
DDI-DrugBank.d756.s2.e0_DDI-DrugBank.d756.s2.e1 true levomepromazine_9\NN\1740| (r_nsubjpass) given_11\VBN\2327200|if|levomepromazine|is|benzodiazepines (l_nmod) benzodiazepines_13\NNS\3771443|with|or|barbiturates
DDI-DrugBank.d756.s2.e0_DDI-DrugBank.d756.s2.e2 true levomepromazine_9\NN\1740| (r_nsubjpass) given_11\VBN\2327200|if|levomepromazine|is|benzodiazepines (l_nmod) benzodiazepines_13\NNS\3771443|with|or|barbiturates (l_conj) barbiturates_15\NNS\4166841|
DDI-DrugBank.d756.s2.e1_DDI-DrugBank.d756.s2.e2 false benzodiazepines_13\NNS\3771443|with|or|barbiturates (l_conj) barbiturates_15\NNS\4166841|
DDI-DrugBank.d633.s20
DDI-DrugBank.d633.s20.e0_DDI-DrugBank.d633.s20.e1 true caffeine_17\NN\14712692|of (r_nmod) clearance_15\NN\5089947|the|caffeine (r_nsubjpass) decreased_19\VBN\169651|additionally|,|study|,|clearance|was|%|administration (l_nmod) administration_24\NN\1133281|following|the|mexitil (l_nmod) mexitil_26\NN\2715941|of
DDI-DrugBank.d619.s2
DDI-DrugBank.d619.s2.e0_DDI-DrugBank.d619.s2.e1 true meperidine_7\NN\3808564|of|and|maois (l_conj) maois_9\NNS\2718811|
DDI-DrugBank.d753.s5
DDI-DrugBank.d665.s4
DDI-DrugBank.d603.s5
DDI-DrugBank.d603.s5.e2_DDI-DrugBank.d603.s5.e3 false prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (l_conj) terazosin_8\NN\2698769|
DDI-DrugBank.d603.s5.e2_DDI-DrugBank.d603.s5.e4 false prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (l_conj) doxazosin_11\NN\2721160|
DDI-DrugBank.d603.s5.e2_DDI-DrugBank.d603.s5.e5 false prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (r_nmod) agents_2\NNS\7347|alpha-adrenergic|blocking|,|prazosin|, (r_nsubj) antagonize_14\VB\1787955|agents|can|effects|. (l_dobj) effects_16\NNS\13245626|the|proamatine (l_nmod) proamatine_18\NN\1740|of
DDI-DrugBank.d603.s5.e2_DDI-DrugBank.d603.s5.e1 false prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (r_nmod) agents_2\NNS\7347|alpha-adrenergic|blocking|,|prazosin|,
DDI-DrugBank.d603.s5.e3_DDI-DrugBank.d603.s5.e4 false terazosin_8\NN\2698769| (r_conj) prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (l_conj) doxazosin_11\NN\2721160|
DDI-DrugBank.d603.s5.e3_DDI-DrugBank.d603.s5.e5 false terazosin_8\NN\2698769| (r_conj) prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (r_nmod) agents_2\NNS\7347|alpha-adrenergic|blocking|,|prazosin|, (r_nsubj) antagonize_14\VB\1787955|agents|can|effects|. (l_dobj) effects_16\NNS\13245626|the|proamatine (l_nmod) proamatine_18\NN\1740|of
DDI-DrugBank.d603.s5.e3_DDI-DrugBank.d603.s5.e1 false terazosin_8\NN\2698769| (r_conj) prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (r_nmod) agents_2\NNS\7347|alpha-adrenergic|blocking|,|prazosin|,
DDI-DrugBank.d603.s5.e4_DDI-DrugBank.d603.s5.e5 false doxazosin_11\NN\2721160| (r_conj) prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (r_nmod) agents_2\NNS\7347|alpha-adrenergic|blocking|,|prazosin|, (r_nsubj) antagonize_14\VB\1787955|agents|can|effects|. (l_dobj) effects_16\NNS\13245626|the|proamatine (l_nmod) proamatine_18\NN\1740|of
DDI-DrugBank.d603.s5.e4_DDI-DrugBank.d603.s5.e1 false doxazosin_11\NN\2721160| (r_conj) prazosin_6\NN\2698769|such|,|terazosin|,|and|doxazosin (r_nmod) agents_2\NNS\7347|alpha-adrenergic|blocking|,|prazosin|,
DDI-DrugBank.d603.s5.e5_DDI-DrugBank.d603.s5.e1 false proamatine_18\NN\1740|of (r_nmod) effects_16\NNS\13245626|the|proamatine (r_dobj) antagonize_14\VB\1787955|agents|can|effects|. (l_nsubj) agents_2\NNS\7347|alpha-adrenergic|blocking|,|prazosin|,
DDI-DrugBank.d603.s5.e6_DDI-DrugBank.d603.s5.e7 false desglymidodrine_23\NN\1740|of|base (r_nmod) clearance_21\NN\5089947|the|high|renal|desglymidodrine (r_nsubj) due_29\JJ\1740|that|clearance|is|secretion (l_nmod) secretion_33\NN\13526110|to|active|tubular|system (l_nmod) system_37\NN\3575240|by|the|base-secreting|responsible (l_amod) responsible_39\JJ\1740|also|secretion (l_nmod) secretion_42\NN\13526110|for|the|drugs (l_nmod) drugs_45\NNS\14778436|of|such|metformin (l_nmod) metformin_47\NN\2719105|as|,|cimetidine|,|ranitidine|,|procainamide|,|triamterene|,|flecainide|,|and|quinidine
DDI-DrugBank.d603.s5.e6_DDI-DrugBank.d603.s5.e8 false desglymidodrine_23\NN\1740|of|base (r_nmod) clearance_21\NN\5089947|the|high|renal|desglymidodrine (r_nsubj) due_29\JJ\1740|that|clearance|is|secretion (l_nmod) secretion_33\NN\13526110|to|active|tubular|system (l_nmod) system_37\NN\3575240|by|the|base-secreting|responsible (l_amod) responsible_39\JJ\1740|also|secretion (l_nmod) secretion_42\NN\13526110|for|the|drugs (l_nmod) drugs_45\NNS\14778436|of|such|metformin (l_nmod) metformin_47\NN\2719105|as|,|cimetidine|,|ranitidine|,|procainamide|,|triamterene|,|flecainide|,|and|quinidine (l_conj) cimetidine_49\NN\14778019|
DDI-DrugBank.d603.s5.e6_DDI-DrugBank.d603.s5.e9 false desglymidodrine_23\NN\1740|of|base (r_nmod) clearance_21\NN\5089947|the|high|renal|desglymidodrine (r_nsubj) due_29\JJ\1740|that|clearance|is|secretion (l_nmod) secretion_33\NN\13526110|to|active|tubular|system (l_nmod) system_37\NN\3575240|by|the|base-secreting|responsible (l_amod) responsible_39\JJ\1740|also|secretion (l_nmod) secretion_42\NN\13526110|for|the|drugs (l_nmod) drugs_45\NNS\14778436|of|such|metformin (l_nmod) metformin_47\NN\2719105|as|,|cimetidine|,|ranitidine|,|procainamide|,|triamterene|,|flecainide|,|and|quinidine (l_conj) ranitidine_51\NN\14778019|
DDI-DrugBank.d603.s5.e7_DDI-DrugBank.d603.s5.e8 false metformin_47\NN\2719105|as|,|cimetidine|,|ranitidine|,|procainamide|,|triamterene|,|flecainide|,|and|quinidine (l_conj) cimetidine_49\NN\14778019|
DDI-DrugBank.d603.s5.e7_DDI-DrugBank.d603.s5.e9 false metformin_47\NN\2719105|as|,|cimetidine|,|ranitidine|,|procainamide|,|triamterene|,|flecainide|,|and|quinidine (l_conj) ranitidine_51\NN\14778019|
DDI-DrugBank.d603.s5.e8_DDI-DrugBank.d603.s5.e9 false cimetidine_49\NN\14778019| (r_conj) metformin_47\NN\2719105|as|,|cimetidine|,|ranitidine|,|procainamide|,|triamterene|,|flecainide|,|and|quinidine (l_conj) ranitidine_51\NN\14778019|
DDI-DrugBank.d590.s0
DDI-DrugBank.d590.s0.e1_DDI-DrugBank.d590.s0.e2 false clarithromycin_4\NN\1740|with (r_nmod) coadministration_0\NN\1740|tritec|clarithromycin (r_nsubj) resulted_5\VBD\2633881|coadministration|concentrations|. (l_nmod) concentrations_10\NNS\4916342|in|increased|plasma|ranitidine|%|,|concentrations|,|and|concentrations (l_compound) ranitidine_9\NN\14778019|
DDI-DrugBank.d590.s0.e1_DDI-DrugBank.d590.s0.e3 false clarithromycin_4\NN\1740|with (r_nmod) coadministration_0\NN\1740|tritec|clarithromycin (r_nsubj) resulted_5\VBD\2633881|coadministration|concentrations|. (l_nmod) concentrations_10\NNS\4916342|in|increased|plasma|ranitidine|%|,|concentrations|,|and|concentrations (l_conj) concentrations_32\NNS\4916342|increased|14-|hydroxy-|clarithromycin|plasma|% (l_compound) clarithromycin_30\NN\1740|
DDI-DrugBank.d590.s0.e1_DDI-DrugBank.d590.s0.e0 false clarithromycin_4\NN\1740|with (r_nmod) coadministration_0\NN\1740|tritec|clarithromycin (l_nmod) tritec_2\NNP\1740|of
DDI-DrugBank.d590.s0.e2_DDI-DrugBank.d590.s0.e3 false ranitidine_9\NN\14778019| (r_compound) concentrations_10\NNS\4916342|in|increased|plasma|ranitidine|%|,|concentrations|,|and|concentrations (l_conj) concentrations_32\NNS\4916342|increased|14-|hydroxy-|clarithromycin|plasma|% (l_compound) clarithromycin_30\NN\1740|
DDI-DrugBank.d590.s0.e2_DDI-DrugBank.d590.s0.e0 false ranitidine_9\NN\14778019| (r_compound) concentrations_10\NNS\4916342|in|increased|plasma|ranitidine|%|,|concentrations|,|and|concentrations (r_nmod) resulted_5\VBD\2633881|coadministration|concentrations|. (l_nsubj) coadministration_0\NN\1740|tritec|clarithromycin (l_nmod) tritec_2\NNP\1740|of
DDI-DrugBank.d590.s0.e3_DDI-DrugBank.d590.s0.e0 false clarithromycin_30\NN\1740| (r_compound) concentrations_32\NNS\4916342|increased|14-|hydroxy-|clarithromycin|plasma|% (r_conj) concentrations_10\NNS\4916342|in|increased|plasma|ranitidine|%|,|concentrations|,|and|concentrations (r_nmod) resulted_5\VBD\2633881|coadministration|concentrations|. (l_nsubj) coadministration_0\NN\1740|tritec|clarithromycin (l_nmod) tritec_2\NNP\1740|of
DDI-DrugBank.d588.s5
DDI-DrugBank.d634.s1
DDI-DrugBank.d776.s12
DDI-DrugBank.d784.s5
DDI-DrugBank.d572.s27
DDI-DrugBank.d572.s27.e2_DDI-DrugBank.d572.s27.e0 false inhibitor_28\NN\20090|for|the|hmg-coa|reductase (r_nmod) labeling_23\NN\1740|package|inhibitor (r_conj) refer_16\VB\730052|administered|,|category|and|labeling|. (l_advcl) administered_3\VBN\2436349|when|zetia|is|inhibitor|woman (l_nsubjpass) zetia_1\NN\1740|
DDI-DrugBank.d572.s27.e2_DDI-DrugBank.d572.s27.e1 false inhibitor_28\NN\20090|for|the|hmg-coa|reductase (r_nmod) labeling_23\NN\1740|package|inhibitor (r_conj) refer_16\VB\730052|administered|,|category|and|labeling|. (l_advcl) administered_3\VBN\2436349|when|zetia|is|inhibitor|woman (l_nmod) inhibitor_8\NN\20090|with|an|reductase
DDI-DrugBank.d572.s27.e0_DDI-DrugBank.d572.s27.e1 false zetia_1\NN\1740| (r_nsubjpass) administered_3\VBN\2436349|when|zetia|is|inhibitor|woman (l_nmod) inhibitor_8\NN\20090|with|an|reductase
DDI-DrugBank.d780.s7
DDI-DrugBank.d780.s7.e1_DDI-DrugBank.d780.s7.e0 false hydrochloride_6\NN\14817592|of|procaine|and|sulfonamides (r_nmod) use_3\NN\407535|concurrent|hydrochloride (r_nsubj) result_10\VB\2633881|sulfonamides|:|use|may|reduction|. (l_dep) sulfonamides_0\NNS\2716205|
DDI-DrugBank.d780.s7.e1_DDI-DrugBank.d780.s7.e2 true hydrochloride_6\NN\14817592|of|procaine|and|sulfonamides (l_conj) sulfonamides_8\NNS\2716205|
DDI-DrugBank.d780.s7.e1_DDI-DrugBank.d780.s7.e3 false hydrochloride_6\NN\14817592|of|procaine|and|sulfonamides (r_nmod) use_3\NN\407535|concurrent|hydrochloride (r_nsubj) result_10\VB\2633881|sulfonamides|:|use|may|reduction|. (l_nmod) reduction_13\NN\351485|in|a|action (l_nmod) action_17\NN\30358|of|the|antibacterial|sulfonamide (l_nmod) sulfonamide_20\NN\2716205|of|the
DDI-DrugBank.d780.s7.e0_DDI-DrugBank.d780.s7.e2 false sulfonamides_0\NNS\2716205| (r_dep) result_10\VB\2633881|sulfonamides|:|use|may|reduction|. (l_nsubj) use_3\NN\407535|concurrent|hydrochloride (l_nmod) hydrochloride_6\NN\14817592|of|procaine|and|sulfonamides (l_conj) sulfonamides_8\NNS\2716205|
DDI-DrugBank.d780.s7.e0_DDI-DrugBank.d780.s7.e3 false sulfonamides_0\NNS\2716205| (r_dep) result_10\VB\2633881|sulfonamides|:|use|may|reduction|. (l_nmod) reduction_13\NN\351485|in|a|action (l_nmod) action_17\NN\30358|of|the|antibacterial|sulfonamide (l_nmod) sulfonamide_20\NN\2716205|of|the
DDI-DrugBank.d780.s7.e2_DDI-DrugBank.d780.s7.e3 false sulfonamides_8\NNS\2716205| (r_conj) hydrochloride_6\NN\14817592|of|procaine|and|sulfonamides (r_nmod) use_3\NN\407535|concurrent|hydrochloride (r_nsubj) result_10\VB\2633881|sulfonamides|:|use|may|reduction|. (l_nmod) reduction_13\NN\351485|in|a|action (l_nmod) action_17\NN\30358|of|the|antibacterial|sulfonamide (l_nmod) sulfonamide_20\NN\2716205|of|the
DDI-DrugBank.d578.s8
DDI-DrugBank.d578.s8.e2_DDI-DrugBank.d578.s8.e0 false methylprednisolone_16\NN\1740| (r_nsubjpass) withdrawn_18\VBN\1835496|when|methylprednisolone|is (r_advcl) increase_9\VB\169651|risk|withdrawn (r_conj) lead_2\VB\1752884|this|could|levels|or|increase|. (l_nmod) levels_7\NNS\4916342|to|decreased|salicylate|serum (l_compound) salicylate_5\NN\3828465|
DDI-DrugBank.d578.s8.e2_DDI-DrugBank.d578.s8.e1 false methylprednisolone_16\NN\1740| (r_nsubjpass) withdrawn_18\VBN\1835496|when|methylprednisolone|is (r_advcl) increase_9\VB\169651|risk|withdrawn (l_dobj) risk_11\NN\14541044|the|toxicity (l_nmod) toxicity_14\NN\13576101|of|salicylate (l_compound) salicylate_13\NN\3828465|
DDI-DrugBank.d578.s8.e0_DDI-DrugBank.d578.s8.e1 false salicylate_5\NN\3828465| (r_compound) levels_7\NNS\4916342|to|decreased|salicylate|serum (r_nmod) lead_2\VB\1752884|this|could|levels|or|increase|. (l_conj) increase_9\VB\169651|risk|withdrawn (l_dobj) risk_11\NN\14541044|the|toxicity (l_nmod) toxicity_14\NN\13576101|of|salicylate (l_compound) salicylate_13\NN\3828465|
DDI-DrugBank.d773.s4
DDI-DrugBank.d726.s1
DDI-DrugBank.d726.s1.e0_DDI-DrugBank.d726.s1.e1 true ketoconazole_8\NN\1740| (r_nsubj) doubled_10\VBD\247390|that|ketoconazole|approximately|auc0- (l_dobj) auc0-_12\NN\1740|paricalcitol (l_compound) paricalcitol_11\NNP\1740|
DDI-DrugBank.d726.s1.e2_DDI-DrugBank.d726.s1.e3 false paricalcitol_1\NN\1740| (r_nsubjpass) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (l_conj) known_11\VBN\2110220|le|is|inhibitor (l_nsubjpass) le_9\NN\14187378|ketoconazole (l_compound) ketoconazole_8\NN\1740|
DDI-DrugBank.d726.s1.e2_DDI-DrugBank.d726.s1.e4 false paricalcitol_1\NN\1740| (r_nsubjpass) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_dobj) paricalcitol_29\NN\1740|
DDI-DrugBank.d726.s1.e2_DDI-DrugBank.d726.s1.e5 false paricalcitol_1\NN\1740| (r_nsubjpass) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors
DDI-DrugBank.d726.s1.e2_DDI-DrugBank.d726.s1.e6 false paricalcitol_1\NN\1740| (r_nsubjpass) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole
DDI-DrugBank.d726.s1.e2_DDI-DrugBank.d726.s1.e7 false paricalcitol_1\NN\1740| (r_nsubjpass) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) clarithromycin_41\NN\1740|
DDI-DrugBank.d726.s1.e2_DDI-DrugBank.d726.s1.e8 false paricalcitol_1\NN\1740| (r_nsubjpass) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) indinavir_43\NN\4013993|
DDI-DrugBank.d726.s1.e2_DDI-DrugBank.d726.s1.e9 false paricalcitol_1\NN\1740| (r_nsubjpass) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) itraconazole_45\NN\2720201|
DDI-DrugBank.d726.s1.e3_DDI-DrugBank.d726.s1.e4 false ketoconazole_8\NN\1740| (r_compound) le_9\NN\14187378|ketoconazole (r_nsubjpass) known_11\VBN\2110220|le|is|inhibitor (r_conj) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_dobj) paricalcitol_29\NN\1740|
DDI-DrugBank.d726.s1.e3_DDI-DrugBank.d726.s1.e5 false ketoconazole_8\NN\1740| (r_compound) le_9\NN\14187378|ketoconazole (r_nsubjpass) known_11\VBN\2110220|le|is|inhibitor (r_conj) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors
DDI-DrugBank.d726.s1.e3_DDI-DrugBank.d726.s1.e6 false ketoconazole_8\NN\1740| (r_compound) le_9\NN\14187378|ketoconazole (r_nsubjpass) known_11\VBN\2110220|le|is|inhibitor (r_conj) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole
DDI-DrugBank.d726.s1.e3_DDI-DrugBank.d726.s1.e7 false ketoconazole_8\NN\1740| (r_compound) le_9\NN\14187378|ketoconazole (r_nsubjpass) known_11\VBN\2110220|le|is|inhibitor (r_conj) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) clarithromycin_41\NN\1740|
DDI-DrugBank.d726.s1.e3_DDI-DrugBank.d726.s1.e8 false ketoconazole_8\NN\1740| (r_compound) le_9\NN\14187378|ketoconazole (r_nsubjpass) known_11\VBN\2110220|le|is|inhibitor (r_conj) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) indinavir_43\NN\4013993|
DDI-DrugBank.d726.s1.e3_DDI-DrugBank.d726.s1.e9 false ketoconazole_8\NN\1740| (r_compound) le_9\NN\14187378|ketoconazole (r_nsubjpass) known_11\VBN\2110220|le|is|inhibitor (r_conj) metabolized_4\VBN\1740|since|paricalcitol|is|partially|cyp3a|and|known (r_advcl) taken_26\VBN\2367363|metabolized|,|care|should|be|dosing|. (l_advcl) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) itraconazole_45\NN\2720201|
DDI-DrugBank.d726.s1.e4_DDI-DrugBank.d726.s1.e5 false paricalcitol_29\NN\1740| (r_dobj) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors
DDI-DrugBank.d726.s1.e4_DDI-DrugBank.d726.s1.e6 false paricalcitol_29\NN\1740| (r_dobj) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole
DDI-DrugBank.d726.s1.e4_DDI-DrugBank.d726.s1.e7 false paricalcitol_29\NN\1740| (r_dobj) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) clarithromycin_41\NN\1740|
DDI-DrugBank.d726.s1.e4_DDI-DrugBank.d726.s1.e8 false paricalcitol_29\NN\1740| (r_dobj) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) indinavir_43\NN\4013993|
DDI-DrugBank.d726.s1.e4_DDI-DrugBank.d726.s1.e9 false paricalcitol_29\NN\1740| (r_dobj) dosing_28\VBG\515154|while|paricalcitol|ketoconazole (l_nmod) ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) itraconazole_45\NN\2720201|
DDI-DrugBank.d726.s1.e5_DDI-DrugBank.d726.s1.e6 false ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole
DDI-DrugBank.d726.s1.e5_DDI-DrugBank.d726.s1.e7 false ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) clarithromycin_41\NN\1740|
DDI-DrugBank.d726.s1.e5_DDI-DrugBank.d726.s1.e8 false ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) indinavir_43\NN\4013993|
DDI-DrugBank.d726.s1.e5_DDI-DrugBank.d726.s1.e9 false ketoconazole_31\NN\1740|with|and|inhibitors (l_conj) inhibitors_37\NNS\20090|other|strong|p450|3a|atazanavir (l_nmod) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) itraconazole_45\NN\2720201|
DDI-DrugBank.d726.s1.e6_DDI-DrugBank.d726.s1.e7 false atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) clarithromycin_41\NN\1740|
DDI-DrugBank.d726.s1.e6_DDI-DrugBank.d726.s1.e8 false atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) indinavir_43\NN\4013993|
DDI-DrugBank.d726.s1.e6_DDI-DrugBank.d726.s1.e9 false atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) itraconazole_45\NN\2720201|
DDI-DrugBank.d726.s1.e7_DDI-DrugBank.d726.s1.e8 false clarithromycin_41\NN\1740| (r_conj) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) indinavir_43\NN\4013993|
DDI-DrugBank.d726.s1.e7_DDI-DrugBank.d726.s1.e9 false clarithromycin_41\NN\1740| (r_conj) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) itraconazole_45\NN\2720201|
DDI-DrugBank.d726.s1.e8_DDI-DrugBank.d726.s1.e9 false indinavir_43\NN\4013993| (r_conj) atazanavir_39\NN\1740|including|,|clarithromycin|,|indinavir|,|itraconazole|,|nefazodone|,|nelfinavir|,|ritonavir|,|saquinavir|,|telithromycin|or|voriconazole (l_conj) itraconazole_45\NN\2720201|
DDI-DrugBank.d689.s0
DDI-DrugBank.d689.s0.e1_DDI-DrugBank.d689.s0.e2 true metaraminol_3\NN\1740|particularly (r_appos) vasopressors_0\NNS\4522421|,|metaraminol|, (r_nsubj) cause_6\VB\1617192|vasopressors|may|arrhythmias|anesthesia|and|used|. (l_nmod) anesthesia_12\NN\14034177|during|halothane (l_compound) halothane_11\NN\3570838|
DDI-DrugBank.d689.s0.e1_DDI-DrugBank.d689.s0.e0 false metaraminol_3\NN\1740|particularly (r_appos) vasopressors_0\NNS\4522421|,|metaraminol|,
DDI-DrugBank.d689.s0.e2_DDI-DrugBank.d689.s0.e0 false halothane_11\NN\3570838| (r_compound) anesthesia_12\NN\14034177|during|halothane (r_nmod) cause_6\VB\1617192|vasopressors|may|arrhythmias|anesthesia|and|used|. (l_nsubj) vasopressors_0\NNS\4522421|,|metaraminol|,
DDI-DrugBank.d742.s4
DDI-DrugBank.d737.s1
DDI-DrugBank.d642.s2
DDI-DrugBank.d742.s9
DDI-DrugBank.d742.s9.e0_DDI-DrugBank.d742.s9.e1 true alcohol_8\NN\7881800| (r_dobj) avoid_7\VB\2452885|to|alcohol|taking (l_advcl) taking_10\VBG\2367363|while|soltab (l_dobj) soltab_12\NNP\1740|remeron
DDI-DrugBank.d742.s9.e2_DDI-DrugBank.d742.s9.e3 false diazepam_0\NN\2830852| (r_nsubj) had_10\VBD\2108377|diazepam|:|administration|effect|levels|. (l_nsubj) administration_3\NN\1133281|concomitant|diazepam (l_nmod) diazepam_5\NN\2830852|of|mg
DDI-DrugBank.d742.s9.e2_DDI-DrugBank.d742.s9.e4 false diazepam_0\NN\2830852| (r_nsubj) had_10\VBD\2108377|diazepam|:|administration|effect|levels|. (l_nmod) levels_16\NNS\4916342|on|plasma|mirtazapine|subjects (l_nmod) mirtazapine_18\NN\1740|of|mg
DDI-DrugBank.d742.s9.e3_DDI-DrugBank.d742.s9.e4 true diazepam_5\NN\2830852|of|mg (r_nmod) administration_3\NN\1133281|concomitant|diazepam (r_nsubj) had_10\VBD\2108377|diazepam|:|administration|effect|levels|. (l_nmod) levels_16\NNS\4916342|on|plasma|mirtazapine|subjects (l_nmod) mirtazapine_18\NN\1740|of|mg
DDI-DrugBank.d677.s1
DDI-DrugBank.d677.s1.e0_DDI-DrugBank.d677.s1.e1 false atropine_3\NN\14712692|and|phosphorous (r_compound) insecticides_6\NNS\14980215|as|atropine|.
DDI-DrugBank.d713.s4
DDI-DrugBank.d624.s3
DDI-DrugBank.d624.s3.e1_DDI-DrugBank.d624.s3.e2 false acid_8\NN\14818238|with|ethacrynic|,|furosemide (l_conj) furosemide_10\NN\3214670|,|urea
DDI-DrugBank.d624.s3.e1_DDI-DrugBank.d624.s3.e3 false acid_8\NN\14818238|with|ethacrynic|,|furosemide (l_conj) furosemide_10\NN\3214670|,|urea (l_conj) urea_12\NN\14727670|,|or|mannitol
DDI-DrugBank.d624.s3.e1_DDI-DrugBank.d624.s3.e4 false acid_8\NN\14818238|with|ethacrynic|,|furosemide (l_conj) furosemide_10\NN\3214670|,|urea (l_conj) urea_12\NN\14727670|,|or|mannitol (l_conj) mannitol_15\NN\3214670|
DDI-DrugBank.d624.s3.e1_DDI-DrugBank.d624.s3.e0 false acid_8\NN\14818238|with|ethacrynic|,|furosemide (r_nmod) administered_4\VBN\2436349|tobi|should|not|be|concomitantly|acid|. (l_nsubjpass) tobi_0\NN\1740|
DDI-DrugBank.d624.s3.e2_DDI-DrugBank.d624.s3.e3 false furosemide_10\NN\3214670|,|urea (l_conj) urea_12\NN\14727670|,|or|mannitol
DDI-DrugBank.d624.s3.e2_DDI-DrugBank.d624.s3.e4 false furosemide_10\NN\3214670|,|urea (l_conj) urea_12\NN\14727670|,|or|mannitol (l_conj) mannitol_15\NN\3214670|
DDI-DrugBank.d624.s3.e2_DDI-DrugBank.d624.s3.e0 false furosemide_10\NN\3214670|,|urea (r_conj) acid_8\NN\14818238|with|ethacrynic|,|furosemide (r_nmod) administered_4\VBN\2436349|tobi|should|not|be|concomitantly|acid|. (l_nsubjpass) tobi_0\NN\1740|
DDI-DrugBank.d624.s3.e3_DDI-DrugBank.d624.s3.e4 false urea_12\NN\14727670|,|or|mannitol (l_conj) mannitol_15\NN\3214670|
DDI-DrugBank.d624.s3.e3_DDI-DrugBank.d624.s3.e0 false urea_12\NN\14727670|,|or|mannitol (r_conj) furosemide_10\NN\3214670|,|urea (r_conj) acid_8\NN\14818238|with|ethacrynic|,|furosemide (r_nmod) administered_4\VBN\2436349|tobi|should|not|be|concomitantly|acid|. (l_nsubjpass) tobi_0\NN\1740|
DDI-DrugBank.d624.s3.e4_DDI-DrugBank.d624.s3.e0 false mannitol_15\NN\3214670| (r_conj) urea_12\NN\14727670|,|or|mannitol (r_conj) furosemide_10\NN\3214670|,|urea (r_conj) acid_8\NN\14818238|with|ethacrynic|,|furosemide (r_nmod) administered_4\VBN\2436349|tobi|should|not|be|concomitantly|acid|. (l_nsubjpass) tobi_0\NN\1740|
DDI-DrugBank.d633.s2
DDI-DrugBank.d633.s2.e0_DDI-DrugBank.d633.s2.e1 false propafenone_21\NN\1740|of (r_nmod) coadministration_19\NN\1740|propafenone (r_nsubj) alter_24\VB\126264|study|,|coadministration|did|not|kinetics|. (l_dobj) kinetics_26\NNS\6100236|the|mexiletine|group (l_nmod) mexiletine_28\NN\2715941|of
DDI-DrugBank.d776.s6
DDI-DrugBank.d776.s6.e1_DDI-DrugBank.d776.s6.e0 false diflucan_12\NN\1740|and|coumarin-type (r_compound) anticoagulants_15\NNS\3740161|concomitant|diflucan (r_dobj) receiving_10\VBG\2210855|anticoagulants (r_acl) patients_9\NNS\9898892|in|receiving (r_nmod) increased_7\VBN\169651|anticoagulants|:|time|may|be|patients|. (l_dep) anticoagulants_1\NNS\3740161|coumarin-type
DDI-DrugBank.d776.s6.e1_DDI-DrugBank.d776.s6.e2 true diflucan_12\NN\1740|and|coumarin-type (r_compound) anticoagulants_15\NNS\3740161|concomitant|diflucan
DDI-DrugBank.d776.s6.e0_DDI-DrugBank.d776.s6.e2 false anticoagulants_1\NNS\3740161|coumarin-type (r_dep) increased_7\VBN\169651|anticoagulants|:|time|may|be|patients|. (l_nmod) patients_9\NNS\9898892|in|receiving (l_acl) receiving_10\VBG\2210855|anticoagulants (l_dobj) anticoagulants_15\NNS\3740161|concomitant|diflucan
DDI-DrugBank.d783.s2
DDI-DrugBank.d632.s3
DDI-DrugBank.d632.s3.e1_DDI-DrugBank.d632.s3.e0 false symlin_37\NNP\1740| (r_compound) injection_38\NN\320852|prior|symlin (r_nmod) administered_26\VBN\2436349|determinant|,|agent|should|be|injection|. (l_advcl) determinant_13\NN\5686481|when|onset|is|a|critical|effectiveness|(|analgesics (l_nmod) analgesics_19\NNS\3740161|such|)
DDI-DrugBank.d633.s19
DDI-DrugBank.d712.s0
DDI-DrugBank.d704.s4
DDI-DrugBank.d704.s4.e1_DDI-DrugBank.d704.s4.e0 false cimetidine_12\NN\14778019|with (r_nmod) combination_10\NN\7951464|in|cimetidine (r_nmod) used_6\VBN\1156834|therefore|,|capsules|should|be|caution|combination|,|doses (l_nsubjpass) capsules_3\NNS\3094503|flomax (l_compound) flomax_2\NNP\1740|
DDI-DrugBank.d690.s2
DDI-DrugBank.d595.s1
DDI-DrugBank.d595.s1.e0_DDI-DrugBank.d595.s1.e1 false norepinephrine_0\NN\14807929|and|dobutamine (l_conj) dobutamine_2\NN\1740|
DDI-DrugBank.d595.s1.e0_DDI-DrugBank.d595.s1.e2 true norepinephrine_0\NN\14807929|and|dobutamine (r_nsubj) incompatible_4\JJ\1740|norepinephrine|are|solution|. (l_nmod) solution_8\NN\14586258|with|sodium|bicarbonate (l_compound) bicarbonate_7\NN\14798450|
DDI-DrugBank.d595.s1.e1_DDI-DrugBank.d595.s1.e2 true dobutamine_2\NN\1740| (r_conj) norepinephrine_0\NN\14807929|and|dobutamine (r_nsubj) incompatible_4\JJ\1740|norepinephrine|are|solution|. (l_nmod) solution_8\NN\14586258|with|sodium|bicarbonate (l_compound) bicarbonate_7\NN\14798450|
DDI-DrugBank.d686.s0
DDI-DrugBank.d686.s0.e0_DDI-DrugBank.d686.s0.e1 true thiabendazole_0\NN\2720201| (r_nsubj) compete_2\VB\1740|thiabendazole|may|drugs|,|sites|,|elevating|. (l_nmod) drugs_5\NNS\14778436|with|other|,|theophylline (l_nmod) theophylline_9\NN\2905612|such
DDI-DrugBank.d653.s9
DDI-DrugBank.d710.s0
DDI-DrugBank.d710.s0.e1_DDI-DrugBank.d710.s0.e2 false cimetidine_5\NN\14778019| (r_compound) use_6\NN\407535|of|chronic|cimetidine (r_nmod) effects_2\NNS\13245626|the|use|metabolism (l_nmod) metabolism_9\NN\13526110|on|the|rimantadine (l_nmod) rimantadine_11\NN\1740|of
DDI-DrugBank.d752.s10
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e3 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (l_conj) meperidine_27\NN\3808564|and|fentanyl
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e4 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (l_conj) meperidine_27\NN\3808564|and|fentanyl (l_conj) fentanyl_29\NN\2707683|
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e5 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e6 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) ketamine_34\NN\3054098|
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e7 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) oxide_37\NN\14818238|nitrous
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e8 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e9 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol (l_conj) droperidol_41\NN\1740|
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e0 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e2_DDI-DrugBank.d752.s10.e1 false morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e4 false meperidine_27\NN\3808564|and|fentanyl (l_conj) fentanyl_29\NN\2707683|
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e5 false meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e6 false meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) ketamine_34\NN\3054098|
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e7 false meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) oxide_37\NN\14818238|nitrous
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e8 false meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e9 false meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol (l_conj) droperidol_41\NN\1740|
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e0 false meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e3_DDI-DrugBank.d752.s10.e1 false meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e4_DDI-DrugBank.d752.s10.e5 false fentanyl_29\NN\2707683| (r_conj) meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital
DDI-DrugBank.d752.s10.e4_DDI-DrugBank.d752.s10.e6 false fentanyl_29\NN\2707683| (r_conj) meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) ketamine_34\NN\3054098|
DDI-DrugBank.d752.s10.e4_DDI-DrugBank.d752.s10.e7 false fentanyl_29\NN\2707683| (r_conj) meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) oxide_37\NN\14818238|nitrous
DDI-DrugBank.d752.s10.e4_DDI-DrugBank.d752.s10.e8 false fentanyl_29\NN\2707683| (r_conj) meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol
DDI-DrugBank.d752.s10.e4_DDI-DrugBank.d752.s10.e9 false fentanyl_29\NN\2707683| (r_conj) meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (l_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol (l_conj) droperidol_41\NN\1740|
DDI-DrugBank.d752.s10.e4_DDI-DrugBank.d752.s10.e0 false fentanyl_29\NN\2707683| (r_conj) meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e4_DDI-DrugBank.d752.s10.e1 false fentanyl_29\NN\2707683| (r_conj) meperidine_27\NN\3808564|and|fentanyl (r_conj) morphine_25\NN\2707683|(|eg|,|,|meperidine|) (r_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e5_DDI-DrugBank.d752.s10.e6 false propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) ketamine_34\NN\3054098|
DDI-DrugBank.d752.s10.e5_DDI-DrugBank.d752.s10.e7 false propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) oxide_37\NN\14818238|nitrous
DDI-DrugBank.d752.s10.e5_DDI-DrugBank.d752.s10.e8 false propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol
DDI-DrugBank.d752.s10.e5_DDI-DrugBank.d752.s10.e9 false propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol (l_conj) droperidol_41\NN\1740|
DDI-DrugBank.d752.s10.e5_DDI-DrugBank.d752.s10.e0 false propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e5_DDI-DrugBank.d752.s10.e1 false propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e6_DDI-DrugBank.d752.s10.e7 false ketamine_34\NN\3054098| (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) oxide_37\NN\14818238|nitrous
DDI-DrugBank.d752.s10.e6_DDI-DrugBank.d752.s10.e8 false ketamine_34\NN\3054098| (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol
DDI-DrugBank.d752.s10.e6_DDI-DrugBank.d752.s10.e9 false ketamine_34\NN\3054098| (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol (l_conj) droperidol_41\NN\1740|
DDI-DrugBank.d752.s10.e6_DDI-DrugBank.d752.s10.e0 false ketamine_34\NN\3054098| (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e6_DDI-DrugBank.d752.s10.e1 false ketamine_34\NN\3054098| (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e7_DDI-DrugBank.d752.s10.e8 false oxide_37\NN\14818238|nitrous (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol
DDI-DrugBank.d752.s10.e7_DDI-DrugBank.d752.s10.e9 false oxide_37\NN\14818238|nitrous (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (l_conj) secobarbital_39\NN\2792049|and|droperidol (l_conj) droperidol_41\NN\1740|
DDI-DrugBank.d752.s10.e7_DDI-DrugBank.d752.s10.e0 false oxide_37\NN\14818238|nitrous (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e7_DDI-DrugBank.d752.s10.e1 false oxide_37\NN\14818238|nitrous (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e8_DDI-DrugBank.d752.s10.e9 false secobarbital_39\NN\2792049|and|droperidol (l_conj) droperidol_41\NN\1740|
DDI-DrugBank.d752.s10.e8_DDI-DrugBank.d752.s10.e0 false secobarbital_39\NN\2792049|and|droperidol (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e8_DDI-DrugBank.d752.s10.e1 false secobarbital_39\NN\2792049|and|droperidol (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e9_DDI-DrugBank.d752.s10.e0 false droperidol_41\NN\1740| (r_conj) secobarbital_39\NN\2792049|and|droperidol (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol (r_appos) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (r_nmod) accentuated_7\VBN\943837|effect|is|medication|. (l_nsubjpass) effect_2\NN\34213|the|sedative|syrup (l_nmod) syrup_5\NN\7858595|of|versed
DDI-DrugBank.d752.s10.e9_DDI-DrugBank.d752.s10.e1 false droperidol_41\NN\1740| (r_conj) secobarbital_39\NN\2792049|and|droperidol (r_conj) propofol_32\NN\1740|,|ketamine|,|oxide|,|secobarbital (r_conj) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d752.s10.e0_DDI-DrugBank.d752.s10.e1 true syrup_5\NN\7858595|of|versed (r_nmod) effect_2\NN\34213|the|sedative|syrup (r_nsubjpass) accentuated_7\VBN\943837|effect|is|medication|. (l_nmod) medication_12\NN\3247620|by|any|administered|depresses|,|narcotics (l_appos) narcotics_21\NNS\3247620|particularly|morphine|,|propofol
DDI-DrugBank.d776.s22
DDI-DrugBank.d776.s22.e0_DDI-DrugBank.d776.s22.e2 false fluconazole_10\NN\1740|of (r_nmod) dose_8\NN\3740161|at|a|400-mg|daily|fluconazole (r_nmod) study_1\NN\635850|another|dose (r_nsubj) demonstrated_11\VBD\2137132|study|increases|. (l_ccomp) increases_25\VBZ\169651|that|diflucan|significantly|levels|taken (l_dobj) levels_27\NNS\4916342|plasma|terfenadine (l_nmod) terfenadine_29\NN\1740|of
DDI-DrugBank.d776.s22.e0_DDI-DrugBank.d776.s22.e1 false fluconazole_10\NN\1740|of (r_nmod) dose_8\NN\3740161|at|a|400-mg|daily|fluconazole (r_nmod) study_1\NN\635850|another|dose (r_nsubj) demonstrated_11\VBD\2137132|study|increases|. (l_ccomp) increases_25\VBZ\169651|that|diflucan|significantly|levels|taken (l_nsubj) diflucan_13\NN\1740|taken
DDI-DrugBank.d776.s22.e2_DDI-DrugBank.d776.s22.e1 false terfenadine_29\NN\1740|of (r_nmod) levels_27\NNS\4916342|plasma|terfenadine (r_dobj) increases_25\VBZ\169651|that|diflucan|significantly|levels|taken (l_nsubj) diflucan_13\NN\1740|taken
DDI-DrugBank.d599.s0
DDI-DrugBank.d597.s4
DDI-DrugBank.d597.s4.e1_DDI-DrugBank.d597.s4.e2 true meloxicam_10\NN\1740|of|and|aspirin (l_conj) aspirin_12\NN\2707683|
DDI-DrugBank.d597.s4.e1_DDI-DrugBank.d597.s4.e0 false meloxicam_10\NN\1740|of|and|aspirin (r_nmod) administration_8\NN\1133281|concomitant|meloxicam (r_nsubjpass) recommended_16\VBN\875394|however|,|as|,|administration|is|not|generally|potential|. (l_prep) as_2\IN\14622893|nsaids (l_nmod) nsaids_5\NNS\2721538|with|other
DDI-DrugBank.d597.s4.e2_DDI-DrugBank.d597.s4.e0 false aspirin_12\NN\2707683| (r_conj) meloxicam_10\NN\1740|of|and|aspirin (r_nmod) administration_8\NN\1133281|concomitant|meloxicam (r_nsubjpass) recommended_16\VBN\875394|however|,|as|,|administration|is|not|generally|potential|. (l_prep) as_2\IN\14622893|nsaids (l_nmod) nsaids_5\NNS\2721538|with|other
DDI-DrugBank.d710.s4
DDI-DrugBank.d579.s0
DDI-DrugBank.d579.s0.e0_DDI-DrugBank.d579.s0.e1 false antibiotics_2\NNS\2716205|and|sulfonamides (l_conj) sulfonamides_4\NNS\2716205|
DDI-DrugBank.d579.s0.e0_DDI-DrugBank.d579.s0.e2 true antibiotics_2\NNS\2716205|and|sulfonamides (r_dobj) receiving_1\VBG\2210855|antibiotics (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) treated_9\VBN\2376958|patients|generally|should|not|be|blockers|. (l_nmod) blockers_12\NNS\10101634|with|ganglion
DDI-DrugBank.d579.s0.e1_DDI-DrugBank.d579.s0.e2 true sulfonamides_4\NNS\2716205| (r_conj) antibiotics_2\NNS\2716205|and|sulfonamides (r_dobj) receiving_1\VBG\2210855|antibiotics (r_acl) patients_0\NNS\9898892|receiving (r_nsubjpass) treated_9\VBN\2376958|patients|generally|should|not|be|blockers|. (l_nmod) blockers_12\NNS\10101634|with|ganglion
DDI-DrugBank.d608.s0
DDI-DrugBank.d608.s0.e0_DDI-DrugBank.d608.s0.e1 false warfarin_5\NN\2718259|of (r_nmod) binding_3\NN\4688246|the|in|warfarin|proteins (r_nsubj) unaffected_11\VBN\1740|binding|is|tolmetin|,|and|alter (l_nmod) tolmetin_13\NN\1740|by
DDI-DrugBank.d608.s0.e0_DDI-DrugBank.d608.s0.e2 false warfarin_5\NN\2718259|of (r_nmod) binding_3\NN\4688246|the|in|warfarin|proteins (r_nsubj) unaffected_11\VBN\1740|binding|is|tolmetin|,|and|alter (l_conj) alter_19\VB\126264|tolmetin|does|not|time|. (l_nsubj) tolmetin_16\NN\1740|
DDI-DrugBank.d608.s0.e1_DDI-DrugBank.d608.s0.e2 false tolmetin_13\NN\1740|by (r_nmod) unaffected_11\VBN\1740|binding|is|tolmetin|,|and|alter (l_conj) alter_19\VB\126264|tolmetin|does|not|time|. (l_nsubj) tolmetin_16\NN\1740|
DDI-DrugBank.d575.s5
DDI-DrugBank.d575.s5.e0_DDI-DrugBank.d575.s5.e1 true methotrexate_6\NN\2722166|of (r_nmod) levels_4\NNS\4916342|in|intracellular|methotrexate (r_nmod) increase_1\NN\13576355|an|levels (r_nsubjpass) observed_8\VBN\2163746|increase|was|vitro|presence|. (l_nmod) presence_13\NN\13954253|in|the|teniposide (l_nmod) teniposide_15\NN\1740|of
DDI-DrugBank.d588.s2
DDI-DrugBank.d690.s4
DDI-DrugBank.d762.s1
DDI-DrugBank.d675.s4
DDI-DrugBank.d675.s4.e0_DDI-DrugBank.d675.s4.e1 false saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) nefazodone_6\NN\2718811|
DDI-DrugBank.d675.s4.e0_DDI-DrugBank.d675.s4.e2 false saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) fluconazole_8\NN\1740|
DDI-DrugBank.d675.s4.e0_DDI-DrugBank.d675.s4.e3 false saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine
DDI-DrugBank.d675.s4.e0_DDI-DrugBank.d675.s4.e4 false saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton
DDI-DrugBank.d675.s4.e0_DDI-DrugBank.d675.s4.e5 false saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole
DDI-DrugBank.d675.s4.e0_DDI-DrugBank.d675.s4.e6 false saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole (l_conj) clotrimazole_20\NN\1740|
DDI-DrugBank.d675.s4.e1_DDI-DrugBank.d675.s4.e2 false nefazodone_6\NN\2718811| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) fluconazole_8\NN\1740|
DDI-DrugBank.d675.s4.e1_DDI-DrugBank.d675.s4.e3 false nefazodone_6\NN\2718811| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine
DDI-DrugBank.d675.s4.e1_DDI-DrugBank.d675.s4.e4 false nefazodone_6\NN\2718811| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton
DDI-DrugBank.d675.s4.e1_DDI-DrugBank.d675.s4.e5 false nefazodone_6\NN\2718811| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole
DDI-DrugBank.d675.s4.e1_DDI-DrugBank.d675.s4.e6 false nefazodone_6\NN\2718811| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole (l_conj) clotrimazole_20\NN\1740|
DDI-DrugBank.d675.s4.e2_DDI-DrugBank.d675.s4.e3 false fluconazole_8\NN\1740| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine
DDI-DrugBank.d675.s4.e2_DDI-DrugBank.d675.s4.e4 false fluconazole_8\NN\1740| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton
DDI-DrugBank.d675.s4.e2_DDI-DrugBank.d675.s4.e5 false fluconazole_8\NN\1740| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole
DDI-DrugBank.d675.s4.e2_DDI-DrugBank.d675.s4.e6 false fluconazole_8\NN\1740| (r_conj) saquinavir_4\NN\4013993|,|nefazodone|,|fluconazole|,|juice (l_conj) juice_11\NN\7566340|grapefruit|,|fluoxetine (l_conj) fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole (l_conj) clotrimazole_20\NN\1740|
DDI-DrugBank.d675.s4.e3_DDI-DrugBank.d675.s4.e4 false fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton
DDI-DrugBank.d675.s4.e3_DDI-DrugBank.d675.s4.e5 false fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole
DDI-DrugBank.d675.s4.e3_DDI-DrugBank.d675.s4.e6 false fluoxetine_13\NN\4169152|,|fluvoxamine (l_conj) fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole (l_conj) clotrimazole_20\NN\1740|
DDI-DrugBank.d675.s4.e4_DDI-DrugBank.d675.s4.e5 false fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole
DDI-DrugBank.d675.s4.e4_DDI-DrugBank.d675.s4.e6 false fluvoxamine_15\NN\1740|,|zileuton (l_conj) zileuton_17\NN\1740|,|and|clotrimazole (l_conj) clotrimazole_20\NN\1740|
DDI-DrugBank.d675.s4.e5_DDI-DrugBank.d675.s4.e6 false zileuton_17\NN\1740|,|and|clotrimazole (l_conj) clotrimazole_20\NN\1740|
DDI-DrugBank.d597.s5
DDI-DrugBank.d597.s5.e0_DDI-DrugBank.d597.s5.e1 true aspirin_4\NN\2707683|of|low-dose (r_nmod) administration_1\NN\1133281|concomitant|aspirin|mobic (l_nmod) mobic_6\NNP\1740|with
DDI-DrugBank.d597.s5.e0_DDI-DrugBank.d597.s5.e2 false aspirin_4\NN\2707683|of|low-dose (r_nmod) administration_1\NN\1133281|concomitant|aspirin|mobic (r_nsubj) result_8\VB\2633881|administration|may|rate|,|compared|. (l_prep) compared_20\VBN\644583|use (l_nmod) use_22\NN\407535|to|mobic (l_nmod) mobic_24\NN\1740|of|alone
DDI-DrugBank.d597.s5.e1_DDI-DrugBank.d597.s5.e2 false mobic_6\NNP\1740|with (r_nmod) administration_1\NN\1133281|concomitant|aspirin|mobic (r_nsubj) result_8\VB\2633881|administration|may|rate|,|compared|. (l_prep) compared_20\VBN\644583|use (l_nmod) use_22\NN\407535|to|mobic (l_nmod) mobic_24\NN\1740|of|alone
DDI-DrugBank.d775.s11
DDI-DrugBank.d775.s11.e0_DDI-DrugBank.d775.s11.e1 true mivacron_5\NN\1740|of (r_nmod) effect_3\NN\34213|the|neuromuscular|blocking|mivacron (r_nsubjpass) enhanced_8\VBN\227165|effect|may|be|drugs|. (l_nmod) drugs_10\NNS\14778436|by|reduce|contraceptives|or|drugs (l_dep) contraceptives_22\NNS\3183080|(|e.g.|,|administered|oral|,|glucocorticoids|,|or|inhibitors|)
DDI-DrugBank.d775.s11.e0_DDI-DrugBank.d775.s11.e2 true mivacron_5\NN\1740|of (r_nmod) effect_3\NN\34213|the|neuromuscular|blocking|mivacron (r_nsubjpass) enhanced_8\VBN\227165|effect|may|be|drugs|. (l_nmod) drugs_10\NNS\14778436|by|reduce|contraceptives|or|drugs (l_dep) contraceptives_22\NNS\3183080|(|e.g.|,|administered|oral|,|glucocorticoids|,|or|inhibitors|) (l_conj) glucocorticoids_24\NNS\14751417|
DDI-DrugBank.d775.s11.e0_DDI-DrugBank.d775.s11.e3 true mivacron_5\NN\1740|of (r_nmod) effect_3\NN\34213|the|neuromuscular|blocking|mivacron (r_nsubjpass) enhanced_8\VBN\227165|effect|may|be|drugs|. (l_nmod) drugs_10\NNS\14778436|by|reduce|contraceptives|or|drugs (l_dep) contraceptives_22\NNS\3183080|(|e.g.|,|administered|oral|,|glucocorticoids|,|or|inhibitors|) (l_conj) inhibitors_30\NNS\20090|certain|monoamine|oxidase
DDI-DrugBank.d775.s11.e1_DDI-DrugBank.d775.s11.e2 false contraceptives_22\NNS\3183080|(|e.g.|,|administered|oral|,|glucocorticoids|,|or|inhibitors|) (l_conj) glucocorticoids_24\NNS\14751417|
DDI-DrugBank.d775.s11.e1_DDI-DrugBank.d775.s11.e3 false contraceptives_22\NNS\3183080|(|e.g.|,|administered|oral|,|glucocorticoids|,|or|inhibitors|) (l_conj) inhibitors_30\NNS\20090|certain|monoamine|oxidase
DDI-DrugBank.d775.s11.e2_DDI-DrugBank.d775.s11.e3 false glucocorticoids_24\NNS\14751417| (r_conj) contraceptives_22\NNS\3183080|(|e.g.|,|administered|oral|,|glucocorticoids|,|or|inhibitors|) (l_conj) inhibitors_30\NNS\20090|certain|monoamine|oxidase
DDI-DrugBank.d775.s11.e5_DDI-DrugBank.d775.s11.e6 false phenytoin_18\NN\3550533|or|carbamazepine (l_conj) carbamazepine_20\NN\1740|
DDI-DrugBank.d775.s11.e5_DDI-DrugBank.d775.s11.e4 false phenytoin_18\NN\3550533|or|carbamazepine (r_dobj) administered_17\VBN\2436349|chronically|phenytoin (r_acl) patients_15\NNS\9898892|in|administered (r_nmod) demonstrated_13\VBN\2137132|resistance|has|been|patients|. (l_nsubjpass) resistance_0\NN\37396|action (l_nmod) action_5\NN\30358|to|the|neuromuscular|blocking|agents (l_nmod) agents_10\NNS\7347|of|nondepolarizing|neuromuscular|blocking
DDI-DrugBank.d775.s11.e6_DDI-DrugBank.d775.s11.e4 false carbamazepine_20\NN\1740| (r_conj) phenytoin_18\NN\3550533|or|carbamazepine (r_dobj) administered_17\VBN\2436349|chronically|phenytoin (r_acl) patients_15\NNS\9898892|in|administered (r_nmod) demonstrated_13\VBN\2137132|resistance|has|been|patients|. (l_nsubjpass) resistance_0\NN\37396|action (l_nmod) action_5\NN\30358|to|the|neuromuscular|blocking|agents (l_nmod) agents_10\NNS\7347|of|nondepolarizing|neuromuscular|blocking
DDI-DrugBank.d596.s5
DDI-DrugBank.d596.s5.e1_DDI-DrugBank.d596.s5.e0 false rivastigmine_25\NN\1740|of (r_nmod) metabolism_23\NN\13526110|the|rivastigmine (r_dobj) alter_21\VB\126264|to|metabolism (r_xcomp) expected_19\VBN\670261|drugs|are|not|alter|. (r_dep) effect_0\NN\34213|drugs|metabolism|:|expected (l_nmod) metabolism_6\NN\13526110|on|the|exelon (l_nmod) exelon_8\NN\1740|of
DDI-DrugBank.d766.s2
DDI-DrugBank.d766.s2.e0_DDI-DrugBank.d766.s2.e1 true cimetidine_10\NN\14778019| (r_nsubj) caused_11\VBD\1617192|that|cimetidine|reduction|and|altered (l_dobj) reduction_14\NN\351485|a|significant|metabolism (l_nmod) metabolism_17\NN\13526110|in|trimetrexate (l_compound) trimetrexate_16\NN\1740|
DDI-DrugBank.d766.s2.e0_DDI-DrugBank.d766.s2.e2 false cimetidine_10\NN\14778019| (r_nsubj) caused_11\VBD\1617192|that|cimetidine|reduction|and|altered (l_conj) altered_21\VBD\126264|that|acetaminophen|concentration|competing (l_nsubj) acetaminophen_20\NN\2707683|
DDI-DrugBank.d766.s2.e1_DDI-DrugBank.d766.s2.e2 false trimetrexate_16\NN\1740| (r_compound) metabolism_17\NN\13526110|in|trimetrexate (r_nmod) reduction_14\NN\351485|a|significant|metabolism (r_dobj) caused_11\VBD\1617192|that|cimetidine|reduction|and|altered (l_conj) altered_21\VBD\126264|that|acetaminophen|concentration|competing (l_nsubj) acetaminophen_20\NN\2707683|
DDI-DrugBank.d613.s2
DDI-DrugBank.d610.s1
DDI-DrugBank.d610.s1.e0_DDI-DrugBank.d610.s1.e1 false lamivudine_5\NN\3834836|or|zidovudine (l_conj) zidovudine_7\NN\3834836|
DDI-DrugBank.d610.s1.e0_DDI-DrugBank.d610.s1.e2 false lamivudine_5\NN\3834836|or|zidovudine (r_compound) pharmacokinetics_8\NNS\6054892|to|lamivudine (r_nmod) changes_3\NNS\7283608|no|significant|pharmacokinetics (r_nsubjpass) observed_10\VBN\2163746|changes|were|administration|. (l_nmod) administration_13\NN\1133281|following|concomitant|abacavir (l_nmod) abacavir_15\NN\1740|of
DDI-DrugBank.d610.s1.e1_DDI-DrugBank.d610.s1.e2 false zidovudine_7\NN\3834836| (r_conj) lamivudine_5\NN\3834836|or|zidovudine (r_compound) pharmacokinetics_8\NNS\6054892|to|lamivudine (r_nmod) changes_3\NNS\7283608|no|significant|pharmacokinetics (r_nsubjpass) observed_10\VBN\2163746|changes|were|administration|. (l_nmod) administration_13\NN\1133281|following|concomitant|abacavir (l_nmod) abacavir_15\NN\1740|of
DDI-DrugBank.d680.s5
DDI-DrugBank.d680.s5.e1_DDI-DrugBank.d680.s5.e2 true pantoprazole_19\NN\1740|including|,|and|warfarin (l_conj) warfarin_22\NN\2718259|concomitantly
DDI-DrugBank.d680.s5.e1_DDI-DrugBank.d680.s5.e0 false pantoprazole_19\NN\1740|including|,|and|warfarin (r_nmod) inhibitors_16\NNS\20090|pump|,|pantoprazole
DDI-DrugBank.d680.s5.e2_DDI-DrugBank.d680.s5.e0 false warfarin_22\NN\2718259|concomitantly (r_conj) pantoprazole_19\NN\1740|including|,|and|warfarin (r_nmod) inhibitors_16\NNS\20090|pump|,|pantoprazole
DDI-DrugBank.d616.s0
DDI-DrugBank.d679.s0
DDI-DrugBank.d679.s0.e0_DDI-DrugBank.d679.s0.e1 true cimetidine_4\NN\14778019| (r_nsubj) inhibits_5\VBZ\2510337|that|cimetidine|metabolism|and|result (l_dobj) metabolism_7\NN\13526110|mebendazole (l_compound) mebendazole_6\NN\4528630|
DDI-DrugBank.d679.s0.e0_DDI-DrugBank.d679.s0.e2 false cimetidine_4\NN\14778019| (r_nsubj) inhibits_5\VBZ\2510337|that|cimetidine|metabolism|and|result (l_conj) result_10\VB\2633881|may|increase (l_nmod) increase_13\NN\13576355|in|an|concentrations (l_nmod) concentrations_16\NNS\4916342|in|plasma|mebendazole (l_nmod) mebendazole_18\NN\4528630|of
DDI-DrugBank.d679.s0.e1_DDI-DrugBank.d679.s0.e2 false mebendazole_6\NN\4528630| (r_compound) metabolism_7\NN\13526110|mebendazole (r_dobj) inhibits_5\VBZ\2510337|that|cimetidine|metabolism|and|result (l_conj) result_10\VB\2633881|may|increase (l_nmod) increase_13\NN\13576355|in|an|concentrations (l_nmod) concentrations_16\NNS\4916342|in|plasma|mebendazole (l_nmod) mebendazole_18\NN\4528630|of
DDI-DrugBank.d577.s5
DDI-DrugBank.d655.s0
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e4 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine (l_dep) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|)
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e5 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine (l_dep) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) linezolid_17\NN\1740|
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e6 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine (l_dep) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) tranylcypromine_19\NN\3783017|
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e7 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine (l_dep) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) isocarboxazid_21\NN\3783017|
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e8 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine (l_dep) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) selegiline_23\NN\1740|
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e9 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine (l_dep) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) furazolidone_25\NN\1740|
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e1 false methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e2 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e0_DDI-DrugBank.d655.s0.e3 true methscopolamine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|methscopolamine|may|antidepressants|. (l_nmod) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e5 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) linezolid_17\NN\1740|
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e6 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) tranylcypromine_19\NN\3783017|
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e7 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) isocarboxazid_21\NN\3783017|
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e8 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) selegiline_23\NN\1740|
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e9 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) furazolidone_25\NN\1740|
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e1 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e2 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e4_DDI-DrugBank.d655.s0.e3 false phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e5_DDI-DrugBank.d655.s0.e6 false linezolid_17\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) tranylcypromine_19\NN\3783017|
DDI-DrugBank.d655.s0.e5_DDI-DrugBank.d655.s0.e7 false linezolid_17\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) isocarboxazid_21\NN\3783017|
DDI-DrugBank.d655.s0.e5_DDI-DrugBank.d655.s0.e8 false linezolid_17\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) selegiline_23\NN\1740|
DDI-DrugBank.d655.s0.e5_DDI-DrugBank.d655.s0.e9 false linezolid_17\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) furazolidone_25\NN\1740|
DDI-DrugBank.d655.s0.e5_DDI-DrugBank.d655.s0.e1 false linezolid_17\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines
DDI-DrugBank.d655.s0.e5_DDI-DrugBank.d655.s0.e2 false linezolid_17\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e5_DDI-DrugBank.d655.s0.e3 false linezolid_17\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e6_DDI-DrugBank.d655.s0.e7 false tranylcypromine_19\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) isocarboxazid_21\NN\3783017|
DDI-DrugBank.d655.s0.e6_DDI-DrugBank.d655.s0.e8 false tranylcypromine_19\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) selegiline_23\NN\1740|
DDI-DrugBank.d655.s0.e6_DDI-DrugBank.d655.s0.e9 false tranylcypromine_19\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) furazolidone_25\NN\1740|
DDI-DrugBank.d655.s0.e6_DDI-DrugBank.d655.s0.e1 false tranylcypromine_19\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines
DDI-DrugBank.d655.s0.e6_DDI-DrugBank.d655.s0.e2 false tranylcypromine_19\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e6_DDI-DrugBank.d655.s0.e3 false tranylcypromine_19\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e7_DDI-DrugBank.d655.s0.e8 false isocarboxazid_21\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) selegiline_23\NN\1740|
DDI-DrugBank.d655.s0.e7_DDI-DrugBank.d655.s0.e9 false isocarboxazid_21\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) furazolidone_25\NN\1740|
DDI-DrugBank.d655.s0.e7_DDI-DrugBank.d655.s0.e1 false isocarboxazid_21\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines
DDI-DrugBank.d655.s0.e7_DDI-DrugBank.d655.s0.e2 false isocarboxazid_21\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e7_DDI-DrugBank.d655.s0.e3 false isocarboxazid_21\NN\3783017| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e8_DDI-DrugBank.d655.s0.e9 false selegiline_23\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (l_appos) furazolidone_25\NN\1740|
DDI-DrugBank.d655.s0.e8_DDI-DrugBank.d655.s0.e1 false selegiline_23\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines
DDI-DrugBank.d655.s0.e8_DDI-DrugBank.d655.s0.e2 false selegiline_23\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e8_DDI-DrugBank.d655.s0.e3 false selegiline_23\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e9_DDI-DrugBank.d655.s0.e1 false furazolidone_25\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines
DDI-DrugBank.d655.s0.e9_DDI-DrugBank.d655.s0.e2 false furazolidone_25\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine (r_conj) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e9_DDI-DrugBank.d655.s0.e3 false furazolidone_25\NN\1740| (r_appos) phenelzine_15\NN\3783017|(|e.g.|,|,|linezolid|,|tranylcypromine|,|isocarboxazid|,|selegiline|,|furazolidone|) (r_dep) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e1_DDI-DrugBank.d655.s0.e2 false antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_appos) type_7\NN\5839024|(|tricyclic|) (l_amod) tricyclic_6\JJ\1740|
DDI-DrugBank.d655.s0.e1_DDI-DrugBank.d655.s0.e3 false antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d655.s0.e2_DDI-DrugBank.d655.s0.e3 false tricyclic_6\JJ\1740| (r_amod) type_7\NN\5839024|(|tricyclic|) (r_appos) antidepressants_4\NNS\3740161|with|type|,|inhibitors|,|quinidine|,|amantadine|,|antihistamines|,|anticholinergics|,|phenothiazines (l_conj) inhibitors_11\NNS\20090|mao|phenelzine
DDI-DrugBank.d572.s23
DDI-DrugBank.d742.s10
DDI-DrugBank.d742.s10.e1_DDI-DrugBank.d742.s10.e0 false diazepam_20\NN\2830852|by (r_nmod) caused_18\VBN\1617192|diazepam (r_acl) those_17\DT\1740|with|caused (r_nmod) additive_15\JJ\1740|to|be|those (r_xcomp) shown_12\VBN\2137132|however|,|impairment|has|been|additive|. (l_nsubjpass) impairment_3\NN\7296428|the|skills (l_nmod) skills_6\NNS\5616246|of|motor|produced (l_acl) produced_7\VBN\1617192|remeron (l_nmod) remeron_9\NNP\1740|by
DDI-DrugBank.d711.s4
DDI-DrugBank.d711.s4.e0_DDI-DrugBank.d711.s4.e1 true tetracyclines_3\NNS\2716205|of (r_nmod) use_1\NN\407535|concurrent|tetracyclines|contraceptives (l_nmod) contraceptives_6\NNS\3183080|with|oral
DDI-DrugBank.d711.s4.e0_DDI-DrugBank.d711.s4.e2 false tetracyclines_3\NNS\2716205|of (r_nmod) use_1\NN\407535|concurrent|tetracyclines|contraceptives (r_nsubj) render_8\VB\120316|use|may|effective|. (l_ccomp) effective_12\JJ\1740|contraceptives|less (l_nsubj) contraceptives_10\NNS\3183080|oral
DDI-DrugBank.d711.s4.e1_DDI-DrugBank.d711.s4.e2 false contraceptives_6\NNS\3183080|with|oral (r_nmod) use_1\NN\407535|concurrent|tetracyclines|contraceptives (r_nsubj) render_8\VB\120316|use|may|effective|. (l_ccomp) effective_12\JJ\1740|contraceptives|less (l_nsubj) contraceptives_10\NNS\3183080|oral
DDI-DrugBank.d628.s1
DDI-DrugBank.d628.s1.e4_DDI-DrugBank.d628.s1.e5 false hydrate_14\NN\14818238|chloral|,|droperidol (l_conj) droperidol_16\NN\1740|,|etc
DDI-DrugBank.d628.s1.e4_DDI-DrugBank.d628.s1.e0 false hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate (r_conj) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|) (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) opioids_3\NNS\1740|of|and|sedatives
DDI-DrugBank.d628.s1.e4_DDI-DrugBank.d628.s1.e1 false hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate (r_conj) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|) (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) opioids_3\NNS\1740|of|and|sedatives (l_conj) sedatives_5\NNS\3248958|
DDI-DrugBank.d628.s1.e4_DDI-DrugBank.d628.s1.e2 false hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate (r_conj) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|)
DDI-DrugBank.d628.s1.e4_DDI-DrugBank.d628.s1.e3 false hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate
DDI-DrugBank.d628.s1.e5_DDI-DrugBank.d628.s1.e0 false droperidol_16\NN\1740|,|etc (r_conj) hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate (r_conj) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|) (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) opioids_3\NNS\1740|of|and|sedatives
DDI-DrugBank.d628.s1.e5_DDI-DrugBank.d628.s1.e1 false droperidol_16\NN\1740|,|etc (r_conj) hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate (r_conj) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|) (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) opioids_3\NNS\1740|of|and|sedatives (l_conj) sedatives_5\NNS\3248958|
DDI-DrugBank.d628.s1.e5_DDI-DrugBank.d628.s1.e2 false droperidol_16\NN\1740|,|etc (r_conj) hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate (r_conj) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|)
DDI-DrugBank.d628.s1.e5_DDI-DrugBank.d628.s1.e3 false droperidol_16\NN\1740|,|etc (r_conj) hydrate_14\NN\14818238|chloral|,|droperidol (r_conj) barbiturates_11\NNS\4166841|,|hydrate
DDI-DrugBank.d628.s1.e0_DDI-DrugBank.d628.s1.e1 false opioids_3\NNS\1740|of|and|sedatives (l_conj) sedatives_5\NNS\3248958|
DDI-DrugBank.d628.s1.e0_DDI-DrugBank.d628.s1.e2 false opioids_3\NNS\1740|of|and|sedatives (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|)
DDI-DrugBank.d628.s1.e0_DDI-DrugBank.d628.s1.e3 false opioids_3\NNS\1740|of|and|sedatives (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|) (l_conj) barbiturates_11\NNS\4166841|,|hydrate
DDI-DrugBank.d628.s1.e1_DDI-DrugBank.d628.s1.e2 false sedatives_5\NNS\3248958| (r_conj) opioids_3\NNS\1740|of|and|sedatives (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|)
DDI-DrugBank.d628.s1.e1_DDI-DrugBank.d628.s1.e3 false sedatives_5\NNS\3248958| (r_conj) opioids_3\NNS\1740|of|and|sedatives (r_nmod) combinations_1\NNS\7951464|and|opioids|benzodiazepines|. (l_nmod) benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|) (l_conj) barbiturates_11\NNS\4166841|,|hydrate
DDI-DrugBank.d628.s1.e2_DDI-DrugBank.d628.s1.e3 false benzodiazepines_9\NNS\3771443|(|eg|,|,|barbiturates|) (l_conj) barbiturates_11\NNS\4166841|,|hydrate
DDI-DrugBank.d666.s5
DDI-DrugBank.d781.s13
DDI-DrugBank.d700.s3
DDI-DrugBank.d700.s3.e0_DDI-DrugBank.d700.s3.e1 false acyclovir/ganciclovir_0\NN\1740|
DDI-DrugBank.d700.s3.e0_DDI-DrugBank.d700.s3.e2 false acyclovir/ganciclovir_0\NN\1740| (r_dep) taken_4\VBN\2367363|acyclovir/ganciclovir|:|may|be|myfortic|; (l_nmod) myfortic_6\JJ\1740|with
DDI-DrugBank.d700.s3.e1_DDI-DrugBank.d700.s3.e2 false acyclovir/ganciclovir_0\NN\1740| (r_dep) taken_4\VBN\2367363|acyclovir/ganciclovir|:|may|be|myfortic|; (l_nmod) myfortic_6\JJ\1740|with
DDI-DrugBank.d640.s8
DDI-DrugBank.d640.s8.e1_DDI-DrugBank.d640.s8.e0 false lithium_10\NN\14625458| (r_compound) toxicity_11\NN\13576101|of|lithium (r_nmod) risk_8\NN\14541044|the|toxicity (r_nsubjpass) increased_14\VBN\169651|used|,|risk|may|be|. (l_advcl) used_5\VBN\1156834|if|diuretic|is|also (l_nsubjpass) diuretic_2\NN\3247620|a
DDI-DrugBank.d639.s6
DDI-DrugBank.d773.s2
DDI-DrugBank.d773.s2.e1_DDI-DrugBank.d773.s2.e3 false heparin_4\NN\2718259|such|and|antagonists|) (r_nmod) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (l_conj) drugs_11\NNS\14778436|alter|(|acid (l_nmod) acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|)
DDI-DrugBank.d773.s2.e1_DDI-DrugBank.d773.s2.e4 false heparin_4\NN\2718259|such|and|antagonists|) (r_nmod) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (l_conj) drugs_11\NNS\14778436|alter|(|acid (l_nmod) acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (l_conj) dipyridamole_22\NN\1740|
DDI-DrugBank.d773.s2.e1_DDI-DrugBank.d773.s2.e5 true heparin_4\NN\2718259|such|and|antagonists|) (r_nmod) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (r_nsubj) increase_30\VB\169651|anticoagulants|may|risk|administered|. (l_advcl) administered_36\VBN\2436349|if|therapy (l_nmod) therapy_45\NN\657604|prior|tnkase (l_compound) tnkase_44\NN\1740|
DDI-DrugBank.d773.s2.e1_DDI-DrugBank.d773.s2.e0 false heparin_4\NN\2718259|such|and|antagonists|) (r_nmod) anticoagulants_0\NNS\3740161|(|heparin|and|drugs
DDI-DrugBank.d773.s2.e1_DDI-DrugBank.d773.s2.e2 false heparin_4\NN\2718259|such|and|antagonists|) (l_conj) antagonists_8\NNS\7846|k
DDI-DrugBank.d773.s2.e3_DDI-DrugBank.d773.s2.e4 false acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (l_conj) dipyridamole_22\NN\1740|
DDI-DrugBank.d773.s2.e3_DDI-DrugBank.d773.s2.e5 false acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (r_nmod) drugs_11\NNS\14778436|alter|(|acid (r_conj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (r_nsubj) increase_30\VB\169651|anticoagulants|may|risk|administered|. (l_advcl) administered_36\VBN\2436349|if|therapy (l_nmod) therapy_45\NN\657604|prior|tnkase (l_compound) tnkase_44\NN\1740|
DDI-DrugBank.d773.s2.e3_DDI-DrugBank.d773.s2.e0 false acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (r_nmod) drugs_11\NNS\14778436|alter|(|acid (r_conj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs
DDI-DrugBank.d773.s2.e3_DDI-DrugBank.d773.s2.e2 false acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (r_nmod) drugs_11\NNS\14778436|alter|(|acid (r_conj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (l_nmod) heparin_4\NN\2718259|such|and|antagonists|) (l_conj) antagonists_8\NNS\7846|k
DDI-DrugBank.d773.s2.e4_DDI-DrugBank.d773.s2.e5 false dipyridamole_22\NN\1740| (r_conj) acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (r_nmod) drugs_11\NNS\14778436|alter|(|acid (r_conj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (r_nsubj) increase_30\VB\169651|anticoagulants|may|risk|administered|. (l_advcl) administered_36\VBN\2436349|if|therapy (l_nmod) therapy_45\NN\657604|prior|tnkase (l_compound) tnkase_44\NN\1740|
DDI-DrugBank.d773.s2.e4_DDI-DrugBank.d773.s2.e0 false dipyridamole_22\NN\1740| (r_conj) acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (r_nmod) drugs_11\NNS\14778436|alter|(|acid (r_conj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs
DDI-DrugBank.d773.s2.e4_DDI-DrugBank.d773.s2.e2 false dipyridamole_22\NN\1740| (r_conj) acid_20\NN\14818238|such|acetylsalicylic|,|dipyridamole|,|and|inhibitors|) (r_nmod) drugs_11\NNS\14778436|alter|(|acid (r_conj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (l_nmod) heparin_4\NN\2718259|such|and|antagonists|) (l_conj) antagonists_8\NNS\7846|k
DDI-DrugBank.d773.s2.e5_DDI-DrugBank.d773.s2.e0 false tnkase_44\NN\1740| (r_compound) therapy_45\NN\657604|prior|tnkase (r_nmod) administered_36\VBN\2436349|if|therapy (r_advcl) increase_30\VB\169651|anticoagulants|may|risk|administered|. (l_nsubj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs
DDI-DrugBank.d773.s2.e5_DDI-DrugBank.d773.s2.e2 false tnkase_44\NN\1740| (r_compound) therapy_45\NN\657604|prior|tnkase (r_nmod) administered_36\VBN\2436349|if|therapy (r_advcl) increase_30\VB\169651|anticoagulants|may|risk|administered|. (l_nsubj) anticoagulants_0\NNS\3740161|(|heparin|and|drugs (l_nmod) heparin_4\NN\2718259|such|and|antagonists|) (l_conj) antagonists_8\NNS\7846|k
DDI-DrugBank.d773.s2.e0_DDI-DrugBank.d773.s2.e2 false anticoagulants_0\NNS\3740161|(|heparin|and|drugs (l_nmod) heparin_4\NN\2718259|such|and|antagonists|) (l_conj) antagonists_8\NNS\7846|k
DDI-DrugBank.d596.s0
DDI-DrugBank.d596.s0.e1_DDI-DrugBank.d596.s0.e2 false tartrate_7\NN\15010703|(|rivastigmine (r_appos) exelon_4\NN\1740|of|tartrate|) (r_nmod) effect_2\NN\34213|interactions|exelon|metabolism (r_nsubjpass) metabolized_19\VBN\1740|effect|:|rivastigmine|is|primarily|hydrolysis|. (l_nsubjpass) rivastigmine_16\NN\1740|
DDI-DrugBank.d596.s0.e1_DDI-DrugBank.d596.s0.e0 false tartrate_7\NN\15010703|(|rivastigmine (r_appos) exelon_4\NN\1740|of|tartrate|)
DDI-DrugBank.d596.s0.e2_DDI-DrugBank.d596.s0.e0 false rivastigmine_16\NN\1740| (r_nsubjpass) metabolized_19\VBN\1740|effect|:|rivastigmine|is|primarily|hydrolysis|. (l_nsubjpass) effect_2\NN\34213|interactions|exelon|metabolism (l_nmod) exelon_4\NN\1740|of|tartrate|)
DDI-DrugBank.d597.s12
DDI-DrugBank.d597.s12.e0_DDI-DrugBank.d597.s12.e1 false digoxin_0\NN\15060131| (r_compound) mg_4\NN\13717155|digoxin|:|meloxicam|15|daily|days (l_compound) meloxicam_2\NN\1740|
DDI-DrugBank.d597.s12.e0_DDI-DrugBank.d597.s12.e2 false digoxin_0\NN\15060131| (r_compound) mg_4\NN\13717155|digoxin|:|meloxicam|15|daily|days (r_nsubj) alter_12\VB\126264|mg|did|not|profile|administration|doses|. (l_dobj) profile_16\NN\6999802|the|plasma|concentration|digoxin (l_nmod) digoxin_18\NN\15060131|of
DDI-DrugBank.d597.s12.e1_DDI-DrugBank.d597.s12.e2 false meloxicam_2\NN\1740| (r_compound) mg_4\NN\13717155|digoxin|:|meloxicam|15|daily|days (r_nsubj) alter_12\VB\126264|mg|did|not|profile|administration|doses|. (l_dobj) profile_16\NN\6999802|the|plasma|concentration|digoxin (l_nmod) digoxin_18\NN\15060131|of
DDI-DrugBank.d736.s2
DDI-DrugBank.d624.s1
DDI-DrugBank.d725.s3
DDI-DrugBank.d725.s3.e0_DDI-DrugBank.d725.s3.e1 true agents_5\NNS\7347|of|adrenergic (r_nmod) response_2\NN\11410625|the|pressor|agents (r_nsubjpass) potentiated_9\VBN\229605|response|may|also|be|antidepressants|. (l_nmod) antidepressants_12\NNS\3740161|by|tricyclic
DDI-DrugBank.d739.s12
DDI-DrugBank.d739.s12.e0_DDI-DrugBank.d739.s12.e1 false hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) hypnotics_7\NNS\3247620|sedative
DDI-DrugBank.d739.s12.e0_DDI-DrugBank.d739.s12.e2 false hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) agents_11\NNS\7347|non-steroidal|anti-inflammatory
DDI-DrugBank.d739.s12.e0_DDI-DrugBank.d739.s12.e3 false hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) benzodiazepines_13\NNS\3771443|,|and|decongestants
DDI-DrugBank.d739.s12.e0_DDI-DrugBank.d739.s12.e4 false hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) benzodiazepines_13\NNS\3771443|,|and|decongestants (l_conj) decongestants_16\NNS\3740161|
DDI-DrugBank.d739.s12.e1_DDI-DrugBank.d739.s12.e2 false hypnotics_7\NNS\3247620|sedative (r_conj) hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) agents_11\NNS\7347|non-steroidal|anti-inflammatory
DDI-DrugBank.d739.s12.e1_DDI-DrugBank.d739.s12.e3 false hypnotics_7\NNS\3247620|sedative (r_conj) hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) benzodiazepines_13\NNS\3771443|,|and|decongestants
DDI-DrugBank.d739.s12.e1_DDI-DrugBank.d739.s12.e4 false hypnotics_7\NNS\3247620|sedative (r_conj) hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) benzodiazepines_13\NNS\3771443|,|and|decongestants (l_conj) decongestants_16\NNS\3740161|
DDI-DrugBank.d739.s12.e2_DDI-DrugBank.d739.s12.e3 false agents_11\NNS\7347|non-steroidal|anti-inflammatory (r_conj) hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) benzodiazepines_13\NNS\3771443|,|and|decongestants
DDI-DrugBank.d739.s12.e2_DDI-DrugBank.d739.s12.e4 false agents_11\NNS\7347|non-steroidal|anti-inflammatory (r_conj) hormones_4\NNS\5404728|thyroid|,|hypnotics|,|agents|,|benzodiazepines (l_conj) benzodiazepines_13\NNS\3771443|,|and|decongestants (l_conj) decongestants_16\NNS\3740161|
DDI-DrugBank.d739.s12.e3_DDI-DrugBank.d739.s12.e4 false benzodiazepines_13\NNS\3771443|,|and|decongestants (l_conj) decongestants_16\NNS\3740161|
DDI-DrugBank.d572.s32
DDI-DrugBank.d572.s18
DDI-DrugBank.d628.s4
DDI-DrugBank.d628.s4.e0_DDI-DrugBank.d628.s4.e1 false isoflurane_10\NN\3570838|(|eg|,|,|enflurane|) (l_conj) enflurane_12\NN\3299929|,|and|halothane
DDI-DrugBank.d628.s4.e0_DDI-DrugBank.d628.s4.e2 false isoflurane_10\NN\3570838|(|eg|,|,|enflurane|) (l_conj) enflurane_12\NN\3299929|,|and|halothane (l_conj) halothane_15\NN\3570838|
DDI-DrugBank.d628.s4.e0_DDI-DrugBank.d628.s4.e3 false isoflurane_10\NN\3570838|(|eg|,|,|enflurane|) (r_appos) agents_6\NNS\7347|of|potent|inhalational|isoflurane (r_nmod) administration_2\NN\1133281|the|concurrent|agents|maintenance (l_nmod) maintenance_18\NN\266806|during|emulsion (l_nmod) emulsion_22\NN\14588219|with|diprivan|injectable (l_amod) diprivan_20\JJ\1740|
DDI-DrugBank.d628.s4.e1_DDI-DrugBank.d628.s4.e2 false enflurane_12\NN\3299929|,|and|halothane (l_conj) halothane_15\NN\3570838|
DDI-DrugBank.d628.s4.e1_DDI-DrugBank.d628.s4.e3 false enflurane_12\NN\3299929|,|and|halothane (r_conj) isoflurane_10\NN\3570838|(|eg|,|,|enflurane|) (r_appos) agents_6\NNS\7347|of|potent|inhalational|isoflurane (r_nmod) administration_2\NN\1133281|the|concurrent|agents|maintenance (l_nmod) maintenance_18\NN\266806|during|emulsion (l_nmod) emulsion_22\NN\14588219|with|diprivan|injectable (l_amod) diprivan_20\JJ\1740|
DDI-DrugBank.d628.s4.e2_DDI-DrugBank.d628.s4.e3 false halothane_15\NN\3570838| (r_conj) enflurane_12\NN\3299929|,|and|halothane (r_conj) isoflurane_10\NN\3570838|(|eg|,|,|enflurane|) (r_appos) agents_6\NNS\7347|of|potent|inhalational|isoflurane (r_nmod) administration_2\NN\1133281|the|concurrent|agents|maintenance (l_nmod) maintenance_18\NN\266806|during|emulsion (l_nmod) emulsion_22\NN\14588219|with|diprivan|injectable (l_amod) diprivan_20\JJ\1740|
DDI-DrugBank.d739.s3
DDI-DrugBank.d739.s3.e0_DDI-DrugBank.d739.s3.e1 false terfenadine_9\NN\1740|of|substrate|or|fexofenadine|, (l_conj) fexofenadine_19\NN\1740|,|metabolite
DDI-DrugBank.d739.s3.e0_DDI-DrugBank.d739.s3.e2 false terfenadine_9\NN\1740|of|substrate|or|fexofenadine|, (r_nmod) profile_7\NN\6999802|the|plasma|concentration|terfenadine (r_dobj) change_3\VB\46534|-|did|not|profile|and|prolong|. (l_conj) prolong_28\VB\317700|did|not|interval|co-administration (l_nmod) co-administration_33\NN\1740|following|terfenadine|mg|daily (l_nmod) terfenadine_35\NN\1740|with
DDI-DrugBank.d739.s3.e1_DDI-DrugBank.d739.s3.e2 false fexofenadine_19\NN\1740|,|metabolite (r_conj) terfenadine_9\NN\1740|of|substrate|or|fexofenadine|, (r_nmod) profile_7\NN\6999802|the|plasma|concentration|terfenadine (r_dobj) change_3\VB\46534|-|did|not|profile|and|prolong|. (l_conj) prolong_28\VB\317700|did|not|interval|co-administration (l_nmod) co-administration_33\NN\1740|following|terfenadine|mg|daily (l_nmod) terfenadine_35\NN\1740|with
DDI-DrugBank.d739.s11
DDI-DrugBank.d732.s2
DDI-DrugBank.d732.s2.e1_DDI-DrugBank.d732.s2.e0 false edta_13\NN\14682133|such|cana|2 (r_nmod) therapy_7\NN\657604|with|other|chelation|,|edta (r_nmod) administration_1\NN\1133281|concomitant|chemet|therapy (l_nmod) chemet_3\NN\1740|of
DDI-DrugBank.d573.s1
DDI-DrugBank.d573.s1.e0_DDI-DrugBank.d573.s1.e1 true guanethidine_4\NN\1740|possible (r_nsubjpass) discontinued_7\VBN\2609764|if|guanethidine|should|be|begun|. (l_advcl) begun_12\VBN\941990|well|before|minoxidil|is (l_nsubjpass) minoxidil_10\NN\4522904|
DDI-DrugBank.d572.s21
DDI-DrugBank.d608.s2
DDI-DrugBank.d608.s2.e0_DDI-DrugBank.d608.s2.e1 true tolectin_8\NN\3828465| (r_dobj) administering_7\VBG\2436349|when|tolectin|patients (l_nmod) patients_10\NNS\9898892|to|anticoagulants (l_nmod) anticoagulants_12\NNS\3740161|on
DDI-DrugBank.d761.s1
DDI-DrugBank.d761.s1.e0_DDI-DrugBank.d761.s1.e2 false cyclosporine_0\NN\1740| (r_dep) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_nsubj) data_3\NNS\7951464|preliminary|study (l_nmod) study_11\NN\635850|from|a|xenical (l_compound) xenical_6\NN\1740|and|interaction (l_conj) interaction_10\NN\37396|cyclosporine|drug (l_compound) cyclosporine_8\NN\1740|
DDI-DrugBank.d761.s1.e0_DDI-DrugBank.d761.s1.e3 false cyclosporine_0\NN\1740| (r_dep) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_dobj) reduction_14\NN\351485|a|levels (l_nmod) levels_18\NNS\4916342|in|cyclosporine|plasma (l_compound) cyclosporine_16\NN\1740|
DDI-DrugBank.d761.s1.e0_DDI-DrugBank.d761.s1.e5 false cyclosporine_0\NN\1740| (r_dep) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_ccomp) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nmod) cyclosporine_24\NN\1740|with
DDI-DrugBank.d761.s1.e0_DDI-DrugBank.d761.s1.e1 false cyclosporine_0\NN\1740| (r_dep) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_nsubj) data_3\NNS\7951464|preliminary|study (l_nmod) study_11\NN\635850|from|a|xenical (l_compound) xenical_6\NN\1740|and|interaction
DDI-DrugBank.d761.s1.e0_DDI-DrugBank.d761.s1.e4 false cyclosporine_0\NN\1740| (r_dep) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_ccomp) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nsubjpass) xenical_20\NN\1740|
DDI-DrugBank.d761.s1.e2_DDI-DrugBank.d761.s1.e3 false cyclosporine_8\NN\1740| (r_compound) interaction_10\NN\37396|cyclosporine|drug (r_conj) xenical_6\NN\1740|and|interaction (r_compound) study_11\NN\635850|from|a|xenical (r_nmod) data_3\NNS\7951464|preliminary|study (r_nsubj) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_dobj) reduction_14\NN\351485|a|levels (l_nmod) levels_18\NNS\4916342|in|cyclosporine|plasma (l_compound) cyclosporine_16\NN\1740|
DDI-DrugBank.d761.s1.e2_DDI-DrugBank.d761.s1.e5 false cyclosporine_8\NN\1740| (r_compound) interaction_10\NN\37396|cyclosporine|drug (r_conj) xenical_6\NN\1740|and|interaction (r_compound) study_11\NN\635850|from|a|xenical (r_nmod) data_3\NNS\7951464|preliminary|study (r_nsubj) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_ccomp) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nmod) cyclosporine_24\NN\1740|with
DDI-DrugBank.d761.s1.e2_DDI-DrugBank.d761.s1.e1 false cyclosporine_8\NN\1740| (r_compound) interaction_10\NN\37396|cyclosporine|drug (r_conj) xenical_6\NN\1740|and|interaction
DDI-DrugBank.d761.s1.e2_DDI-DrugBank.d761.s1.e4 false cyclosporine_8\NN\1740| (r_compound) interaction_10\NN\37396|cyclosporine|drug (r_conj) xenical_6\NN\1740|and|interaction (r_compound) study_11\NN\635850|from|a|xenical (r_nmod) data_3\NNS\7951464|preliminary|study (r_nsubj) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_ccomp) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nsubjpass) xenical_20\NN\1740|
DDI-DrugBank.d761.s1.e3_DDI-DrugBank.d761.s1.e5 false cyclosporine_16\NN\1740| (r_compound) levels_18\NNS\4916342|in|cyclosporine|plasma (r_nmod) reduction_14\NN\351485|a|levels (r_dobj) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_ccomp) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nmod) cyclosporine_24\NN\1740|with
DDI-DrugBank.d761.s1.e3_DDI-DrugBank.d761.s1.e1 false cyclosporine_16\NN\1740| (r_compound) levels_18\NNS\4916342|in|cyclosporine|plasma (r_nmod) reduction_14\NN\351485|a|levels (r_dobj) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_nsubj) data_3\NNS\7951464|preliminary|study (l_nmod) study_11\NN\635850|from|a|xenical (l_compound) xenical_6\NN\1740|and|interaction
DDI-DrugBank.d761.s1.e3_DDI-DrugBank.d761.s1.e4 false cyclosporine_16\NN\1740| (r_compound) levels_18\NNS\4916342|in|cyclosporine|plasma (r_nmod) reduction_14\NN\351485|a|levels (r_dobj) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_ccomp) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nsubjpass) xenical_20\NN\1740|
DDI-DrugBank.d761.s1.e5_DDI-DrugBank.d761.s1.e1 false cyclosporine_24\NN\1740|with (r_nmod) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (r_ccomp) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_nsubj) data_3\NNS\7951464|preliminary|study (l_nmod) study_11\NN\635850|from|a|xenical (l_compound) xenical_6\NN\1740|and|interaction
DDI-DrugBank.d761.s1.e5_DDI-DrugBank.d761.s1.e4 false cyclosporine_24\NN\1740|with (r_nmod) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nsubjpass) xenical_20\NN\1740|
DDI-DrugBank.d761.s1.e1_DDI-DrugBank.d761.s1.e4 false xenical_6\NN\1740|and|interaction (r_compound) study_11\NN\635850|from|a|xenical (r_nmod) data_3\NNS\7951464|preliminary|study (r_nsubj) indicate_12\VBP\952524|cyclosporine|:|data|reduction|coadministered|. (l_ccomp) coadministered_22\VBN\1740|when|xenical|was|cyclosporine (l_nsubjpass) xenical_20\NN\1740|
DDI-DrugBank.d611.s0
DDI-DrugBank.d611.s0.e2_DDI-DrugBank.d611.s0.e1 false sulfate_14\NN\15010703|(|metaproterenol|usp|) (r_appos) alupent_11\NN\2905612|with|sulfate
DDI-DrugBank.d611.s0.e2_DDI-DrugBank.d611.s0.e0 false sulfate_14\NN\15010703|(|metaproterenol|usp|) (r_appos) alupent_11\NN\2905612|with|sulfate (r_nmod) used_8\VBN\1156834|bronchodilators|should|not|be|concomitantly|alupent|have|. (l_nsubjpass) bronchodilators_4\NNS\3740161|other|adrenergic|aerosol
DDI-DrugBank.d611.s0.e1_DDI-DrugBank.d611.s0.e0 false alupent_11\NN\2905612|with|sulfate (r_nmod) used_8\VBN\1156834|bronchodilators|should|not|be|concomitantly|alupent|have|. (l_nsubjpass) bronchodilators_4\NNS\3740161|other|adrenergic|aerosol
DDI-DrugBank.d591.s5
DDI-DrugBank.d591.s5.e0_DDI-DrugBank.d591.s5.e1 false theophylline_15\NN\2905612|such|and|imipramine (l_conj) imipramine_17\NN\4482543|
DDI-DrugBank.d639.s7
DDI-DrugBank.d597.s15
DDI-DrugBank.d670.s1
DDI-DrugBank.d756.s10
DDI-DrugBank.d584.s11
DDI-DrugBank.d744.s0
DDI-DrugBank.d744.s0.e0_DDI-DrugBank.d744.s0.e2 true insulin_8\NN\5407119|with|and/or|agents (r_nmod) treated_6\VBN\2376958|patients|being|insulin (r_nsubj) require_14\VB\754942|treated|may|reductions|initiation|. (l_nmod) initiation_23\NN\7450842|after|the|therapy (l_nmod) therapy_25\NN\657604|of|somavert (l_nmod) somavert_27\NNP\1740|with
DDI-DrugBank.d744.s0.e0_DDI-DrugBank.d744.s0.e1 false insulin_8\NN\5407119|with|and/or|agents (l_conj) agents_12\NNS\7347|oral|hypoglycemic (l_amod) hypoglycemic_11\JJ\1740|
DDI-DrugBank.d744.s0.e2_DDI-DrugBank.d744.s0.e1 false somavert_27\NNP\1740|with (r_nmod) therapy_25\NN\657604|of|somavert (r_nmod) initiation_23\NN\7450842|after|the|therapy (r_nmod) require_14\VB\754942|treated|may|reductions|initiation|. (l_nsubj) treated_6\VBN\2376958|patients|being|insulin (l_nmod) insulin_8\NN\5407119|with|and/or|agents (l_conj) agents_12\NNS\7347|oral|hypoglycemic (l_amod) hypoglycemic_11\JJ\1740|
DDI-DrugBank.d770.s4
DDI-DrugBank.d770.s4.e1_DDI-DrugBank.d770.s4.e0 false salmon_20\NN\2512938|(|) (r_appos) calcitonin_18\NN\5413241|salmon (r_compound) spray_23\NN\14980215|to|calcitonin|nasal (r_nmod) response_16\NN\11410625|the|anti-resorptive|spray (r_dobj) reduce_13\VB\441445|to|response (r_xcomp) appears_11\VBZ\2604760|however|,|patients|use|reduce|. (l_nsubj) use_10\NN\407535|prior|diphosphonate (l_compound) diphosphonate_9\NN\1740|
DDI-DrugBank.d784.s1
DDI-DrugBank.d739.s1
DDI-DrugBank.d739.s1.e0_DDI-DrugBank.d739.s1.e1 false warfarin_8\NN\2718259|of (r_nmod) profile_6\NN\6999802|the|pharmacokinetic|warfarin|substrate (r_dobj) change_3\VB\46534|-|did|not|profile|or|influence|. (l_conj) influence_20\VBD\137313|effect (l_dobj) effect_22\NN\34213|the|dose|time (l_nmod) dose_28\NN\3740161|of|a|single|30-mg|oral|warfarin (l_nmod) warfarin_30\NN\2718259|of
DDI-DrugBank.d727.s1
DDI-DrugBank.d727.s1.e0_DDI-DrugBank.d727.s1.e1 true zidovudine_4\NN\3834836|of (r_nmod) use_2\NN\407535|zidovudine|combination (l_nmod) combination_6\NN\7951464|in|zerit (l_nmod) zerit_8\NN\1740|with
DDI-DrugBank.d711.s1
DDI-DrugBank.d711.s1.e0_DDI-DrugBank.d711.s1.e2 false penicillin_10\NN\2716866|of (r_nmod) action_8\NN\30358|with|the|bactericidal|penicillin (r_nmod) interfere_4\VB\2451370|since|drugs|may|action (r_advcl) advisable_14\JJ\1740|interfere|,|it|is|avoid|. (l_xcomp) avoid_16\VB\2452885|to|giving (l_xcomp) giving_17\VBG\2327200|drugs|conjunction (l_nmod) conjunction_22\NN\5048123|in|penicillin (l_nmod) penicillin_24\NN\2716866|with
DDI-DrugBank.d711.s1.e0_DDI-DrugBank.d711.s1.e1 false penicillin_10\NN\2716866|of (r_nmod) action_8\NN\30358|with|the|bactericidal|penicillin (r_nmod) interfere_4\VB\2451370|since|drugs|may|action (r_advcl) advisable_14\JJ\1740|interfere|,|it|is|avoid|. (l_xcomp) avoid_16\VB\2452885|to|giving (l_xcomp) giving_17\VBG\2327200|drugs|conjunction (l_dobj) drugs_20\NNS\14778436|tetracycline|class
DDI-DrugBank.d711.s1.e2_DDI-DrugBank.d711.s1.e1 false penicillin_24\NN\2716866|with (r_nmod) conjunction_22\NN\5048123|in|penicillin (r_nmod) giving_17\VBG\2327200|drugs|conjunction (l_dobj) drugs_20\NNS\14778436|tetracycline|class
DDI-DrugBank.d776.s4
DDI-DrugBank.d776.s4.e1_DDI-DrugBank.d776.s4.e2 false tolbutamide_5\NN\14914301|of|,|glyburide|,|and|glipizide (l_conj) glyburide_7\NN\2719105|
DDI-DrugBank.d776.s4.e1_DDI-DrugBank.d776.s4.e3 false tolbutamide_5\NN\14914301|of|,|glyburide|,|and|glipizide (l_conj) glipizide_10\NN\2719105|
DDI-DrugBank.d776.s4.e1_DDI-DrugBank.d776.s4.e0 false tolbutamide_5\NN\14914301|of|,|glyburide|,|and|glipizide (r_nmod) metabolism_3\NN\13526110|the|tolbutamide (r_dobj) reduces_1\VBZ\441445|diflucan|metabolism|and|increases|. (l_nsubj) diflucan_0\NN\1740|
DDI-DrugBank.d776.s4.e2_DDI-DrugBank.d776.s4.e3 false glyburide_7\NN\2719105| (r_conj) tolbutamide_5\NN\14914301|of|,|glyburide|,|and|glipizide (l_conj) glipizide_10\NN\2719105|
DDI-DrugBank.d776.s4.e2_DDI-DrugBank.d776.s4.e0 false glyburide_7\NN\2719105| (r_conj) tolbutamide_5\NN\14914301|of|,|glyburide|,|and|glipizide (r_nmod) metabolism_3\NN\13526110|the|tolbutamide (r_dobj) reduces_1\VBZ\441445|diflucan|metabolism|and|increases|. (l_nsubj) diflucan_0\NN\1740|
DDI-DrugBank.d776.s4.e3_DDI-DrugBank.d776.s4.e0 false glipizide_10\NN\2719105| (r_conj) tolbutamide_5\NN\14914301|of|,|glyburide|,|and|glipizide (r_nmod) metabolism_3\NN\13526110|the|tolbutamide (r_dobj) reduces_1\VBZ\441445|diflucan|metabolism|and|increases|. (l_nsubj) diflucan_0\NN\1740|
DDI-DrugBank.d600.s1
DDI-DrugBank.d600.s1.e0_DDI-DrugBank.d600.s1.e2 true alcohol_3\NN\7881800|of|and|drugs (r_nmod) use_1\NN\407535|concurrent|alcohol (r_nsubj) increase_10\VB\169651|use|may|effects (l_dobj) effects_14\NNS\13245626|the|cns|depressant|methyprylon (l_nmod) methyprylon_16\NN\1740|of|or|medications.
DDI-DrugBank.d600.s1.e0_DDI-DrugBank.d600.s1.e1 false alcohol_3\NN\7881800|of|and|drugs (l_conj) drugs_8\NNS\14778436|other|depression-producing
DDI-DrugBank.d600.s1.e2_DDI-DrugBank.d600.s1.e1 false methyprylon_16\NN\1740|of|or|medications. (r_nmod) effects_14\NNS\13245626|the|cns|depressant|methyprylon (r_dobj) increase_10\VB\169651|use|may|effects (l_nsubj) use_1\NN\407535|concurrent|alcohol (l_nmod) alcohol_3\NN\7881800|of|and|drugs (l_conj) drugs_8\NNS\14778436|other|depression-producing
DDI-DrugBank.d575.s4
DDI-DrugBank.d723.s0
DDI-DrugBank.d723.s0.e0_DDI-DrugBank.d723.s0.e2 false chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_conj) carbachol_13\NN\1740|(|carboptic|)
DDI-DrugBank.d723.s0.e0_DDI-DrugBank.d723.s0.e5 true chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (r_nmod) medications_4\NNS\3247620|chloride (r_conj) drops_2\NNS\13899200|other|eye|or|medications (r_nsubj) decrease_21\VB\169651|drops|may|effects|. (l_dobj) effects_23\NNS\13245626|the|ophthalmic (l_nmod) ophthalmic_26\NNP\1740|suprofen (l_compound) suprofen_25\NNP\1740|of
DDI-DrugBank.d723.s0.e0_DDI-DrugBank.d723.s0.e1 false chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_appos) miochol_10\NN\1740|(|)
DDI-DrugBank.d723.s0.e0_DDI-DrugBank.d723.s0.e3 false chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_conj) carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol
DDI-DrugBank.d723.s0.e0_DDI-DrugBank.d723.s0.e4 false chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_conj) carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol (l_appos) carbachol_18\NN\1740|isopto
DDI-DrugBank.d723.s0.e2_DDI-DrugBank.d723.s0.e5 false carbachol_13\NN\1740|(|carboptic|) (r_conj) chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (r_nmod) medications_4\NNS\3247620|chloride (r_conj) drops_2\NNS\13899200|other|eye|or|medications (r_nsubj) decrease_21\VB\169651|drops|may|effects|. (l_dobj) effects_23\NNS\13245626|the|ophthalmic (l_nmod) ophthalmic_26\NNP\1740|suprofen (l_compound) suprofen_25\NNP\1740|of
DDI-DrugBank.d723.s0.e2_DDI-DrugBank.d723.s0.e1 false carbachol_13\NN\1740|(|carboptic|) (r_conj) chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_appos) miochol_10\NN\1740|(|)
DDI-DrugBank.d723.s0.e2_DDI-DrugBank.d723.s0.e3 false carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol
DDI-DrugBank.d723.s0.e2_DDI-DrugBank.d723.s0.e4 false carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol (l_appos) carbachol_18\NN\1740|isopto
DDI-DrugBank.d723.s0.e5_DDI-DrugBank.d723.s0.e1 false suprofen_25\NNP\1740|of (r_compound) ophthalmic_26\NNP\1740|suprofen (r_nmod) effects_23\NNS\13245626|the|ophthalmic (r_dobj) decrease_21\VB\169651|drops|may|effects|. (l_nsubj) drops_2\NNS\13899200|other|eye|or|medications (l_conj) medications_4\NNS\3247620|chloride (l_nmod) chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_appos) miochol_10\NN\1740|(|)
DDI-DrugBank.d723.s0.e5_DDI-DrugBank.d723.s0.e3 false suprofen_25\NNP\1740|of (r_compound) ophthalmic_26\NNP\1740|suprofen (r_nmod) effects_23\NNS\13245626|the|ophthalmic (r_dobj) decrease_21\VB\169651|drops|may|effects|. (l_nsubj) drops_2\NNS\13899200|other|eye|or|medications (l_conj) medications_4\NNS\3247620|chloride (l_nmod) chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_conj) carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol
DDI-DrugBank.d723.s0.e5_DDI-DrugBank.d723.s0.e4 false suprofen_25\NNP\1740|of (r_compound) ophthalmic_26\NNP\1740|suprofen (r_nmod) effects_23\NNS\13245626|the|ophthalmic (r_dobj) decrease_21\VB\169651|drops|may|effects|. (l_nsubj) drops_2\NNS\13899200|other|eye|or|medications (l_conj) medications_4\NNS\3247620|chloride (l_nmod) chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_conj) carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol (l_appos) carbachol_18\NN\1740|isopto
DDI-DrugBank.d723.s0.e1_DDI-DrugBank.d723.s0.e3 false miochol_10\NN\1740|(|) (r_appos) chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_conj) carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol
DDI-DrugBank.d723.s0.e1_DDI-DrugBank.d723.s0.e4 false miochol_10\NN\1740|(|) (r_appos) chloride_8\NN\14818238|such|acetylcholine|miochol|and|carbachol (l_conj) carbachol_13\NN\1740|(|carboptic|) (l_appos) carboptic_15\NN\1740|,|carbachol (l_appos) carbachol_18\NN\1740|isopto
DDI-DrugBank.d723.s0.e3_DDI-DrugBank.d723.s0.e4 false carboptic_15\NN\1740|,|carbachol (l_appos) carbachol_18\NN\1740|isopto
DDI-DrugBank.d741.s3
DDI-DrugBank.d633.s0
DDI-DrugBank.d633.s0.e1_DDI-DrugBank.d633.s0.e0 false mexiletine_28\NN\2715941| (r_compound) concentrations_30\NNS\4916342|mexiletine|plasma (r_dobj) alter_27\VB\126264|to|concentrations (r_xcomp) expected_25\VBN\670261|substrate|,|inhibition|would|be|alter|. (l_advcl) substrate_4\NN\19613|since|mexitil|is|a|pathways (l_nsubj) mexitil_1\NN\2715941|
DDI-DrugBank.d736.s4
DDI-DrugBank.d661.s2
DDI-DrugBank.d661.s2.e1_DDI-DrugBank.d661.s2.e0 false succinylcholine_16\NN\3800001|of (r_nmod) dose_14\NN\3740161|after|a|mg/kg|succinylcholine (r_nmod) administered_9\VBN\2436349|dose|returned (r_acl) mg/kg_8\NN\1740|zemuron|0.6|administered (l_compound) zemuron_6\NN\1740|of
DDI-DrugBank.d619.s4
DDI-DrugBank.d619.s4.e1_DDI-DrugBank.d619.s4.e3 false eldepryl_15\NN\1740|and|inhibitors (l_conj) inhibitors_20\NNS\20090|selective|serotonin|reuptake|and|eldepryl (l_conj) eldepryl_22\NN\1740|
DDI-DrugBank.d619.s4.e1_DDI-DrugBank.d619.s4.e0 false eldepryl_15\NN\1740|and|inhibitors (r_conj) antidepressants_13\NNS\3740161|of|tricyclic|and|eldepryl
DDI-DrugBank.d619.s4.e1_DDI-DrugBank.d619.s4.e2 false eldepryl_15\NN\1740|and|inhibitors (l_conj) inhibitors_20\NNS\20090|selective|serotonin|reuptake|and|eldepryl
DDI-DrugBank.d619.s4.e3_DDI-DrugBank.d619.s4.e0 false eldepryl_22\NN\1740| (r_conj) inhibitors_20\NNS\20090|selective|serotonin|reuptake|and|eldepryl (r_conj) eldepryl_15\NN\1740|and|inhibitors (r_conj) antidepressants_13\NNS\3740161|of|tricyclic|and|eldepryl
DDI-DrugBank.d619.s4.e3_DDI-DrugBank.d619.s4.e2 false eldepryl_22\NN\1740| (r_conj) inhibitors_20\NNS\20090|selective|serotonin|reuptake|and|eldepryl
DDI-DrugBank.d619.s4.e0_DDI-DrugBank.d619.s4.e2 false antidepressants_13\NNS\3740161|of|tricyclic|and|eldepryl (l_conj) eldepryl_15\NN\1740|and|inhibitors (l_conj) inhibitors_20\NNS\20090|selective|serotonin|reuptake|and|eldepryl
DDI-DrugBank.d597.s28
DDI-DrugBank.d597.s28.e0_DDI-DrugBank.d597.s28.e1 false meloxicam_4\NN\1740| (r_nsubj) alter_7\VB\126264|subjects|,|meloxicam|did|not|pharmacokinetics|determined|. (l_dobj) pharmacokinetics_9\NNS\6054892|warfarin|and|effect (l_compound) warfarin_8\NN\2718259|
DDI-DrugBank.d597.s28.e0_DDI-DrugBank.d597.s28.e2 false meloxicam_4\NN\1740| (r_nsubj) alter_7\VB\126264|subjects|,|meloxicam|did|not|pharmacokinetics|determined|. (l_dobj) pharmacokinetics_9\NNS\6054892|warfarin|and|effect (l_conj) effect_14\NN\34213|the|average|anticoagulant|warfarin (l_nmod) warfarin_16\NN\2718259|of
DDI-DrugBank.d597.s28.e1_DDI-DrugBank.d597.s28.e2 false warfarin_8\NN\2718259| (r_compound) pharmacokinetics_9\NNS\6054892|warfarin|and|effect (l_conj) effect_14\NN\34213|the|average|anticoagulant|warfarin (l_nmod) warfarin_16\NN\2718259|of
DDI-DrugBank.d599.s2
DDI-DrugBank.d706.s1
DDI-DrugBank.d780.s4
DDI-DrugBank.d780.s4.e1_DDI-DrugBank.d780.s4.e0 false hydrochloride_8\NN\14817592|of|procaine|and|medications (r_nmod) use_5\NN\407535|concurrent|hydrochloride (r_nsubj) result_14\VB\2633881|medications|:|use|may|effects|. (l_nsubj) medications_2\NNS\3247620|cns|depressant (l_compound) depressant_1\NN\3248958|
DDI-DrugBank.d780.s4.e1_DDI-DrugBank.d780.s4.e2 true hydrochloride_8\NN\14817592|of|procaine|and|medications (l_conj) medications_12\NNS\3247620|cns|depressant
DDI-DrugBank.d780.s4.e0_DDI-DrugBank.d780.s4.e2 false depressant_1\NN\3248958| (r_compound) medications_2\NNS\3247620|cns|depressant (r_nsubj) result_14\VB\2633881|medications|:|use|may|effects|. (l_nsubj) use_5\NN\407535|concurrent|hydrochloride (l_nmod) hydrochloride_8\NN\14817592|of|procaine|and|medications (l_conj) medications_12\NNS\3247620|cns|depressant
DDI-DrugBank.d631.s1
DDI-DrugBank.d640.s9
DDI-DrugBank.d640.s9.e1_DDI-DrugBank.d640.s9.e2 false hydrochlorothiazide_15\NN\4423288|with|,|digoxin|,|or|cimetidine (l_conj) digoxin_17\NN\15060131|
DDI-DrugBank.d640.s9.e1_DDI-DrugBank.d640.s9.e3 false hydrochlorothiazide_15\NN\4423288|with|,|digoxin|,|or|cimetidine (l_conj) cimetidine_20\NN\14778019|
DDI-DrugBank.d640.s9.e1_DDI-DrugBank.d640.s9.e0 false hydrochlorothiazide_15\NN\4423288|with|,|digoxin|,|or|cimetidine (r_nmod) administered_12\VBN\2436349|when|univasc|was|concomitantly|hydrochlorothiazide (l_nsubjpass) univasc_10\NNP\1740|
DDI-DrugBank.d640.s9.e2_DDI-DrugBank.d640.s9.e3 false digoxin_17\NN\15060131| (r_conj) hydrochlorothiazide_15\NN\4423288|with|,|digoxin|,|or|cimetidine (l_conj) cimetidine_20\NN\14778019|
DDI-DrugBank.d640.s9.e2_DDI-DrugBank.d640.s9.e0 false digoxin_17\NN\15060131| (r_conj) hydrochlorothiazide_15\NN\4423288|with|,|digoxin|,|or|cimetidine (r_nmod) administered_12\VBN\2436349|when|univasc|was|concomitantly|hydrochlorothiazide (l_nsubjpass) univasc_10\NNP\1740|
DDI-DrugBank.d640.s9.e3_DDI-DrugBank.d640.s9.e0 false cimetidine_20\NN\14778019| (r_conj) hydrochlorothiazide_15\NN\4423288|with|,|digoxin|,|or|cimetidine (r_nmod) administered_12\VBN\2436349|when|univasc|was|concomitantly|hydrochlorothiazide (l_nsubjpass) univasc_10\NNP\1740|
DDI-DrugBank.d696.s0
DDI-DrugBank.d696.s0.e0_DDI-DrugBank.d696.s0.e1 true methysergide_0\NN\1740| (r_nsubj) reverse_2\VB\109660|methysergide|may|activity|. (l_dobj) activity_5\NN\30358|the|analgesic|analgesics (l_nmod) analgesics_8\NNS\3740161|of|narcotic
DDI-DrugBank.d651.s0
DDI-DrugBank.d651.s0.e0_DDI-DrugBank.d651.s0.e1 true contraceptives_6\NNS\3183080|on|oral (r_nmod) women_3\NNS\9605289|contraceptives (r_nsubj) shown_8\VBN\2137132|interactions|:|women|have|increase|. (l_dobj) increase_11\NN\13576355|a|significant|levels (l_nmod) levels_16\NNS\4916342|in|plasma|a (l_compound) a_15\NN\13649268|vitamin (l_compound) vitamin_14\NN\7570720|
DDI-DrugBank.d700.s9
DDI-DrugBank.d700.s9.e1_DDI-DrugBank.d700.s9.e0 false myfortic_8\JJ\1740|and|oral (r_amod) contraceptives_11\NNS\3183080|of|myfortic (r_nmod) metabolism_6\NN\13526110|given|the|different|contraceptives (r_nmod) expected_23\VBN\670261|metabolism|,|interaction|is|. (r_dep) contraceptives_1\NNS\3183080|oral|:|expected
DDI-DrugBank.d700.s9.e1_DDI-DrugBank.d700.s9.e2 false myfortic_8\JJ\1740|and|oral (r_amod) contraceptives_11\NNS\3183080|of|myfortic
DDI-DrugBank.d700.s9.e0_DDI-DrugBank.d700.s9.e2 false contraceptives_1\NNS\3183080|oral|:|expected (l_dep) expected_23\VBN\670261|metabolism|,|interaction|is|. (l_nmod) metabolism_6\NN\13526110|given|the|different|contraceptives (l_nmod) contraceptives_11\NNS\3183080|of|myfortic
DDI-DrugBank.d725.s1
DDI-DrugBank.d725.s1.e0_DDI-DrugBank.d725.s1.e1 false inhibitors_1\NNS\20090|mao (r_dep) potentiated_12\VBN\229605|inhibitors|:|effect|is|markedly|patients|. (l_nsubjpass) effect_5\NN\34213|the|pressor|amines (l_nmod) amines_9\NNS\14951377|of|sympathomimetic|pressor
DDI-DrugBank.d725.s1.e0_DDI-DrugBank.d725.s1.e2 false inhibitors_1\NNS\20090|mao (r_dep) potentiated_12\VBN\229605|inhibitors|:|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi
DDI-DrugBank.d725.s1.e0_DDI-DrugBank.d725.s1.e3 false inhibitors_1\NNS\20090|mao (r_dep) potentiated_12\VBN\229605|inhibitors|:|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi (l_appos) maoi_20\NNS\2718811|(|)
DDI-DrugBank.d725.s1.e1_DDI-DrugBank.d725.s1.e2 true amines_9\NNS\14951377|of|sympathomimetic|pressor (r_nmod) effect_5\NN\34213|the|pressor|amines (r_nsubjpass) potentiated_12\VBN\229605|inhibitors|:|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi
DDI-DrugBank.d725.s1.e1_DDI-DrugBank.d725.s1.e3 true amines_9\NNS\14951377|of|sympathomimetic|pressor (r_nmod) effect_5\NN\34213|the|pressor|amines (r_nsubjpass) potentiated_12\VBN\229605|inhibitors|:|effect|is|markedly|patients|. (l_nmod) patients_14\NNS\9898892|in|receiving (l_acl) receiving_15\VBG\2210855|inhibitors (l_dobj) inhibitors_18\NNS\20090|monoamine|oxidase|maoi (l_appos) maoi_20\NNS\2718811|(|)
DDI-DrugBank.d725.s1.e2_DDI-DrugBank.d725.s1.e3 false inhibitors_18\NNS\20090|monoamine|oxidase|maoi (l_appos) maoi_20\NNS\2718811|(|)
DDI-DrugBank.d599.s1
DDI-DrugBank.d773.s0
DDI-DrugBank.d648.s0
DDI-DrugBank.d648.s0.e0_DDI-DrugBank.d648.s0.e1 false cholestyramine_0\NN\1740|: (r_dep) causes_3\VBZ\1617192|cholestyramine|cholestyramine|reduction|and|coadministered|. (l_nsubj) cholestyramine_2\NN\1740|
DDI-DrugBank.d648.s0.e0_DDI-DrugBank.d648.s0.e2 false cholestyramine_0\NN\1740|: (r_dep) causes_3\VBZ\1617192|cholestyramine|cholestyramine|reduction|and|coadministered|. (l_dobj) reduction_7\NN\351485|a|%|absorption (l_nmod) absorption_10\NN\13558490|in|the|and|cycling|raloxifene (l_nmod) raloxifene_15\NN\1740|of
DDI-DrugBank.d648.s0.e0_DDI-DrugBank.d648.s0.e3 false cholestyramine_0\NN\1740|: (r_dep) causes_3\VBZ\1617192|cholestyramine|cholestyramine|reduction|and|coadministered|. (l_conj) coadministered_20\VBN\1740|should|not|be|evista (l_nmod) evista_22\NNP\1740|with
DDI-DrugBank.d648.s0.e1_DDI-DrugBank.d648.s0.e2 true cholestyramine_2\NN\1740| (r_nsubj) causes_3\VBZ\1617192|cholestyramine|cholestyramine|reduction|and|coadministered|. (l_dobj) reduction_7\NN\351485|a|%|absorption (l_nmod) absorption_10\NN\13558490|in|the|and|cycling|raloxifene (l_nmod) raloxifene_15\NN\1740|of
DDI-DrugBank.d648.s0.e1_DDI-DrugBank.d648.s0.e3 true cholestyramine_2\NN\1740| (r_nsubj) causes_3\VBZ\1617192|cholestyramine|cholestyramine|reduction|and|coadministered|. (l_conj) coadministered_20\VBN\1740|should|not|be|evista (l_nmod) evista_22\NNP\1740|with
DDI-DrugBank.d648.s0.e2_DDI-DrugBank.d648.s0.e3 false raloxifene_15\NN\1740|of (r_nmod) absorption_10\NN\13558490|in|the|and|cycling|raloxifene (r_nmod) reduction_7\NN\351485|a|%|absorption (r_dobj) causes_3\VBZ\1617192|cholestyramine|cholestyramine|reduction|and|coadministered|. (l_conj) coadministered_20\VBN\1740|should|not|be|evista (l_nmod) evista_22\NNP\1740|with
DDI-DrugBank.d776.s33
DDI-DrugBank.d776.s33.e0_DDI-DrugBank.d776.s33.e1 false tacrolimus_0\NN\1740| (r_dep) been_4\VBN\836236|tacrolimus|:|there|have|reports|. (l_attr) reports_5\NNS\6470073|nephrotoxicity|patients (l_nmod) patients_9\NNS\9898892|in|coadministered (l_acl:relcl) coadministered_16\VBN\1740|whom|fluconazole|were (l_nsubjpass) fluconazole_12\NN\1740|and|tacrolimus
DDI-DrugBank.d776.s33.e0_DDI-DrugBank.d776.s33.e2 false tacrolimus_0\NN\1740| (r_dep) been_4\VBN\836236|tacrolimus|:|there|have|reports|. (l_attr) reports_5\NNS\6470073|nephrotoxicity|patients (l_nmod) patients_9\NNS\9898892|in|coadministered (l_acl:relcl) coadministered_16\VBN\1740|whom|fluconazole|were (l_nsubjpass) fluconazole_12\NN\1740|and|tacrolimus (l_conj) tacrolimus_14\NN\1740|
DDI-DrugBank.d776.s33.e1_DDI-DrugBank.d776.s33.e2 true fluconazole_12\NN\1740|and|tacrolimus (l_conj) tacrolimus_14\NN\1740|
DDI-DrugBank.d640.s3
DDI-DrugBank.d640.s3.e1_DDI-DrugBank.d640.s3.e2 false spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (l_appos) triamterene_7\NN\1740|
DDI-DrugBank.d640.s3.e1_DDI-DrugBank.d640.s3.e3 false spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (l_appos) amiloride_9\NN\1740|
DDI-DrugBank.d640.s3.e1_DDI-DrugBank.d640.s3.e4 false spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements (l_conj) supplements_13\NNS\6365467|potassium|inhibitors (l_compound) potassium_12\NN\14625458|
DDI-DrugBank.d640.s3.e1_DDI-DrugBank.d640.s3.e0 false spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements
DDI-DrugBank.d640.s3.e1_DDI-DrugBank.d640.s3.e5 true spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements (l_conj) supplements_13\NNS\6365467|potassium|inhibitors (l_nmod) inhibitors_17\NNS\20090|with|ace
DDI-DrugBank.d640.s3.e2_DDI-DrugBank.d640.s3.e3 false triamterene_7\NN\1740| (r_appos) spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (l_appos) amiloride_9\NN\1740|
DDI-DrugBank.d640.s3.e2_DDI-DrugBank.d640.s3.e4 false triamterene_7\NN\1740| (r_appos) spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements (l_conj) supplements_13\NNS\6365467|potassium|inhibitors (l_compound) potassium_12\NN\14625458|
DDI-DrugBank.d640.s3.e2_DDI-DrugBank.d640.s3.e0 false triamterene_7\NN\1740| (r_appos) spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements
DDI-DrugBank.d640.s3.e2_DDI-DrugBank.d640.s3.e5 false triamterene_7\NN\1740| (r_appos) spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements (l_conj) supplements_13\NNS\6365467|potassium|inhibitors (l_nmod) inhibitors_17\NNS\20090|with|ace
DDI-DrugBank.d640.s3.e3_DDI-DrugBank.d640.s3.e4 false amiloride_9\NN\1740| (r_appos) spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements (l_conj) supplements_13\NNS\6365467|potassium|inhibitors (l_compound) potassium_12\NN\14625458|
DDI-DrugBank.d640.s3.e3_DDI-DrugBank.d640.s3.e0 false amiloride_9\NN\1740| (r_appos) spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements
DDI-DrugBank.d640.s3.e3_DDI-DrugBank.d640.s3.e5 false amiloride_9\NN\1740| (r_appos) spironolactone_5\NN\2721160|(|,|triamterene|,|amiloride|) (r_dep) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements (l_conj) supplements_13\NNS\6365467|potassium|inhibitors (l_nmod) inhibitors_17\NNS\20090|with|ace
DDI-DrugBank.d640.s3.e4_DDI-DrugBank.d640.s3.e0 false potassium_12\NN\14625458| (r_compound) supplements_13\NNS\6365467|potassium|inhibitors (r_conj) diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements
DDI-DrugBank.d640.s3.e4_DDI-DrugBank.d640.s3.e5 false potassium_12\NN\14625458| (r_compound) supplements_13\NNS\6365467|potassium|inhibitors (l_nmod) inhibitors_17\NNS\20090|with|ace
DDI-DrugBank.d640.s3.e0_DDI-DrugBank.d640.s3.e5 true diuretics_3\NNS\3247620|of|potassium-sparing|spironolactone|or|supplements (l_conj) supplements_13\NNS\6365467|potassium|inhibitors (l_nmod) inhibitors_17\NNS\20090|with|ace
DDI-DrugBank.d625.s0
DDI-DrugBank.d625.s0.e2_DDI-DrugBank.d625.s0.e3 true acid_13\NN\14818238|nalidixic (r_dep) recommended_8\VBN\875394|vaccinations|are|not|individuals|acid|melphalan (l_nmod) melphalan_18\NN\2722458|with|high-dose|intravenous
DDI-DrugBank.d625.s0.e2_DDI-DrugBank.d625.s0.e1 false acid_13\NN\14818238|nalidixic (r_dep) recommended_8\VBN\875394|vaccinations|are|not|individuals|acid|melphalan (l_nsubjpass) vaccinations_1\NNS\828990|vaccines (l_nmod) vaccines_5\NNS\3562739|with|live|organism
DDI-DrugBank.d625.s0.e3_DDI-DrugBank.d625.s0.e1 false melphalan_18\NN\2722458|with|high-dose|intravenous (r_nmod) recommended_8\VBN\875394|vaccinations|are|not|individuals|acid|melphalan (l_nsubjpass) vaccinations_1\NNS\828990|vaccines (l_nmod) vaccines_5\NNS\3562739|with|live|organism
DDI-DrugBank.d645.s9
DDI-DrugBank.d645.s9.e2_DDI-DrugBank.d645.s9.e3 false theophyllines_26\NNS\2905612| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) phenytoins_28\NNS\3550533|
DDI-DrugBank.d645.s9.e2_DDI-DrugBank.d645.s9.e0 false theophyllines_26\NNS\2905612| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers
DDI-DrugBank.d645.s9.e2_DDI-DrugBank.d645.s9.e1 false theophyllines_26\NNS\2905612| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) hypoglycemics_24\NNS\1740|
DDI-DrugBank.d645.s9.e2_DDI-DrugBank.d645.s9.e4 false theophyllines_26\NNS\2905612| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) diuretics_31\NNS\3247620|thiazide
DDI-DrugBank.d645.s9.e2_DDI-DrugBank.d645.s9.e5 false theophyllines_26\NNS\2905612| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_34\NNS\10101634|beta
DDI-DrugBank.d645.s9.e2_DDI-DrugBank.d645.s9.e6 false theophyllines_26\NNS\2905612| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_39\NNS\10101634|channel
DDI-DrugBank.d645.s9.e3_DDI-DrugBank.d645.s9.e0 false phenytoins_28\NNS\3550533| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers
DDI-DrugBank.d645.s9.e3_DDI-DrugBank.d645.s9.e1 false phenytoins_28\NNS\3550533| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) hypoglycemics_24\NNS\1740|
DDI-DrugBank.d645.s9.e3_DDI-DrugBank.d645.s9.e4 false phenytoins_28\NNS\3550533| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) diuretics_31\NNS\3247620|thiazide
DDI-DrugBank.d645.s9.e3_DDI-DrugBank.d645.s9.e5 false phenytoins_28\NNS\3550533| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_34\NNS\10101634|beta
DDI-DrugBank.d645.s9.e3_DDI-DrugBank.d645.s9.e6 false phenytoins_28\NNS\3550533| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_39\NNS\10101634|channel
DDI-DrugBank.d645.s9.e0_DDI-DrugBank.d645.s9.e1 false contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) hypoglycemics_24\NNS\1740|
DDI-DrugBank.d645.s9.e0_DDI-DrugBank.d645.s9.e4 false contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) diuretics_31\NNS\3247620|thiazide
DDI-DrugBank.d645.s9.e0_DDI-DrugBank.d645.s9.e5 false contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_34\NNS\10101634|beta
DDI-DrugBank.d645.s9.e0_DDI-DrugBank.d645.s9.e6 false contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_39\NNS\10101634|channel
DDI-DrugBank.d645.s9.e1_DDI-DrugBank.d645.s9.e4 false hypoglycemics_24\NNS\1740| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) diuretics_31\NNS\3247620|thiazide
DDI-DrugBank.d645.s9.e1_DDI-DrugBank.d645.s9.e5 false hypoglycemics_24\NNS\1740| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_34\NNS\10101634|beta
DDI-DrugBank.d645.s9.e1_DDI-DrugBank.d645.s9.e6 false hypoglycemics_24\NNS\1740| (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_39\NNS\10101634|channel
DDI-DrugBank.d645.s9.e4_DDI-DrugBank.d645.s9.e5 false diuretics_31\NNS\3247620|thiazide (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_34\NNS\10101634|beta
DDI-DrugBank.d645.s9.e4_DDI-DrugBank.d645.s9.e6 false diuretics_31\NNS\3247620|thiazide (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_39\NNS\10101634|channel
DDI-DrugBank.d645.s9.e5_DDI-DrugBank.d645.s9.e6 false blockers_34\NNS\10101634|beta (r_conj) contraceptives_18\NNS\3183080|oral|,|therapies|,|hypoglycemics|,|theophyllines|,|phenytoins|,|diuretics|,|blockers|,|and|blockers (l_conj) blockers_39\NNS\10101634|channel
DDI-DrugBank.d737.s7
DDI-DrugBank.d737.s7.e0_DDI-DrugBank.d737.s7.e1 false pramipexole_14\NN\1740| (r_compound) elimination_15\NN\391599|pramipexole (r_dobj) affect_13\VB\126264|to|elimination (r_xcomp) expected_11\VBN\670261|inhibitors|would|not|be|affect|metabolized|. (l_advcl) metabolized_21\VBN\1740|because|pramipexole|is|not|appreciably|enzymes|or (l_nsubjpass) pramipexole_17\NN\1740|
DDI-DrugBank.d628.s2
DDI-DrugBank.d603.s1
DDI-DrugBank.d776.s18
DDI-DrugBank.d776.s18.e0_DDI-DrugBank.d776.s18.e2 false theophylline_0\NN\2905612| (r_dep) increases_3\VBZ\169651|theophylline|:|diflucan|concentrations|. (l_dobj) concentrations_6\NNS\4916342|the|serum|theophylline (l_nmod) theophylline_8\NN\2905612|of
DDI-DrugBank.d776.s18.e0_DDI-DrugBank.d776.s18.e1 false theophylline_0\NN\2905612| (r_dep) increases_3\VBZ\169651|theophylline|:|diflucan|concentrations|. (l_nsubj) diflucan_2\NN\1740|
DDI-DrugBank.d776.s18.e2_DDI-DrugBank.d776.s18.e1 false theophylline_8\NN\2905612|of (r_nmod) concentrations_6\NNS\4916342|the|serum|theophylline (r_dobj) increases_3\VBZ\169651|theophylline|:|diflucan|concentrations|. (l_nsubj) diflucan_2\NN\1740|
DDI-DrugBank.d727.s0
DDI-DrugBank.d727.s0.e0_DDI-DrugBank.d727.s0.e1 true zidovudine_0\NN\3834836| (r_nsubj) inhibits_2\VBZ\2510337|zidovudine|competitively|phosphorylation|. (l_dobj) phosphorylation_5\NN\1740|the|intracellular|stavudine (l_nmod) stavudine_7\NN\1740|of
DDI-DrugBank.d776.s0
DDI-DrugBank.d623.s8
DDI-DrugBank.d576.s1
DDI-DrugBank.d576.s1.e3_DDI-DrugBank.d576.s1.e0 false acid_17\NN\14818238|of|salicylic (r_nmod) concentrations_14\NNS\4916342|plasma|acid (r_dobj) increase_12\VB\169651|may|concentrations|levels (r_conj) additive_7\JJ\1740|aspirin|will|be|disalcid|and|increase|. (l_nsubj) aspirin_0\NN\2707683|and|drugs
DDI-DrugBank.d576.s1.e3_DDI-DrugBank.d576.s1.e2 false acid_17\NN\14818238|of|salicylic (r_nmod) concentrations_14\NNS\4916342|plasma|acid (r_dobj) increase_12\VB\169651|may|concentrations|levels (r_conj) additive_7\JJ\1740|aspirin|will|be|disalcid|and|increase|. (l_nmod) disalcid_9\NN\1740|to
DDI-DrugBank.d576.s1.e3_DDI-DrugBank.d576.s1.e1 false acid_17\NN\14818238|of|salicylic (r_nmod) concentrations_14\NNS\4916342|plasma|acid (r_dobj) increase_12\VB\169651|may|concentrations|levels (r_conj) additive_7\JJ\1740|aspirin|will|be|disalcid|and|increase|. (l_nsubj) aspirin_0\NN\2707683|and|drugs (l_conj) drugs_4\NNS\14778436|other|salicylate
DDI-DrugBank.d576.s1.e0_DDI-DrugBank.d576.s1.e2 true aspirin_0\NN\2707683|and|drugs (r_nsubj) additive_7\JJ\1740|aspirin|will|be|disalcid|and|increase|. (l_nmod) disalcid_9\NN\1740|to
DDI-DrugBank.d576.s1.e0_DDI-DrugBank.d576.s1.e1 false aspirin_0\NN\2707683|and|drugs (l_conj) drugs_4\NNS\14778436|other|salicylate
DDI-DrugBank.d576.s1.e2_DDI-DrugBank.d576.s1.e1 false disalcid_9\NN\1740|to (r_nmod) additive_7\JJ\1740|aspirin|will|be|disalcid|and|increase|. (l_nsubj) aspirin_0\NN\2707683|and|drugs (l_conj) drugs_4\NNS\14778436|other|salicylate
DDI-DrugBank.d622.s0
DDI-DrugBank.d622.s0.e0_DDI-DrugBank.d622.s0.e1 true atropine_1\NN\14712692|and|pralidoxime (l_conj) pralidoxime_3\NN\1740|
DDI-DrugBank.d622.s0.e0_DDI-DrugBank.d622.s0.e2 false atropine_1\NN\14712692|and|pralidoxime (r_nsubjpass) used_5\VBN\1156834|when|atropine|are|together (r_advcl) occur_27\VB\2623529|used|,|signs|may|earlier|. (l_advmod) earlier_28\RBR\1740|expected (l_ccomp) expected_32\VBN\670261|than|might|be|used (l_advcl) used_36\VBN\1156834|when|atropine|is|alone (l_nsubjpass) atropine_34\NN\14712692|
DDI-DrugBank.d622.s0.e1_DDI-DrugBank.d622.s0.e2 false pralidoxime_3\NN\1740| (r_conj) atropine_1\NN\14712692|and|pralidoxime (r_nsubjpass) used_5\VBN\1156834|when|atropine|are|together (r_advcl) occur_27\VB\2623529|used|,|signs|may|earlier|. (l_advmod) earlier_28\RBR\1740|expected (l_ccomp) expected_32\VBN\670261|than|might|be|used (l_advcl) used_36\VBN\1156834|when|atropine|is|alone (l_nsubjpass) atropine_34\NN\14712692|
DDI-DrugBank.d761.s13
DDI-DrugBank.d761.s13.e2_DDI-DrugBank.d761.s13.e1 false warfarin_18\NN\2718259|of (r_nmod) doses_16\NNS\3740161|on|chronic|stable|warfarin (r_nmod) patients_12\NNS\9898892|doses|prescribed (r_nsubjpass) monitored_25\VBN\2169352|therefore|,|decreased|,|patients|should|be|closely|changes|. (l_advcl) decreased_8\VBN\169651|as|absorption|may|be|xenical (l_nmod) xenical_10\NN\1740|with
DDI-DrugBank.d761.s13.e2_DDI-DrugBank.d761.s13.e3 true warfarin_18\NN\2718259|of (r_nmod) doses_16\NNS\3740161|on|chronic|stable|warfarin (r_nmod) patients_12\NNS\9898892|doses|prescribed (l_acl:relcl) prescribed_21\VBN\748282|who|are|xenical (l_dobj) xenical_22\NN\1740|
DDI-DrugBank.d761.s13.e2_DDI-DrugBank.d761.s13.e0 false warfarin_18\NN\2718259|of (r_nmod) doses_16\NNS\3740161|on|chronic|stable|warfarin (r_nmod) patients_12\NNS\9898892|doses|prescribed (r_nsubjpass) monitored_25\VBN\2169352|therefore|,|decreased|,|patients|should|be|closely|changes|. (l_advcl) decreased_8\VBN\169651|as|absorption|may|be|xenical (l_nsubjpass) absorption_5\NN\13558490|vitamin|k (l_compound) vitamin_3\NN\7570720|
DDI-DrugBank.d761.s13.e1_DDI-DrugBank.d761.s13.e3 false xenical_10\NN\1740|with (r_nmod) decreased_8\VBN\169651|as|absorption|may|be|xenical (r_advcl) monitored_25\VBN\2169352|therefore|,|decreased|,|patients|should|be|closely|changes|. (l_nsubjpass) patients_12\NNS\9898892|doses|prescribed (l_acl:relcl) prescribed_21\VBN\748282|who|are|xenical (l_dobj) xenical_22\NN\1740|
DDI-DrugBank.d761.s13.e1_DDI-DrugBank.d761.s13.e0 false xenical_10\NN\1740|with (r_nmod) decreased_8\VBN\169651|as|absorption|may|be|xenical (l_nsubjpass) absorption_5\NN\13558490|vitamin|k (l_compound) vitamin_3\NN\7570720|
DDI-DrugBank.d761.s13.e3_DDI-DrugBank.d761.s13.e0 false xenical_22\NN\1740| (r_dobj) prescribed_21\VBN\748282|who|are|xenical (r_acl:relcl) patients_12\NNS\9898892|doses|prescribed (r_nsubjpass) monitored_25\VBN\2169352|therefore|,|decreased|,|patients|should|be|closely|changes|. (l_advcl) decreased_8\VBN\169651|as|absorption|may|be|xenical (l_nsubjpass) absorption_5\NN\13558490|vitamin|k (l_compound) vitamin_3\NN\7570720|
DDI-DrugBank.d770.s3
DDI-DrugBank.d641.s4
DDI-DrugBank.d641.s4.e1_DDI-DrugBank.d641.s4.e0 false alimta_33\NN\1740|of (r_nmod) administration_31\NN\1133281|alimta (r_nmod) period_17\NN\13575869|for|a|days|following|administration (r_nmod) taking_9\VBG\2367363|nsaids|period (l_dobj) nsaids_10\NNS\2721538|half-lives
DDI-DrugBank.d668.s4
DDI-DrugBank.d737.s9
DDI-DrugBank.d656.s0
DDI-DrugBank.d775.s5
DDI-DrugBank.d775.s5.e0_DDI-DrugBank.d775.s5.e1 false isoflurane_0\NN\3570838|and|enflurane|(|administered (l_conj) enflurane_2\NN\3299929|
DDI-DrugBank.d775.s5.e0_DDI-DrugBank.d775.s5.e2 false isoflurane_0\NN\3570838|and|enflurane|(|administered (l_acl) administered_4\VBN\2436349|oxide/oxygen|achieve (l_nmod) oxide/oxygen_7\NN\1740|with|nitrous
DDI-DrugBank.d775.s5.e0_DDI-DrugBank.d775.s5.e3 false isoflurane_0\NN\3570838|and|enflurane|(|administered (l_acl) administered_4\VBN\2436349|oxide/oxygen|achieve (l_nmod) oxide/oxygen_7\NN\1740|with|nitrous
DDI-DrugBank.d775.s5.e1_DDI-DrugBank.d775.s5.e2 false enflurane_2\NN\3299929| (r_conj) isoflurane_0\NN\3570838|and|enflurane|(|administered (l_acl) administered_4\VBN\2436349|oxide/oxygen|achieve (l_nmod) oxide/oxygen_7\NN\1740|with|nitrous
DDI-DrugBank.d775.s5.e1_DDI-DrugBank.d775.s5.e3 false enflurane_2\NN\3299929| (r_conj) isoflurane_0\NN\3570838|and|enflurane|(|administered (l_acl) administered_4\VBN\2436349|oxide/oxygen|achieve (l_nmod) oxide/oxygen_7\NN\1740|with|nitrous
DDI-DrugBank.d775.s5.e2_DDI-DrugBank.d775.s5.e3 false oxide/oxygen_7\NN\1740|with|nitrous
DDI-DrugBank.d735.s6
DDI-DrugBank.d736.s7
DDI-DrugBank.d736.s7.e0_DDI-DrugBank.d736.s7.e1 true thiazides_0\NNS\3214670| (r_nsubj) add_2\VB\156601|thiazides|may|to|or|potentiate|action|. (l_dobj) action_7\NN\30358|the|drugs (l_nmod) drugs_11\NNS\14778436|of|other|antihypertensive
DDI-DrugBank.d633.s16
DDI-DrugBank.d633.s16.e1_DDI-DrugBank.d633.s16.e2 false theophylline_5\NN\2905612| (r_conj) mexitil_3\NN\2715941|of|and|theophylline (r_nmod) use_1\NN\407535|concurrent|mexitil (r_nsubj) lead_7\VB\1752884|use|may|levels|. (l_nmod) levels_12\NNS\4916342|to|increased|plasma|theophylline (l_compound) theophylline_11\NN\2905612|
DDI-DrugBank.d633.s16.e1_DDI-DrugBank.d633.s16.e0 false theophylline_5\NN\2905612| (r_conj) mexitil_3\NN\2715941|of|and|theophylline
DDI-DrugBank.d633.s16.e2_DDI-DrugBank.d633.s16.e0 false theophylline_11\NN\2905612| (r_compound) levels_12\NNS\4916342|to|increased|plasma|theophylline (r_nmod) lead_7\VB\1752884|use|may|levels|. (l_nsubj) use_1\NN\407535|concurrent|mexitil (l_nmod) mexitil_3\NN\2715941|of|and|theophylline
DDI-DrugBank.d597.s14
DDI-DrugBank.d597.s14.e2_DDI-DrugBank.d597.s14.e1 false furosemide_20\NN\3214670|of|and|diuretics (r_nmod) effect_18\NN\34213|the|natriuretic|furosemide|patients (r_dobj) reduce_15\VB\441445|that|nsaids|can|effect (l_nsubj) nsaids_13\NNS\2721538|
DDI-DrugBank.d597.s14.e2_DDI-DrugBank.d597.s14.e3 false furosemide_20\NN\3214670|of|and|diuretics (l_conj) diuretics_23\NNS\3247620|thiazide
DDI-DrugBank.d597.s14.e1_DDI-DrugBank.d597.s14.e3 true nsaids_13\NNS\2721538| (r_nsubj) reduce_15\VB\441445|that|nsaids|can|effect (l_dobj) effect_18\NN\34213|the|natriuretic|furosemide|patients (l_nmod) furosemide_20\NN\3214670|of|and|diuretics (l_conj) diuretics_23\NNS\3247620|thiazide
DDI-DrugBank.d704.s3
DDI-DrugBank.d699.s0
DDI-DrugBank.d699.s0.e0_DDI-DrugBank.d699.s0.e5 true mequitazine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|mequitazine|can|depressant|. (l_nmod) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) alcohol_14\NN\7881800|
DDI-DrugBank.d699.s0.e0_DDI-DrugBank.d699.s0.e1 true mequitazine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|mequitazine|can|depressant|. (l_nmod) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol
DDI-DrugBank.d699.s0.e0_DDI-DrugBank.d699.s0.e2 true mequitazine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|mequitazine|can|depressant|. (l_nmod) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) antichlolinergic_7\NN\1740|
DDI-DrugBank.d699.s0.e0_DDI-DrugBank.d699.s0.e3 true mequitazine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|mequitazine|can|depressant|. (l_nmod) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) tca_9\NN\1740|
DDI-DrugBank.d699.s0.e0_DDI-DrugBank.d699.s0.e4 true mequitazine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|mequitazine|can|depressant|. (l_nmod) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) maois_11\NNS\2718811|
DDI-DrugBank.d699.s0.e5_DDI-DrugBank.d699.s0.e1 false alcohol_14\NN\7881800| (r_conj) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol
DDI-DrugBank.d699.s0.e5_DDI-DrugBank.d699.s0.e2 false alcohol_14\NN\7881800| (r_conj) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) antichlolinergic_7\NN\1740|
DDI-DrugBank.d699.s0.e5_DDI-DrugBank.d699.s0.e3 false alcohol_14\NN\7881800| (r_conj) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) tca_9\NN\1740|
DDI-DrugBank.d699.s0.e5_DDI-DrugBank.d699.s0.e4 false alcohol_14\NN\7881800| (r_conj) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) maois_11\NNS\2718811|
DDI-DrugBank.d699.s0.e1_DDI-DrugBank.d699.s0.e2 false depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) antichlolinergic_7\NN\1740|
DDI-DrugBank.d699.s0.e1_DDI-DrugBank.d699.s0.e3 false depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) tca_9\NN\1740|
DDI-DrugBank.d699.s0.e1_DDI-DrugBank.d699.s0.e4 false depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) maois_11\NNS\2718811|
DDI-DrugBank.d699.s0.e2_DDI-DrugBank.d699.s0.e3 false antichlolinergic_7\NN\1740| (r_conj) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) tca_9\NN\1740|
DDI-DrugBank.d699.s0.e2_DDI-DrugBank.d699.s0.e4 false antichlolinergic_7\NN\1740| (r_conj) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) maois_11\NNS\2718811|
DDI-DrugBank.d699.s0.e3_DDI-DrugBank.d699.s0.e4 false tca_9\NN\1740| (r_conj) depressant_5\NN\3248958|with|cns|,|antichlolinergic|,|tca|,|maois|,|and|alcohol (l_conj) maois_11\NNS\2718811|
DDI-DrugBank.d700.s11
DDI-DrugBank.d700.s11.e1_DDI-DrugBank.d700.s11.e0 false myfortic_12\NN\1740|with (r_nmod) administered_10\VBN\2436349|myfortic|caution (r_xcomp) co-_9\VBN\1740|that|contraceptives|are|administered|and|considered (l_nsubjpass) contraceptives_7\NNS\3183080|oral
DDI-DrugBank.d577.s3
DDI-DrugBank.d577.s3.e0_DDI-DrugBank.d577.s3.e1 true sulfamethoxazole_0\NN\4352070| (r_nsubj) inhibit_2\VB\2510337|sulfamethoxazole|may|metabolism|. (l_dobj) metabolism_5\NN\13526110|the|hepatic|phenytoin (l_nmod) phenytoin_7\NN\3550533|of
DDI-DrugBank.d577.s0
DDI-DrugBank.d577.s0.e0_DDI-DrugBank.d577.s0.e1 false diuretics_6\NNS\3247620|certain|,|thiazides (l_appos) thiazides_9\NNS\3214670|primarily
DDI-DrugBank.d576.s7
DDI-DrugBank.d603.s4
DDI-DrugBank.d597.s26
DDI-DrugBank.d597.s26.e0_DDI-DrugBank.d597.s26.e2 false warfarin_0\NN\2718259| (r_dep) monitored_6\VBN\2169352|warfarin|:|activity|should|be|,|days|,|since|. (l_nmod) days_13\NNS\15140892|in|the|first|few|initiating (l_advcl) initiating_15\VBG\1617192|after|or|changing (l_conj) changing_17\VBG\46534|therapy|patients (l_nmod) patients_21\NNS\9898892|in|receiving (l_acl) receiving_22\VBG\2210855|warfarin (l_dobj) warfarin_23\NN\2718259|or|agents
DDI-DrugBank.d597.s26.e0_DDI-DrugBank.d597.s26.e1 false warfarin_0\NN\2718259| (r_dep) monitored_6\VBN\2169352|warfarin|:|activity|should|be|,|days|,|since|. (l_nmod) days_13\NNS\15140892|in|the|first|few|initiating (l_advcl) initiating_15\VBG\1617192|after|or|changing (l_conj) changing_17\VBG\46534|therapy|patients (l_dobj) therapy_19\NN\657604|mobic (l_amod) mobic_18\JJ\1740|
DDI-DrugBank.d597.s26.e2_DDI-DrugBank.d597.s26.e1 false warfarin_23\NN\2718259|or|agents (r_dobj) receiving_22\VBG\2210855|warfarin (r_acl) patients_21\NNS\9898892|in|receiving (r_nmod) changing_17\VBG\46534|therapy|patients (l_dobj) therapy_19\NN\657604|mobic (l_amod) mobic_18\JJ\1740|
DDI-DrugBank.d624.s2
DDI-DrugBank.d624.s2.e0_DDI-DrugBank.d624.s2.e1 true diuretics_1\NNS\3247620|some (r_nsubj) enhance_3\VB\227165|diuretics|can|toxicity|altering|. (l_dobj) toxicity_5\NN\13576101|aminoglycoside (l_compound) aminoglycoside_4\NN\1740|
DDI-DrugBank.d624.s2.e0_DDI-DrugBank.d624.s2.e2 false diuretics_1\NNS\3247620|some (r_nsubj) enhance_3\VB\227165|diuretics|can|toxicity|altering|. (l_advcl) altering_7\VBG\126264|by|concentrations (l_dobj) concentrations_9\NNS\4916342|antibiotic|serum (l_amod) antibiotic_8\JJ\1740|
DDI-DrugBank.d624.s2.e1_DDI-DrugBank.d624.s2.e2 false aminoglycoside_4\NN\1740| (r_compound) toxicity_5\NN\13576101|aminoglycoside (r_dobj) enhance_3\VB\227165|diuretics|can|toxicity|altering|. (l_advcl) altering_7\VBG\126264|by|concentrations (l_dobj) concentrations_9\NNS\4916342|antibiotic|serum (l_amod) antibiotic_8\JJ\1740|
DDI-DrugBank.d752.s2
DDI-DrugBank.d693.s5
DDI-DrugBank.d584.s2
DDI-DrugBank.d619.s3
DDI-DrugBank.d619.s5
DDI-DrugBank.d619.s5.e0_DDI-DrugBank.d619.s5.e2 true selegiline_16\NN\1740|of|and|medication (l_conj) medication_20\NN\3247620|a|sympathomimetic|ephedrine (l_appos) ephedrine_22\NN\14712692|(|)
DDI-DrugBank.d619.s5.e0_DDI-DrugBank.d619.s5.e1 true selegiline_16\NN\1740|of|and|medication (l_conj) medication_20\NN\3247620|a|sympathomimetic|ephedrine
DDI-DrugBank.d619.s5.e2_DDI-DrugBank.d619.s5.e1 false ephedrine_22\NN\14712692|(|) (r_appos) medication_20\NN\3247620|a|sympathomimetic|ephedrine
DDI-DrugBank.d666.s2
DDI-DrugBank.d666.s2.e0_DDI-DrugBank.d666.s2.e2 false pindolol_0\NN\2832168| (r_nsubjpass) used_3\VBN\1156834|pindolol|has|been|variety|interactions|. (l_nmod) variety_6\NN\7951464|with|a|agents (l_nmod) agents_9\NNS\7347|of|antihypertensive|,|hydrochlorothiazide (l_nmod) hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine
DDI-DrugBank.d666.s2.e0_DDI-DrugBank.d666.s2.e3 false pindolol_0\NN\2832168| (r_nsubjpass) used_3\VBN\1156834|pindolol|has|been|variety|interactions|. (l_nmod) variety_6\NN\7951464|with|a|agents (l_nmod) agents_9\NNS\7347|of|antihypertensive|,|hydrochlorothiazide (l_nmod) hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (l_conj) hydralazine_14\NN\2721160|
DDI-DrugBank.d666.s2.e0_DDI-DrugBank.d666.s2.e4 false pindolol_0\NN\2832168| (r_nsubjpass) used_3\VBN\1156834|pindolol|has|been|variety|interactions|. (l_nmod) variety_6\NN\7951464|with|a|agents (l_nmod) agents_9\NNS\7347|of|antihypertensive|,|hydrochlorothiazide (l_nmod) hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (l_conj) guanethidine_17\NN\1740|
DDI-DrugBank.d666.s2.e0_DDI-DrugBank.d666.s2.e1 false pindolol_0\NN\2832168| (r_nsubjpass) used_3\VBN\1156834|pindolol|has|been|variety|interactions|. (l_nmod) variety_6\NN\7951464|with|a|agents (l_nmod) agents_9\NNS\7347|of|antihypertensive|,|hydrochlorothiazide
DDI-DrugBank.d666.s2.e2_DDI-DrugBank.d666.s2.e3 false hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (l_conj) hydralazine_14\NN\2721160|
DDI-DrugBank.d666.s2.e2_DDI-DrugBank.d666.s2.e4 false hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (l_conj) guanethidine_17\NN\1740|
DDI-DrugBank.d666.s2.e2_DDI-DrugBank.d666.s2.e1 false hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (r_nmod) agents_9\NNS\7347|of|antihypertensive|,|hydrochlorothiazide
DDI-DrugBank.d666.s2.e3_DDI-DrugBank.d666.s2.e4 false hydralazine_14\NN\2721160| (r_conj) hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (l_conj) guanethidine_17\NN\1740|
DDI-DrugBank.d666.s2.e3_DDI-DrugBank.d666.s2.e1 false hydralazine_14\NN\2721160| (r_conj) hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (r_nmod) agents_9\NNS\7347|of|antihypertensive|,|hydrochlorothiazide
DDI-DrugBank.d666.s2.e4_DDI-DrugBank.d666.s2.e1 false guanethidine_17\NN\1740| (r_conj) hydrochlorothiazide_12\NN\4423288|including|,|hydralazine|,|and|guanethidine (r_nmod) agents_9\NNS\7347|of|antihypertensive|,|hydrochlorothiazide
DDI-DrugBank.d700.s12
DDI-DrugBank.d700.s12.e1_DDI-DrugBank.d700.s12.e0 false myfortic_6\JJ\1740|with (r_nmod) treatment_4\NN\654885|during|myfortic (r_nmod) avoided_16\VBN\2452885|vaccines|:|treatment|,|use|should|be|and|advised|. (l_dep) vaccines_1\NNS\3562739|live
DDI-DrugBank.d700.s12.e1_DDI-DrugBank.d700.s12.e2 true myfortic_6\JJ\1740|with (r_nmod) treatment_4\NN\654885|during|myfortic (r_nmod) avoided_16\VBN\2452885|vaccines|:|treatment|,|use|should|be|and|advised|. (l_nsubjpass) use_9\NN\407535|the|vaccines (l_nmod) vaccines_13\NNS\3562739|of|live|attenuated
DDI-DrugBank.d700.s12.e0_DDI-DrugBank.d700.s12.e2 false vaccines_1\NNS\3562739|live (r_dep) avoided_16\VBN\2452885|vaccines|:|treatment|,|use|should|be|and|advised|. (l_nsubjpass) use_9\NN\407535|the|vaccines (l_nmod) vaccines_13\NNS\3562739|of|live|attenuated
DDI-DrugBank.d671.s0
DDI-DrugBank.d671.s0.e1_DDI-DrugBank.d671.s0.e0 false pemoline_5\NN\1740|(|) (r_appos) cylert_3\NNP\1740|of|pemoline
DDI-DrugBank.d739.s10
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e1 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e2 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) prednisone_26\NN\2721538|
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e3 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) prednisolone_28\NN\2721538|
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e5 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|)
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e6 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|) (l_appos) estradiol_36\NN\14749794|1|mg/ethinyl
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e7 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) terfenadine_41\NN\1740|
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e8 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) digoxin_43\NN\15060131|
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e9 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e0_DDI-DrugBank.d739.s10.e4 false montelukast_9\NN\1740|of (r_nmod) dose_7\NN\3740161|the|recommended|clinical|montelukast (r_nsubj) have_12\VB\2108377|studies|,|dose|did|not|effects|pharmacokinetics|. (l_nmod) pharmacokinetics_18\NNS\6054892|on|the|drugs (l_nmod) drugs_22\NNS\14778436|of|the|following|:|theophylline (l_appos) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e2 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) prednisone_26\NN\2721538|
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e3 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) prednisolone_28\NN\2721538|
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e5 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|)
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e6 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|) (l_appos) estradiol_36\NN\14749794|1|mg/ethinyl
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e7 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) terfenadine_41\NN\1740|
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e8 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) digoxin_43\NN\15060131|
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e9 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e1_DDI-DrugBank.d739.s10.e4 false theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e2_DDI-DrugBank.d739.s10.e3 false prednisone_26\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) prednisolone_28\NN\2721538|
DDI-DrugBank.d739.s10.e2_DDI-DrugBank.d739.s10.e5 false prednisone_26\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|)
DDI-DrugBank.d739.s10.e2_DDI-DrugBank.d739.s10.e6 false prednisone_26\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|) (l_appos) estradiol_36\NN\14749794|1|mg/ethinyl
DDI-DrugBank.d739.s10.e2_DDI-DrugBank.d739.s10.e7 false prednisone_26\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) terfenadine_41\NN\1740|
DDI-DrugBank.d739.s10.e2_DDI-DrugBank.d739.s10.e8 false prednisone_26\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) digoxin_43\NN\15060131|
DDI-DrugBank.d739.s10.e2_DDI-DrugBank.d739.s10.e9 false prednisone_26\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e2_DDI-DrugBank.d739.s10.e4 false prednisone_26\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e3_DDI-DrugBank.d739.s10.e5 false prednisolone_28\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|)
DDI-DrugBank.d739.s10.e3_DDI-DrugBank.d739.s10.e6 false prednisolone_28\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone (l_dep) norethindrone_33\NN\14747338|(|estradiol|mcg|) (l_appos) estradiol_36\NN\14749794|1|mg/ethinyl
DDI-DrugBank.d739.s10.e3_DDI-DrugBank.d739.s10.e7 false prednisolone_28\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) terfenadine_41\NN\1740|
DDI-DrugBank.d739.s10.e3_DDI-DrugBank.d739.s10.e8 false prednisolone_28\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) digoxin_43\NN\15060131|
DDI-DrugBank.d739.s10.e3_DDI-DrugBank.d739.s10.e9 false prednisolone_28\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e3_DDI-DrugBank.d739.s10.e4 false prednisolone_28\NN\2721538| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e5_DDI-DrugBank.d739.s10.e6 false norethindrone_33\NN\14747338|(|estradiol|mcg|) (l_appos) estradiol_36\NN\14749794|1|mg/ethinyl
DDI-DrugBank.d739.s10.e5_DDI-DrugBank.d739.s10.e7 false norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) terfenadine_41\NN\1740|
DDI-DrugBank.d739.s10.e5_DDI-DrugBank.d739.s10.e8 false norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) digoxin_43\NN\15060131|
DDI-DrugBank.d739.s10.e5_DDI-DrugBank.d739.s10.e9 false norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e5_DDI-DrugBank.d739.s10.e4 false norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e6_DDI-DrugBank.d739.s10.e7 false estradiol_36\NN\14749794|1|mg/ethinyl (r_appos) norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) terfenadine_41\NN\1740|
DDI-DrugBank.d739.s10.e6_DDI-DrugBank.d739.s10.e8 false estradiol_36\NN\14749794|1|mg/ethinyl (r_appos) norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) digoxin_43\NN\15060131|
DDI-DrugBank.d739.s10.e6_DDI-DrugBank.d739.s10.e9 false estradiol_36\NN\14749794|1|mg/ethinyl (r_appos) norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e6_DDI-DrugBank.d739.s10.e4 false estradiol_36\NN\14749794|1|mg/ethinyl (r_appos) norethindrone_33\NN\14747338|(|estradiol|mcg|) (r_dep) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e7_DDI-DrugBank.d739.s10.e8 false terfenadine_41\NN\1740| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) digoxin_43\NN\15060131|
DDI-DrugBank.d739.s10.e7_DDI-DrugBank.d739.s10.e9 false terfenadine_41\NN\1740| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e7_DDI-DrugBank.d739.s10.e4 false terfenadine_41\NN\1740| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e8_DDI-DrugBank.d739.s10.e9 false digoxin_43\NN\15060131| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) warfarin_46\NN\2718259|
DDI-DrugBank.d739.s10.e8_DDI-DrugBank.d739.s10.e4 false digoxin_43\NN\15060131| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d739.s10.e9_DDI-DrugBank.d739.s10.e4 false warfarin_46\NN\2718259| (r_conj) theophylline_24\NN\2905612|,|prednisone|,|prednisolone|,|contraceptives|,|terfenadine|,|digoxin|,|and|warfarin (l_conj) contraceptives_31\NNS\3183080|oral|norethindrone
DDI-DrugBank.d710.s7
DDI-DrugBank.d602.s1
DDI-DrugBank.d602.s1.e1_DDI-DrugBank.d602.s1.e0 false doxorubicin_14\NN\2716866|of (r_nmod) auc_12\NN\1740|in|the|doxorubicin (r_nmod) increase_9\NN\13576355|in|a|%|auc (r_nmod) resulted_4\VBD\2633881|treatment|increase|. (l_nsubj) treatment_1\NN\654885|concomitant|nexavar (l_nmod) nexavar_3\NNP\1740|with
DDI-DrugBank.d716.s0
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e3 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_nmod) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e5 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_nmod) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e7 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_nmod) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e4 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_nmod) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_appos) marplan_20\NN\3783017|
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e6 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_nmod) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_appos) parnate_25\NN\1740|(|)
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e8 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_nmod) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil (l_appos) nardil_31\NN\3783017|(|)
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e1 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid
DDI-DrugBank.d716.s0.e0_DDI-DrugBank.d716.s0.e2 true mazindol_4\NN\1740| (r_dobj) take_3\VB\2367363|you|can|not|mazindol|taken|. (l_advcl) taken_8\VBN\2367363|if|you|have|inhibitor|days (l_dobj) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d716.s0.e3_DDI-DrugBank.d716.s0.e5 false isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine
DDI-DrugBank.d716.s0.e3_DDI-DrugBank.d716.s0.e7 false isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil
DDI-DrugBank.d716.s0.e3_DDI-DrugBank.d716.s0.e4 false isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_appos) marplan_20\NN\3783017|
DDI-DrugBank.d716.s0.e3_DDI-DrugBank.d716.s0.e6 false isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_appos) parnate_25\NN\1740|(|)
DDI-DrugBank.d716.s0.e3_DDI-DrugBank.d716.s0.e8 false isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil (l_appos) nardil_31\NN\3783017|(|)
DDI-DrugBank.d716.s0.e3_DDI-DrugBank.d716.s0.e1 false isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid
DDI-DrugBank.d716.s0.e3_DDI-DrugBank.d716.s0.e2 false isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d716.s0.e5_DDI-DrugBank.d716.s0.e7 false tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil
DDI-DrugBank.d716.s0.e5_DDI-DrugBank.d716.s0.e4 false tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_appos) marplan_20\NN\3783017|
DDI-DrugBank.d716.s0.e5_DDI-DrugBank.d716.s0.e6 false tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_appos) parnate_25\NN\1740|(|)
DDI-DrugBank.d716.s0.e5_DDI-DrugBank.d716.s0.e8 false tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil (l_appos) nardil_31\NN\3783017|(|)
DDI-DrugBank.d716.s0.e5_DDI-DrugBank.d716.s0.e1 false tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid
DDI-DrugBank.d716.s0.e5_DDI-DrugBank.d716.s0.e2 false tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d716.s0.e7_DDI-DrugBank.d716.s0.e4 false phenelzine_29\NN\3783017|nardil (r_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_appos) marplan_20\NN\3783017|
DDI-DrugBank.d716.s0.e7_DDI-DrugBank.d716.s0.e6 false phenelzine_29\NN\3783017|nardil (r_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_appos) parnate_25\NN\1740|(|)
DDI-DrugBank.d716.s0.e7_DDI-DrugBank.d716.s0.e8 false phenelzine_29\NN\3783017|nardil (l_appos) nardil_31\NN\3783017|(|)
DDI-DrugBank.d716.s0.e7_DDI-DrugBank.d716.s0.e1 false phenelzine_29\NN\3783017|nardil (r_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid
DDI-DrugBank.d716.s0.e7_DDI-DrugBank.d716.s0.e2 false phenelzine_29\NN\3783017|nardil (r_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d716.s0.e4_DDI-DrugBank.d716.s0.e6 false marplan_20\NN\3783017| (r_appos) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_appos) parnate_25\NN\1740|(|)
DDI-DrugBank.d716.s0.e4_DDI-DrugBank.d716.s0.e8 false marplan_20\NN\3783017| (r_appos) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (l_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil (l_appos) nardil_31\NN\3783017|(|)
DDI-DrugBank.d716.s0.e4_DDI-DrugBank.d716.s0.e1 false marplan_20\NN\3783017| (r_appos) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid
DDI-DrugBank.d716.s0.e4_DDI-DrugBank.d716.s0.e2 false marplan_20\NN\3783017| (r_appos) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d716.s0.e6_DDI-DrugBank.d716.s0.e8 false parnate_25\NN\1740|(|) (r_appos) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (l_conj) phenelzine_29\NN\3783017|nardil (l_appos) nardil_31\NN\3783017|(|)
DDI-DrugBank.d716.s0.e6_DDI-DrugBank.d716.s0.e1 false parnate_25\NN\1740|(|) (r_appos) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid
DDI-DrugBank.d716.s0.e6_DDI-DrugBank.d716.s0.e2 false parnate_25\NN\1740|(|) (r_appos) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d716.s0.e8_DDI-DrugBank.d716.s0.e1 false nardil_31\NN\3783017|(|) (r_appos) phenelzine_29\NN\3783017|nardil (r_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid
DDI-DrugBank.d716.s0.e8_DDI-DrugBank.d716.s0.e2 false nardil_31\NN\3783017|(|) (r_appos) phenelzine_29\NN\3783017|nardil (r_conj) tranylcypromine_23\NN\3783017|parnate|,|or|phenelzine (r_conj) isocarboxazid_18\NN\3783017|such|(|marplan|)|,|tranylcypromine (r_nmod) inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d716.s0.e1_DDI-DrugBank.d716.s0.e2 false inhibitor_12\NN\20090|a|monoamine|oxidase|maoi|isocarboxazid (l_appos) maoi_14\NN\2718811|(|)
DDI-DrugBank.d769.s1
DDI-DrugBank.d769.s1.e0_DDI-DrugBank.d769.s1.e1 true zolinza_11\NN\1740|and|derivatives (l_conj) derivatives_14\NNS\5802185|coumarin
DDI-DrugBank.d736.s8
DDI-DrugBank.d736.s8.e0_DDI-DrugBank.d736.s8.e0 false ganglionic_3\JJ\1740|or|peripheral (r_amod) adrenergic_6\JJ\1740|ganglionic (r_amod) drugs_8\NNS\14778436|with|adrenergic|blocking
DDI-DrugBank.d736.s8.e0_DDI-DrugBank.d736.s8.e1 false ganglionic_3\JJ\1740|or|peripheral (r_amod) adrenergic_6\JJ\1740|ganglionic (r_amod) drugs_8\NNS\14778436|with|adrenergic|blocking
DDI-DrugBank.d736.s8.e0_DDI-DrugBank.d736.s8.e1 false drugs_8\NNS\14778436|with|adrenergic|blocking
DDI-DrugBank.d666.s3
DDI-DrugBank.d666.s3.e0_DDI-DrugBank.d666.s3.e1 true pindolol_0\NN\2832168| (r_nsubjpass) shown_3\VBN\2137132|pindolol|has|been|increase|. (l_xcomp) increase_5\VB\169651|to|levels|co-administered (l_dobj) levels_8\NNS\4916342|serum|thioridazine (l_compound) thioridazine_7\NN\3713736|
DDI-DrugBank.d736.s3
DDI-DrugBank.d736.s3.e1_DDI-DrugBank.d736.s3.e0 false norepinephrine_6\NN\14807929|to (r_nmod) responsiveness_4\NN\5652926|arterial|norepinephrine (r_dobj) decrease_2\VB\169651|thiazides|may|responsiveness|. (l_nsubj) thiazides_0\NNS\3214670|
DDI-DrugBank.d709.s1
DDI-DrugBank.d709.s1.e0_DDI-DrugBank.d709.s1.e1 false terfenadine_6\NN\1740|-|and|astemizole (l_conj) astemizole_8\NN\1740|
DDI-DrugBank.d709.s1.e0_DDI-DrugBank.d709.s1.e3 false terfenadine_6\NN\1740|-|and|astemizole (r_dep) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nmod) terfenadine_14\NN\1740|with|and|astemizole
DDI-DrugBank.d709.s1.e0_DDI-DrugBank.d709.s1.e4 false terfenadine_6\NN\1740|-|and|astemizole (r_dep) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nmod) terfenadine_14\NN\1740|with|and|astemizole (l_conj) astemizole_16\NN\1740|
DDI-DrugBank.d709.s1.e0_DDI-DrugBank.d709.s1.e2 false terfenadine_6\NN\1740|-|and|astemizole (r_dep) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nsubj) macrolides_11\NNS\1740|certain
DDI-DrugBank.d709.s1.e1_DDI-DrugBank.d709.s1.e3 false astemizole_8\NN\1740| (r_conj) terfenadine_6\NN\1740|-|and|astemizole (r_dep) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nmod) terfenadine_14\NN\1740|with|and|astemizole
DDI-DrugBank.d709.s1.e1_DDI-DrugBank.d709.s1.e4 false astemizole_8\NN\1740| (r_conj) terfenadine_6\NN\1740|-|and|astemizole (r_dep) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nmod) terfenadine_14\NN\1740|with|and|astemizole (l_conj) astemizole_16\NN\1740|
DDI-DrugBank.d709.s1.e1_DDI-DrugBank.d709.s1.e2 false astemizole_8\NN\1740| (r_conj) terfenadine_6\NN\1740|-|and|astemizole (r_dep) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nsubj) macrolides_11\NNS\1740|certain
DDI-DrugBank.d709.s1.e3_DDI-DrugBank.d709.s1.e4 false terfenadine_14\NN\1740|with|and|astemizole (l_conj) astemizole_16\NN\1740|
DDI-DrugBank.d709.s1.e3_DDI-DrugBank.d709.s1.e2 false terfenadine_14\NN\1740|with|and|astemizole (r_nmod) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nsubj) macrolides_11\NNS\1740|certain
DDI-DrugBank.d709.s1.e4_DDI-DrugBank.d709.s1.e2 false astemizole_16\NN\1740| (r_conj) terfenadine_14\NN\1740|with|and|astemizole (r_nmod) interact_12\VBP\2367363|administrations|terfenadine|:|macrolides|terfenadine|leading|. (l_nsubj) macrolides_11\NNS\1740|certain
DDI-DrugBank.d597.s18
DDI-DrugBank.d597.s18.e0_DDI-DrugBank.d597.s18.e1 true furosemide_6\NN\3214670|with|and|mobic (l_conj) mobic_8\NNP\1740|
DDI-DrugBank.d742.s6
DDI-DrugBank.d670.s4
DDI-DrugBank.d732.s4
DDI-DrugBank.d596.s2
DDI-DrugBank.d639.s3
DDI-DrugBank.d779.s17
DDI-DrugBank.d776.s15
DDI-DrugBank.d661.s1
DDI-DrugBank.d661.s1.e1_DDI-DrugBank.d661.s1.e2 false succinylcholine_7\NN\3800001|of (r_nmod) administration_5\NN\1133281|following|succinylcholine (r_nmod) administered_3\VBN\2436349|if|zemuron|is|administration (r_advcl) given_13\VBN\2327200|administered|,|it|should|not|be|observed|. (l_advcl) observed_20\VBN\2163746|until|recovery|has|been (l_nsubjpass) recovery_15\NN\7357388|succinylcholine (l_nmod) succinylcholine_17\NN\3800001|from
DDI-DrugBank.d661.s1.e1_DDI-DrugBank.d661.s1.e0 false succinylcholine_7\NN\3800001|of (r_nmod) administration_5\NN\1133281|following|succinylcholine (r_nmod) administered_3\VBN\2436349|if|zemuron|is|administration (l_nsubjpass) zemuron_1\NN\1740|
DDI-DrugBank.d661.s1.e2_DDI-DrugBank.d661.s1.e0 false succinylcholine_17\NN\3800001|from (r_nmod) recovery_15\NN\7357388|succinylcholine (r_nsubjpass) observed_20\VBN\2163746|until|recovery|has|been (r_advcl) given_13\VBN\2327200|administered|,|it|should|not|be|observed|. (l_advcl) administered_3\VBN\2436349|if|zemuron|is|administration (l_nsubjpass) zemuron_1\NN\1740|
DDI-DrugBank.d584.s9
DDI-DrugBank.d584.s9.e1_DDI-DrugBank.d584.s9.e0 false oxandrolone_3\NN\1740| (r_nsubj) inhibit_5\VB\2510337|agents|oxandrolone|may|metabolism|. (l_nsubj) agents_2\NNS\7347|oral|hypoglycemic
DDI-DrugBank.d584.s9.e1_DDI-DrugBank.d584.s9.e2 true oxandrolone_3\NN\1740| (r_nsubj) inhibit_5\VB\2510337|agents|oxandrolone|may|metabolism|. (l_dobj) metabolism_7\NN\13526110|the|agents (l_nmod) agents_11\NNS\7347|of|oral|hypoglycemic
DDI-DrugBank.d584.s9.e0_DDI-DrugBank.d584.s9.e2 false agents_2\NNS\7347|oral|hypoglycemic (r_nsubj) inhibit_5\VB\2510337|agents|oxandrolone|may|metabolism|. (l_dobj) metabolism_7\NN\13526110|the|agents (l_nmod) agents_11\NNS\7347|of|oral|hypoglycemic
DDI-DrugBank.d722.s0
DDI-DrugBank.d722.s0.e1_DDI-DrugBank.d722.s0.e3 true mercaptopurine_8\NN\2722166|) (r_appos) purinethol_6\NN\2722166|between|(|mercaptopurine|and|thioguanine (l_conj) thioguanine_13\NN\2722458|brand
DDI-DrugBank.d722.s0.e1_DDI-DrugBank.d722.s0.e0 false mercaptopurine_8\NN\2722166|) (r_appos) purinethol_6\NN\2722166|between|(|mercaptopurine|and|thioguanine
DDI-DrugBank.d722.s0.e1_DDI-DrugBank.d722.s0.e2 true mercaptopurine_8\NN\2722166|) (r_appos) purinethol_6\NN\2722166|between|(|mercaptopurine|and|thioguanine (l_conj) thioguanine_13\NN\2722458|brand (l_compound) brand_12\NN\6333653|tabloid (l_amod) tabloid_11\NN\6266417|
DDI-DrugBank.d722.s0.e3_DDI-DrugBank.d722.s0.e0 false thioguanine_13\NN\2722458|brand (r_conj) purinethol_6\NN\2722166|between|(|mercaptopurine|and|thioguanine
DDI-DrugBank.d722.s0.e3_DDI-DrugBank.d722.s0.e2 false thioguanine_13\NN\2722458|brand (l_compound) brand_12\NN\6333653|tabloid (l_amod) tabloid_11\NN\6266417|
DDI-DrugBank.d722.s0.e0_DDI-DrugBank.d722.s0.e2 true purinethol_6\NN\2722166|between|(|mercaptopurine|and|thioguanine (l_conj) thioguanine_13\NN\2722458|brand (l_compound) brand_12\NN\6333653|tabloid (l_amod) tabloid_11\NN\6266417|
DDI-DrugBank.d575.s0
DDI-DrugBank.d575.s0.e0_DDI-DrugBank.d575.s0.e1 false tolbutamide_15\NN\14914301|of|,|salicylate|and|sulfamethizole (l_conj) salicylate_18\NN\3828465|sodium
DDI-DrugBank.d575.s0.e0_DDI-DrugBank.d575.s0.e2 false tolbutamide_15\NN\14914301|of|,|salicylate|and|sulfamethizole (l_conj) sulfamethizole_20\NN\1740|
DDI-DrugBank.d575.s0.e0_DDI-DrugBank.d575.s0.e3 true tolbutamide_15\NN\14914301|of|,|salicylate|and|sulfamethizole (r_nmod) concentrations_13\NNS\4916342|relevant|tolbutamide (r_nsubj) displaced_21\VBD\1850315|study|,|concentrations|teniposide|serum|extent|. (l_dobj) teniposide_23\NN\1740|protein-bound
DDI-DrugBank.d575.s0.e1_DDI-DrugBank.d575.s0.e2 false salicylate_18\NN\3828465|sodium (r_conj) tolbutamide_15\NN\14914301|of|,|salicylate|and|sulfamethizole (l_conj) sulfamethizole_20\NN\1740|
DDI-DrugBank.d575.s0.e1_DDI-DrugBank.d575.s0.e3 true salicylate_18\NN\3828465|sodium (r_conj) tolbutamide_15\NN\14914301|of|,|salicylate|and|sulfamethizole (r_nmod) concentrations_13\NNS\4916342|relevant|tolbutamide (r_nsubj) displaced_21\VBD\1850315|study|,|concentrations|teniposide|serum|extent|. (l_dobj) teniposide_23\NN\1740|protein-bound
DDI-DrugBank.d575.s0.e2_DDI-DrugBank.d575.s0.e3 true sulfamethizole_20\NN\1740| (r_conj) tolbutamide_15\NN\14914301|of|,|salicylate|and|sulfamethizole (r_nmod) concentrations_13\NNS\4916342|relevant|tolbutamide (r_nsubj) displaced_21\VBD\1850315|study|,|concentrations|teniposide|serum|extent|. (l_dobj) teniposide_23\NN\1740|protein-bound
DDI-DrugBank.d603.s3
DDI-DrugBank.d603.s3.e1_DDI-DrugBank.d603.s3.e0 false acetate_16\NN\15010703|(|i.e.|,|fludrocortisone|) (r_appos) therapy_11\NN\657604|with|salt-retaining|steroid|acetate (r_nmod) treated_7\VBN\2376958|concomitantly|therapy|,|supplementation (r_acl) patients_5\NNS\9898892|in|treated (r_nmod) used_3\VBN\1156834|proamatine|has|been|patients|. (l_nsubjpass) proamatine_0\NN\1740|
DDI-DrugBank.d784.s0
DDI-DrugBank.d784.s0.e0_DDI-DrugBank.d784.s0.e1 true oxybutynin_4\NN\1740|of (r_nmod) use_2\NN\407535|the|concomitant|oxybutynin|drugs (l_nmod) drugs_8\NNS\14778436|with|other|anticholinergic|or|agents
DDI-DrugBank.d713.s3
DDI-DrugBank.d713.s3.e0_DDI-DrugBank.d713.s3.e1 false sanctura_2\NN\1740|of (r_nmod) coadministration_0\NN\1740|sanctura|drugs (r_nsubj) increase_14\VB\169651|coadministration|may|concentration|competition|. (l_dobj) concentration_17\NN\4916342|the|serum|sanctura (l_nmod) sanctura_19\NN\1740|of|and/or|drug
DDI-DrugBank.d645.s6
DDI-DrugBank.d645.s6.e0_DDI-DrugBank.d645.s6.e1 true terbinafine_17\NN\2720201|oral|and|warfarin (l_conj) warfarin_19\NN\2718259|
DDI-DrugBank.d645.s6.e0_DDI-DrugBank.d645.s6.e2 false terbinafine_17\NN\2720201|oral|and|warfarin (r_dobj) taking_15\VBG\2367363|concomitantly|terbinafine (r_acl) patients_13\NNS\9898892|in|taking (r_nmod) increase_6\NN\13576355|of|or|decrease|times|patients (r_nmod) reports_4\NNS\6470073|spontaneous|increase (r_attr) been_2\VBN\836236|there|have|reports|,|however|established (l_parataxis) established_35\VBN\2426171|,|relationship|has|not|been|. (l_nsubjpass) relationship_25\NN\31921|a|causal|tablets (l_nmod) tablets_28\NNS\4233405|between|lamisil|and|changes (l_compound) lamisil_27\NN\2720201|
DDI-DrugBank.d645.s6.e1_DDI-DrugBank.d645.s6.e2 false warfarin_19\NN\2718259| (r_conj) terbinafine_17\NN\2720201|oral|and|warfarin (r_dobj) taking_15\VBG\2367363|concomitantly|terbinafine (r_acl) patients_13\NNS\9898892|in|taking (r_nmod) increase_6\NN\13576355|of|or|decrease|times|patients (r_nmod) reports_4\NNS\6470073|spontaneous|increase (r_attr) been_2\VBN\836236|there|have|reports|,|however|established (l_parataxis) established_35\VBN\2426171|,|relationship|has|not|been|. (l_nsubjpass) relationship_25\NN\31921|a|causal|tablets (l_nmod) tablets_28\NNS\4233405|between|lamisil|and|changes (l_compound) lamisil_27\NN\2720201|
DDI-DrugBank.d781.s11
DDI-DrugBank.d781.s11.e0_DDI-DrugBank.d781.s11.e1 false digoxin_0\NN\15060131| (r_dep) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_dobj) effect_9\NN\34213|no|concentrations (l_nmod) concentrations_13\NNS\4916342|on|plasma|digoxin (l_compound) digoxin_12\NN\15060131|
DDI-DrugBank.d781.s11.e0_DDI-DrugBank.d781.s11.e3 false digoxin_0\NN\15060131| (r_dep) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_conj) excluded_34\VBN\471711|effect|has|not|been (l_nsubjpass) effect_22\NN\34213|an|digoxin|concentration (l_nmod) digoxin_24\NN\15060131|of
DDI-DrugBank.d781.s11.e0_DDI-DrugBank.d781.s11.e4 false digoxin_0\NN\15060131| (r_dep) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_conj) excluded_34\VBN\471711|effect|has|not|been (l_nsubjpass) effect_22\NN\34213|an|digoxin|concentration (l_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (l_nmod) perindopril/perindoprilat_30\NN\1740|of
DDI-DrugBank.d781.s11.e0_DDI-DrugBank.d781.s11.e5 false digoxin_0\NN\15060131| (r_dep) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_conj) excluded_34\VBN\471711|effect|has|not|been (l_nsubjpass) effect_22\NN\34213|an|digoxin|concentration (l_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (l_nmod) perindopril/perindoprilat_30\NN\1740|of
DDI-DrugBank.d781.s11.e0_DDI-DrugBank.d781.s11.e2 false digoxin_0\NN\15060131| (r_dep) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_advcl) coadministered_15\VBN\1740|when|tablets (l_nmod) tablets_18\NNS\4233405|with|aceon (l_compound) aceon_17\NN\1740|
DDI-DrugBank.d781.s11.e1_DDI-DrugBank.d781.s11.e3 false digoxin_12\NN\15060131| (r_compound) concentrations_13\NNS\4916342|on|plasma|digoxin (r_nmod) effect_9\NN\34213|no|concentrations (r_dobj) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_conj) excluded_34\VBN\471711|effect|has|not|been (l_nsubjpass) effect_22\NN\34213|an|digoxin|concentration (l_nmod) digoxin_24\NN\15060131|of
DDI-DrugBank.d781.s11.e1_DDI-DrugBank.d781.s11.e4 false digoxin_12\NN\15060131| (r_compound) concentrations_13\NNS\4916342|on|plasma|digoxin (r_nmod) effect_9\NN\34213|no|concentrations (r_dobj) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_conj) excluded_34\VBN\471711|effect|has|not|been (l_nsubjpass) effect_22\NN\34213|an|digoxin|concentration (l_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (l_nmod) perindopril/perindoprilat_30\NN\1740|of
DDI-DrugBank.d781.s11.e1_DDI-DrugBank.d781.s11.e5 false digoxin_12\NN\15060131| (r_compound) concentrations_13\NNS\4916342|on|plasma|digoxin (r_nmod) effect_9\NN\34213|no|concentrations (r_dobj) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_conj) excluded_34\VBN\471711|effect|has|not|been (l_nsubjpass) effect_22\NN\34213|an|digoxin|concentration (l_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (l_nmod) perindopril/perindoprilat_30\NN\1740|of
DDI-DrugBank.d781.s11.e1_DDI-DrugBank.d781.s11.e2 false digoxin_12\NN\15060131| (r_compound) concentrations_13\NNS\4916342|on|plasma|digoxin (r_nmod) effect_9\NN\34213|no|concentrations (r_dobj) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_advcl) coadministered_15\VBN\1740|when|tablets (l_nmod) tablets_18\NNS\4233405|with|aceon (l_compound) aceon_17\NN\1740|
DDI-DrugBank.d781.s11.e3_DDI-DrugBank.d781.s11.e4 false digoxin_24\NN\15060131|of (r_nmod) effect_22\NN\34213|an|digoxin|concentration (l_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (l_nmod) perindopril/perindoprilat_30\NN\1740|of
DDI-DrugBank.d781.s11.e3_DDI-DrugBank.d781.s11.e5 false digoxin_24\NN\15060131|of (r_nmod) effect_22\NN\34213|an|digoxin|concentration (l_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (l_nmod) perindopril/perindoprilat_30\NN\1740|of
DDI-DrugBank.d781.s11.e3_DDI-DrugBank.d781.s11.e2 false digoxin_24\NN\15060131|of (r_nmod) effect_22\NN\34213|an|digoxin|concentration (r_nsubjpass) excluded_34\VBN\471711|effect|has|not|been (r_conj) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_advcl) coadministered_15\VBN\1740|when|tablets (l_nmod) tablets_18\NNS\4233405|with|aceon (l_compound) aceon_17\NN\1740|
DDI-DrugBank.d781.s11.e4_DDI-DrugBank.d781.s11.e5 false perindopril/perindoprilat_30\NN\1740|of
DDI-DrugBank.d781.s11.e4_DDI-DrugBank.d781.s11.e2 false perindopril/perindoprilat_30\NN\1740|of (r_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (r_nmod) effect_22\NN\34213|an|digoxin|concentration (r_nsubjpass) excluded_34\VBN\471711|effect|has|not|been (r_conj) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_advcl) coadministered_15\VBN\1740|when|tablets (l_nmod) tablets_18\NNS\4233405|with|aceon (l_compound) aceon_17\NN\1740|
DDI-DrugBank.d781.s11.e5_DDI-DrugBank.d781.s11.e2 false perindopril/perindoprilat_30\NN\1740|of (r_nmod) concentration_28\NN\4916342|on|the|plasma|perindopril/perindoprilat (r_nmod) effect_22\NN\34213|an|digoxin|concentration (r_nsubjpass) excluded_34\VBN\471711|effect|has|not|been (r_conj) shown_7\VBN\2137132|digoxin|:|study|has|effect|coadministered|,|but|excluded|. (l_advcl) coadministered_15\VBN\1740|when|tablets (l_nmod) tablets_18\NNS\4233405|with|aceon (l_compound) aceon_17\NN\1740|
DDI-DrugBank.d784.s4
DDI-DrugBank.d784.s4.e1_DDI-DrugBank.d784.s4.e2 false itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (l_conj) miconazole_19\NN\2720201|
DDI-DrugBank.d784.s4.e1_DDI-DrugBank.d784.s4.e4 false itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (l_appos) erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|)
DDI-DrugBank.d784.s4.e1_DDI-DrugBank.d784.s4.e5 false itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (l_appos) erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (l_conj) clarithromycin_29\NN\1740|
DDI-DrugBank.d784.s4.e1_DDI-DrugBank.d784.s4.e6 false itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (r_nmod) inhibitors_1\NNS\20090|other|system|,|agents (r_nsubj) alter_33\VB\126264|inhibitors|may|parameters|cmax|. (l_dobj) parameters_37\NNS\5858936|oxybutynin|mean|pharmacokinetic (l_compound) oxybutynin_34\NN\1740|
DDI-DrugBank.d784.s4.e1_DDI-DrugBank.d784.s4.e0 false itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics
DDI-DrugBank.d784.s4.e1_DDI-DrugBank.d784.s4.e3 false itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|,
DDI-DrugBank.d784.s4.e2_DDI-DrugBank.d784.s4.e4 false miconazole_19\NN\2720201| (r_conj) itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (l_appos) erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|)
DDI-DrugBank.d784.s4.e2_DDI-DrugBank.d784.s4.e5 false miconazole_19\NN\2720201| (r_conj) itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (l_appos) erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (l_conj) clarithromycin_29\NN\1740|
DDI-DrugBank.d784.s4.e2_DDI-DrugBank.d784.s4.e6 false miconazole_19\NN\2720201| (r_conj) itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (r_nmod) inhibitors_1\NNS\20090|other|system|,|agents (r_nsubj) alter_33\VB\126264|inhibitors|may|parameters|cmax|. (l_dobj) parameters_37\NNS\5858936|oxybutynin|mean|pharmacokinetic (l_compound) oxybutynin_34\NN\1740|
DDI-DrugBank.d784.s4.e2_DDI-DrugBank.d784.s4.e0 false miconazole_19\NN\2720201| (r_conj) itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics
DDI-DrugBank.d784.s4.e2_DDI-DrugBank.d784.s4.e3 false miconazole_19\NN\2720201| (r_conj) itraconazole_17\NN\2720201|(|e.g.|,|and|miconazole|) (r_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|,
DDI-DrugBank.d784.s4.e4_DDI-DrugBank.d784.s4.e5 false erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (l_conj) clarithromycin_29\NN\1740|
DDI-DrugBank.d784.s4.e4_DDI-DrugBank.d784.s4.e6 false erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (r_conj) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (r_nmod) inhibitors_1\NNS\20090|other|system|,|agents (r_nsubj) alter_33\VB\126264|inhibitors|may|parameters|cmax|. (l_dobj) parameters_37\NNS\5858936|oxybutynin|mean|pharmacokinetic (l_compound) oxybutynin_34\NN\1740|
DDI-DrugBank.d784.s4.e4_DDI-DrugBank.d784.s4.e0 false erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (r_conj) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics
DDI-DrugBank.d784.s4.e4_DDI-DrugBank.d784.s4.e3 false erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|,
DDI-DrugBank.d784.s4.e5_DDI-DrugBank.d784.s4.e6 false clarithromycin_29\NN\1740| (r_conj) erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (r_conj) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (r_nmod) inhibitors_1\NNS\20090|other|system|,|agents (r_nsubj) alter_33\VB\126264|inhibitors|may|parameters|cmax|. (l_dobj) parameters_37\NNS\5858936|oxybutynin|mean|pharmacokinetic (l_compound) oxybutynin_34\NN\1740|
DDI-DrugBank.d784.s4.e5_DDI-DrugBank.d784.s4.e0 false clarithromycin_29\NN\1740| (r_conj) erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|, (r_conj) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics
DDI-DrugBank.d784.s4.e5_DDI-DrugBank.d784.s4.e3 false clarithromycin_29\NN\1740| (r_conj) erythromycin_27\NN\2716866|e.g.|,|and|clarithromycin|) (r_appos) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|,
DDI-DrugBank.d784.s4.e6_DDI-DrugBank.d784.s4.e0 false oxybutynin_34\NN\1740| (r_compound) parameters_37\NNS\5858936|oxybutynin|mean|pharmacokinetic (r_dobj) alter_33\VB\126264|inhibitors|may|parameters|cmax|. (l_nsubj) inhibitors_1\NNS\20090|other|system|,|agents (l_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics
DDI-DrugBank.d784.s4.e6_DDI-DrugBank.d784.s4.e3 false oxybutynin_34\NN\1740| (r_compound) parameters_37\NNS\5858936|oxybutynin|mean|pharmacokinetic (r_dobj) alter_33\VB\126264|inhibitors|may|parameters|cmax|. (l_nsubj) inhibitors_1\NNS\20090|other|system|,|agents (l_nmod) agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|,
DDI-DrugBank.d784.s4.e0_DDI-DrugBank.d784.s4.e3 false agents_13\NNS\7347|such|antimycotic|itraconazole|or|antibiotics (l_conj) antibiotics_23\NNS\2716205|macrolide|(|erythromycin|,
DDI-DrugBank.d781.s5
DDI-DrugBank.d781.s5.e0_DDI-DrugBank.d781.s5.e2 false potassium_0\NN\14625458| (r_compound) supplements_1\NNS\6365467|potassium|and|diuretics|: (r_nsubj) increase_9\VB\169651|supplements|tablets|may|potassium|potential|. (l_nsubj) tablets_7\NNS\4233405|aceon (l_compound) aceon_6\NN\1740|
DDI-DrugBank.d781.s5.e0_DDI-DrugBank.d781.s5.e1 false potassium_0\NN\14625458| (r_compound) supplements_1\NNS\6365467|potassium|and|diuretics|: (l_conj) diuretics_4\NNS\3247620|potassium-sparing
DDI-DrugBank.d781.s5.e2_DDI-DrugBank.d781.s5.e1 false aceon_6\NN\1740| (r_compound) tablets_7\NNS\4233405|aceon (r_nsubj) increase_9\VB\169651|supplements|tablets|may|potassium|potential|. (l_nsubj) supplements_1\NNS\6365467|potassium|and|diuretics|: (l_conj) diuretics_4\NNS\3247620|potassium-sparing
DDI-DrugBank.d595.s4
DDI-DrugBank.d735.s1
DDI-DrugBank.d728.s4
DDI-DrugBank.d588.s8
DDI-DrugBank.d588.s8.e3_DDI-DrugBank.d588.s8.e0 false tubocurarine_16\NN\14712692|such (r_nmod) drugs_12\NNS\14778436|of|curariform|(|tubocurarine|) (r_nmod) effects_9\NNS\13245626|neuromuscular|blocking|drugs (r_dobj) enhance_6\VB\227165|drugs|:|hypokalemia|may|effects (l_dep) drugs_1\NNS\14778436|curariform
DDI-DrugBank.d588.s8.e3_DDI-DrugBank.d588.s8.e1 false tubocurarine_16\NN\14712692|such (r_nmod) drugs_12\NNS\14778436|of|curariform|(|tubocurarine|) (r_nmod) effects_9\NNS\13245626|neuromuscular|blocking|drugs (r_dobj) enhance_6\VB\227165|drugs|:|hypokalemia|may|effects (l_nsubj) hypokalemia_4\NN\14299637|diuretic-induced (l_amod) diuretic-induced_3\JJ\1740|
DDI-DrugBank.d588.s8.e3_DDI-DrugBank.d588.s8.e2 false tubocurarine_16\NN\14712692|such (r_nmod) drugs_12\NNS\14778436|of|curariform|(|tubocurarine|)
DDI-DrugBank.d588.s8.e0_DDI-DrugBank.d588.s8.e1 false drugs_1\NNS\14778436|curariform (r_dep) enhance_6\VB\227165|drugs|:|hypokalemia|may|effects (l_nsubj) hypokalemia_4\NN\14299637|diuretic-induced (l_amod) diuretic-induced_3\JJ\1740|
DDI-DrugBank.d588.s8.e0_DDI-DrugBank.d588.s8.e2 false drugs_1\NNS\14778436|curariform (r_dep) enhance_6\VB\227165|drugs|:|hypokalemia|may|effects (l_dobj) effects_9\NNS\13245626|neuromuscular|blocking|drugs (l_nmod) drugs_12\NNS\14778436|of|curariform|(|tubocurarine|)
DDI-DrugBank.d588.s8.e1_DDI-DrugBank.d588.s8.e2 true diuretic-induced_3\JJ\1740| (r_amod) hypokalemia_4\NN\14299637|diuretic-induced (r_nsubj) enhance_6\VB\227165|drugs|:|hypokalemia|may|effects (l_dobj) effects_9\NNS\13245626|neuromuscular|blocking|drugs (l_nmod) drugs_12\NNS\14778436|of|curariform|(|tubocurarine|)
DDI-DrugBank.d770.s0
DDI-DrugBank.d654.s3
DDI-DrugBank.d658.s1
DDI-DrugBank.d779.s7
DDI-DrugBank.d779.s7.e0_DDI-DrugBank.d779.s7.e1 true methyldopa_9\NN\2721160|of (r_nmod) bioavailability_7\NN\1740|in|the|methyldopa (r_nmod) decrease_4\NN\7296428|a|bioavailability (r_dobj) demonstrate_2\VBP\2137132|studies|decrease|ingested|. (l_advcl) ingested_13\VBN\597915|when|it|is|sulfate (l_nmod) sulfate_16\NN\15010703|with|ferrous|or|gluconate
DDI-DrugBank.d779.s7.e0_DDI-DrugBank.d779.s7.e2 true methyldopa_9\NN\2721160|of (r_nmod) bioavailability_7\NN\1740|in|the|methyldopa (r_nmod) decrease_4\NN\7296428|a|bioavailability (r_dobj) demonstrate_2\VBP\2137132|studies|decrease|ingested|. (l_advcl) ingested_13\VBN\597915|when|it|is|sulfate (l_nmod) sulfate_16\NN\15010703|with|ferrous|or|gluconate (l_conj) gluconate_19\NN\1740|ferrous
DDI-DrugBank.d779.s7.e1_DDI-DrugBank.d779.s7.e2 false sulfate_16\NN\15010703|with|ferrous|or|gluconate (l_conj) gluconate_19\NN\1740|ferrous
DDI-DrugBank.d632.s7
DDI-DrugBank.d632.s7.e1_DDI-DrugBank.d632.s7.e0 false insulin_4\NN\5407119| (r_conj) symlin_2\NN\1740|and|insulin
DDI-DrugBank.d624.s0
DDI-DrugBank.d624.s0.e2_DDI-DrugBank.d624.s0.e0 false alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (r_nmod) taking_7\VBG\2367363|tobi|alfa (r_acl) patients_6\NNS\9898892|taking (r_nsubj) demonstrated_31\VBD\2137132|studies|,|patients|profiles|. (l_nmod) studies_2\NNS\635850|in|clinical|tobi (l_nmod) tobi_4\NN\1740|of
DDI-DrugBank.d624.s0.e2_DDI-DrugBank.d624.s0.e1 false alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (r_nmod) taking_7\VBG\2367363|tobi|alfa (l_dobj) tobi_8\NN\1740|
DDI-DrugBank.d624.s0.e2_DDI-DrugBank.d624.s0.e3 false alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_appos) pulmozyme_14\NN\1740|(|,|genentech|)
DDI-DrugBank.d624.s0.e2_DDI-DrugBank.d624.s0.e4 false alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) (beta)-agonists_19\NNS\1740|
DDI-DrugBank.d624.s0.e2_DDI-DrugBank.d624.s0.e5 false alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) corticosteroids_22\NNS\14745635|inhaled
DDI-DrugBank.d624.s0.e2_DDI-DrugBank.d624.s0.e6 false alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) antibiotics_26\NNS\2716205|other|anti-pseudomonal
DDI-DrugBank.d624.s0.e2_DDI-DrugBank.d624.s0.e7 false alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) aminoglycosides_30\NNS\1740|parenteral
DDI-DrugBank.d624.s0.e0_DDI-DrugBank.d624.s0.e1 false tobi_4\NN\1740|of (r_nmod) studies_2\NNS\635850|in|clinical|tobi (r_nmod) demonstrated_31\VBD\2137132|studies|,|patients|profiles|. (l_nsubj) patients_6\NNS\9898892|taking (l_acl) taking_7\VBG\2367363|tobi|alfa (l_dobj) tobi_8\NN\1740|
DDI-DrugBank.d624.s0.e0_DDI-DrugBank.d624.s0.e3 false tobi_4\NN\1740|of (r_nmod) studies_2\NNS\635850|in|clinical|tobi (r_nmod) demonstrated_31\VBD\2137132|studies|,|patients|profiles|. (l_nsubj) patients_6\NNS\9898892|taking (l_acl) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_appos) pulmozyme_14\NN\1740|(|,|genentech|)
DDI-DrugBank.d624.s0.e0_DDI-DrugBank.d624.s0.e4 false tobi_4\NN\1740|of (r_nmod) studies_2\NNS\635850|in|clinical|tobi (r_nmod) demonstrated_31\VBD\2137132|studies|,|patients|profiles|. (l_nsubj) patients_6\NNS\9898892|taking (l_acl) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) (beta)-agonists_19\NNS\1740|
DDI-DrugBank.d624.s0.e0_DDI-DrugBank.d624.s0.e5 false tobi_4\NN\1740|of (r_nmod) studies_2\NNS\635850|in|clinical|tobi (r_nmod) demonstrated_31\VBD\2137132|studies|,|patients|profiles|. (l_nsubj) patients_6\NNS\9898892|taking (l_acl) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) corticosteroids_22\NNS\14745635|inhaled
DDI-DrugBank.d624.s0.e0_DDI-DrugBank.d624.s0.e6 false tobi_4\NN\1740|of (r_nmod) studies_2\NNS\635850|in|clinical|tobi (r_nmod) demonstrated_31\VBD\2137132|studies|,|patients|profiles|. (l_nsubj) patients_6\NNS\9898892|taking (l_acl) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) antibiotics_26\NNS\2716205|other|anti-pseudomonal
DDI-DrugBank.d624.s0.e0_DDI-DrugBank.d624.s0.e7 false tobi_4\NN\1740|of (r_nmod) studies_2\NNS\635850|in|clinical|tobi (r_nmod) demonstrated_31\VBD\2137132|studies|,|patients|profiles|. (l_nsubj) patients_6\NNS\9898892|taking (l_acl) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) aminoglycosides_30\NNS\1740|parenteral
DDI-DrugBank.d624.s0.e1_DDI-DrugBank.d624.s0.e3 true tobi_8\NN\1740| (r_dobj) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_appos) pulmozyme_14\NN\1740|(|,|genentech|)
DDI-DrugBank.d624.s0.e1_DDI-DrugBank.d624.s0.e4 true tobi_8\NN\1740| (r_dobj) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) (beta)-agonists_19\NNS\1740|
DDI-DrugBank.d624.s0.e1_DDI-DrugBank.d624.s0.e5 false tobi_8\NN\1740| (r_dobj) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) corticosteroids_22\NNS\14745635|inhaled
DDI-DrugBank.d624.s0.e1_DDI-DrugBank.d624.s0.e6 false tobi_8\NN\1740| (r_dobj) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) antibiotics_26\NNS\2716205|other|anti-pseudomonal
DDI-DrugBank.d624.s0.e1_DDI-DrugBank.d624.s0.e7 false tobi_8\NN\1740| (r_dobj) taking_7\VBG\2367363|tobi|alfa (l_nmod) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) aminoglycosides_30\NNS\1740|parenteral
DDI-DrugBank.d624.s0.e3_DDI-DrugBank.d624.s0.e4 false pulmozyme_14\NN\1740|(|,|genentech|) (r_appos) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) (beta)-agonists_19\NNS\1740|
DDI-DrugBank.d624.s0.e3_DDI-DrugBank.d624.s0.e5 false pulmozyme_14\NN\1740|(|,|genentech|) (r_appos) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) corticosteroids_22\NNS\14745635|inhaled
DDI-DrugBank.d624.s0.e3_DDI-DrugBank.d624.s0.e6 false pulmozyme_14\NN\1740|(|,|genentech|) (r_appos) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) antibiotics_26\NNS\2716205|other|anti-pseudomonal
DDI-DrugBank.d624.s0.e3_DDI-DrugBank.d624.s0.e7 false pulmozyme_14\NN\1740|(|,|genentech|) (r_appos) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) aminoglycosides_30\NNS\1740|parenteral
DDI-DrugBank.d624.s0.e4_DDI-DrugBank.d624.s0.e5 false (beta)-agonists_19\NNS\1740| (r_conj) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) corticosteroids_22\NNS\14745635|inhaled
DDI-DrugBank.d624.s0.e4_DDI-DrugBank.d624.s0.e6 false (beta)-agonists_19\NNS\1740| (r_conj) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) antibiotics_26\NNS\2716205|other|anti-pseudomonal
DDI-DrugBank.d624.s0.e4_DDI-DrugBank.d624.s0.e7 false (beta)-agonists_19\NNS\1740| (r_conj) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) aminoglycosides_30\NNS\1740|parenteral
DDI-DrugBank.d624.s0.e5_DDI-DrugBank.d624.s0.e6 false corticosteroids_22\NNS\14745635|inhaled (r_conj) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) antibiotics_26\NNS\2716205|other|anti-pseudomonal
DDI-DrugBank.d624.s0.e5_DDI-DrugBank.d624.s0.e7 false corticosteroids_22\NNS\14745635|inhaled (r_conj) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) aminoglycosides_30\NNS\1740|parenteral
DDI-DrugBank.d624.s0.e6_DDI-DrugBank.d624.s0.e7 false antibiotics_26\NNS\2716205|other|anti-pseudomonal (r_conj) alfa_12\NN\1740|concomitantly|with|dornase|pulmozyme|,|(beta)-agonists|,|corticosteroids|,|antibiotics|,|or|aminoglycosides (l_conj) aminoglycosides_30\NNS\1740|parenteral
DDI-DrugBank.d695.s1
DDI-DrugBank.d695.s1.e1_DDI-DrugBank.d695.s1.e0 false imiglucerase_5\NN\1740|(|) (r_appos) cerezyme_3\NN\1740|with|imiglucerase|and|zavesca
DDI-DrugBank.d695.s1.e1_DDI-DrugBank.d695.s1.e2 true imiglucerase_5\NN\1740|(|) (r_appos) cerezyme_3\NN\1740|with|imiglucerase|and|zavesca (l_conj) zavesca_8\NNP\1740|
DDI-DrugBank.d695.s1.e0_DDI-DrugBank.d695.s1.e2 true cerezyme_3\NN\1740|with|imiglucerase|and|zavesca (l_conj) zavesca_8\NNP\1740|
DDI-DrugBank.d602.s0
DDI-DrugBank.d602.s0.e1_DDI-DrugBank.d602.s0.e0 false irinotecan_18\NN\1740|(|e.g.|) (r_nmod) compounds_7\NNS\5869584|with|metabolized/eliminated|irinotecan (r_nmod) administering_4\VBG\2436349|when|nexavar|compounds (l_dobj) nexavar_5\NNP\1740|
DDI-DrugBank.d747.s0
DDI-DrugBank.d747.s0.e2_DDI-DrugBank.d747.s0.e0 false penicillin_12\NN\2716866|of (r_nmod) effect_10\NN\34213|the|bactericidal|penicillin (r_dobj) antagonize_7\VB\1787955|tetracycline|may|effect|and|avoided (l_nsubj) tetracycline_0\NN\2716205|,|antibiotic|,
DDI-DrugBank.d747.s0.e2_DDI-DrugBank.d747.s0.e1 false penicillin_12\NN\2716866|of (r_nmod) effect_10\NN\34213|the|bactericidal|penicillin (r_dobj) antagonize_7\VB\1787955|tetracycline|may|effect|and|avoided (l_nsubj) tetracycline_0\NN\2716205|,|antibiotic|, (l_appos) antibiotic_4\NN\2716205|a|bacteriostatic
DDI-DrugBank.d747.s0.e0_DDI-DrugBank.d747.s0.e1 false tetracycline_0\NN\2716205|,|antibiotic|, (l_appos) antibiotic_4\NN\2716205|a|bacteriostatic
DDI-DrugBank.d602.s3
DDI-DrugBank.d779.s15
DDI-DrugBank.d743.s12
DDI-DrugBank.d743.s12.e0_DDI-DrugBank.d743.s12.e1 true terfenadine_3\NN\1740|of (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (l_nmod) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin
DDI-DrugBank.d743.s12.e0_DDI-DrugBank.d743.s12.e2 true terfenadine_3\NN\1740|of (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (l_nmod) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (l_conj) erythromycin_7\NN\2716866|
DDI-DrugBank.d743.s12.e0_DDI-DrugBank.d743.s12.e3 true terfenadine_3\NN\1740|of (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (l_nmod) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (l_conj) troleandomycin_10\NN\1740|
DDI-DrugBank.d743.s12.e0_DDI-DrugBank.d743.s12.e4 false terfenadine_3\NN\1740|of (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) terfenadine_24\NN\1740|of
DDI-DrugBank.d743.s12.e0_DDI-DrugBank.d743.s12.e6 false terfenadine_3\NN\1740|of (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|, (l_nmod) azithromycin_31\NN\2716205|including
DDI-DrugBank.d743.s12.e0_DDI-DrugBank.d743.s12.e5 false terfenadine_3\NN\1740|of (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|,
DDI-DrugBank.d743.s12.e1_DDI-DrugBank.d743.s12.e2 false clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (l_conj) erythromycin_7\NN\2716866|
DDI-DrugBank.d743.s12.e1_DDI-DrugBank.d743.s12.e3 false clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (l_conj) troleandomycin_10\NN\1740|
DDI-DrugBank.d743.s12.e1_DDI-DrugBank.d743.s12.e4 false clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) terfenadine_24\NN\1740|of
DDI-DrugBank.d743.s12.e1_DDI-DrugBank.d743.s12.e6 false clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|, (l_nmod) azithromycin_31\NN\2716205|including
DDI-DrugBank.d743.s12.e1_DDI-DrugBank.d743.s12.e5 false clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|,
DDI-DrugBank.d743.s12.e2_DDI-DrugBank.d743.s12.e3 false erythromycin_7\NN\2716866| (r_conj) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (l_conj) troleandomycin_10\NN\1740|
DDI-DrugBank.d743.s12.e2_DDI-DrugBank.d743.s12.e4 false erythromycin_7\NN\2716866| (r_conj) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) terfenadine_24\NN\1740|of
DDI-DrugBank.d743.s12.e2_DDI-DrugBank.d743.s12.e6 false erythromycin_7\NN\2716866| (r_conj) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|, (l_nmod) azithromycin_31\NN\2716205|including
DDI-DrugBank.d743.s12.e2_DDI-DrugBank.d743.s12.e5 false erythromycin_7\NN\2716866| (r_conj) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|,
DDI-DrugBank.d743.s12.e3_DDI-DrugBank.d743.s12.e4 false troleandomycin_10\NN\1740| (r_conj) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) terfenadine_24\NN\1740|of
DDI-DrugBank.d743.s12.e3_DDI-DrugBank.d743.s12.e6 false troleandomycin_10\NN\1740| (r_conj) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|, (l_nmod) azithromycin_31\NN\2716205|including
DDI-DrugBank.d743.s12.e3_DDI-DrugBank.d743.s12.e5 false troleandomycin_10\NN\1740| (r_conj) clarithromycin_5\NN\1740|with|,|erythromycin|,|or|troleandomycin (r_nmod) administration_1\NN\1133281|concomitant|terfenadine|clarithromycin (r_nsubj) contraindicated_12\JJ\1740|administration|is (r_ccomp) recommended_35\VBN\875394|contraindicated|:|characterization|,|administration|is|not|. (l_nsubjpass) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|,
DDI-DrugBank.d743.s12.e4_DDI-DrugBank.d743.s12.e6 false terfenadine_24\NN\1740|of (r_nmod) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|, (l_nmod) azithromycin_31\NN\2716205|including
DDI-DrugBank.d743.s12.e4_DDI-DrugBank.d743.s12.e5 false terfenadine_24\NN\1740|of (r_nmod) administration_22\NN\1133281|concomitant|terfenadine|antibiotics (l_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|,
DDI-DrugBank.d743.s12.e6_DDI-DrugBank.d743.s12.e5 false azithromycin_31\NN\2716205|including (r_nmod) antibiotics_28\NNS\2716205|with|other|macrolide|,|azithromycin|,
DDI-DrugBank.d743.s10
DDI-DrugBank.d742.s1
DDI-DrugBank.d619.s1
DDI-DrugBank.d597.s23
DDI-DrugBank.d597.s23.e0_DDI-DrugBank.d597.s23.e1 false methotrexate_0\NN\2722166|:|evaluated (l_dep) evaluated_12\VBD\670261|study|effects|. (l_dobj) effects_14\NNS\13245626|the|doses|pharmacokinetics (l_nmod) doses_17\NNS\3740161|of|multiple|meloxicam (l_nmod) meloxicam_19\NN\1740|of
DDI-DrugBank.d597.s23.e0_DDI-DrugBank.d597.s23.e2 false methotrexate_0\NN\2722166|:|evaluated (l_dep) evaluated_12\VBD\670261|study|effects|. (l_dobj) effects_14\NNS\13245626|the|doses|pharmacokinetics (l_nmod) pharmacokinetics_22\NNS\6054892|on|the|methotrexate (l_nmod) methotrexate_24\NN\2722166|of|taken
DDI-DrugBank.d597.s23.e1_DDI-DrugBank.d597.s23.e2 false meloxicam_19\NN\1740|of (r_nmod) doses_17\NNS\3740161|of|multiple|meloxicam (r_nmod) effects_14\NNS\13245626|the|doses|pharmacokinetics (l_nmod) pharmacokinetics_22\NNS\6054892|on|the|methotrexate (l_nmod) methotrexate_24\NN\2722166|of|taken
DDI-DrugBank.d693.s2
DDI-DrugBank.d693.s2.e0_DDI-DrugBank.d693.s2.e1 false sulfasalazine_3\NN\1740|of (r_compound) g_5\NN\13717155|sulfasalazine|2|g (r_nmod) doses_1\NNS\3740161|daily|g|and|doses (l_conj) doses_13\NNS\3740161|weekly|methotrexate|mg (l_nmod) methotrexate_15\NN\2722166|of
DDI-DrugBank.d694.s2
DDI-DrugBank.d694.s2.e0_DDI-DrugBank.d694.s2.e1 false digoxin_4\NN\15060131|of|or|januvia (l_conj) januvia_6\NNP\1740|
DDI-DrugBank.d693.s0
DDI-DrugBank.d693.s0.e0_DDI-DrugBank.d693.s0.e1 false acid_4\NN\14818238|of|folic|and|digoxin (l_conj) digoxin_6\NN\15060131|
DDI-DrugBank.d693.s0.e0_DDI-DrugBank.d693.s0.e2 true acid_4\NN\14818238|of|folic|and|digoxin (r_nmod) absorption_1\NN\13558490|reduced|acid (r_nsubjpass) reported_9\VBN\831651|absorption|have|been|administered|. (l_advcl) administered_14\VBN\2436349|when|agents|were|concomitantly|sulfasalazine (l_nmod) sulfasalazine_17\NN\1740|with
DDI-DrugBank.d693.s0.e1_DDI-DrugBank.d693.s0.e2 true digoxin_6\NN\15060131| (r_conj) acid_4\NN\14818238|of|folic|and|digoxin (r_nmod) absorption_1\NN\13558490|reduced|acid (r_nsubjpass) reported_9\VBN\831651|absorption|have|been|administered|. (l_advcl) administered_14\VBN\2436349|when|agents|were|concomitantly|sulfasalazine (l_nmod) sulfasalazine_17\NN\1740|with
DDI-DrugBank.d775.s2
DDI-DrugBank.d775.s2.e0_DDI-DrugBank.d775.s2.e1 true succinylcholine_5\NN\3800001|from (r_nmod) recovery_3\NN\7357388|of|spontaneous|succinylcholine (r_nmod) evidence_0\NN\5816287|recovery (r_nsubjpass) observed_8\VBN\2163746|evidence|should|be|administration|. (l_nmod) administration_11\NN\1133281|before|the|mivacron (l_nmod) mivacron_13\NN\1740|of
DDI-DrugBank.d603.s2
DDI-DrugBank.d603.s2.e0_DDI-DrugBank.d603.s2.e1 false phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) pseudoephedrine_13\NN\14712692|
DDI-DrugBank.d603.s2.e0_DDI-DrugBank.d603.s2.e2 false phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) ephedrine_15\NN\14712692|
DDI-DrugBank.d603.s2.e0_DDI-DrugBank.d603.s2.e3 false phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) phenylpropanolamine_17\NN\2682038|or|dihydroergotamine
DDI-DrugBank.d603.s2.e0_DDI-DrugBank.d603.s2.e4 false phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) phenylpropanolamine_17\NN\2682038|or|dihydroergotamine (l_conj) dihydroergotamine_19\NN\1740|
DDI-DrugBank.d603.s2.e0_DDI-DrugBank.d603.s2.e5 true phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (r_dep) drugs_3\NNS\14778436|of|stimulate|phenylephrine (r_nmod) use_1\NN\407535|the|drugs (r_nsubj) enhance_22\VB\227165|use|may|or|potentiate|effects (l_dobj) effects_27\NNS\13245626|the|pressor|proamatine (l_nmod) proamatine_29\NN\1740|of
DDI-DrugBank.d603.s2.e1_DDI-DrugBank.d603.s2.e2 false pseudoephedrine_13\NN\14712692| (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) ephedrine_15\NN\14712692|
DDI-DrugBank.d603.s2.e1_DDI-DrugBank.d603.s2.e3 false pseudoephedrine_13\NN\14712692| (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) phenylpropanolamine_17\NN\2682038|or|dihydroergotamine
DDI-DrugBank.d603.s2.e1_DDI-DrugBank.d603.s2.e4 false pseudoephedrine_13\NN\14712692| (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) phenylpropanolamine_17\NN\2682038|or|dihydroergotamine (l_conj) dihydroergotamine_19\NN\1740|
DDI-DrugBank.d603.s2.e1_DDI-DrugBank.d603.s2.e5 true pseudoephedrine_13\NN\14712692| (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (r_dep) drugs_3\NNS\14778436|of|stimulate|phenylephrine (r_nmod) use_1\NN\407535|the|drugs (r_nsubj) enhance_22\VB\227165|use|may|or|potentiate|effects (l_dobj) effects_27\NNS\13245626|the|pressor|proamatine (l_nmod) proamatine_29\NN\1740|of
DDI-DrugBank.d603.s2.e2_DDI-DrugBank.d603.s2.e3 false ephedrine_15\NN\14712692| (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) phenylpropanolamine_17\NN\2682038|or|dihydroergotamine
DDI-DrugBank.d603.s2.e2_DDI-DrugBank.d603.s2.e4 false ephedrine_15\NN\14712692| (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (l_conj) phenylpropanolamine_17\NN\2682038|or|dihydroergotamine (l_conj) dihydroergotamine_19\NN\1740|
DDI-DrugBank.d603.s2.e2_DDI-DrugBank.d603.s2.e5 false ephedrine_15\NN\14712692| (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (r_dep) drugs_3\NNS\14778436|of|stimulate|phenylephrine (r_nmod) use_1\NN\407535|the|drugs (r_nsubj) enhance_22\VB\227165|use|may|or|potentiate|effects (l_dobj) effects_27\NNS\13245626|the|pressor|proamatine (l_nmod) proamatine_29\NN\1740|of
DDI-DrugBank.d603.s2.e3_DDI-DrugBank.d603.s2.e4 false phenylpropanolamine_17\NN\2682038|or|dihydroergotamine (l_conj) dihydroergotamine_19\NN\1740|
DDI-DrugBank.d603.s2.e3_DDI-DrugBank.d603.s2.e5 false phenylpropanolamine_17\NN\2682038|or|dihydroergotamine (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (r_dep) drugs_3\NNS\14778436|of|stimulate|phenylephrine (r_nmod) use_1\NN\407535|the|drugs (r_nsubj) enhance_22\VB\227165|use|may|or|potentiate|effects (l_dobj) effects_27\NNS\13245626|the|pressor|proamatine (l_nmod) proamatine_29\NN\1740|of
DDI-DrugBank.d603.s2.e4_DDI-DrugBank.d603.s2.e5 false dihydroergotamine_19\NN\1740| (r_conj) phenylpropanolamine_17\NN\2682038|or|dihydroergotamine (r_conj) phenylephrine_11\NN\2682038|(|e.g.|,|,|pseudoephedrine|,|ephedrine|,|phenylpropanolamine|) (r_dep) drugs_3\NNS\14778436|of|stimulate|phenylephrine (r_nmod) use_1\NN\407535|the|drugs (r_nsubj) enhance_22\VB\227165|use|may|or|potentiate|effects (l_dobj) effects_27\NNS\13245626|the|pressor|proamatine (l_nmod) proamatine_29\NN\1740|of
DDI-DrugBank.d604.s6
DDI-DrugBank.d632.s6
DDI-DrugBank.d632.s6.e1_DDI-DrugBank.d632.s6.e3 false insulin_3\NN\5407119| (r_conj) symlin_1\NN\1740|mixing|and|insulin (r_nmod) altered_10\VBN\126264|symlin|parameters|were|mixed|. (l_advcl) mixed_12\VBN\140123|when|nph|prior (l_nmod) nph_16\JJ\1740|with|regular|,|,|and|formulations (l_conj) formulations_21\NNS\14818238|70/30|premixed|insulin (l_nmod) insulin_25\NN\5407119|of|recombinant|human
DDI-DrugBank.d632.s6.e1_DDI-DrugBank.d632.s6.e0 false insulin_3\NN\5407119| (r_conj) symlin_1\NN\1740|mixing|and|insulin
DDI-DrugBank.d632.s6.e1_DDI-DrugBank.d632.s6.e2 false insulin_3\NN\5407119| (r_conj) symlin_1\NN\1740|mixing|and|insulin (r_nmod) altered_10\VBN\126264|symlin|parameters|were|mixed|. (l_nsubjpass) parameters_6\NNS\5858936|the|pharmacokinetic|symlin (l_nmod) symlin_8\NNP\1740|of
DDI-DrugBank.d632.s6.e3_DDI-DrugBank.d632.s6.e0 false insulin_25\NN\5407119|of|recombinant|human (r_nmod) formulations_21\NNS\14818238|70/30|premixed|insulin (r_conj) nph_16\JJ\1740|with|regular|,|,|and|formulations (r_nmod) mixed_12\VBN\140123|when|nph|prior (r_advcl) altered_10\VBN\126264|symlin|parameters|were|mixed|. (l_nmod) symlin_1\NN\1740|mixing|and|insulin
DDI-DrugBank.d632.s6.e3_DDI-DrugBank.d632.s6.e2 false insulin_25\NN\5407119|of|recombinant|human (r_nmod) formulations_21\NNS\14818238|70/30|premixed|insulin (r_conj) nph_16\JJ\1740|with|regular|,|,|and|formulations (r_nmod) mixed_12\VBN\140123|when|nph|prior (r_advcl) altered_10\VBN\126264|symlin|parameters|were|mixed|. (l_nsubjpass) parameters_6\NNS\5858936|the|pharmacokinetic|symlin (l_nmod) symlin_8\NNP\1740|of
DDI-DrugBank.d632.s6.e0_DDI-DrugBank.d632.s6.e2 false symlin_1\NN\1740|mixing|and|insulin (r_nmod) altered_10\VBN\126264|symlin|parameters|were|mixed|. (l_nsubjpass) parameters_6\NNS\5858936|the|pharmacokinetic|symlin (l_nmod) symlin_8\NNP\1740|of
DDI-DrugBank.d775.s9
DDI-DrugBank.d777.s1
DDI-DrugBank.d777.s1.e3_DDI-DrugBank.d777.s1.e2 false streptokinase_9\NN\14732946| (r_conj) streptase_7\NN\1740|,|streptokinase
DDI-DrugBank.d777.s1.e3_DDI-DrugBank.d777.s1.e0 false streptokinase_9\NN\14732946| (r_conj) streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or
DDI-DrugBank.d777.s1.e3_DDI-DrugBank.d777.s1.e1 false streptokinase_9\NN\14732946| (r_conj) streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_conj) agents_5\NNS\7347|antiplatelet
DDI-DrugBank.d777.s1.e3_DDI-DrugBank.d777.s1.e4 false streptokinase_9\NN\14732946| (r_conj) streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants
DDI-DrugBank.d777.s1.e3_DDI-DrugBank.d777.s1.e5 false streptokinase_9\NN\14732946| (r_conj) streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants (l_conj) anticoagulants_19\NNS\3740161|
DDI-DrugBank.d777.s1.e2_DDI-DrugBank.d777.s1.e0 false streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or
DDI-DrugBank.d777.s1.e2_DDI-DrugBank.d777.s1.e1 false streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_conj) agents_5\NNS\7347|antiplatelet
DDI-DrugBank.d777.s1.e2_DDI-DrugBank.d777.s1.e4 false streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants
DDI-DrugBank.d777.s1.e2_DDI-DrugBank.d777.s1.e5 false streptase_7\NN\1740|,|streptokinase (r_appos) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants (l_conj) anticoagulants_19\NNS\3740161|
DDI-DrugBank.d777.s1.e0_DDI-DrugBank.d777.s1.e1 false anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_conj) agents_5\NNS\7347|antiplatelet
DDI-DrugBank.d777.s1.e0_DDI-DrugBank.d777.s1.e4 false anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants
DDI-DrugBank.d777.s1.e0_DDI-DrugBank.d777.s1.e5 false anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants (l_conj) anticoagulants_19\NNS\3740161|
DDI-DrugBank.d777.s1.e1_DDI-DrugBank.d777.s1.e4 false agents_5\NNS\7347|antiplatelet (r_conj) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants
DDI-DrugBank.d777.s1.e1_DDI-DrugBank.d777.s1.e5 false agents_5\NNS\7347|antiplatelet (r_conj) anticoagulants_2\NNS\3740161|of|and|agents|--|streptase|,|or (l_cc) or_12\CC\3541091|alone|combination (l_conj) combination_14\NN\7951464|in|agents (l_nmod) agents_17\NNS\7347|with|antiplatelet|and|anticoagulants (l_conj) anticoagulants_19\NNS\3740161|
DDI-DrugBank.d777.s1.e4_DDI-DrugBank.d777.s1.e5 false agents_17\NNS\7347|with|antiplatelet|and|anticoagulants (l_conj) anticoagulants_19\NNS\3740161|
DDI-DrugBank.d776.s40
DDI-DrugBank.d776.s40.e0_DDI-DrugBank.d776.s40.e1 false estradiol_12\NN\14749794|ethinyl|and|levonorgestrel (l_conj) levonorgestrel_14\NN\1740|
DDI-DrugBank.d776.s40.e0_DDI-DrugBank.d776.s40.e2 false estradiol_12\NN\14749794|ethinyl|and|levonorgestrel (r_compound) values_16\NNS\5941423|in|some|individual|estradiol|auc (r_nmod) decreases_7\NNS\7296428|the|values|treatment (l_nmod) treatment_19\NN\654885|with|fluconazole (l_compound) fluconazole_18\NN\1740|
DDI-DrugBank.d776.s40.e1_DDI-DrugBank.d776.s40.e2 false levonorgestrel_14\NN\1740| (r_conj) estradiol_12\NN\14749794|ethinyl|and|levonorgestrel (r_compound) values_16\NNS\5941423|in|some|individual|estradiol|auc (r_nmod) decreases_7\NNS\7296428|the|values|treatment (l_nmod) treatment_19\NN\654885|with|fluconazole (l_compound) fluconazole_18\NN\1740|
DDI-DrugBank.d634.s2
DDI-DrugBank.d765.s2
DDI-DrugBank.d680.s10
DDI-DrugBank.d648.s5
DDI-DrugBank.d648.s5.e0_DDI-DrugBank.d648.s5.e1 false raloxifene_3\NN\1740| (r_nsubj) affect_6\VB\126264|vitro|,|raloxifene|did|not|binding|. (l_dobj) binding_8\NN\4688246|the|warfarin (l_nmod) warfarin_10\NN\2718259|of|,|phenytoin|,|or|tamoxifen
DDI-DrugBank.d648.s5.e0_DDI-DrugBank.d648.s5.e2 false raloxifene_3\NN\1740| (r_nsubj) affect_6\VB\126264|vitro|,|raloxifene|did|not|binding|. (l_dobj) binding_8\NN\4688246|the|warfarin (l_nmod) warfarin_10\NN\2718259|of|,|phenytoin|,|or|tamoxifen (l_conj) phenytoin_12\NN\3550533|
DDI-DrugBank.d648.s5.e0_DDI-DrugBank.d648.s5.e3 false raloxifene_3\NN\1740| (r_nsubj) affect_6\VB\126264|vitro|,|raloxifene|did|not|binding|. (l_dobj) binding_8\NN\4688246|the|warfarin (l_nmod) warfarin_10\NN\2718259|of|,|phenytoin|,|or|tamoxifen (l_conj) tamoxifen_15\NN\2714883|
DDI-DrugBank.d648.s5.e1_DDI-DrugBank.d648.s5.e2 false warfarin_10\NN\2718259|of|,|phenytoin|,|or|tamoxifen (l_conj) phenytoin_12\NN\3550533|
DDI-DrugBank.d648.s5.e1_DDI-DrugBank.d648.s5.e3 false warfarin_10\NN\2718259|of|,|phenytoin|,|or|tamoxifen (l_conj) tamoxifen_15\NN\2714883|
DDI-DrugBank.d648.s5.e2_DDI-DrugBank.d648.s5.e3 false phenytoin_12\NN\3550533| (r_conj) warfarin_10\NN\2718259|of|,|phenytoin|,|or|tamoxifen (l_conj) tamoxifen_15\NN\2714883|
DDI-DrugBank.d653.s3
DDI-DrugBank.d690.s1
DDI-DrugBank.d653.s2
DDI-DrugBank.d653.s2.e0_DDI-DrugBank.d653.s2.e1 false troleandomycin_3\NN\1740|such|and|ketoconazole (l_conj) ketoconazole_5\NN\1740|
DDI-DrugBank.d653.s2.e0_DDI-DrugBank.d653.s2.e2 true troleandomycin_3\NN\1740|such|and|ketoconazole (r_nmod) drugs_0\NNS\14778436|troleandomycin (r_nsubj) inhibit_7\VB\2510337|drugs|may|metabolism|and|decrease|. (l_dobj) metabolism_9\NN\13526110|the|corticosteroids (l_nmod) corticosteroids_11\NNS\14745635|of
DDI-DrugBank.d653.s2.e1_DDI-DrugBank.d653.s2.e2 true ketoconazole_5\NN\1740| (r_conj) troleandomycin_3\NN\1740|such|and|ketoconazole (r_nmod) drugs_0\NNS\14778436|troleandomycin (r_nsubj) inhibit_7\VB\2510337|drugs|may|metabolism|and|decrease|. (l_dobj) metabolism_9\NN\13526110|the|corticosteroids (l_nmod) corticosteroids_11\NNS\14745635|of
DDI-DrugBank.d743.s9
DDI-DrugBank.d743.s9.e1_DDI-DrugBank.d743.s9.e2 false erythromycin_8\NN\2716866|and|clarithromycin (l_conj) clarithromycin_10\NN\1740|
DDI-DrugBank.d743.s9.e1_DDI-DrugBank.d743.s9.e3 true erythromycin_8\NN\2716866|and|clarithromycin (r_nsubj) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (l_nmod) metabolism_17\NN\13526110|on|terfenadine (l_compound) terfenadine_16\NN\1740|
DDI-DrugBank.d743.s9.e1_DDI-DrugBank.d743.s9.e4 false erythromycin_8\NN\2716866|and|clarithromycin (r_nsubj) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (l_nmod) mechanism_20\NN\13446390|by|a|similar (l_acl:relcl) similar_24\JJ\1740|which|may|be|that|,|but|extent (l_nmod) that_26\DT\1740|to|ketoconazole (l_nmod) ketoconazole_28\NN\1740|of
DDI-DrugBank.d743.s9.e1_DDI-DrugBank.d743.s9.e0 false erythromycin_8\NN\2716866|and|clarithromycin (r_nsubj) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (r_ccomp) indicate_6\VBP\952524|macrolides|:|studies|exert|. (l_nsubj) macrolides_0\NNS\1740|
DDI-DrugBank.d743.s9.e2_DDI-DrugBank.d743.s9.e3 true clarithromycin_10\NN\1740| (r_conj) erythromycin_8\NN\2716866|and|clarithromycin (r_nsubj) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (l_nmod) metabolism_17\NN\13526110|on|terfenadine (l_compound) terfenadine_16\NN\1740|
DDI-DrugBank.d743.s9.e2_DDI-DrugBank.d743.s9.e4 false clarithromycin_10\NN\1740| (r_conj) erythromycin_8\NN\2716866|and|clarithromycin (r_nsubj) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (l_nmod) mechanism_20\NN\13446390|by|a|similar (l_acl:relcl) similar_24\JJ\1740|which|may|be|that|,|but|extent (l_nmod) that_26\DT\1740|to|ketoconazole (l_nmod) ketoconazole_28\NN\1740|of
DDI-DrugBank.d743.s9.e2_DDI-DrugBank.d743.s9.e0 false clarithromycin_10\NN\1740| (r_conj) erythromycin_8\NN\2716866|and|clarithromycin (r_nsubj) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (r_ccomp) indicate_6\VBP\952524|macrolides|:|studies|exert|. (l_nsubj) macrolides_0\NNS\1740|
DDI-DrugBank.d743.s9.e3_DDI-DrugBank.d743.s9.e4 false terfenadine_16\NN\1740| (r_compound) metabolism_17\NN\13526110|on|terfenadine (r_nmod) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (l_nmod) mechanism_20\NN\13446390|by|a|similar (l_acl:relcl) similar_24\JJ\1740|which|may|be|that|,|but|extent (l_nmod) that_26\DT\1740|to|ketoconazole (l_nmod) ketoconazole_28\NN\1740|of
DDI-DrugBank.d743.s9.e3_DDI-DrugBank.d743.s9.e0 false terfenadine_16\NN\1740| (r_compound) metabolism_17\NN\13526110|on|terfenadine (r_nmod) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (r_ccomp) indicate_6\VBP\952524|macrolides|:|studies|exert|. (l_nsubj) macrolides_0\NNS\1740|
DDI-DrugBank.d743.s9.e4_DDI-DrugBank.d743.s9.e0 false ketoconazole_28\NN\1740|of (r_nmod) that_26\DT\1740|to|ketoconazole (r_nmod) similar_24\JJ\1740|which|may|be|that|,|but|extent (r_acl:relcl) mechanism_20\NN\13446390|by|a|similar (r_nmod) exert_12\VB\1158872|that|erythromycin|can|effect|metabolism|mechanism (r_ccomp) indicate_6\VBP\952524|macrolides|:|studies|exert|. (l_nsubj) macrolides_0\NNS\1740|
DDI-DrugBank.d676.s0
DDI-DrugBank.d676.s0.e0_DDI-DrugBank.d676.s0.e1 false barbiturates_8\NNS\4166841|,|antihistamines (l_conj) antihistamines_10\NNS\3740161|,|narcotics
DDI-DrugBank.d676.s0.e0_DDI-DrugBank.d676.s0.e2 false barbiturates_8\NNS\4166841|,|antihistamines (l_conj) antihistamines_10\NNS\3740161|,|narcotics (l_conj) narcotics_12\NNS\3247620|,|agents
DDI-DrugBank.d676.s0.e0_DDI-DrugBank.d676.s0.e3 false barbiturates_8\NNS\4166841|,|antihistamines (l_conj) antihistamines_10\NNS\3740161|,|narcotics (l_conj) narcotics_12\NNS\3247620|,|agents (l_conj) agents_15\NNS\7347|hypotensive|or|phenothiazines
DDI-DrugBank.d676.s0.e0_DDI-DrugBank.d676.s0.e4 false barbiturates_8\NNS\4166841|,|antihistamines (l_conj) antihistamines_10\NNS\3740161|,|narcotics (l_conj) narcotics_12\NNS\3247620|,|agents (l_conj) agents_15\NNS\7347|hypotensive|or|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|
DDI-DrugBank.d676.s0.e1_DDI-DrugBank.d676.s0.e2 false antihistamines_10\NNS\3740161|,|narcotics (l_conj) narcotics_12\NNS\3247620|,|agents
DDI-DrugBank.d676.s0.e1_DDI-DrugBank.d676.s0.e3 false antihistamines_10\NNS\3740161|,|narcotics (l_conj) narcotics_12\NNS\3247620|,|agents (l_conj) agents_15\NNS\7347|hypotensive|or|phenothiazines
DDI-DrugBank.d676.s0.e1_DDI-DrugBank.d676.s0.e4 false antihistamines_10\NNS\3740161|,|narcotics (l_conj) narcotics_12\NNS\3247620|,|agents (l_conj) agents_15\NNS\7347|hypotensive|or|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|
DDI-DrugBank.d676.s0.e2_DDI-DrugBank.d676.s0.e3 false narcotics_12\NNS\3247620|,|agents (l_conj) agents_15\NNS\7347|hypotensive|or|phenothiazines
DDI-DrugBank.d676.s0.e2_DDI-DrugBank.d676.s0.e4 false narcotics_12\NNS\3247620|,|agents (l_conj) agents_15\NNS\7347|hypotensive|or|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|
DDI-DrugBank.d676.s0.e3_DDI-DrugBank.d676.s0.e4 false agents_15\NNS\7347|hypotensive|or|phenothiazines (l_conj) phenothiazines_17\NNS\14771088|
DDI-DrugBank.d782.s0
DDI-DrugBank.d782.s0.e0_DDI-DrugBank.d782.s0.e1 true vindesine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|vindesine|can|drugs|:|dyscrasia|cause|increase (l_conj) increase_50\VB\169651|phenytoin|:|can|activity (l_dep) phenytoin_47\NN\3550533|-
DDI-DrugBank.d782.s0.e3_DDI-DrugBank.d782.s0.e4 false vaccine_10\NN\3562739| (r_compound) virus_11\NN\9312843|of|the|vaccine (r_nmod) replication_7\NN\1019524|the|virus (r_dobj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_conj) increase_14\VB\169651|may|effects|,|and|decrease (l_conj) decrease_23\VB\169651|response (l_dobj) response_26\NN\11410625|patient|mitomycin-c (l_nmod) mitomycin-c_31\NN\1740|to|the|vaccine
DDI-DrugBank.d782.s0.e3_DDI-DrugBank.d782.s0.e2 false vaccine_10\NN\3562739| (r_compound) virus_11\NN\9312843|of|the|vaccine (r_nmod) replication_7\NN\1019524|the|virus (r_dobj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_nsubj) vaccines_2\NNS\3562739|live|virus|:
DDI-DrugBank.d782.s0.e3_DDI-DrugBank.d782.s0.e5 false vaccine_10\NN\3562739| (r_compound) virus_11\NN\9312843|of|the|vaccine (r_nmod) replication_7\NN\1019524|the|virus (r_dobj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_dep) cause_34\VB\1617192|may|shortness|and|vaccines|:|decrease (l_dobj) vaccines_43\NNS\3562739|-|killed|virus
DDI-DrugBank.d782.s0.e3_DDI-DrugBank.d782.s0.e6 false vaccine_10\NN\3562739| (r_compound) virus_11\NN\9312843|of|the|vaccine (r_nmod) replication_7\NN\1019524|the|virus (r_dobj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_dep) cause_34\VB\1617192|may|shortness|and|vaccines|:|decrease (l_dep) decrease_46\VB\169651|may|response (l_dobj) response_49\NN\11410625|patient|vaccine (l_nmod) vaccine_52\NN\3562739|to|the
DDI-DrugBank.d782.s0.e4_DDI-DrugBank.d782.s0.e2 false mitomycin-c_31\NN\1740|to|the|vaccine (r_nmod) response_26\NN\11410625|patient|mitomycin-c (r_dobj) decrease_23\VB\169651|response (r_conj) increase_14\VB\169651|may|effects|,|and|decrease (r_conj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_nsubj) vaccines_2\NNS\3562739|live|virus|:
DDI-DrugBank.d782.s0.e4_DDI-DrugBank.d782.s0.e5 false mitomycin-c_31\NN\1740|to|the|vaccine (r_nmod) response_26\NN\11410625|patient|mitomycin-c (r_dobj) decrease_23\VB\169651|response (r_conj) increase_14\VB\169651|may|effects|,|and|decrease (r_conj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_dep) cause_34\VB\1617192|may|shortness|and|vaccines|:|decrease (l_dobj) vaccines_43\NNS\3562739|-|killed|virus
DDI-DrugBank.d782.s0.e4_DDI-DrugBank.d782.s0.e6 false mitomycin-c_31\NN\1740|to|the|vaccine (r_nmod) response_26\NN\11410625|patient|mitomycin-c (r_dobj) decrease_23\VB\169651|response (r_conj) increase_14\VB\169651|may|effects|,|and|decrease (r_conj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_dep) cause_34\VB\1617192|may|shortness|and|vaccines|:|decrease (l_dep) decrease_46\VB\169651|may|response (l_dobj) response_49\NN\11410625|patient|vaccine (l_nmod) vaccine_52\NN\3562739|to|the
DDI-DrugBank.d782.s0.e2_DDI-DrugBank.d782.s0.e5 false vaccines_2\NNS\3562739|live|virus|: (r_nsubj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_dep) cause_34\VB\1617192|may|shortness|and|vaccines|:|decrease (l_dobj) vaccines_43\NNS\3562739|-|killed|virus
DDI-DrugBank.d782.s0.e2_DDI-DrugBank.d782.s0.e6 false vaccines_2\NNS\3562739|live|virus|: (r_nsubj) potentiate_5\VB\229605|vaccines|may|replication|,|increase|:|cause (l_dep) cause_34\VB\1617192|may|shortness|and|vaccines|:|decrease (l_dep) decrease_46\VB\169651|may|response (l_dobj) response_49\NN\11410625|patient|vaccine (l_nmod) vaccine_52\NN\3562739|to|the
DDI-DrugBank.d782.s0.e5_DDI-DrugBank.d782.s0.e6 false vaccines_43\NNS\3562739|-|killed|virus (r_dobj) cause_34\VB\1617192|may|shortness|and|vaccines|:|decrease (l_dep) decrease_46\VB\169651|may|response (l_dobj) response_49\NN\11410625|patient|vaccine (l_nmod) vaccine_52\NN\3562739|to|the
DDI-DrugBank.d720.s0
DDI-DrugBank.d779.s16
DDI-DrugBank.d779.s16.e0_DDI-DrugBank.d779.s16.e1 false methyldopa_0\NN\2721160| (r_nsubj) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) measurement_5\NN\407535|with|vma (l_nmod) vma_7\NN\1740|of|acid|,|test
DDI-DrugBank.d779.s16.e0_DDI-DrugBank.d779.s16.e2 false methyldopa_0\NN\2721160| (r_nsubj) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) measurement_5\NN\407535|with|vma (l_nmod) vma_7\NN\1740|of|acid|,|test (l_appos) acid_10\NN\14818238|(|vanillylmandelic|)
DDI-DrugBank.d779.s16.e0_DDI-DrugBank.d779.s16.e3 false methyldopa_0\NN\2721160| (r_nsubj) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) methods_20\NNS\5616786|by|those|convert (l_acl:relcl) convert_22\VBP\126264|which|vma|vanillin (l_dobj) vma_23\NN\1740|
DDI-DrugBank.d779.s16.e0_DDI-DrugBank.d779.s16.e4 false methyldopa_0\NN\2721160| (r_nsubj) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) methods_20\NNS\5616786|by|those|convert (l_acl:relcl) convert_22\VBP\126264|which|vma|vanillin (l_nmod) vanillin_25\NN\14818238|to
DDI-DrugBank.d779.s16.e1_DDI-DrugBank.d779.s16.e2 false vma_7\NN\1740|of|acid|,|test (l_appos) acid_10\NN\14818238|(|vanillylmandelic|)
DDI-DrugBank.d779.s16.e1_DDI-DrugBank.d779.s16.e3 false vma_7\NN\1740|of|acid|,|test (r_nmod) measurement_5\NN\407535|with|vma (r_nmod) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) methods_20\NNS\5616786|by|those|convert (l_acl:relcl) convert_22\VBP\126264|which|vma|vanillin (l_dobj) vma_23\NN\1740|
DDI-DrugBank.d779.s16.e1_DDI-DrugBank.d779.s16.e4 false vma_7\NN\1740|of|acid|,|test (r_nmod) measurement_5\NN\407535|with|vma (r_nmod) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) methods_20\NNS\5616786|by|those|convert (l_acl:relcl) convert_22\VBP\126264|which|vma|vanillin (l_nmod) vanillin_25\NN\14818238|to
DDI-DrugBank.d779.s16.e2_DDI-DrugBank.d779.s16.e3 false acid_10\NN\14818238|(|vanillylmandelic|) (r_appos) vma_7\NN\1740|of|acid|,|test (r_nmod) measurement_5\NN\407535|with|vma (r_nmod) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) methods_20\NNS\5616786|by|those|convert (l_acl:relcl) convert_22\VBP\126264|which|vma|vanillin (l_dobj) vma_23\NN\1740|
DDI-DrugBank.d779.s16.e2_DDI-DrugBank.d779.s16.e4 false acid_10\NN\14818238|(|vanillylmandelic|) (r_appos) vma_7\NN\1740|of|acid|,|test (r_nmod) measurement_5\NN\407535|with|vma (r_nmod) interfere_3\VB\2451370|methyldopa|does|not|measurement|,|methods|. (l_nmod) methods_20\NNS\5616786|by|those|convert (l_acl:relcl) convert_22\VBP\126264|which|vma|vanillin (l_nmod) vanillin_25\NN\14818238|to
DDI-DrugBank.d779.s16.e3_DDI-DrugBank.d779.s16.e4 false vma_23\NN\1740| (r_dobj) convert_22\VBP\126264|which|vma|vanillin (l_nmod) vanillin_25\NN\14818238|to
DDI-DrugBank.d776.s42
DDI-DrugBank.d572.s30
DDI-DrugBank.d578.s5
DDI-DrugBank.d578.s5.e0_DDI-DrugBank.d578.s5.e1 false troleandomycin_3\NN\1740|such|and|ketoconazole (l_conj) ketoconazole_5\NN\1740|
DDI-DrugBank.d578.s5.e0_DDI-DrugBank.d578.s5.e2 true troleandomycin_3\NN\1740|such|and|ketoconazole (r_nmod) drugs_0\NNS\14778436|troleandomycin (r_nsubj) inhibit_7\VB\2510337|drugs|may|metabolism|and|thus|decrease|. (l_dobj) metabolism_9\NN\13526110|the|methylprednisolone (l_nmod) methylprednisolone_11\NN\1740|of
DDI-DrugBank.d578.s5.e1_DDI-DrugBank.d578.s5.e2 true ketoconazole_5\NN\1740| (r_conj) troleandomycin_3\NN\1740|such|and|ketoconazole (r_nmod) drugs_0\NNS\14778436|troleandomycin (r_nsubj) inhibit_7\VB\2510337|drugs|may|metabolism|and|thus|decrease|. (l_dobj) metabolism_9\NN\13526110|the|methylprednisolone (l_nmod) methylprednisolone_11\NN\1740|of
DDI-DrugBank.d780.s5
DDI-DrugBank.d780.s5.e0_DDI-DrugBank.d780.s5.e1 false hyaluronidase_0\NN\14732946| (r_compound) hyaluronidase_2\NN\14732946|hyaluronidase|:
DDI-DrugBank.d780.s5.e0_DDI-DrugBank.d780.s5.e2 false hyaluronidase_0\NN\14732946| (r_compound) hyaluronidase_2\NN\14732946|hyaluronidase|: (r_nsubj) increase_4\VB\169651|hyaluronidase|may|rate|,|resulting|. (l_dobj) rate_7\NN\13815152|the|diffusion|hydrochloride (l_nmod) hydrochloride_10\NN\14817592|of|procaine
DDI-DrugBank.d780.s5.e1_DDI-DrugBank.d780.s5.e2 true hyaluronidase_2\NN\14732946|hyaluronidase|: (r_nsubj) increase_4\VB\169651|hyaluronidase|may|rate|,|resulting|. (l_dobj) rate_7\NN\13815152|the|diffusion|hydrochloride (l_nmod) hydrochloride_10\NN\14817592|of|procaine
DDI-DrugBank.d572.s29
DDI-DrugBank.d712.s1
DDI-DrugBank.d712.s1.e0_DDI-DrugBank.d712.s1.e1 true paclitaxel_2\NN\1740|of (r_nmod) administration_0\NN\1133281|paclitaxel|combination (l_nmod) combination_4\NN\7951464|in|herceptin (l_nmod) herceptin_6\NN\1740|with
DDI-DrugBank.d712.s1.e0_DDI-DrugBank.d712.s1.e2 false paclitaxel_2\NN\1740|of (r_nmod) administration_0\NN\1133281|paclitaxel|combination (r_nsubj) resulted_7\VBD\2633881|administration|decrease|. (l_nmod) decrease_11\NN\7296428|in|a|two-fold|clearance|study|and|increase (l_nmod) clearance_14\NN\5089947|in|herceptin (l_compound) herceptin_13\NN\1740|
DDI-DrugBank.d712.s1.e0_DDI-DrugBank.d712.s1.e3 false paclitaxel_2\NN\1740|of (r_nmod) administration_0\NN\1133281|paclitaxel|combination (r_nsubj) resulted_7\VBD\2633881|administration|decrease|. (l_nmod) decrease_11\NN\7296428|in|a|two-fold|clearance|study|and|increase (l_conj) increase_24\NN\13576355|in|a|1.5-fold|levels (l_nmod) levels_28\NNS\4916342|in|herceptin|serum|studies (l_compound) herceptin_26\NN\1740|
DDI-DrugBank.d712.s1.e1_DDI-DrugBank.d712.s1.e2 false herceptin_6\NN\1740|with (r_nmod) combination_4\NN\7951464|in|herceptin (r_nmod) administration_0\NN\1133281|paclitaxel|combination (r_nsubj) resulted_7\VBD\2633881|administration|decrease|. (l_nmod) decrease_11\NN\7296428|in|a|two-fold|clearance|study|and|increase (l_nmod) clearance_14\NN\5089947|in|herceptin (l_compound) herceptin_13\NN\1740|
DDI-DrugBank.d712.s1.e1_DDI-DrugBank.d712.s1.e3 false herceptin_6\NN\1740|with (r_nmod) combination_4\NN\7951464|in|herceptin (r_nmod) administration_0\NN\1133281|paclitaxel|combination (r_nsubj) resulted_7\VBD\2633881|administration|decrease|. (l_nmod) decrease_11\NN\7296428|in|a|two-fold|clearance|study|and|increase (l_conj) increase_24\NN\13576355|in|a|1.5-fold|levels (l_nmod) levels_28\NNS\4916342|in|herceptin|serum|studies (l_compound) herceptin_26\NN\1740|
DDI-DrugBank.d712.s1.e2_DDI-DrugBank.d712.s1.e3 false herceptin_13\NN\1740| (r_compound) clearance_14\NN\5089947|in|herceptin (r_nmod) decrease_11\NN\7296428|in|a|two-fold|clearance|study|and|increase (l_conj) increase_24\NN\13576355|in|a|1.5-fold|levels (l_nmod) levels_28\NNS\4916342|in|herceptin|serum|studies (l_compound) herceptin_26\NN\1740|
DDI-DrugBank.d744.s1
DDI-DrugBank.d744.s1.e1_DDI-DrugBank.d744.s1.e0 false pegvisomant_11\NN\1740| (r_compound) concentrations_12\NNS\4916342|higher|serum|pegvisomant (r_dobj) needed_8\VBD\2604760|studies|,|patients|often|concentrations|achieve|patients|. (l_nsubj) patients_4\NNS\9898892|opioids (l_nmod) opioids_6\NNS\1740|on
DDI-DrugBank.d744.s1.e1_DDI-DrugBank.d744.s1.e2 false pegvisomant_11\NN\1740| (r_compound) concentrations_12\NNS\4916342|higher|serum|pegvisomant (r_dobj) needed_8\VBD\2604760|studies|,|patients|often|concentrations|achieve|patients|. (l_advcl) patients_20\NNS\9898892|compared|with|receiving (l_acl) receiving_22\VBG\2210855|not|opioids (l_dobj) opioids_23\NNS\1740|
DDI-DrugBank.d744.s1.e0_DDI-DrugBank.d744.s1.e2 false opioids_6\NNS\1740|on (r_nmod) patients_4\NNS\9898892|opioids (r_nsubj) needed_8\VBD\2604760|studies|,|patients|often|concentrations|achieve|patients|. (l_advcl) patients_20\NNS\9898892|compared|with|receiving (l_acl) receiving_22\VBG\2210855|not|opioids (l_dobj) opioids_23\NNS\1740|
DDI-DrugBank.d752.s5
DDI-DrugBank.d609.s0
DDI-DrugBank.d609.s0.e0_DDI-DrugBank.d609.s0.e1 true gemfibrozil_7\NN\3740161|such (r_nmod) inhibitor_1\NN\20090|an|cyp2c8|(|gemfibrozil|) (r_nsubj) increase_10\VB\169651|inhibitor|may|auc|and|decrease|. (l_dobj) auc_12\NN\1740|the|rosiglitazone (l_nmod) rosiglitazone_14\NN\1740|of
DDI-DrugBank.d609.s0.e0_DDI-DrugBank.d609.s0.e2 false gemfibrozil_7\NN\3740161|such (r_nmod) inhibitor_1\NN\20090|an|cyp2c8|(|gemfibrozil|) (r_nsubj) increase_10\VB\169651|inhibitor|may|auc|and|decrease|. (l_conj) decrease_26\VB\169651|inducer|may|auc (l_nsubj) inducer_17\NN\14778436|an|cyp2c8|(|rifampin|) (l_nmod) rifampin_23\NN\2716205|such
DDI-DrugBank.d609.s0.e0_DDI-DrugBank.d609.s0.e3 false gemfibrozil_7\NN\3740161|such (r_nmod) inhibitor_1\NN\20090|an|cyp2c8|(|gemfibrozil|) (r_nsubj) increase_10\VB\169651|inhibitor|may|auc|and|decrease|. (l_conj) decrease_26\VB\169651|inducer|may|auc (l_dobj) auc_28\NN\1740|the|rosiglitazone (l_nmod) rosiglitazone_30\NN\1740|of
DDI-DrugBank.d609.s0.e1_DDI-DrugBank.d609.s0.e2 false rosiglitazone_14\NN\1740|of (r_nmod) auc_12\NN\1740|the|rosiglitazone (r_dobj) increase_10\VB\169651|inhibitor|may|auc|and|decrease|. (l_conj) decrease_26\VB\169651|inducer|may|auc (l_nsubj) inducer_17\NN\14778436|an|cyp2c8|(|rifampin|) (l_nmod) rifampin_23\NN\2716205|such
DDI-DrugBank.d609.s0.e1_DDI-DrugBank.d609.s0.e3 false rosiglitazone_14\NN\1740|of (r_nmod) auc_12\NN\1740|the|rosiglitazone (r_dobj) increase_10\VB\169651|inhibitor|may|auc|and|decrease|. (l_conj) decrease_26\VB\169651|inducer|may|auc (l_dobj) auc_28\NN\1740|the|rosiglitazone (l_nmod) rosiglitazone_30\NN\1740|of
DDI-DrugBank.d609.s0.e2_DDI-DrugBank.d609.s0.e3 true rifampin_23\NN\2716205|such (r_nmod) inducer_17\NN\14778436|an|cyp2c8|(|rifampin|) (r_nsubj) decrease_26\VB\169651|inducer|may|auc (l_dobj) auc_28\NN\1740|the|rosiglitazone (l_nmod) rosiglitazone_30\NN\1740|of
DDI-DrugBank.d584.s8
DDI-DrugBank.d776.s19
DDI-DrugBank.d776.s19.e0_DDI-DrugBank.d776.s19.e2 false theophylline_4\NN\2905612| (r_compound) concentrations_5\NNS\4916342|of|serum|theophylline|patients (l_nmod) patients_7\NNS\9898892|in|receiving (l_acl) receiving_8\VBG\2210855|diflucan (l_dobj) diflucan_9\NN\1740|and|theophylline (l_conj) theophylline_11\NN\2905612|
DDI-DrugBank.d776.s19.e0_DDI-DrugBank.d776.s19.e1 false theophylline_4\NN\2905612| (r_compound) concentrations_5\NNS\4916342|of|serum|theophylline|patients (l_nmod) patients_7\NNS\9898892|in|receiving (l_acl) receiving_8\VBG\2210855|diflucan (l_dobj) diflucan_9\NN\1740|and|theophylline
DDI-DrugBank.d776.s19.e2_DDI-DrugBank.d776.s19.e1 false theophylline_11\NN\2905612| (r_conj) diflucan_9\NN\1740|and|theophylline
DDI-DrugBank.d675.s3
DDI-DrugBank.d628.s5
DDI-DrugBank.d650.s2
DDI-DrugBank.d650.s2.e0_DDI-DrugBank.d650.s2.e1 false mesylate_2\NN\1740|pergolide (r_nsubjpass) bound_7\VBN\1831531|because|mesylate|is|%|proteins (r_advcl) exercised_15\VBN\1158872|bound|,|caution|should|be|coadministered|. (l_advcl) coadministered_20\VBN\1740|if|mesylate|is|drugs (l_nsubjpass) mesylate_18\NN\1740|pergolide
DDI-DrugBank.d573.s0
DDI-DrugBank.d573.s0.e0_DDI-DrugBank.d573.s0.e1 false guanethidine_2\NN\1740|with (r_nmod) interaction_0\NN\37396|guanethidine|:|result (l_dep) result_21\VB\2633881|cause|,|administration|can|effects|. (l_advcl) cause_9\VB\1617192|although|minoxidil|does|hypotension (l_nsubj) minoxidil_5\NN\4522904|
DDI-DrugBank.d573.s0.e0_DDI-DrugBank.d573.s0.e2 false guanethidine_2\NN\1740|with (r_nmod) interaction_0\NN\37396|guanethidine|:|result (l_dep) result_21\VB\2633881|cause|,|administration|can|effects|. (l_nsubj) administration_14\NN\1133281|its|patients (l_nmod) patients_16\NNS\9898892|to|receiving (l_acl) receiving_18\VBG\2210855|already|guanethidine (l_dobj) guanethidine_19\NN\1740|
DDI-DrugBank.d573.s0.e1_DDI-DrugBank.d573.s0.e2 true minoxidil_5\NN\4522904| (r_nsubj) cause_9\VB\1617192|although|minoxidil|does|hypotension (r_advcl) result_21\VB\2633881|cause|,|administration|can|effects|. (l_nsubj) administration_14\NN\1133281|its|patients (l_nmod) patients_16\NNS\9898892|to|receiving (l_acl) receiving_18\VBG\2210855|already|guanethidine (l_dobj) guanethidine_19\NN\1740|
